<SEC-DOCUMENT>0001564590-14-002121.txt : 20140513
<SEC-HEADER>0001564590-14-002121.hdr.sgml : 20140513
<ACCEPTANCE-DATETIME>20140513172816
ACCESSION NUMBER:		0001564590-14-002121
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		10
CONFORMED PERIOD OF REPORT:	20140331
FILED AS OF DATE:		20140513
DATE AS OF CHANGE:		20140513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		14838521

	BUSINESS ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>abio-10q_20140331.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;border-top:Solid 0.75pt #000000;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM 10-Q </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark One) </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;"><font style="font-family:'Wingdings';font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:12pt;font-family:'Wingdings'">&#120;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;"><font style="font-family:'Wingdings';font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OR </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-family:'Wingdings';font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:12pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-family:'Wingdings';font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE TRANSITION PERIOD FROM </font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> TO </font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number 000-22873 </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:24pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in Its Charter) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Delaware</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">36-3855489</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction of<br>Incorporation or Organization)</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br>Identification Number)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">11080 CirclePoint Road, Suite 140, Westminster, CO</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">80020</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(720) 940-2200 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s Telephone Number, including Area Code) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Wingdings';font-size:10pt;"><font style="font-family:'Wingdings';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Wingdings';font-size:10pt;"><font style="font-family:'Wingdings';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font></p></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated filer</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Wingdings';font-size:10pt;"><font style="font-family:'Wingdings';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;(Do not check if smaller reporting company)</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Wingdings';font-size:10pt;"><font style="font-family:'Wingdings';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#120;</font></font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:50%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Class</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:48%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of<br>Shares&#160;Outstanding</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common Stock $0.001 par value</font></p></td>
<td valign="bottom"  style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top"  style="width:48%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May&#160;9, 2014: 21,010,815</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:10pt;text-align:center;border-top:Solid 1pt;line-height:1pt;border-top:Solid 0.75pt #000000;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt; clear:both;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM 10-Q </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE QUARTER ENDED MARCH 31, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PAGE</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#PART_I"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Part&#160;I Financial Information</font></a></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_1"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1. Consolidated Financial Statements (unaudited)</font></a></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_2"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_3"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3. Quantitative and Qualitative Disclosures about Market Risk</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_4"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4. Controls and Procedures</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#PART_II"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Part&#160;II Other Information</font></a></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_1_LEGAL"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1. Legal Proceedings</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#Item_1A_Risk"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A. Risk Factors</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_2_UNREGISTERED"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_3_DEFAULTS"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3. Defaults Upon Senior Securities</font></a></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_4_MINE"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4. Mine Safety Disclosures</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_5_OTHER"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5. Other Information</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:36pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#ITEM_6_EXHIBITS"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 6. Exhibits</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"><a href="#SIGNATURE"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature</font></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom"  style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</font></p></td>
<td valign="bottom"  style="width:auto;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="PART_I"></a>PART I. FINANCIAL INFORMATION </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.06%;text-indent:-9.06%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1"></a>ITEM&#160;1. CONSOLIDATED FINANCIAL STATEMENTS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a development stage enterprise) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED BALANCE SHEETS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:72.43%;"></td>
<td style="width:1.92%;"></td>
<td style="width:10.75%;"></td>
<td style="width:0.76%;"></td>
<td style="width:0.36%;"></td>
<td style="width:1.81%;"></td>
<td style="width:10.31%;"></td>
<td style="width:1.19%;"></td>
<td style="width:0.62%;"></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31,</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ASSETS</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,202</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,756</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,801</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,925</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">828</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,655</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,084</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">552</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation and employee benefits</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">459</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">457</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">446</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent, current portion</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,120</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,502</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent, net of current portion</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,121</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,503</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock, $0.001 par value; 135,000</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; shares authorized, no shares issued and outstanding at</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; March 31, 2014 and December 31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $0.001 par value; 100 million shares authorized</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; at March 31, 2014 and December 31, 2013; 21,001,690 and</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; 15,685,562 shares issued and outstanding at March 31, 2014</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; and December 31, 2013, respectively</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,835</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=""><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,498</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deficit accumulated during the development stage</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(77,322</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(74,933</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,534</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,581</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,655</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,084</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying Notes to Consolidated Financial Statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a development stage enterprise) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Period from</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 17,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2001 (date of</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">inception) to</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs and expenses:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,308</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,913</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,082</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">889</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,677</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Merger transaction costs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,470</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring expense, net</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,413</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on impairment of in-process research and</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; development</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total costs and expenses</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,390</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,070</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,473</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,390</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,070</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(108,473</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on assignment of patent rights</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on bargain purchase</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,282</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,035</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other expense</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(447</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(79,603</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Benefit from income taxes</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,281</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss and comprehensive loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(77,322</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accretion of redeemable convertible preferred</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(245</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less:&nbsp;&nbsp;Deemed preferred stock dividend</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,807</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss available to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,374</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss available to common stockholders per share:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.13</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares outstanding:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,034,763</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying Notes to Consolidated Financial Statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a development stage enterprise) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99%;">
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="14" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="26" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; Equity (Deficit)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A&#160;Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;B&#160;Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;A&#160;Convertible<br>Preferred Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional<br>Paid In</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit<br>Accumulated<br>During the<br>Development</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stage</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="42" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;17, 2001 (date of inception)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock to founders on December&#160;31, 2002, for cash,<br> at $0.36 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,588</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2003</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,588</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(115</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on September&#160;30, 2004, for cash, at $0.36 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(511</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(511</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2004</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,308</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(627</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(619</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on January&#160;3, 2005, for cash, at $0.36 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,922</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on January&#160;3, 2005, upon conversion of notes payable and related accrued interest at $0.36 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,978</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on October&#160;14, 2005, for intellectual property license rights, at $48.84 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">903</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on October&#160;14, 2005, upon conversion of notes payable and related accrued interest</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,095</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,354</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,354</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,459</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,459</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2005</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,206</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,408</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,086</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(678</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on February&#160;21, 2006, for intellectual property license rights, at $4.32 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,372</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A on February&#160;22, 2006, for cash, at $1.6265 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,354</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,316</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A on February&#160;22, 2006, upon conversion of notes payable and related accrued interest, at $1.6265 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">420,817</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">684</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options, for cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,019</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying notes to consolidated financial statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99%;">
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="14" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="26" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; Equity (Deficit)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A&#160;Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series B&#160;Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;A&#160;Convertible<br>Preferred Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional<br>Paid In</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit<br>Accumulated</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">During the<br>Development</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stage</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="42" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on February&#160;22, 2006, for intellectual property and product license rights, at $4.32 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,907</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on June&#160;23, 2006, for intellectual property license rights, at $5.40 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock on November&#160;7, 2006, for intellectual property license rights, at $5.40 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A on December&#160;8, 2006, for cash, at $1.6265 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,074,086</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of offering costs of redeemable convertible preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,241</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,241</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2006</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,222,257</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,919</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,047</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,583</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,327</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,744</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series B convertible redeemable preferred stock, on May&#160;31, 2007 for $2.439 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,688,902</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series B convertible redeemable preferred stock, on December&#160;28, 2007 for $3.253 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,766,677</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series B offering Costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(147</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series A offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series B offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for intellectual property license rights, on January&#160;18, 2007 at $10.08 per share</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,303</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for intellectual property license rights, on June&#160;30, 2007 at $10.80 per share</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for commercial license rights, on July&#160;19, 2007, vests upon achievement of specified criteria</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,783</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of shares to executive on February&#160;19, 2007, vesting upon achievement of specified criteria, subject to repurchase</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,915</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying notes to consolidated financial statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99%;">
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="14" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="26" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; Equity (Deficit)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series B Redeemable</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;A&#160;Convertible<br>Preferred Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional<br>Paid In</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit<br>Accumulated<br>During the<br>Development</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stage</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="42" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options for cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,227</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,994</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,994</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2007</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,222,257</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,938</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,455,579</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,871</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,917</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,632</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,321</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,689</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series A offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series B offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">545</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">545</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimated fair value of warrants issued in connection with convertible notes payable</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">399</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">399</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options, for cash</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,154</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,431</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,431</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2008</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,222,257</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,958</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,455,579</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,907</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,071</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,574</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,752</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,178</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment for fractional shares on common</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">conversion</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">781</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(781</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(781</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series A offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of Series B offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(93</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(93</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,222,257</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,455,579</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,781</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">507,123</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,780</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,781</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock release from restriction</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of convertible notes and related accrued interest</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145,465</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,501</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,501</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of warrants for preferred stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Merger with Nuvelo, Inc.</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">447,826</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,913</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,913</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment for fractional shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">845</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">845</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options for cash</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,521</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimated fair value of warrants issued in connection with lease termination</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,138</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,138</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2009</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,270,074</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,301</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,890</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,412</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying notes to consolidated financial statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99%;">
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="14" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="26" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; Equity (Deficit)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;A&#160;Redeemable</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series&#160;B&#160;Redeemable</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible&#160;Preferred</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A&#160;Convertible<br>Preferred Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="6" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid In</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit<br>Accumulated<br>During the<br>Development</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stage</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td colspan="2" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="42" valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash, net <br>of offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">194,100</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,182</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,182</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options for cash</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,248</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">458</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">458</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,420</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,420</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2010</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,472,422</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,080</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,310</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,771</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash, net<br> of offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">557,890</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,016</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,017</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options for cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">308</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">308</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,364</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,364</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2011</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,030,500</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,404</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(63,674</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,732</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash, net <br>of offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">629,815</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,188</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">306</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">306</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,320</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,320</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2012</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,660,315</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,898</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,994</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,907</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash, net <br>of offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">521,066</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment for fractional shares</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(64</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of warrants for cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,245</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A convertible preferred stock, net of offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,000</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,917</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,917</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed preferred stock dividend for beneficial conversion feature</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,026</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,026</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of deemed preferred stock dividend for beneficial conversion feature on common stockholders</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,026</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,026</font></p></td>
<td valign="bottom"  style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of preferred stock to common stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(125,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,500,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,939</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,939</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,685,562</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,498</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(74,933</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,581</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash, net of offering costs</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,116,228&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,861&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,866&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of warrants for cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,900&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318&#160;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;158</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#8212;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;158</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:24%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:4%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:24%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:7.5pt;;"><font style="font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance, March&#160;31, 2014</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,001,690</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,835</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(77,322</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  style="width:4%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,534</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying notes to consolidated financial statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a development stage enterprise) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED STATEMENTS OF CASH FLOWS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited) </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period from</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 17,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2001 (date of</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="width:30%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">inception) to</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="width:30%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;;"><font style="color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom"  BGCOLOR="#FFFFFF" style="width:46%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:7.5pt;;"><font style="font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from operating activities:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(77,322</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; in operating activities:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on patent rights assignment</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on bargain purchase</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,282</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,809</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash interest expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,029</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of warrants for lease termination</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impairment of property and equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impairment of in-process research and development</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-off of deferred tax liability</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,281</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on marketable securities available for sale</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(263</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Gain) loss from disposal of property and equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in operating assets and liabilities (net of amounts</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; acquired):</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(251</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(157</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,699</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(698</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,642</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">312</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,638</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(465</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,005</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,687</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,396</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from investing activities:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash received from merger</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,392</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of deferred transaction costs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,186</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of property and equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,911</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sale of marketable securities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,369</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sale of property and equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">358</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from patent rights assignment</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,022</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from financing activities:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of convertible notes payable</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; and related warrants for common stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,841</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of bank note payable</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from stock subject to repurchase</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from the issuance of preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,316</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,329</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from the issuance of common stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,018</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,741</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,868</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock offering costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(834</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(308</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,548</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of principal on bank note payable</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of principal on convertible notes payables</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(105</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of principal on vendor finance agreement</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(505</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,133</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,390</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,576</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net increase in cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,446</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">617</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,202</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents, beginning of period</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,756</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,920</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents, end of period</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,202</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,537</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,202</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest paid</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of noncash investing and financing</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; transactions:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest on notes payable converted to equity</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant issued in connection with credit facility</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued deferred transaction costs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">482</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vendor finance agreement</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"><font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See accompanying Notes to Consolidated Financial Statements </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:4pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a development stage enterprise) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited) </font></p><p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(1) The Company and Summary of Significant Accounting Policies </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA biopharma, Inc., or the Company or ARCA, a Delaware corporation, is headquartered in Westminster, Colorado and is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases.  The Company&#8217;s lead product candidate, Gencaro&#8482; (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that ARCA plans to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  The Company has identified common genetic variations in receptors in the cardiovascular system that it believes interact with Gencaro&#8217;s pharmacology and may predict patient response to the drug. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company plans to test this hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. The AF indication for Gencaro was chosen based on prior clinical data from the previously conducted Phase 3 heart failure (HF) trial of Gencaro in 2,708 HF patients, or the BEST trial, which suggested that Gencaro may be successful in reducing or preventing AF.  GENETIC-AF is a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype the Company believes responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF is time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality. </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA has created an adaptive design for GENETIC-AF. The Company has initiated screening of patients for the Phase 2B study of approximately 200 HFREF patients. The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to the pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&#8217;s primary end-point.&#160;The interim analysis will focus on available data regarding the trial&#8217;s primary end point, AF event rates, AF burden, and safety. &nbsp;&nbsp;Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.  The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3.  The Company, in consultation with the trial&#8217;s clinical steering committee and the DSMB, will make the final determination on the trial&#8217;s development steps.  The Company believes the Phase 2B portion of the study would take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which the Company believes may provide market exclusivity for these uses of Gencaro into at least 2026 in the U.S. and into 2025 in Europe.  In addition, the Company believes that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the U.S. and Europe. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To complete both phases of the GENETIC-AF clinical trial and submit for FDA approval, the Company will need to raise additional capital. If the Company is unable to obtain additional funding or is unable to complete a strategic transaction, it may have to discontinue development activities on Gencaro or discontinue its operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Development Stage Risks, Liquidity and Going Concern </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is in the development stage and devotes substantially all of its efforts towards obtaining regulatory approval and raising capital necessary to fund its operations.  The Company has not generated revenue to date and is subject to a number of risks similar to those of other development stage companies, including dependence on key individuals, the development of and regulatory approval of commercially viable products, the need to raise adequate additional financing necessary to fund the development and commercialization of its products, and competition from larger companies. The Company has historically funded its operations through issuances of common and preferred stock, as well as through the business combination with Nuvelo, Inc., or Nuvelo. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since ARCA was founded on December&#160;17, 2001, or Inception, the Company has incurred substantial losses and negative cash flows from operations. Since Inception, the Company incurred a loss from operations of $108.5 million and had negative cash flows from operations of $106.4 million. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2013, the Company raised approximately $19.3 million, net of offering costs, through sales of its convertible preferred and common stock and warrants.  In February 2014, the Company completed a public equity offering raising approximately $7.9 million in net proceeds to provide additional funds for the Phase 2B/3 GENETIC-AF trial and the Company&#8217;s ongoing operations. The Company has initiated screening of patients for the Phase 2B/3 GENETIC-AF trial, and the Company anticipates that its current cash and cash equivalents&nbsp;&nbsp;will be sufficient to fund its operations, at its projected cost structure, through at least the end of 2015.  However, in light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, the Company expects to need to raise additional capital to finance the completion of GENETIC-AF and the Company&#8217;s ongoing operations.&#160;If the Company is delayed in completing or is unable to complete additional funding and/or a strategic transaction, the Company may discontinue its development activities or operations. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s liquidity, and its ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress of GENETIC-AF enrollment and any data that may become available; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs and timing for the GENETIC-AF clinical trial in order to gain possible FDA approval for Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market price of the Company&#8217;s stock and the availability and cost of additional equity capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to retain the listing of its common stock on the Nasdaq Capital Market; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general economic and industry conditions affecting the availability and cost of capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to control costs associated with its operations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions of the Company&#8217;s existing collaborative and licensing agreements. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities would likely result in substantial additional dilution to the Company&#8217;s stockholders.  If the Company raises additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of the Company&#8217;s capital stock and could contain covenants that would restrict the Company&#8217;s operations.  The Company also cannot predict what consideration might be available, if any, to the Company or its stockholders, in connection with any strategic transaction.  Should strategic alternatives or additional capital not be available to the Company,&nbsp;&nbsp;or not be available on acceptable terms, the Company may be unable to realize value from its assets and discharge its liabilities in the normal course of business which may, among other alternatives, cause the Company to further delay, substantially reduce or discontinue operational activities to conserve its cash resources. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The significant uncertainties surrounding the clinical development timelines and costs and the need to raise a significant amount of capital raises substantial doubt about the Company&#8217;s ability to continue as a going concern for a reasonable period of time.  These consolidated financial statements have been prepared with the assumption that the Company will continue as a going concern and will be able to realize its assets and discharge its liabilities in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability of the Company to continue as a going concern.  The Company may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or to otherwise continue operations and may not be able to execute any strategic transaction. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reverse Stock Split </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;4, 2013, the Company completed a 1-for-6 reverse split of its common stock. All common shares and per common share amounts in the financial statements and footnotes have been adjusted retroactively to reflect the effects of this action. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&nbsp;&nbsp;Accordingly, these financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&#160; In the opinion of management, these financial statements include all normal and recurring adjustments considered necessary for a fair presentation of these interim consolidated financial statements.  The results of operations for the three months ended March&#160;31, 2014 are not necessarily indicative of results expected for the full year ending December&#160;31, 2014.&#160; The Company has generated no revenue to date and its activities have consisted of seeking regulatory approval, research and development, exploring strategic alternatives for further developing and commercializing Gencaro, and raising capital. Accordingly, the Company continues to be considered in the development stage at March&#160;31, 2014. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes thereto for the year ended December&#160;31, 2013 included in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission, as amended. Amounts presented are rounded to the nearest thousand, where indicated, except per share data and par values. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company has no off-balance-sheet concentrations of credit risk, such as foreign exchange contracts, option contracts, or foreign currency hedging arrangements.  The Company maintains cash and cash equivalent balances in the form of bank demand deposits, money market fund accounts and debt securities with financial institutions that management believes are creditworthy. Such balances may at times exceed the insured amount. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing its financial statements, the Company is required to estimate accrued expenses.  This process involves identifying services that third parties have performed on the Company&#8217;s behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date. Examples of estimated accrued expenses include contract service fees, such as fees payable to contract manufacturers in connection with the production of materials related to the Company&#8217;s drug product, and professional service fees, such as attorneys, consultants, and clinical research organizations.  The Company develops estimates of liabilities using its judgment based upon the facts and circumstances known at the time. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(2) Net Loss Per Share </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company calculates basic earnings per share by dividing loss attributable to common stockholders by the weighted average common shares outstanding during the period, excluding common stock subject to vesting provisions.  Diluted earnings per share is computed by dividing loss attributable to common stockholders by the weighted average number of common shares outstanding during the period increased to include, if dilutive, the number of additional common shares that would have been outstanding if the potential common shares had been issued. The Company&#8217;s potentially dilutive shares include stock options and warrants for common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the numerator and denominator used in the calculation of basic and diluted loss per share follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except shares and per share data)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss available to common shareholders</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares of common stock outstanding</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,037,546</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Weighted-average shares of unvested common stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,783</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total weighted-average shares used in computing net loss</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; per share attributed to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,034,763</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted loss per share</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.13</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potentially dilutive securities representing&#160;10.2 million and 1.3&#160;million weighted average shares of common stock were excluded for the three months ended March&#160;31, 2014 and 2013, respectively, because including them would have an anti-dilutive effect on net loss per share. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(3) Merger with Nuvelo, Inc. on January&#160;27, 2009 </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;27, 2009, ARCA Colorado, Inc. (ARCA Colorado) completed the Merger with Nuvelo in accordance with the terms of the Merger Agreement, in which a wholly-owned subsidiary of Nuvelo merged with and into ARCA Colorado, with ARCA Colorado continuing after the Merger as the surviving corporation and a wholly-owned subsidiary of Nuvelo.  Immediately following the Merger, the Company changed its name from Nuvelo, Inc. to ARCA biopharma, Inc., and its common stock began trading on the Nasdaq Global Market under the symbol &#8220;ABIO&#8221; on January&#160;28, 2009.  On March&#160;7, 2011, the listing of the Company&#8217;s common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger was treated as a reverse merger and accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.  For accounting purposes, ARCA Colorado was considered to have acquired Nuvelo in the Merger, as the stockholders of ARCA Colorado prior to the Merger had a controlling interest in the combined company and the Company&#8217;s management is the former management of ARCA Colorado.  The results of operations and cash flows include the activities of Nuvelo since the date of the Merger. Pursuant to the rules and regulations of the United States Securities and Exchange Commission, or the SEC, the historical financial statements of ARCA Colorado replaced the historical financial statements of Nuvelo, and the disclosures in this report relating to the pre-Merger business of the Company, unless noted as being the business of Nuvelo prior to the Merger, pertain to the business of ARCA Colorado prior to the Merger. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated total acquisition consideration of $11.9 million to acquire Nuvelo was based on the market capitalization of Nuvelo as of January&#160;27, 2009 and the estimated fair values of its vested stock options and warrants outstanding on that date, as this was deemed the most reliable measure of the consideration effectively transferred to acquire Nuvelo on that date.  The Company estimated the net assets acquired in the Merger to be $37.2 million, including $45.5 million of cash, cash equivalents and marketable securities. In accordance with ASC 805, any excess of fair value of net assets acquired in a business combination over the acquisition consideration results in a gain on bargain purchase, and as a result, the Company recorded a gain on bargain purchase of $25.3 million. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(4) Fair Value Disclosures </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March&#160;31, 2014, the Company had $21.1 million of cash equivalents consisting of money market funds with maturities of 90 days or less. The Company has the ability to liquidate these investments without restriction.  The Company determines fair value for these money market funds and equity securities with Level 1 inputs through quoted market prices.  There were no transfers of assets between fair value hierarchy levels during the three month period ended March&#160;31, 2014. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Inputs used to measure fair value are classified into the following hierarchy: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#8212;Unadjusted quoted prices in active markets for identical assets or liabilities </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#8212;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#8212;Unobservable inputs for the asset or liability </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Other Financial Instruments </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying amount of other financial instruments, including cash, accounts payable, and short-term notes payable approximated fair value due to their short maturities. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(5) Property and Equipment </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Life</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of useful life or life of the lease</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation and amortization</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(488</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(485</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended March&#160;31, 2014 and 2013, and for the period from Inception through March&#160;31, 2014, depreciation and amortization expense was $3,000, $10,000, and $1.8 million respectively. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(6) Commitments and Contingencies </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has or is subject to the following commitments and contingencies: </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employment Agreements </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains employment agreements with several executive employees.  Most of these agreements provide for payments to be made under certain conditions related to a change in control of the Company and entitle the employee to wages and certain benefits payments not exceeding one calendar year from the date of termination without cause or by the employee for good reason.  The agreements may be terminated at any time by the Company with or without cause upon written notice to the employee. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Operating Lease </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;1, 2013 the Company entered into a lease agreement for approximately 5,300 square feet of office facilities in Westminster, Colorado which has served as the Company&#8217;s primary business office since October&#160;1, 2013.&nbsp;&nbsp;The lease has a three year term and expires on September&#160;30, 2016.&nbsp;&nbsp;The Company&#8217;s previous office lease, entered into on February 8, 2008 for office facilities in Broomfield, Colorado, served as the Company&#8217;s primary business office through September 30, 2013.&nbsp;&nbsp;Below is a summary of the future minimum lease payments committed for the Company&#8217;s facility in Westminster, Colorado as of March&#160;31, 2014 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;">
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Remainder of 2014</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense under these leases for the three months ended March&#160;31, 2014 and 2013 was $19,000 and $12,000, respectively, and was $597,000 from Inception through March&#160;31, 2014. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Duke University </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2013, the Company entered into a clinical research agreement with Duke University (Duke) to serve as the clinical research organization for the Company&#8217;s GENETIC-AF clinical study.  Under the agreement the Company is responsible to pay Duke for its work managing certain aspects of the clinical study, including clinical site recruitment and clinical site management.  Upon completion of the clinical study, the agreement will terminate.  The agreement can be terminated earlier by the Company for any reason with 90 days written notice to Duke. In the event of an early termination, the Company and Duke would coordinate efforts for an orderly wind-down of the study, and the Company would be responsible to pay Duke for time and effort incurred through the date of termination and through the wind-down period. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">University of Cincinnati </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2011, the Company entered into a license agreement with the University of Cincinnati to license exclusive worldwide rights to a portfolio of U.S. and international patents, which includes certain U.S. and international diagnostic patents covering genetic markers for ARCA&#8217;s lead drug candidate, Gencaro.  These patents provide the basis for exclusive worldwide development, use and commercialization of the genetic test which may indicate a patient&#8217;s likely response to Gencaro as a treatment for chronic HF, AF, and other indications.  Under the terms of the agreement, ARCA agreed to pay the University of Cincinnati annual license fees and is obligated to future milestone payments for each United States patent issued subsequent to the date of the agreement.  The agreement also requires royalty payments on net sales from genetic testing performed expressly for the purpose of prescribing bucindolol. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA has licensed worldwide rights to Gencaro, including all preclinical and clinical data from Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC, who has licensed rights in Gencaro from BMS. CPEC is a licensing subsidiary of Indevus Pharmaceuticals Inc. (a wholly owned subsidiary of Endo Pharmaceuticals), holding ownership rights to certain clinical trial data of Gencaro.  Under the terms of its license agreement with CPEC, the Company will incur milestone and royalty obligations upon the occurrence of certain events.&nbsp;&nbsp; If the FDA grants marketing approval for Gencaro, the license agreement states that the Company will owe CPEC a milestone payment of $8.0&#160;million within six months after FDA approval. The license agreement states that a milestone payment of up to $5.0 million in the aggregate shall be paid upon regulatory marketing approval in Europe and Japan.  The license agreement also states that the Company&#8217;s royalty obligation ranges from 12.5% to 25% of revenue from the related product based on achievement of specified product sales levels, including a 5% royalty that CPEC is obligated to pay under its original license agreement for Gencaro. The Company has the right to buy down the royalties to a range of 12.5% to 17% by making a payment to CPEC within six months of regulatory approval. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(7) </font><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Equity Financings and Warrants</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">2013 Equity Financings </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Private Investment in Public Equity (PIPE) Transaction </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;22, 2013, the Company entered into a Subscription Agreement (the &#8220;January 2013 Purchase Agreement&#8221;) with various accredited investors and its Chief Executive Officer in connection with a private placement of its common stock and warrants.  Pursuant to the January 2013 Purchase Agreement, the Company sold an aggregate of 356,430 shares of its common stock and warrants to purchase up to 249,501 additional shares of its common stock for aggregate gross proceeds of approximately $1 million, before deducting estimated offering expenses payable by the Company. The net proceeds to the Company were approximately $805,000, and the private placement closed on January&#160;25, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.70 shares of common stock.  The purchase price for each unit was $2.81. The warrants were exercisable upon issuance, expire seven years from the date of issuance, and have an exercise price of $2.28 per share, equal to 100% of the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on January&#160;22, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company filed a registration statement for the resale of the shares underlying the units sold in the private placement.  That registration statement was declared effective by the Securities and Exchange Commission on February&#160;14, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with this transaction, the Company agreed that, subject to certain exceptions, it would not, while the warrants are outstanding, effect or enter into an agreement to effect any issuance of common stock or securities convertible into, exercisable for or exchangeable for common stock in a &#8220;variable rate transaction,&#8221; which means a transaction in which the Company issues or sells any convertible securities either (A)&#160;at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of, or quotations for, the shares of common stock at any time after the initial issuance of such convertible securities, or (B)&#160;with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of the convertible securities or upon the occurrence of the specified or contingent events directly or indirectly related to our business or the market for our common stock.  In addition, the Company agreed that, subject to certain exceptions, if it issues securities within one year following the closing of the offering, each investor would have the right to purchase its pro rata share of a specified portion of the securities in the future offering on the same terms, conditions and price provided for in the proposed issuance of securities. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Registered Direct Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;31, 2013, the Company entered into a subscription agreement with certain institutional investors (the &#8220;Investors&#8221;) in connection with its Registered Direct public offering, pursuant to which the Company sold an aggregate of 164,636 shares of its common stock and warrants to purchase up to 65,855 additional shares of its common stock to the Investors for aggregate gross proceeds of approximately $730,000, before deducting placement agent fee and other estimated offering expenses payable by the Company.  The net proceeds to the Company were approximately $616,000, and the offering closed on February&#160;4, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.40 shares of common stock.  The purchase price for each unit was $4.43.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $4.13 per share, equal to the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on January&#160;31, 2013.  The Offering was effected as a takedown of the Company&#8217;s Registration Statement on Form S-3, as amended, which became effective on April&#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&#160;1, 2013.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Public Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;4, 2013, the Company sold shares of its Series A Convertible Preferred Stock (Preferred Stock) and warrants to purchase common stock in a public offering for aggregate gross proceeds of $20.0 million. The Company issued 125,000 shares of Preferred Stock and warrants to purchase up to 6,250,000 shares of common stock at a purchase price of $160 per share of Preferred Stock.  The net proceeds, after deducting placement agent fees and other offering expenses payable by the Company, were approximately $17.9 million. ARCA&#8217;s Director and Chief Executive Officer participated in the offering, purchasing 781 shares of Preferred Stock and warrants to purchase 39,050 shares of common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each share of Preferred Stock was convertible into 100 shares of the Company&#8217;s common stock at any time at the option of the holder. Each share of Preferred Stock had a liquidation preference of $.001 per share.  The shares of Preferred Stock had no preferential dividends or redemption rights, and no voting rights except as required by law.  During 2013, all of the shares of the Preferred Stock were converted into shares of ARCA common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each purchaser in the offering was issued a warrant to purchase 50 shares of the Company&#8217;s common stock for each share of Preferred Stock purchased.  The warrants have an exercise price of $1.60 per share, will expire on the five year anniversary of the date of issuance, and were exercisable immediately upon issuance, provided that the holder will be prohibited from exercising the warrants if, as a result of such exercise, the holder, together with its affiliates, would beneficially own more than 9.99% of the total number of shares of common stock then issued and outstanding. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The securities were sold pursuant to a placement agreement and have been registered under the Securities Act of 1933 pursuant to the Company&#8217;s Registration Statement on Form S-1, as amended (No.333-187508), which was declared effective by the Securities and Exchange Commission on May&#160;29, 2013, and the Preferred Stock and Warrants were offered and sold pursuant to a prospectus dated May&#160;30, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Preferred Stock financing, the Company recorded a non-cash dividend of approximately $2.0 million to recognize the intrinsic value of the embedded beneficial conversion feature.  Typically, such a deemed dividend would be represented as a reduction in a company&#8217;s retained earnings and an increase in additional paid in capital in recognition of the reapportionment of common shareholder value to the preferred stock purchasers.  However, since ARCA has an accumulated deficit, the deemed dividend is recognized by a reapportionment of additional paid in capital from common shareholders to additional paid in capital of preferred stock purchasers, which are combined in the Company&#8217;s statement of stockholders&#8217; equity. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">2014 Equity Financing </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Registered Direct Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;3, 2014, the Company agreed to sell to certain investors an aggregate of 5,116,228 shares of the Company&#8217;s common stock and warrants to purchase an aggregate of 1,279,057 shares of the Company&#8217;s common stock at a purchase price of $1.70 per share of Common Stock, for aggregate gross proceeds of approximately of $8.7 million, before deducting placement agent fees and other offering related expenses.  The offering closed on February&#160;7, 2014, and the net proceeds to the Company were approximately $7.9 million. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in combination consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $2.125 per share, equal to 125% of the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on February&#160;3, 2014.  The offering was effected as a takedown off the Company&#8217;s Registration Statement on Form S-3, as amended, which became effective on April&#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&#160;4, 2014.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Warrants </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March&#160;31, 2014, warrants to purchase approximately 9.4&#160;million shares of common stock were outstanding at exercise prices ranging from $1.60 to $116.89, with a weighted average exercise price per share of $2.31.  These warrants, which were granted as part of various financing and business agreements, expire at various times between April 2016 and January 2020. Warrants were recorded in additional paid-in capital at their estimated fair market value at the date of grant using a Black-Scholes option-pricing model. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(8) Share-based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three month period ended March&#160;31, 2014 and 2013 and for the period from Inception through March&#160;31, 2014, the Company recognized the following non-cash, share-based compensation expense in the consolidated statement of operations (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Period from December 17, 2001 (date of inception) to March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">707</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, General and Administrative</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,935</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring Expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,029</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option and stock award transactions for the three month period ended March&#160;31, 2014 under the Company&#8217;s stock incentive  plans were as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Options</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Price</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Remaining Contractual Term</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in years)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843,442</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.76</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.94</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200,079</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.91</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,908.00</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at March 31, 2014</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,043,494</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.35</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.93</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at March 31, 2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,655</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.42</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.13</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and expected to vest</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,031,382</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.37</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.92</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Grant Date Fair Value</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">419,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191,700</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.95</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and released</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at March 31, 2014</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610,700</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.57</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(9) Income Taxes </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with United States Generally Accepted Accounting Principles, a valuation allowance should be provided if it is more likely than not that some or all of the Company&#8217;s deferred tax assets will not be realized.  The Company&#8217;s ability to realize the benefit of its deferred tax assets will depend on the generation of future taxable income. Due to the uncertainty of future profitable operations and taxable income, the Company has recorded a full valuation allowance against its net deferred tax assets.  The Company believes its tax filing positions and deductions related to tax periods subject to examination will be sustained upon audit and, therefore, has no reserve for uncertain tax positions. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_2"></a>ITEM&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, Section&#160;21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to, statements regarding the Company&#8217;s anticipated timing for initiation or completion of its clinical trials for any of its product candidates; the potential for Gencaro to be an effective potential treatment for atrial fibrillation and, the Company&#8217;s ability to fund future operations. Such statements are based on management&#8217;s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, the risks and uncertainties associated with: the Company&#8217;s financial resources and whether they will be sufficient to meet the Company&#8217;s business objectives and operational requirements; and/or obtain additional financing; the Company&#8217;s anticipated timing for initiation or completion of its clinical trials for any of its product candidates; the Company&#8217;s ability to identify, develop and achieve commercial success for products and technologies; drug discovery and the regulatory approval process; estimated timelines for regulatory filings and the implications of interim or final results of the Company&#8217;s clinical trials; the extent to which the Company&#8217;s issued and pending patents may protect its products and technology; the potential of the Company&#8217;s clinical development program to lead to the approval of the Company&#8217;s New Drug Application for Gencaro; and, the impact of competitive products and technological changes. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors discussed herein and elsewhere. These and other factors are identified and described in more detail in ARCA&#8217;s filings with the SEC, including without limitation the Company&#8217;s annual report on Form 10-K for the year ended December&#160;31, 2012, as amended, the Company&#8217;s Registration Statement on Form S-1 (Registration No.&#160;333-187508), and subsequent filings. Forward-looking statements may be identified by words including &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;estimates,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;may,&#8221; &#8220;potential&#8221; and similar expressions. The Company disclaims any intent or obligation to update these forward-looking statements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The terms &#8220;ARCA,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms refer to ARCA biopharma, Inc. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Overview </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. Our lead product candidate is Gencaro&#8482; (bucindolol hydrochloride), a pharmacologically unique beta-blocker and mild vasodilator that we plan to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  We have identified common genetic variations in receptors in the cardiovascular system that we believe interact with Gencaro&#8217;s pharmacology and may predict patient response to the drug. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AF is considered an epidemic cardiovascular disease. The estimated number of individuals with AF globally in 2010 was 33.5 million. According to the 2014 American Heart Association report on Heart Disease and Stroke Statistics, the estimated number of individuals with AF in the U.S. in 2010 ranged from 2.7&#160;million to 6.1&#160;million people.  AF is a disorder in which the normally regular and coordinated contraction pattern of the heart&#8217;s two small upper chambers (the atria) becomes irregular and uncoordinated.  The irregular contraction pattern associated with AF causes blood to pool in the atria, predisposing the formation of clots potentially resulting in stroke.&nbsp;&nbsp;AF increases the risk of stroke and may also contribute to worsening heart failure.  The approved therapies for the treatment or prevention AF have certain disadvantages in HFREF patients, such as toxic or cardiovascular adverse effects, and most of the approved drugs for AF are contra indicated or have warnings in their prescribing information for such patients.  We believe there is an unmet medical need for new AF treatments that have fewer side effects than currently available therapies and are more effective, particularly in HFREF patients. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our GENETIC-AF clinical trial is&nbsp;&nbsp;a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator, the beta-blocker Toprol XL (metoprolol succinate), in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype we believe responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF, time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality, will be measured over a twenty-four week period after a patient has been electrically cardioverted to restore normal heart rhythm. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The AF indication for Gencaro was chosen based on clinical data from the previously conducted Phase 3 heart failure trial of 2,708 patients, or the BEST trial.&nbsp;&nbsp;We believe data from the BEST trial indicate that Gencaro may have a genetically regulated effect in reducing or preventing AF, whereas we believe the therapeutic benefit of Toprol XL does not appear to be enhanced in patients with this genotype. A retrospective analysis of data from the BEST trial shows that the entire cohort of patients in the BEST trial treated with Gencaro had a 41% reduction in the risk of new onset AF (time-to-event) compared to placebo (p = 0.0004). In the BEST DNA substudy, patients with the beta-1 389 arginine homozygous genotype experienced a 74% (p = 0.0003) reduction in risk of AF when receiving Gencaro, based on the same analysis.  The beta-1 389 arginine homozygous genotype was present in about 47% of the patients in the BEST pharmacogenetic substudy, and we estimate it is present in about 50% of the US general population.  </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have created an adaptive design for GENETIC-AF.&nbsp;&nbsp;We have initiated screening of patients for the  Phase 2B study of approximately 200 HFREF patients with recent onset, persistent AF who have the beta-1 389 arginine homozygous genotype that we believe responds most favorably to Gencaro.  In addition to measuring the primary endpoint of recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality, an additional efficacy measure in the Phase 2B portion of GENETIC-AF is AF burden, defined as a patient&#8217;s percentage of time in AF per day, regardless of symptoms.  Certain</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patients in the Phase 2B portion of the trial will have either a newly or previously implanted Medtronic device that measures and records AF burden.  The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to our pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and seek to enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&#8217;s primary end-point.  The interim analysis will focus on available data regarding the trial&#8217;s primary endpoint, AF event rates, AF burden, and safety.  Should the DSMB interim analysis conclude that the interim data is consistent with pre-trial statistical assumptions, including the potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.&#160;The DSMB may also recommend changes to the study design before the trial proceeds to Phase 3, or it may recommend that the study not proceed to Phase 3.  Based on the DSMB recommendation, and other factors,&nbsp;&nbsp;the Company, in consultation with the trial&#8217;s clinical steering committee, will make the final determination on the trial&#8217;s development steps.  The full Phase 2B/3 trial is designed for 90 percent power at a p-value of less than 0.01 significance level to detect a 25 percent reduction in the risk of AF/AFL recurrence or death in patients in the Gencaro arm compared to patients in the Toprol XL arm.  The Company believes the Phase 2B portion of the study will take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our GENETIC-AF clinical trial of Gencaro requires a companion diagnostic test to identify the patient&#8217;s receptor genotype. Accordingly, the GENETIC AF trial requires the use of a third party diagnostic service to perform the genetic testing.  We have an agreement with Laboratory Corporation of America, or LabCorp, to provide the companion diagnostic test and services to support our GENETIC-AF trial.  LabCorp has developed the genetic test and obtained an Investigational Device Exemption, or IDE, from the FDA for the companion diagnostic test which is being used in our GENETIC-AF clinical trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases including cardiac rhythm disorders is collaborating with us on the GENETIC-AF trial. Under the collaboration with Medtronic, we plan to conduct a substudy that will include continuous monitoring of the cardiac rhythms of certain  </font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patients enrolled during the Phase 2B portion of the trial and approximately 100 additional patients in the Phase 3 portion of GENETIC-AF. The collaboration is being administered by a joint ARCA-Medtronic committee.  Medtronic will use its proprietary CareLink System to collect and analyze the cardiac rhythm data from the implanted Medtronic devices and the data will be used by the DSMB as part of the interim analysis.  Medtronic will support the reimbursement process for patients enrolled in the Phase 2B portion, and agreed to provide financial support of unreimbursed costs for a certain number of patients in the Phase 2B portion up to a certain maximum amount per patient.  If GENETIC-AF proceeds to Phase 3, we will seek to enroll an additional 100 patients with Medtronic devices for monitoring and recording AF burden.  Medtronic will provide the agreed-on CareLink System cardiac rhythm data collection and analysis for the Phase 3 portion of the substudy and support the reimbursement process. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which we believe may provide market exclusivity for these uses of Gencaro into at least 2026 in the US and into 2025 in Europe.  In addition, we believe that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the US and Europe. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To support the continued development of Gencaro,  we completed a public equity offering in February 2014 that raised approximately $7.9 million of net proceeds as additional funds for the&nbsp;&nbsp;Phase 2B portion of the GENETIC-AF trial and to support our ongoing operations.&nbsp;&nbsp;In light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, we will need to raise a significant amount of additional capital to finance the completion of GENETIC-AF and our ongoing operations.&#160;&nbsp;&nbsp;We anticipate that our current cash and cash equivalents will be sufficient to fund our operations, at our projected cost structure, through at least the end of 2015.  However, changing circumstances may cause us to consume capital significantly faster or slower than we currently anticipate.  We have based these estimates on assumptions that may prove to be wrong, and we could exhaust our available financial resources sooner than we currently anticipate. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Results of Operations </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development, or R&amp;D, expense is comprised of clinical, regulatory, and manufacturing process development activities and costs. Our R&amp;D expense continues to be almost entirely generated by our activities relating to the development of Gencaro. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D expense for the three months ended March 31, 2014 was $1.3 million compared to $181,000 for the corresponding period of 2013, an increase of approximately $1.1 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical expense increased approximately $563,000 for the three months ended March 31, 2014.  The increase in the three month period is primarily due to costs incurred through clinical research organizations (CRO&#8217;s) and related support services in preparing for and initiating our GENETIC-AF trial as well as increased personnel costs.&nbsp;&nbsp;During the comparative three months of 2013 we had no clinical staff or clinical trial expenses.&nbsp;&nbsp;The clinical staff roles were added in the latter part of 2013 as we began preparing to initiate our GENETIC-AF clinical trial.  </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory and manufacturing process costs increased $419,000 for the three months ended March 31, 2014 compared to the corresponding period of 2013.  The increase in the three month period ended March 31, 2014 compared to the corresponding period of 2013 is primarily due to costs of production, packaging and distribution of clinical trial drug materials for our GENETIC-AF clinical trial.  A portion of the increase is also attributable to increased personnel costs as we increased staff in the latter part of 2013 in preparation of the clinical trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D expenses for the remainder of 2014 are expected to increase as our GENETIC-AF trial begins enrolling and treating patients.  </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General and Administrative Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses, or G&amp;A, primarily consist of personnel costs, consulting and professional fees, insurance, facilities and depreciation expenses, and various other administrative costs. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">G&amp;A expense was $1.1 million for the three months ended March 31, 2014 as compared to $889,000 for the corresponding period in 2013, an increase of $193,000.  The increase in the three months ended March 31, 2014 as compared to the corresponding period of 2013 is comprised of increased personnel costs of approximately $266,000, primarily attributable to personnel returned from furlough and salary changes for executives and other administrative employees.&nbsp;&nbsp;During the first quarter of 2013, employees were working at reduced levels and salaries or were furloughed.&nbsp;&nbsp;In the latter part of 2013 we returned personnel to work to support initiating our GENETIC-AF clinical trial.&nbsp;&nbsp;A portion of the personnel cost is attributable to increased non-cash, stock-based compensation for stock awards made during the third quarter of 2013 and the first quarter of 2014.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The increased personnel costs were partially offset by decreased consulting, legal, accounting and other professional services of approximately $130,000.&nbsp;&nbsp;During the first quarter of 2013 we incurred additional costs for a special proxy and shareholder meeting.&nbsp;&nbsp;These activities and related costs were not recurring in the first quarter of 2014. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">G&amp;A expenses for the remainder of 2014 are expected to increase as we increase our activities to support our GENETIC-AF clinical trial. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Interest and Other Income </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income was $2,000 in the three months ended March 31, 2014.  Interest and other income for the comparative three month period ended March 31, 2013 was less than $1,000.  We expect interest income to continue to be nominal for 2014 due to low investment yields and utilizing our cash and cash equivalents to fund our operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Interest and Other Expense </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other expense was less than $1,000 in the three months ended March 31, 2014 and in the three months ended March 31, 2013.  Based on our current capital structure, interest expense for the remainder of 2014 is expected to be minimal. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,202</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,756</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2014, we had total cash and cash equivalents of approximately $21.2 million, as compared to $16.8 million as of December&#160;31, 2013.  The net increase of $4.4 million in the three month period reflects the $8.1 million of net proceeds from our equity offering and proceeds from common stock issued for warrant exercises less approximately $3.7 million of cash used to fund operating activities and approximately $51,000 in payments on a vendor financing arrangement during the three months ended March 31, 2014. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash Flows from Operating, Investing and Financing Activities </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,687</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,133</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,390</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net increase in cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,446</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">617</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities for the three months ended March 31, 2014 increased approximately $2.9 million compared with the same period in 2013 primarily due to  trial initiation activities and increased expenses discussed above. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in investing activities for the three months ended March 31, 2014 was $0 compared to $9,000 used in investing activities in the three months ended March 31, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities was $8.1 million for the three months ended March 31, 2014 representing approximately $7.9 million of net proceeds from our stock offering completed in February 2014, plus approximately $318,000 of net proceeds from common stock issued for warrant exercises, less approximately $51,000 in payments on a vendor financing arrangement. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sources and Uses of Capital </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our primary sources of liquidity to date have been capital raised from issuances of shares of our preferred and common stock and funds provided by the merger with Nuvelo.  The primary uses of our capital resources to date have been to fund operating activities, including research, clinical development and drug manufacturing expenses, license payments, and spending on capital items. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;3, 2014, we agreed to sell to certain investors an aggregate of 5,116,228 shares of our common stock and warrants to purchase an aggregate of 1,279,057 shares of our common stock at a purchase price of $1.70 per share of common stock, for aggregate gross proceeds of approximately $8.7 million, before deducting placement agent fees and other offering related expenses.  The offering closed on February&#160;7, 2014, and the net proceeds to us were approximately $7.9 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in combination consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $2.125 per share, equal to 125% of the closing bid price of our common stock on the Nasdaq Capital Market on February&#160;3, 2014.  The offering was effected as a takedown off our Registration Statement on Form S-3, as amended, which became effective on April&#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&#160;4, 2014.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance of the shares of common stock underlying the warrants at the time of exercise.  The common stock and warrants were sold pursuant to a placement agency agreement dated January&#160;21, 2014, as amended. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the cash compensation paid to the placement agent in conjunction with the transaction and pursuant to the placement agency agreement, we issued warrants to the placement agent to purchase 153,486 shares of our common stock, which have not been registered under the Securities Act of 1933, as amended.  The warrants issued to the placement agent have substantially the same terms as the warrants issued to the purchasers in the offering, except that such warrants expire on April&#160;4, 2016, or the five year anniversary of the effective date of the registration statement, and are restricted from transfer for a period of 180 days from the date of commencement of sales in connection with the offering.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:;font-size:12pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to&nbsp;&nbsp;execute our GENETIC-AF Phase 2B trial in accordance with our projected time line depends on a number of factors, including, but not limited to, the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recruitment of sufficient clinical trial sites, enrollment of patients and enrollment at a rate consistent with our projected timeline; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to control costs associated with the clinical trial and our operations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to retain the listing of our common stock on the Nasdaq Capital Market; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market price of our stock and the availability and cost of additional equity capital from existing and potential new investors; general economic and industry conditions affecting the availability and cost of capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions of our existing collaborative and licensing agreements. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities will be necessary for us to complete both Phase 2B and Phase 3 of the GENETIC-AF clinical trial and submit for FDA approval of Gencaro.  Such financing would likely result in additional dilution to our existing stockholders. If we raise additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of our capital stock and could contain covenants that would restrict our operations.  We anticipate that our current cash and cash equivalents will be sufficient to fund our operations, at our projected cost structure, through at least the end of 2015</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">. </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">However, our forecast of the period of time through which our financial resources will be adequate to support our current and forecasted operations could vary materially. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Critical Accounting Policies and Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A critical accounting policy is one that is both important to the portrayal of our financial condition and results of operation and requires our management&#8217;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.  Our significant accounting policies are described in Note 1 of &#8220;Notes to Consolidated Financial Statements&#8221; included within our 2013 Annual Report on Form 10-K filed with the Securities and Exchange Commission. Following is a discussion of the accounting policies that we believe involve the most difficult, subjective or complex judgments and estimates. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accrued Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing our financial statements, we are required to estimate accrued expenses.  This process involves identifying services that third parties have performed on our behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date.  Examples of estimated accrued expenses include contract service fees, such as fees payable to clinical research organizations and contract manufacturers in connection with the execution of our clinical trial program,  and professional service fees, such as attorneys and consultants.  We develop our estimates of liabilities using our judgment based upon the facts and circumstances known at the time. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Share-based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our share-based compensation cost recognized includes: (a)&#160;compensation costs for current period vesting of all share-based awards granted prior to January&#160;1, 2006, based on the intrinsic value method, and (b)&#160;compensation cost for current period vesting of all share-based awards granted or modified subsequent to January&#160;1, 2006, based on the estimated grant date fair value. We recognize compensation costs for our share-based awards on a straight-line basis over the requisite service period for the entire award, as adjusted for estimated forfeitures. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From Inception through December&#160;31, 2005, we accounted for issuances of share-based compensation under the intrinsic-value-based method of accounting. Under this method, compensation expense is generally recorded on the date of grant only if the estimated fair value of the underlying stock exceeds the exercise price. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Off-Balance Sheet Arrangements </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not participated in any transactions with unconsolidated entities, such as special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Indemnifications </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of business, we enter into contractual arrangements under which we may agree to indemnify certain parties from any losses incurred relating to the services they perform on our behalf or for losses arising from certain events as defined within the particular contract. Such indemnification obligations may not be subject to maximum loss clauses.  We have entered into indemnity agreements with each of our directors, officers and certain employees. Such indemnity agreements contain provisions, which are in some respects broader than the specific indemnification provisions contained in Delaware law.  We also maintain an insurance policy for our directors and executive officers insuring against certain liabilities arising in their capacities as such. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_3"></a>ITEM&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_4"></a>ITEM&#160;4. CONTROLS AND PROCEDURES </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.  In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, an evaluation was carried out under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the quarter covered by this report.  Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable level of assurance. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Changes in Internal Control over Financial Reporting </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There has been no change in our internal control over financial reporting during our most recent fiscal quarter that would materially affect or is reasonably likely to materially affect, our internal control over financial reporting. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="PART_II"></a>PART II. OTHER INFORMATION </font></p><p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1_LEGAL"></a>ITEM&#160;1. LEGAL PROCEEDINGS </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Item_1A_Risk"></a>Item&#160;1A. Risk Factors </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">An investment in ARCA&#8217;s securities involves certain risks, including those set forth below and elsewhere in this report. In addition to the risks set forth below and elsewhere in this report, other risks and uncertainties not known to ARCA, that are beyond its control or that ARCA deems to be immaterial may also materially adversely affect ARCA&#8217;s business operations. You should carefully consider the risks described below as well as other information and data included in this report. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Our Business and Financial Condition </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our management and our independent registered public accountant, in their report on our financial statements as of and for the year ended December&#160;31, 2013, have concluded that due to our need for additional capital, and the uncertainties surrounding our ability to raise such funding, substantial doubt exists as to our ability to continue as a going concern. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audited consolidated financial statements for the fiscal year ended December&#160;31, 2013 were prepared assuming that we will continue as a going concern. The going concern basis of presentation assumes that we will continue in operation for the foreseeable future and will be able to realize our assets and discharge our liabilities and commitments in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from our inability to continue as a going concern. Our management and our independent registered public accountants concluded as of December&#160;31, 2013 that due to our need for additional capital, and the uncertainties surrounding our ability to raise such funding, substantial doubt exists as to our ability to continue as a going concern. In February 2014, the Company completed an equity financing transaction that raised aggregate net proceeds of $7.9 million. We believe our cash and cash equivalents balance as of March 31, 2014,&nbsp;&nbsp;will be sufficient to fund our operations, at our projected cost structure, through at least the end of 2015. Changing circumstances may cause us to consume capital significantly faster or slower than we currently anticipate. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have based these estimates on assumptions that may prove to be wrong, and we could exhaust our available financial resources sooner than we currently anticipate. We may be forced to reduce our operating expenses and raise additional funds to meet our working capital needs, principally through the additional sales of our securities or debt financings. However, we cannot guarantee that will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to us. If we are unable to raise sufficient additional capital or complete a strategic transaction, we may be unable to continue to fund our operations, develop Gencaro or our other product candidates, or realize value from our assets and discharge our liabilities in the normal course of business. If we cannot raise sufficient funds, we may have to liquidate our assets, and might realize significantly less than the values at which they are carried on our financial statements, and stockholders may lose all or part of their investment in our common stock. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We will need to raise substantial additional funds through public or private equity transactions and/or complete one or more strategic transactions, to continue development of Gencaro. If we are unable to raise such financing or complete such a transaction, we may not be able to continue operations. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of the expected development timeline to potentially obtain FDA approval for Gencaro, if at all, the substantial additional costs associated with the development of Gencaro, including the costs associated with the GENETIC-AF clinical trial, and the substantial cost of commercializing Gencaro, if it is approved, we will need to raise substantial additional funding through public or private equity transactions or a strategic combination or partnership. If we are delayed in obtaining funding or are unable to complete a strategic transaction, we may discontinue our development activities on Gencaro or discontinue our operations. Even if we are able to fund continued development and Gencaro is approved, we expect that we will need to complete a strategic transaction or raise substantial additional funding through public or private debt or equity securities to successfully commercialize Gencaro. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe our cash and cash equivalents balance as of March 31, 2014 will be sufficient to fund our operations, at our projected cost structure, through at least the end of 2015. Changing circumstances may cause us to consume capital significantly faster or slower than we currently anticipate. We have based these estimates on assumptions that may prove to be wrong, and we could exhaust our available financial resources sooner than we currently anticipate. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our liquidity, and our ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress of GENETIC-AF enrollment and any data that may become available;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs and timing for additional clinical trials in order to gain possible FDA approval for Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market price of our stock and the availability and cost of additional equity capital from existing and potential new investors; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to retain the listing of our common stock on the Nasdaq Capital Market; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general economic and industry conditions affecting the availability and cost of capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to control costs associated with our operations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions of our existing collaborative and licensing agreements. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities would likely result in substantial dilution to our stockholders. If we raise additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of our capital stock and could contain covenants that would restrict our operations. We also cannot predict what consideration might be available, if any, to us or our stockholders, in connection with any strategic transaction. Should strategic alternatives or additional capital not be available to us in the near term, or not be available on acceptable terms, we may be unable to realize value from our assets and discharge our liabilities in the normal course of business which may, among other alternatives, cause us to further delay, substantially reduce or discontinue operational activities to conserve our cash resources. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we are not able to successfully develop, obtain FDA approval for, and provide for the commercialization of Gencaro in a timely manner, we may not be able to continue our business operations. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently have no products that have received regulatory approval for commercial sale. The process to develop, obtain regulatory approval for and commercialize potential product candidates is long, complex and costly. We have initiated screening of patients for our Phase 2B clinical study of Gencaro in 200 hundred HFREF patients with AF, and it could expand to a Phase 3 clinical study of approximately 420 HFREF additional patients with AF/atrial flutter (AFL). Clinical trials are typically lengthy, complex and expensive and we do not currently have the resources to fully fund such a trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Failure to demonstrate that a product candidate, including Gencaro, is safe and effective, or significant delays in demonstrating such safety and efficacy, would adversely affect our business.  Failure to obtain marketing approval of Gencaro from appropriate regulatory authorities, or significant delays in obtaining such approval, would also adversely affect our business and could, among other things, preclude us from completing a strategic transaction or obtaining additional financing necessary to continue as a going concern. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if approved for sale, a product candidate must be successfully commercialized to generate value. We do not currently have the capital resources or management expertise to commercialize Gencaro and, as a result, will need to complete a strategic transaction, or, alternatively, raise substantial additional funds to enable commercialization of Gencaro, if it is approved. Failure to successfully provide for the commercialization of Gencaro, if it is approved, would damage our business. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our clinical trials for our product candidates may not yield results that will enable us to further develop our products and obtain the regulatory approvals necessary to sell them. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will receive regulatory approval for our product candidates only if we can demonstrate in carefully designed and conducted clinical trials that the product candidate is safe and effective.  We do not know whether any future clinical trials, including the&nbsp;&nbsp;GENETIC-AF clinical trial for Gencaro, will demonstrate sufficient safety and efficacy to obtain the requisite regulatory approvals or will result in marketable products. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, GENETIC-AF is designed to be an adaptive trial.  The DSMB will analyze certain data from the Phase 2B portion and recommend whether the trial should proceed to Phase 3 and seek to enroll an additional 420 patients. The DSMB will make their recommendation after 200 patients have been enrolled and have completed 24 weeks of follow-up. The interim analysis will focus on data regarding the trial&#8217;s primary endpoint, AF event rates, AF burden, and safety.&nbsp;&nbsp;Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and that the data indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.&#160;The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3. The Company, in consultation with the trial&#8217;s&nbsp;&nbsp;Steering Committee and the DSMB, will make the final determination on the trial&#8217;s development steps. If we do not see sufficient efficacy and safety in the Phase 2B portion of the trial, we will not initiate the Phase 3 portion of the trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical trials are lengthy, complex and expensive processes with uncertain results.  We have spent, and expect to continue to spend, significant amounts of time and money in the clinical development of our product candidates.  We have never conducted a Phase 2 or Phase 3 clinical trial and do not currently have sufficient staff with the requisite experience to do so, and we therefore will have to rely on contract research organizations to conduct certain of our clinical trials.  While certain of our employees have experience in designing and administering clinical trials, these employees have no such experience as employees of ARCA. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The results we obtain in preclinical testing and early clinical trials may not be predictive of results that are obtained in later studies.  We may suffer significant setbacks in advanced clinical trials, even after seeing promising results in earlier studies. Based on results at any stage of clinical trials, we may decide to repeat or redesign a trial or discontinue development of one or more of our product candidates.  If we fail to adequately demonstrate the safety and efficacy of our products under development, we will not be able to obtain the required regulatory approvals to commercialize our product candidates, and our business, results of operations and financial condition would be materially adversely affected. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Administering our product candidates to humans may produce undesirable side effects.  These side effects could interrupt, delay or halt clinical trials of our product candidates and could result in the FDA or other regulatory authorities denying approval of our product candidates for any or all targeted indications. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If clinical trials for a product candidate are unsuccessful, we will be unable to commercialize the product candidate.  If one or more of our clinical trials are delayed, we will be unable to meet our anticipated development timelines.  Either circumstance could cause the market price of our common stock to decline. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are relying on contract research organizations to conduct substantial portions of our GENETIC&#8211;AF clinical trial, and as a result, we will be unable to directly control the timing, conduct and expense of the clinical trial. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently have sufficient staff with the requisite experience to conduct our clinical trial and are therefore relying primarily on third parties to conduct our clinical trial.  We have contracted with Duke University, as our contract research organization (CRO) to conduct the clinical component of our GENETIC-AF trial.  As a result of this contract, we will have less control over many details and steps of the trial, the timing and completion of the trial, the required reporting of adverse events and the management of data developed through the trial than would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also be challenging, potentially leading to mistakes as well as difficulties in coordinating activities.  Outside parties, such as CROs, may have staffing difficulties, may undergo changes in priorities or may become financially distressed, adversely affecting their willingness or ability to conduct our trial.  We may experience unexpected cost increases that are beyond our control. Problems with the timeliness or quality of the work of a CRO may lead us to seek to terminate the relationship and use an alternative service provider.  However, making this change may be costly and may delay ongoing trials, and contractual restrictions may make such a change difficult or impossible.  Additionally, it may be impossible to find a replacement organization that can conduct clinical trials in an acceptable manner and at an acceptable cost. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even though we are using a CRO to conduct our clinical trial, we have to devote substantial resources and rely on the expertise of our employees to manage the work being done by the CRO.  We have never conducted a clinical trial and the inability of our current staff to adequately manage any CRO that we engage may exacerbate the risks associated with relying on a CRO. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we encounter difficulties enrolling patients in our clinical trials, our trials could be delayed or otherwise adversely affected. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The GENETIC-AF clinical trial requires that we identify and enroll a large number of patients with the condition under investigation and the trial will enroll only those patients having a specific genotype, and certain patients who have or are willing to have a Medtronic device implanted for monitoring and recording AF burden data.  Because of the rigorous enrollment criteria, we may not be able to enroll a sufficient number of patients to complete our clinical trial in a timely manner. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient enrollment is affected by factors including: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">design of the protocol; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the size of the patient population; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eligibility criteria for the study in question; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">perceived risks and benefits of the drug under study; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">availability of competing therapies, including the off-label use of therapies approved for related indications; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">efforts to facilitate timely enrollment in clinical trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the success of our personnel in making the arrangements with potential clinical trial sites necessary for those sites to begin enrolling patients; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patient referral practices of physicians; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">availability of clinical trial sites; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other clinical trials seeking to enroll subjects with similar profiles; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the number of patients having the specific genotype needed for our trial; and, </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the number of patients having, or willing to have, a Medtronic device implanted for monitoring and recording AF burden data. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay or terminate ongoing or planned clinical trials, either of which would have a negative effect on our business.  Delays in enrolling patients in our clinical trials would also adversely affect our ability to generate any product, milestone and royalty revenues under collaboration agreements, if any, and could impose significant additional costs on us or on any future collaborators. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not achieve our projected development goals in the time frames we announce and expect. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We set goals for, and make public statements regarding, the timing of certain accomplishments, such as, the commencement and completion of clinical trials, particularly with respect to steps for commencing and continuing GENETIC-AF, the disclosure of trial results, the obtainment of regulatory approval and the sale of drug product, which we sometimes refer to as milestones.  These milestones may not be achieved, and the actual timing of these events can vary dramatically due to a number of factors such as delays or failures in our clinical trials, disagreements with any collaborative partners, the uncertainties inherent in the regulatory approval process and manufacturing scale-up and delays in achieving manufacturing or marketing arrangements sufficient to commercialize our products. FDA approval of Gencaro, if it occurs, is expected to require years of additional clinical development, including the completion of genetic trials.  There can be no assurance that our genetic trials will be initiated or completed, or that we will make regulatory submissions or receive regulatory approvals as planned.  If we fail to achieve one or more of these milestones as planned, our business will be materially adversely affected. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we are not able to maintain the requirements for listing on the Nasdaq Capital Market, we could be delisted, which could have a materially adverse effect on our ability to raise additional funds as well as the price and liquidity of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock is currently listed on the Nasdaq Capital Market.  To maintain the listing of our common stock on the Nasdaq Capital Market we are required to meet certain listing requirements, including, among others, either: (i)&#160;a minimum closing bid price of $1.00 per share, a market value of publicly held shares (excluding shares held by our executive officers, directors and 10% or more stockholders) of at least $1 million and stockholders&#8217; equity of at least $2.5 million; or (ii)&#160;a minimum closing bid price of $1.00 per share, a market value of publicly held shares (excluding shares held by our executive officers, directors and 10% or more stockholders) of at least $1 million and a total market value of listed securities of at least $35 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2012 our stock price fell below the Nasdaq Capital Market&#8217;s minimum bid price requirements and we became subject to delisting from the exchange.  On March&#160;4, 2013 we executed a 1 for 6 reverse split of our common stock and have subsequently regained compliance with the minimum bid price requirements. In future periods, if we do not meet the minimum stockholders&#8217; equity, minimum closing bid price requirements, or any other listing requirements, we would be subject to delisting from the Nasdaq Capital Market. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of May 9, 2014, the closing price of our common stock was $1.39&#160;per share, and the total market value of our listed securities was approximately $29.2&#160;million. As of March&#160;31, 2014, we had stockholders&#8217; equity of $21.5 million. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We expect to depend on existing and future collaborations with third parties for the development of some of our product candidates. If those collaborations are not successful, we may not be able to complete the development of these product candidates. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently have a collaboration agreement with Medtronic, Inc., or Medtronic for the support of our GENETIC-AF trial. Medtronic can terminate its collaboration with us for various reasons including uncured material breach, an ARCA bankruptcy, if, after FDA communication, it is reasonably concluded that the FDA will not allow GENETIC-AF to enroll or proceed, or if Medtronic&#8217;s obligations are unilaterally expanded.  We may seek additional third party collaborators for the development of Gencaro or other product candidates. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our current arrangement with Medtronic, we have limited control over the amount and timing of resources that they dedicate to the development of Gencaro.  This is also likely to be true in any future collaboration with third parties.  Our ability to benefit from these arrangements will depend on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these arrangements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaborations involving our product candidates pose the following risks to us: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator&#8217;s strategic focus or available funding, or external factors such as an acquisition that diverts resources or creates competing priorities; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disputes may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may elect to take over manufacturing rather than retain us as manufacturers and may encounter problems in starting up or gaining approval for their manufacturing facility and so be unable to continue development of product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we may be required to undertake the expenditure of substantial operational, financial and management resources in connection with any collaboration; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we may be required to issue equity securities to collaborators that would dilute our existing stockholders&#8217; percentage ownership; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we may be required to assume substantial actual or contingent liabilities; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may not commit adequate resources to the marketing and distribution of our product candidates, limiting our potential revenues from these products; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators may experience financial difficulties. </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We face a number of challenges in seeking additional collaborations.  Collaborations are complex and any potential discussions may not result in a definitive agreement for many reasons.  For example, whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#8217;s evaluation of a number of factors, such as the design or results of our clinical trials, the potential market for our product candidates, the costs and complexities of manufacturing and delivering our product candidates to patients, the potential of competing products, the existence of uncertainty with respect to ownership or the coverage of our intellectual property, and industry and market conditions generally.  If we were to determine that additional collaborations for our Gencaro development is necessary and were unable to enter into such collaborations on acceptable terms, we might elect to delay or scale back the development or commercialization of Gencaro in order to preserve our financial resources or to allow us adequate time to develop the required physical resources and systems and expertise ourselves. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner, or at all.  In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators. If a present or future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development or commercialization program could be delayed, diminished or terminated. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our GENETIC-AF clinical trial requires the use of a third-party diagnostic services provider to administer the genetic test needed to identify the patient receptor genotypes of clinical trial participants, and as a result, we will be unable to directly control the timing, conduct and expense of the genetic test. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our GENETIC-AF clinical trial of Gencaro requires a companion diagnostic test that identifies the patient&#8217;s receptor genotype.  The trial will only enroll those patients with the receptor that has the potential for enhanced efficacy, the beta-1 389 Arg receptor as detected by a beta-1 389 Arg/Arg genotype.  Accordingly, the GENETIC-AF trial&nbsp;&nbsp;requires use of a third-party diagnostic service to perform the genetic testing.  There has been limited experience in our industry in prospective development of companion diagnostics required to perform the required molecular profiling.  We entered into an agreement with Laboratory Corporation of America, LabCorp, to provide the diagnostic services of the genetic test needed to support our GENETIC-AF trial.  To provide those services, LabCorp obtained from the FDA an Investigational Device Exemption, or IDE, for the companion diagnostic test to be used in our Genetic AF clinical trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and similar regulatory authorities outside the United States regulate companion diagnostics. Companion diagnostics require separate or coordinated regulatory approval prior to commercialization.&#160; Changes to regulatory advice could delay our development programs or delay or prevent eventual marketing approval for our product candidates that may otherwise be approvable.  In July 2011, the FDA issued draft guidance that stated that if safe and effective use of a therapeutic depends on an </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">in vitro</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> diagnostic, then the FDA generally will not approve the therapeutic unless the FDA approves or clears this &#8220;</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">in vitro</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> companion diagnostic device&#8221; at the same time that the FDA approves the therapeutic.  The approval or clearance of the companion diagnostic would occur through the FDA&#8217;s Center for Devices and Radiological Health.  The draft guidance on companion diagnostics remains in draft form, and it is unclear how closely the final guidance, when published, will track the 2011 draft guidance. It is also difficult to predict how FDA will implement the guidance once finalized.  For example, the draft guidance allows for flexibility by the FDA in the case of therapeutic products to treat serious conditions for which no alternative treatment exists and the benefits of using the companion diagnostic outweigh the risk, but it is unclear how this discretion will be applied by the agency.  The FDA&#8217;s evolving position on the topic of companion diagnostics could affect our clinical development programs that utilize companion diagnostics.  In particular, the FDA may limit our ability to use retrospective data, otherwise disagree with our approaches to trial design, biomarker qualification, clinical and analytical validity, and clinical utility, or make us repeat aspects of a trial or initiate new trials. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given our limited experience in developing diagnostics, we expect to rely primarily on third parties for their design and manufacture.  If we, or any third parties that we engage to assist us, are unable to successfully develop companion diagnostics for our product candidates that require such diagnostics, or experience delays in doing so, the development of our product candidates may be adversely affected, our product candidates may not receive marketing approval and we may not realize the full commercial potential of any products that receive marketing approval.  As a result, our business could be materially harmed. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We will need to establish a collaborative arrangement with a third-party diagnostics services provider to obtain marketing clearance or approval of the companion genetic test.  There is no guarantee that the FDA will grant timely clearance or approval of the genetic test, if at all, and failure to obtain such timely clearance or approval would adversely affect our ability to market Gencaro. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The drug label we intend to seek for Gencaro would identify the patient receptor genotype for which the drug is approved. Accordingly, we believe developing a genetic test that is simple to administer and widely available will be critical to the successful commercialization of Gencaro and also to the ability to conduct our GENETIC-AF clinical trial.  The genetic test will be subject to regulation by the FDA and by comparable agencies in various foreign countries.  The process of complying with the requirements of the FDA and comparable agencies is costly, time consuming and burdensome. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Despite the time and expense expended, regulatory clearance or approval is never guaranteed. If regulatory clearance or approval is delayed, or if one or more third-party diagnostic services providers are unable to obtain FDA approval of the genetic test at all or in parallel with the approval of Gencaro, or are unable to commercialize the test successfully and in a manner that effectively supports the commercial efforts for Gencaro, or if the information concerning the differential response to Gencaro resulting from certain genetic variation is not included in the approval label for Gencaro, the commercial launch of Gencaro may be significantly and adversely affected. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Regulatory approval is required for the genetic test to be used in the GENETIC-AF trial and to support the commercialization of the test, if approved. Delays or failures in obtaining such regulatory approval, including any required validation analyses may prevent a third-party diagnostics provider from commercializing such genetic test and will adversely affect our business, operating results and prospects. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before a genetic test can be used commercially, including in conjunction with Gencaro, if it is approved for marketing, the third-party diagnostics provider must obtain FDA Premarket Approval, or PMA, for such test.  The FDA may require additional validation of the genetic test we are using in GENETIC-AF prior to any approval of Gencaro or the genetic test.  We anticipate the genetic test will be required as a condition to prescribing Gencaro. There is no guarantee the FDA will approve the anticipated PMA submission for the genetic test. Even if the genetic test is eventually approved, performing additional validation work necessary to support the PMA, if required, for current or future genetic test products, including one associated with Gencaro, would require additional time and expense and the outcome would be uncertain. Moreover, such delays or increased costs or failures could adversely affect our business, operating results and prospects for commercializing the genetic test. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If a third-party diagnostics provider responsible for the genetic test or certain of its third-party suppliers fails to comply with ongoing FDA or other foreign regulatory authority requirements, or if there are unanticipated problems with the genetic test, these products could be subject to restrictions or withdrawal from use in trial or from the market. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any diagnostic for which a third-party diagnostics provider obtains clearance or approval, and the manufacturing processes, reporting requirements, post-approval clinical data and promotional activities for such product, will be subject to continued regulatory review, oversight and periodic inspections by the FDA and other domestic and foreign regulatory bodies.  With respect to the genetic test, to the extent applicable, any third-party diagnostics provider and certain of its suppliers will be required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and International Standards Organization, or ISO, requirements which cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage and shipping of any product for which clearance or approval is obtained. Regulatory bodies, such as the FDA, enforce the QSR and other regulations through periodic inspections.  The failure by a third-party diagnostics provider, or certain of its third-party manufacturers or suppliers, as the case may be, to comply with applicable statutes and regulations administered by the FDA and other regulatory bodies, or the failure to timely and adequately respond to any adverse inspectional observations or product safety issues, could result in, among other things, enforcement actions. If any of these actions were to occur, it could harm our reputation and cause product sales and profitability of Gencaro to suffer and may prevent us from generating revenue or utilizing the genetic test further in any clinical trial. Even if regulatory clearance or approval is granted, such clearance or approval may be subject to limitations on the intended uses for which the product may be marketed and reduce our potential to successfully commercialize the product and generate revenue from the product. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future sales of Gencaro may suffer if its marketplace acceptance is negatively affected by the genetic test. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The genetic test is an important component of the commercial strategy for Gencaro in addition to being required to proceed with our GENETIC-AF trial. We believe that the genetic test helps predict patient response to Gencaro, and that this aspect of the drug is important to its ability to compete effectively with current therapies. The genetic test adds an additional step in the prescribing process, an additional cost for the patient and payors, the risk that the test results may not be rapidly available and the possibility that it may not be available at all to hospitals and medical centers. Although we anticipate that Gencaro, if approved in a timely manner, would be the first genetically-targeted cardiovascular drug, Gencaro will be one of a number of successful drugs in the beta-blocker </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">class currently on the market. Prescribers may be more familiar with these other beta-blockers, and may be resistant to prescribing Gencaro as an AF therapy in patients with HF.  Any one of these factors could affect prescriber behavior, which in turn may substantially impede market acceptance of the genetic test, which could cause significant harm to Gencaro&#8217;s ability to compete, and in turn harm our business. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our failure to raise substantial additional funding or enter into a strategic transaction may materially and adversely affect our business. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless we are able to raise substantial additional funding for the development of Gencaro through other means, we will need to complete a strategic transaction to continue the development of Gencaro through the clinical development and commercialization phases, and to continue our other operations.  The strategic transactions that we may consider include a potential combination or partnership. Our board of directors and management team has and will continue to devote substantial time and resources to obtaining additional capital or the consideration and implementation of any such strategic transaction. In addition, conditions in the financial markets may lead to an increased number of biotechnology companies that are also seeking to enter into strategic transactions, which may limit our ability to negotiate favorable terms for any such transaction.  Further, our current employees do not have experience in the strategic transaction process, and our previous efforts to enter into a strategic transaction have not been successful. As a result of these and other factors, there is substantial risk that we may not be able to complete a strategic transaction on favorable terms, or at all. The failure to complete such a strategic transaction may materially and adversely affect our business. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may be limited in our ability to access sufficient funding through a private equity or convertible debt offering. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nasdaq rules impose restrictions on our ability to raise funds through a private offering of our common stock, convertible debt or similar instruments without obtaining stockholder approval. Under Nasdaq rules, an offering of more than 20% of our total shares outstanding for less than the greater of book or market value requires stockholder approval unless the offering qualifies as a &#8220;public&#160;offering&#8221; for purposes of the Nasdaq rules. As of March 31, 2014 we had approximately 21&#160;million shares of common stock outstanding, 20% of which is approximately 4.2&#160;million shares. To the extent we seek to raise funds through a private offering of stock, convertible debt or similar instruments, we are limited in how much funding we could raise privately without requiring a stockholder vote. SEC rules impose restrictions on our ability to raise funds through the registered offering of our securities pursuant to our &#8220;shelf&#8221; registration statement on Form S-3. Under SEC rules, we are prohibited from selling securities under such registration statement if the aggregate market value of the securities sold thereunder in any twelve-month period exceeds one-third of the market value of our outstanding common stock held by non-affiliates. Our February 2014 equity financing substantially exhausted the availability under our shelf registration statement until the one year anniversary of such financing. In addition, we are currently subject to certain contractual rights of investors arising from our public and private equity financing transactions that limit the nature and price of future public and private financing transactions that we may effect. For example, in January 2013, we entered into separate subscription agreements with certain institutional investors in connection with a private investment in public equity, pursuant to which we sold shares of our common stock and warrants to purchase shares of our common stock to the investors. In connection with this transaction, we agreed that, subject to certain exceptions, we would not, while the warrants issued in such financing are outstanding, effect or enter into an agreement to effect any issuance of common stock or securities convertible into, exercisable for or exchangeable for common stock in a &#8220;variable rate transaction,&#8221; which means a transaction in which we issue or sell any convertible securities either (A)&#160;at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of, or quotations for, the shares of common stock at any time after the initial issuance of such convertible securities, or (B)&#160;with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of the convertible securities or upon the occurrence of the specified or contingent events directly or indirectly related to our business or the market for our common stock. The restrictions imposed by the terms of our previous offerings, and that could be imposed in future offerings, may limit our access to capital on agreeable terms and delay or make impossible certain otherwise available equity financing opportunities and could severely restrict our access to the capital necessary to conduct our business. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Unless we are able to generate sufficient product revenue, we will continue to incur losses from operations and will not achieve or maintain profitability. We are years away from commercializing a product and generating product revenue. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our historical losses have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital, among other things. We are years away from commercializing a product and generating any product revenue. As a result, we expect to continue to incur significant operating losses for the foreseeable future. Even if we ultimately receive regulatory approval for Gencaro or our other product candidates, sales of such products may not generate sufficient revenue for it to achieve or maintain profitability. Because of the numerous risks and uncertainties associated with developing therapeutic drugs, we may experience larger than expected future losses and may never reach profitability. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our product candidates are subject to extensive regulation, which can be costly and time-consuming, and unsuccessful or delayed regulatory approvals could increase our future development costs or impair our future revenue. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preclinical and clinical development, testing, manufacture, safety, efficacy, labeling, storage, recordkeeping, and subsequent advertising, promotion, sale, marketing, and distribution, if approved, of our product candidates are subject to extensive regulation by the FDA and other regulatory authorities in the United States and elsewhere. These regulations also vary in important, meaningful ways from country to country. We are not permitted to market a potential drug in the United States until we receive approval of an NDA from the FDA. We have not received an NDA approval from the FDA for Gencaro or any of our other product candidates. There can be no guarantees with respect to our product candidates that clinical studies will adequately support an NDA, that the products will receive necessary regulatory approvals, or that they will prove to be commercially successful. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To receive regulatory approval for the commercial sale of any product candidates, we must demonstrate safety and efficacy in humans to the satisfaction of regulatory authorities through preclinical studies and adequate and well-controlled clinical trials of the product candidates. This process is expensive and can take many years, and failure can occur at any stage of the testing.  Our failure to adequately demonstrate the safety and efficacy of our product candidates will prevent regulatory approval and commercialization of such products. In 2008, we submitted and the FDA accepted our NDA filing for Gencaro for the treatment of chronic HF.  In 2009, the FDA issued a Complete Response Letter (CRL) in which the FDA stated that it could not approve the Gencaro NDA in its current form and specified actions required for approval of the NDA, including conducting an additional Phase 3 clinical trial of Gencaro in patients with HF.  We have initiated screening of patients for our clinical study of Gencaro in HFREF patients to assess its efficacy in reducing or preventing AF.  This trial has been initiated as a Phase 2B study in approximately 200 patients and, depending on the outcome of the Phase 2B portion, may be expanded to a Phase 3 study with up to an estimated additional 420 patients. We believe the Phase 2B study will take approximately two and a half years to complete from the time the first patient is enrolled.&nbsp;&nbsp;This product candidate will require years of clinical development.  Even if we conduct additional studies in accordance with further FDA guidance and submit or file a new or amended NDA, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that we or our collaborators conduct preclinical studies that do not comply with Good Laboratory Practices or GLP or incorrectly design or carry out human clinical trials in accordance with Good Clinical Practices or GCP or those clinical trials fail to demonstrate clinical significance, it is unlikely that we will be able to obtain FDA approval for product development candidates. Our inability to successfully initiate and effectively complete clinical trials for any product candidate on schedule, or at all, will severely harm our business. Significant delays in clinical development could materially increase product development costs or allow our competitors to bring products to market before we do, impairing our ability to effectively commercialize any future product candidate. We do not know whether planned clinical trials will begin on time, will need to be redesigned or will be completed on schedule, if at all. Clinical trials can be delayed for a variety of reasons, including: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or failures in obtaining regulatory authorization to commence a trial because of safety concerns of regulators relating to our product candidates or similar product candidates of our competitors or failure to follow regulatory guidelines; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or failures in obtaining clinical materials and manufacturing sufficient quantities of the product candidates for use in trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or failures in reaching agreement on acceptable terms with prospective study sites; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or failures in obtaining approval of our clinical trial protocol from an institutional review board, or IRB, to conduct a clinical trial at a prospective study site; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays in recruiting patients to participate in a clinical trial, which may be due to the size of the patient population, eligibility criteria, protocol design, perceived risks and benefits of the drug, availability of other approved and standard of care therapies, availability of clinical trial sites; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other clinical trials seeking to enroll subjects with similar profile; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure of our clinical trials and clinical investigators to be in compliance with the FDA&#8217;s Good Clinical Practices; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unforeseen safety issues, including negative results from ongoing preclinical studies; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inability to monitor patients adequately during or after treatment; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">difficulty recruiting and monitoring multiple study sites; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure of our third-party contract research organizations, clinical site organizations and other clinical trial managers, to satisfy their contractual duties, comply with regulations or meet expected deadlines; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an insufficient number of patients who have, or are willing to have, a Medtronic device implanted for monitoring and recording AF burden data. </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, any approvals we may obtain may not cover all of the clinical indications for which we seek approval or permit us to make claims of superiority over currently marketed competitive products.  Also, an approval might contain significant limitations in the form of narrow indications, warnings, precautions or contraindications with respect to conditions of use.  If the FDA determines that a risk evaluation and mitigation strategy, or REMS, is necessary to ensure that the benefits of the drug outweigh the risks, we may be required to include as part of the NDA a proposed REMS that may include a package insert directed to patients, a plan for communication with healthcare providers, restrictions on a drug&#8217;s distribution, or a Medication Guide, to provide better information to consumers about the drug&#8217;s risks and benefits. Finally, an approval could be conditioned on our commitment to conduct further clinical trials, which we may not have the resources to conduct or which may negatively impact our financial situation. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The manufacture and tableting of Gencaro is done by third party suppliers, who must also meet current Good Manufacturing Practices, or cGMP, requirements and pass a pre-approval inspection of their facilities before we can obtain marketing approval. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of our product candidates are prone to the risks of failure inherent in drug development.  The results from preclinical animal testing and early human clinical trials may not be predictive of results obtained in later human clinical trials. Further, although a new product may show promising results in preclinical or early human clinical trials, it may subsequently prove unfeasible or impossible to generate sufficient safety and efficacy data to obtain necessary regulatory approvals. The data obtained from preclinical and clinical studies are susceptible to varying interpretations that may delay, limit or prevent regulatory approval, and the FDA and other regulatory authorities in the United States and elsewhere exercise substantial discretion in the drug approval process.  The numbers, size and design of preclinical studies and clinical trials that will be required for FDA or other regulatory approval will vary depending on the product candidate, the disease or condition for which the product candidate is intended to be used and the regulations and guidance documents applicable to any particular product candidate. The FDA or other regulators can delay, limit or deny approval of any product candidate for many reasons, including, but not limited to: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Side effects; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Safety and efficacy; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Defects in the design of clinical trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fact that the FDA or other regulatory officials may not approve our or our third party manufacturer&#8217;s processes or facilities; or </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fact that new regulations may be enacted by the FDA or other regulators may change their approval policies or adopt new regulations requiring new or different evidence of safety and efficacy for the intended use of a product candidate. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of widely publicized events concerning the safety of certain drug products, regulatory authorities, members of Congress, the Government Accountability Office, medical professionals and the general public have raised concerns about potential drug safety issues.  These events have resulted in the withdrawal of certain drug products, revisions to certain drug labeling that further limit use of the drug products and establishment of risk management programs that may, for instance, restrict distribution of drug products. The increased attention to drug safety issues may result in a more cautious approach by the FDA to clinical trials and approval. Data from clinical trials may receive greater scrutiny with respect to safety and the product&#8217;s risk/benefit profile, which may make the FDA or other regulatory authorities more likely to terminate clinical trials before completion, or require longer or additional clinical trials that may result in substantial additional expense, and a delay or failure in obtaining approval or approval for a more limited indication than originally sought. Aside from issues concerning the quality and sufficiency of submitted preclinical and clinical data, the FDA may be constrained by limited resources from reviewing and determining the approvability of the Gencaro NDA in a timely manner. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In pursuing clinical development of Gencaro for an AF indication, we will be required to amend the Gencaro HF NDA or prepare a new NDA. The FDA could approve Gencaro, but without including some or all of the prescribing information that we have requested. For instance, the FDA could approve Gencaro for AF in a more limited patient population or include additional warnings in the drug&#8217;s label. This, in turn, could substantially and detrimentally impact our ability to successfully commercialize Gencaro and effectively protect our intellectual property rights in Gencaro. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our product candidates receive regulatory approval, we would be subject to ongoing regulatory obligations and restrictions, which may result in significant expenses and limit our ability to develop and commercialize other potential products. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a product candidate of ours is approved by the FDA or by another regulatory authority, we would be held to extensive regulatory requirements over product manufacturing, testing, distribution, labeling, packaging, adverse event reporting and other reporting to regulatory authorities, storage, advertising, marketing, promotion, distribution, and record keeping.  Regulatory approvals may also be subject to significant limitations on the indicated uses or marketing of the product candidates.  Potentially costly follow-up or post-marketing clinical studies may be required as a condition of approval to further substantiate safety or efficacy, or to investigate specific issues of interest to the regulatory authority.  Previously unknown problems with the product candidate, including adverse events of unanticipated severity or frequency, may result in additional regulatory controls or restrictions on the marketing or use of the product or the need for post marketing studies, and could include suspension or withdrawal of the products from the market. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, our third-party manufacturers and the manufacturing facilities that they use to make our product candidates are regulated by the FDA.  Quality control and manufacturing procedures must continue to conform to cGMP after approval.  Drug manufacturers and their subcontractors are required to register their facilities and products manufactured annually with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA, state and/or other foreign authorities.  Any subsequent discovery of problems with a product, or a manufacturing or laboratory facility used by us or our collaborators, may result in restrictions on the product, or on the manufacturing or laboratory facility, including a withdrawal of the drug from the market or suspension of manufacturing.  Any changes to an approved product, including the way it is manufactured or promoted, often require FDA approval before the product, as modified, can be marketed.  We and our third-party manufacturers will also be subject to ongoing FDA requirements for submission of safety and other post-market information. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The marketing and advertising of our drug products by our collaborators or us will be regulated by the FDA, certain state agencies or foreign regulatory authorities.  Violations of these laws and regulations, including promotion of our products for unapproved uses or failing to disclose risk information, are punishable by criminal and civil sanctions and may result in the issuance of enforcement letters or other enforcement action by the FDA, U.S. Department of Justice, state agencies, or foreign regulatory authorities that could jeopardize our ability to market the product. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the FDA, state or foreign regulations, the marketing of our drug products by us or our collaborators will be regulated by federal, state or foreign laws pertaining to health care &#8220;fraud and abuse,&#8221; such as the federal anti-kickback law prohibiting bribes, kickbacks or other remuneration for the order or recommendation of items or services reimbursed by federal health care programs.  Many states have similar laws applicable to items or services reimbursed by commercial insurers.  Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, imprisonment and exclusion from participation in federal and state health care programs, including the Medicare, Medicaid and Veterans Affairs healthcare programs.  Because of the far-reaching nature of these laws, we may be required to discontinue one or more of our practices to be in compliance with these laws. Health care fraud and abuse regulations are complex, and even minor irregularities can potentially give rise to claims that a statute or prohibition has been violated.  Any violations of these laws, or any action against us for violations of these laws, even if we successfully defend against it, could have a material adverse effect on our business, financial condition and results of operations. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We could also become subject to false claims litigation under federal statutes, which can lead to civil money penalties, restitution, criminal fines and imprisonment, and exclusion from participation in Medicare, Medicaid and other federal and state health care programs. These false claims statutes include the False Claims Act, which allows any person to bring a suit on behalf of the federal government alleging submission of false or fraudulent claims, or causing to present such false or fraudulent claims, under federal programs or contracts claims or other violations of the statute and to share in any amounts paid by the entity to the government in fines or settlement. These suits against pharmaceutical companies have increased significantly in volume and breadth in recent years. Some of these suits have been brought on the basis of certain sales practices promoting drug products for unapproved uses. This new growth in litigation has increased the risk that a pharmaceutical company will have to defend a false claim action, pay fines or restitution, or be excluded from the Medicare, Medicaid, Veterans Affairs and other federal and state healthcare programs as a result of an investigation arising out of such action. We may become subject to such litigation and, if we are not successful in defending against such actions, those actions may have a material adverse effect on our business, financial condition and results of operations. We could also become subject to false claims litigation and consumer protection claims under state statutes, which also could lead to civil monetary penalties, restitution, criminal fines and imprisonment, and exclusion from participation in state health care programs. Of note, over the past few years there has been an increased focus on the sales and marketing practices of the pharmaceutical industry at both the federal and state level. Additionally, the law or regulatory policies governing pharmaceuticals may change. New statutory requirements may be enacted or additional regulations may be adopted that could prevent or delay regulatory approval of our product candidates or limit our ability to commercialize our products. We cannot predict the likelihood, nature or extent of adverse government regulation that may arise from future legislation or administrative action, either in the U.S. or elsewhere. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we, our collaborators or our third-party manufacturers fail to comply with applicable continuing regulatory requirements, our business could be seriously harmed because a regulatory agency may: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issue untitled or warning letters; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suspend or withdraw our regulatory approval for approved products; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">seize or detain products or recommend a product recall of a drug or medical device, or issue a mandatory recall of a medical device; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">refuse to approve pending applications or supplements to approved applications filed by us; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suspend our ongoing clinical trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restrict our operations, including costly new manufacturing requirements, or restrict the sale, marketing and/or distribution of our products; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">seek an injunction; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pursue criminal prosecutions; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">close the facilities of our contract manufacturers; or </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">impose civil or criminal penalties. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reliance on third parties to commercialize Gencaro could negatively impact our business. If we are required to establish a direct sales force in the U.S. and are unable to do so, our business may be harmed. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercialization of Gencaro, particularly the establishment of a sales organization, will require substantial additional capital resources. We currently intend to pursue a strategic partnership alternative for the commercialization of Gencaro, if it is approved, and we have suspended our efforts to build internal sales, marketing and distribution capabilities. If we elect to rely on third parties to sell Gencaro and any other products, then we may receive less revenue than if we sold such products directly. In addition, we may have little or no control over the sales efforts of those third parties. If we are unable to complete a strategic transaction, we would be unable to commercialize Gencaro or any other product candidate without substantial additional capital. Even if such capital were secured, we would be required to build internal sales, marketing and distribution capabilities to market Gencaro in the U.S. None of our current employees have experience in establishing and managing a sales force. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event we are unable to sell Gencaro and other selected product candidates, either directly or through third parties via a strategic transaction, the commercialization of Gencaro, if it is approved, may be delayed indefinitely. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are dependent on our key personnel. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The success of our business is highly dependent on the principal members of our board of directors and executive management, including our President and Chief Executive Officer, Michael R. Bristow. The loss of the services of any such individual might seriously harm our product development, partnering and financing efforts. Recruiting and training personnel with the requisite skills is challenging and we compete for talent with companies that are larger and have more financial resources. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have no manufacturing capacity which puts us at risk of lengthy and costly delays of bringing our products to market. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently operate manufacturing facilities for clinical or commercial production of our product candidates, including their active pharmaceutical ingredients, or API. We have no experience in drug formulation or manufacturing, and we lack the resources and the capabilities to manufacture any of our product candidates on a clinical or commercial scale. We do not intend to develop facilities for the manufacture of product candidates for clinical trials or commercial purposes in the foreseeable future. We have contracted with Groupe Novasep to manufacture commercial quantities of the API for Gencaro. For drug production, we have contracted with Patheon, Inc. to manufacture the Gencaro tablets. These contract manufacturers may not perform as agreed or may not remain in the contract manufacturing business for the time required to successfully produce, store and distribute our products. In addition, these manufacturers may have staffing difficulties, may not be able to manufacture our products on a timely basis or may become financially distressed. In the event of errors in forecasting production quantities required to meet demand, natural disaster, equipment malfunctions or failures, technology malfunctions, strikes, lock-outs or work stoppages, regional power outages, product tampering, war or terrorist activities, actions of regulatory authorities, business failure, strike or other difficulty, we may be unable to find an alternative third-party manufacturer in a timely manner and the production of our product candidates would be interrupted, resulting in delays and additional costs, which could impact our ability to commercialize and sell our product candidates. We or our contract manufacturers may also fail to achieve and maintain required manufacturing standards, which could result in patient injury or death, product recalls or withdrawals, an order by governmental authorities to halt production, delays or failures in product testing or delivery, cost overruns or other problems that could seriously hurt our business. Contract manufacturers also often encounter </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">difficulties involving production yields, quality control and quality assurance, as well as shortages of qualified personnel. In addition, our contract manufacturers are subject to ongoing inspections and regulation by the FDA, the U.S. Drug Enforcement Agency and corresponding foreign and state agencies and they may fail to meet these agencies&#8217; acceptable standards of compliance. If our contract manufacturers fail to comply with applicable governmental regulations, such as quality control, quality assurance and the maintenance of records and documentation, we may not be able to continue production of the API or finished product. If the safety of any API or product supplied is compromised due to failure to adhere to applicable laws or for other reasons, this may jeopardize our regulatory approval for Gencaro and other product candidates, and we may be held liable for any injuries sustained as a result. Upon the occurrence of one of the aforementioned events, the ability to switch manufacturers may be difficult for a number of reasons, including: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the number of potential manufacturers is limited and we may not be able to negotiate agreements with alternative manufacturers on commercially reasonable terms, if at all; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">long lead times are often needed to manufacture drugs; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the manufacturing process is complex and may require a significant learning curve; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the FDA must approve any replacement prior to manufacturing, which requires new testing and compliance inspections. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Transitioning from a developmental stage company will require successful completion of a number of steps, many of which are outside of our control and, consequently, we can provide no assurance of our successful and timely transition from a developmental stage company. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a development stage biopharmaceutical company with a limited operating history. To date we have not generated any product revenue and have historically funded our operations through investment capital. Our future growth depends on our ability to emerge from the developmental stage and successfully commercialize or provide for the commercialization of Gencaro and our other product candidates which in turn, will depend, among other things, on our ability to: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">conduct an additional clinical trial and develop and obtain regulatory approval for Gencaro or other product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">successfully partner a companion genetic test with the commercial launch of Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enter into a strategic transaction enabling the continued development and commercialization of Gencaro, or alternatively, raise significant additional capital to enable these activities; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pursue additional indications for Gencaro and develop other product candidates, including other cardiovascular therapies; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obtain commercial quantities of Gencaro or other product candidates at acceptable cost levels. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any one of these factors or other factors discussed in this report could affect our ability to successfully commercialize Gencaro and other product candidates, which could impact our ability to earn sufficient revenues to transition from a developmental stage company and continue our business. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If approved by the FDA, Gencaro will be entering a competitive marketplace and may not succeed. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gencaro is a new type of beta-blocker and vasodilator being developed for AF. While we anticipate that this drug, if approved, would be the first genetically-targeted cardiovascular drug, and potentially the only beta-blocker approved for AF, Gencaro will be one of a number of accepted treatments for AF. In addition, our proposed prescribing information for Gencaro is expected to include a requirement for genetic testing of the patient to ascertain if they have the genotype that we believe responds most favorably to Gencaro. This additional step will add incremental cost and procedures to prescribing Gencaro, which could make it more difficult to compete against existing therapies. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our commercial opportunity may be reduced or eliminated if competitors develop and commercialize products that are safer, more effective, have fewer side effects, are more convenient or are less expensive than Gencaro. If products with any of these properties are developed, or any of the existing products are better marketed, then prescriptions of Gencaro by physicians and patient use of Gencaro could be significantly reduced or rendered obsolete and noncompetitive. Further, public announcements regarding the development of any such competing drugs could adversely affect the market price of our common stock and the value of our assets. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future sales of our products may suffer if they are not accepted in the marketplace by physicians, patients and the medical community. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gencaro or our other product candidates may not gain market acceptance among physicians, patients and the medical community. The degree of market acceptance of Gencaro or our other product candidates will depend on a number of factors, such as its effectiveness and tolerability, as compared with competitive drugs. Also, prevalence and severity of side-effects could negatively affect market acceptance of Gencaro or our other product candidates. Failure to achieve market acceptance of Gencaro would significantly harm our business. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we are unable to obtain acceptable prices or adequate reimbursement from third-party payors for Gencaro, or any other product candidates that we may seek to commercialize, then our revenues and prospects for profitability will suffer. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our or any strategic partner&#8217;s ability to commercialize Gencaro, or any other product candidates that we may seek to commercialize, is highly dependent on the extent to which coverage and reimbursement for these product candidates will be available from: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">governmental payors, such as Medicare and Medicaid; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">private health insurers, including managed-care organizations; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other third-party payors. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many patients will not be capable of paying for our potential products themselves and will rely on third-party payors to pay for their medical needs. A primary current trend in the U.S. health care industry is toward cost containment. Large private payors, managed-care organizations, group purchasing organizations and similar organizations are exerting increasing influence on decisions regarding the use of, and reimbursement levels for, particular treatments. Such third-party payors, including Medicare, are challenging the prices charged for medical products and services, and many third-party payors limit reimbursement for newly approved health care products. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost-control initiatives could decrease the price we might establish for products, which could result in product revenues lower than anticipated. If the prices for our product candidates decrease, or if governmental and other third-party payors do not provide adequate coverage and reimbursement levels, then our revenue and prospects for profitability will suffer. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Health care reform measures could materially and adversely affect our business. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The business and financial condition of pharmaceutical and biotechnology companies are affected by the efforts of governmental and third-party payors to contain or reduce the costs of health care. The U.S. Congress has enacted legislation to reform the health care system. While we anticipate that this legislation may, over time, increase the number of patients who have insurance coverage for pharmaceutical products, it also imposes cost containment measures that may adversely affect the amount of reimbursement for pharmaceutical products. These measures include increasing the minimum rebates for products covered by Medicaid programs and extending such rebates to drugs dispensed to Medicaid beneficiaries enrolled in Medicaid managed care organizations as well as expansion of the 340(B) Public Health Services drug discount program. In addition, such legislation contains a number of provisions designed to generate the revenues necessary to fund the coverage expansion, including new fees or taxes on certain health-related industries, including medical device manufacturers. Each medical device manufacturer has to pay an excise tax (or sales tax) in an amount equal to 2.3% of the price for which such manufacturer sells its medical devices. Such excise taxes may impact any potential sales of the genetic test if it is approved for marketing. In foreign jurisdictions there have been, and we expect that there will continue to be, a number of legislative and regulatory proposals aimed at changing the health care system. For example, in some countries other than the United States, pricing of prescription drugs is subject to government control and we expect to see continued efforts to reduce healthcare costs in international markets. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some states are also considering legislation that would control the prices of drugs, and state Medicaid programs are increasingly requesting manufacturers to pay supplemental rebates and requiring prior authorization by the state program for use of any drug for which supplemental rebates are not being paid. Managed care organizations continue to seek price discounts and, in some cases, to impose restrictions on the coverage of particular drugs. Government efforts to reduce Medicaid expenses may lead to increased use of managed care organizations by Medicaid programs. This may result in managed care organizations influencing prescription decisions for a larger segment of the population and a corresponding constraint on prices and reimbursement for drugs. It is likely that federal and state legislatures and health agencies will continue to focus on additional health care reform in the future although we are unable to predict what additional legislation or regulation, if any, relating to the health care industry or third-party coverage and reimbursement may be enacted in the future or what effect such legislation or regulation would have on our business. We or any strategic partner&#8217;s ability to commercialize Gencaro, or any other product candidates that we may seek to commercialize, is highly dependent on the extent to which coverage and reimbursement for these product candidates will be available from government payors, such as Medicare and Medicaid, private health insurers, including managed care organizations, and other third-party payors, and any change in reimbursement levels could materially and adversely affect our business. Further, the pendency or approval of future proposals or reforms could result in a decrease in our stock price or limit our ability to raise capital or to obtain strategic partnerships or licenses. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our competitors may be better positioned in the marketplace and thereby may be more successful than us at developing, manufacturing and marketing approved products. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our competitors currently have significantly greater financial resources and expertise in conducting clinical trials, obtaining regulatory approvals, managing manufacturing and marketing approved products than us. Other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. In addition, these third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring therapies and therapy licenses complementary to our programs or advantageous to our business. We expect that our ability to compete effectively will depend upon our ability to: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">successfully and rapidly complete clinical trials for any product candidates and obtain all requisite regulatory approvals in a cost-effective manner; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">build an adequate sales and marketing infrastructure, raise additional funding, or enter into strategic transactions enabling the commercialization of our products; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">develop competitive formulations of our product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">attract and retain key personnel; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">identify and obtain other product candidates on commercially reasonable terms. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we fail to identify and license or acquire other products or product candidates, then we may be unable to expand our business, and the acquisition or licensing of other products or product candidates may put a strain on our operations and will likely require us to seek additional financing. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One of our strategies is to license or acquire clinical-stage products or product candidates and further develop them for commercialization. The market for licensing and acquiring products and product candidates is intensely competitive and many of our competitors may have greater resources than us. If we undertake any additional acquisitions, whether of product candidates or other biopharmaceutical companies, the process of integrating an acquired product candidate or complementary company into our business may put a strain on our operations, divert personnel, financial resources and management&#8217;s attention. In 2014, we expect our research and development activities will be dedicated to Gencaro. If we are not able to substantially expand our research and development efforts, or identify, or license or acquire other products or product candidates or complete future acquisitions, then we will likely be unable expand our pipeline of product candidates. In addition, any future acquisition would give rise to additional operating costs and will likely require us to seek additional financing. Future acquisitions could result in additional issuances of equity securities that would dilute the ownership of existing stockholders. Future acquisitions could also result in the incurrence of debt, contingent liabilities or the amortization of expenses related to other intangible assets, any of which could adversely affect our operating results. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We would be subject to applicable regulatory approval requirements of the foreign countries in which we market our products, which are costly and may prevent or delay us from marketing our products in those countries. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to regulatory requirements in the United States, we would be subject to the regulatory approval requirements in each foreign country where we market our products. In addition, we might be required to identify one or more collaborators in these foreign countries to develop, seek approval for and manufacture our products and any companion genetic test for Gencaro. If we decide to pursue regulatory approvals and commercialization of our product candidates internationally, we may not be able to obtain the required foreign regulatory approvals on a timely basis, if at all, and any failure to do so may cause us to incur additional costs or prevent us from marketing our products in foreign countries, which may have a material adverse effect on our business, financial condition and results of operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our internal control over financial reporting is not considered effective, our business and stock price could be adversely affected. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;404 of the Sarbanes-Oxley Act of 2002 requires us to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year, and to include a management report assessing the effectiveness of our internal control over financial reporting in our annual report on Form 10-K for that fiscal year. Our management, including our chief executive officer and chief financial officer, does not expect that our internal control over financial reporting will prevent all error and all fraud. During the first quarter of 2011 there was a reduction in our workforce which included personnel involved in financial reporting and our internal control processes. Since that time we have continued to operate with a reduced staff for financial reporting. Though the process and design of our internal controls over financial reporting have not been altered, the small number of staff involved in financial reporting may limit our ability to properly segregate internal control procedures which could result in deficiencies or material weaknesses in our internal controls in the future. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud involving a company have been, or will be, detected. The design of any system of controls is based in part on certain assumptions about the&#160;likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become ineffective because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We cannot assure you that we or our independent registered public accounting firm will not identify a material weakness in our internal control over financial reporting in the future. A material weakness in our internal control over financial reporting would require management to consider our internal control over financial reporting as ineffective. If our internal control over financial reporting is not considered effective, we may experience a loss of public confidence, which could have an adverse effect on our business and on the market price of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Intellectual Property and Other Legal Matters </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If product liability lawsuits are successfully brought against us, then we will incur substantial liabilities and may be required to limit commercialization of Gencaro or other product candidates. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We face product liability exposure related to the testing of our product candidates in human clinical trials, and may face exposure to claims by an even greater number of persons once we begin marketing and distributing our products commercially. If we cannot successfully defend against product liability claims, then we will incur substantial liabilities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regardless of merit or eventual outcome, liability claims may result in: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">decreased demand for our products and product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">injury to our reputation; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">withdrawal of clinical trial participants; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs of related litigation; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">substantial monetary awards to patients and others; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">loss of revenues; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the inability to commercialize our products and product candidates. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have obtained limited product liability insurance coverage. Such coverage, however, may not be adequate or may not continue to be available to us in sufficient amounts or at an acceptable cost, or at all. We may not be able to obtain commercially reasonable product liability insurance for any product candidate. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Defending against claims relating to improper handling, storage or disposal of hazardous chemicals, radioactive or biological materials could be time consuming and expensive. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development of product candidates may involve the controlled use of hazardous materials, including chemicals, radioactive and biological materials. We cannot eliminate the risk of accidental contamination or discharge and any resultant injury from the materials. Various laws and regulations govern the use, manufacture, storage, handling and disposal of hazardous materials. We may be sued or be required to pay fines for any injury or contamination that results from our use or the use by third parties of these materials. Compliance with environmental laws and regulations may be expensive, and current or future environmental regulations may impair our research, development and production efforts. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The loss of any rights to market key products would significantly impair our operating results. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have licensed from CPEC, who has licensed rights in Gencaro from Bristol Meyers Squibb (BMS), the exclusive rights to Gencaro for all therapeutic and diagnostic uses in any country until the later of (i)&#160;10&#160;years from the first commercial sale of Gencaro in such country, or (ii)&#160;the termination of our commercial exclusivity in such country. This license includes a sublicense to us from BMS. We are obligated to use commercially reasonable efforts to develop and commercialize Gencaro, including obtaining regulatory approvals. Our ability to develop and commercialize Gencaro is dependent on numerous factors, including some factors that are outside of our control. CPEC has the right to terminate our license if we materially breach our obligations under the license agreement and fail to cure any such breach within the terms of the license. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our license agreement with CPEC is terminated for reasons related to non-payment of fees, or for any other breach, then we would have no further rights to develop and commercialize Gencaro for any indication. The termination of this license, or of any other agreement which enables us to market a key product or product candidate, could significantly and adversely affect our business. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain intellectual property licensed by us is the subject of additional licensing arrangements to which the party that has licensed rights to us is subject. If such parties were to breach the terms of such licenses or such licenses were otherwise to terminate, our and our partners&#8217; rights to use such technology and develop and commercialize their products such as the genetic test may terminate and our business would be materially harmed. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Third parties may own or control patents or patent applications that we may be required to license to commercialize our product candidates or that could result in litigation that would be costly and time consuming. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our or any strategic partner&#8217;s ability to commercialize Gencaro and other product candidates depends upon our ability to develop, manufacture, market and sell these drugs without infringing the proprietary rights of third parties. A number of pharmaceutical and biotechnology companies, universities and research institutions have or may be granted patents that cover technologies similar to the technologies owned by or licensed to us. We may choose to seek, or be required to seek, licenses under third party patents, which would likely require the payment of license fees or royalties or both. We may also be unaware of existing patents that may be infringed by Gencaro, the genetic testing we intend to use in connection with Gencaro or our other product candidates. Because patent applications can take many years to issue, there may be other currently pending applications that may later result in issued patents that are infringed by Gencaro or our other product candidates. Moreover, a license may not be available to us on commercially reasonable terms, or at all. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is a substantial amount of litigation involving patent and other intellectual property rights in the biotechnology and biopharmaceutical industries generally. If a third party claims that we are infringing on its technology, then our business and results of operations could be harmed by a number of factors, including: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">infringement and other intellectual property claims, even if without merit, are expensive and time-consuming to litigate and can divert management&#8217;s attention from our core business; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">monetary damage awards for past infringement can be substantial; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a court may prohibit us from selling or licensing product candidates unless the patent holder chooses to license the patent to us; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if a license is available from a patent holder, we may have to pay substantial royalties. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also be forced to bring an infringement action if we believe that a competitor is infringing our protected intellectual property. Any such litigation will be costly, time-consuming and divert management&#8217;s attention, and the outcome of any such litigation may not be favorable to us. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our intellectual property rights may not preclude competitors from developing competing products and our business may suffer. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our competitive success will depend, in part, on our ability to obtain and maintain patent protection for our inventions, technologies and discoveries, including intellectual property that we license. The patent positions of biotechnology companies involve complex legal and factual questions, and we cannot be certain that our patents and licenses will successfully preclude others from using our technology. Consequently, we cannot be certain that any of our patents will provide significant market protection or will not be circumvented or challenged and found to be unenforceable or invalid. In some cases, patent applications in the U.S. and certain other jurisdictions are maintained in secrecy until patents issue, and since publication of discoveries in the scientific or patent literature often lags behind actual discoveries, we cannot be certain of the priority of inventions covered by pending patent applications. Moreover, we may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office to determine priority of invention or in opposition proceedings in a foreign patent office, any of which could result in substantial cost to us, even if the eventual outcome is favorable. There can be no assurance that a court of competent jurisdiction would hold any claims in any issued patent to be valid. An adverse outcome could subject us to significant liabilities to third parties, require disputed rights to be licensed from third parties or require us to cease using such technology. Regardless of merit, the listing of patents in the FDA Orange Book for Gencaro may be challenged as being improperly listed. We may have to defend against such claims and possible associated antitrust issues. We could also incur substantial costs in seeking to enforce our proprietary rights against infringement. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While the composition of matter patents on the compound that comprises Gencaro have expired, we hold the intellectual property concerning the interaction of Gencaro with the polymorphisms of the beta-1 and alpha-2C receptors. We have obtained patents that claim methods involving Gencaro after a patient&#8217;s receptor genotype has been determined. Our NDA requested a label that will include a claim that efficacy varies based on receptor genotype and a recommendation in the prescribing information that prospective patients be tested for their receptor genotype. We believe that under applicable law, a generic bucindolol label would likely be required to include this recommendation as it pertains directly to the safe or efficacious use of the drug. Such a label may be considered as inducing infringement, carrying the same liability as direct infringement. If the label with the genotype information for Gencaro is not approved, or if generic labels are not required to copy the approved label, competitors could have an easier path to introduce competing products and our business may suffer. The approved label may not contain language covered by the patents, or we may be unsuccessful in enforcing them. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not be able to effectively protect our intellectual property rights in some foreign countries, as our patents are limited by jurisdiction and many countries do not offer the same level of legal protection for intellectual property as the U.S. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We require our employees, consultants, business partners and members of our scientific advisory board to execute confidentiality agreements upon the commencement of employment, consulting or business relationships with us. These agreements provide that all confidential information developed or made known during the course of the relationship with us be kept confidential and not disclosed to third parties except in specific circumstances. In the case of employees, the agreements provide that all inventions resulting from work performed for us, utilizing the property or relating to our business and conceived or completed by the individual during employment shall be our exclusive property to the extent permitted by applicable law. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties may breach these and other agreements with us regarding our intellectual property and we may not have adequate remedies for the breach. Third parties could also fail to take necessary steps to protect our licensed intellectual property, which could seriously harm our intellectual property position. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we are not able to protect our proprietary technology, trade secrets and know-how, then our competitors may develop competing products. Any issued patent may not be sufficient to prevent others from competing with us. Further, we have trade secrets relating to Gencaro, and such trade secrets may become known or independently discovered. Our issued patents and those that may issue in the future, or those licensed to us, may be challenged, opposed, invalidated or circumvented, which could allow competitors to market similar products or limit the patent protection term of our product candidates. All of these factors may affect our competitive position. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If the manufacture, use or sale of our products infringe on the intellectual property rights of others, we could face costly litigation, which could cause us to pay substantial damages or licensing fees and limit our ability to sell some or all of our products. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Extensive litigation regarding patents and other intellectual property rights has been common in the biopharmaceutical industry. Litigation may be necessary to assert infringement claims, enforce patent rights, protect trade secrets or know-how and determine the enforceability, scope and validity of certain proprietary rights. Litigation may even be necessary to defend disputes of inventorship or ownership of proprietary rights. The defense and prosecution of intellectual property lawsuits, U.S. Patent and Trademark Office interference proceedings, and related legal and administrative proceedings (e.g., a reexamination) in the U.S. and internationally involve complex legal and factual questions. As a result, such proceedings are costly and time-consuming to pursue, and their outcome is uncertain. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regardless of merit or outcome, our involvement in any litigation, interference or other administrative proceedings could cause us to incur substantial expense and could significantly divert the efforts of our technical and management personnel. Any public announcements related to litigation or interference proceedings initiated or threatened against us could cause our stock price to decline. Adverse outcomes in patent litigation may potentially subject us to antitrust litigation which, regardless of the outcome, would adversely affect our business. An adverse determination may subject us to the loss of our proprietary position or to significant liabilities, or require us to seek licenses that may include substantial cost and ongoing royalties. Licenses may not be available from third parties, or may not be obtainable on satisfactory terms. An adverse determination or a failure to obtain necessary licenses may restrict or prevent us from manufacturing and selling our products, if any. These outcomes could materially harm our business, financial condition and results of operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Stock Price Volatility </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our stock price is expected to be volatile. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock could be subject to significant fluctuations. Market prices for securities of early-stage pharmaceutical, biotechnology and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the regulatory status of Gencaro and the genetic test, and whether and when they are approved for sale, if at all, and the labeling or other conditions of use imposed by the FDA; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to secure additional funding or complete a strategic transaction or to complete development of and commercialize Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress of GENETIC-AF and enrollment and any data that may become available; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the results of our future clinical trials and any future NDAs of our current and future product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the entry into, or termination of, key agreements, including key strategic alliance agreements; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the results and timing of regulatory reviews relating to our product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure of any of our product candidates, if approved, to achieve commercial success; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general and industry-specific economic conditions that may affect our research and development expenditures; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the results of clinical trials conducted by others on drugs that would compete with our product candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issues in manufacturing our product candidates or any approved products; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the initiation of or material developments in or the conclusion of litigation to enforce or defend any of our intellectual property rights; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the loss of key employees; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the introduction of technological innovations or new commercial products by our competitors; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes in estimates or recommendations by securities analysts, if any, who cover our common stock; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">future sales of our common stock; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes in the structure of health care payment systems; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">period-to-period fluctuations in our financial results; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to retain the listing of our common stock on the Nasdaq Capital Market. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock. In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future sales or the possibility of future sales of our common stock may depress the market price of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales in the public market of substantial amounts of our common stock could depress prevailing market prices of our common stock. As of March 31, 2014, approximately 21.0 &#160;million shares of common stock were outstanding.  During the quarter, warrant holders exercised warrants for common shares totaling 199,900. All of these shares are freely transferable without restriction or further registration under the Securities Act, except for shares held by our directors, officers and other affiliates and unregistered shares held by non-affiliates. The sale of these additional shares, or the perception that such sales may occur, could depress the market price of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2014 approximately 9.4&#160;million shares of our common stock were issuable upon the exercise of outstanding warrants. Once a warrant is exercised, if the shares of our common stock issued upon the exercise of any such warrant are not available for sale in the open market without further registration under the Securities Act, then the holder can arrange for the resale of shares either by invoking any applicable registration rights, causing the shares to be registered under the Securities Act and thus freely transferable, or by relying on an exemption to the Securities Act. If these registration rights, or similar registration rights that may apply to securities we may issue in the future, are exercised, it could result in additional sales of our common stock in the market, which may have an adverse effect on our stock price. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2014, there were approximately 1.7&#160;million shares of our common stock which may be issued upon the exercise of outstanding stock options and the vesting of restricted stock units. If and when these options are exercised, such shares will be available for sale in the open market without further registration under the Securities Act. The existence of these outstanding options may negatively affect our ability to complete future equity financings at acceptable prices and on acceptable terms. The exercise of those options, and the prompt resale of shares of our common stock received, may also result in downward pressure on the price of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the absence of a significant strategic transaction, we will need to raise significant additional capital to finance the research, development and commercialization of Gencaro. If future securities offerings occur, they would dilute our current stockholders&#8217; equity interests and could reduce the market price of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We do not expect to pay cash dividends, and accordingly, stockholders must rely on stock appreciation for any return on their investment. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate that we will retain our earnings, if any, for future growth and therefore do not anticipate paying cash dividends in the future. As a result, only appreciation of the price of our common stock will provide a return to stockholders. Investors seeking cash dividends should not invest in our common stock. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have implemented anti-takeover provisions that could discourage, prevent or delay a takeover, even if the acquisition would be beneficial to our stockholders. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions of our certificate of incorporation and bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us, even if doing so would benefit our stockholders. These provisions: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">establish a classified board of directors so that not all members of our board may be elected at one time; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">authorize the issuance of up to approximately 5&#160;million additional shares of preferred stock that could be issued by our board of directors to increase the number of outstanding shares and hinder a takeover attempt; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">limit who may call a special meeting of stockholders; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">prohibit stockholder action by written consent, thereby requiring all stockholder actions to be taken at a meeting of our stockholders; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">establish advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon at a stockholder meeting. </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Specifically, our certificate of incorporation provides that all stockholder action must be effected at a duly called meeting and not by a written consent. The bylaws provide, however, that our stockholders may call a special meeting of stockholders only upon a request of stockholders owning at least 50% of our outstanding common stock. These provisions of our certificate of incorporation and bylaws could discourage potential acquisition proposals and could delay or prevent a change in control. We designed these provisions to reduce our vulnerability to unsolicited acquisition proposals and to discourage certain tactics that may be used in proxy fights. These provisions, however, could also have the effect of discouraging others from making tender offers for our shares. As a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual or rumored takeover attempts. Such provisions also may have the effect of preventing changes in our management. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are permitted to issue shares of our preferred stock without stockholder approval upon such terms as our board of directors determines. Therefore, the rights of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of our preferred stock that may be issued in the future. In addition, the issuance of preferred stock could have a dilutive effect on the holdings of our current stockholders. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to the Delaware anti-takeover laws regulating corporate takeovers. These anti-takeover laws prevent a Delaware corporation from engaging in a merger or sale of more than 10% of its assets with any stockholder, including all affiliates and associates of the stockholder, who owns 15% or more of the corporation&#8217;s outstanding voting stock, for three years following the date that the stockholder acquired 15% or more of the corporation&#8217;s stock unless: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the board of directors approved the transaction where the stockholder acquired 15% or more of the corporation&#8217;s stock; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">after the transaction in which the stockholder acquired 15% or more of the corporation&#8217;s stock, the stockholder owned at least 85% of the corporation&#8217;s outstanding voting stock, excluding shares owned by directors, officers and employee stock plans in which employee participants do not have the right to determine confidentially whether shares held under the plan will be tendered in a tender or exchange offer; or </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on or after this date, the merger or sale is approved by the board of directors and the holders of at least two-thirds of the outstanding voting stock that is not owned by the stockholder. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The provisions of our governing documents and current Delaware law may, collectively: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lengthen the time required for a person or entity to acquire control of us through a proxy contest for the election of a majority of our board of directors; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">discourage bids for our common stock at a premium over market price; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings 2';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generally deter efforts to obtain control of us. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_2_UNREGISTERED"></a>ITEM&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_3_DEFAULTS"></a>ITEM&#160;3. DEFAULTS UPON SENIOR SECURITIES </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_4_MINE"></a>ITEM&#160;4. MINE SAFETY DISCLOSURES </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_5_OTHER"></a>ITEM&#160;5. OTHER INFORMATION </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_6_EXHIBITS"></a>ITEM&#160;6. EXHIBITS </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following documents are filed as part of this quarterly report on Form 10-Q. The Company will furnish a copy of any exhibit listed to requesting stockholders upon payment of the Company&#8217;s reasonable expenses in furnishing those materials. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:7.98%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:91.42%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Certificate of Incorporation of the Registrant, as amended.(1)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1(a)</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment to Restated Certificate of Incorporation.(2)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1(b)</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock of the Registrant.(5)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Amended and Restated Bylaws of the Registrant.(3)</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;4.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Common Stock Purchase Warrant. (4)</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;4.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant Agency Agreement by and Among ARCA biopharma, Inc., Computershare, Inc., and Computershare Trust Company, N.A. dated February 3, 2014. (4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Placement Agency Agreement by and between ARCA biopharma, Inc. and Dawson James Securities, Inc., dated January 21, 2014.(4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 1 to Placement Agency Agreement by and between ARCA biopharma, Inc. and Dawson James Securities, Inc., dated January 31, 2014.(4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Instance Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Schema Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Calculation Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Label Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Presentation Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Definition Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;line-height:6pt;margin-right:66.67%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 10-K, filed March&#160;27, 2009, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 8-K, filed on March&#160;5, 2013, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 10-Q, filed November&#160;16, 2009, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit and incorporated herein by reference from ARCA biopharma, Inc.&#8217;s Form 8-K, filed on February 4, 2014, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit and incorporated herein by reference from ARCA biopharma, Inc.&#8217;s Form S-1, filed on March 25, 2013.  </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed herewith. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><a name="SIGNATURE"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURE </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:30%;">
<tr>
<td colspan="3" valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA biopharma, Inc. (Registrant)</font></p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:38%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:38%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="width:38%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated: May&#160;13, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</font></p>

<hr style="page-break-after:always"><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT INDEX </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following documents are filed as part of this quarterly report on Form 10-Q. The Company will furnish a copy of any exhibit listed to requesting stockholders upon payment of the Company&#8217;s reasonable expenses in furnishing those materials. </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:7.98%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:91.42%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Certificate of Incorporation of the Registrant, as amended.(1)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1(a)</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment to Restated Certificate of Incorporation.(2)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1(b)</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock of the Registrant.(5)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Amended and Restated Bylaws of the Registrant.(3)</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;4.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Common Stock Purchase Warrant. (4)</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.35pt;;text-indent:0.35pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:0.35pt;;">&nbsp;&nbsp;&nbsp;&nbsp;4.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant Agency Agreement by and Among ARCA biopharma, Inc., Computershare, Inc., and Computershare Trust Company, N.A. dated February 3, 2014. (4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Placement Agency Agreement by and between ARCA biopharma, Inc. and Dawson James Securities, Inc., dated January 21, 2014.(4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 1 to Placement Agency Agreement by and between ARCA biopharma, Inc. and Dawson James Securities, Inc., dated January 31, 2014.(4)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Instance Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Schema Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Calculation Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Label Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Presentation Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="width:92.02%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.98%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF*</font></p></td>
<td valign="bottom"  style="width:0.6%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top"  style="width:91.42%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Definition Linkbase Document (filed electronically herewith)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;line-height:6pt;margin-right:66.67%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 10-K, filed March&#160;27, 2009, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 8-K, filed on March&#160;5, 2013, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit to and incorporated herein by reference from ARCA biopharma, Inc&#8217;s Form 10-Q, filed November&#160;16, 2009, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit and incorporated herein by reference from ARCA biopharma, Inc.&#8217;s Form 8-K, filed on February 4, 2014, File No. 000-22873. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Previously filed with the SEC as an Exhibit and incorporated herein by reference from ARCA biopharma, Inc.&#8217;s Form S-1, filed on March 25, 2013. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed herewith. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:-4.54%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>2
<FILENAME>abio-ex31_201403316.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Michael R. Bristow, certify that:</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. I have reviewed this quarterly report on Form 10-Q of ARCA biopharma, Inc.;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: May 13, 2014</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:55%;">
<tr>
<td style="width:55%;"></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael R. Bristow</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:1pt;border-top:Solid 0.75pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael R. Bristow</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>abio-ex31_201403317.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Patrick M. Wheeler, certify that:</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. I have reviewed this quarterly report on Form 10-Q of ARCA biopharma, Inc.;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p><p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: May 13, 2014</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:55.83%;">
<tr>
<td style="width:55.83%;"></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:1pt;border-top:Solid 0.75pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>abio-ex32_201403318.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ARCA BIOPHARMA, INC.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SEC. 1350</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Michael R. Bristow, Chief Executive Officer of ARCA biopharma, Inc. (the "Company"), and Patrick M. Wheeler, Chief Financial Officer of the Company, each hereby certifies that, to the best of his/her knowledge:</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) The Company's Quarterly Report on Form 10-Q for the period ended March 31, 2014, to which this Certification is attached as Exhibit 32.1 (the "Periodic Report") fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and</font></p><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p><p style="margin-bottom:0pt;margin-top:13pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">In Witness Whereof</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the undersigned have set their hands hereto as of the 13<sup style="font-size:85%; vertical-align:top">th</sup> day of May 2014.</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:46.56%;"></td>
<td style="width:1.72%;"></td>
<td style="width:0.86%;"></td>
<td style="width:1.72%;"></td>
<td style="width:49.14%;"></td>
</tr>
<tr>
<td valign="middle"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="middle"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="middle"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael R. Bristow</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-top:Solid 0.75pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-top:Solid 0.75pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael R. Bristow</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patrick M. Wheeler</font></p></td>
</tr>
<tr>
<td valign="top"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom"  style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom"  style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;;"><font style="font-style:italic;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal&#160;Financial and Accounting Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A signed original of this written statement required by Section&#160;906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. &#167; 1350, as adopted) has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of ARCA biopharma, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>abio-20140331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Instance Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<xbrl xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.xbrl.org/2003/instance" xmlns:abio="http://www.nuvelo.com/20140331" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="abio-20140331.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <unit id="U_shares">
    <measure>shares</measure>
  </unit>
  <unit id="U_iso4217USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="U_iso4217USD_abioshares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="U_abioPatients">
    <measure>abio:Patients</measure>
  </unit>
  <unit id="U_utrsqft">
    <measure>utr:sqft</measure>
  </unit>
  <unit id="U_pure">
    <measure>pure</measure>
  </unit>
  <context id="C_0000907654_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20140509">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2014-05-09</instant>
    </period>
  </context>
  <context id="C_0000907654_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_20011217">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2001-12-17</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20011218_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20011218_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011218_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20011218_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040101_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20040101_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040101_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20040101_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20050101_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfConvertibleRedeemablePreferredStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_us-gaapRedeemableConvertiblePreferredStockMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RedeemableConvertiblePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioSeriesOfferingCostsMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeriesOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20060101_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioIssuanceOfCommonStockForCommercialLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:IssuanceOfCommonStockForCommercialLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioIssuanceOfSharesToExecutiveSubjectToRepurchaseMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:IssuanceOfSharesToExecutiveSubjectToRepurchaseMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-01-03</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-01-03</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-10-14</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-02-21</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-02-22</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060623">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-06-23</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioFifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-11-07</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070118">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-01-18</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-06-30</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfConvertibleRedeemablePreferredStockMember_20060222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:FirstIssuanceOfConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-02-22</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_20060222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-02-22</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_20061208">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-08</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfSeriesBRedeemablePreferredStockMember_20070531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:ThirdIssuanceOfSeriesBRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-05-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20071228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-28</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20070101_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20080101_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:AccretionOfSeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioNotesAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:NotesAndRelatedAccruedInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20090101_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20091231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CommonConversionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:CashNetOfOfferingCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DeficitAccumulatedDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2013-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapHealthCareTrustFundAxis_abioPhaseThreeHeartFailureMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:HealthCareTrustFundAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PhaseThreeHeartFailureMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20020101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityTransactionsTypeAxis_abioRegisteredDirectOfferingMember_us-gaapSecuritiesFinancingTransactionAxis_abioTwoZeroOneFourEquityFinancingsMember_20140201_20140228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:TwoZeroOneFourEquityFinancingsMember</explicitMember>
        <explicitMember dimension="abio:EquityTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:RegisteredDirectOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-02-01</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="C_0000907654_20130205_20130304">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2013-02-05</startDate>
      <endDate>2013-03-04</endDate>
    </period>
  </context>
  <context id="C_0000907654_20090101_20090127">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-01-27</endDate>
    </period>
  </context>
  <context id="C_0000907654_20090127">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2009-01-27</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapRangeAxis_us-gaapMaximumMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FurnitureAndFixturesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FurnitureAndFixturesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FurnitureAndFixturesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioWestminsterMember_20130801">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:WestminsterMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-08-01</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioBroomfieldMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:BroomfieldMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioWestminsterMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:WestminsterMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_20080731">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <instant>2008-07-31</instant>
    </period>
  </context>
  <context id="C_0000907654_20080701_20080731">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
    </entity>
    <period>
      <startDate>2008-07-01</startDate>
      <endDate>2008-07-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PrivateInvestmentInPublicEquityTransactionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PrivateInvestmentInPublicEquityTransactionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:RegisteredDirectOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:RegisteredDirectOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeriesAConvertiblePreferredStockMember</explicitMember>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PublicOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:SeriesAConvertiblePreferredStockMember</explicitMember>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PublicOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapTitleOfIndividualAxis_abioDirectorAndChiefExecutiveOfficerMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:DirectorAndChiefExecutiveOfficerMember</explicitMember>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:PublicOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:RegisteredDirectOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="abio:EquityFinancingTransactionsTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">abio:RegisteredDirectOfferingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapRangeAxis_us-gaapMinimumMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapRangeAxis_us-gaapWeightedAverageMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WeightedAverageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SellingGeneralAndAdministrativeExpensesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SellingGeneralAndAdministrativeExpensesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SellingGeneralAndAdministrativeExpensesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapRestructuringChargesMember_20011218_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestructuringChargesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-12-18</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <dei:EntityRegistrantName id="F_000000" contextRef="C_0000907654_20140101_20140331">ARCA Biopharma, Inc.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="F_000001" contextRef="C_0000907654_20140101_20140331">0000907654</dei:EntityCentralIndexKey>
  <dei:DocumentType id="F_000002" contextRef="C_0000907654_20140101_20140331">10-Q</dei:DocumentType>
  <dei:AmendmentFlag id="F_000003" contextRef="C_0000907654_20140101_20140331">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate id="F_000004" contextRef="C_0000907654_20140101_20140331">2014-03-31</dei:DocumentPeriodEndDate>
  <dei:DocumentFiscalPeriodFocus id="F_000005" contextRef="C_0000907654_20140101_20140331">Q1</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus id="F_000006" contextRef="C_0000907654_20140101_20140331">2014</dei:DocumentFiscalYearFocus>
  <dei:CurrentFiscalYearEndDate id="F_000007" contextRef="C_0000907654_20140101_20140331">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory id="F_000008" contextRef="C_0000907654_20140101_20140331">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding id="F_000009" contextRef="C_0000907654_20140509" decimals="INF" unitRef="U_shares">21010815</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000010" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">21202000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000011" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">16756000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:OtherAssetsCurrent id="F_000012" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">599000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent id="F_000013" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">169000</us-gaap:OtherAssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000014" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">21801000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000015" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">16925000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000016" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">26000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000017" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">29000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:OtherAssetsNoncurrent id="F_000018" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">828000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="F_000019" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">130000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets id="F_000020" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">22655000</us-gaap:Assets>
  <us-gaap:Assets id="F_000021" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">17084000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="F_000022" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">552000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="F_000023" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">597000</us-gaap:AccountsPayableCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000024" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">111000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000025" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">459000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000026" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">457000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000027" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">446000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:DeferredRentCreditCurrent id="F_000028" xsi:nil="true" contextRef="C_0000907654_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredRentCreditCurrent id="F_000029" xsi:nil="true" contextRef="C_0000907654_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:LiabilitiesCurrent id="F_000030" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">1120000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000031" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">1502000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="F_000032" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="F_000033" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:Liabilities id="F_000034" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">1121000</us-gaap:Liabilities>
  <us-gaap:Liabilities id="F_000035" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">1503000</us-gaap:Liabilities>
  <us-gaap:CommitmentsAndContingencies id="F_000036" xsi:nil="true" contextRef="C_0000907654_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingencies id="F_000037" xsi:nil="true" contextRef="C_0000907654_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000038" xsi:nil="true" contextRef="C_0000907654_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000039" xsi:nil="true" contextRef="C_0000907654_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommonStockValue id="F_000040" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">21000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="F_000041" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">16000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital id="F_000042" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">98835000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="F_000043" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">90498000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000044" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">-77322000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000045" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">-74933000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="F_000046" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">21534000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000047" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">15581000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000048" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">22655000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000049" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">17084000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000050" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000051" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_iso4217USD_abioshares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="F_000052" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">135000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="F_000053" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">135000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="F_000054" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="F_000055" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="F_000056" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="F_000057" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000058" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000059" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_iso4217USD_abioshares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="F_000060" contextRef="C_0000907654_20140331" decimals="-6" unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="F_000061" contextRef="C_0000907654_20131231" decimals="-6" unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="F_000062" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">21001690</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000063" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">15685562</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="F_000064" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">21001690</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="F_000065" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">15685562</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000066" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">1308000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000067" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">181000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000068" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">46913000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="F_000069" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">1082000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="F_000070" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">889000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="F_000071" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">47677000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="F_000072" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">5470000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:RestructuringCharges id="F_000073" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2413000</us-gaap:RestructuringCharges>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill id="F_000074" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">6000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
  <us-gaap:OperatingExpenses id="F_000075" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">2390000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000076" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">1070000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000077" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">108473000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="F_000078" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-2390000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000079" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-1070000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000080" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-108473000</us-gaap:OperatingIncomeLoss>
  <abio:GainLossOnAssignmentOfPatentRights id="F_000081" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2000000</abio:GainLossOnAssignmentOfPatentRights>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount id="F_000082" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">25282000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:InterestAndOtherIncome id="F_000083" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">2000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome id="F_000084" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2035000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestExpenseDebt id="F_000085" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:InterestExpenseDebt>
  <us-gaap:InterestExpenseDebt id="F_000086" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:InterestExpenseDebt>
  <us-gaap:InterestExpenseDebt id="F_000087" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">447000</us-gaap:InterestExpenseDebt>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000088" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-2389000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000089" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-1071000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000090" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-79603000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit id="F_000091" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-2281000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss id="F_000092" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-2389000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000093" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-1071000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000094" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-77322000</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount id="F_000095" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">245000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:PreferredStockDividendsAndOtherAdjustments id="F_000096" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2807000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000097" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-2389000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000098" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-1071000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000099" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-80374000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000100" contextRef="C_0000907654_20140101_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">-0.13</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000101" contextRef="C_0000907654_20130101_20130331" decimals="2" unitRef="U_iso4217USD_abioshares">-0.35</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000102" contextRef="C_0000907654_20140101_20140331" decimals="0" unitRef="U_shares">18785418</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000103" contextRef="C_0000907654_20130101_20130331" decimals="0" unitRef="U_shares">3034763</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockholdersEquity id="F_000104" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000105" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000106" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000107" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000108" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000109" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000110" xsi:nil="true" contextRef="C_0000907654_20011217" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000111" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000112" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000113" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000114" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000115" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000116" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharesOutstanding id="F_000117" xsi:nil="true" contextRef="C_0000907654_20011217" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000118" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20011218_20031231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000119" contextRef="C_0000907654_20011218_20031231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000120" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011218_20031231" decimals="INF" unitRef="U_shares">2588</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:NetIncomeLoss id="F_000121" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20011218_20031231" decimals="-3" unitRef="U_iso4217USD">-116000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000122" contextRef="C_0000907654_20011218_20031231" decimals="-3" unitRef="U_iso4217USD">-116000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000123" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000124" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20031231" decimals="-3" unitRef="U_iso4217USD">-116000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000125" contextRef="C_0000907654_20031231" decimals="-3" unitRef="U_iso4217USD">-115000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000126" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031231" decimals="INF" unitRef="U_shares">2588</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000127" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040101_20041231" decimals="-3" unitRef="U_iso4217USD">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000128" contextRef="C_0000907654_20040101_20041231" decimals="-3" unitRef="U_iso4217USD">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000129" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040101_20041231" decimals="INF" unitRef="U_shares">19720</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:NetIncomeLoss id="F_000130" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20040101_20041231" decimals="-3" unitRef="U_iso4217USD">-511000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000131" contextRef="C_0000907654_20040101_20041231" decimals="-3" unitRef="U_iso4217USD">-511000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000132" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041231" decimals="-3" unitRef="U_iso4217USD">8000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000133" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20041231" decimals="-3" unitRef="U_iso4217USD">-627000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000134" contextRef="C_0000907654_20041231" decimals="-3" unitRef="U_iso4217USD">-619000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000135" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041231" decimals="INF" unitRef="U_shares">22308</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000136" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000137" contextRef="C_0000907654_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000138" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231" decimals="INF" unitRef="U_shares">2922</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000139" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000140" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000141" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231" decimals="INF" unitRef="U_shares">2978</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000142" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">44000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000143" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">44000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000144" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231" decimals="INF" unitRef="U_shares">903</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000145" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1354000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000146" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">1354000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000147" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050101_20051231" decimals="INF" unitRef="U_shares">31095</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:NetIncomeLoss id="F_000148" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">-1459000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000149" contextRef="C_0000907654_20050101_20051231" decimals="-3" unitRef="U_iso4217USD">-1459000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000150" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051231" decimals="-3" unitRef="U_iso4217USD">1408000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000151" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20051231" decimals="-3" unitRef="U_iso4217USD">-2086000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000152" contextRef="C_0000907654_20051231" decimals="-3" unitRef="U_iso4217USD">-678000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000153" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051231" decimals="INF" unitRef="U_shares">60206</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000154" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">75000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000155" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">75000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000156" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">17372</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000157" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfConvertibleRedeemablePreferredStockMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">9316000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000158" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfConvertibleRedeemablePreferredStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">5727354</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <abio:StockIssuedDuringPeriodUponConversionOfNotesPayableValue id="F_000159" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">684000</abio:StockIssuedDuringPeriodUponConversionOfNotesPayableValue>
  <abio:StockIssuedDuringPeriodUponConversionOfNotesPayableShares id="F_000160" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_20060101_20061231" decimals="INF" unitRef="U_shares">420817</abio:StockIssuedDuringPeriodUponConversionOfNotesPayableShares>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000161" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000162" contextRef="C_0000907654_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000163" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">8019</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000164" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">60000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000165" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">60000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000166" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">13907</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000167" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000168" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000169" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">2505</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000170" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">38</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000171" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_us-gaapRedeemableConvertiblePreferredStockMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000172" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_us-gaapRedeemableConvertiblePreferredStockMember_20060101_20061231" decimals="INF" unitRef="U_shares">3074086</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000173" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioSeriesOfferingCostsMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">-98000</abio:AccretionOfOfferingCostEffectOnEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000174" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">39000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000175" contextRef="C_0000907654_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">39000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000176" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">17000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000177" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">-17000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000178" contextRef="C_0000907654_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">-17000</abio:AccretionOfOfferingCostEffectOnEquity>
  <us-gaap:NetIncomeLoss id="F_000179" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">-5241000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000180" contextRef="C_0000907654_20060101_20061231" decimals="-3" unitRef="U_iso4217USD">-5241000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000181" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20061231" decimals="-3" unitRef="U_iso4217USD">14919000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000182" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061231" decimals="-3" unitRef="U_iso4217USD">1583000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000183" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20061231" decimals="-3" unitRef="U_iso4217USD">-7327000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000184" contextRef="C_0000907654_20061231" decimals="-3" unitRef="U_iso4217USD">-5744000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000185" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20061231" decimals="INF" unitRef="U_shares">9222257</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000186" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061231" decimals="INF" unitRef="U_shares">102047</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000187" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">9000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000188" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">3688902</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000189" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">9000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000190" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">2766677</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000191" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-147000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000192" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">19000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000193" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-19000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000194" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-19000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000195" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">18000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000196" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-18000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000197" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-18000</abio:AccretionOfOfferingCostEffectOnEquity>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000198" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">13000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000199" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">13000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000200" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">1303</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000201" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000202" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000203" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">642</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000204" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioIssuanceOfCommonStockForCommercialLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">2783</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000205" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioIssuanceOfSharesToExecutiveSubjectToRepurchaseMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">13915</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <abio:CommonStockMarketPricePerShare id="F_000206" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021231" decimals="INF" unitRef="U_iso4217USD_abioshares">0.36</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000207" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930" decimals="INF" unitRef="U_iso4217USD_abioshares">0.36</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000208" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050103" decimals="INF" unitRef="U_iso4217USD_abioshares">0.36</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000209" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050103" decimals="INF" unitRef="U_iso4217USD_abioshares">0.36</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000210" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051014" decimals="INF" unitRef="U_iso4217USD_abioshares">48.84</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000211" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060221" decimals="INF" unitRef="U_iso4217USD_abioshares">4.32</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000212" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060222" decimals="INF" unitRef="U_iso4217USD_abioshares">4.32</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000213" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060623" decimals="INF" unitRef="U_iso4217USD_abioshares">5.40</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000214" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioFifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061107" decimals="INF" unitRef="U_iso4217USD_abioshares">5.40</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000215" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070118" decimals="INF" unitRef="U_iso4217USD_abioshares">10.08</abio:CommonStockMarketPricePerShare>
  <abio:CommonStockMarketPricePerShare id="F_000216" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioSeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070630" decimals="INF" unitRef="U_iso4217USD_abioshares">10.80</abio:CommonStockMarketPricePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000217" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioFirstIssuanceOfConvertibleRedeemablePreferredStockMember_20060222" decimals="INF" unitRef="U_iso4217USD_abioshares">1.6265</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000218" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_20060222" decimals="INF" unitRef="U_iso4217USD_abioshares">1.6265</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000219" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_20061208" decimals="INF" unitRef="U_iso4217USD_abioshares">1.6265</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000220" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioThirdIssuanceOfSeriesBRedeemablePreferredStockMember_20070531" decimals="INF" unitRef="U_iso4217USD_abioshares">2.439</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000221" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioSecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_20071228" decimals="INF" unitRef="U_iso4217USD_abioshares">3.253</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000222" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">16000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000223" contextRef="C_0000907654_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">16000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000224" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070101_20071231" decimals="INF" unitRef="U_shares">2227</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000225" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">50000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000226" contextRef="C_0000907654_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">50000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000227" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-13994000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000228" contextRef="C_0000907654_20070101_20071231" decimals="-3" unitRef="U_iso4217USD">-13994000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000229" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20071231" decimals="-3" unitRef="U_iso4217USD">14938000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000230" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20071231" decimals="-3" unitRef="U_iso4217USD">17871000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000231" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071231" decimals="-3" unitRef="U_iso4217USD">1632000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000232" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20071231" decimals="-3" unitRef="U_iso4217USD">-21321000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000233" contextRef="C_0000907654_20071231" decimals="-3" unitRef="U_iso4217USD">-19689000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000234" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20071231" decimals="INF" unitRef="U_shares">9222257</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000235" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20071231" decimals="INF" unitRef="U_shares">6455579</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000236" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071231" decimals="INF" unitRef="U_shares">122917</us-gaap:SharesOutstanding>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000237" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">20000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000238" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-20000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000239" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-20000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000240" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">36000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000241" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-36000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000242" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-36000</abio:AccretionOfOfferingCostEffectOnEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="F_000243" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="F_000244" contextRef="C_0000907654_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000245" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">54000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000246" contextRef="C_0000907654_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">54000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000247" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080101_20081231" decimals="INF" unitRef="U_shares">36154</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000248" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000249" contextRef="C_0000907654_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000250" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-19431000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000251" contextRef="C_0000907654_20080101_20081231" decimals="-3" unitRef="U_iso4217USD">-19431000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000252" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20081231" decimals="-3" unitRef="U_iso4217USD">14958000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000253" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20081231" decimals="-3" unitRef="U_iso4217USD">17907000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000254" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081231" decimals="-3" unitRef="U_iso4217USD">2574000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000255" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20081231" decimals="-3" unitRef="U_iso4217USD">-40752000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000256" contextRef="C_0000907654_20081231" decimals="-3" unitRef="U_iso4217USD">-38178000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000257" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20081231" decimals="INF" unitRef="U_shares">9222257</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000258" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20081231" decimals="INF" unitRef="U_shares">6455579</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000259" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081231" decimals="INF" unitRef="U_shares">159071</us-gaap:SharesOutstanding>
  <abio:AdjustmentForFractionalShares id="F_000260" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="0" unitRef="U_shares">-7</abio:AdjustmentForFractionalShares>
  <us-gaap:DividendsPreferredStockStock id="F_000261" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">781000</us-gaap:DividendsPreferredStockStock>
  <us-gaap:DividendsPreferredStockStock id="F_000262" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-781000</us-gaap:DividendsPreferredStockStock>
  <us-gaap:DividendsPreferredStockStock id="F_000263" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-781000</us-gaap:DividendsPreferredStockStock>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000264" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">42000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000265" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-42000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000266" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-42000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000267" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">93000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000268" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-93000</abio:AccretionOfOfferingCostEffectOnEquity>
  <abio:AccretionOfOfferingCostEffectOnEquity id="F_000269" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioAccretionOfSeriesBMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-93000</abio:AccretionOfOfferingCostEffectOnEquity>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000270" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-15000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000271" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-18781000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000272" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000273" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">33780000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000274" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">33781000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <abio:ConversionOfPreferredStockToCommonStockShares id="F_000275" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20090101_20091231" decimals="INF" unitRef="U_shares">-9222257</abio:ConversionOfPreferredStockToCommonStockShares>
  <abio:ConversionOfPreferredStockToCommonStockShares id="F_000276" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20090101_20091231" decimals="INF" unitRef="U_shares">-6455579</abio:ConversionOfPreferredStockToCommonStockShares>
  <abio:ConversionOfPreferredStockToCommonStockShares id="F_000277" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="INF" unitRef="U_shares">507123</abio:ConversionOfPreferredStockToCommonStockShares>
  <abio:AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction id="F_000278" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">75000</abio:AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction>
  <abio:AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction id="F_000279" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">75000</abio:AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction>
  <abio:StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest id="F_000280" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">8501000</abio:StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest>
  <abio:StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest id="F_000281" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">8501000</abio:StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="F_000282" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioNotesAndRelatedAccruedInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="INF" unitRef="U_shares">145465</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <abio:AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock id="F_000283" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">36000</abio:AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock>
  <abio:AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock id="F_000284" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">36000</abio:AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="F_000285" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">11913000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="F_000286" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">11913000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="F_000287" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="INF" unitRef="U_shares">447826</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <abio:AdjustmentForFractionalShares id="F_000288" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="0" unitRef="U_shares">-102</abio:AdjustmentForFractionalShares>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000289" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">114000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000290" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">114000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000291" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="INF" unitRef="U_shares">10521</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan id="F_000292" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan id="F_000293" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan id="F_000294" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090101_20091231" decimals="INF" unitRef="U_shares">177</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
  <abio:AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued id="F_000295" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">377000</abio:AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued>
  <abio:AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued id="F_000296" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">377000</abio:AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000297" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">845000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000298" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-9138000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000299" contextRef="C_0000907654_20090101_20091231" decimals="-3" unitRef="U_iso4217USD">-9138000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000300" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000301" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091231" decimals="-3" unitRef="U_iso4217USD">57301000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000302" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20091231" decimals="-3" unitRef="U_iso4217USD">-49890000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000303" contextRef="C_0000907654_20091231" decimals="-3" unitRef="U_iso4217USD">7412000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000304" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091231" decimals="INF" unitRef="U_shares">1270074</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000305" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">7182000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000306" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">7182000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000307" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100101_20101231" decimals="INF" unitRef="U_shares">194100</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000308" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">139000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000309" contextRef="C_0000907654_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">139000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000310" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100101_20101231" decimals="INF" unitRef="U_shares">8248</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000311" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">458000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000312" contextRef="C_0000907654_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">458000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000313" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">-8420000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000314" contextRef="C_0000907654_20100101_20101231" decimals="-3" unitRef="U_iso4217USD">-8420000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000315" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000316" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101231" decimals="-3" unitRef="U_iso4217USD">65080000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000317" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20101231" decimals="-3" unitRef="U_iso4217USD">-58310000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000318" contextRef="C_0000907654_20101231" decimals="-3" unitRef="U_iso4217USD">6771000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000319" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231" decimals="INF" unitRef="U_shares">1472422</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000320" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000321" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">4016000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000322" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">4017000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000323" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="INF" unitRef="U_shares">557890</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000324" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000325" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000326" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000327" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000328" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000329" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000330" xsi:nil="true" contextRef="C_0000907654_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000331" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="INF" unitRef="U_shares">188</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000332" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">308000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000333" contextRef="C_0000907654_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">308000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000334" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-5364000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000335" contextRef="C_0000907654_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-5364000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000336" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231" decimals="-3" unitRef="U_iso4217USD">2000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000337" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111231" decimals="-3" unitRef="U_iso4217USD">69404000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000338" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20111231" decimals="-3" unitRef="U_iso4217USD">-63674000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000339" contextRef="C_0000907654_20111231" decimals="-3" unitRef="U_iso4217USD">5732000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000340" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231" decimals="INF" unitRef="U_shares">2030500</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000341" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000342" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1188000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000343" contextRef="C_0000907654_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1189000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000344" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="INF" unitRef="U_shares">629815</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000345" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000346" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000347" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000348" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000349" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000350" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000351" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000352" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">306000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000353" contextRef="C_0000907654_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">306000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000354" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-4320000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000355" contextRef="C_0000907654_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-4320000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000356" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231" decimals="-3" unitRef="U_iso4217USD">3000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000357" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121231" decimals="-3" unitRef="U_iso4217USD">70898000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000358" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20121231" decimals="-3" unitRef="U_iso4217USD">-67994000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000359" contextRef="C_0000907654_20121231" decimals="-3" unitRef="U_iso4217USD">2907000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000360" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231" decimals="INF" unitRef="U_shares">2660315</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000361" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1421000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000362" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1421000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000363" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">521066</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <abio:AdjustmentForFractionalShares id="F_000364" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">-64</abio:AdjustmentForFractionalShares>
  <abio:IssuanceCommonStockUponExerciseOfWarrantsForCashValue id="F_000365" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">12000</abio:IssuanceCommonStockUponExerciseOfWarrantsForCashValue>
  <abio:IssuanceCommonStockUponExerciseOfWarrantsForCashValue id="F_000366" contextRef="C_0000907654_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">12000</abio:IssuanceCommonStockUponExerciseOfWarrantsForCashValue>
  <abio:IssuanceCommonStockUponExerciseOfWarrantsForCashShares id="F_000367" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">4245</abio:IssuanceCommonStockUponExerciseOfWarrantsForCashShares>
  <abio:PreferredStockIssuedDuringPeriodSharesNewIssues id="F_000368" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">125000</abio:PreferredStockIssuedDuringPeriodSharesNewIssues>
  <abio:PreferredStockIssuedDuringPeriodSharesNewIssues id="F_000369" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="INF" unitRef="U_shares">17917</abio:PreferredStockIssuedDuringPeriodSharesNewIssues>
  <abio:PreferredStockIssuedDuringPeriodSharesNewIssues id="F_000370" contextRef="C_0000907654_20130101_20131231" decimals="INF" unitRef="U_shares">17917</abio:PreferredStockIssuedDuringPeriodSharesNewIssues>
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000371" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesAMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000372" xsi:nil="true" contextRef="C_0000907654_us-gaapAuctionMarketPreferredSecuritiesStockSeriesAxis_us-gaapSeriesBMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000373" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000374" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000375" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000376" xsi:nil="true" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:PreferredStockIssuedDuringPeriodValueNewIssues id="F_000377" xsi:nil="true" contextRef="C_0000907654_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <abio:DeemedDividendBeneficialConversionPreferredStock id="F_000378" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">2026000</abio:DeemedDividendBeneficialConversionPreferredStock>
  <abio:DeemedDividendBeneficialConversionPreferredStock id="F_000379" contextRef="C_0000907654_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">2026000</abio:DeemedDividendBeneficialConversionPreferredStock>
  <us-gaap:PreferredStockDividendsAndOtherAdjustments id="F_000380" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-2026000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
  <us-gaap:PreferredStockDividendsAndOtherAdjustments id="F_000381" contextRef="C_0000907654_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-2026000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000382" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">13000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000383" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-33000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000384" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCommonConversionMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-20000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <abio:ConversionOfPreferredStockToCommonStockShares id="F_000385" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">-125000</abio:ConversionOfPreferredStockToCommonStockShares>
  <abio:ConversionOfPreferredStockToCommonStockShares id="F_000386" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">12500000</abio:ConversionOfPreferredStockToCommonStockShares>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000387" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">283000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000388" contextRef="C_0000907654_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">283000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000389" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-6939000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000390" contextRef="C_0000907654_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-6939000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000391" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231" decimals="-3" unitRef="U_iso4217USD">16000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000392" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131231" decimals="-3" unitRef="U_iso4217USD">90498000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000393" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20131231" decimals="-3" unitRef="U_iso4217USD">-74933000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000394" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231" decimals="INF" unitRef="U_shares">15685562</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000395" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000396" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">7861000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000397" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">7866000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000398" contextRef="C_0000907654_us-gaapStatementClassOfStockAxis_abioCashNetOfOfferingCostsMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331" decimals="INF" unitRef="U_shares">5116228</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000399" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">318000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000400" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">318000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000401" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331" decimals="INF" unitRef="U_shares">199900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000402" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000403" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="F_000404" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-2389000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000405" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331" decimals="-3" unitRef="U_iso4217USD">21000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000406" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140331" decimals="-3" unitRef="U_iso4217USD">98835000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000407" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_abioDeficitAccumulatedDuringDevelopmentStageMember_20140331" decimals="-3" unitRef="U_iso4217USD">-77322000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000408" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331" decimals="INF" unitRef="U_shares">21001690</us-gaap:SharesOutstanding>
  <us-gaap:DepreciationAndAmortization id="F_000409" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">3000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="F_000410" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">10000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="F_000411" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">1809000</us-gaap:DepreciationAndAmortization>
  <us-gaap:PaidInKindInterest id="F_000412" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">211000</us-gaap:PaidInKindInterest>
  <us-gaap:ShareBasedCompensation id="F_000413" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">158000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000414" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">42000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000415" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">3029000</us-gaap:ShareBasedCompensation>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="F_000416" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">377000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:AccretionExpense id="F_000417" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">152000</us-gaap:AccretionExpense>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="F_000418" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">125000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <abio:WriteOffOfDeferredTaxLiability id="F_000419" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2281000</abio:WriteOffOfDeferredTaxLiability>
  <us-gaap:MarketableSecuritiesGainLoss id="F_000420" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">263000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000421" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-83000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:OtherNoncashIncomeExpense id="F_000422" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-267000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000423" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">251000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000424" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">157000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000425" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-2699000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000426" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">698000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000427" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-20000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000428" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-6642000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000429" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-45000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000430" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">312000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000431" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-1638000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000432" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-465000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000433" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">88000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000434" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-19005000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredCharges id="F_000435" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">8000</us-gaap:IncreaseDecreaseInDeferredCharges>
  <us-gaap:IncreaseDecreaseInDeferredCharges id="F_000436" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-1000</us-gaap:IncreaseDecreaseInDeferredCharges>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000437" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">-3687000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000438" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-764000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000439" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">-106396000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:CashAcquiredFromAcquisition id="F_000440" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">30392000</us-gaap:CashAcquiredFromAcquisition>
  <us-gaap:OtherPaymentsToAcquireBusinesses id="F_000441" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">1186000</us-gaap:OtherPaymentsToAcquireBusinesses>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000442" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">9000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000443" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">1911000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="F_000444" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">15369000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000445" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">358000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfIntangibleAssets id="F_000446" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2000000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000447" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-9000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000448" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">45022000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000449" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">10841000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromNotesPayable id="F_000450" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">4000000</us-gaap:ProceedsFromNotesPayable>
  <abio:ProceedsFromIssuanceOfRestrictedStock id="F_000451" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">38000</abio:ProceedsFromIssuanceOfRestrictedStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000452" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">52316000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000453" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2329000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000454" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">9018000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000455" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">1741000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000456" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">24868000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000457" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">834000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000458" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">308000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000459" contextRef="C_0000907654_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">2548000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:RepaymentsOfNotesPayable id="F_000460" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">4000000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfConvertibleDebt id="F_000461" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">105000</us-gaap:RepaymentsOfConvertibleDebt>
  <abio:RepaymentOfPrincipalOnVendorFinanceAgreement id="F_000462" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">51000</abio:RepaymentOfPrincipalOnVendorFinanceAgreement>
  <abio:RepaymentOfPrincipalOnVendorFinanceAgreement id="F_000463" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">43000</abio:RepaymentOfPrincipalOnVendorFinanceAgreement>
  <abio:RepaymentOfPrincipalOnVendorFinanceAgreement id="F_000464" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">505000</abio:RepaymentOfPrincipalOnVendorFinanceAgreement>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000465" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">8133000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000466" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">1390000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000467" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">82576000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000468" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">4446000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000469" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">617000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000470" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">21202000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000471" contextRef="C_0000907654_20121231" decimals="-3" unitRef="U_iso4217USD">2920000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000472" contextRef="C_0000907654_20130331" decimals="-3" unitRef="U_iso4217USD">3537000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid id="F_000473" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000474" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">1000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000475" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">119000</us-gaap:InterestPaid>
  <abio:AccruedInterestOnNotesPayableConvertedToEquity id="F_000476" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">163000</abio:AccruedInterestOnNotesPayableConvertedToEquity>
  <abio:WarrantIssuedInConnectionWithCreditFacility id="F_000477" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">111000</abio:WarrantIssuedInConnectionWithCreditFacility>
  <abio:AccruedDeferredTransactionCosts id="F_000478" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">482000</abio:AccruedDeferredTransactionCosts>
  <abio:VendorFinanceAgreement id="F_000479" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">128000</abio:VendorFinanceAgreement>
  <abio:VendorFinanceAgreement id="F_000480" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">131000</abio:VendorFinanceAgreement>
  <abio:VendorFinanceAgreement id="F_000481" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">128000</abio:VendorFinanceAgreement>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock id="F_000482" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1) The Company and Summary of Significant Accounting Policies &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Description of Business &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ARCA biopharma, Inc., or the Company or ARCA, a Delaware corporation, is headquartered in Westminster, Colorado and is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases.  The Company&amp;#8217;s lead product candidate, Gencaro&amp;#8482; (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that ARCA plans to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  The Company has identified common genetic variations in receptors in the cardiovascular system that it believes interact with Gencaro&amp;#8217;s pharmacology and may predict patient response to the drug. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company plans to test this hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. The AF indication for Gencaro was chosen based on prior clinical data from the previously conducted Phase 3 heart failure (HF) trial of Gencaro in 2,708 HF patients, or the BEST trial, which suggested that Gencaro may be successful in reducing or preventing AF.  GENETIC-AF is a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype the Company believes responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF is time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality. &lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;ARCA has created an adaptive design for GENETIC-AF. The Company has initiated screening of patients for the Phase 2B study of approximately 200 HFREF patients. The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to the pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&amp;#8217;s primary end-point.&amp;#160;The interim analysis will focus on available data regarding the trial&amp;#8217;s primary end point, AF event rates, AF burden, and safety.   Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.  The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3.  The Company, in consultation with the trial&amp;#8217;s clinical steering committee and the DSMB, will make the final determination on the trial&amp;#8217;s development steps.  The Company believes the Phase 2B portion of the study would take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which the Company believes may provide market exclusivity for these uses of Gencaro into at least 2026 in the U.S. and into 2025 in Europe.  In addition, the Company believes that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the U.S. and Europe. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To complete both phases of the GENETIC-AF clinical trial and submit for FDA approval, the Company will need to raise additional capital. If the Company is unable to obtain additional funding or is unable to complete a strategic transaction, it may have to discontinue development activities on Gencaro or discontinue its operations. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Development Stage Risks, Liquidity and Going Concern &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is in the development stage and devotes substantially all of its efforts towards obtaining regulatory approval and raising capital necessary to fund its operations.  The Company has not generated revenue to date and is subject to a number of risks similar to those of other development stage companies, including dependence on key individuals, the development of and regulatory approval of commercially viable products, the need to raise adequate additional financing necessary to fund the development and commercialization of its products, and competition from larger companies. The Company has historically funded its operations through issuances of common and preferred stock, as well as through the business combination with Nuvelo, Inc., or Nuvelo. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Since ARCA was founded on December&amp;#160;17, 2001, or Inception, the Company has incurred substantial losses and negative cash flows from operations. Since Inception, the Company incurred a loss from operations of $108.5 million and had negative cash flows from operations of $106.4 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During 2013, the Company raised approximately $19.3 million, net of offering costs, through sales of its convertible preferred and common stock and warrants.  In February 2014, the Company completed a public equity offering raising approximately $7.9 million in net proceeds to provide additional funds for the Phase 2B/3 GENETIC-AF trial and the Company&amp;#8217;s ongoing operations. The Company has initiated screening of patients for the Phase 2B/3 GENETIC-AF trial, and the Company anticipates that its current cash and cash equivalents  will be sufficient to fund its operations, at its projected cost structure, through at least the end of 2015.  However, in light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, the Company expects to need to raise additional capital to finance the completion of GENETIC-AF and the Company&amp;#8217;s ongoing operations.&amp;#160;If the Company is delayed in completing or is unable to complete additional funding and/or a strategic transaction, the Company may discontinue its development activities or operations. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s liquidity, and its ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;progress of GENETIC-AF enrollment and any data that may become available; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the costs and timing for the GENETIC-AF clinical trial in order to gain possible FDA approval for Gencaro; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the market price of the Company&amp;#8217;s stock and the availability and cost of additional equity capital; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the Company&amp;#8217;s ability to retain the listing of its common stock on the Nasdaq Capital Market; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;general economic and industry conditions affecting the availability and cost of capital; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the Company&amp;#8217;s ability to control costs associated with its operations; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the terms and conditions of the Company&amp;#8217;s existing collaborative and licensing agreements. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The sale of additional equity or convertible debt securities would likely result in substantial additional dilution to the Company&amp;#8217;s stockholders.  If the Company raises additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of the Company&amp;#8217;s capital stock and could contain covenants that would restrict the Company&amp;#8217;s operations.  The Company also cannot predict what consideration might be available, if any, to the Company or its stockholders, in connection with any strategic transaction.  Should strategic alternatives or additional capital not be available to the Company,  or not be available on acceptable terms, the Company may be unable to realize value from its assets and discharge its liabilities in the normal course of business which may, among other alternatives, cause the Company to further delay, substantially reduce or discontinue operational activities to conserve its cash resources. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The significant uncertainties surrounding the clinical development timelines and costs and the need to raise a significant amount of capital raises substantial doubt about the Company&amp;#8217;s ability to continue as a going concern for a reasonable period of time.  These consolidated financial statements have been prepared with the assumption that the Company will continue as a going concern and will be able to realize its assets and discharge its liabilities in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability of the Company to continue as a going concern.  The Company may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or to otherwise continue operations and may not be able to execute any strategic transaction. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Reverse Stock Split &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March&amp;#160;4, 2013, the Company completed a 1-for-6 reverse split of its common stock. All common shares and per common share amounts in the financial statements and footnotes have been adjusted retroactively to reflect the effects of this action. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&amp;nbsp;&amp;nbsp;Accordingly, these financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&amp;#160; In the opinion of management, these financial statements include all normal and recurring adjustments considered necessary for a fair presentation of these interim consolidated financial statements.  The results of operations for the three months ended March&amp;#160;31, 2014 are not necessarily indicative of results expected for the full year ending December&amp;#160;31, 2014.&amp;#160; The Company has generated no revenue to date and its activities have consisted of seeking regulatory approval, research and development, exploring strategic alternatives for further developing and commercializing Gencaro, and raising capital. Accordingly, the Company continues to be considered in the development stage at March&amp;#160;31, 2014. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes thereto for the year ended December&amp;#160;31, 2013 included in the Company&amp;#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission, as amended. Amounts presented are rounded to the nearest thousand, where indicated, except per share data and par values. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company has no off-balance-sheet concentrations of credit risk, such as foreign exchange contracts, option contracts, or foreign currency hedging arrangements.  The Company maintains cash and cash equivalent balances in the form of bank demand deposits, money market fund accounts and debt securities with financial institutions that management believes are creditworthy. Such balances may at times exceed the insured amount. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accrued Expenses &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As part of the process of preparing its financial statements, the Company is required to estimate accrued expenses.  This process involves identifying services that third parties have performed on the Company&amp;#8217;s behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date. Examples of estimated accrued expenses include contract service fees, such as fees payable to contract manufacturers in connection with the production of materials related to the Company&amp;#8217;s drug product, and professional service fees, such as attorneys, consultants, and clinical research organizations.  The Company develops estimates of liabilities using its judgment based upon the facts and circumstances known at the time. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:EarningsPerShareTextBlock id="F_000483" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2) Net Loss Per Share &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company calculates basic earnings per share by dividing loss attributable to common stockholders by the weighted average common shares outstanding during the period, excluding common stock subject to vesting provisions.  Diluted earnings per share is computed by dividing loss attributable to common stockholders by the weighted average number of common shares outstanding during the period increased to include, if dilutive, the number of additional common shares that would have been outstanding if the potential common shares had been issued. The Company&amp;#8217;s potentially dilutive shares include stock options and warrants for common stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the numerator and denominator used in the calculation of basic and diluted loss per share follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In thousands, except shares and per share data)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,389&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,071&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss available to common shareholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,389&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,071&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares of common stock outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,785,418&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,037,546&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Weighted-average shares of unvested common stock&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,783&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total weighted-average shares used in computing net loss&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; per share attributed to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,785,418&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,034,763&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted loss per share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.35&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Potentially dilutive securities representing&amp;#160;10.2 million and 1.3&amp;#160;million weighted average shares of common stock were excluded for the three months ended March&amp;#160;31, 2014 and 2013, respectively, because including them would have an anti-dilutive effect on net loss per share. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:BusinessCombinationDisclosureTextBlock id="F_000484" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3) Merger with Nuvelo, Inc. on January&amp;#160;27, 2009 &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&amp;#160;27, 2009, ARCA Colorado, Inc. (ARCA Colorado) completed the Merger with Nuvelo in accordance with the terms of the Merger Agreement, in which a wholly-owned subsidiary of Nuvelo merged with and into ARCA Colorado, with ARCA Colorado continuing after the Merger as the surviving corporation and a wholly-owned subsidiary of Nuvelo.  Immediately following the Merger, the Company changed its name from Nuvelo, Inc. to ARCA biopharma, Inc., and its common stock began trading on the Nasdaq Global Market under the symbol &amp;#8220;ABIO&amp;#8221; on January&amp;#160;28, 2009.  On March&amp;#160;7, 2011, the listing of the Company&amp;#8217;s common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Merger was treated as a reverse merger and accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.  For accounting purposes, ARCA Colorado was considered to have acquired Nuvelo in the Merger, as the stockholders of ARCA Colorado prior to the Merger had a controlling interest in the combined company and the Company&amp;#8217;s management is the former management of ARCA Colorado.  The results of operations and cash flows include the activities of Nuvelo since the date of the Merger. Pursuant to the rules and regulations of the United States Securities and Exchange Commission, or the SEC, the historical financial statements of ARCA Colorado replaced the historical financial statements of Nuvelo, and the disclosures in this report relating to the pre-Merger business of the Company, unless noted as being the business of Nuvelo prior to the Merger, pertain to the business of ARCA Colorado prior to the Merger. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The estimated total acquisition consideration of $11.9 million to acquire Nuvelo was based on the market capitalization of Nuvelo as of January&amp;#160;27, 2009 and the estimated fair values of its vested stock options and warrants outstanding on that date, as this was deemed the most reliable measure of the consideration effectively transferred to acquire Nuvelo on that date.  The Company estimated the net assets acquired in the Merger to be $37.2 million, including $45.5 million of cash, cash equivalents and marketable securities. In accordance with ASC 805, any excess of fair value of net assets acquired in a business combination over the acquisition consideration results in a gain on bargain purchase, and as a result, the Company recorded a gain on bargain purchase of $25.3 million. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="F_000485" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4) Fair Value Disclosures &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of March&amp;#160;31, 2014, the Company had $21.1 million of cash equivalents consisting of money market funds with maturities of 90 days or less. The Company has the ability to liquidate these investments without restriction.  The Company determines fair value for these money market funds and equity securities with Level 1 inputs through quoted market prices.  There were no transfers of assets between fair value hierarchy levels during the three month period ended March&amp;#160;31, 2014. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Inputs used to measure fair value are classified into the following hierarchy: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&amp;#8212;Unadjusted quoted prices in active markets for identical assets or liabilities &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&amp;#8212;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&amp;#8212;Unobservable inputs for the asset or liability &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value of Other Financial Instruments &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The carrying amount of other financial instruments, including cash, accounts payable, and short-term notes payable approximated fair value due to their short maturities. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="F_000486" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5) Property and Equipment &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lab equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer software&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;176&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;176&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lesser of useful life or life of the lease&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(488&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(485&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the three months ended March&amp;#160;31, 2014 and 2013, and for the period from Inception through March&amp;#160;31, 2014, depreciation and amortization expense was $3,000, $10,000, and $1.8 million respectively. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="F_000487" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6) Commitments and Contingencies &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has or is subject to the following commitments and contingencies: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Employment Agreements &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company maintains employment agreements with several executive employees.  Most of these agreements provide for payments to be made under certain conditions related to a change in control of the Company and entitle the employee to wages and certain benefits payments not exceeding one calendar year from the date of termination without cause or by the employee for good reason.  The agreements may be terminated at any time by the Company with or without cause upon written notice to the employee. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Operating Lease &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On August&amp;#160;1, 2013 the Company entered into a lease agreement for approximately 5,300 square feet of office facilities in Westminster, Colorado which has served as the Company&amp;#8217;s primary business office since October&amp;#160;1, 2013.  The lease has a three year term and expires on September&amp;#160;30, 2016.  The Company&amp;#8217;s previous office lease, entered into on February 8, 2008 for office facilities in Broomfield, Colorado, served as the Company&amp;#8217;s primary business office through September 30, 2013.&amp;nbsp;&amp;nbsp;Below is a summary of the future minimum lease payments committed for the Company&amp;#8217;s facility in Westminster, Colorado as of March&amp;#160;31, 2014 (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remainder of 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum lease payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Rent expense under these leases for the three months ended March&amp;#160;31, 2014 and 2013 was $19,000 and $12,000, respectively, and was $597,000 from Inception through March&amp;#160;31, 2014. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Duke University &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2013, the Company entered into a clinical research agreement with Duke University (Duke) to serve as the clinical research organization for the Company&amp;#8217;s GENETIC-AF clinical study.  Under the agreement the Company is responsible to pay Duke for its work managing certain aspects of the clinical study, including clinical site recruitment and clinical site management.  Upon completion of the clinical study, the agreement will terminate.  The agreement can be terminated earlier by the Company for any reason with 90 days written notice to Duke. In the event of an early termination, the Company and Duke would coordinate efforts for an orderly wind-down of the study, and the Company would be responsible to pay Duke for time and effort incurred through the date of termination and through the wind-down period. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;University of Cincinnati &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2011, the Company entered into a license agreement with the University of Cincinnati to license exclusive worldwide rights to a portfolio of U.S. and international patents, which includes certain U.S. and international diagnostic patents covering genetic markers for ARCA&amp;#8217;s lead drug candidate, Gencaro.  These patents provide the basis for exclusive worldwide development, use and commercialization of the genetic test which may indicate a patient&amp;#8217;s likely response to Gencaro as a treatment for chronic HF, AF, and other indications.  Under the terms of the agreement, ARCA agreed to pay the University of Cincinnati annual license fees and is obligated to future milestone payments for each United States patent issued subsequent to the date of the agreement.  The agreement also requires royalty payments on net sales from genetic testing performed expressly for the purpose of prescribing bucindolol. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ARCA has licensed worldwide rights to Gencaro, including all preclinical and clinical data from Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC, who has licensed rights in Gencaro from BMS. CPEC is a licensing subsidiary of Indevus Pharmaceuticals Inc. (a wholly owned subsidiary of Endo Pharmaceuticals), holding ownership rights to certain clinical trial data of Gencaro.  Under the terms of its license agreement with CPEC, the Company will incur milestone and royalty obligations upon the occurrence of certain events.   If the FDA grants marketing approval for Gencaro, the license agreement states that the Company will owe CPEC a milestone payment of $8.0&amp;#160;million within six months after FDA approval. The license agreement states that a milestone payment of up to $5.0 million in the aggregate shall be paid upon regulatory marketing approval in Europe and Japan.  The license agreement also states that the Company&amp;#8217;s royalty obligation ranges from 12.5% to 25% of revenue from the related product based on achievement of specified product sales levels, including a 5% royalty that CPEC is obligated to pay under its original license agreement for Gencaro. The Company has the right to buy down the royalties to a range of 12.5% to 17% by making a payment to CPEC within six months of regulatory approval. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <abio:EquityFinancingsAndWarrantsDisclosureTextBlock id="F_000488" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7) &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Equity Financings and Warrants&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;2013 Equity Financings &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Private Investment in Public Equity (PIPE) Transaction &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&amp;#160;22, 2013, the Company entered into a Subscription Agreement (the &amp;#8220;January 2013 Purchase Agreement&amp;#8221;) with various accredited investors and its Chief Executive Officer in connection with a private placement of its common stock and warrants.  Pursuant to the January 2013 Purchase Agreement, the Company sold an aggregate of 356,430 shares of its common stock and warrants to purchase up to 249,501 additional shares of its common stock for aggregate gross proceeds of approximately $1 million, before deducting estimated offering expenses payable by the Company. The net proceeds to the Company were approximately $805,000, and the private placement closed on January&amp;#160;25, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.70 shares of common stock.  The purchase price for each unit was $2.81. The warrants were exercisable upon issuance, expire seven years from the date of issuance, and have an exercise price of $2.28 per share, equal to 100% of the closing bid price of ARCA&amp;#8217;s common stock on the Nasdaq Capital Market on January&amp;#160;22, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company filed a registration statement for the resale of the shares underlying the units sold in the private placement.  That registration statement was declared effective by the Securities and Exchange Commission on February&amp;#160;14, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with this transaction, the Company agreed that, subject to certain exceptions, it would not, while the warrants are outstanding, effect or enter into an agreement to effect any issuance of common stock or securities convertible into, exercisable for or exchangeable for common stock in a &amp;#8220;variable rate transaction,&amp;#8221; which means a transaction in which the Company issues or sells any convertible securities either (A)&amp;#160;at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of, or quotations for, the shares of common stock at any time after the initial issuance of such convertible securities, or (B)&amp;#160;with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of the convertible securities or upon the occurrence of the specified or contingent events directly or indirectly related to our business or the market for our common stock.  In addition, the Company agreed that, subject to certain exceptions, if it issues securities within one year following the closing of the offering, each investor would have the right to purchase its pro rata share of a specified portion of the securities in the future offering on the same terms, conditions and price provided for in the proposed issuance of securities. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Registered Direct Offering &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&amp;#160;31, 2013, the Company entered into a subscription agreement with certain institutional investors (the &amp;#8220;Investors&amp;#8221;) in connection with its Registered Direct public offering, pursuant to which the Company sold an aggregate of 164,636 shares of its common stock and warrants to purchase up to 65,855 additional shares of its common stock to the Investors for aggregate gross proceeds of approximately $730,000, before deducting placement agent fee and other estimated offering expenses payable by the Company.  The net proceeds to the Company were approximately $616,000, and the offering closed on February&amp;#160;4, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.40 shares of common stock.  The purchase price for each unit was $4.43.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $4.13 per share, equal to the closing bid price of ARCA&amp;#8217;s common stock on the Nasdaq Capital Market on January&amp;#160;31, 2013.  The Offering was effected as a takedown of the Company&amp;#8217;s Registration Statement on Form S-3, as amended, which became effective on April&amp;#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&amp;#160;1, 2013.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Public Offering &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June&amp;#160;4, 2013, the Company sold shares of its Series A Convertible Preferred Stock (Preferred Stock) and warrants to purchase common stock in a public offering for aggregate gross proceeds of $20.0 million. The Company issued 125,000 shares of Preferred Stock and warrants to purchase up to 6,250,000 shares of common stock at a purchase price of $160 per share of Preferred Stock.  The net proceeds, after deducting placement agent fees and other offering expenses payable by the Company, were approximately $17.9 million. ARCA&amp;#8217;s Director and Chief Executive Officer participated in the offering, purchasing 781 shares of Preferred Stock and warrants to purchase 39,050 shares of common stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each share of Preferred Stock was convertible into 100 shares of the Company&amp;#8217;s common stock at any time at the option of the holder. Each share of Preferred Stock had a liquidation preference of $.001 per share.  The shares of Preferred Stock had no preferential dividends or redemption rights, and no voting rights except as required by law.  During 2013, all of the shares of the Preferred Stock were converted into shares of ARCA common stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each purchaser in the offering was issued a warrant to purchase 50 shares of the Company&amp;#8217;s common stock for each share of Preferred Stock purchased.  The warrants have an exercise price of $1.60 per share, will expire on the five year anniversary of the date of issuance, and were exercisable immediately upon issuance, provided that the holder will be prohibited from exercising the warrants if, as a result of such exercise, the holder, together with its affiliates, would beneficially own more than 9.99% of the total number of shares of common stock then issued and outstanding. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The securities were sold pursuant to a placement agreement and have been registered under the Securities Act of 1933 pursuant to the Company&amp;#8217;s Registration Statement on Form S-1, as amended (No.333-187508), which was declared effective by the Securities and Exchange Commission on May&amp;#160;29, 2013, and the Preferred Stock and Warrants were offered and sold pursuant to a prospectus dated May&amp;#160;30, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the Preferred Stock financing, the Company recorded a non-cash dividend of approximately $2.0 million to recognize the intrinsic value of the embedded beneficial conversion feature.  Typically, such a deemed dividend would be represented as a reduction in a company&amp;#8217;s retained earnings and an increase in additional paid in capital in recognition of the reapportionment of common shareholder value to the preferred stock purchasers.  However, since ARCA has an accumulated deficit, the deemed dividend is recognized by a reapportionment of additional paid in capital from common shareholders to additional paid in capital of preferred stock purchasers, which are combined in the Company&amp;#8217;s statement of stockholders&amp;#8217; equity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;2014 Equity Financing &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Registered Direct Offering &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February&amp;#160;3, 2014, the Company agreed to sell to certain investors an aggregate of 5,116,228 shares of the Company&amp;#8217;s common stock and warrants to purchase an aggregate of 1,279,057 shares of the Company&amp;#8217;s common stock at a purchase price of $1.70 per share of Common Stock, for aggregate gross proceeds of approximately of $8.7 million, before deducting placement agent fees and other offering related expenses.  The offering closed on February&amp;#160;7, 2014, and the net proceeds to the Company were approximately $7.9 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The common stock and warrants were sold in combination consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $2.125 per share, equal to 125% of the closing bid price of ARCA&amp;#8217;s common stock on the Nasdaq Capital Market on February&amp;#160;3, 2014.  The offering was effected as a takedown off the Company&amp;#8217;s Registration Statement on Form S-3, as amended, which became effective on April&amp;#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&amp;#160;4, 2014.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Warrants &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of March&amp;#160;31, 2014, warrants to purchase approximately 9.4&amp;#160;million shares of common stock were outstanding at exercise prices ranging from $1.60 to $116.89, with a weighted average exercise price per share of $2.31.  These warrants, which were granted as part of various financing and business agreements, expire at various times between April 2016 and January 2020. Warrants were recorded in additional paid-in capital at their estimated fair market value at the date of grant using a Black-Scholes option-pricing model. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</abio:EquityFinancingsAndWarrantsDisclosureTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="F_000489" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8) Share-based Compensation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the three month period ended March&amp;#160;31, 2014 and 2013 and for the period from Inception through March&amp;#160;31, 2014, the Company recognized the following non-cash, share-based compensation expense in the consolidated statement of operations (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Period from December 17, 2001 (date of inception) to March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;707&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, General and Administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restructuring Expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;158&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,029&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock option and stock award transactions for the three month period ended March&amp;#160;31, 2014 under the Company&amp;#8217;s stock incentive  plans were as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average Remaining Contractual Term&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;843,442&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200,079&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.91&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited and cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,908.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,043,494&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.35&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;266,655&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.42&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested and expected to vest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,031,382&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.37&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.92&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average Grant Date Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;419,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.95&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and released&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited and cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units outstanding at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.57&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="F_000490" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9) Income Taxes &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accordance with United States Generally Accepted Accounting Principles, a valuation allowance should be provided if it is more likely than not that some or all of the Company&amp;#8217;s deferred tax assets will not be realized.  The Company&amp;#8217;s ability to realize the benefit of its deferred tax assets will depend on the generation of future taxable income. Due to the uncertainty of future profitable operations and taxable income, the Company has recorded a full valuation allowance against its net deferred tax assets.  The Company believes its tax filing positions and deductions related to tax periods subject to examination will be sustained upon audit and, therefore, has no reserve for uncertain tax positions. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock id="F_000491" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Description of Business &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ARCA biopharma, Inc., or the Company or ARCA, a Delaware corporation, is headquartered in Westminster, Colorado and is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases.  The Company&amp;#8217;s lead product candidate, Gencaro&amp;#8482; (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that ARCA plans to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  The Company has identified common genetic variations in receptors in the cardiovascular system that it believes interact with Gencaro&amp;#8217;s pharmacology and may predict patient response to the drug. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company plans to test this hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. The AF indication for Gencaro was chosen based on prior clinical data from the previously conducted Phase 3 heart failure (HF) trial of Gencaro in 2,708 HF patients, or the BEST trial, which suggested that Gencaro may be successful in reducing or preventing AF.  GENETIC-AF is a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype the Company believes responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF is time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality. &lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;ARCA has created an adaptive design for GENETIC-AF. The Company has initiated screening of patients for the Phase 2B study of approximately 200 HFREF patients. The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to the pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&amp;#8217;s primary end-point.&amp;#160;The interim analysis will focus on available data regarding the trial&amp;#8217;s primary end point, AF event rates, AF burden, and safety.   Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.  The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3.  The Company, in consultation with the trial&amp;#8217;s clinical steering committee and the DSMB, will make the final determination on the trial&amp;#8217;s development steps.  The Company believes the Phase 2B portion of the study would take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which the Company believes may provide market exclusivity for these uses of Gencaro into at least 2026 in the U.S. and into 2025 in Europe.  In addition, the Company believes that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the U.S. and Europe. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To complete both phases of the GENETIC-AF clinical trial and submit for FDA approval, the Company will need to raise additional capital. If the Company is unable to obtain additional funding or is unable to complete a strategic transaction, it may have to discontinue development activities on Gencaro or discontinue its operations. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
  <abio:DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock id="F_000492" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Development Stage Risks, Liquidity and Going Concern &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is in the development stage and devotes substantially all of its efforts towards obtaining regulatory approval and raising capital necessary to fund its operations.  The Company has not generated revenue to date and is subject to a number of risks similar to those of other development stage companies, including dependence on key individuals, the development of and regulatory approval of commercially viable products, the need to raise adequate additional financing necessary to fund the development and commercialization of its products, and competition from larger companies. The Company has historically funded its operations through issuances of common and preferred stock, as well as through the business combination with Nuvelo, Inc., or Nuvelo. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Since ARCA was founded on December&amp;#160;17, 2001, or Inception, the Company has incurred substantial losses and negative cash flows from operations. Since Inception, the Company incurred a loss from operations of $108.5 million and had negative cash flows from operations of $106.4 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During 2013, the Company raised approximately $19.3 million, net of offering costs, through sales of its convertible preferred and common stock and warrants.  In February 2014, the Company completed a public equity offering raising approximately $7.9 million in net proceeds to provide additional funds for the Phase 2B/3 GENETIC-AF trial and the Company&amp;#8217;s ongoing operations. The Company has initiated screening of patients for the Phase 2B/3 GENETIC-AF trial, and the Company anticipates that its current cash and cash equivalents  will be sufficient to fund its operations, at its projected cost structure, through at least the end of 2015.  However, in light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, the Company expects to need to raise additional capital to finance the completion of GENETIC-AF and the Company&amp;#8217;s ongoing operations.&amp;#160;If the Company is delayed in completing or is unable to complete additional funding and/or a strategic transaction, the Company may discontinue its development activities or operations. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s liquidity, and its ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;progress of GENETIC-AF enrollment and any data that may become available; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the costs and timing for the GENETIC-AF clinical trial in order to gain possible FDA approval for Gencaro; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the market price of the Company&amp;#8217;s stock and the availability and cost of additional equity capital; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the Company&amp;#8217;s ability to retain the listing of its common stock on the Nasdaq Capital Market; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;general economic and industry conditions affecting the availability and cost of capital; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the Company&amp;#8217;s ability to control costs associated with its operations; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Wingdings 2&apos;;font-size:10pt;"&gt;&amp;#151;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the terms and conditions of the Company&amp;#8217;s existing collaborative and licensing agreements. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The sale of additional equity or convertible debt securities would likely result in substantial additional dilution to the Company&amp;#8217;s stockholders.  If the Company raises additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of the Company&amp;#8217;s capital stock and could contain covenants that would restrict the Company&amp;#8217;s operations.  The Company also cannot predict what consideration might be available, if any, to the Company or its stockholders, in connection with any strategic transaction.  Should strategic alternatives or additional capital not be available to the Company,  or not be available on acceptable terms, the Company may be unable to realize value from its assets and discharge its liabilities in the normal course of business which may, among other alternatives, cause the Company to further delay, substantially reduce or discontinue operational activities to conserve its cash resources. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The significant uncertainties surrounding the clinical development timelines and costs and the need to raise a significant amount of capital raises substantial doubt about the Company&amp;#8217;s ability to continue as a going concern for a reasonable period of time.  These consolidated financial statements have been prepared with the assumption that the Company will continue as a going concern and will be able to realize its assets and discharge its liabilities in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability of the Company to continue as a going concern.  The Company may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or to otherwise continue operations and may not be able to execute any strategic transaction. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</abio:DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock>
  <abio:ReverseStockSplitPolicyTextBlock id="F_000493" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Reverse Stock Split &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March&amp;#160;4, 2013, the Company completed a 1-for-6 reverse split of its common stock. All common shares and per common share amounts in the financial statements and footnotes have been adjusted retroactively to reflect the effects of this action. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</abio:ReverseStockSplitPolicyTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="F_000494" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&amp;nbsp;&amp;nbsp;Accordingly, these financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&amp;#160; In the opinion of management, these financial statements include all normal and recurring adjustments considered necessary for a fair presentation of these interim consolidated financial statements.  The results of operations for the three months ended March&amp;#160;31, 2014 are not necessarily indicative of results expected for the full year ending December&amp;#160;31, 2014.&amp;#160; The Company has generated no revenue to date and its activities have consisted of seeking regulatory approval, research and development, exploring strategic alternatives for further developing and commercializing Gencaro, and raising capital. Accordingly, the Company continues to be considered in the development stage at March&amp;#160;31, 2014. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes thereto for the year ended December&amp;#160;31, 2013 included in the Company&amp;#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission, as amended. Amounts presented are rounded to the nearest thousand, where indicated, except per share data and par values. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk id="F_000495" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company has no off-balance-sheet concentrations of credit risk, such as foreign exchange contracts, option contracts, or foreign currency hedging arrangements.  The Company maintains cash and cash equivalent balances in the form of bank demand deposits, money market fund accounts and debt securities with financial institutions that management believes are creditworthy. Such balances may at times exceed the insured amount. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <abio:AccruedExpensesPolicyTextBlock id="F_000496" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accrued Expenses &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As part of the process of preparing its financial statements, the Company is required to estimate accrued expenses.  This process involves identifying services that third parties have performed on the Company&amp;#8217;s behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date. Examples of estimated accrued expenses include contract service fees, such as fees payable to contract manufacturers in connection with the production of materials related to the Company&amp;#8217;s drug product, and professional service fees, such as attorneys, consultants, and clinical research organizations.  The Company develops estimates of liabilities using its judgment based upon the facts and circumstances known at the time. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</abio:AccruedExpensesPolicyTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock id="F_000497" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the numerator and denominator used in the calculation of basic and diluted loss per share follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In thousands, except shares and per share data)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,389&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,071&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss available to common shareholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,389&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,071&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares of common stock outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,785,418&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,037,546&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Weighted-average shares of unvested common stock&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,783&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total weighted-average shares used in computing net loss&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; per share attributed to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,785,418&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,034,763&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted loss per share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.35&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="F_000498" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lab equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer software&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;176&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;176&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lesser of useful life or life of the lease&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(488&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(485&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="F_000499" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s previous office lease, entered into on February 8, 2008 for office facilities in Broomfield, Colorado, served as the Company&amp;#8217;s primary business office through September 30, 2013.&amp;nbsp;&amp;nbsp;Below is a summary of the future minimum lease payments committed for the Company&amp;#8217;s facility in Westminster, Colorado as of March&amp;#160;31, 2014 (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remainder of 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum lease payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="F_000500" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the three month period ended March&amp;#160;31, 2014 and 2013 and for the period from Inception through March&amp;#160;31, 2014, the Company recognized the following non-cash, share-based compensation expense in the consolidated statement of operations (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Period from December 17, 2001 (date of inception) to March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;707&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, General and Administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restructuring Expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;158&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,029&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock id="F_000501" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock option and stock award transactions for the three month period ended March&amp;#160;31, 2014 under the Company&amp;#8217;s stock incentive  plans were as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average Remaining Contractual Term&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;843,442&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200,079&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.91&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited and cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,908.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,043,494&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.35&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;266,655&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.42&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested and expected to vest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,031,382&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.37&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.92&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock id="F_000502" contextRef="C_0000907654_20140101_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted Average Grant Date Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;419,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.95&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and released&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited and cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units outstanding at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.57&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <abio:NumberOfPatients id="F_000503" contextRef="C_0000907654_us-gaapHealthCareTrustFundAxis_abioPhaseThreeHeartFailureMember_20140101_20140331" decimals="INF" unitRef="U_abioPatients">2708</abio:NumberOfPatients>
  <abio:NumberOfPatientsCompanyPlansToEnroll id="F_000504" contextRef="C_0000907654_20140101_20140331" decimals="INF" unitRef="U_abioPatients">200</abio:NumberOfPatientsCompanyPlansToEnroll>
  <abio:NumberOfPatientsCompanyPlansToEnroll id="F_000505" contextRef="C_0000907654_us-gaapHealthCareTrustFundAxis_abioPhaseThreeHeartFailureMember_20140101_20140331" decimals="INF" unitRef="U_abioPatients">420</abio:NumberOfPatientsCompanyPlansToEnroll>
  <abio:TermOfCompletion id="F_000506" contextRef="C_0000907654_20140101_20140331">P2Y6M</abio:TermOfCompletion>
  <us-gaap:OperatingIncomeLoss id="F_000507" contextRef="C_0000907654_20020101_20140331" decimals="-5" unitRef="U_iso4217USD">-108500000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="F_000508" contextRef="C_0000907654_20020101_20140331" decimals="-5" unitRef="U_iso4217USD">-106400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000509" contextRef="C_0000907654_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">19300000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000510" contextRef="C_0000907654_abioEquityTransactionsTypeAxis_abioRegisteredDirectOfferingMember_us-gaapSecuritiesFinancingTransactionAxis_abioTwoZeroOneFourEquityFinancingsMember_20140201_20140228" decimals="-5" unitRef="U_iso4217USD">7900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockholdersEquityReverseStockSplit id="F_000511" contextRef="C_0000907654_20130205_20130304">1-for-6 reverse split</us-gaap:StockholdersEquityReverseStockSplit>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="F_000512" contextRef="C_0000907654_20140101_20140331" decimals="0" unitRef="U_shares">18785418</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="F_000513" contextRef="C_0000907654_20130101_20130331" decimals="0" unitRef="U_shares">3037546</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="F_000514" contextRef="C_0000907654_20130101_20130331" decimals="0" unitRef="U_shares">2783</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="F_000515" contextRef="C_0000907654_20140101_20140331" decimals="0" unitRef="U_shares">18785418</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="F_000516" contextRef="C_0000907654_20130101_20130331" decimals="0" unitRef="U_shares">3034763</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000517" contextRef="C_0000907654_20140101_20140331" decimals="-5" unitRef="U_shares">10200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000518" contextRef="C_0000907654_20130101_20130331" decimals="-5" unitRef="U_shares">1300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable id="F_000519" contextRef="C_0000907654_20090101_20090127" decimals="-5" unitRef="U_iso4217USD">11900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet id="F_000520" contextRef="C_0000907654_20090127" decimals="-5" unitRef="U_iso4217USD">37200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents id="F_000521" contextRef="C_0000907654_20090127" decimals="-5" unitRef="U_iso4217USD">45500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount id="F_000522" contextRef="C_0000907654_20090101_20090127" decimals="-5" unitRef="U_iso4217USD">25300000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <abio:CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod id="F_000523" contextRef="C_0000907654_us-gaapRangeAxis_us-gaapMaximumMember_20140331">P90D</abio:CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod>
  <abio:FairValueAssetsBetweenHierarchyLevelsTransfersAmount id="F_000524" contextRef="C_0000907654_20140101_20140331" decimals="0" unitRef="U_iso4217USD">0</abio:FairValueAssetsBetweenHierarchyLevelsTransfersAmount>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_000525" contextRef="C_0000907654_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_20140331" decimals="-5" unitRef="U_iso4217USD">21100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000526" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20140101_20140331">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000527" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20140101_20140331">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000528" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20140101_20140331">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000529" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20140101_20140331">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives id="F_000530" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20140101_20140331">Lesser of useful life or life of the lease</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000531" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20140331" decimals="-3" unitRef="U_iso4217USD">99000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000532" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20131231" decimals="-3" unitRef="U_iso4217USD">99000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000533" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20140331" decimals="-3" unitRef="U_iso4217USD">142000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000534" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20131231" decimals="-3" unitRef="U_iso4217USD">142000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000535" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20140331" decimals="-3" unitRef="U_iso4217USD">89000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000536" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20131231" decimals="-3" unitRef="U_iso4217USD">89000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000537" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20140331" decimals="-3" unitRef="U_iso4217USD">176000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000538" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20131231" decimals="-3" unitRef="U_iso4217USD">176000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000539" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20140331" decimals="-3" unitRef="U_iso4217USD">8000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000540" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20131231" decimals="-3" unitRef="U_iso4217USD">8000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000541" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">514000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000542" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">514000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000543" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">488000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000544" contextRef="C_0000907654_20131231" decimals="-3" unitRef="U_iso4217USD">485000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:DepreciationAndAmortization id="F_000545" contextRef="C_0000907654_20020101_20140331" decimals="-3" unitRef="U_iso4217USD">1809000</us-gaap:DepreciationAndAmortization>
  <us-gaap:AreaOfRealEstateProperty id="F_000546" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioWestminsterMember_20130801" decimals="INF" unitRef="U_utrsqft">5300</us-gaap:AreaOfRealEstateProperty>
  <us-gaap:LeaseExpirationDate1 id="F_000547" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioBroomfieldMember_20140101_20140331">2013-09-30</us-gaap:LeaseExpirationDate1>
  <abio:LeaseTerm id="F_000548" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioWestminsterMember_20140101_20140331">P3Y</abio:LeaseTerm>
  <us-gaap:LeaseExpirationDate1 id="F_000549" contextRef="C_0000907654_us-gaapPropertyPlantAndEquipmentByTypeAxis_abioWestminsterMember_20140101_20140331">2016-09-30</us-gaap:LeaseExpirationDate1>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear id="F_000550" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">59000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="F_000551" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">80000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="F_000552" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">62000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="F_000553" contextRef="C_0000907654_20140331" decimals="-3" unitRef="U_iso4217USD">201000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000554" contextRef="C_0000907654_20140101_20140331" decimals="0" unitRef="U_iso4217USD">19000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000555" contextRef="C_0000907654_20130101_20130331" decimals="0" unitRef="U_iso4217USD">12000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000556" contextRef="C_0000907654_20020101_20140331" decimals="0" unitRef="U_iso4217USD">597000</us-gaap:OperatingLeasesRentExpenseNet>
  <abio:AgreementTerminationNoticePeriod id="F_000557" contextRef="C_0000907654_20140101_20140331">P90D</abio:AgreementTerminationNoticePeriod>
  <abio:ExpectedMilestonePaymentsUponApproval id="F_000558" contextRef="C_0000907654_20080731" decimals="-5" unitRef="U_iso4217USD">8000000</abio:ExpectedMilestonePaymentsUponApproval>
  <abio:AnotherExpectedMilestonePaymentsUponApproval id="F_000559" contextRef="C_0000907654_20080731" decimals="-5" unitRef="U_iso4217USD">5000000</abio:AnotherExpectedMilestonePaymentsUponApproval>
  <abio:MinimumPercentageOfRoyaltyObligation id="F_000560" contextRef="C_0000907654_20080701_20080731" decimals="INF" unitRef="U_pure">0.125</abio:MinimumPercentageOfRoyaltyObligation>
  <abio:MaximumPercentageOfRoyaltyObligation id="F_000561" contextRef="C_0000907654_20080701_20080731" decimals="INF" unitRef="U_pure">0.25</abio:MaximumPercentageOfRoyaltyObligation>
  <abio:PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement id="F_000562" contextRef="C_0000907654_20080701_20080731" decimals="INF" unitRef="U_pure">0.05</abio:PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement>
  <abio:MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown id="F_000563" contextRef="C_0000907654_20080701_20080731" decimals="INF" unitRef="U_pure">0.125</abio:MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown>
  <abio:MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown id="F_000564" contextRef="C_0000907654_20080701_20080731" decimals="INF" unitRef="U_pure">0.17</abio:MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown>
  <abio:MilestonePaymentDuePeriod id="F_000565" contextRef="C_0000907654_20080701_20080731">P6M</abio:MilestonePaymentDuePeriod>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash id="F_000566" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231" decimals="INF" unitRef="U_shares">356430</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="F_000567" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20131231" decimals="INF" unitRef="U_shares">249501</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash id="F_000568" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231" decimals="-6" unitRef="U_iso4217USD">1000000</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <abio:StockIssuedDuringPeriodNetProceeds id="F_000569" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231" decimals="0" unitRef="U_iso4217USD">805000</abio:StockIssuedDuringPeriodNetProceeds>
  <abio:EquityIssuanceCloseDate id="F_000570" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231">2013-01-25</abio:EquityIssuanceCloseDate>
  <us-gaap:EquityIssuanceDates id="F_000571" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231">2013-01-22</us-gaap:EquityIssuanceDates>
  <us-gaap:EquityIssuancePerShareAmount id="F_000572" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_abioshares">2.81</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="F_000573" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20131231" decimals="INF" unitRef="U_shares">0.70</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000574" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20131231" decimals="INF" unitRef="U_iso4217USD_abioshares">2.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <abio:ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares id="F_000575" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20131231" decimals="INF" unitRef="U_pure">1.00</abio:ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares>
  <abio:ClassOfWarrantOrRightExercisableExpirationPeriod id="F_000576" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231">P7Y</abio:ClassOfWarrantOrRightExercisableExpirationPeriod>
  <abio:ClosingBidPriceDate id="F_000577" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPrivateInvestmentInPublicEquityTransactionMember_20130101_20131231">2013-01-22</abio:ClosingBidPriceDate>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash id="F_000578" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231" decimals="INF" unitRef="U_shares">164636</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="F_000579" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20131231" decimals="INF" unitRef="U_shares">65855</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash id="F_000580" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231" decimals="0" unitRef="U_iso4217USD">730000</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <abio:StockIssuedDuringPeriodNetProceeds id="F_000581" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231" decimals="0" unitRef="U_iso4217USD">616000</abio:StockIssuedDuringPeriodNetProceeds>
  <abio:EquityIssuanceCloseDate id="F_000582" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231">2013-02-04</abio:EquityIssuanceCloseDate>
  <us-gaap:EquityIssuanceDates id="F_000583" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231">2013-01-31</us-gaap:EquityIssuanceDates>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="F_000584" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20131231" decimals="INF" unitRef="U_shares">0.40</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <abio:ClassOfWarrantOrRightExercisableExpirationPeriod id="F_000585" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231">P5Y</abio:ClassOfWarrantOrRightExercisableExpirationPeriod>
  <us-gaap:EquityIssuancePerShareAmount id="F_000586" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_abioshares">4.43</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000587" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20131231" decimals="INF" unitRef="U_iso4217USD_abioshares">4.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <abio:ClosingBidPriceDate id="F_000588" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20130101_20131231">2013-01-31</abio:ClosingBidPriceDate>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash id="F_000589" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">20000000</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash id="F_000590" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">125000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="F_000591" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_shares">6250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:EquityIssuancePerShareAmount id="F_000592" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231" decimals="0" unitRef="U_iso4217USD_abioshares">160</us-gaap:EquityIssuancePerShareAmount>
  <abio:StockIssuedDuringPeriodNetProceeds id="F_000593" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">17900000</abio:StockIssuedDuringPeriodNetProceeds>
  <abio:PreferredStockPurchasedByOfficer id="F_000594" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapTitleOfIndividualAxis_abioDirectorAndChiefExecutiveOfficerMember_20131231" decimals="INF" unitRef="U_shares">781</abio:PreferredStockPurchasedByOfficer>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="F_000595" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapTitleOfIndividualAxis_abioDirectorAndChiefExecutiveOfficerMember_20131231" decimals="INF" unitRef="U_shares">39050</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="F_000596" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_shares">100</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:PreferredStockLiquidationPreference id="F_000597" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="3" unitRef="U_iso4217USD_abioshares">0.001</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="F_000598" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_shares">50</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000599" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_iso4217USD_abioshares">1.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <abio:PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership id="F_000600" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_pure">0.0999</abio:PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership>
  <abio:ClassOfWarrantOrRightExercisableExpirationPeriod id="F_000601" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231">P5Y</abio:ClassOfWarrantOrRightExercisableExpirationPeriod>
  <abio:IntrinsicValueOfEmbeddedBeneficialConversionFeature id="F_000602" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioPublicOfferingMember_us-gaapStatementClassOfStockAxis_abioSeriesAConvertiblePreferredStockMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">2000000</abio:IntrinsicValueOfEmbeddedBeneficialConversionFeature>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash id="F_000603" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331" decimals="INF" unitRef="U_shares">5116228</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="F_000604" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140331" decimals="INF" unitRef="U_shares">1279057</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:EquityIssuancePerShareAmount id="F_000605" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">1.70</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash id="F_000606" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331" decimals="-5" unitRef="U_iso4217USD">8700000</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <abio:StockIssuedDuringPeriodNetProceeds id="F_000607" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331" decimals="-5" unitRef="U_iso4217USD">7900000</abio:StockIssuedDuringPeriodNetProceeds>
  <abio:ClosingBidPriceDate id="F_000608" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331">2014-02-03</abio:ClosingBidPriceDate>
  <abio:EquityIssuanceCloseDate id="F_000609" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331">2014-02-07</abio:EquityIssuanceCloseDate>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="F_000610" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140331" decimals="INF" unitRef="U_shares">0.25</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <abio:ClassOfWarrantOrRightExercisableExpirationPeriod id="F_000611" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140101_20140331">P5Y</abio:ClassOfWarrantOrRightExercisableExpirationPeriod>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000612" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">2.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <abio:ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares id="F_000613" contextRef="C_0000907654_abioEquityFinancingTransactionsTypeAxis_abioRegisteredDirectOfferingMember_20140331" decimals="INF" unitRef="U_pure">1.25</abio:ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000614" contextRef="C_0000907654_20140331" decimals="-5" unitRef="U_shares">9400000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000615" contextRef="C_0000907654_us-gaapRangeAxis_us-gaapMinimumMember_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">1.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000616" contextRef="C_0000907654_us-gaapRangeAxis_us-gaapMaximumMember_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">116.89</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000617" contextRef="C_0000907654_us-gaapRangeAxis_us-gaapWeightedAverageMember_20140331" decimals="INF" unitRef="U_iso4217USD_abioshares">2.31</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <abio:ClassOfWarrantOrRightsExpirationDateEarliest id="F_000618" contextRef="C_0000907654_20140101_20140331">2016-04</abio:ClassOfWarrantOrRightsExpirationDateEarliest>
  <abio:ClassOfWarrantOrRightsExpirationDateLatest id="F_000619" contextRef="C_0000907654_20140101_20140331">2020-01</abio:ClassOfWarrantOrRightsExpirationDateLatest>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000620" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">40000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000621" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">15000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000622" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">707000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000623" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">118000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000624" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">27000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000625" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">1935000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000626" contextRef="C_0000907654_us-gaapIncomeStatementLocationAxis_us-gaapRestructuringChargesMember_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">387000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000627" contextRef="C_0000907654_20140101_20140331" decimals="-3" unitRef="U_iso4217USD">158000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000628" contextRef="C_0000907654_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">42000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000629" contextRef="C_0000907654_20011218_20140331" decimals="-3" unitRef="U_iso4217USD">3029000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000630" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">843442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_000631" contextRef="C_0000907654_20140101_20140331" decimals="INF" unitRef="U_shares">200079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000632" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod id="F_000633" contextRef="C_0000907654_20140101_20140331" decimals="INF" unitRef="U_shares">27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000634" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">1043494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="F_000635" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">266655</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="F_000636" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">1031382</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_000637" contextRef="C_0000907654_20131231" decimals="2" unitRef="U_iso4217USD_abioshares">3.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_000638" contextRef="C_0000907654_20140101_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">1.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_000639" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_iso4217USD_abioshares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice id="F_000640" contextRef="C_0000907654_20140101_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">1908.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_000641" contextRef="C_0000907654_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">3.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="F_000642" contextRef="C_0000907654_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">8.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="F_000643" contextRef="C_0000907654_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">3.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="F_000644" contextRef="C_0000907654_20130101_20131231">P8Y11M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="F_000645" contextRef="C_0000907654_20140101_20140331">P8Y11M5D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="F_000646" contextRef="C_0000907654_20140101_20140331">P7Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 id="F_000647" contextRef="C_0000907654_20140101_20140331">P8Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_000648" contextRef="C_0000907654_20131231" decimals="INF" unitRef="U_shares">419000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="F_000649" contextRef="C_0000907654_20140101_20140331" decimals="INF" unitRef="U_shares">191700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="F_000650" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="F_000651" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_000652" contextRef="C_0000907654_20140331" decimals="INF" unitRef="U_shares">610700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_000653" contextRef="C_0000907654_20131231" decimals="2" unitRef="U_iso4217USD_abioshares">1.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000654" contextRef="C_0000907654_20140101_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">1.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="F_000655" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_iso4217USD_abioshares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="F_000656" xsi:nil="true" contextRef="C_0000907654_20140101_20140331" unitRef="U_iso4217USD_abioshares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_000657" contextRef="C_0000907654_20140331" decimals="2" unitRef="U_iso4217USD_abioshares">1.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>abio-20140331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Schema Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:abio="http://www.nuvelo.com/20140331" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nuvelo.com/20140331" xmlns="http://www.w3.org/2001/XMLSchema">
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" namespace="http://fasb.org/us-types/2013-01-31" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" namespace="http://fasb.org/us-gaap/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" namespace="http://xbrl.sec.gov/country/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2012-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2011-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2011-01-31" />
  <annotation>
    <appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.nuvelo.com/20140331/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20140331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20140331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20140331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20140331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit" id="Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit">
        <link:definition>100040 - Statement - Consolidated Statements of Preferred Stock and Stockholders&apos; Equity (Deficit)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical" id="Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100050 - Statement - Consolidated Statements of Preferred Stock and Stockholders&apos; Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies" id="Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies">
        <link:definition>100070 - Disclosure - The Company and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100080 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009" id="Role_DisclosureMergerWithNuveloIncOnJanuary272009">
        <link:definition>100090 - Disclosure - Merger with Nuvelo, Inc. on January 27, 2009</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures" id="Role_DisclosureFairValueDisclosures">
        <link:definition>100100 - Disclosure - Fair Value Disclosures</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100110 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100120 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants" id="Role_DisclosureEquityFinancingsAndWarrants">
        <link:definition>100130 - Disclosure - Equity Financings and Warrants</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation" id="Role_DisclosureShareBasedCompensation">
        <link:definition>100140 - Disclosure - Share- based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100150 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100160 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100170 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100180 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100190 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables" id="Role_DisclosureShareBasedCompensationTables">
        <link:definition>100200 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails" id="Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>100210 - Disclosure - The Company and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareDetails">
        <link:definition>100220 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual" id="Role_DisclosureNetLossPerShareDetailsTextual">
        <link:definition>100230 - Disclosure - Net Loss Per Share (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details" id="Role_DisclosureMergerWithNuveloIncOnJanuary272009Details">
        <link:definition>100240 - Disclosure - Merger with Nuvelo, Inc. on January 27, 2009 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails" id="Role_DisclosureFairValueDisclosuresDetails">
        <link:definition>100250 - Disclosure - Fair Value Disclosures (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails" id="Role_DisclosurePropertyAndEquipmentDetails">
        <link:definition>100260 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual" id="Role_DisclosurePropertyAndEquipmentDetailsTextual">
        <link:definition>100270 - Disclosure - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual" id="Role_DisclosureCommitmentsAndContingenciesDetailsTextual">
        <link:definition>100280 - Disclosure - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails" id="Role_DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>100290 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual" id="Role_DisclosureEquityFinancingsAndWarrantsDetailsTextual">
        <link:definition>100300 - Disclosure - Equity Financings and Warrants (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails" id="Role_DisclosureShareBasedCompensationDetails">
        <link:definition>100310 - Disclosure - Share-based Compensation (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1" id="Role_DisclosureShareBasedCompensationDetails1">
        <link:definition>100320 - Disclosure - Share-based Compensation (Details 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2" id="Role_DisclosureShareBasedCompensationDetails2">
        <link:definition>100330 - Disclosure - Share-based Compensation (Details 2)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <element id="abio_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_GainLossOnAssignmentOfPatentRights" name="GainLossOnAssignmentOfPatentRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_AdjustmentForFractionalShares" name="AdjustmentForFractionalShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_AccretionOfOfferingCostEffectOnEquity" name="AccretionOfOfferingCostEffectOnEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" name="StockIssuedDuringPeriodUponConversionOfNotesPayableValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" name="StockIssuedDuringPeriodUponConversionOfNotesPayableShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" name="FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" name="SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SeriesOfferingCostsMember" name="SeriesOfferingCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" name="FirstIssuanceOfConvertibleRedeemablePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" name="ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_DeficitAccumulatedDuringDevelopmentStageMember" name="DeficitAccumulatedDuringDevelopmentStageMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" name="ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" name="SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_AccretionOfSeriesMember" name="AccretionOfSeriesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_AccretionOfSeriesBMember" name="AccretionOfSeriesBMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" name="SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" name="IssuanceOfCommonStockForCommercialLicenseRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" name="IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_CommonStockMarketPricePerShare" name="CommonStockMarketPricePerShare" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="abio_CashNetOfOfferingCostsMember" name="CashNetOfOfferingCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" name="SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" name="ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ConversionOfPreferredStockToCommonStockShares" name="ConversionOfPreferredStockToCommonStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" name="AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" name="StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" name="AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" name="AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_CommonConversionMember" name="CommonConversionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_NotesAndRelatedAccruedInterestMember" name="NotesAndRelatedAccruedInterestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" name="IssuanceCommonStockUponExerciseOfWarrantsForCashValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" name="IssuanceCommonStockUponExerciseOfWarrantsForCashShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" name="PreferredStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_PreferredStockIssuedDuringPeriodValueNewIssues" name="PreferredStockIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_DeemedDividendBeneficialConversionPreferredStock" name="DeemedDividendBeneficialConversionPreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_WriteOffOfDeferredTaxLiability" name="WriteOffOfDeferredTaxLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_ProceedsFromIssuanceOfRestrictedStock" name="ProceedsFromIssuanceOfRestrictedStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" name="RepaymentOfPrincipalOnVendorFinanceAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_AccruedInterestOnNotesPayableConvertedToEquity" name="AccruedInterestOnNotesPayableConvertedToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_WarrantIssuedInConnectionWithCreditFacility" name="WarrantIssuedInConnectionWithCreditFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_AccruedDeferredTransactionCosts" name="AccruedDeferredTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_VendorFinanceAgreement" name="VendorFinanceAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" name="EquityFinancingsAndWarrantsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" name="DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_AccruedExpensesPolicyTextBlock" name="AccruedExpensesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" name="CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_NumberOfPatients" name="NumberOfPatients" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" name="CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" name="CompanyAndSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_PhaseThreeHeartFailureMember" name="PhaseThreeHeartFailureMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_NumberOfPatientsCompanyPlansToEnroll" name="NumberOfPatientsCompanyPlansToEnroll" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_TermOfCompletion" name="TermOfCompletion" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_TwoZeroOneFourEquityFinancingsMember" name="TwoZeroOneFourEquityFinancingsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_EquityTransactionsTypeAxis" name="EquityTransactionsTypeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_EquityTransactionsTypeDomain" name="EquityTransactionsTypeDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_RegisteredDirectOfferingMember" name="RegisteredDirectOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" name="ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_EarningsLossPerShareTextualAbstract" name="EarningsLossPerShareTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_FairValueDisclosuresTextualAbstract" name="FairValueDisclosuresTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" name="CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" name="FairValueAssetsBetweenHierarchyLevelsTransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_ComponentsOfPropertyAndEquipmentAbstract" name="ComponentsOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_PropertyAndEquipmentTextualAbstract" name="PropertyAndEquipmentTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_CommitmentsAndContingenciesTextualAbstract" name="CommitmentsAndContingenciesTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_LeaseTerm" name="LeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_WestminsterMember" name="WestminsterMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_BroomfieldMember" name="BroomfieldMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_AgreementTerminationNoticePeriod" name="AgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_ExpectedMilestonePaymentsUponApproval" name="ExpectedMilestonePaymentsUponApproval" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_AnotherExpectedMilestonePaymentsUponApproval" name="AnotherExpectedMilestonePaymentsUponApproval" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="abio_MinimumPercentageOfRoyaltyObligation" name="MinimumPercentageOfRoyaltyObligation" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_MaximumPercentageOfRoyaltyObligation" name="MaximumPercentageOfRoyaltyObligation" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" name="PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" name="MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" name="MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_MilestonePaymentDuePeriod" name="MilestonePaymentDuePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_EquityFinancingsAndWarrantsTextualAbstract" name="EquityFinancingsAndWarrantsTextualAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_StockIssuedDuringPeriodNetProceeds" name="StockIssuedDuringPeriodNetProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_EquityIssuanceCloseDate" name="EquityIssuanceCloseDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_EquityFinancingTransactionsTypeAxis" name="EquityFinancingTransactionsTypeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_EquityFinancingTransactionsTypeDomain" name="EquityFinancingTransactionsTypeDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_PrivateInvestmentInPublicEquityTransactionMember" name="PrivateInvestmentInPublicEquityTransactionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" name="ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" name="ClassOfWarrantOrRightExercisableExpirationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_ClosingBidPriceDate" name="ClosingBidPriceDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_PreferredStockPurchasedByOfficer" name="PreferredStockPurchasedByOfficer" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="abio_PublicOfferingMember" name="PublicOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_DirectorAndChiefExecutiveOfficerMember" name="DirectorAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" name="PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" name="IntrinsicValueOfEmbeddedBeneficialConversionFeature" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="abio_ClassOfWarrantOrRightsExpirationDateEarliest" name="ClassOfWarrantOrRightsExpirationDateEarliest" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="abio_ClassOfWarrantOrRightsExpirationDateLatest" name="ClassOfWarrantOrRightsExpirationDateLatest" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>abio-20140331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="abio-20140331.xsd#TemplateLink" roleURI="http://www.nuvelo.com/20140331/role/TemplateLink" />
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRentCreditNoncurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10130.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10150.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="10160.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:type="locator" xlink:label="us-gaap_RestructuringCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="10030.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InterestAndOtherIncome" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InterestExpenseDebt" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10120.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10130.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_RestructuringCharges" order="10150.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="10160.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_WriteOffOfDeferredTaxLiability" xlink:type="locator" xlink:label="abio_WriteOffOfDeferredTaxLiability" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:type="locator" xlink:label="us-gaap_AccretionExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <loc xlink:href="abio-20140331.xsd#abio_RepaymentOfPrincipalOnVendorFinanceAgreement" xlink:type="locator" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="abio-20140331.xsd#abio_ProceedsFromIssuanceOfRestrictedStock" xlink:type="locator" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromNotesPayable" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="abio_ProceedsFromIssuanceOfRestrictedStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" order="10130.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="10150.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10160.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="10170.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="10180.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" order="10190.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetIncomeLoss" order="10200.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="10210.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10220.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationAndAmortization" order="10230.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_PaidInKindInterest" order="10240.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ShareBasedCompensation" order="10250.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="10260.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AccretionExpense" order="10270.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="10280.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="10290.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="abio_WriteOffOfDeferredTaxLiability" order="10300.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_MarketableSecuritiesGainLoss" order="10310.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="10320.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10330.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="10340.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="10350.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10360.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="10370.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="10380.00" priority="2" use="optional" weight="-1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareDetails" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentDetails" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10450.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10460.00" priority="2" use="optional" weight="-1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesDetails" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10030.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>abio-20140331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <roleRef xlink:type="simple" xlink:href="abio-20140331.xsd#TemplateLink" roleURI="http://www.nuvelo.com/20140331/role/TemplateLink" />
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="abio-20140331.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain_2" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10390.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="10510.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10630.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10210.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="11130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="11210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" order="11290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" order="11450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="11930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12170.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10650.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:type="locator" xlink:label="us-gaap_RestructuringCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10210.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RestructuringCharges" order="10690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="11090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="11170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="11470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="11790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="11870.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="11950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="12070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="12190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="12290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12410.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <loc xlink:href="abio-20140331.xsd#abio_DeemedDividendBeneficialConversionPreferredStock" xlink:type="locator" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" />
    <loc xlink:href="abio-20140331.xsd#abio_CashNetOfOfferingCostsMember" xlink:type="locator" xlink:label="abio_CashNetOfOfferingCostsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" />
    <loc xlink:href="abio-20140331.xsd#abio_ConversionOfPreferredStockToCommonStockShares" xlink:type="locator" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares" />
    <loc xlink:href="abio-20140331.xsd#abio_NotesAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_NotesAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_CommonConversionMember" xlink:type="locator" xlink:label="abio_CommonConversionMember" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" xlink:type="locator" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" xlink:type="locator" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesBMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesBMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfOfferingCostEffectOnEquity" xlink:type="locator" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStockStock" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentForFractionalShares" xlink:type="locator" xlink:label="abio_AdjustmentForFractionalShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_DeficitAccumulatedDuringDevelopmentStageMember" xlink:type="locator" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeriesOfferingCostsMember" xlink:type="locator" xlink:label="abio_SeriesOfferingCostsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:type="locator" xlink:label="us-gaap_SeriesBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:type="locator" xlink:label="us-gaap_SeriesAMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesAMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesBMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeriesOfferingCostsMember" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10520.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="abio_DeficitAccumulatedDuringDevelopmentStageMember" order="10580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10600.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10620.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="11020.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentForFractionalShares" order="11400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStockStock" order="11640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="11880.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="12360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="12840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="13080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" order="13560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" order="13800.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="14040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14320.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="14580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="14820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AccretionOfOfferingCostEffectOnEquity" order="26280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" order="29740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" order="30000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="30260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="30540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="30960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="31080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="31140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="31180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_AccretionOfSeriesMember" order="31220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_AccretionOfSeriesBMember" order="31240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" order="31340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" order="31380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CommonConversionMember" order="44310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_NotesAndRelatedAccruedInterestMember" order="44410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_ConversionOfPreferredStockToCommonStockShares" order="47820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" order="48060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" order="48300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" order="48780.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="49980.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" order="51280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CashNetOfOfferingCostsMember" order="59690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" order="73910.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" order="74190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" order="74450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_PreferredStockIssuedDuringPeriodValueNewIssues" order="74750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_DeemedDividendBeneficialConversionPreferredStock" order="75130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="75410.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="abio-20140331.xsd#abio_CommonStockMarketPricePerShare" xlink:type="locator" xlink:label="abio_CommonStockMarketPricePerShare" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_CashNetOfOfferingCostsMember" xlink:type="locator" xlink:label="abio_CashNetOfOfferingCostsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:type="locator" xlink:label="us-gaap_SeriesBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:type="locator" xlink:label="us-gaap_SeriesAMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesAMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesBMember" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CashNetOfOfferingCostsMember" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10520.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10620.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" order="10680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10700.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" order="10740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="10760.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10780.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10800.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_CommonStockMarketPricePerShare" order="10820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="11360.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="abio-20140331.xsd#abio_VendorFinanceAgreement" xlink:type="locator" xlink:label="abio_VendorFinanceAgreement" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedDeferredTransactionCosts" xlink:type="locator" xlink:label="abio_AccruedDeferredTransactionCosts" />
    <loc xlink:href="abio-20140331.xsd#abio_WarrantIssuedInConnectionWithCreditFacility" xlink:type="locator" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedInterestOnNotesPayableConvertedToEquity" xlink:type="locator" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" xlink:label="us-gaap_InterestPaid" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <loc xlink:href="abio-20140331.xsd#abio_RepaymentOfPrincipalOnVendorFinanceAgreement" xlink:type="locator" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="abio-20140331.xsd#abio_ProceedsFromIssuanceOfRestrictedStock" xlink:type="locator" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_WriteOffOfDeferredTaxLiability" xlink:type="locator" xlink:label="abio_WriteOffOfDeferredTaxLiability" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:type="locator" xlink:label="us-gaap_AccretionExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10500.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10510.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10520.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="10840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="11080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="11280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionExpense" order="11360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="11440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="11520.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="abio_WriteOffOfDeferredTaxLiability" order="11580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesGainLoss" order="11660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="11740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="12020.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="12140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="12380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="12500.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="12600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="12840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="12920.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="13000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="13100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="13180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" order="13260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="13340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="13560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="13640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="abio_ProceedsFromIssuanceOfRestrictedStock" order="13720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="13800.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="13880.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="14200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="14280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" order="14360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="14480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="14600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="14720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14880.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="15000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="15120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_AccruedInterestOnNotesPayableConvertedToEquity" order="15240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_WarrantIssuedInConnectionWithCreditFacility" order="15320.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_AccruedDeferredTransactionCosts" order="15400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_VendorFinanceAgreement" order="15480.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009" xlink:href="abio-20140331.xsd#Role_DisclosureMergerWithNuveloIncOnJanuary272009" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures" xlink:href="abio-20140331.xsd#Role_DisclosureFairValueDisclosures" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants" xlink:href="abio-20140331.xsd#Role_DisclosureEquityFinancingsAndWarrants" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants">
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsDisclosureTextBlock" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensation" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes" xlink:href="abio-20140331.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:href="abio-20140331.xsd#abio_AccruedExpensesPolicyTextBlock" xlink:type="locator" xlink:label="abio_AccruedExpensesPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <loc xlink:href="abio-20140331.xsd#abio_ReverseStockSplitPolicyTextBlock" xlink:type="locator" xlink:label="abio_ReverseStockSplitPolicyTextBlock" />
    <loc xlink:href="abio-20140331.xsd#abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" xlink:type="locator" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_ReverseStockSplitPolicyTextBlock" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AccruedExpensesPolicyTextBlock" order="10490.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="10250.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="abio-20140331.xsd#abio_RegisteredDirectOfferingMember" xlink:type="locator" xlink:label="abio_RegisteredDirectOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeDomain_2" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeDomain" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_TwoZeroOneFourEquityFinancingsMember" xlink:type="locator" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_TermOfCompletion" xlink:type="locator" xlink:label="abio_TermOfCompletion" />
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatientsCompanyPlansToEnroll" xlink:type="locator" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll" />
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatients" xlink:type="locator" xlink:label="abio_NumberOfPatients" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:type="locator" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_PhaseThreeHeartFailureMember" xlink:type="locator" xlink:label="abio_PhaseThreeHeartFailureMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_HealthCareTrustFundAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_HealthCareTrustFundAxis" xlink:to="us-gaap_HealthCareTrustFundNameDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_HealthCareTrustFundAxis" xlink:to="us-gaap_HealthCareTrustFundNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareTrustFundNameDomain" xlink:to="abio_PhaseThreeHeartFailureMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:to="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:to="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_NumberOfPatients" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_NumberOfPatientsCompanyPlansToEnroll" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_TermOfCompletion" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10630.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" order="10680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_2" order="10700.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" order="10700.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="abio_TwoZeroOneFourEquityFinancingsMember" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="abio_EquityTransactionsTypeAxis" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="abio_EquityTransactionsTypeAxis" xlink:to="abio_EquityTransactionsTypeDomain_2" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="abio_EquityTransactionsTypeAxis" xlink:to="abio_EquityTransactionsTypeDomain" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityTransactionsTypeDomain" xlink:to="abio_RegisteredDirectOfferingMember" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="10910.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="11130.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:type="locator" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" order="10070.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="dei_LegalEntityAxis" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10490.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareDetailsTextual" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_EarningsLossPerShareTextualAbstract" xlink:type="locator" xlink:label="abio_EarningsLossPerShareTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="abio_EarningsLossPerShareTextualAbstract" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EarningsLossPerShareTextualAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10170.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details" xlink:href="abio-20140331.xsd#Role_DisclosureMergerWithNuveloIncOnJanuary272009Details" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10270.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails" xlink:href="abio-20140331.xsd#Role_DisclosureFairValueDisclosuresDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <loc xlink:href="abio-20140331.xsd#abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" xlink:type="locator" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" xlink:type="locator" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_FairValueDisclosuresTextualAbstract" xlink:type="locator" xlink:label="abio_FairValueDisclosuresTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_RangeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10150.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="dei_LegalEntityAxis" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="abio_FairValueDisclosuresTextualAbstract" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="10310.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <loc xlink:href="abio-20140331.xsd#abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:type="locator" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10180.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="abio_ComponentsOfPropertyAndEquipmentAbstract" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="11230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11310.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentDetailsTextual" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="abio-20140331.xsd#abio_PropertyAndEquipmentTextualAbstract" xlink:type="locator" xlink:label="abio_PropertyAndEquipmentTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="abio_PropertyAndEquipmentTextualAbstract" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_PropertyAndEquipmentTextualAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10210.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesDetailsTextual" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual">
    <loc xlink:href="abio-20140331.xsd#abio_MilestonePaymentDuePeriod" xlink:type="locator" xlink:label="abio_MilestonePaymentDuePeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" xlink:type="locator" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRoyaltyObligation" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRoyaltyObligation" />
    <loc xlink:href="abio-20140331.xsd#abio_AnotherExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval" />
    <loc xlink:href="abio-20140331.xsd#abio_ExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_ExpectedMilestonePaymentsUponApproval" />
    <loc xlink:href="abio-20140331.xsd#abio_AgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="abio_AgreementTerminationNoticePeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <loc xlink:href="abio-20140331.xsd#abio_LeaseTerm" xlink:type="locator" xlink:label="abio_LeaseTerm" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTextualAbstract" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_BroomfieldMember" xlink:type="locator" xlink:label="abio_BroomfieldMember" />
    <loc xlink:href="abio-20140331.xsd#abio_WestminsterMember" xlink:type="locator" xlink:label="abio_WestminsterMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="abio_WestminsterMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="abio_BroomfieldMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_CommitmentsAndContingenciesTable" order="10180.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_CommitmentsAndContingenciesTextualAbstract" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_AreaOfRealEstateProperty" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_LeaseExpirationDate1" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="abio_LeaseTerm" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="abio_AgreementTerminationNoticePeriod" order="10820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_ExpectedMilestonePaymentsUponApproval" order="10960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_AnotherExpectedMilestonePaymentsUponApproval" order="11000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MinimumPercentageOfRoyaltyObligation" order="11040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MaximumPercentageOfRoyaltyObligation" order="11080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" order="11120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" order="11160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" order="11200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MilestonePaymentDuePeriod" order="11240.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTable" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_CommitmentsAndContingenciesTable" order="10080.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10240.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureEquityFinancingsAndWarrantsDetailsTextual" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual">
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateLatest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateEarliest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageMember" xlink:type="locator" xlink:label="us-gaap_WeightedAverageMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" xlink:type="locator" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" />
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" xlink:type="locator" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockPurchasedByOfficer" xlink:type="locator" xlink:label="abio_PreferredStockPurchasedByOfficer" />
    <loc xlink:href="abio-20140331.xsd#abio_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="abio_SeriesAConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_DirectorAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_PublicOfferingMember" xlink:type="locator" xlink:label="abio_PublicOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_RegisteredDirectOfferingMember" xlink:type="locator" xlink:label="abio_RegisteredDirectOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ClosingBidPriceDate" xlink:type="locator" xlink:label="abio_ClosingBidPriceDate" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisableExpirationPeriod" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuanceDates" xlink:type="locator" xlink:label="us-gaap_EquityIssuanceDates" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityIssuanceCloseDate" xlink:type="locator" xlink:label="abio_EquityIssuanceCloseDate" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodNetProceeds" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodNetProceeds" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_PrivateInvestmentInPublicEquityTransactionMember" xlink:type="locator" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeDomain_2" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeDomain" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="abio_EquityFinancingTransactionsTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="abio_EquityFinancingTransactionsTypeAxis" xlink:to="abio_EquityFinancingTransactionsTypeDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="abio_EquityFinancingTransactionsTypeAxis" xlink:to="abio_EquityFinancingTransactionsTypeDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_PrivateInvestmentInPublicEquityTransactionMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="abio_EquityFinancingsAndWarrantsTextualAbstract" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_StockIssuedDuringPeriodNetProceeds" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_EquityIssuanceCloseDate" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_EquityIssuanceDates" order="10380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_EquityIssuancePerShareAmount" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" order="10690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClosingBidPriceDate" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_RegisteredDirectOfferingMember" order="10860.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_PublicOfferingMember" order="11900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="12030.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2" order="12050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="12050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="abio_DirectorAndChiefExecutiveOfficerMember" order="12070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="12120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeriesAConvertiblePreferredStockMember" order="12140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_PreferredStockPurchasedByOfficer" order="12660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="13060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="13120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" order="13600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" order="13920.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RangeAxis" order="15130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="15150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="15170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="15190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_WeightedAverageMember" order="15210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="15350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateEarliest" order="15590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateLatest" order="15650.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:type="locator" xlink:label="us-gaap_RestructuringChargesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_RestructuringChargesMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10140.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10300.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails1" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10390.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="10690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="11150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="11450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="11810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="11910.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails2" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10870.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11030.00" priority="2" use="optional" />
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>abio-20140331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_DocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="abio_DocumentAndEntityInformationAbstract" />
    <label xml:lang="en-US" xlink:label="abio_DocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Document and entity information.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_DocumentAndEntityInformationAbstract" xlink:to="abio_DocumentAndEntityInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="abio_DocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_DocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Abstract]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" />
    <label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</label>
    <label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Financial Position [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent, current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Rent Credit Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Rent Credit Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A convertible preferred stock, $0.001 par value; 135,000 shares authorized, no shares issued and outstanding at March 31, 2014 and December 31, 2013</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value; 100 million shares authorized at March 31, 2014 and December 31, 2013; 21,001,690 and 15,685,562 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deficit accumulated during the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</label>
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <label xml:lang="en-US" xlink:label="abio_GainLossOnAssignmentOfPatentRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The gain or loss on transfer of all or part of the rights and interests in certain patents and patent applications.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_GainLossOnAssignmentOfPatentRights" xlink:to="abio_GainLossOnAssignmentOfPatentRights_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Costs and expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Costs And Expenses [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Acquisition Related Costs</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:type="locator" xlink:label="us-gaap_RestructuringCharges" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestructuringCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restructuring expense, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestructuringCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Charges</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on impairment of in-process research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Intangible Assets Excluding Goodwill</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total costs and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</label>
    <label xml:lang="en-US" xlink:label="abio_GainLossOnAssignmentOfPatentRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on assignment of patent rights</label>
    <label xml:lang="en-US" xlink:label="abio_GainLossOnAssignmentOfPatentRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Assignment Of Patent Rights</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on bargain purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Bargain Purchase Gain Recognized Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest And Other Income</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest and other expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense Debt</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Benefit from income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accretion of redeemable convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Accretion Of Redemption Discount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Deemed preferred stock dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Dividends And Other Adjustments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss available to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Available To Common Stockholders Basic</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss available to common stockholders per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average shares outstanding:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</label>
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentForFractionalShares" xlink:type="locator" xlink:label="abio_AdjustmentForFractionalShares" />
    <label xml:lang="en-US" xlink:label="abio_AdjustmentForFractionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustment for fractional shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AdjustmentForFractionalShares" xlink:to="abio_AdjustmentForFractionalShares_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfOfferingCostEffectOnEquity" xlink:type="locator" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity" />
    <label xml:lang="en-US" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion of offering cost effect on equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccretionOfOfferingCostEffectOnEquity" xlink:to="abio_AccretionOfOfferingCostEffectOnEquity_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" />
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period upon conversion of notes payable value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" />
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period upon conversion of notes payable shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auction Market Preferred Securities, Stock Series</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auction Market Preferred Securities Stock Series [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auction Market Preferred Securities, Stock Series, Title</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auction Market Preferred Securities Stock Series Title [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:type="locator" xlink:label="us-gaap_SeriesAMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_SeriesAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAMember" xlink:to="us-gaap_SeriesAMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SeriesAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:type="locator" xlink:label="us-gaap_SeriesBMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_SeriesBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBMember" xlink:to="us-gaap_SeriesBMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SeriesBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series B [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">First issuance for notes payable and related accrued interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:to="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Notes Payable and Related Accrued Interest on January 3, 2005</label>
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">First Issuance For Notes Payable And Related Accrued Interest [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">First issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on October 14, 2005</label>
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">First Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Second issuance for notes payable and related accrued interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:to="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Notes Payable and Related Accrued Interest on October 14, 2005</label>
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Second Issuance For Notes Payable And Related Accrued Interest [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SeriesOfferingCostsMember" xlink:type="locator" xlink:label="abio_SeriesOfferingCostsMember" />
    <label xml:lang="en-US" xlink:label="abio_SeriesOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SeriesOfferingCostsMember" xlink:to="abio_SeriesOfferingCostsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SeriesOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A offering costs</label>
    <label xml:lang="en-US" xlink:label="abio_SeriesOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series Offering Costs [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Second issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on February 21, 2006</label>
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Second Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">First Issuance Of Convertible Redeemable Preferred Stock Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:to="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series A on February 22, 2006</label>
    <label xml:lang="en-US" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">First Issuance Of Convertible Redeemable Preferred Stock [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Third issuance for notes payable and related accrued interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:to="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Issuance For Notes Payable And Related Accrued Interest</label>
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Third Issuance For Notes Payable And Related Accrued Interest [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_DeficitAccumulatedDuringDevelopmentStageMember" xlink:type="locator" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember" />
    <label xml:lang="en-US" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deficit accumulated during development stage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_DeficitAccumulatedDuringDevelopmentStageMember" xlink:to="abio_DeficitAccumulatedDuringDevelopmentStageMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deficit Accumulated During Development Stage</label>
    <label xml:lang="en-US" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deficit Accumulated During Development Stage [Member]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentForFractionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustment for fractional shares</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentForFractionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment For Fractional Shares</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStockStock" />
    <label xml:lang="en-US" xlink:label="us-gaap_DividendsPreferredStockStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DividendsPreferredStockStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Preferred Stock Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Stock Issued Issuance Costs</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Units</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible notes, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger with Nuvelo, Inc., value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Acquisitions</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger with Nuvelo, Inc., shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Acquisitions</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Ownership Plan</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Ownership Plan</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of equity for cash or intellectual property rights, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of equity for cash or intellectual property rights, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</label>
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, value</label>
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, shares</label>
    <label xml:lang="en-US" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering Costs</label>
    <label xml:lang="en-US" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Of Offering Cost Effect On Equity</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of preferred stock upon conversion of note payable and accrued interest, value</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Upon Conversion Of Notes Payable Value</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of preferred stock upon conversion of note payable and accrued interest, shares</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Upon Conversion Of Notes Payable Shares</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, for cash, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, for cash, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</label>
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Third issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on February 22, 2006</label>
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Third Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fourth issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on June 23, 2006</label>
    <label xml:lang="en-US" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fourth Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fifth issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on November 7, 2006</label>
    <label xml:lang="en-US" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fifth Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Third issuance of series b convertible redeemable preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:to="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Issuance Of Series B Convertible Redeemable Preferred Stock</label>
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Third Issuance Of Series B Convertible Redeemable Preferred Stock [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Second issuance of series b convertible redeemable preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:to="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Series B on December 28, 2007</label>
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Second Issuance Of Series B Convertible Redeemable Preferred Stock [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesMember" />
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion of series.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccretionOfSeriesMember" xlink:to="abio_AccretionOfSeriesMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of Series A</label>
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Of Series [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesBMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesBMember" />
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion of series b.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccretionOfSeriesBMember" xlink:to="abio_AccretionOfSeriesBMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of Series B</label>
    <label xml:lang="en-US" xlink:label="abio_AccretionOfSeriesBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Of Series B [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sixth issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on January 18, 2007</label>
    <label xml:lang="en-US" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sixth Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Seventh issuance of stock for intellectual property license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:to="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance for Intellectual Property License Rights on June 30, 2007</label>
    <label xml:lang="en-US" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Seventh Issuance Of Stock For Intellectual Property License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" xlink:type="locator" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock for commercial license rights.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" xlink:to="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Common Stock for Commercial License Rights, on July 19, 2007</label>
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock For Commercial License Rights [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" xlink:type="locator" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of shares to executive subject to repurchase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" xlink:to="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Shares to Executive Subject to Repurchase</label>
    <label xml:lang="en-US" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Shares To Executive Subject To Repurchase [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_CommonStockMarketPricePerShare" xlink:type="locator" xlink:label="abio_CommonStockMarketPricePerShare" />
    <label xml:lang="en-US" xlink:label="abio_CommonStockMarketPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock market price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CommonStockMarketPricePerShare" xlink:to="abio_CommonStockMarketPricePerShare_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_CashNetOfOfferingCostsMember" xlink:type="locator" xlink:label="abio_CashNetOfOfferingCostsMember" />
    <label xml:lang="en-US" xlink:label="abio_CashNetOfOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash net of offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CashNetOfOfferingCostsMember" xlink:to="abio_CashNetOfOfferingCostsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_CashNetOfOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Net of Offering Costs</label>
    <label xml:lang="en-US" xlink:label="abio_CashNetOfOfferingCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Net Of Offering Costs [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Second issuance of series convertible redeemable preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" xlink:to="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Issuance Of Series Redeemable Preferred Stock</label>
    <label xml:lang="en-US" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Second Issuance Of Series Convertible Redeemable Preferred Stock [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Third issuance of series B redeemable preferred stock member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" xlink:to="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Issuance Of Series B Redeemable Preferred Stock</label>
    <label xml:lang="en-US" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Third Issuance Of Series B Redeemable Preferred Stock [Member]</label>
    <label xml:lang="en-US" xlink:label="abio_CommonStockMarketPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock market price per share</label>
    <label xml:lang="en-US" xlink:label="abio_CommonStockMarketPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Market Price Per Share</label>
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, par value</label>
    <loc xlink:href="abio-20140331.xsd#abio_ConversionOfPreferredStockToCommonStockShares" xlink:type="locator" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares" />
    <label xml:lang="en-US" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of Preferred Stock to Common Stock Shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ConversionOfPreferredStockToCommonStockShares" xlink:to="abio_ConversionOfPreferredStockToCommonStockShares_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" />
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The adjustment to additional paid in capital to record the release of restriction agreements on stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" />
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value Conversion of Convertible Notes and Related Accrued Interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" xlink:to="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" />
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount recorded to additional Paid in Capital account as a result of the conversion of warrants for preferred stock to outstanding common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" />
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustment to additional paid in capital estimated fair value of warrants issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_CommonConversionMember" xlink:type="locator" xlink:label="abio_CommonConversionMember" />
    <label xml:lang="en-US" xlink:label="abio_CommonConversionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common conversion.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CommonConversionMember" xlink:to="abio_CommonConversionMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_CommonConversionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Conversion</label>
    <label xml:lang="en-US" xlink:label="abio_CommonConversionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Conversion [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_NotesAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_NotesAndRelatedAccruedInterestMember" />
    <label xml:lang="en-US" xlink:label="abio_NotesAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Notes and related accrued interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_NotesAndRelatedAccruedInterestMember" xlink:to="abio_NotesAndRelatedAccruedInterestMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_NotesAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes and Related Accrued Interest</label>
    <label xml:lang="en-US" xlink:label="abio_NotesAndRelatedAccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Notes And Related Accrued Interest [Member]</label>
    <label xml:lang="en-US" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock, shares</label>
    <label xml:lang="en-US" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Preferred Stock To Common Stock Shares</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock release from restriction</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment To Additional Paid In Capital Restricted Stock Release From Restriction</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible notes and related accrued interest</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Notes And Related Accrued Interest</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of warrants for preferred stock</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment To Additional Paid In Capital Conversion Of Warrants For Preferred Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value of warrants issued in connection with convertible notes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Warrant Issued</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value of warrants issued in connection with lease termination</label>
    <label xml:lang="en-US" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment To Additional Paid In Capital Estimated Fair Value Of Warrants Issued</label>
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Common Stock Upon Exercise Of Warrants For Cash ,Value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Common Stock Upon Exercise Of Warrants For Cash, Shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" />
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock issued during period value new issues.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" xlink:to="abio_PreferredStockIssuedDuringPeriodSharesNewIssues_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues" />
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock issued during period value, new issues.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PreferredStockIssuedDuringPeriodValueNewIssues" xlink:to="abio_PreferredStockIssuedDuringPeriodValueNewIssues_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_DeemedDividendBeneficialConversionPreferredStock" xlink:type="locator" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock" />
    <label xml:lang="en-US" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deemed Dividend Beneficial Conversion Preferred Stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_DeemedDividendBeneficialConversionPreferredStock" xlink:to="abio_DeemedDividendBeneficialConversionPreferredStock_lbl" />
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of warrants for cash, value</label>
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Common Stock Upon Exercise Of Warrants For Cash Value</label>
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of warrants for cash, share</label>
    <label xml:lang="en-US" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Common Stock Upon Exercise Of Warrants For Cash Shares</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series A convertible preferred stock, net of offering costs, Shares</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Issued During Period Shares New Issues</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series A convertible preferred stock, net of offering costs, Value</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Issued During Period Value New Issues</label>
    <label xml:lang="en-US" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed preferred stock dividend for beneficial conversion feature</label>
    <label xml:lang="en-US" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deemed Dividend Beneficial Conversion Preferred Stock</label>
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impact of deemed preferred stock dividend for beneficial conversion feature on common stockholders</label>
    <loc xlink:href="abio-20140331.xsd#abio_WriteOffOfDeferredTaxLiability" xlink:type="locator" xlink:label="abio_WriteOffOfDeferredTaxLiability" />
    <label xml:lang="en-US" xlink:label="abio_WriteOffOfDeferredTaxLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The write off of deferred tax liability associated with the impairment of the in-process research and development asset.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_WriteOffOfDeferredTaxLiability" xlink:to="abio_WriteOffOfDeferredTaxLiability_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_ProceedsFromIssuanceOfRestrictedStock" xlink:type="locator" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock" />
    <label xml:lang="en-US" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of restricted stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ProceedsFromIssuanceOfRestrictedStock" xlink:to="abio_ProceedsFromIssuanceOfRestrictedStock_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_RepaymentOfPrincipalOnVendorFinanceAgreement" xlink:type="locator" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" />
    <label xml:lang="en-US" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Repayment of principal on vendor finance agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" xlink:to="abio_RepaymentOfPrincipalOnVendorFinanceAgreement_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedInterestOnNotesPayableConvertedToEquity" xlink:type="locator" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity" />
    <label xml:lang="en-US" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of the interest accrued on notes payable that was recorded by the Company but converted by the holder to equity during the period that resulted in a noncash transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccruedInterestOnNotesPayableConvertedToEquity" xlink:to="abio_AccruedInterestOnNotesPayableConvertedToEquity_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_WarrantIssuedInConnectionWithCreditFacility" xlink:type="locator" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility" />
    <label xml:lang="en-US" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The non-cash value of warrants issued in connection with a bank credit facility.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_WarrantIssuedInConnectionWithCreditFacility" xlink:to="abio_WarrantIssuedInConnectionWithCreditFacility_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedDeferredTransactionCosts" xlink:type="locator" xlink:label="abio_AccruedDeferredTransactionCosts" />
    <label xml:lang="en-US" xlink:label="abio_AccruedDeferredTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred transaction costs accrued at the end of the respective period and applied to proceeds in the subsequent period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccruedDeferredTransactionCosts" xlink:to="abio_AccruedDeferredTransactionCosts_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_VendorFinanceAgreement" xlink:type="locator" xlink:label="abio_VendorFinanceAgreement" />
    <label xml:lang="en-US" xlink:label="abio_VendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Vendor finance agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_VendorFinanceAgreement" xlink:to="abio_VendorFinanceAgreement_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Cash Flows [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_GainLossOnAssignmentOfPatentRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on patent rights assignment</label>
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on bargain purchase</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation And Amortization</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Paid In Kind Interest</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <label xml:lang="en-US" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants for lease termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Stock And Warrants For Services Or Claims</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:type="locator" xlink:label="us-gaap_AccretionExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccretionExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccretionExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Long Lived Assets Held For Use</label>
    <label xml:lang="en-US" xlink:label="abio_WriteOffOfDeferredTaxLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Write-off of deferred tax liability</label>
    <label xml:lang="en-US" xlink:label="abio_WriteOffOfDeferredTaxLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Write Off Of Deferred Tax Liability</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on marketable securities available for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Gain Loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">(Gain) loss from disposal of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Sale Of Property Plant Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in operating assets and liabilities (net of amounts acquired):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Current Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Liabilities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Deferred Charges</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities Continuing Operations</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash received from merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Acquired From Acquisition</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of deferred transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Payments To Acquire Businesses</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Marketable Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Property Plant And Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from patent rights assignment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Intangible Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities Continuing Operations</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible notes payable and related warrants for common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Or Sale Of Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of bank note payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Notes Payable</label>
    <label xml:lang="en-US" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from stock subject to repurchase</label>
    <label xml:lang="en-US" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Restricted Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Preferred Stock And Preference Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of principal on bank note payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Notes Payable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of principal on convertible notes payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Convertible Debt</label>
    <label xml:lang="en-US" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of principal on vendor finance agreement</label>
    <label xml:lang="en-US" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayment Of Principal On Vendor Finance Agreement</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities Continuing Operations</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Period Increase Decrease</label>
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents, beginning of period</label>
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents, end of period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" xlink:label="us-gaap_InterestPaid" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash investing and financing transactions:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest on notes payable converted to equity</label>
    <label xml:lang="en-US" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest On Notes Payable Converted To Equity</label>
    <label xml:lang="en-US" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant issued in connection with credit facility</label>
    <label xml:lang="en-US" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Issued In Connection With Credit Facility</label>
    <label xml:lang="en-US" xlink:label="abio_AccruedDeferredTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued deferred transaction costs</label>
    <label xml:lang="en-US" xlink:label="abio_AccruedDeferredTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Deferred Transaction Costs</label>
    <label xml:lang="en-US" xlink:label="abio_VendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vendor finance agreement</label>
    <label xml:lang="en-US" xlink:label="abio_VendorFinanceAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vendor Finance Agreement</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_TextBlockAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The Company and Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger with Nuvelo, Inc. on January 27, 2009</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsDisclosureTextBlock" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity financings and warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" xlink:to="abio_EquityFinancingsAndWarrantsDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Financings and Warrants</label>
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Financings And Warrants Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Description And Accounting Policies [Text Block]</label>
    <loc xlink:href="abio-20140331.xsd#abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" xlink:type="locator" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development stage risks liquidity and going concern.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" xlink:to="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Stage Risks, Liquidity and Going Concern</label>
    <label xml:lang="en-US" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Stage Risks Liquidity And Going Concern Policy [Text Block]</label>
    <loc xlink:href="abio-20140331.xsd#abio_ReverseStockSplitPolicyTextBlock" xlink:type="locator" xlink:label="abio_ReverseStockSplitPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="abio_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reverse stock split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ReverseStockSplitPolicyTextBlock" xlink:to="abio_ReverseStockSplitPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse Stock Split</label>
    <label xml:lang="en-US" xlink:label="abio_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reverse Stock Split Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</label>
    <loc xlink:href="abio-20140331.xsd#abio_AccruedExpensesPolicyTextBlock" xlink:type="locator" xlink:label="abio_AccruedExpensesPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="abio_AccruedExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for estimating costs incurred that have not yet been billed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AccruedExpensesPolicyTextBlock" xlink:to="abio_AccruedExpensesPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="abio_AccruedExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</label>
    <label xml:lang="en-US" xlink:label="abio_AccruedExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expenses Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Basic and Diluted Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future Minimum Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-Cash, Share-Based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Activity Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of RSU activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]</label>
    <loc xlink:href="abio-20140331.xsd#abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:type="locator" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Company development stage, and basis of presentation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatients" xlink:type="locator" xlink:label="abio_NumberOfPatients" />
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatients_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of patients</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_NumberOfPatients" xlink:to="abio_NumberOfPatients_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" />
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Company and Summary of Significant Accounting Policies Table [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:to="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Policies [Abstract]</label>
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" />
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Company and summary of significant accounting policies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable_lbl" />
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company And Summary Of Significant Accounting Policies [Table]</label>
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Company And Summary Of Significant Accounting Policies [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_HealthCareTrustFundAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Health Care Trust Fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareTrustFundAxis" xlink:to="us-gaap_HealthCareTrustFundAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_HealthCareTrustFundAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Trust Fund [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_HealthCareTrustFundNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Health Care Trust Fund, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareTrustFundNameDomain" xlink:to="us-gaap_HealthCareTrustFundNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_HealthCareTrustFundNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Trust Fund Name [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_PhaseThreeHeartFailureMember" xlink:type="locator" xlink:label="abio_PhaseThreeHeartFailureMember" />
    <label xml:lang="en-US" xlink:label="abio_PhaseThreeHeartFailureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase three heart failure.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PhaseThreeHeartFailureMember" xlink:to="abio_PhaseThreeHeartFailureMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_PhaseThreeHeartFailureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Phase 3 heart failure (HF) trial of Gencaro</label>
    <label xml:lang="en-US" xlink:label="abio_PhaseThreeHeartFailureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Phase Three Heart Failure [Member]</label>
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company And Summary Of Significant Accounting Policies Table [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Company And Summary Of Significant Accounting Policies Table [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company Development Stage and Basis of Presentation (Textual) [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Company Development Stage And Basis Of Presentation Textual [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatients_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of patients</label>
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatients_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Patients</label>
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatientsCompanyPlansToEnroll" xlink:type="locator" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll" />
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of patients company plans to enroll.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_NumberOfPatientsCompanyPlansToEnroll" xlink:to="abio_NumberOfPatientsCompanyPlansToEnroll_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_TermOfCompletion" xlink:type="locator" xlink:label="abio_TermOfCompletion" />
    <label xml:lang="en-US" xlink:label="abio_TermOfCompletion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of completion.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_TermOfCompletion" xlink:to="abio_TermOfCompletion_lbl" />
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of patients company plans to enroll</label>
    <label xml:lang="en-US" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Patients Company Plans To Enroll</label>
    <label xml:lang="en-US" xlink:label="abio_TermOfCompletion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of years to complete the study</label>
    <label xml:lang="en-US" xlink:label="abio_TermOfCompletion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Of Completion</label>
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Financing Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Financing Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction Type [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_TwoZeroOneFourEquityFinancingsMember" xlink:type="locator" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember" />
    <label xml:lang="en-US" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two zero one four equity financings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_TwoZeroOneFourEquityFinancingsMember" xlink:to="abio_TwoZeroOneFourEquityFinancingsMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Zero One Four Equity Financings</label>
    <label xml:lang="en-US" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Zero One Four Equity Financings [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeAxis" />
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity transactions type.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityTransactionsTypeAxis" xlink:to="abio_EquityTransactionsTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Transactions Type</label>
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Transactions Type [Axis]</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeDomain" />
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity transactions type.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityTransactionsTypeDomain" xlink:to="abio_EquityTransactionsTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Transactions Type</label>
    <label xml:lang="en-US" xlink:label="abio_EquityTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Transactions Type [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_RegisteredDirectOfferingMember" xlink:type="locator" xlink:label="abio_RegisteredDirectOfferingMember" />
    <label xml:lang="en-US" xlink:label="abio_RegisteredDirectOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Registered direct offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_RegisteredDirectOfferingMember" xlink:to="abio_RegisteredDirectOfferingMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_RegisteredDirectOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Registered Direct Offering</label>
    <label xml:lang="en-US" xlink:label="abio_RegisteredDirectOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Registered Direct Offering [Member]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fund raised through sale of convertible preferred and common stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Reverse Stock Split</label>
    <loc xlink:href="abio-20140331.xsd#abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:type="locator" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" />
    <label xml:lang="en-US" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reconciliation of numerator and denominator used in the calculation of basic and diluted loss per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Earnings Per Share Basic By Common Class [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic By Common Class [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share Basic [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of basic and diluted loss per share</label>
    <label xml:lang="en-US" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation Of Numerator And Denominator Used In Calculation Of Basic And Diluted Loss Per Share [Abstract]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss available to common shareholders</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average shares of common stock outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Basic</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Weighted-average shares of unvested common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Diluted Shares Outstanding Adjustment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total weighted-average shares used in computing net loss per share attributed to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesIssuedBasic_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Issued Basic</label>
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic and diluted loss per share</label>
    <loc xlink:href="abio-20140331.xsd#abio_EarningsLossPerShareTextualAbstract" xlink:type="locator" xlink:label="abio_EarningsLossPerShareTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_EarningsLossPerShareTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings loss per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EarningsLossPerShareTextualAbstract" xlink:to="abio_EarningsLossPerShareTextualAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EarningsLossPerShareTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings (Loss) Per Share (Textual) [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_EarningsLossPerShareTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Loss Per Share Textual [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potentially dilutive shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combinations [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Business Acquisitions By Acquisition [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated total acquisition consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Consideration Transferred Equity Interests Issued And Issuable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net assets acquired in the Merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net assets acquired, including cash, cash equivalents and marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents</label>
    <loc xlink:href="abio-20140331.xsd#abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" xlink:type="locator" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" />
    <label xml:lang="en-US" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash equivalents consisting of money market funds maturity period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" xlink:to="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" xlink:type="locator" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" />
    <label xml:lang="en-US" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets between hierarchy levels transfers amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" xlink:to="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosures [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value By Balance Sheet Grouping [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Balance Sheet Grouping [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</label>
    <loc xlink:href="abio-20140331.xsd#abio_FairValueDisclosuresTextualAbstract" xlink:type="locator" xlink:label="abio_FairValueDisclosuresTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_FairValueDisclosuresTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosures (Textual) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="abio_FairValueDisclosuresTextualAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="abio_FairValueDisclosuresTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures Textual [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents consisting of money market funds, maturity period</label>
    <label xml:lang="en-US" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents Consisting Of Money Market Funds Maturity Period</label>
    <label xml:lang="en-US" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transfers of assets between fair value hierarchy levels</label>
    <label xml:lang="en-US" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Between Hierarchy Levels Transfers Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents consisting of money market funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure</label>
    <loc xlink:href="abio-20140331.xsd#abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:type="locator" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract" />
    <label xml:lang="en-US" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Components of Property and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="abio_ComponentsOfPropertyAndEquipmentAbstract_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Software And Software Development Costs [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Property and equipment</label>
    <label xml:lang="en-US" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Components Of Property And Equipment [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Estimated Useful Lives</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</label>
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</label>
    <loc xlink:href="abio-20140331.xsd#abio_PropertyAndEquipmentTextualAbstract" xlink:type="locator" xlink:label="abio_PropertyAndEquipmentTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_PropertyAndEquipmentTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PropertyAndEquipmentTextualAbstract" xlink:to="abio_PropertyAndEquipmentTextualAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="abio_PropertyAndEquipmentTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment (Textual) [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_PropertyAndEquipmentTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property And Equipment Textual [Abstract]</label>
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTextualAbstract" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="abio_CommitmentsAndContingenciesTextualAbstract_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_LeaseTerm" xlink:type="locator" xlink:label="abio_LeaseTerm" />
    <label xml:lang="en-US" xlink:label="abio_LeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_LeaseTerm" xlink:to="abio_LeaseTerm_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesLineItems" />
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_CommitmentsAndContingenciesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Abstract]</label>
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTable" />
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="abio_CommitmentsAndContingenciesTable_lbl" />
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</label>
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</label>
    <loc xlink:href="abio-20140331.xsd#abio_WestminsterMember" xlink:type="locator" xlink:label="abio_WestminsterMember" />
    <label xml:lang="en-US" xlink:label="abio_WestminsterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Westminster.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_WestminsterMember" xlink:to="abio_WestminsterMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_WestminsterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Westminster, Colorado</label>
    <label xml:lang="en-US" xlink:label="abio_WestminsterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Westminster [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_BroomfieldMember" xlink:type="locator" xlink:label="abio_BroomfieldMember" />
    <label xml:lang="en-US" xlink:label="abio_BroomfieldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Broomfield.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_BroomfieldMember" xlink:to="abio_BroomfieldMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_BroomfieldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Broomfield, Colorado</label>
    <label xml:lang="en-US" xlink:label="abio_BroomfieldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Broomfield [Member]</label>
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies (Textual) [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Textual [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" />
    <label xml:lang="en-US" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of office facilities taken on lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Real Estate Property</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiry period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date1</label>
    <label xml:lang="en-US" xlink:label="abio_LeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</label>
    <label xml:lang="en-US" xlink:label="abio_LeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Term</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remainder of 2014</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Remainder Of Fiscal Year</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Two Years</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future minimum lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Rent Expense Net</label>
    <loc xlink:href="abio-20140331.xsd#abio_AgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="abio_AgreementTerminationNoticePeriod" />
    <label xml:lang="en-US" xlink:label="abio_AgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement termination notice period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AgreementTerminationNoticePeriod" xlink:to="abio_AgreementTerminationNoticePeriod_lbl" />
    <label xml:lang="en-US" xlink:label="abio_AgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical research agreement with Duke University, termination notice period</label>
    <label xml:lang="en-US" xlink:label="abio_AgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement Termination Notice Period</label>
    <loc xlink:href="abio-20140331.xsd#abio_ExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_ExpectedMilestonePaymentsUponApproval" />
    <label xml:lang="en-US" xlink:label="abio_ExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Expected milestone payments upon approval.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ExpectedMilestonePaymentsUponApproval" xlink:to="abio_ExpectedMilestonePaymentsUponApproval_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_AnotherExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval" />
    <label xml:lang="en-US" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Another expected milestone payments upon approval.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_AnotherExpectedMilestonePaymentsUponApproval" xlink:to="abio_AnotherExpectedMilestonePaymentsUponApproval_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRoyaltyObligation" />
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum percentage of royalty obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_MinimumPercentageOfRoyaltyObligation" xlink:to="abio_MinimumPercentageOfRoyaltyObligation_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRoyaltyObligation" />
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum percentage of royalty obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_MaximumPercentageOfRoyaltyObligation" xlink:to="abio_MaximumPercentageOfRoyaltyObligation_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" xlink:type="locator" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" />
    <label xml:lang="en-US" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of royalty obligated to pay under its original license agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" xlink:to="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum percentage of range of royalties that can be buy down.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:to="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum percentage of range of royalties that can be buy down.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:to="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_MilestonePaymentDuePeriod" xlink:type="locator" xlink:label="abio_MilestonePaymentDuePeriod" />
    <label xml:lang="en-US" xlink:label="abio_MilestonePaymentDuePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payment due period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_MilestonePaymentDuePeriod" xlink:to="abio_MilestonePaymentDuePeriod_lbl" />
    <label xml:lang="en-US" xlink:label="abio_ExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected milestone payments upon approval</label>
    <label xml:lang="en-US" xlink:label="abio_ExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Expected Milestone Payments Upon Approval</label>
    <label xml:lang="en-US" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Another expected milestone payments upon approval</label>
    <label xml:lang="en-US" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Another Expected Milestone Payments Upon Approval</label>
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum percentage of royalty obligation</label>
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Percentage Of Royalty Obligation</label>
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum percentage of royalty obligation</label>
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRoyaltyObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Percentage Of Royalty Obligation</label>
    <label xml:lang="en-US" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product sales levels royalty</label>
    <label xml:lang="en-US" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Royalty Obligated To Pay Under Its Original License Agreement</label>
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum percentage of range of royalties that can be buy down</label>
    <label xml:lang="en-US" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Percentage Of Range Of Royalties That Can Be Buy Down</label>
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum percentage of range of royalties that can be buy down</label>
    <label xml:lang="en-US" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Percentage Of Range Of Royalties That Can Be Buy Down</label>
    <label xml:lang="en-US" xlink:label="abio_MilestonePaymentDuePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payment due period</label>
    <label xml:lang="en-US" xlink:label="abio_MilestonePaymentDuePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment Due Period</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity Financings And Warrants (Textual) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_EquityFinancingsAndWarrantsTextualAbstract_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodNetProceeds" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodNetProceeds" />
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodNetProceeds_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period net proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_StockIssuedDuringPeriodNetProceeds" xlink:to="abio_StockIssuedDuringPeriodNetProceeds_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityIssuanceCloseDate" xlink:type="locator" xlink:label="abio_EquityIssuanceCloseDate" />
    <label xml:lang="en-US" xlink:label="abio_EquityIssuanceCloseDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity issuance close date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityIssuanceCloseDate" xlink:to="abio_EquityIssuanceCloseDate_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeAxis" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity financing transactions type.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityFinancingTransactionsTypeAxis" xlink:to="abio_EquityFinancingTransactionsTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Financing Transactions Type</label>
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Financing Transactions Type [Axis]</label>
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeDomain" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity financing transactions type.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_EquityFinancingTransactionsTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Financing Transactions Type</label>
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingTransactionsTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Financing Transactions Type [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_PrivateInvestmentInPublicEquityTransactionMember" xlink:type="locator" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember" />
    <label xml:lang="en-US" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Private investment in public equity transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PrivateInvestmentInPublicEquityTransactionMember" xlink:to="abio_PrivateInvestmentInPublicEquityTransactionMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PIPE Transaction</label>
    <label xml:lang="en-US" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Private Investment In Public Equity Transaction [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</label>
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity financings and warrants (Textual) [Abstract]</label>
    <label xml:lang="en-US" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Financings And Warrants Textual [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate common stock sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Issued For Cash</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants available to purchase additional commons shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Issued For Cash</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodNetProceeds_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of common stock</label>
    <label xml:lang="en-US" xlink:label="abio_StockIssuedDuringPeriodNetProceeds_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Net Proceeds</label>
    <label xml:lang="en-US" xlink:label="abio_EquityIssuanceCloseDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Equity Offering Close Date</label>
    <label xml:lang="en-US" xlink:label="abio_EquityIssuanceCloseDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Issuance Close Date</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuanceDates" xlink:type="locator" xlink:label="us-gaap_EquityIssuanceDates" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuanceDates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subscription agreement date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuanceDates" xlink:to="us-gaap_EquityIssuanceDates_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuanceDates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Issuance Dates</label>
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" />
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right exercise price of share percentage of closing bid price of common shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" xlink:to="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisableExpirationPeriod" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" />
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right exercisable expiration period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" xlink:to="abio_ClassOfWarrantOrRightExercisableExpirationPeriod_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_ClosingBidPriceDate" xlink:type="locator" xlink:label="abio_ClosingBidPriceDate" />
    <label xml:lang="en-US" xlink:label="abio_ClosingBidPriceDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Date of closing bid price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ClosingBidPriceDate" xlink:to="abio_ClosingBidPriceDate_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuancePerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price for common stock unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuancePerShareAmount" xlink:to="us-gaap_EquityIssuancePerShareAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuancePerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Issuance Per Share Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant coverage ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing bid price of the common stock</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Share Percentage Of Closing Bid Price Of Common Shares</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants were exercisable upon issuance, expiry year</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercisable Expiration Period</label>
    <label xml:lang="en-US" xlink:label="abio_ClosingBidPriceDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing bid price date</label>
    <label xml:lang="en-US" xlink:label="abio_ClosingBidPriceDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Closing Bid Price Date</label>
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockPurchasedByOfficer" xlink:type="locator" xlink:label="abio_PreferredStockPurchasedByOfficer" />
    <label xml:lang="en-US" xlink:label="abio_PreferredStockPurchasedByOfficer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred Stock Purchased by Officer.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PreferredStockPurchasedByOfficer" xlink:to="abio_PreferredStockPurchasedByOfficer_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_PublicOfferingMember" xlink:type="locator" xlink:label="abio_PublicOfferingMember" />
    <label xml:lang="en-US" xlink:label="abio_PublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Public Offering Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PublicOfferingMember" xlink:to="abio_PublicOfferingMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_PublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offering</label>
    <label xml:lang="en-US" xlink:label="abio_PublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Relationship to Entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</label>
    <loc xlink:href="abio-20140331.xsd#abio_DirectorAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember" />
    <label xml:lang="en-US" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Director and Chief Executive Officer.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_DirectorAndChiefExecutiveOfficerMember" xlink:to="abio_DirectorAndChiefExecutiveOfficerMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Director and Chief Executive Officer</label>
    <label xml:lang="en-US" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Director And Chief Executive Officer [Member]</label>
    <loc xlink:href="abio-20140331.xsd#abio_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="abio_SeriesAConvertiblePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="abio_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Convertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_SeriesAConvertiblePreferredStockMember" xlink:to="abio_SeriesAConvertiblePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="abio_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</label>
    <label xml:lang="en-US" xlink:label="abio_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockPurchasedByOfficer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Purchased by Officer</label>
    <label xml:lang="en-US" xlink:label="abio_PreferredStockPurchasedByOfficer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Purchased By Officer</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares issued upon conversion of each share of convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Shares Issued Upon Conversion</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock liquidation preference per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Liquidation Preference</label>
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" xlink:type="locator" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" />
    <label xml:lang="en-US" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of total number of shares of common stock then issued and outstanding limit on beneficial ownership.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" xlink:to="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership_lbl" />
    <label xml:lang="en-US" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of total number of shares of common stock then issued and outstanding limit on beneficial ownership</label>
    <label xml:lang="en-US" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Total Number Of Shares Of Common Stock Then Issued And Outstanding Limit On Beneficial Ownership</label>
    <loc xlink:href="abio-20140331.xsd#abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" xlink:type="locator" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" />
    <label xml:lang="en-US" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Intrinsic value of embedded beneficial conversion feature.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" xlink:to="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature_lbl" />
    <label xml:lang="en-US" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic value of embedded beneficial conversion feature</label>
    <label xml:lang="en-US" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Intrinsic Value Of Embedded Beneficial Conversion Feature</label>
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateEarliest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest" />
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or rights expiration date earliest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ClassOfWarrantOrRightsExpirationDateEarliest" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateEarliest_lbl" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateLatest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest" />
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or rights expiration date latest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abio_ClassOfWarrantOrRightsExpirationDateLatest" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateLatest_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageMember" xlink:type="locator" xlink:label="us-gaap_WeightedAverageMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageMember" xlink:to="us-gaap_WeightedAverageMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrant or rights expiration date earliest.</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Rights Expiration Date Earliest</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrant or rights expiration date latest</label>
    <label xml:lang="en-US" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Rights Expiration Date Latest</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, General and Administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expenses [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:type="locator" xlink:label="us-gaap_RestructuringChargesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestructuringChargesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restructuring Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringChargesMember" xlink:to="us-gaap_RestructuringChargesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestructuringChargesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Charges [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash, share-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Aggregate Disclosures [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Options outstanding beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options Forfeited, cancelled or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options outstanding end of the period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable, end of period, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average exercise Price, Options Outstanding, Beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Forfeited, cancelled or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average exercise Price, Options Outstanding, end of period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Options exercisable, end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average exercise Price, Options vested and expected to vest, end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (in years) Options Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at March 31, 2014, Weighted Average Remaining Contractual Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest, Weighted Average Remaining Contractual Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Restricted stock units outstanding at December 31, 2013</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested and released</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited and cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Restricted stock units outstanding at March 31, 2014</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Restricted stock units outstanding at December 31, 2013</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and released</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited and cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Restricted stock units outstanding at March 31, 2014</label>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>abio-20140331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-13T20:12:34.7258741+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : 2EA91F65504EA3A12F67016533784C83-0000907654-001404 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.nuvelo.com/20140331/role/TemplateLink" xlink:href="abio-20140331.xsd#TemplateLink" xlink:type="simple" />
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="abio-20140331.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <loc xlink:href="abio-20140331.xsd#abio_DocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="abio_DocumentAndEntityInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:type="locator" xlink:label="us-gaap_RestructuringCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RestructuringCharges" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="11860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="12280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <loc xlink:href="abio-20140331.xsd#abio_DeemedDividendBeneficialConversionPreferredStock" xlink:type="locator" xlink:label="abio_DeemedDividendBeneficialConversionPreferredStock" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" xlink:type="locator" xlink:label="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" />
    <loc xlink:href="abio-20140331.xsd#abio_CashNetOfOfferingCostsMember" xlink:type="locator" xlink:label="abio_CashNetOfOfferingCostsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" xlink:type="locator" xlink:label="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" />
    <loc xlink:href="abio-20140331.xsd#abio_ConversionOfPreferredStockToCommonStockShares" xlink:type="locator" xlink:label="abio_ConversionOfPreferredStockToCommonStockShares" />
    <loc xlink:href="abio-20140331.xsd#abio_NotesAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_NotesAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_CommonConversionMember" xlink:type="locator" xlink:label="abio_CommonConversionMember" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" xlink:type="locator" xlink:label="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" />
    <loc xlink:href="abio-20140331.xsd#abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" xlink:type="locator" xlink:label="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesBMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesBMember" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfSeriesMember" xlink:type="locator" xlink:label="abio_AccretionOfSeriesMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" />
    <loc xlink:href="abio-20140331.xsd#abio_AccretionOfOfferingCostEffectOnEquity" xlink:type="locator" xlink:label="abio_AccretionOfOfferingCostEffectOnEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStockStock" />
    <loc xlink:href="abio-20140331.xsd#abio_AdjustmentForFractionalShares" xlink:type="locator" xlink:label="abio_AdjustmentForFractionalShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_DeficitAccumulatedDuringDevelopmentStageMember" xlink:type="locator" xlink:label="abio_DeficitAccumulatedDuringDevelopmentStageMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeriesOfferingCostsMember" xlink:type="locator" xlink:label="abio_SeriesOfferingCostsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:type="locator" xlink:label="us-gaap_SeriesBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:type="locator" xlink:label="us-gaap_SeriesAMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesAMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesBMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeriesOfferingCostsMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="abio_DeficitAccumulatedDuringDevelopmentStageMember" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentForFractionalShares" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStockStock" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="12350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="12830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="13070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" order="13550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" order="13790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="14030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="14570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="14810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="15090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="15390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AccretionOfOfferingCostEffectOnEquity" order="26270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue" order="29730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares" order="29990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="30250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="30530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="30950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="30990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="31070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="31130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="31170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_AccretionOfSeriesMember" order="31210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_AccretionOfSeriesBMember" order="31230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="31290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_IssuanceOfCommonStockForCommercialLicenseRightsMember" order="31330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_IssuanceOfSharesToExecutiveSubjectToRepurchaseMember" order="31370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CommonConversionMember" order="44300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_NotesAndRelatedAccruedInterestMember" order="44400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_ConversionOfPreferredStockToCommonStockShares" order="47810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction" order="48050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest" order="48290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock" order="48770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="49970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued" order="51270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CashNetOfOfferingCostsMember" order="59680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue" order="73900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares" order="74180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_PreferredStockIssuedDuringPeriodSharesNewIssues" order="74440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_PreferredStockIssuedDuringPeriodValueNewIssues" order="74740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_DeemedDividendBeneficialConversionPreferredStock" order="75120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="75400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="abio-20140331.xsd#abio_CommonStockMarketPricePerShare" xlink:type="locator" xlink:label="abio_CommonStockMarketPricePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" xlink:type="locator" xlink:label="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" />
    <loc xlink:href="abio-20140331.xsd#abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" xlink:type="locator" xlink:label="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" />
    <loc xlink:href="abio-20140331.xsd#abio_CashNetOfOfferingCostsMember" xlink:type="locator" xlink:label="abio_CashNetOfOfferingCostsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:type="locator" xlink:label="us-gaap_SeriesBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:type="locator" xlink:label="us-gaap_SeriesAMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesAMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesBMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_CashNetOfOfferingCostsMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FourthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FifthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SixthIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeventhIssuanceOfStockForIntellectualPropertyLicenseRightsMember" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_FirstIssuanceOfConvertibleRedeemablePreferredStockMember" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceForNotesPayableAndRelatedAccruedInterestMember" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesConvertibleRedeemablePreferredStockMember" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_ThirdIssuanceOfSeriesBRedeemablePreferredStockMember" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SecondIssuanceOfSeriesBConvertibleRedeemablePreferredStockMember" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_CommonStockMarketPricePerShare" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="abio-20140331.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="abio-20140331.xsd#abio_VendorFinanceAgreement" xlink:type="locator" xlink:label="abio_VendorFinanceAgreement" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedDeferredTransactionCosts" xlink:type="locator" xlink:label="abio_AccruedDeferredTransactionCosts" />
    <loc xlink:href="abio-20140331.xsd#abio_WarrantIssuedInConnectionWithCreditFacility" xlink:type="locator" xlink:label="abio_WarrantIssuedInConnectionWithCreditFacility" />
    <loc xlink:href="abio-20140331.xsd#abio_AccruedInterestOnNotesPayableConvertedToEquity" xlink:type="locator" xlink:label="abio_AccruedInterestOnNotesPayableConvertedToEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" xlink:label="us-gaap_InterestPaid" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <loc xlink:href="abio-20140331.xsd#abio_RepaymentOfPrincipalOnVendorFinanceAgreement" xlink:type="locator" xlink:label="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="abio-20140331.xsd#abio_ProceedsFromIssuanceOfRestrictedStock" xlink:type="locator" xlink:label="abio_ProceedsFromIssuanceOfRestrictedStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_WriteOffOfDeferredTaxLiability" xlink:type="locator" xlink:label="abio_WriteOffOfDeferredTaxLiability" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:type="locator" xlink:label="us-gaap_AccretionExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_GainLossOnAssignmentOfPatentRights" xlink:type="locator" xlink:label="abio_GainLossOnAssignmentOfPatentRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10400.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="abio_GainLossOnAssignmentOfPatentRights" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionExpense" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="abio_WriteOffOfDeferredTaxLiability" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesGainLoss" order="11650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="12490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="12590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="12830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="12910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="13090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="13170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" order="13250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="13330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="13550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="13630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="abio_ProceedsFromIssuanceOfRestrictedStock" order="13710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="13790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="13870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="14190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="14270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="abio_RepaymentOfPrincipalOnVendorFinanceAgreement" order="14350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="14470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="14590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="14710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_li0l2" order="14790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="14990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="15110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_AccruedInterestOnNotesPayableConvertedToEquity" order="15230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_WarrantIssuedInConnectionWithCreditFacility" order="15310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_AccruedDeferredTransactionCosts" order="15390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="abio_VendorFinanceAgreement" order="15470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009" xlink:href="abio-20140331.xsd#Role_DisclosureMergerWithNuveloIncOnJanuary272009" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures" xlink:href="abio-20140331.xsd#Role_DisclosureFairValueDisclosures" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants" xlink:href="abio-20140331.xsd#Role_DisclosureEquityFinancingsAndWarrants" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants">
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsDisclosureTextBlock" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_EquityFinancingsAndWarrantsDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensation" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes" xlink:href="abio-20140331.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:href="abio-20140331.xsd#abio_AccruedExpensesPolicyTextBlock" xlink:type="locator" xlink:label="abio_AccruedExpensesPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <loc xlink:href="abio-20140331.xsd#abio_ReverseStockSplitPolicyTextBlock" xlink:type="locator" xlink:label="abio_ReverseStockSplitPolicyTextBlock" />
    <loc xlink:href="abio-20140331.xsd#abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" xlink:type="locator" xlink:label="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_ReverseStockSplitPolicyTextBlock" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="abio_AccruedExpensesPolicyTextBlock" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="abio-20140331.xsd#Role_DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="abio-20140331.xsd#abio_RegisteredDirectOfferingMember" xlink:type="locator" xlink:label="abio_RegisteredDirectOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeDomain" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityTransactionsTypeAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_TwoZeroOneFourEquityFinancingsMember" xlink:type="locator" xlink:label="abio_TwoZeroOneFourEquityFinancingsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_TermOfCompletion" xlink:type="locator" xlink:label="abio_TermOfCompletion" />
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatientsCompanyPlansToEnroll" xlink:type="locator" xlink:label="abio_NumberOfPatientsCompanyPlansToEnroll" />
    <loc xlink:href="abio-20140331.xsd#abio_NumberOfPatients" xlink:type="locator" xlink:label="abio_NumberOfPatients" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:type="locator" xlink:label="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_PhaseThreeHeartFailureMember" xlink:type="locator" xlink:label="abio_PhaseThreeHeartFailureMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:type="locator" xlink:label="us-gaap_HealthCareTrustFundAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_HealthCareTrustFundAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareTrustFundAxis" xlink:to="us-gaap_HealthCareTrustFundNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareTrustFundNameDomain" xlink:to="abio_PhaseThreeHeartFailureMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems" xlink:to="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_NumberOfPatients" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_NumberOfPatientsCompanyPlansToEnroll" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="abio_TermOfCompletion" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="abio_TwoZeroOneFourEquityFinancingsMember" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="abio_EquityTransactionsTypeAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityTransactionsTypeAxis" xlink:to="abio_EquityTransactionsTypeDomain" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityTransactionsTypeDomain" xlink:to="abio_RegisteredDirectOfferingMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="abio-20140331.xsd#abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:type="locator" xlink:label="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_EarningsPerShareBasicLineItems" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberOfSharesIssuedBasic" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureNetLossPerShareDetailsTextual" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_EarningsLossPerShareTextualAbstract" xlink:type="locator" xlink:label="abio_EarningsLossPerShareTextualAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_EarningsPerShareBasicLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="abio_EarningsLossPerShareTextualAbstract" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EarningsLossPerShareTextualAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details" xlink:href="abio-20140331.xsd#Role_DisclosureMergerWithNuveloIncOnJanuary272009Details" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails" xlink:href="abio-20140331.xsd#Role_DisclosureFairValueDisclosuresDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <loc xlink:href="abio-20140331.xsd#abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" xlink:type="locator" xlink:label="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" />
    <loc xlink:href="abio-20140331.xsd#abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" xlink:type="locator" xlink:label="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_FairValueDisclosuresTextualAbstract" xlink:type="locator" xlink:label="abio_FairValueDisclosuresTextualAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_RangeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="abio_FairValueDisclosuresTextualAbstract" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_FairValueDisclosuresTextualAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <loc xlink:href="abio-20140331.xsd#abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:type="locator" xlink:label="abio_ComponentsOfPropertyAndEquipmentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="abio_ComponentsOfPropertyAndEquipmentAbstract" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_ComponentsOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosurePropertyAndEquipmentDetailsTextual" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="abio-20140331.xsd#abio_PropertyAndEquipmentTextualAbstract" xlink:type="locator" xlink:label="abio_PropertyAndEquipmentTextualAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="abio_PropertyAndEquipmentTextualAbstract" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_PropertyAndEquipmentTextualAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesDetailsTextual" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual">
    <loc xlink:href="abio-20140331.xsd#abio_MilestonePaymentDuePeriod" xlink:type="locator" xlink:label="abio_MilestonePaymentDuePeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" />
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" xlink:type="locator" xlink:label="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" />
    <loc xlink:href="abio-20140331.xsd#abio_MaximumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MaximumPercentageOfRoyaltyObligation" />
    <loc xlink:href="abio-20140331.xsd#abio_MinimumPercentageOfRoyaltyObligation" xlink:type="locator" xlink:label="abio_MinimumPercentageOfRoyaltyObligation" />
    <loc xlink:href="abio-20140331.xsd#abio_AnotherExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_AnotherExpectedMilestonePaymentsUponApproval" />
    <loc xlink:href="abio-20140331.xsd#abio_ExpectedMilestonePaymentsUponApproval" xlink:type="locator" xlink:label="abio_ExpectedMilestonePaymentsUponApproval" />
    <loc xlink:href="abio-20140331.xsd#abio_AgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="abio_AgreementTerminationNoticePeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <loc xlink:href="abio-20140331.xsd#abio_LeaseTerm" xlink:type="locator" xlink:label="abio_LeaseTerm" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTextualAbstract" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTextualAbstract" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_BroomfieldMember" xlink:type="locator" xlink:label="abio_BroomfieldMember" />
    <loc xlink:href="abio-20140331.xsd#abio_WestminsterMember" xlink:type="locator" xlink:label="abio_WestminsterMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="abio_CommitmentsAndContingenciesTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="abio_WestminsterMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="abio_BroomfieldMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="abio_CommitmentsAndContingenciesLineItems" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_CommitmentsAndContingenciesTextualAbstract" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_AreaOfRealEstateProperty" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_LeaseExpirationDate1" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="abio_LeaseTerm" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTextualAbstract" xlink:to="abio_AgreementTerminationNoticePeriod" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_ExpectedMilestonePaymentsUponApproval" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_AnotherExpectedMilestonePaymentsUponApproval" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MinimumPercentageOfRoyaltyObligation" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MaximumPercentageOfRoyaltyObligation" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="abio_MilestonePaymentDuePeriod" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails" xlink:href="abio-20140331.xsd#Role_DisclosureCommitmentsAndContingenciesDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="abio_CommitmentsAndContingenciesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="abio_CommitmentsAndContingenciesTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesTable" xlink:to="abio_CommitmentsAndContingenciesLineItems" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual" xlink:href="abio-20140331.xsd#Role_DisclosureEquityFinancingsAndWarrantsDetailsTextual" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual">
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateLatest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateLatest" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightsExpirationDateEarliest" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightsExpirationDateEarliest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageMember" xlink:type="locator" xlink:label="us-gaap_WeightedAverageMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" xlink:type="locator" xlink:label="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" />
    <loc xlink:href="abio-20140331.xsd#abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" xlink:type="locator" xlink:label="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <loc xlink:href="abio-20140331.xsd#abio_PreferredStockPurchasedByOfficer" xlink:type="locator" xlink:label="abio_PreferredStockPurchasedByOfficer" />
    <loc xlink:href="abio-20140331.xsd#abio_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="abio_SeriesAConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_DirectorAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="abio_DirectorAndChiefExecutiveOfficerMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" />
    <loc xlink:href="abio-20140331.xsd#abio_PublicOfferingMember" xlink:type="locator" xlink:label="abio_PublicOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_RegisteredDirectOfferingMember" xlink:type="locator" xlink:label="abio_RegisteredDirectOfferingMember" />
    <loc xlink:href="abio-20140331.xsd#abio_ClosingBidPriceDate" xlink:type="locator" xlink:label="abio_ClosingBidPriceDate" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisableExpirationPeriod" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" />
    <loc xlink:href="abio-20140331.xsd#abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" xlink:type="locator" xlink:label="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuanceDates" xlink:type="locator" xlink:label="us-gaap_EquityIssuanceDates" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityIssuanceCloseDate" xlink:type="locator" xlink:label="abio_EquityIssuanceCloseDate" />
    <loc xlink:href="abio-20140331.xsd#abio_StockIssuedDuringPeriodNetProceeds" xlink:type="locator" xlink:label="abio_StockIssuedDuringPeriodNetProceeds" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:type="locator" xlink:label="abio_EquityFinancingsAndWarrantsTextualAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <loc xlink:href="abio-20140331.xsd#abio_PrivateInvestmentInPublicEquityTransactionMember" xlink:type="locator" xlink:label="abio_PrivateInvestmentInPublicEquityTransactionMember" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeDomain" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeDomain" />
    <loc xlink:href="abio-20140331.xsd#abio_EquityFinancingTransactionsTypeAxis" xlink:type="locator" xlink:label="abio_EquityFinancingTransactionsTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="abio_EquityFinancingTransactionsTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingTransactionsTypeAxis" xlink:to="abio_EquityFinancingTransactionsTypeDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_PrivateInvestmentInPublicEquityTransactionMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="abio_EquityFinancingsAndWarrantsTextualAbstract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_StockIssuedDuringPeriodNetProceeds" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_EquityIssuanceCloseDate" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_EquityIssuanceDates" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_EquityIssuancePerShareAmount" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightExercisableExpirationPeriod" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClosingBidPriceDate" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_RegisteredDirectOfferingMember" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingTransactionsTypeDomain" xlink:to="abio_PublicOfferingMember" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="abio_DirectorAndChiefExecutiveOfficerMember" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="abio_SeriesAConvertiblePreferredStockMember" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_PreferredStockPurchasedByOfficer" order="12650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership" order="13590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature" order="13910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RangeAxis" order="10020.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="15140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="15160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="15180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_WeightedAverageMember" order="15200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="15340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateEarliest" order="15580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="abio_EquityFinancingsAndWarrantsTextualAbstract" xlink:to="abio_ClassOfWarrantOrRightsExpirationDateLatest" order="15640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:type="locator" xlink:label="us-gaap_RestructuringChargesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_RestructuringChargesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails1" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2" xlink:href="abio-20140331.xsd#Role_DisclosureShareBasedCompensationDetails2" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/&
MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ,
MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N
M);GWYIY2E^50"1=K`RK<F6I;"1^^VADU(IN+&5#>[?9HII4'Y3N^GD&&@T>8
MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@
MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A
M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD
M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E
M6,S*L9B58S$KQV)6CL6L'(M9.1:S<BQFY5C,RK&8-<%BU@2+61,L9DVPF#7Y
M+[/Z4,@!;3[__G0T8WYIA)Q?E^#._!:W&?I;<BXLR#=O0W5Y=H#OLX]QA&)O
M;+5QH>*T</HI[#K,>G?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[
M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?<F5L<R\N
M<F5L<R"B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````",DL].PS`,QN](O$/D^^IN
M2`BAI;M,2+LA5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][NYFE4'QQB+T[#
MNBA!L3-B>]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\
M(V(T'4\4"_'L<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'JC[Z//FR
MMS1-;W@OYGUBETZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1R?LB8P.>)MI<
M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````
M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS(*($`2B@``$`````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````O)C-;L(P$(3OE?H.D>_%[)K?BL"EJL2UI0]@)88@((EL]X>W
MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/
M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M:
M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+->
M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA
MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$#
M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T
MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B<TL<'
MAL<'TVD$AGC<I^/AM8!/8U2Y)`U+@K`D:5@2A*611H*!2)`F`@2"])>"'XJD
MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8Z<PS,'-,I+V-JO+FK,Z>A/EWA
MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`AT$0`DX#
M```N"P``#P```'AL+W=O<FMB;V]K+GAM;)266V_B,!"%WU?:_Q#E?9L;]*9"
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MQK'*+82H!,\H1$1NJ*`R961:+35(HK+>:,1':)`)Q3)(I0[[H).I!4-5OPU1
M<_*G8$AE@%0&O5[:*A.-59)3)#,\3@82;=)-SI!.S<47-W5+<<)8Y:SK!@@D
MMRHOJ-S4W9Z6>4[UIHIFRA?8#!S=ID_G79EG9LEO90R9,`T]INT\+M#2B^[2
M)Z87L&C%[9(\EQ],*&`M)4J27U26R,$`D&\<1&%7YX%R35ZH*!FYXR85RI0:
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MOAZ`9X\.YCAV..[7:6T,TQP[-/=CB(6&K98=R7.+']RSQ`&Z?U9A1PD4S>R&
MHM.S0R=C&S:"*,%`0W&43LL0CBAQJ.XWA"-*6A'56`<U1O!.E5*1PLM>]5&]
M+=7Y!;M7W?%_````__\#`%!+`P04``8`"````"$`65+Y4S`%``"$%0``&```
M`'AL+W=O<FMS:&5E=',O<VAE970T+GAM;)2876^K.!"&[U?:_X"X;_@,D"C)
MT0&KNT?:(ZU6^W%-B).@`HZ`-NV_WS'C`#8)D)NVJ1^_O#,>>X@WWS[S3/N@
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MDKJ6O%<UR_]#R!)2*&(+$0?<BW'[:1%7B,#OFX@_5\3`J)HDD;B.=YN2736H
M//!=76)>Q]8:A&_9P5C:?#U*%^2)BWSG*HT69**"-?[8+5<;XP.6)1%(B`CL
MJA:Q9"*Z$7P-N"H9JGK='`,":*.`_*I1.%`I]]?X9II/DDU[IFPI'"*V3$1#
MPE,0,D0Z0HH"JJ,?Q;A[#F]U6+(VGYXC>PL1@2IM$5<FHDF"C!&2>7`RWSR'
M82/UG'F*M1"155-,EF,&BG-I..C*`BNG/^IZ*ZO+C.094C/?,X<5STO95(B(
MCY[-H%OFQE6$P\MF.`B4#4+ZDUW?\_U67/+L/>.9PXIGKY5M3(6(P,,?%LDD
M09#`N)>NW^TBR;G_C',.*\Z[A*!S1,:<3Q($"71NNX_JA+\+*(?D]/'")RD1
M*$4<(C(6P21!D,`(/--\D/N5','XT<)AQ;E2K"$B(F_.JGLJ5GI_V#)[!=$,
M$WDX</T'^].",[R?^'';#2W[5I\<"@:-O]A#YS)PQ[L*C+CG_:M7-A/NL=OU
MST1?.=9""YFQ@IE&B$#$XCTL&8OWK?GVL<M)]I7S+VP4M_JH?90908A0$?:7
M=N^8E8X;B[>N^?XYK11/5Y5XX#2*W#]_P5&"B]K!AP<I$<@M\4[7/F3CO'O-
M-XZ]3DJ\VDLM9-#XBU)5T>@HD4==MSN%9=.P9$^8YK22[2X;(MO(M%M5;9@1
M?XL'$0'`5E4"(S+@KSRS6U'9/&]@\S..[4[*N-I5K<FF&4TC1""B8.S>:XYL
MGW>Q^?:QYTGVNT45N>_W13@FA[F7@'NYEP#?=^QNP\CF>0/KF>??0*:;JX5M
M3PI"[:Z"@2IY^&HSC9`6X9O^Q7:[,I7#X#VM%\;$88\=4+*OME@+F5'[DP@1
M*K==%)C=4DO^;:75SEN&9I:\CP/E72`4#+[)WZLE&;A32S(0F([?'7!R$$K'
MG1D$=E4X(]LZZ>TTW!#V=.>=1L@H(D?R5/.UA\VWUQ5%!,C`ZTM3R.:B][+;
M$)%0Z8A>@VH((HC[)2G[A]*>OQUL3LM?9H/NJ!;^D;G_;!'`)$+$D^ZKR!$\
MU87A!DMM:,,50`:WHA7XP=*UE#,K$CK(.*8#7P251/#+,OZHL1#P,@SO>7):
MGFA$LZS2$O;.+[HLJ(#VOW@)%UIKN'[AUVCM`-R!7>(3_1F7I[2HM(P>8:JY
M\.&Y)=ZBX8>:79I+E#VKX?:K^?,,MYT4+G#,!<!'QNK;!_Z`]OYT]S\```#_
M_P,`4$L#!!0`!@`(````(0"ZF(-MD0(``*$&```9````>&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;)Q5VXZ;,!!]K]1_L/R^&,@]"EEMNMIVI5:JJEZ>'6/`
M"L;(=B[[]QW;";FU5=(7P/C,.7-FS#![W,D:;;@V0C493J(8(]XPE8NFS/"/
M[R\/8XR,I4U.:]7P#+]Q@Q_G[]_-MDJO3,6Y1<#0F`Q7UK930@RKN*0F4BUO
M8*=06E(+2UT2TVI.<Q\D:Y+&\9!(*AH<&*;Z%@Y5%(+Q9\76DC<VD&A>4POY
MFTJTYL`FV2UTDNK5NGU@2K9`L12UL&^>%"/)IJ]EHS1=UN![E_0I.W#[Q16]
M%$PKHPH;`1T)B5Y[GI`)`:;Y+!?@P)4=:5YD^"F9+D:8S&>^/C\%WYJ39V0J
MM?VH1?Y9-!R*#6UR#5@JM7+0U]R]@F!R%?WB&_!5HYP7=%W;;VK[B8NRLM#M
M`1AROJ;YVS,W#`H*-%$Z<$Q,U9``7)$4[F1`0>C.W[<BMU6&>\-H,(I["<#1
MDAO[(APE1FQMK)*_`BC94P62=$\"]SU)DMY*0D)"WM\SM70^TVJ+X,R`I&FI
M.X')%(B=L1Z4Y\_&P)&+>7)!/A30!IJQF??'DQG90`79'K,(&#C_'2;M$`3$
MNPQ`]?X,7-!Y!FF_H_=)+@)D[/MZJM?['ST7E.'^B9O^)+X0#!CH9^?XF-*9
M8Z`Y=?SO6CLP].2$M9<.+I0#9N([,3@VXDP4\KI=U(&=J&MM&B>7>F%[X+?'
MQS*<Z0WOT7/@$[WAA;^P'?2&?SE&HWOT'/BRJ)>B`1.*"C7H4@HNPZ@(GY+D
MNN0?>%T;Q-3:C8$$2M.]#1-J`1,J]8>QVX`)T=*2?Z&Z%(U!-2\@-(Y&4%X=
M9DQ86-7ZL[Y4%F:#?ZS@5\#A4XPC`!=*V</"3;'NYS+_#0``__\#`%!+`P04
M``8`"````"$`**\Z?HP%``!\&P``&0```'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6R4F=N.JD@4AN\GF7<@W&\Y"*)&W6GDM),]R60RAVL:2R4ME@&Z[7[[
M645QL`IW+;UIV^7'3]6_5E$'5M\_BY/V0<HJI^>U;DU,72/GC.[R\V&M__-W
M]&VN:U6=GG?IB9[)6O\BE?Y]\_MOJRLMWZHC(;4&"N=JK1_K^K(TC"H[DB*M
M)O1"SO#+GI9%6L/7\F!4EY*DN^:BXF38ICDSBC0_ZUQA63ZB0??[/",!S=X+
M<JZY2$E.:0WMKX[YI>K4BNP1N2(MW]XOWS):7$#B-3_E]5<CJFM%MOQQ.-,R
M?3U!OS\M)\TZ[>;+2+[(LY)6=%]/0,[@#1WW>6$L#%#:K'8Y](#9KI5DO]9?
MK&5BS75CLVH,^C<GU^KF?ZTZTFM<YKN?^9F`VY`GEH%72M\8^F/'0G"Q,;HZ
M:C+P9ZGMR#Y]/]5_T6M"\L.QAG2[T"/6L>7N*R!5!HZ"S,1VF5)&3]``^*L5
M.2L-<"3];#ZO^:X^KO7I;.)ZYM0"7'LE51WE3%+7LO>JIL5_'+):*2YBMR+P
MV8I8[L2Q76_^C,JT57$&%?OIID"CF_[`9]<4[VF162OB]2(V=.U!,V!D-2V`
MS[8%-G@_=RUWAEMJ\/0TV0[2.MVL2GK58`A!`JI+R@:DM03E+LT\*7WB?Y5W
M2#@3>6$J:QVNAY164*P?&V<V7QD?4&!9R_B<@;\#8\Y$9CO6L40BZ`A6<>S6
MX5AV)ET3C1&)B#NB4TVZP-#8X1(#K.O]@_S=^G=_>'0V,9C9U-W&[P+#;9S9
M0NSQ=LS8(A&,B9F$A&-$(B).0+_[]$A$/"8<;W"ER48R9@85P3<8E(_[QF#!
M-SFPE0.!'`CE0,0#MQUV/%-T-GZ`2>XQTUY'Z#0\@1[O-(.%3LN!K1P(Y$`H
M!R(>X$]9-GSB+C"DW?&&E/&D=@R4K=`=>!;>=H<].Z8PT:C'`+MHK8-D7V>.
MY_1V-3?T.0-_!T8DMB@1H$2($A%*Q"B1J`C!39@<;MU4N\A@</O6(<\5/?(Y
M`_?_I8LH$:!$B!(12L2<\)J)PYV:TBA,5`*"A3"O/FXA@V4+I?G(YXS*0I0(
M4")$B8@3,SZSVC-G>+XT`R9&%1)!P7(=KR\6P4&8PA]WD,&R@X,N'\J<43F(
M$@%*A"@1W2%<:::-[S"]2_Q)J"($'Q?/^,A@V4=Y]<09E8^<6#0U8BU,>10%
MPN^PFY)&67C[N[OP1D"$-B%&B41%"`9:,)'<5N)CDTMSE6REE&:_A51>WD-<
M:98*[D%BO80X$N%(C".)$A&-94M;:<6/S]H67Q`+$\Y<JB"_A?AS?`X%-*JA
M;8LHO`]P),21"$=B'$F4B&@K6_D^;RM?+XNV2FMJW^(0']GN?5LYHK051<+V
M1@J5"$=B'$F4B&@K6UT_;RN[2GH,S*55K6]QR..SJCF!(P5Q]&Y;0N%'@",A
MCD0X$N-(HD1$5]F*_GE7^3Y`+%9I)>);'.I='9O*`:6I*!*VMU&H1#@2XTBB
M1$13H3&WIJH7\.PL;52BT@SCMU!OICFJ4*ZBL"%H-11(B",1CL0XDB@1T4RV
MYG^^0OE.0:Q0R3/?:G<;BG&OVG`T"\&@%5&ZBJI$N$J,(XD2$5UENX#G7>5[
M!]%5>:=D<:@O54O:"&Q;0.%8@",ACD0X$N-(HD1$4]FFX,949-SS+81HIN25
M#P?[[.$@>#67=@3;>Y`X@04X$N)(A",QCK"7%:,^]<WEAO*7$?QXNB#E@6S)
MZ51I&7UG+QK8>.VC_4N0%X>=IDKQK;6$@^)QW+>7_EW>7L)AVI@/["6<J8WC
MH;V$HS6(&_V-X=W')3V0/]+RD)\K[43VT&1SXD$.2_[VA'^IZ:4Y='^E-;SU
M:/X]PELN`F=QY@3@/:5U]X7=H']OMOD?``#__P,`4$L#!!0`!@`(````(0#<
MMJ3TIP(``/$&```9````>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;)Q56V_:
M,!1^G[3_8/F]N0%IB0A5(72KM$G3M,NS<9S$(HXCVY3VW^\X)AF!KJWV`K'/
M=[Z<[]RRN'T2-7ID2G/9I#CT`HQ80V7.FS+%/W_<7]U@I`UI<E++AJ7XF6E\
MN_SX87&0:J<KQ@P"AD:GN#*F37Q?TXH)HCW9L@8LA52"&#BJTM>M8B3OG$3M
M1T$0^X+P!CN&1+V'0Q8%IRR3="]88QR)8C4Q$+^N>*M[-D'?0R>(VNW;*RI%
M"Q1;7G/SW)%B)&CR4#92D6T-NI_"*:$]=W>XH!><*JEE83R@\UV@EYKG_MP'
MIN4BYZ#`IATI5J3X+DPV4^PO%UU^?G%VT"?/2%?R\$GQ_`MO&"0;RF0+L)5R
M9Z$/N;T"9__"^[XKP#>%<E:0?6V^R\-GQLO*0+5G(,CJ2O+GC&D*"04:+YI9
M)BIK"`!^D>"V,R`AY*G[/_#<5"F>Q-[L.IB$`$=;ILT]MY08T;TV4OQVH/!(
MY4BB(PEX'$G"Z+TDO@NHTY<10Y8+)0\(>@9>J5MB.S!,@+@7YL(8I/Y+*4BT
M)'>6I>,"$1JJ\[B<QO'"?X24TB-FY3`P$`,F'"/6/<+FS])F_<5?E_C,9]-#
M;/5`TJ`+DG6N:P)E?[E@O0SK-)813<<QKEZ`C!'K2T0<C2'9)>0,L7D-,=(Y
M^1^=UBG%TY-23./K<8PKAX&6&,IUEHKUFXCL3<3F-<1()P1[6L_7ZVC!,&(G
ML8?SLPRO'&;>->MDK'U]:@N#L3$;&6^"^=@,6\B^V_&&IV8GQZT8-X*"J9*M
M65UK1.7>KH\(PAENW69;A0D,!K3WV7T&&Z^[]P<#;)R6E.PK425O-*I9`92!
M=PU%5&YGN8.1;=?E6VE@UW2/%7Q:&(Q<X`&XD-+T!SM7P\=J^0<``/__`P!0
M2P,$%``&``@````A`(TZ^&QL!```@1,``!D```!X;"]W;W)K<VAE971S+W-H
M965T,C<N>&ULG%C;CJ,X$'T?:?\!\=XA)D`N2C(:TNJ=D6:EU6HOSP2<!'7`
M$:8[W7\_98H0RA"'[$LG:1\?'Y\J5X&77S^RH_7."YF*?&6ST=BV>!Z+),WW
M*_N?OU^>9K8ERRA/HJ/(^<K^Y-+^NO[MR_(LBE=YX+RT@"&7*_M0EJ>%X\CX
MP+-(CL2)YS"R$T46E?"SV#OR5/`HJ29E1\<=CP,GB]+<1H9%,81#['9IS)]%
M_);QO$22@A^C$O3+0WJ2%[8L'D*71<7KV^DI%MD)*+;I,2T_*U+;RN+%CWTN
MBFA[A'U_,"^*+]S5CPY]EL:%D&)7CH#.0:'=/<^=N0-,ZV62P@Z4[5;!=RO[
M&UMLW,!VULO*H']3?I:M[Y8\B//O19K\3',.;D.<5`2V0KPJZ(]$_0LF.YW9
M+U4$_BRLA.^BMV/YESA_Y^G^4$*X?=B1VM@B^7SF,@9'@6;D^HHI%D<0`'^M
M+%6I`8Y$']7G.4W*P\J>!"-_.IXP@%M;+LN75%':5OPF2Y']AR!64R&)6Y/`
MYY6$>>/@`8Y)S0&?-0=S1^[,9_X`%@=W59GT')71>EF(LP69![KE*5)YS!;`
MK-R9@,?][H`M:LXW-:F:"F@)(7U?>[Z_=-XA#'&-";L81A&;"T)%#]0TDL"D
MQR6I2522Z]'UPAX(16QZ$-=M$8U@U>,:U:25[=E6R[:`2@@1`YEUQ5#$QH0@
M&F&AMD9S2!480M]>UY_2E4/$S*N`^TRS=W-KE&B"C;4U#4LW-8EJF^BKAXCQ
M*VU/WFQ&I6^TX1M1#:@ZLV,*K*D:TU5#A*`H5XOTA@S.FYG$KNDC@A28"O)\
MS8<0,>#&S?0R(8@VU2`?KAQJTKTC@!B31A.":)Q3C>:`*C#U;S*>-'&I*E^(
M&*+-O\:NPFQZ,`T+4<>@T+8M-,NKT%2?USFB-0A3;JXKNS5*56DMX8XJK.*D
M<`3Z.6`((K8UEJ!I1@C5][_Z`\/:#D7JFOF^=B3#&F34B3S]$*I3%>K6`;GC
M(Y;UMH_=[&,((HL'G;;:`VK,I@I5R1ZN$`M\6V%/_B$(\X]Y;K-P'>5;PU07
M;/`!70JMG8M`6SA43WP`(L[IVDP0JD_K$\.Z&,."#PZ8,O#2%5H@7:<)0G4^
MU#Y8MW_T9&!/>^AF8`^HV015J#61.V<$Z_Z=#+PT!_58.NM4P!NC5-5#;8-U
M^X87Z'VC!AGS;W#?<+6^,2S_JEGW>F\-,NDT0HB/[D.=I$+3<]S-OQI$]'4:
M<!^H/_]<K9>8\Z]"4X7="EB#Z@HXU5K,YN8P=4[5\,&5V<6*3\Y%H#V>AS6(
M.->8@M79"*'Z5!UOZ1N8@5C]S17019!1IPE"=0)-6^>=^"HTC6]/!B*(Z`NN
M[Q.UDSV@QFRJ4.LE=Q1B[2>1[CP#PFV*V@:^IVDO`.JJI6\0->$E"MX/G*(]
M_R,J]FDNK2/?0<\:CZ:PK0*O4/!'*4[52_=6E'#U47T]P%47ATN"\0C`.R'*
MRP_UFM]<GJU_`0``__\#`%!+`P04``8`"````"$`@;V6G\P"``!%"```&0``
M`'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6R<5EU/VS`4?9^T_V#YG7PUH;1J
MBF"(#6E(T[2/9]=Q$HLXCFR7PK_?O7$)38L@6A_R>>XY]QP[=E>73ZHAC\)8
MJ=N<QD%$B6BY+F1;Y?3WK]NS"TJL8VW!&MV*G#X+2R_7GS^M=MH\V%H(1X"A
MM3FMG>N686AY+12S@>Y$"V]*;11S<&NJT'9&L*(O4DV81-%YJ)ALJ6=8FBD<
MNBPE%S>:;Y5HG2<QHF$.^K>U[.P+F^)3Z!0S#]ONC&O5`<5&-M(]]Z24*+Z\
MJUIMV*8!WT]QRO@+=W]S0J\D-]KJT@5`%_I&3STOPD4(3.M5(<$!QDZ,*'-Z
M%2^OXXB&ZU4?T!\I=O;@FMA:[[X:67R7K8"T89QP!#9:/R#TKL!'4!R>5-_V
M(_##D$*4;-NXGWKW3<BJ=C#<&3A"8\OB^498#HD"39!DR,1U`PW`D2B)4P,2
M84_]>2<+5^=T=AYD\V@6`YQLA'6W$BDIX5OKM/KK0?&>RI,D>Q(X[TGB+$B3
M;'XQ@27T'?4&;YACZY71.P*S!C1MQW`.QDM@?ML16$'L%8)S"K,:FK4P#(_K
M-)VOPD>(CN\QUQX#QP$3#X@01`=E4)NNC&!4QFRQE6O_X%`F>5MF-I;!H9O!
M!'C?*!;E-#TPD:87`[_OP&-@_`:CZ8`8&06:0Z/3.L`BZ/20/5T,_+X#CUGT
M`Q$-[T;:T-ZA]ONN$7RDF;WR>DV/F>#Z?*P\S346?92[QTSH8/X_'6#1<0:O
M$]AGX#$^]R2.(_R]'3]N`)._+@0?2[].:B_M,1/,+\;*T^+'HH_B]Y@)'<""
M/#(_K86^ZCB%V9"N3V$/&C61'7]]?C7WBYT2IA)?1--8PO465^H8OIKAZ;"+
M7"7]/C"\@$6\8Y6X9Z:2K26-**$T"N:@;/PVX&^<[OJE=*,=+-_]90W;M8"5
M*@H`7&KM7FYPHQG^`*S_`0``__\#`%!+`P04``8`"````"$`&8*!5^,"```+
M"```&0```'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R4E4N/VC`4A?>5^A\L
M[R?OD`$11@.C:2NU4E7UL3:.DUB3Q)%MAIE_W^L8`@:**(N\.#[Y?*Y],W]X
M:QOTRJ3BHLMQZ`48L8Z*@G=5CG_]?+Z[QTAITA6D$1W+\3M3^&'Q\<-\*^2+
MJAG3"!PZE>-:ZW[F^XK6K"7*$SWKX)]2R)9HN)65KWK)2#$,:AL_"H*)WQ+>
M8>LPD[=XB++DE#T)NFE9IZV)9`W1P*]JWJN]6TMOL6N)?-GT=U2T/5BL></U
M^V"*44MG7ZI.2+)N8-YO84+HWGNX.;-O.95"B5)[8.=;T/,Y3_VI#TZ+><%A
M!B9V)%F9X\=PMLJPOY@/^?SF;*N.KI&JQ?:3Y,57WC$(&\ID"K`6XL5(OQ3F
M$0SVST8_#P7X+E'!2K)I]`^Q_<QX56NH=@H3,O.:%>]/3%$(%&R\*#5.5#0`
M`$?4<K,R(!#R-IRWO-!UCN.)EV9!'((<K9G2S]Q88D0W2HOVCQ6%.RMK$NU,
MX+PS"5,OB=+L_G]<XIT+G/<NV:THOIW6D-(3T60QEV*+8.4!N.J)6<?A#(SW
M\=C)C(']*R\(RI@\&I<<PY:!*!34^'61).'<?X7"T)UF:35P/&B"B:M9G6LF
M!QL?D$=NB/*8^W(Y]WA&;/!,>0WOTCYP6)+HA.5<<U`X*!#;[2A&G./D.(4D
M=M^\M!I87H>D7,7JFL)A@Q<=LYGRQK"'KL=E!H'N^/U)XA(LK68ZU#H,IX'Y
MN9*5E5R>A@,)DF/(ZW!&?`J7NF]>6DTVP,49--QS."N!XX6,';B)"V<23&#8
M=4@SZ!3R9*TOK<9")FEZ"=)*;H#,7,CK<$;LPF6'E6WWAY78ZD9I?(G-E43W
M)N6Q##9!VY1MNVF9K-B*-8U"5&Q,PPVA/./3\5OP&`WM?/P#>G%/*O:-R(IW
M"C6LA*&!ET$HTG9S>Z-%/S2SM=#0A8?+&CZZ#'9[X(&X%$+O;\SW8OR,+_X"
M``#__P,`4$L#!!0`!@`(````(0#`J\I3?`(``.H%```9````>&PO=V]R:W-H
M965T<R]S:&5E=#(T+GAM;(Q476_:,!1]G[3_8/F]<4)"6Q"A*J!NE59IFO;Q
M;)R;Q"*.(]N4]M_O.H:,C*TJ#Q#CX^-SSKTWB[L7U9!G,%;J-J=)%%,"K="%
M;*N<_OC^<'5+B76\+7BC6\CI*UAZM_SX87'09F=K`$>0H;4YK9WKYHQ948/B
M-M(=M+A3:J.XPZ6IF.T,\*(_I!HVB>-KIKAL:6"8F_=PZ+*4`C9:[!6T+I`8
M:+A#_;:6G3VQ*?$>.L7-;M]=":TZI-C*1KK7GI02)>:/5:L-WS;H^R7)N#AQ
M]XL+>B6%T5:7+D(Z%H1>>IZQ&4.FY:*0Z,#'3@R4.;U/YNN,LN6BS^>GA(,]
M>R:VUH=/1A9?9`L8-I;)%V"K]<Y#'PO_%QYF%Z<?^@)\-:2`DN\;]TT?/H.L
M:H?5GJ(A[VM>O&[`"@P4::+)U#,)W:``_"9*^L[`0/A+_WN0A:MSFEY'TYLX
M31!.MF#=@_24E(B]=5K]"J#D2!5()D>2%-4?]R?O)6%!4.]OPQU?+HP^$.P9
MO-)VW'=@,D?BD[$@8[#Z/Z=HT9/<>Y:>"TU8K,[S,DMO%NP9(Q5'S"I@<"`&
M3#)&K$\(7PF4-VA$X^<:_QWZ28H'_RWE=GS1ZA(S&2/6EXCK/Y"1.`SM7)P/
M,,7^>END/Y33["R++)V-):P"!MMCR"L;(]9O(48:\:)SC6]K\V#T<'YO%H]O
M7@7,M*]T$D?);/09@W$N/>$1'*7#;I`89B[TI`)3P1J:QA*A]WZ>$KQB^#>,
M^@I'O1\,-FS@J'6\@B=N*ME:TD")1^/H!L,S85C#PNFN;XVM=CAD_6.-[U3`
M%HXC!)=:N]/"-^'PEE[^!@``__\#`%!+`P04``8`"````"$`\+.]$4`(``!6
M*@``&0```'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R<6EUOHU80?:_4_V#Y
M/3;?MJ,XJ\6[VU9JI:KJQS.Q<8+6-A:0S>Z_[]P[`Y<9\`62AR1.#L/AS,<9
M;!X^?#^?9M_2HLSRRW;N+ISY++WL\T-V>=[.__G[R]UZ/BNKY')(3ODEW<Y_
MI.7\P^///SV\Y<77\B5-JQE$N)3;^4M57>^7RW+_DIZ3<I%?TPO\YY@7YZ2"
ME\7SLKP6:7+0!YU/2\]QHN4YR2YSC'!?C(F1'X_9/OV4[U_/Z:7"($5Z2BK@
M7[YDU[*.=MZ/"7=.BJ^OU[M]?KY"B*?LE%4_=-#Y[+R__^WYDA?)TPFN^[L;
M)/LZMG[1"7_.]D5>YL=J`>&62+1[S9OE9@F1'A\.&5R!DGU6I,?M_*-[OXO<
M^?+Q00OT;Y:^E:W?9^5+_O9+D1U^SRXIJ`UY4AEXRO.O"OK;0?T)#EYVCOZB
M,_!G,3NDQ^3U5/V5O_V:9L\O%:0[A"M2%W9_^/$I+?>@*(19>*&*M,]/0`"^
MS\Z9*@U0)/FN?[YEA^IE._>C1;AR?!?@LZ>TK+YD*N1\MG\MJ_S\'X+T%35!
M/`H"/RF(&RX"+URMIT3Q*0K\K*-$HZ,L\;JT3)^2*GE\*/*W&=0>,"^OB:ID
M]QXBU_K@U32*W1(,E%)!/JHHVSDT#6A10I:_/08;]V'Y#3*S)TR,&/C>8`1B
MUT4$SJJ)L@3&#6V0LDV[/YTU.P56[%1Z%=T8_]"FXC6GT8A=#R)L((P)B-9F
MH@3TH4SMC-1!VWG0TB+8"`HQ8J#*&KV"A@&2M"$81SA1FZ.=FP+#-;3/N_'Y
MF6/$K'2F-X&COCABAXA^]HP;0-K<QNFG#I(<A3HQ8AB#C<DA*MB#::Z#L8S>
MPU(=)%E&37PL1<1PEJ;FD64/IHG"6*XX2WN>%5BR6S=QD1UB&#N.V-D0C)MR
M5#%HAOM$'334)XBQ<;0A&,<-YVC73X&E?ANN3HP8U]&-XBY$\G?X[W[JC!A$
M8.K9F6FTH!;*\4*@_I-CW5DAG)\:W9.SZ^+`AU%A1EQG#!+(RA/C]$,XSTF^
MX:(+\%$H4TP@T$K9GNM&B[6`[`@RAI\:Z2T=!_*,!M#FYT>BQF(70?TGISS;
M(%P_-=9;_,9-:Q?-8"#/"++RM$$X3PC3YCF@HT*+?MF(),9J:P00Y=E;^)WM
M!0'PW51S,PXX.^$F`^RZ-A)*NXU=FT=0EFT0SD_XR,@LHQ4,9-GF%\33!N$\
MA:<,Z(@VT.Z6T!%)C%V;5Q`_A.#RXX=1X)O=A],3=C)2QJZOA$YG>-N<@V@B
M!&EZP:9]K8RF-\E;-)KW2NC(]9!`_:V`]`BRP:FI-\@;,GKO\A9]%.?IN6*Q
MB@EDY8G>@C*N'>B\6S0G68O7M9;0D1LL@:ST,$ZD90Q<KS6V>)+5B&\-;GNK
M>&@(O%7$[AP3R,H.XQAVQIPX.S78Q[-#&^#L3&1=7[%G\PHJ080T$WUMA@%G
M!Y<X@9U"\\(+6W>QQ`Y!5NUJB%HKG(4I7<YMDI5X72L)6A5#W&P^0<HAI%'.
M6VW:7^8N@G,5MC)0@V@#/,LF,G&U>05Q1<@*B_!6BH63C!O57I^CR+V!0-94
M=TTG=&^-&6$J`R+VF(EK-"`1A\W$0\A@(ZL[NO&MHM&\56"$-3L3LB.033\K
MA)6@_RXOT4<-W882R,IS]'V*/\E,-)KKV'9[TA&=`HTLA/L4SQ/=M*,X"'&C
M(/+-5.4RJKG>FM?CVL5'-^`=W4DW@H@##!8G-*,/.YKB("0*UZ%Q)LYRDJOX
M?:XB%QL"X:G7*[VV\'K=,<C*5Y`&P>FI`3]=1'44SW5WK_$1A#1!0D:"1&Q#
M(C>Z37.2P_A=A^GN-02JITFTZF08H]0`WS%#E4LXR5'\/D<QM4-M,NPH%,>P
M,S$X.V$J]E'M]YF)Z3]BAZ#ZS8;65D!99?\/%H$I8$YMDHOX/2[266D(%.I-
M5'V:TE0]4:M=!O<9L^LR8L$D`]%HW@S=?89`S;("G[D(:AP1+-P;J@7"/>P)
MU6A.+G3$R(T)5&\G7=D(`-TZ]*Y"(#QCW%#61TF6IMVP[`C$2$1BC=@-@'B:
MA8$,*-EC')TM)D!0W971RB01"U``?,>4`><F;&.DCCWVT=EE`@0Q'64MVB"<
MIYK@D_TC4$<-[3($LO+$./T0SG.2@01]!B)*+290_\DIVQBGWB-NW[<'PD-&
MIKO/2^0NHT-OYU::&(=V&4_1O+$N!)/<1*-E6XN.B`EDY8>&@OS@V07]U90L
MS[/PE)%"=KVEN\\$M7?T#4'*-T(HWW+G843#21ZCT5))Z<L$LBE)$'K#*[J1
MY7"2Q6BTY":6J9A`5F[UC8GRYO`6->$O]ID=XNT&#&7C6YVW&@ADI89QFHW'
M*,]S*@QE7/&%/<;2VC71_`AD)8EQ&*3ECYQIC[VH>3L@9Y^]R'X.;=Z!;=)`
M](=5MV9-"'RF6XL^2E2C:_8\4E.%ML]$BE.G_/.=N4ZNI#`6E?,(>GM`R1Z#
M<<TJ0"P1Q!+:3#U2D@P&%X[-8H.W630B'?_SG;$#3OM=AA/V&(YKFH%H(\A*
M&R$XAFB@-U?&>0K#&=E2:!CMO@\[[[N'"++RM$$XSW?Y3HA^`1W3FD\F8Z3G
ML.]0G/Y+83Q5:4YO*GV4:*K.QT$$ZB>!Y4H0]$<?WE6Y,>7A83S&TMY,&BW8
MN?(>AT!6=FT#@L?B1$7BXWWXW-HY+9[377HZE;-]_JH>W7/AEK/Y:_-8X4=/
M/QC8_`.>ZKLFS^D?2?&<7<K9*3W"H?"^.M`J\+E`?%'E5_U4W%->P?-\^M<7
M>'XSA>?&G`6`CWE>U2_4DX?-$Z&/_P,``/__`P!02P,$%``&``@````A`)8-
M6\FD`P``:0T``!D```!X;"]W;W)K<VAE971S+W-H965T,S(N>&ULE%==;YLP
M%'V?M/^`>%_`$)(F"JF:H&Z3-FF:]O'L@$FL`D:VT[3_?M>8$!PZD[XT'SX^
M.>?>@WV[NG\I"^>9<$%9%;MHXKL.J5*6T6H?N[]_/7ZZ<QTA<97A@E4D=E^)
M<._7'S^L3HP_B0,AT@&&2L3N0<IZZ7DB/9`2BPFK204K.>,EEO"1[SU1<X*S
M9E-9>('OS[P2T\K5#$M^"P?+<YJ2A*7'DE12DW!28`GZQ8'6XLQ6IK?0E9@_
M'>M/*2MKH-C1@LK7AM1URG3Y=5\QCG<%^'Y!4YR>N9L/`_J2IIP)ELL)T'E:
MZ-#SPEMXP+1>910<J+([G.2Q^X"6"0I=;[UJ"O2'DI/HO7?$@9T^<YI]HQ6!
M:D.?5`=VC#TIZ-=,?06;O<'NQZ8#/[B3D1P?"_F3G;X0NC](:'<$CI2Q9?::
M$)%"18%F$D2**64%"("_3DE5-*`B^*5Y/=%,'F(WG$VBN1\B@#L[(N0C592N
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MQ6$OE5JQQMCJ/8I(;`A#_<Q4KQ[A\>RK36.IT1B;BU%$8D,8+N:F"WMJ%-CL
MP3`U&A,UJ9E>/1#;_B**S$0E_<6Y/^]6#;UJ/N@=G':]"FSJ#:]/B8W&V*H]
MBDAL"$/]PE1_6V;4IK',:(S-Q2@BL2$,%PB.^-N;T*#-+@Q3TX)T;!"Z/FR,
MY>`2C?:^4GIB=ZY/JD5X"98I6]UK-V<'Z5NP?T2&L[`+I3YP6I"M[N.0Q`HQ
M+:@[K6?AM@`A?1/"H=S=0\.[J@59K6@>"R2QLIA6U,76LV)_DF%4O7Z4WPB1
M!EGT;5L>"T1-Q>JG]+T7WEW"IN7KB5</<R7A>[(E12&<E!W5-(L@@]VW>M+>
MH"6,6&I6[A9@T*WQGGS'?$\KX10DAZW^9`ZRN!Z5]0?)ZF90VC$)(V[S]@#_
MTA`8TOP)@'/&Y/F#^H'NGZ3U/P```/__`P!02P,$%``&``@````A`/+@&%E)
M!```/!```!D```!X;"]W;W)K<VAE971S+W-H965T,S,N>&ULG%?;;J-($'T?
M:?\!\1Z@N?@FVZ-`E)V19J35:B_/&-HV"M"(QG'R]U--8^@N2(SFQ3;F=''J
MU(W:?GTK<N.5UCQCY<XDEF,:M$Q8FI6GG?GO/\\/*]/@35RF<<Y*NC/?*3>_
M[O_XLKVR^H6?*6T,L%#RG7ENFFICVSPYTR+F%JMH"7>.K"[B!B[KD\VKFL9I
M>ZC(;==Q%G819Z4I+6SJ.3;8\9@E](DEEX*6C312TSQN@#\_9Q6_62N2.>:*
MN'ZY5`\)*RHP<<CRK'EOC9I&D6R^GTI6QX<<_'XC?IS<;+<7(_-%EM2,LV-C
M@3E;$AW[O+;7-EC:;],,/!"R&S4][LQ'LHE<Q[3WVU:@_S)ZY<IO@Y_9]<\Z
M2W]D)06U(4XB`@?&7@3T>RK^@L/VZ/1S&X&_:B.EQ_B2-W^SZS>:G<X-A#L`
MCX1CF_3]B?($%`4SEAL(2PG+@0!\&D4F4@,4B=_:[VN6-N>=Z2VL8.EX!.#&
M@?+F.1,F32.Y\(85_TL0Z4Q)(VYGQ`/V\K[K6;X;+%<SK-B24>O@4]S$^VW-
MK@9D#3R35['(0;(!RS?/)(_>UX]<!1^%D4=A96="NH,7'.+SN@]<=VN_@J9)
MAPDE!CY[#-$1T1CA.\L>8P/CGC:(H=*>#L2-G0`+=B(P@FXH_U"I(++1!"*8
M9@*BJ4R$@/Z'J7%C)`X!3M$B<+W>OB0I,6"JU\O7$=%G"$TM>!#FZ$$1?*Z:
M.`2)JCP_<!&#4&*6;<17ON?[6$<)F'9"HP@0E>+GU`084QO"(^63&$D-VJ6S
M7"/U)``^)_35J"UT:O,B+`[I%(F'Q`DE1F7@K1#),60(@49R.29Y/\3BD$XR
M<!<Z@U!B@C;$#^Y0CJW*T>WN71'%*%3ZS.?Q%6#,"STYE!@97^)`[JT'920W
M%8&24Y-NK5,3\;TOG3B$*:+@A1+3I>!BL0A0CD82H";`X(-&D4"UJO+-X]B>
MPB11&80=Z":D1[P5RM.H@\SA*5JX$N9YM4)DX]=:C>>@/.Q`P$6,%\]:HD2-
M.L`<EFAZS%13S@2=)1IA(>D&AV1)K#4"1!U@#DO1WI&6]_.2B%,HYJ/&TX%4
M$J/.,X'Y*#E_:[R0B?GBX1G8@=9MS,G:0146=?=51SXB"9C?4%.<PFH.3Y"3
M1KP)`JC/3`^7.08HJ:M7^<2DF1'Q\:@),(602%#'<07OC7IY11U@CI(3H^;^
M&P^9F#4>*N&P`PU*HJ8?=8`Y+-'`F=F))B:/ATB$1()4$L&X?*9`0^_5XSXQ
M@68H.C&"_%'7'(^8P!_UI#%HR'&-*2Q9HRJZS[0]A:H()V#8@315?=0/Q)(G
M2DT%8:9RB9,[3D'K$XUHGG,C81>QH!'H)/V__?+XZ+;K7W\#=K<J/M&?<7W*
M2F[D]`A''6L)SZWE]B<O&E:U&]2!-;"UM3_/L*53V#$<"\!'QIK;A=@O^[U_
M_PL``/__`P!02P,$%``&``@````A`($,N;O&!```RQ(``!@```!X;"]W;W)K
M<VAE971S+W-H965T,BYX;6R<6%UOJS@0?5]I_P/BO0$;2$*4Y.I"U=TK[4JK
MU7X\4^(DJ(`CH$W[[W?,.("'-`W[TA3F>'SFP\?&ZV_O16Z]B:K.9+FQV<RU
M+5&F<I>5AXW]]U]/#TO;JINDW"6Y+,7&_A"U_6W[\T_KLZQ>ZJ,0C04>RGIC
M'YOFM'*<.CV*(JEG\B1*L.QE520-/%8'ISY5(MFU@XK<X:X[=XHD*VWTL*KN
M\2'W^RP5CS)]+439H)-*Y$D#_.MC=JHOWHKT'G=%4KV\GAY269S`Q7.69\U'
MZ]2VBG3UXU#**GG.(>YWYB?IQ7?[,')?9&DE:[EO9N#.0:+CF$,G=,#3=KW+
M(`*5=JL2^XW]G:UB'MC.=MTFZ)],G.O!_U9]E.=?JFSW6U8*R#;4257@6<H7
M!?VQ4Z]@L#,:_=16X(_*VHE]\IHW?\KSKR(['!LH=P`1J<!6NX]'4:>047`S
M0QJIS($`_+6*3+4&9"1Y;W_/V:XY;FQO/@L6KL<`;CV+NGG*E$O;2E_K1A;_
M(H@I4IT3KIW`KW;"^&0GGG8"O[T3O@Q8,/^:BH-AM5EZ3)IDNZ[DV8+6`^+U
M*5&-S%;@^7I:(!2%_:[`[1"(N(9:OFVYMW;>(/VIAD0(@=730TQ$?`41=!`'
M:'7<(%U#;JIT'C3`;8YJ$.'H=^[;,"*$+-L2J;CBP0N#`"1D2.#VQ`J\L?UA
MY',R,4*@;[KD$&KQ+81!#>:YGYH"0^X&\_(%H8:0$(O*N,M->SRTL_DBZ$,S
M:$%L]]-28$)K:4X;(21H:05A:%KCH97->ZM!:3Z%D@(32KU;[!Z$+'2FEBXC
MI(9V(,4_:>[%%%H*;-+R7'/:""&8*=Y7I^4<&\8^("-/:L>[6PD4F!`B>8@0
M@H26G!0V'EK9(!B#4CB%D@(32J2)(X3HTO%YT)<&TS2TLX6[[%>G08N!"-V?
MJA9M"H,W4DWE<6-#/W^J#-K-=8A);YJFHQX/Q<'KX\:69XC1RS`@:8U-<]A+
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MQWN%WT>O\X<8),=90$\&L79RT>)@V1?>I`8-/-PE[LR?&D7R1W<+]>T+&/WE
M<N509P"NG>KP[@"_B@M1'40L\KRV4OFJ[@4X'/2[MWAG$;%5Q-77(WD?J[N,
M]C:B,\!5PBDYB-^3ZI"5M96+/;AT9TH;*KR,P(=&GMJ/UF?9P"5"^^\1+HT$
M?)VZ,P#OI6PN#^JZH[N&VOX'``#__P,`4$L#!!0`!@`(````(0"ET:DAUP(`
M`-\(```8````>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULE)9=;]HP&(7O)^T_
M6+XGB4/#EX"JT'6KU$G3M(]KDSC$:A)'MBGMO]]KFU(<(`,N2(R/3QX?O]B9
MWKY6)7IA4G%1SS`)(HQ8G8J,U^L9_OWKH3?"2&E:9[04-9OA-Z;P[?SSI^E6
MR&=5,*81.-1JA@NMFTD8JK1@%56!:%@-/;F0%=70E.M0-9+1S`ZJRC".HD%8
M45YCYS"1EWB(/.<INQ?IIF*U=B:2E50#ORIXH][=JO02NXK*YTW32T75@,6*
MEUR_65.,JG3RN*Z%I*L2YOU*;FCZ[FT;1_853Z50(M<!V(4.]'C.XW`<@M-\
MFG&8@8D=29;/\!V9+,<XG$]M/G\XVZJ#>Z0*L?TJ>?;$:P9APS*9!5@)\6RD
MCYGY"0:'1Z,?[`+\D"AC.=V4^J?8?F-\76A8[00F9.8UR=[NF4HA4+`)XL0X
MI:($`/A&%3>5`8'05WO=\DP7,]P?!,DPZA.0HQ53^H$;2XS2C=*B^NM$9&?E
M3.*="5QW)B2^VJ2_,X'KATD\2D@R^#]*Z*9E4[JGFLZG4FP15!Z`JX::.B83
M<#;Q]"'DT_%`+F;,G1EDAX):P9*^S)-H&K[`,J0[R>)8$ON*Y0E%LI>$@+=G
MA-@.&;O9C!CF@-$'&]G;6OR%DY#(DI,OO;[?OSS?[V'!,PZQ+HO.#&KAM8)9
M.,G0T?63*&IEN^P0>(`W/F!W;D;<`FOELG"2Q(*UF4[W>3CP?[D^+S.HA77C
M+]?"24YCG>[SL`8^5G=*1MS"^2A:5UU.<KZZSO=[6,-KL(RXA35HI>0DNZJ"
MFK(?7[/LUGAXYG@\V#>Z4S/B%M[0?_3"21Q>3**(#,;M$CN4P*8W2F#CV[MX
M<.-KX(RX!3?:V[HE=9).N$/)&3AW1KG=MZ%K]IW*-:\5*ED.>U44#*%8I3NA
M7$.+QNZR*Z'A9+&W!;Q(,-B"HP#$N1#ZO6'.P/VKR?P?````__\#`%!+`P04
M``8`"````"$`**!:Y&='```+[@``%````'AL+W-H87)E9%-T<FEN9W,N>&UL
MO)W;;AS)F>?O%]AW2`@:-`60;!Y$'>RV!A0EV?)TMS0B/=[%8B^254FRW,4J
MNK)*$GUE#/81]F:!7:`QU_L4O6_B)]G?__LB(B,/117;/6/8%JLJ(^*+[WR*
MR&_^\?/UM/A8+>K)?/:;!_N[>P^*:C::CR>SR]\\^,/9FYUG#XIZ6<[&Y70^
MJW[SX+:J'_SCB__\G[ZIZV7!V%G]FP=7R^7-K[[^NAY=5==EO3N_J6;\<C%?
M7)=+/BXNOZYO%E4YKJ^J:GD]_?I@;^_)U]?E9/:@&,U7L^5O'CS;VS]Z4*QF
MDS^OJA/_ZNCQLP<OOJDG+[Y9OG@U'ZVNJ]FR`([B]6PY6=X6;V>^`'!_\_7R
MQ3=?ZU%__+#X;CY;7M4\.J[&W5^_*Q>[Q>'^=G&PM_^X^V-:*9N^^&_?3F95
M\7997=?_O3O@J^X7`;P/U>6D7BY*@/Z^O*ZZ3WUU_.'DN'@YF=]<E:!IF^V,
M=KL/A:E.V/FBG/+(N/I<_%-UVWWNJSW^\WSOZ9.C]?LYN[WI`[&_M_//W<F.
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ML8)R(YBBFM7E$AWF(%_?3.>W556<5[/J8M)'5!Q9?=9`F$0;-2H6&4#=O;ZJ
M+BI8?UR(_;<3#HTW^]KSJY]^_.G'[A1M[&^^%I@OYA=?6M)GOV-6Q.=ZLA0Q
M?<LC]#MR@:4"_UU838RNYM,Q5NW__=O?_O7__NU__)MQP_*VQZ*G*"S0>`PM
M9EC!Y01R%1BK@+#:)?+AWN[>WC[D7!1P\*KZ=;%_>+2-TBUJE]5RM;R:+R9_
MJ<8PVSQ^.ZEKD=EHU`AS42X+;-#H*ADA>P)!JZ[/$8-@FOK"YDIB/4B`<SV9
M3L5,/;`V7?37Q<$^&]O??O)\S\#:/]I^\NQH^^C)09ST[]O5-DPH9;.<?*RF
M/7UX/!XC4O,9DGY33L8[DUDQ*F\F2'Z7R/#T9#3!(QCA&JRFI@G'JX5T+<JD
M&%=,/S?QE_MRV9-!9SE#YC"K=!?L\:BAYQX3W*FTWZ/R<5FJY02[^&B=$F>*
M]4R:N+,+^9VC>IQRK]'."_<:,F\DH3_.S&#@\#OVDS^VP08&'E\'^,"C=P*<
MV>'3)4SH*@J-]PY#9(K=%9;L_Z*Z0FG#]\6W<XSO1H:Z^CRJ;I;N$A38>SS%
MS6WW_N.G&WO"`^JF#LHV&IN>\OQ0U7A@*#)IN$SBNG0]K=!*L\OM`H4-5J;V
M?#F^GLS,198JZ`[YKEI<H@OE0-<ER@*=-IH#4/<Y0%@N5J.E2WZ`=-#@&\Z9
M9H(C-EF8@PN9)K.=F\5\)&<(O;31;H(I%#2VD8B>+FBVX,5B?EW(*7%>Z#[S
M6X*@0L:_KB>7LPC4#8R$G[J87%[U=QR'G)>+2XV^64&!LN^3OYTM*[;D,9.[
M"!,"NWXH,O!@V%(76MO1>47<58$XS54LR\]]`_S2O9?"-G_7@]_C'4PE"V(@
MYLM$1%_WUH=,ORKD`Z$GP1KTPZNI"#IEM>^PX,,3O6(DYIE%<VM?C"<?)V-B
MH.Z@!MB/Y61J2R[G@EJN>VX'?O;``CYQ*]L3M9=E/1FYG$VF*]S^[B)_K,0M
M\C:P$-B[:*TS[=6;M&61VNKK?4+*J5P@6]G^"L;RJ^(U[C6>]E8PQ&MM5COP
MZ.FS[CY,NKI?*J39ZL<TR7G++5P'\NY4)UFHU?TM\S[>!^_CY&[O`UY,WL<K
MUT&O,L\#G/8]C[=XA1:P(4?%]_,E[N=[CQ,,RQ\J=V:BJY_$$R[[?3E;E8O;
MXE#)B[VC+ORMF36.(!35B,)-@=&WDY$"A^*#Z1:IGG>CY5QNY_[C#2:]'[CW
MFGI3>-]4YPM#`HZJL/#D%\%",^O!+SCK[U?DC0Z<6K\,G-_//WJ4\'08S)9R
MC/+1Q=#00R^[#_TL9HH,NO_,P'OZRTPJ+![N?6%&C$$NVX6D2U]4B]$$"6@S
M_K8X__>KZ6VQ__S+\YYZD(>V?_VY&JWDKQ2GJ_,_(5P%7Y+E66.#`T"NGI1A
M[>+C>Q-_6;]U8M\=<4(J9;N0+9*3>8'E4LAS,N0;K2-__)X9PO!!URHQ``LU
M0V;%%T7E[&JR&!=I^)N>FCN^QWX_-`;^'EH^P-MCZ@YH[]+.7H+")K;*%OV"
M.4F[%+O%5<5<*9P_6",*+TD0SV8B7DC@;7MN09&Z)=WV7<1[*<B!@3$&^L+(
M!"P4578,\RVP+3O'OY/<8N`5>RK-O=``7)<;_ZX9'>KNE-'-ZGY/IO8.9'G2
M9*\7Q71'=3"UZ3#+^B3*A%&]9/MFBWUQV.!B/6._V6*]8:;+=LX)&-KYQRZZ
M[U8M.=V[_O/J!O8?F31)Y4E/S5!S,1EJ3DX9,J!B.04I&[#7+[/,,,_EVQEE
M#GUA>ZD^RX;@-+$3\_,)Z!1_U-M)?#:`_V?..PQPE_B#+-/S.+JCAH7AB\,&
M%^N9^LT6ZP^KEQ/*AG#G!6%Z4(D@_E.Y4#&M+B:>5%5F<#Z;*9$(CWV:+*]:
M`:`X;FW^O0O:X(:>=26B.VH8>[UAQ^,_K6I+71NW7"P\G8%+,DS:+T2E-DG9
MI$DC6[F+(N189+JB5KA`U):3G;$"1B$)E?YQ,N2%N.F+PNJBZYGP&G=G846.
M+C;6CS'4;Z_97<CK&+V^7RE'ZZ7/-0*T_O%AY*T79,-'%>LK+L;1;2MNJ*"9
M7C)Y_XA"DJF!ZZ2;%I.1V-&'4*)>(O?&,5V4_$<M/KSU-D$ZVG(=.3YT][>H
MIA6VP5,W<?<P3W>O[=5REC'R&S*9RP2YJ^SOGBL)NER3SC:Z(U__?&7AV\3Z
MD(6TW%QO[DW\C>=?&C6L)+XX;$@C[>_]K,6^/&QPL9[;N9'ZV__BL,'%#G[>
MSGK#UDN@?)+<CK>X3`[PO65Z@QF-^-VMY3"FL"H7H`[/6S);NJ@=K<4V@7^W
MZ?]%A<[N[)L8)Z]=6]#MVS+#<E&5).E[$[XE&T\4S?:4QT7-=G:?LK%F]^Z<
M6E%7M(;*689,97<+73X>9,B?%T?L?W%86NS.)J0NB(T2N7,8.KGI"OG[T[F;
ME23)^.P6>X>61.D'&]4-S2.>N>F%/5EGR5Y/DDD=[JY-29*!V%6=>C#]YS^N
MR>*1D&.D0]OS<\FML94UB37;Y[JTEDV[+D-E^]SS+$!OS=,*&<F2)>]21F+S
M',0=28W-)S$HU^4J3O*8Z+I<_$#ZZ0:_B*`N5BRZ8O8^%1#,<=INFB>Z3][!
MMDIV%6^F\T]KJZ7VQ(4]D9?:\-[D9G]<TY^37/):^;N%:#"BHTM]0EZ/XEO]
M;9F1E4)EE>F\BG?WU+$ZURKA9>6][N9?52@\=*4YZ,H#EM?J&/O+H$OR_7RV
M8R#%L!F39GU`W5ES&].R=%_T>EJIX3L:<J2WFRIJ2A9I!ZGOJ@O5'XDDJAW,
MF*O[4'2C@IAZEWK](!&=SG,6V30A":6N6(B3KUC36]9=<DL3/'*:&G^,)_7-
MG"<%PF906Z/88$7YY*JD!:G#&M8)9^YOAKUB2]S$DE!W93U,(])OBVK\J%>3
M:_5J=;>CW-@7>;([J"LB$_*<'N#<(2(V",ZLR'43BJN*32:=DGQW=DI7L6P]
MCG74+U;MWX=\^>94>*\B?36N'1216F,'V:('X>#0S8C?7G93H4YDV@JZXY%X
M357E<7%^"\/T"=`%NDNT"Z(4=-3=RJ<-[236&4$4"HZRL,?TLSPUT@K46JHB
M=Z6ZT*U?Z+R<_=!*]]T]U(/JNJFE+-;64MIKJL<KWV#';;Q[U>[@N[9*<:?A
M<&P>1+B1^I@57]SJ^J%KR=%K>5@_Q\=J-D;K.6-417FYD`,]6W:WGI@Q9\$A
M=AH:R'9IW"<?H'2;C+$4O/TA+8\WRX(]F(UWAQ[<IJ\U%CVD?ZE=S<?=9>\8
MS8Y-8PR..UW=W$P-`Y#'0)1;`.#8!A**Y#!ZNE8E9^4XK->P"T=K/LS&B(X4
M`A@!,,-=$#(R00:R!J>9_AML#K;FWV3#8:592R0#=Z`L<$.\3M,%[H^>#;TK
M&8IUH3WRHL2QH=#3G4!V7KVIF^OL?]F0WQK'[U116'?AS%ZT`]KN@V=(.'[G
M#5WSQG6GJVO4_:WP?TJO%,WJ(QVN8",RJ=*,[VF)'^@'UBF57]6$F9Q>04W4
MU>)C]>#%UOXC&N)_[A)%!]KA-5Y5]6@QL5J!P'ZYJCE'0K?31H/M@,AY^X`(
M96MZXC*H^:CGMHN2FN&T1(&K#VI!9[=Q_#8,4EQQ\N;/=$R(U\V1_2,L3]:K
MYHMM4#SEX?'<<,S399'6'%7DC6E'551M9$CJC[KYA<YL,!_<&SK_1`(U^-F8
MZ>W.D@:U2IE3`%[01D,^WJN-B_%D_K&L1W3M+HCOZ;JCDWTWI\;?_OJ_Z@)?
M5>F`^9CV/@2:=)S..VP7OZ7KNUS,U=2]=;[")H[9PK2XNAUCZ*_8#7;VD>V\
M+/QTS8@'+K43X/8S1BBB9;ES/H5!+4T^5N?TF+1NS<DGLI:&9@JQ1@1EARU0
MJ!2^`X.T85F,Z&DT])`A!DG:FTBS1&%ZNA^2E^&WR?F"SNQ`$Q'M#0"2D><;
M:5"O7T"HA226?#UD9,-?\^2TNEAR/HL30).`L-OZ8C4CN)G/C!U^]^;#ZS<M
M[!6T`Q9J85O:B8Z8%`FT89/`J^$\-"ODX]VP7_L@^,%M3I_Z%CZY9F=@`WUR
M7DTG-#CI:=A'J1M+Y4>:B&X9SEURK\M;Z(@ZXNFP8Y;%#U<C$BI.JXX7J\O=
MS03C+./_1!JJ/?1B7(G=;V_4[5CSIY'IO9HCBX.77Q]V*09]`MS;Q0^S^2>U
M81:_??W]Z[.W)SO'`:?';Y@&T`UC1N0PAHI478RNYG4E5R"(`A("S1)GJ&'7
M/5;M$1Q\G'`$!RY$Q8NM$0X'[U!2FA%_ZW=O'L%)XJL&2NWG8/OIWK/B=V\B
M(NND$EZ^/CWS(=O%IZL)7;GUZO(2M)@$0KT(M\AQ3G_@:J2VUXO55/-"'HD2
M10]+NHOA]$E8:#`B;5(6=-M35:*-S/0'1;GQ_-I//HSG*QHQ$2LPUB#!MS&&
M(I<SP6(]DS1W0WN04I<753RP<R&=/C(5'X'E:95F%,M+LZ&'T&S`",C&^`D/
M[$`@@=OQI+R<09:QLR9>!KQ@#;704F[)5?E1>S,5L%\</GM>H*F09;J,KN;7
M\[_<7D(DJ;+YDD-SVP9F_&0?HEE*PN#<3'1R31\.$OP1E7H.*$`?-N(""GN8
M#<.4WLR1("-N8CBAE^*GR02[":>AZMMKY%,>S`AR?!TU"C4]\%]L';_Y]I&(
MAG(C-X!*!H8%YR6P^1O*D^DXJ0RY>N(6(7Q<8K9`N9/-^3X!.J!M*(NA5!B,
MQ:LJ:VN!<9-^B\HQ"B/5M-78"%W>H.(_6\D7A-'/UZ&KKY7QX"O)U*ES#<<\
M)W"#J/ERCMZB&_7TNY>/(/Q43>;E]/8O<`V!CQJEV\*8(,%62AF*%.)'YU:Q
M"210^]B,(SU)OM'ZQH.3FA%!=2'6.SZJ7D(E0FO93#JZ5Q!.:E;R6#%WM`^2
MZIJS>!@<]JZP5E-%1:"EJ]EB;CN`$.E`S..#O810QXHVZWN]+G\P<:)BGL!V
MC=6`+G1(*[+1B)(@FL)H>2%V$OX3T9`3G41#OSD\QAHF/BZ*4[/N!X^+3U7U
M@\U[`=3S3SNK&Q<:=_"->:XQ\E22(51"LAGY3")V3"1V?_KQ##*8>9E<.Q$%
MM9'4G`ZY'$WFQZBZJ"YEM>Z:O;#9MQ&A`ONE[GK8%=+P^7RUP%CB0X%Y5T>[
MQ:G31\`:EGOPH,%'T]78E9@!`9!\&76-F44-_R)[V+K!QJAG@5@`Y0N/2&C*
MT17V5CO+F4NJU!W@$:5:'M-"D8&B<C$:P*5Q"]+[B3GL:Q?"/@]FW*5!G/CU
M)*E)`S9/:2]SB#2W3Q+T1#@<D/:`2(?IC3B)R\UJX4YT8<),-7.B?^/H3$!:
MRL>\*&$=F^3\GO!NO&T\ELPQ5H#0$5Q*L"?H3_.R$H:04^F-*$L6T$W1@`A&
M+!*+]P1@,WEV[`545#=M1[;QES1JG<YQ%'XRC;"4)+>5XO*3>^><O]^Y*J<7
MQ2V^@N%?RDA2V/@8;C]8ZV*RP!1%=PO>3#*\@KNFM@MY3S+)PQR.GC"^MN2?
MP,=$&E_F2F)#&W/&\),01<C4F%:Y5$,/RP,D')\<T#_LGNYN%Z]7:D!TH?33
M*W]"?]1R(LUU%==?HU7G6%VI;MDND3;8^,Q#@JHT!T6'(NE#++I"E0(MH('1
M:=)&(Z3)OHM-X6-E\$+.D<P[XL]AKMA$R3AL+_;7P(FKH3:@'44%U-\2[7KP
M1)Z+UM`N@^3S"+\<Z1??]6[Q5B;8-;^KTAY([I`G#]9<LQO!J".H9=JNX]89
M&Z</[_W2CK@*?>$WL3?;@096J$T(FJ^:(]E)A-QBN-MM7B82>%$$2FZ;/'\!
M42W4L._G\EX.]@[W>IB)R-@H7#YSM]*DX1R&41@2B"%T9PY$9R^F]5?GZ`/3
MI&]>';OX$>NU46_*81:L]:)40V"D$<HZ'%.%=.Y'1((A>:M9/"PT/S=/)!M&
M*&=V"QRTGAQ%R2[1*C)5Q*\P>3H-!]I=>YJ1AH.4H;)#T:OVX=<FQR_=%9'/
M<OD`>IIB>0M=NJ%,]PZZ<*BD_@&3^BVW>$Q@7H_^?HNCJP9UKBA8S.X?X8&5
M(#%M35M2>1'I^-:29^20L9!F.#$Z>,/2"MI7=0&O\^]R3G9$RL)H()CP&DA!
MX#_RO(D.9-24HJU^#R2E$JA`2;DG\"R"V;S-H;Z612JDWF2YI%]$.#F2.!R0
M153B"Y?ZF@`LG2`HB]G*SGX#,TH.9ZJ>D)`@/<(8=!RLQB^N!OMH$*^4,_(K
MLH9R2@3\N*(RB%N#@P#=?ZA4=ACK9!O'@7A0,I'/Q/2V]0&4\!,KA',4X/8C
M-Q_8(7G+S(2YNG)!VM*VVKBO37JTC\\N-`*E63-40R-!T2^*G5DX/':#'C<7
MWBP56-/)T824/G7($BAH\'R0Z`F-VA(`>A;SU249WE!#,:4NB.1[`AQ.72A?
MANHV1/_$<2ME$.)8;>H\IOP8>QX:S=P>M9L?D4?_8D/9.X70E6>GE(:X(`6J
M70`==7P[(/33C_'\@/E:;WG>HI&V3A.S,I5"37S?1H2L8HHITUYG.-<>?BOG
MW:^UF\9P@-:LDE8HLTIL(S\B[,/]O6>[1^G^`JU[1?IO@[7#Z">[C^/H#7$8
MSNMQ4\QA&RFFVPF#I1-29/IP__GN85QA;4]6I'U-9<1X1GR%7D[%MX9Q`O.F
MPZ.&:U24G")4,!Y`<]!F3X?SQ$\GP8<2=WOX18Z3I`O&P0L%8`/&-.T6M%AG
M&T]WG\==2+'B`\',H;:*LHG&NV.BQ&)YE&'IM,RFNEN@+650FO,]GUV:`6C(
MW1=(=RRE*C?+'I#*ZZ[MRB!;''3BW5&KP[\#*,M>0HJ05+'RC5%`/)W5LI*G
M5*^4C5)V=HW69T5E1`G8%G.=!`-Z':.2N48[D<$5Q5R+)`=0\*&5Q;*PW=%N
M\;OY)XP#:7A(@6MV91DA/=5$>$O\AQ"OZ[(96:T0ZR9')E?D"@#(OP79M8-=
M1KOPC)D&<JTR/Z0($?_@$K3Y2WTEJ%AMO:O94SXBFD>><=WNL7!@S9!2R>BT
M(7?\]&/?@QI3V[@%P6`I3H^)6^\S958'Q:@]L[BRZ6N]J9QSY.UWO:,<Q;E+
MM;B_WW36R+'7.:*[Y#PLEO*KA<S?6.=H:O=1"["[VW5NHOL!Z"(,5^9E4!?$
M!F)#T<WN,9#E6BW-<YGB>XB=E_3F"R^>U0&+O^JZ;R_^]M?_N9%WCHQ0GZ;T
M!>=G+.$QJ?6/B#NT#0LY35Y%AG/EX/"88J//K[L0#!?>!+6SOC$=^X$%H@;+
MUD\2Y/H+]IJ3"C*OR^]6X!(""Y?RJ,`F"E)S#WB\5P5MH;8YT)!QG+&!.1+B
M4_LE[-AJM_:EZ1:&98HY:/P@A_<`Y<2MB"V;LQHU,5`@P*9*8TK$W(>&"(V=
M@I/TR/=E/2[_S!UH-[J>1S<:T16X(1#N&T\+-=Y1/!C9#O%/5RA/+XZ80X<@
M8,T(^(%$2ZY%RB^&`H50I%XC\]3U7+UYR(+E$-I.XH9[%>#.BR#S`H(JUX`\
MJ(]-.]O&#[_`*&B3HGZEA@4KQ4@<0HP^FI:3:W?'/`I0/C*=[F<V4JW$6WY6
M\]<VST9R*>`4__O4[-ZUN\FI?LLYI?H<F()R*M=?6(F9!+%@QO]0]D`[B&TH
MFT:19ZPB;TFLUN=M4W*-]S2NSC&PZ4Q2X2FSZ>0'KI+","H+*!N1.[+9G.D@
ME`55[<V9](6.\5X,;SH8%+7-2MO3#SZNQ5L(#>[X.7RC<K\KT3E.FOQHO&4@
M)>PT!>M6.'\Z[$D%.LHH[!]@G:S"4(!P2']$<]SH$1HC*#&(I276(U)#])#)
MJ,L;<M2!,U3?"!^G0^QU[IKE@BG&*\+%EU4ZCNH&\[%,37J,B%>6_]I\&3:1
M-#>61B'F+=CPBF]@+;/B`)43P-PA)FR=[EMKXU*RODF4E%.86L=Z5*F6V6\H
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M2&*A#(\T3V#?7XYGM<J8J`+Q<]>3Q=3AU6W)O]#5-89L^K7=";M8*:Q20L]B
MD^"'J*1%"!7]&,V/M62(F@E,&<FRN+Q)G0I-L0M[\-E<!),C&HQ+5@N)"XJ`
M&9I='M:Q03OVE;:(.B8BW/+*6?`9N7)0]8BGX,NI,M4FA[YN+A>`%WQ5"31/
MF8ZP.U\3,R31=C=@`"R.SN&M.*D:-9OEHS<4]`^*=F'S4[M4ZO2&-H7-//IW
M,[\S\Z<?R83T4S8XJ"D?LK^#K.T\@7=]K=I6`0]B8AY,GNQN<4S&+GX3+O*$
M)9#,UK>)7X)"'A1+\=W%?+Z$GMB<1DB=L1%2[BQ;S$UQREF!$*00$X\GGA8S
MD?+6<W..*GW3OMEZ.-IYR=U@YK&]ATM)6#C7;S3T3-)`!Z7U]\E_HU9!_EC.
MR9<U48?S/]%?*)_`=1*XTL2+L5UU9>YS\/K9O1M1%M$CJD>R,H&1>JN5-Y.N
MC`7W!ME9)Z\YG>I@5*K%7"KP^08[6>A&:_OUPPH-QB>N;07.#Y[7EFMRNO-?
MZ#'XZ<=C@XZ5I_))K'K7K)7IVW%'67EE02+?!:@A_T*AF33SN>UU8(L#N`C<
M]0>JK(P\E<8WJG(AMY+5AI7(YR'C8ITDR32P+:4-!=K\AIP:FV7KU_3!7)KM
MN'.;21FSO^!QB*71KEA?\^PS#2W>D+,'G$TRWRT<[8O60=8PHK,)0A])^D7.
M<BWI*M=0D"DHK:(=DENC?(\LZYYWPB=`(00=7?WT8[@_]S%=79SHPLY$$"=P
MGHH@,@MX*\`5E_!T%U/$V>F*FUJ975-K]TU:/4XO;)\!R(D+C]5]G*HB'Y<`
M#Y9]4$&9\V1JPI!)ZX"E!6M::;3>0&W*;LZE\J^T'93)E/RVSH&I\96!C7;.
MW4#;6./TV=VX1E0FD@+4!2=R5/5=,!>>C9(SI"^#&4)E=L0F[9]MF/6QI"$N
M1,8C@;,SB.70J(`7;D)NB!;]H/OHH=!+Q9JX*R%)./M3Z)'UR%T<L[EB:^MR
MQJ*[\9D#YZG[(G!<CRL.83!K"S(PM&I@#W,5CV=<WS=%&=U0D51&[DU06?^D
MQ``,D)I7.!9*MX/E>P7,Z\_>=*/9KJE)(=J0!U92>UHUABK!H[EQ"\!48G[S
MFOD;X`7*#,")]_C;[X&WOC0>"S*AQH%P/:,L8"V#Z.DX@8!6]R!F4Y_^1(ZO
M7ES@"AII.U&\N+0J\6:&[8T?>@)EKNN5*`SA:]YAA*?N5[$UZ-:6\X`"9NP`
M0YNB@%&UU5D5Q&""R-))30#MVA)!VX?S<B\#+KA4R2[BW['77&C2]4LJY/+T
M.US%S9VZG""0F'$@S>J;?LV09DK?<.`G#/!2!MVR5]68[E52+RH=N::'1F<9
M,O2J#>4`<']4[A`Y[8^F[D&'H\&>BNVLPKVU%W[(:<P-JXPAE3RO<:)H\Z`5
MZ39VPEA%/!AR=R![:1HUX#3&5<2<+$E^845@1I1`8Z.:ABEQGQ/I$])R13?K
MJ5"6`)67RE`%3Q@`KDD6H[-I9B=*0`!,)#9TH=!J=ASF=;Q7?R/OZ5@W#$F2
M/00@#:=&`7U$#OE%5)'3V6R]\2O:>0/\M^0SP+IJ2=(E2/*/#"X9*-WW+[KR
M;%R)`TCSJ77C4^FGV_]6*RH6)Q\74(L[25^LP%3QR`P.TBWR@B-44%='G5?6
M8B9Z!R@TIYZ:XD];5T580'YRF$=/ZQ'"K)@PM7PURM!+RSRG!W`"$G2HKX"W
M0%(T#B^PL!:)731>*8_>GHG8,'>QA8ZH;9.(Q.F+BTKM$$G(^`0.[&4,4@U1
MHL1X*Y5"X!@_`<$OK:R3=@6VU7"0_"FR*QC+5AI/C^6:7L<9XC@WI$QR`7,P
M">HL8K`-9;FD)(-@`3A@6$LC^LZ'IYR'%+SY`+Q6AZ8//RC>D?=@:!&+P$>&
MQCRN55N"\^:?5N-+*\!XWY==@*3=""LNS:/)@DMNX5ST61T/2LB*X(19YJ(C
M*R]TXM"NBGZ/&3F5&>D\,1S&;!T\LGLMVT,WLQ1G#?Y1;=.1^GH`ECVI,EXN
MU)`.!R2SAE]NS3#"@FZ:1I.0!Z4`%A,?<HJ0CCPK*6=>F_[4O6DY/NL19';A
M<C'&B`?I86T..YJ%#1TZ<9B%PLF&S3GL`]48!<?X=5U0]Y5?^CRT%=0!,]T0
MG5NX\<MMJVE)BI!NL$%)I))<4L;S*)Z6^_7L^\=PGJ*9/,_-!J3[.EF:N@FG
M<^R24!8]DBL@/!C1?+SZ1ZS/5$T\<I(R)C%W+`W$X$?HPK5E$7)G`,(I-U;2
M<[%%P_S!N*)HN*FI0=,CWCJ6F=)3V@884?8<1>FV5H4Q4MA\)G^;W,G(W$$9
M.8/;@,`AQLT-HWOMEEO3.R+XXLSBI^\\?GK=Q$]Z_4CWV2V+*M/+@X*3:`ZB
MJXAFO3%G"1YUQS_L?K%UL,VQF^ZWO7%;O(KD:>]&*:D7E]E8%7:5WM!^S<T_
M:Z](]P:W*.Y%QF-=$+]%A?^JB!/M=.]:OR!_(O&%7CEG=&=A^T^?]>X*\O<*
M1.W2G3LR`?,BZ](/:MT1'KJS*[F1J;JHV5PB<[#6H$GII)$SX2!/==?;VMOM
M7WS$EX?=ZX"&U?[[>-ZA)85-_(,GY4$->Z:I;6_W(/4OB>_W=P]_^C&^]B8B
MC[(3LD2`&7@41R/?."H<YQ(VU@&.)NC?)*7`BIY]!*;T%AN=:_<RBT=_0>=?
MAR*;::]2C8/I-D;2#Y[RDPL6"=D0K:=*7GSG[\.P`#%O'=3X>.GVP5.[$:DK
M5\-HWSI\5&PPZ4\_QEF[&F1XVG<)G&8DAVSTLKMXTM@O?.3D6O[E(S-BWM(F
M;=@'#95LZ<(\HZ@G\<8H7P=7,@P[CE5HJR1ZF:RD3DGA^G:'@YX07>4=FI3#
MB7)'J5]Q$L)P,1=AT[P+O)&@!3N@6^I#9/=C5-D.<'/UB9CD(]VW/)$=SS8A
MVP`N"M*D:`"6FK].7NN05>"Q@*AV-.&1).#CP<W($?CQD!;;Q'VEP][Q&D[;
M-N-:\G).SQFA`N?$M2PLIRV%!I#?3N<X\*'_`_U'6M!W?'M]3B?%W_[ZOX]?
MOGWWM[_^GXQ5X0V_#^OY;@''A,2=L>\^UWII]JP#11]//,MF=KL%FMI?`6Q6
M7U36Q)HJ-(/@L>T,])-6[TI/Z(8Y_`QH(G?:VN'0))80R^XEAVN75N$R!,9!
MS3"``_9#3<'ND0NX4G<#$6?+Q/L)%W%WF$?X'Q"$X].3XMD>#85OY#]D2?45
M=P$0-W9$T,\N-TE<T.)**EQ+%)J1M9(@\NU:QDD?6TXQH+6%@22*@CU'=$"4
M7#$=G;3F&G7`2++0P>1<PA+0])RN1;.;-U80!'=:+"=\EB;`Z]6O%G]R$"CE
MN(6J%CSN]K$4O2&F)K)<LNACB1!O:@ZI.YLX2](R8U`/!$TC99XM+68)9/WM
M>]PMN-1(+_8@,O*]+ZA`N'L4DKD0-"FJ=I9_DW2?D,IJIZ]/7$":+O;!_$(/
M$3`GQW9&H%C3;#`ZZ@MAR?:<[D`)62)+6E@JTQI:3"/YUK'8.X'TB=E!HV8)
M]$ROL9IA_F$.'0FS"7@D'Q(P/\!4-%&%@[T!W_FP%@L02?58\A["'H-HL&"O
MH,SE4W%ZT_7"%A_N[^\V#=9`9D_C;82-2%UYI!VT*`E'W:87\NO948<P@.>9
M-ICXQJ::Z1`^&^BL\J(;*N`ZADCY!U_4!'8XB,E\7=?KI-3PX77P3A(&B05Q
MN)M3Z]D)=^CMAT#\6&\2A38ZW,.AU(+1RE5T'RN&B[!R*T[+MJ?%Y2F%4G[`
M:PJ,`KLQ]WE5/#Q\VKB)\@'BJ9B'CX^R4P9@2>*O'AG2HDTVU*76*6,)@:;E
MS!KSI6!S-R1H7V5J;BT5Z4G`AB"BQQK8UY@#M328O*SGMJC39`X*:U<%C=VW
M@GGV"!+*.$D'MCT%A:)TO$H[KYM!L#\\.&H./_1$Y\4;U?S^19Q'HB)>E-2-
M2X:MZ=;C1\7P\,W\S6/C]>!`Q-)<>X\R/@\/]G?W4]P0Z-ZBN+&N)U[XN9?@
M#E>TD)2-=1F>XA69X_(6"'1-2]U)PJDP()Z-?2)PYM0ZO977Y0<KB$I`O:HA
MMQ)A%)6L(P]CT9:$>`X9Z<X8JTFL#H`LS1V:A!L.]B+3MY;,W4<TB"8%J)]4
M^//*U'%02NA-4GX&!AK,@B;JFE&4#?-!&KE+@TL`9CEDG%M?*%%YZXECE$B3
M#,LB+6EQO3+:"EG1$XR$[+':,!,9`YGFTR%*VFG-DPCXMTVP0=2+]SRB'V![
MO]@0HM1V;`L94HN02*D7CYH-#UXELA%3IZH?(^0\A9<;M9I<!4E>0$'$G3+N
M.G^BDI7J%-*==@F"U>)-R19;]-1:V6E4/9)F,5I8I`]@4;=FU+::2&AN0F@M
M/-'$34B0L-[+^`RC+O`!??Q_F*56E<`%3G[;,ELD9/6MA?X,JSB0CHH*64*`
M45#'NBH-G2S!7:L?W'_U>#PRL%][[5^KB\6Z%<!1>R\2%^PUX9H@Y\.=$VGK
M<<_&0,(_#@M&7?CXM28(`N2=ESPTZZR8QLW/E?4W<Q*$MF&YB+C;^Z#MT-"6
M31M`^7MGS]0Q.NX=_,5+UE,E]JUUW;C.VHC&9_`G=THMK#;5=%LZPIK*F(J"
M"U*@5O%H#+;;YQ#1I!J.6S7J_HOECN)_$06>BQ6>[,@;V9WF-2)C/X3+CK!7
M-AKR1H7>TS4OWL>V>NG1UP1E-P)OHTUO'3UJWKG7&KX9A5M+2X7;THJ@=+^(
M3');[+<LC`H9VD<]V7_Q&LNF@N*8P]D7W7+,B^^LH#20^(W]#4-)83GR%!UH
MA8C@=3#SXM`OJNA^_6UYOG[,T?"8-RM*.%`*<PHM+B:?]7?7PWB10*KG%TOR
M]+V-?JO*A-*>>@NL[DHP?NL!B"UG7R`95:S[L:;@3++N_SKN[2;E[LCC['60
M5,LQ,R''+ZCA?4S"\,W.6X^?]5X<PW>;95#?`)K8(;.J:UNB@,/SEX;',#"8
M8$N=O"7$M6J'IK,ST,8=38>.SJO<L3/\7RM56]SP\%`O2=_6Z5[_0ZL^W-]]
MEEPQJ)C2J'T)A*"MU[Z?6**-+JO-KWE\\D@AY_I9-I-'*3%QEQQ\.792_*T3
M_&UQ''561&Z5LG>X>](Y;!M?4_^>WXI!BY3.W-"LYM`VO1_^\AN;L#FEX]Y@
MK;P5!M';?&7JXYMR\/Z^TZE6USCXK-E0*U".+0DCU6NR),<)!^NZY'O/!8Y"
ME`X.:+BQ'$AV_H6L4+I%6UC2X:N@W2*^Q3.RV$NUI$.'")J6^D22WZ.UN(R_
M(@*?*T$TPV![?X@2#'2N8(ZXMW9,0Y.U<J6,H>)>6QR+DI_5EUONZ7W('HK`
M"0A9V\LY#JRW]KO/GB%);2H@1%9*<RK4PG^`C50[C[/%K5INF0EC,."K6DW^
M$^U@2SQL=J,#A.P]QT5/=(9YZAV23M$1-)@FW(SWW\V*X]7EJEY2??'>:ULZ
MP@QIR.0%9Q1762JVX1*KDF;V&*?Y:/N06\9J74D*[ZCE`X+3/Z5MA>MJY4!B
MT88O*O5TOJ10#I40ZH%6`,A+N^&BO2PG9/-[!B^\ES;MQXGFD&O>4KJ/[E)C
M#_,OC`<_W]#3B^S30XR*#+<L^%L?]I^T@K4`@U_W&/=F\],`D..+N=(I?\^(
M/S.,#:+CY6(^O[Z85%/:")IBROV1$!5[VD5X1<?^H35&O^2E7)^DWC@LW=RY
M:PK.#V#`R)/KU74@=9*SD2D]<7CT0'.*!,I:!#5,5ZG5BVX$6'S)L_E`;YK.
MSYF]QK0][MID+ZN&LR/#H'>&#,O.!VGB:-Q2F0->-[IZ4"0DW<,*NXWD#;08
M27-L'NX?N)W,S:([NTK#/3QZ_M2>W<Q2;Z@47JVX<8Q\M$H7NK1G(VR\G?'J
MZO`JXOYQC!:/9S?ELBUO7DH*TNU/%X0M??%(2LZX.TKXW4U0@VPW=-C;KEO;
M9<OB&I&L@4:?HF)#`D0&N=SA<`ZL7ABH8G#E5^E,_`%;1X.]=&HT0:6Y-,;-
MFB]!;>OFV<CF%UK^68Q>OXE?'2Q]T_ZU*7$`.4"I0'=#O52IAV`PFP&Z7-.3
M8,W6[&B7E)F9H8Z=PKXI@Y&;*0C%5;_)X$6L:.LR7V[NG'PQ#]:W4<*6I4R%
M")P,1`A@64NS8P,;2]O.V6G_AFE/V8SF9%P,[G2=D\.!(P81F8EZZ'AGK#M\
M`S("LC513M0L!;2>M&::3>7;W5&8HM#&&#6G9ASR%GPU=YOU3`.5N]@;2F0F
MC.SFA.5Y4S!V>V/1/"9U,Y6C'XJID7@=N?1CVSG_FP,BR->"@$S&8=9`P15X
M['.^F(X_D5@IPE%EGN)B&N(=,E,3SIQ=M.Z[\[.YU@EY@TMD(;];=0_\,;)1
MEO)K\K)AU,)UQR^N$'Z>S8`\H,`DACJ$H1\L<T-7ISA%]2`SRBAK&IG5G=F_
M4=QD`H4>9XS^K?"A1BN?:FC7V<D&"EOR?R2_V,-XKJ+5Z14!)&5!3M*N:I:7
M&-OPA3F>!RT.<3K=+E5DGM]O"22X`5UJ$5<%26Q>+SHB:.-6<B[1U=6F;CH\
MU1*FEP.>ZSZ)8%)525N$>K%]MF2H5-^=?,&1<)UMB+RASE;#`E@+1]]Q#&"+
M9(C)F"_EC"?_072JN.]4O"<O(IR`<FK835Q\J;8-$@Y2)$PFB)(<\G>"OZO>
MPA6F9"KDP2WFMQR.T>4*(6A!AZH\4]NM369<<QJ)J9!?X%//-"X`<^@2;P$L
M"'B-J(KLXG+]Q)7_E+*Y7SK=3;^AV)_H7I_F9OSWM#%>EURV,+^DTQV&>CW#
MS(0;3(F$FP;A;[\]L?/J)^]?GVRF(ZP^*E<WT(N>EP$1#GR6FRQ=K,<FDZDQ
M1J>B;_E42!&N._]%MJ+S*6I,R*`,ZH78(,J`4>OE=Z>[A>W>W%;?E&C0[O)Y
MB\7_N*IU#ZLP&UYO4)-X'^T66[$1IQAJ$'K-+>?=<8^V[3X&K:,AB_IJ<I,I
MP*C"$J[\DAE#$JP2-C`HB_(MHB0EGG9;JUVV;:49=C-1RJH$J1)=(IOG5T^D
M_NXYJ2H:9M30`#`15C/1Z(=P!9.NO;&[/;G9W.K4VJM%<U1;C/\3BT@0^B#;
M>0>%9Z$"$@V1P<S=5TXT[I1/@`>9%%`/G^WN9;U]%,B@>SWY'$_]>:]5?C6/
MB_W=8*Q9;'4CA?+P:'<OY:983;LJ+^DFX^H.ZR:$_7&3K$1DJ,S.Z0U@B!G\
M$E.3W]^7-WI9XMD@IDQ#K4&7V8$^-;FHTBYB-A'8/]@]^@=MX8!_0%X\?6@_
M:ALQZ8)5TVF&I@O!KYCVJA0#Y;SZ>R/BDZX6[?A'W=(%!4M%L(S$401;&E^F
MP^,EL36G%-%B<$^?2M*G22J$I<@M4@&V!;M5A#V>K^C8EK-GWYHV5\J`7RAS
MVTO9V$C"R/[3?U"BA7N=C7VCVM?C!K"<GC9G&?YZEX/VU/@+%06P(Z$ZHB,&
MDKL_ADO\VH'4XL4WR^'(<NOIHZ"U>4;_?<__G7_]XIL)_ZO_HF-WOWFPO_>`
M3[(&9G2N>9G-OKY9O"%KYH^<D5&J.4+QJ?C`^P)F^O6B1+*XLM-FT!=?V^3+
MC2#O0//O`\DP2AI\?%U/0`+_6X,\!9]6G&G3H8W[-6/?+WB%%7+]UIJV+3,*
M'[SW^Q0#;;?>OWW_FE<%J1@<*KT;S?TN;X2UMY%VKYGL...G>#;I;4''L8&U
MV!*+TT29FGRUW_3^O/0<_95Z[0'G[/1Z%[V_@IJ9'7'$9?'W5.D=+V)/2>$)
M=>(+#EGI5@<Y\.\L_:9JIFI,K1-0>*,!3=8^9EA"/C2+/%Q<)V\OTM3Q;$2_
M&>X+X+<M6JT*34FE/6E>%CP\>K+]F%NBFY;N.T&0=..8D5W&,W/E?O#X^?81
M]P%D)T[NF$S:J`'@D@N[R"G'FS*!IYW4?)BZ2]0,SE@<4[U2Q9*MV.10?2.O
MYT%*/-`G960UX9!7#BK/K81\TK0D^Q$K1)UHW1@=&.@`;<HL>KA/.;W%#(Z`
M:DU+V9%G=7OJ;5@TSYAW+>&]2<3H!RNM<.3%)5:T-#>)1"\NOV'=W(XN`^&#
MN?)LD6]O]VE.]WQU1U0B-!O&H1'I+)(0`)YD.]A]MN_/1AZ-AP`4HM5&`C/H
M\<9?G=12OI<,%&D+KTHVU^S'H*-Y6NP?&_W3B\8=')CEX<'NP;.FOY_)27]/
MM<G]O3VSUR*7B",TG=.`DH:FT#7?M@BH$8.7\+6I&W3//:@;6<S/I*MQ[)*B
MLQ_D1MC1F*8$A&7!0,@3[F_3IR!19O"G5O/7M\X)D2_T38\U11V\Q#6+>1<B
M%_NHU)`:"V/]Y,O]L\))S+23]W]\+Y9_V]>*UAIIG5!N%-H*S'QV)9Y*^NV(
M0?QX.N=.0RU,Y2@_4H8_!8?:16VS.0^3#@AEKL2G*I-D;9KPCEV`I!JDF1"4
M-GQDZI*BA9&&S^$AI>HBD_8DCAFROC#DE`R*OR-44TH"&N$0M;5B.*:>^EA:
M7(G,ES)6]HHQ)4UA&C(6C>W<UCF`D/*H]%8UY2\:R\IX_U$<$MG0CN_)<038
M*<=NM:4<UFP+%0:0E.76\:.??E29+3QG[S4P@4I[,@94[--LR8'5-FT2%T!S
M:PDJO6?7-`22KJMDM4?<K90Q8Q^D*.T>&YV3G5]82*[V(TO^6/+(N:0Q.BWD
MY77!YAB)WXT\;1'1CC4/H\`6W7K)_@VP'`/9WO-=M_>9,:LW9"/=6"%@JW41
M:\C>F/J[&T91<!A$X7Q-&*I!3?S!<\P@"ZITCX>F'-0D^Z#7?/&K4EKA4XQN
MX'R]MZ*I^[F.\MC,#(.]UB*S.][1&RX(_#O$6"Z19ZE4F"2X]CZX$%S(['FU
MN75Z)VI\3(3V'MT#2*5$6/3;@H(P\Z+'+`O2LI"RLW@*8F&J=CK_*F'GSR:8
M4_,)2C"LE$&(T&G20-H(0K0PM<X/69+03J7'$K[,G7,.R_J;C:4APEQ\IXP8
MOF;V#N)FR0UMT0>S.U9<?F5TEIOJ[M.]7?#047K8)G#'!5>V*+G@G;Q+5-W9
MY148\$@AWD\O'*+Z/);`US:/''S`PBU_6J3J[RQ<XAZQS^&&[#1)7R<.>LC[
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MY9O`JT%7AQ^BL^B2BL]`NY9M%!6XFKE7;ZH\>#]^>0-V"N>*0P7-1OW17K01
M9\`;,!]'-,^V+$>!/A`(P@_<J#3S>?%</O(^W>2M:E1ND_1YC3O6B6#2YG&%
M-,IJQ*C8&.MM:--"<BGQTL:&;#6K(ND[1LQL0;,)Z?Q3K"0^J,Y<-S[]^_3.
MFE.[<F2K\\4CT[%IGZCW%%:W5!6XA=L\2994HHS_7;K_X<%>DUEW>0I"8O2`
M;OL'EKS(R-&!;SUXGMYYLGUP9!8EFZ(%N$4$:4_NO4#!A_M/>.DE84/RFSH+
M.[AY,@:)M==E-BF>`9.E2(5,B_@Q.7:PBW7'XJT-YGT0?[BWEUMZNIO.%'+7
M6ZQENU,DQ+/.NHR>W?SD[T%1(M!X-U+-5,B(#)GBEJ?/]C/$=5"P'O>'="\=
MK3<L&_'W:SF[Z[!O^1O$NQ6;*FV202N!S'5NC^RQWS((;[A8+?C"?@\&=T[=
M"8:?88Y'N.1*WYA`Q1+:P]T]<HN)CYQI&K'L(E33H??B'/9B1;N[!S-@P2Z)
M#II,S6?WJJ<7\QG#"\]$L%`+]5R"3$BZ08Q<(N^"Y]8@@A`>]/ZL\$JTML;3
MIRYDQH$!X<BE91>:?5CE.,?OAHK/D!N%+P4*D1.-R!;H8U&CH6E%."T>NY/>
M4D46/JWEJ`A&N!,HJ;P[\G?[N[F20$SUIM"0(805!%#R<1`6[Z8+ETOHQV%G
MQU"=9UDFV3T/G71D,+J>5;(%G6\=E'.SAE=T'JAUPGRL,*\X0!"D74[(3)C7
M0FBO%R8@!990B);,0R2?G+_GE_[N8LLGR+CP3@Z[NTBW"L1VJAEG[G2#J.)R
MRG*<=,!"ZC#4\]WGS_\A!IU^?KJY^JGAJIRA!*W,MRYM<A7*"45N'U-V94-F
M.V._3;B9^=-0/IW1QXCI/+PY*4VP)UUJ?&!71T6O`TC,'S!,GC;1_3&%5/"W
M__P0SS2;6PC/%=*'/(4ZY`3BSC5.8+'U_7SW\/!P9__9TZ.]9_09>`3X2R1!
MORMO.47^W/TZ5RD"MJL$A(8_ACJFX\]$-5#$7(Y\ORWW4[RNVWA9*'1'$S5L
M9`C>]L/E(>#"J3%Y@AFB_S][U[835W)%?^4\1*(M`8&V#>;%4M/`Q!$VB,:)
ME%$>`,,H"@.$AO%8FA^9O\U:>^^ZG%UU+HWS$FG>$'WJ7K4O:]]`_V(P\]W]
M':JA(Z@[D%2>DK.63)-`0DK#UJBJC%H-[!-4#[23B9!@.T78F+$*.GU_`=>'
MC2=<>4.Y!&.\@2O6\R,\'L^_/=`CAJFE-0=A"*&/\PDO!^,^$&.#5[@I$R#\
MEFU0)"T\C0=`GNH#(!5Z\"$T*4UIQW/",X/[AV1=(X?/S%OBIX!_A23R^-.6
MF6-!:/GPH/"0JB8I6Q*1)",SN@^F]&/*0&*(Q:OQ+U#4QV56TPQB!1#6Z&J$
M:<(F^?RSY.9C-E&2#$#>W&Y+,!!W!TI!/`]):T<K1#'+GI4*!0Q4):U"?012
M-1"_03CF[J6%9TAT#5W#R0OKQY9F=U!.*9E(T)WLCVXA(*'?+1Y[Y'L`YWY3
M&+?'/:63W-X!C8%=M9]+,%)8"#1.-F%<C$M7>W$FU6,U;]>W@8I,8<M*M-LO
M/^RZ*!F\GY'SY"H%;T-NWMU>G^Y2E-P=W?.3J"%FX<VD>1H+HQC&ASM7M%>T
MGO4542HTAQO2;O`)JAAW<R9B8%55\@\(==``5$",`E`RS"9,21,BX=BXB]SF
M7`<AS<JVOJHXM/2&413X'*-T'Z#(*\&*IT]`/5LA+C(PE;(&=NQE-EY4P$Z7
M*I^#[E2\1870Y`0ED\JB./8]D--T$VIINDW`Y:/==JI^5CR"_R'VE`[?WJR[
M)KW84RO#SO\_^(2+3ZKECO\/\.G%X%,4Z$:1@AF-F#X>"SPP2(4M:OZ`8XFU
M<O<VWR2_S?J;-IDR2?8T,08-!#R8B4?$E8\D19@YPH:A@F%0I%C:V7P'"=8L
MG$72QW8WZ?5R.7#$>*V.('`+"DL)C%THB]6RIS@>DGL'EZHH=PI!CC;&J#Q`
M(3+B@\6$1@0*F=U*$Z3$R(P=Z2.Y10$?<P)W%&=+F6XCD^D4TD!"@V07D90'
M9O)4L<UPCZ"%RAH1J,#-O6CVH0;]>V-Q!2D%,U5L9(-'P)]_OD>-L$)<>;^@
M3+5A9G$P6*):P@K<U;(/U7S>\UW=UVCR[E6C(Y4=C!.#C@`&D$1G47F\$)T9
M9^14")C('X02V-I:R#V$L_A0@#R;<*T:)V5JA7+PE*DEJ"C0$&0O=87@>W$K
M`U@89$PRV5@;K"5D9CGMAN(E3W7QLI28WF%;)`W`5Y-P0RBZ"_@D47@?NQ)$
MG,6`/D@H!S#1W][7DF2\7\!S`[=IG?Z]$FE.B6;VA>&8ZEGT2Y&K`5U+>1_%
ML`X5-W6WJWYK1-"S>RS'*#)X<X'GCD-([B;BDK':[4@@@)VO"?Q(_TP=#/(?
M#5T0">':(M0$5$2/O)*"^=,SM$F)6SU19R"WNO<ASW`S`_@)4ZC__5#]<XK_
MGY)\^H]]9S!",W*6;WS.P'OX,=$E[1SQ0+XI[Y08[XH,S3;QW#^)A#Q<K)@U
MHDAV_`..`1JO'RFLJ/@![_@&WCW4D7%S$+MUA1M5MI],=WV7'5.,5UIDC*Y&
MQDK$?H1UC6MD6?<X40K[4AH<?(O_]N.D*R!DKLAH4AR:[%MS0+>JE*?']RI/
M!Y4YHWJN[G>9$]FX0_H;9FP[#NU%LKJ_;*C^?0-%I6_1^<6O14J7^@.?[+V"
MVT%J-(X5?!#\`0&CJ2+9YU:DF=$F8)C(X\((?Y"HE$H5C\KJDT$?$U1(51^@
M//=?I4MD%&+!585BU2<&5D[Q"E)$U`K5"C!ZAZP4XERVY-IIQ`&@#`$EXQU"
M6U@<6("6IXM?(9/`L$J?,WS+#C`48!$6&*VDM\\2S]E'TKDER.!81',[^]?"
MX<$-"'X8DCH"6#<:FJ\0IB0O`QN#1=#>`$:K6NDS'N@C+;)PRT\-("3>H%HT
M/0,SEB7:;:NK-E#!\(\H#"'`[!FKIUCC]_^"*0P14LEE45.N+$UUB;GQYDND
ML03/0JX)M.#^$M@&/90R-PR4%&+S)>!QG,6M8)M<)#Y7L:"5!^8:=4L8J$S[
MD!P3CFCY#&8M8)'Z#[+`'GN650)(`UB.2#(L$K8=0H$LI4K)(^ZA#L;:.YQ4
M*8R=9_(&-W.1TC8LLJJJ^66&',$<.LWDU/XJ2/N!1#*J`0HGN&])BST!R)@^
M(S9_NF[.4%()DO!Q*&LOF_C#O3$:7(L[W\<9#L%5A?2?[$O\+>9QRAVR&H?^
M(_`Q5W)I#H@2F\TI^8^Q&ZV2/_[W3[A!QW3ZA\2D0F@S.>?5719;E>TWYWDE
M*PXE.]I]^%%.JSG&QHQ4;^G[QU7OR7W4M:`C3?3Q$>(!$WT<2TZ74XN6]4-D
MMT\HU@-"SR0"!=@6O?&%<4`S^B/OR7?D/?&;WJD5=1WI)UA$YK"(K)M"A8L*
M_D9*&#0WA`/Q[T)PS&ZW2M8J48$W0M@5)]=B<HG^G"T^:[9$Q,GYS[*+(R\F
M'VB(;!W0$G*[?-5,/B\.FC\53W(;::ND-.0AO:K\R-O3WI\AKFPV6PH_%9+K
M*8@[[G(AJ@&YVVPTK7TE"<W7^^8?UW#0/8$?\!%=D(O003]'-1F*RY3S?O5?
M(IP98,9K%()C,3(H_[>P0363OQQ!=V.E*C)@R#9,&>";!DY84G'RD2K1!6VZ
M1OJ]B]M7S8^S2VIO5T__]/TFN?:A8[O*+X@[/U!E5O4)//;Z#NG`;KO[5H="
M?,B6K!TA`HYD_O"-UJ;F?KACT</^`[Z-1O/`BVZ<Y!/_Y1&40$!3_^+["0E!
M0@0,5'2P,HVA`!TTT8U[B2G&6#G?8^!_JJ=*O6+_R5JUJK'_JL:SAE[*]$WO
M6X`JM\GTCU23IGZ\_,>B3D_^XU9/RZV]OA^+M(A9MUN%LI?_N-/7[=N^']_T
M_5@0A(QL74;N+_6D<$$0T04<$1*$@#R^WY>6_$D]0I'#&T?A,EY&>0CQEIG1
MT8_9<T>@_.O+]FV@.GV$SD'I,R;N%\<VJ2,>@PQ\L\-@I9Y0"$)&U$R2&J8A
M]<)`Q,H*VFO)WP40#F4+H"!N4GN)$*MB7'O-9.A%H`4HN7WNUQ3D8+`_!'];
MF8X?CR'>-Q\0&+<L2.%A#/X<*!_@1^)!F<)73W8_HD$>KD]_B%52W?ON$]Z0
M9WD?WLZN=N&R];"1<X)U(*)BB;"]"$@Z^)Q5I$4Q"^BF6:IQ/W.(`BA7"J[.
M2@LDW\4%$NH/VQ[BP9$:$MH@L=9DT,2;:M<[+3KX>`'KQW.!G*W<+VJK:D9B
ML$%!:OU:UBS9EO]_71T8/AU*`%@=URS:%?D>=':R+.Y'%<VMCP5PET'2?F(<
M0/($4^*I=K?6DRBXN]&H3,%'0YF"%X.9@C_T9`I>.WYQJN#Z'L;SBJ2X2\#M
M:C_B5>%$^G1"(X^#,_CK,^Q"*AEL%5RZJNKXJX&THI"S5;9X[7]<_N>F@$MK
M&3!]NX'5C=B?&>`R/@;37[.<I(SS``!VISJM'UG59+$`=KU>_83A=+YQGE[2
M_S8/"9:(?8@I)IH<U0@JJ?(`9A)&@:(%8"DEUB-02#6\3DZH\PE07&3@66J0
MICC-@2KZ.<W0+3W;(\*]:@<!7,"\"-H0.<*>AW0R*6>1']@H+=>S4CL\&,E[
MDV>S"<,58QCPX<8(F65TDI)QAB'KECLQ)*4I.E/6X"?\PLZ*1$E,:E\_V[5.
M76<4`>C4K?,7-@.?H/D(Z!XT3&Y)KRP$%M#.TT(^\_?@41`DLT'20ZZ`?J(]
M7H':8,Y?44.-S3+[B#_#.8MN\'[:QP3LH_\]TD0HX"O&4SQ0H,K+ITW?QQHT
MJ)V-K4*Y6*%OHL^E$0D=3[<VM@H%S%Z8GX=MMSI9\.K4=1/FO<G3WOAN9M%[
M[RI3;1$F?EO`+38B3NF7$(P%727XC.8.J]H5$/6JF)^&;*=C\5-K9_`Y"4'#
M<RACJ%"$/?0-6KEW$FWE>?I/3Y];'H?$Z5OKIZG-MPD[+BDJ2>CDOOBO.#V"
MY)=Y]@_0V%;_OE'<VE%><=\$!/%]K.TJ-N+_7TZHOB&7L"6DT.S?1D6?%6.U
M[I"<?@@!$*.)`BOB9(U7V`[OJ(,N`J;X86`],$Q&L9:.<)[N1]%B.M\?SX`L
M:!#%*%%D#N4QF:"?_8?2*7V<0[KOR$<A_@:-#A:V4'RZ(Y:LZ"5NYD)\?</3
M$(=MO#I('8^^33=N/:25$\!6%5:(PP:P%F`>>'L)P*8L4@&P%66Q'PO]9'!&
MS78G)Y2VA$DQDWD^D]DC-->?-+9D_YM"[O:=F5&:V5>ZH_1QRYKGPB4"21!=
M!#*!9U!G^PE9M0ZHF%6]+8HO63Y4W2P(%)B/!7D=-@\7I"#LM1E>@Z-C;B1<
M]?F%1IEO!:U#TDI;K*-:XH!K3.BDQ]=B1"^%>X7-B?$PN+WK31CF)#DJKC?[
MPV<0.PZ%J&/'#]IQQXD,MCLTEY_B*`9;KGBTL3_S/<(5`.T#Z-V[-:UC]&\_
M=MFU*6&W;2@:6]W-Z.QR:):]]V3<K,,0W7Y34JQ`':5J-\=/?NV=V22VD3Q.
MK55O$2CXK2!1E0_WJA]6-I">/FWWF_58OS[XE?6X@F5+*J9O8D-CLV^V=WLG
MU7L$\6ZLM,O%E,H=W>:<_'?#-'_:2?,/I2X/,I(LX*A!Q;J;"<`SZ$HU@Y,;
M['%T!#U5'\PY$ICWZTMGD/9!+PCNJ[S2Z\@5S#0%E))UHYQ:>$]VS?Z\7#Z]
M_R\```#__P,`4$L#!!0`!@`(````(0#UHBX*4PP```5Q```-````>&PO<W1Y
M;&5S+GAM;.Q=^X_;QA'^O4#_!X)NBP3H62_J)%U.%UCRL37@ND%\10LT14%)
MU!UCBE0IRKY+T/^],\O7K/A:4DMM4S1"?!*EG?GFF\>^^+C]]GGG:I_MX.#X
MWEP?O.[KFNVM_8WC/<[UOSR85U-=.X26M[%<W[/G^HM]T+^]^_6O;@_ABVM_
M?++M4`,1WF&N/X7A_J;7.ZR?[)UU>.WO;0^^V?K!S@KA8_#8.^P#V]H<L-'.
M[0W[_>O>SG(\/9)PLUN+"-E9P:?C_FKM[_96Z*P<UPE?F"Q=VZUOWCUZ?F"M
M7(#Z/#"L=2*;?<B)WSGKP#_XV_`UB.OYVZVSMO,H9[U9#R3=W7K'G;D+#]K:
M/WKA7!^FA[3HFW>;N7ZM:Y')2W\#('[WKZ,??O.;Z,^KW[]ZU?_GU]_\_7M[
M\X\?OLI_]\/7>B]10V2"#ZIEONY7BH6O(\F]V(*[VZWO$4,`-"/HYI/G?_%,
M_`Z"`<S#G]W='G[2/ELN'!D@O+7O^H$6@I?!/G;$LW9V](NEY3JKP,&?;:V=
MX[Y$AX=X@`5&_+N=`V["@[U(PV7UK!!-8M,487`VC?`(M6D')EEXL-HFZ\<"
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MI]/IS!@-#(.1O(HCVO$V]K.-\UUI-.41C`'!;#2=70\!2-^8,E4713`"`)/Q
M>#H>S(8&_,_ZQ^X1R.9TK*OV*D&@R*L$@2*OLOE53T+ECS,%5FT4YRI!H,BK
M!($BKTXD5^")<J\2!(J\2A`H\BH;JDK,55C"59RK!($BKQ($BKPJ;?`95^"9
M<J\2!(J\2A!<VJOQM`H'UB9;(\J/S*2-CY,I'*R`F6P0WT07FS7"/'7E!QO8
M:TLVD`;7,$>,CMW=NO8VA!EIX#P^X=_0W\._*S\,86?J[G;C6(^^9[GPMI>T
M2/Y6M(2].]BFF^OAD[/^!,JXE8^(FTA%5QK2JF?@;,*8&/V),1Y>1Q,V2:IW
M]L8Y[O+6I;H+XQ)H1&[K#2<<>JF2.!RRY<D>>B%VGV`+YFKF:<$&$!-)2`BV
MD&%CME0O:B-I(68C:2!H(VDA:B.D3E%R)4QN_"-L&Y\ZV#2G_7ZT*BJJIUH@
M`5X0,<4@2)L\G[5-"ABM;=/45J@ON=Q8#/'%1L<%EM:TR-M9TZ#`RIH6HC;R
M<9-XEQ.>+EU@>2Y`<L(W]_-V,$!1U+`03UR=<'DXVJT1+G8"QN:%%UC,T9-O
MT<YH05L)'#"G6<_97$72XL3'LFS..;HC/<)FU+,;#U!@O+.V7?<CCD#^MDT'
M/;".>'?[O"6GM\`Y1WC^!YX]@V]AL3Y^&PUPH@_`0UFC86DCS=KOW9</Q]W*
M#DQV(A)3P8[BID#V:<%&9MGG-Z[SZ.ULMA*J1V*^"_S07H?L1"FV65*&9U2"
M9Q`+$L%SCGZC1#_P),S'.?IAI:W0B<"+4OT07,+Z9<8#K%$E?(`+:%!7X9&)
M`-93$@3@!!4(\!2V.+$A/%4@@'EJ@@`"-$,`<"JBXIP\&)!J!C&0J03]7:F$
M&I-8R:GLT,JR\@OZ*ZPTN?)[%LVDWD*@9S3#APH`9ZDL*[&J2@QQ.V1:1@%\
MJ*#`A%Y73I<W**OYR@@A11<P9(Q`&:AB1%Y4DIH+.C,`U8PL)(Y#2%!@*5(-
M`>`H@4`<,5#4_PXH!D4],(T&15TPA<#UP1?,">H)KH=4A`'P*,F*;)PPX'J,
M"])`(*BJD"0:AJI*),6@JD9FKABJ*I$$@JH*23VAJD12#*IJ)'&%JA))(``C
M2BHD]82J$DDQJ*J1F2M&JDHD@:"J0A)/C#HND3VZ;!HMHI+UT\FDU?JI]KRM
M74B%_>AT]>#4U4GS:/84S1S!%VPN1:;2>-&@E:R=:D]^X/P$DTR\>'`-BZEV
MH./%IJ&SID>^!-;^P7Z&J6BTT?:\/5GK9;/+>(58'"._S)I@O2QR8+%^:3MU
M30V;&7.P!J]KM;01Y>*L"?)S!A:$%2\%PENNM/-!5AI6M9;3@!%65QPO[4'@
MLE3MML:)[V5CZ#($)"4WUAS5-$'WKAP#=15T]6(I(IBMM0E#E.,\2)ERG(O^
M[RCGBR3L8/9R71LA7KKMO/I&_85P#)261Z7*F\3[X/_)%FV\5_3$7909&)!)
MS73:'>'Y1@T'2*3PC$[7'_AA"4^&R78,DM%E:3HTB<@ACASB$5(K+%7G2I"=
MJU:R:\:H<NS$=7IQTA?QGHE<)Y`=+>5$E3JM+5&M(J2MLIJ0H8G+3OMCIPQ6
M]93#4CZ@WQ*)&U'S08]P5>RB$%`[.2RXGR=B:$1]EB"M#&^KK%N_<WP(TM'*
M?$'9W5K+=4EP'Z9.O2]%6;=\<-YO6YA.PP'[W7@JRI68&F7%D_:J84*6D-VR
MQ#NR42!G$$]9`C&%+$E1)H</(4?FZ&CNQ]+AGLP^;0#6=%GK>;^U5";';S2T
MT(>%@^`+=$?)6K6DT6S+<MV`TU:`H:RE#->4.+%B)EHI>&6Y/&RG#./E%UF\
MQ8#G6&I>K;*2WB"R6HS(.??F<!=[MU7H",JNL;91DL/$-,D9T+YB,\_X:H6J
M&EW:43127EH2%1`AO7C4>(GVJ/\=U:X!X!9)!+X6CB[!J:=4"CO&UX*Q-F6G
M@0_;!!U=TE>^B-1Q]3@[NCK&=]%*>]J=H6U%@Y/J+&K>Q9?V,]0[%;DEA#,_
M(6D.5/98!+NC7P+!T%,7XN2*5Y[@XD%35+TR*D6CKD:9>F^*L01F5(VY^%ZQ
MG*5.E37H8"K2L@PB5S[PI)<N^9"B3#H?2(WH,@&W59<%1`VF1AT'UJ$$#I=F
M@%/<.0W*>*-M_8I53?"N.#YA[@2[';'X;D3A&1#K*<4EJ*2,X]O8X_!V53XC
M+"ZKI:XN"CMV9BB<"TJNK.>OJT_/'-7PEL_PB(K^;[4K[<T:!Z_I*A2>\;`Z
M.B[<D`RGKGA6[_IX@'OA+**#\7F85;+2_5G<JZ:R(.:;RDHC;XAG>A-<L"7?
M5%;:)8S`6B(+;CK06%9:3N&&PIPL.&.M*2YH$F77B.=^+,B]4>1'=L4*X0M,
M%L%%965^Q&)%9(')365E?@3'45E@<E-9F1\!(9%E@)*FLC(_@A>H+`BWIK)2
M/QJ8ZQE?8T'NKPO]R,<JGEXN@HO*ROS(Q^I(,%:IK,R/?*RBR4UQ97X$J80O
M`[YH*BOS(U\G#,$Z06W,_,AS/Q;D_K2B\A$_%(SX2$KF.WA'.,(%`Q&.(BF9
MU_@H'PE&>20E\Q<?WX9@?$=2,D^!/&*1`5^(6Y3Z:,2S:PBRN[`V2=7E`P;[
M&1$8\#"C]=&%ATSY^(@J=OD$[KP3@_!B.2%)3_;ZD[:$N^&D@OA\P&Y41-#]
M\]ZU/"OT@Q<-+YE(Q?%.'PN*^X/OIQSQ$H;P4030'^&!7O"L,`UXB1CB8QBO
M.V@B)LT%GAZ\?KJ)&&@=H>'C#Y?CFHB!UI$8OJCB^$E$S#MO?TP]Q-=2[+I%
M1+QWO$_VAH\<GF$<THM(^F`?P\!*XX]/J:$@,1_P'DJI#+Y$1,^/2&[X%(\_
M/\`MDQ(2<7Y*<@?'T"+`_WP,"8W8B@B!&[(+"7EP0KBW7Y+$G`B$)8+CP8?+
MF%(1)Q5%4,9?K<##;.%2]R1&2RS*+@J#T?_F.;N?%N,]Q$?>L3MMI?,!(&IC
M;ZVC&SZD7\[U[/V?V%TS(9CB7WWG?/9#)F*N9^_?X^U((8MA:0G*S?L#W.(2
M_FK'P)GK/]\O)K.W]^;P:MI?3*^,D3V^FHT7;Z_&QG+Q]JTYZP_[RW\#9?A\
MP!MXP-P9S]]CSPF$R\(&QLW!A:?T!;&Q,?B/V;&Y3CY$\-D)A0`;3L!/C.@=
MTN<7WOT'``#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO
M=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1N
MAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+
M2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>
MD@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,<Q-
MN(BP@E<15,8"'P'=B%76JM5F)<(T]E",(R![>S*A/D%#3=+;RHCW&+S&2NH!
MGXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,
M%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=V<OH&P-0RKM?K=7NUG)X!8-\'
M3:TL19KU_D:MD]$L@.SC,NUNM5&MN_@"_?4EF5N=3J?12F6Q1`W(/M:7\!O5
M9GU[S<$;D,4WEO#USG:WVW3P!F3QS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=,
M.-LMA6\`?*.:PA<HB(8\NC2+"8_5JEB+\'TN^@#00(85C9&:)V2"?8CB+HY&
M@F+-`&\27)BQ0[Y<&M*\D/0%353;^S#!D!$+>J^>?__J^5/TZOF3XX?/CA_^
M=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0
M,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2<C<;X5
MPQ!39P4.@78)Z9X*'>"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W
M.&<=+DH-<$/S*EAX.(N#<N9B5L0=8'Q8QKN+8\>UO5D"53,+2L?VW9`X8NXS
M'"L<D)@HI.?XE)`2[>Y1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I
M#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD<E9$<XH@5#7X3J[!,R,%<
M^$5<3RKP=$`81[TQD;)LS6T!^A:<?@-#O2IU^QZ;1RY2*#HMHWD3<UY$[O!I
M-\114H8=T#@L8C^04PA1C/:Y*H/O<3=#]#OX`<<KW7V7$L?=IQ>".S1P1%H$
MB)Z9B1)?7B?<B=_!G$TP,54&2KI3J2,:_UW99A3JMN7PKFRWO6W8Q,J29_=$
ML5Z%^P^6Z!T\B_<)9,7R%O6N0K^KT-Y;7Z%7Y?+%U^5%*88JK1L2VVN;SCM:
MV7A/*&,#-6?DIC2]MX0-:-R'0;W.'#I)?A!+0GC4F0P,'%P@L%F#!%<?414.
M0IQ`WU[S-)%`IJ0#B1(NX;QHADMI:SST_LJ>-AOZ'&(KA\1JCX_M\+H>SHX;
M.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ
M,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4
MQ<J2(EH/&PSZ['B*U0K<6IKL&W`[BY.*[.HKV&7>>Q,O91&\\!)0.YF.+"XF
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M`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE
M2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-
MJ63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',
M"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A
M/X#:BN#[A28&80-1?<DV'D@72#LX@L;)#MI@TJ2L:=/625LMVZPON-/-^9XP
MMI;L+/X^I['SYLQEY^3B11H[M;!C:SNVTM3@V9,I"D.3["!C'&.^E!4_9O'1
M?7#T#GPVF#$E33#!IRJ!H8<>F#R`Y+<<S=*MOP```/__`P!02P,$%``&``@`
M```A`.KPI`L_`P``2`H``!D```!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL
MG%9;;YLP%'Z?M/^`>"_@`"&)DE3MJFZ5-FF:=GEVP`2K@)'M-.V_WSF8$"Y-
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MMDC>'IB*H:)`XTQ"9(I%#@;@URHXM@94A+[6USU/=+:R_:D31IY/`&YMF-*/
M'"EM*]XI+8H_!D0:*D,R:4C@VI"0T`DF832[@,4UCNJ`#U33]5**O05=`YJJ
MHMB#9`',AV3&1YOU5%3(B"1WR+*RH=TAA8+Y>5F'0;!T7Z"F<8.Y-QCX;3&D
M1;C@IK4$-KJ6WB_R01G!J(Q%1ROWYD%79O*^C-^7P>3!R3D]R.$@P'5"A$'8
M\AL'!@-4;=!C*7I!@:8;%!WXT)OG`^,@P'78PV`Z<&`P43T1`9E[GM<">@;`
M8]?`>6$$]X7]Z%A:$]U@C#"9D^B4\/0:800/A&=#88/IUMR?O9\YND8:P0/I
MZ#B9)K/!7"*-V\'@6_OW?..@@869WT8S%@S&E'U*O)-EG_<-G)]O!`];/1H(
M&TPW^[$ZO4XCT-?79Z]']<./F[T!P077'>+X\]9DWP(N0)WRGT]/S'+5_<[&
M[=Z`6NGY<2GH2U^UI!&SA/6D1PW?@+JE/]7Q!!>DRX,CNE]S?]3S->7*ODC]
MOU8YV,U'+D9MWX#:\H?']C3E-QNZV>\*)K?L$\MS9<5BAYLU@89IG[8'B;M)
M?11H7\`^7M$M^T;EEI?*RED*0STG@NS2G`3,C195O9MNA(8=O/Z;P8F-P9[D
M.0!.A="'&SQKM&?`]5\```#__P,`4$L#!!0`!@`(````(0!NAM_)>`,``*X+
M```8````>&PO=V]R:W-H965T<R]S:&5E=#$N>&ULE)9=;YLP%(;O)^T_(-\W
M8/+51"%5H>I6:9.F?5X[8()5P,QVFO;?[Q@3`DZRDIN$CY?W/#['Q_;J[K7(
MG1<J).-E@/#(0PXM8YZP<AN@7S\?;VZ1(Q4I$Y+SD@;HC4ITM_[X8;7GXEEF
ME"H''$H9H$RI:NFZ,LYH0>2(5[2$-RD7!5%P*[:NK`0E2?U1D;N^Y\W<@K`2
M&8>E&.+!TY3%](''NX*6RI@(FA,%_#)CE3RX%?$0NX*(YUUU$_.B`HL-RYEZ
MJTV14\3+IVW)!=GD,.Y7/"'QP;N^.;$O6"RXY*D:@9UK0$_'O'`7+CBM5PF#
M$>BT.X*F`;K'RPB/D;M>U0GZS>A>=JX=F?'])\&2+ZRDD&VHDR*;'S2GL:()
M5`XYNB(;SI_UIT_PR(,@LA;H(/+O(<R]KZ.X;9CN]2'D8UVV;\)):$IVN?K.
M]Y\IVV8*(DTA#3H;R^3M@<H8R@"Q1OY4N\8\!POX=0JFYQ.DD;P:.I:H+$#C
MV6@Z]\88Y,Z&2O7(M"5RXIU4O/AC1+BQ,B9^8P+_>_/>O]YDW)C`?V."O1&>
M>+/W05PSJ#I?#T21]4KPO0.S%;!E1?3<QTOP/9\4R(;6WFMQ@*";8+P2*O.R
M]E;N"^0^;A2A4<!OJ\!]1710Z/(!0PL"F1D.HL4:1%=+DX7F03>N;\4U"K^F
MGN#Y[+9]W\.`'`S'T.(`33JC';>NALLH8)ZT^9CT%='_%#TR"#.<3(MAHG;B
M3OMQ0Z/HDLWZBNA4<63OD8')<#(M[I/-^W%#H^B2'6M59S4Z55P@FUU#IL5]
MLH5%9A1=,FPU0'0JN8`VOP9-B_MHV.JKT$AZ;'8+G$HNL.G]<O"BH,46F]T%
M1C([])YOY34R[[OL%\`6UX!IL05VM#7M:23=P-CJD^A4<C3I=0&&[6QXUFJU
M16<U8-AH>GA6LT1G-)?X],H[N*K8K-/=%01;;1@VFAZ?7=HSFDM\5^T`V*SG
M73[?ZL6PT73Y?*MMHC.:2WQZI>[D3Y\CQE#S=[9,_56_SK[5ER$<F;2FRWED
M,"M>(YG7+>1C#WNWG9EJYJ$Y#9G=O:!B2R.:Y]*)^4Z?;C!\VCYMCVO-.:I]
M`0>?BFSI5R*VK)1.3E/XU!O-@4V8HY.Y4;RJSPX;KN#(4U]F<"ZFL!=[(Q"G
MG*O#C=[IVY/V^A\```#__P,`4$L#!!0`!@`(````(0!*H/#;\`0``,07```9
M````>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;)R86W.J2!#'W[=JOP/%>X3A
M*I9ZZGC!NVYM[>69X*A4A+&`')-O?WJ8H)F1V$E>%*9_W<QT_V?$[OYX28_:
M+YH7"<MZ.FF9ND:SF&V3;-_3__TG?&CK6E%&V38ZLHSV]%=:Z#_Z?_[1/;/\
MJ3A06FH0(2MZ^J$L3QW#*.(#3:.BQ4XT`\N.Y6E4PFV^-XI33J-MY90>#<LT
M/2.-DDP7$3KY9V*PW2Z)Z8C%SRG-2A$DI\>HA/D7A^14U-'2^#/ATBA_>CX]
MQ"P]08C'Y)B4KU5074OCSFR?L3QZ/,*Z7X@3Q77LZN8F?)K$.2O8KFQ!.$-,
M]';-@1$8$*G?W2:P`IYV+:>[GOZ3=#:!;O2[57[^2^BY>'>M%0=VGN3)=IED
M%)(-9>(%>&3LB:.S+1\"9^/&.ZP*\%>N;>DN>CZ6?[/SE";[0PG5=F%!?%V=
M[>N(%C$D%,*T+)='BMD1)@"?6IIP94!"HI?J^YQLRT-/M[V6ZYLV`5Q[I$49
M)CRDKL7/1<G2_P5$WD*)(-9;$!MF_V:WOAS$J6<B1;':+G&]+\R%7.+`13T;
MK^58KM_^RIIX$D5FX**.XW]V589(<U6U451&_6[.SAKL!$AD<8KXOB(=_HBZ
M7B*[EPI^5$"H'(_RDX>I@D%M"A#=K[YCV5WC%R@E?F,&@H%]?F&(3`QK@LN"
MAQW5`U<7Q_1EIW'-U$ZA.C!1!Z;JP$P=F*L#"W5@J0ZLU(&U&(#/RWH=RY$G
MO[EEO&M2#*C1I5"@Z9M"V;`]FS=671?N)=?%,^4I#&X12R:&MX2G(*-;Q'+E
M*.-;!/:`S(1-C"<SDR9&T<2TB6G+<69-3"`S\P;&5O*W:&*N-:QTO&QBE!2N
MFAAE"ZV;&%52M\SU29*BX%S[AJ*X5T^'L^RJ:ELIXT`P<)I<&3FQ0Y08H<08
M)4*4F*#$%"5F*#%'B05*+%%BA1)KE-C<(R3Q@``D\=P_AC@-O^3O!$$L91\-
M!!-4/QX/EMU6]N)0LA/35_;82+)[@:WXCR6[8ZO/#R6[:WO*OII(]K:C^D\E
M>T!L];R1["1P;&4!<QFP@T"9P4("7,M1`BPE.W%<)0,KR>X2Q7TMF0E1SMV-
M9/9]V_K@6(%M+RF#OU'@/U3<2U:(Y2LS&`CF8X5(]@:%"#M\?G0LC5$B1(D)
M2DQ18H82<Y18H,02)58HL4:)C2#>JM8V;?\J:^E$\;ZE&^ZEZD9Y&Q@(QJ].
M%M+VVZY#E,TY?(_8,$?74<0W$@0LYD/QH$2($A.4F*+$#"7F*+%`B25*K%!B
MC1*;>X2D'O];ZN%>JGH4:0P$<Z?P0T$(?3U8?EMY:QNA$<8H$:+$!"6F*#%#
MB3E*+%!BB1(KE%BCQ.8>(4F'=Y[4O\`.U/O^*PWWDJ7CV,J9,1#,W8/G/0('
MC^-[JGH$<4=_8Y0(46*"$E.4F*'$'"46*+%$B15*K%%B<X^0U!,HZKFO&D[+
MJK':U_>HZL_B0##$%&_"9HLHBABJ@/K_:R2`>Y)!B1`E)B@Q18D92LQ18H$2
M2Y18H<0:):"KRFO;G'4A&=$U%?VWE.9[.J3'8Z'%[)EW1"TH^&54-&L'I`--
M,>AL*>,CTH%^$XP;%P,T44_1GJZB?)]DA7:D.PAIMGR83R[:L.*F9*>J(?3(
M2FB?5I<'Z)93:+>9+8!WC)7U#7_`I?_>_PT``/__`P!02P,$%``&``@````A
M`'NB*QC0#0``CT```!D```!X;"]W;W)K<VAE971S+W-H965T,C$N>&ULK)Q;
M;R([$L??5]KO@'@_0%^X:C)'H>\W:;4ZN_O,$)*@"2$"YO;MM]QV==E5/21(
MYV62_%PNV_\N7\HT\^G/GX>7P??=Z;P_OMX-O=%D.-B];H\/^]>GN^%__DK_
M6`P'Y\OF]6'S<GS=W0U_[<[#/S__\Q^??AQ/7\_/N]UE`!Y>SW?#Y\OE;34>
MG[?/N\/F/#J^[5ZAY/%X.FPN\.?I:7Q^.^TV#VVEP\O8GTQFX\-F_SK4'E:G
MC_@X/C[NM[OXN/UVV+U>M)/3[F5S@?Z?G_=O9_1VV'[$W6%S^OKM[8_M\?`&
M+K[L7_:77ZW3X>"P715/K\?3YLL+C/NG%VZVZ+O]0[@_[+>GX_GX>!F!N['N
MJ!SS<KP<@Z?/GQ[V,`(E^^"T>[P;WGNK)O2'X\^?6H'^N]_].%N_#\[/QQ_9
M:?]0[U]WH#8\)_4$OAR/7Y5I\:`05!Z+VFG[!/YU&CSL'C??7B[_/O[(=_NG
MYPL\[BF,2`UL]?`KWIVWH"BX&?E3Y6E[?($.P+^#PUZ%!BBR^7DW]*'A_</E
M^6X8S$;3^23PP'SP97>^I'OE<CC8?CM?CH?_:2//N-).`N,$?J*3T=R;+(,Y
M^+A2+S3UX*>IY\U&_F+J36>J]2LUH;3M-OSL6O3"R7O59J8:_,0&%Z/%=!K.
M%N]T=6YJPD]3<_:QBC#1VI["3U/1_V#-I:GIJ:`PLG^PMQX^5O4+U@T^UF$/
M0J'ML?K%U+5CXLI3\3`0U"_8[/4NCW4\MN$=;RZ;SY].QQ\#6#.@X^>WC5J!
MO)5RAX&MF^]"_7>1#B&NO-PK-W=#$!^"^`S3\_OG<.)]&G^'*;4U-FMIPRPB
MM%#S1[F-.4@X2#G(.,@Y*#@H.:@XJ#EH+#`&)3LYX5G^'7(J-TI.%&*-@/3U
M774CM,`J,0<)!RD'&0<Y!P4')0<5!S4'C04<[2#Z_@[ME!N(9EA[K%AD:JV-
M$2PS9,0$[4PZ105)!$D%R03)!2D$*06I!*D%:6SB:`M+OZ-M_[Z%LUE9MQ+B
MT->:^+!$=GH%TR53K#/":K$@B2"I()D@N2"%(*4@E2"U((U-',5@RW,4TPOC
M2.U?U\53%5WQ-)FVQY-V78L$B05)!$D%R03)!2D$*06I!*D%:6SB*`4SS5'J
MNCS*VI5'$]^21Y,0GDT7;?Y\XD9;W!EAM"6"I()D@N2"%)KX0;?\EII,B52:
MS)P),6-=K#LC[&)CNW9$A)7H!A&5M2NB)E8/(TW":;L;^Q,O9/IUY=BY1!-K
MW*DA^D2K=N2LJZ7V>/`:N%[SKAR]%L)KJ8G5U\K4"G_3U[HK1Z^-[=414F5<
M]H'F>C0J:U=(30+WP?*#BC&"3E@!RO:86!M-]0,(66PDQ@6%5-JUC(/,/M),
M[C3C3=WG48AF2M%,]9%F:J>9^63NMM/8[3C/`X[7-SP/9>T^#TU\>RT(9DSJ
MR!@MNQD;:S*=MQ'E>0NWNXFHD';M=.H+F]QQZC,)"F%?"I^5L*DUF06ZH\N`
M/<#&KN$(J_*5&Y1MS5UI#6*QSF9TA%8Z%]7'<M4TI+!PDJ/X#YD>"5:T0AQ1
MFVRW6V&&B-SGB*ZZ+]"*W)>(R'V%B-S7B/Q6\F#!^MU@>>O8E5P=^^W%Q3H4
M7)[WVZ_K(^@!1CV+CGK`)E?2R0.<4#'4UBI_!$&=*%_,W)B-C!%<<UBJS]E4
MB-'*!-241SXV17,E111V'<K0R]6V<K32;86L*P7ZI:9*1-14A4ZN-E4;JYG>
M(H*)SPZ?#7IN&W.?&GB63PVN7T!']=#^.K[][J'!]4CWU)07-G\TL@]V*ID'
M*PO%$B42I1)E$N42%1*5$E42U1(U#G(U5)F%C'R\//KX/8')4.`<U*T<X80M
M.6MU$:&TMO=7=GR)R`9G42Q1(E$J4291+E$A42E1)5$M4>,@5VF5D=A*]ZPE
M=ECJ!,993#1RD[69T*^S(OT$2CR!4HDRB7*)"HE*B2J):HD:![GZJ3S%UL]:
MH]^14F<XCI1VTJ-3-W7KRV>X0(FT2B7*),HE*B0J):HDJB5J'.3JIE(36[=W
MQ-*9C".61E-:[B,H5F*Q-(D=<6*RPE!,$%%2F"*BG3Q#Y![6V;Z9DQ6Z+Q"1
M^Q(1N:\0N>[9QE.3%;IO$+7N7955WG*#RCK-`7_H>ZT6115_MLH:@<IH%1LK
M"R6(:,PI(AISAL@=,SLBY62%+1:(R'V)B-Q7B!SW/+6OR0K=-XAZ)%6IQPV2
MZDS%D=3D-K:D&L$5!/8@]@1*#)K1F%-$-.:,*M*>%\S8N2PG*VRQ0%_DOD1$
M[BN#YF152]1@Q1[]5(9Q@WXZ(7'TT\C-(^8\9_:,U=R2U*!%>Q)?A$'(SY`)
MUJ)3?HJ(PCU#!!.A.U;X_&B<&RN3D0>C.5LI"G1#C96(J+$*$0VD=CTO1DNV
MVS981^84:IN^0?[6W#V&&N0D#P$??&2L("/&^(H-,KDG?*(\F;/%+4'?-#52
M1#0U,D1DE1N$"?AHR<*AD'5*1.2Y0D2>:_*,`VD<*V>]]7G&=GU7:\V9NCHU
M8\'-3JR1J3B'@RL%(,^(8[+"KB<&!11R*2(*N8PJ7G&?DQ6Z+]`7N2\1D?L*
M$5G5B.A9-(AZ8IAG6.^H+%,IN/U5NQJ+83:+(F,54M=C0J0,?![NILX)NH?U
MAA[/G+E/T8K&G"&B^,L-FNE[/6\Y82MY(>N4B,ASA8@\UP994[1QK-S([L_(
MV@\H/GX7`9>]2G=[-3>(!3Q;*B-C-:.328S(W+E-8#GGZV""SBG24D3T4#/T
M!#NN];C8]4*.5DM]CS/B5V<%>J;&2D346(5NZ-/6&I'V#,LYF^X-NNF9"BIA
MLG=3*_VXX;9!303^7$PJ1C$4&:LYC29&1`>$Q""?(BU%1+XRK$B^<D3DJ\"*
MY*M$1+XJK$B^:D3DJ\&*K2\WME5"98OXSGJB\R\GB#523701%,S9,392;[^H
ML[2])VJ$>^)L-IN*Q<3X)@U2XPB:PY4W0^0N.2*&NQZHSU,6(W[^*<@->BX1
M46.50=9`:D+*\WS$/ZEIT$V/_+>E@KY,!0UB:PA;*".THH'$!H5>.Z<]>#\J
M6##-$JQ&TSI%1`&7(7)V9'XJRM'*7"N.`A8B!1I08R4B:JQ"1".I">DGNV3#
M:-"@9PU1^=P-X:_3/R?\#:+`CGR!8HD2B5*),HERB0J)2HDJB6J)&@>Y:X5*
MRVX02V=QCE@&V6()%/L")1*E$F42Y1(5$I4251+5$C4.<L52"=<-8NG\S!'+
M(%LL@6+8:]KMBZP2B5*),HERB0J)2HDJB6J)&@<Y8JG5RQ%+;^4WWWFW?MHS
M%NU%X80=/M=H!=.TV[&8340VN!G$$B42I1)E$N42%1*5$E42U1(U#G*5OBU+
M"W1*9H<E(@JX2*)8HD2B5*),HERB0J)2HDJB6J+&0:Y8MR5;ZD-:=I)$9(ME
MK`C%TBJ1*)4HDRB7J)"HE*B2J):H<9`K%L^2KI\D(0T78AE$RD1H12B6*)$H
ME2B3*)>HD*B4J)*HEJAQD"L6SUW>$4OF*(')4>@N,C+(>9DKX/=,,5GARI:@
M+SIYI099;PYE5)&6S6#!7K;)R0K=%XY[5P9U)K<W2;7NP]ODZL#\CB+Z-.\L
M3!JIM:];UH,%NPR+`F-E1Y1!^FXTA'N&"1M5@K5LA;KF<*`96MD;B[P;-5;F
M;M0;!>PFL$`W\K@:W)8NM.;NE8-!+%MC!^;(6%E)3FQ0]_:,-Y<BZ>P$MGE4
M)*7F$&6(R"JGYM0!WALM61Y8.'7<"%)G;3N"W@D;<S2GNY1UH!$+&Z&(MGKG
MUM'X`BL<;H+N":6(**O)J"+%KL\O-7.R0O<%^NJ)%76*OD$9<^BVE=&(Q8HX
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MV8ZQ'9`62W^74G_9[+`[/>VBW<O+>;`]?E/?DPS5W7J'S9<X@\GJ'CS!#&<E
MD!VO5/[85P+?_(1DJ:_$AY)^;P&4M"L);R>$=F"6]'@+U3=,>]L)H9W>7M][
MP>I>[R2\'2A1[X#UM..%4-+>(XHZ4RAI7\7G)?Y\I6[(>KSY"RAI/]D0=990
MTAYW6$D4+%9J9Y3>8-M;J4U-EL#7;^][E0;1>C4#R?KL[T$P>`E1-K!63ZR/
M@UJ]8H%6O5)YT')O"_#2#I3T#0X^W%VICVYEK^!SV97ZU%660-H#(O;U##(6
M$+&O)`KF4*?O,<))#.KTEGA0`N_&R![`:R=0TC<>>/MII=XMD77@):B5>L5$
MEL"[4"OUIE-?R1Q*^GH`;Z9`29^W:+:"K]WT^()&^G@$PO2UD,'@^W@%7>KC
M:QC%NK]'4*+>\)%]@E?15NI%'UD";Z2MU/L^L@1>3`/MVY&,N]D%7P=_VSSM
MFLWI:?]Z'KSL'F$9G+3'E)/^0KG^XV)>1_YRO,`7P>%$`E_*A2_^[^#;-Q/U
MSO+C\7C!/Z#I<?=?"7S^/P```/__`P!02P,$%``&``@````A`/$\9K=I`P``
M[0H``!D```!X;"]W;W)K<VAE971S+W-H965T,3$N>&ULK%;;CILP$'VOU']`
MO&\().2"DJRRK+:MU$I5U<NS`R98"QC9SF;W[SN#P0DFC5)I7T(8SAP?G_%E
M5O>O9>&\4"$9K]:N/QJ[#JT2GK)JOW9__7RZ6[B.5*1*2<$KNG;?J'3O-Q\_
MK(Y</,N<4N4`0R77;JY4'7F>3'):$CGB-:W@2\9%212\BKTG:T%)VB25A1>,
MQS.O)*QR-4,D;N'@6<82^LB30TDKI4D$+8@"_3)GM>S8RN06NI*(YT-]E_"R
M!HH=*YAZ:TA=ITRB+_N*"[(K8-ZO_I0D'7?S,J`O62*XY)D:`9VGA0[GO/26
M'C!M5BF#&:#MCJ#9VMWZ4>S[KK=9-0;]9O0HS_X[,N?'3X*E7UE%P6VH$U9@
MQ_DS0K^D&()D;Y#]U%3@NW!2FI%#H7[PXV?*]KF"<H<P(YQ8E+X]4IF`HT`S
M"D)D2G@!`N#7*1DN#7"$O#;/(TM5OG:#\2B<CR<^P)T=E>J)(:7K)`>I>/E'
M@YH9&9*@)8%G1S):A.%TMI@#R97$29L(SS9Q,KMU=$_/I#'FD2BR60E^=&"U
M@599$UR[?@3$G2-:AO'H7Q:!-TBR19:U"]L$9B^AKB^;8.FOO!>H1=)B'H88
M"Q%W""PAR#,:P:EWT(@LJ!'+BJ(?NL"9Z+[DN$/8@L"H=Q"$+&#[[*IK+6A^
M!II:*@W$ECGMR[R\RKL2(KA18_QI(_VJ!M;@!F0/#FMYX%$P'YDE?O/:0J*^
M,!T)8/N?+;>))<R`;&'@MRUL#ONHVWHWZT*>OBX=L739U3(@6Q>4V-85A*CK
M>MTPK2^CC4!E3O9,YY8]+0CH3Z!E:$"]_8?7GW5&:,>N*\.TOK(V<EU9"^HK
MFUU6MAPJN\4S3.LK:R/7E;6@OK*3L3W/?%B=YZ9=MZI!]Q5U(1CTK$(+XT-S
MAL4GE+V<X![M"<"3/838_Y[L^E"&4PH&T.=FPXQ77T_9TE:F$P%EE.E[65\_
M)15[&M.BD$["#WCGPE0V*Q,V#<$V0`(K_H"-PJ5X$,&A/<1O)]%6-Q8VT22*
M)Q<2'J91/+T4#Z.XZ0QLGED4-Q;9<7\,2AL/!E],L^.93]!LU&1/OQ&Q9Y5T
M"IJ!,>,1-@9"MROZ1?$:#(.6@RMH,YJ_.;25%*XU:$A<)^-<=2]HOVE4-W\!
M``#__P,`4$L#!!0`!@`(````(0`%19B4DP(``($&```9````>&PO=V]R:W-H
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M[>(&7@JFE5&Y#0".>*&W/<_(C`#28IX)Z,#9CC3/4[R,DM4$D\6\]>>WX$=S
M\8Y,J8Z?M<B^BIJ#V3`F-X"M4CN7^I2Y$!23F^I-.X#O&F4\I_O*_E#'+UP4
MI85ICZ`AUU>2O:RY86`HP`3QR"$Q58$`>"(IW,X`0^ASBF,@%IDM4SP8!Z-)
M.(@@'6VYL1OA(#%B>V.5_..3HE:4QVJEK:FEB[E61P3CAFS34+=YH@2`SYH\
M0J?R-9&@SH$L'4J*89\"OP%C#XMX.IZ3`[C!3CDKGP//+B?J,@BHZ22!C$M)
M]^TY,[MDQ^SL<E)6/G!)$]^G&?P/C4L&B\87ZF\[]$DPBZ[#X7WJ89_:F1Z/
MW=!?V0OG9EU=JZ+K]A3IM3N=W&<%^$M?6]9H$KS)ZNKZK*<(]-MU&D^G]UG!
MLFO603@.)F_2NL(^[2G2IYW=IYW<TL9#J/SW;G)5?<Y3I,<Y"Z\X_9'WYTIR
M7?!/O*H,8FKOCG,,!Z*+=C?-,G9[]CH^2);M#42Z#W`#-+3@WZ@N1&U0Q7.`
M#%O_M+]#_,*J!I3#/:`LG/WVM82KGL.9"-V,<Z7L>0'$I/MY+/X"``#__P,`
M4$L#!!0`!@`(````(0"D6GR_VP8``#H;```8````>&PO=V]R:W-H965T<R]S
M:&5E=#DN>&ULK%G;CJ,X$'U?:?\!\3XA$`@$=7K4"5=I5UJM9G>?:4(2U"%$
M0$_/_/V6;V"[TNF+YF68/BX?NXZKRI?<??W1G(SO5=?7[7EMVK.Y:53GLMW5
MY\/:_.=;\B4PC7XHSKOBU)ZKM?FSZLVO][__=O?2=D_]L:H&`QC._=H\#L,E
MM*R^/%9-T<_:2W6&EGW;-<4`?W8'J[]T5;&CG9J3Y<SG2ZLIZK/)&,+N/1SM
M?E^75=26STUU'AA)5YV*`>;?'^M++]B:\CUT3=$]/5^^E&US`8K'^E0//RFI
M:31EF!_.;5<\GL#O'[9;E(*;_H'HF[KLVK[=#S.@L]A$L<\K:V4!T_W=K@8/
MB.Q&5^W7YH,=YO;*M.[OJ$#_UM5++_W?Z(_M2]K5NS_J<P5JPSJ1%7ALVR=B
MFN\(!)TMU#NA*_!79^RJ??%\&OYN7[*J/AP'6&X//"*.A;N?4=67H"C0S!R/
M,)7M"28`_QI-34(#%"E^T.]+O1N.\#]_YOGSA0WFQF/5#TE-*$VC?.Z'MOF/
M&W$J1N)P$OARDL7RPR0+3@)?3K*<.8%G>TLRDQNCN[PC?,7H(..-#D!'?88O
M[^"];Z0E[PA?,9(]<QW/#ZA:-X;T>4_X?LPYR%,Z5_CRC@YPW!AIQ3O`]UW.
M62P@:'Q%Q5#<WW7MBP%)"TO>7PI2`NP0R$1@L:''4'LMTB#$",D#85F;,'L(
MHA[2X_N]LUS>6=\AI$MNL\$VMFJQ%18D?@EMI`.Q#B0ZD.I`I@.Y!%@@PJ@$
MA/4O4(*P$"6$#QL!2-)H;@L+T272@5@'$AU(=2#3@5P"%+<A$7^!VX0%0@A2
MYD8$<".([-'(U;08348Q$!(C)$%(BI`,(;F,*))`B9$EN5YD1>@38^JYF/&&
M(VHV^)JCHY'H%B$D1DB"D!0A&4)R&5$<A=(H.TJ2WX/T^&#R$Q95`88X4)_'
MA7:6@:;`:#0J@)`8(0E"4H1D",EE1%$``E96X/92$V/5489HCJXT1T>CT5&$
MQ`A)$)(B)$-(+B.*HY!TLJ.LSL]\$.:VSZ2?ZC-#/&<L<5N$1`B)$9(@)$5(
MAI!<1A0'(=UD!V][18Q5KQCB2%XQQ(7DF8+8GZMK&XU&8FUCA"0(21&2(21G
MB+,@,BN.PB[]?D>)L>HH0QQW6CZ&N![;M^>V5I.CL7WTD7/0N=&=.N$(.WN2
MO3L=>]'3P-Q>J,IE8[M@S656Q6,;"HGL,@E>QYF]&;NTG^H]AQS($VE5T4&$
M#`AC^*-(D>@X[>RQ@.BYG\D@H$G=5$`35R:@B2L7$.52G2?G%>F$=CNP;7:Z
M@8U8R+KAT$*NQK:C!?)66$%_21A'7;1(6,%A0K+2EC865K#!2E9:6"7"BMY\
MJ'RI@-2.VB0R8:5FIJ=.-1=6*M<T"55D<CIZO\CL+*6(S"!(*]EE[0B\M9G5
M`B)7$D;S+Q)6:HPBD?F(D#42U^0?#\AQ7B(>4D%_<Q*9L%(G@41^8Q*JR.3`
M)8E,TQAN?V_G,>FHY3&#E*!V?/V097.K*?<B`06TVMF!'WBNK1U-8F$D%3@!
MR=&*V#-AQ=@7\X7ON5H0Y,(&5W:;'-0^)1#IJ`G$("T@-4>W=,2UN9A*6,0A
M5RX7CJLI&W,K9^J8"$BN?6P2$GUVE=[7CDRYX'HMN-6X@@#ZG&RDHR8;@]2X
M"E"Q9%;N5&4C\AH#7.[MN&)&WA1$">\'Q^XI01%[IK)#7+G^4BL(N6!B+TGR
MS99<RSXG$.FH"<0@32"T@3(K5TX\#DT1$]-YP95#EH-9*7(@KHQW=">N7.%2
MPX,<&;6LLCUZ]!V.=?FT::%^PK9W96-=0)&@=?3!9N=.&$4LTX9#:H8%6C'?
M<BL7"J54IC6K2%A!19FL`FV%8S'B:UG!2SZ;JG3"2P7]S4EDPDJ=A+:CY&]-
M0M6>G&)U[>'1$-PDTG]K+Z])#[O"J#T["BO:,TB^A-@(BC`48RC!4(JA#$.Y
M`JENDZ.LYK;C$;<_>+6&-V64@`Q2[YR!MC%O>4>P$O$:82C&4(*A%$,9ALCS
M-YDJ&Y&IP9ZSV7-C4W6':EN=3KU1ML_DJ=JQ885'F+VC;^P`'M+IN1BUK,03
MN]8"A0]::&)J+?`J_T`O=!J^(:_U1!@==T)X)L/XPR)\`/=PPV81PBO2%=P-
MX='E"@XSI5<D?>!E"#?W*_9^"!=>C&^#$&Z,5_!5"+<UC*>K$.Y;&-^"=-NK
MTL%^%D976V)H(94;L\%>%B976U)H2:^VP,X6DG(.;-8H"OQR<2D.U9]%=ZC/
MO7&J]A`N<UJQ._;;!_MCX.7CL1W@-PM:28[P&U4%U\\Y2;9]VP[B#S+`^*O7
M_?\```#__P,`4$L#!!0`!@`(````(0`&3?G9,@8``',;```8````>&PO=V]R
M:W-H965T<R]S:&5E=#@N>&ULK%G;CMLV$'TOT'\0]![+DGR'[6#70=H`#5`4
MO3QK9=D68EF&I,TF?]\S)"610\8WY&6U'@Z'AV>&9VQJ^?Y;<?2^9E6=EZ>5
M'PZ&OI>=TG*;G_8K_Y^_/[Z;^5[=)*=M<BQ/V<K_GM7^^_6OORS?RNI+?<BR
MQD.$4[WR#TUS7@1!G1ZR(JD'Y3D[86175D72X&.U#^ISE25;,:DX!M%P.`F*
M)#_Y,L*BNB5&N=OE:?:A3%^+[-3((%5V3!K@KP_YN6ZC%>DMX8JD^O)Z?I>6
MQ1DA7O)CWGP707VO2!>?]J>R2EZ.V/>W<)2D;6SQP0I?Y&E5UN6N&2!<((':
M>YX'\P"1ULMMCAT0[5Z5[5;^4[C8Q!,_6"\%0?_FV5NM_>_5A_+MMRK?_I&?
M,K"-/%$&7LKR"[E^VI()DP-K]D>1@3\K;YOMDM=C\U?Y]GN6[P\-TCW&CFAC
MB^WW#UF=@E&$&41CBI261P#`7Z_(J33`2/)-/-_R;7-8^?%D,)X.XQ#NWDM6
M-Q]S"NE[Z6O=E,5_TBE4H6202`7!4P6)!K/Q>#2931'DPL183<3S[M4#N1-!
MS(>D2=;+JGSS4&W`6I\3JMUP@<`M(Q)&Q]&/*`(W%.2)HJQ\'!/LOD9>OZZC
M>+0,OB(7J?)YMGU"TV/3>E`*`:_#"*9^`D:*0A@IK03ZN35HH!F@UH,#`E$_
M`1!%`>V3BZPIIZGFQ(C=="X<YLB&&8T'79'=G%V*(X!VU"F+F?`Q8Z]SXKB`
M0*?/??K:TB)G<W%EF6N41/&$+=XY\<5!M[XX%7PT!-0[*Y["F+"D)8(H:8=@
MRF!U3AP6$FS!BN8/)(L"F<"DA0&;,6"=$P=&O<\2B`%)U>6\T3P3A[1$4@WI
M!&YTBW'BD5M]T<LKD;.YDK),N[.^T2W&2B'RI2]%]3`:S@=(U)T5(2*9.%H3
M]JG5Q)Q1WWMQ[D.FSI=Y$-X,@)344&.B]1(FDPJGSD)=[B5"RB:$#?N14AM*
MDUF#HR$GHO.RB""-8U4XFU.3OAN<4DL=G#0Q<%9SZKPL<"1T#%R$\W0O;4HO
M=63*A.KMZV<4<=HZ+PL9J2!'%D[$Z;T7G1)4'9TT,=YBCJ[SLM"1&#)T#R95
MRJI1<9W2ZM3QUDG-%]J!+5C@2!`9N'@(]WMYD\)J0.NT5H?&NR?.[(^@D6PR
M:&,<]'N12?4UD"E!-GK8B+?6L/.R2".99<CD-XXKRJ7D62\N94)M:Z7/VVFH
MO%!CFE??VPQ]HT+EZ.*9$)'+\,1$4UA;TV5XK9<)K]=_$QX3>^I$M\%3(J^Q
MAR8K>N(5>,K+@#?N5=F$Y^@.M\&SVT&D3%?@*2\37J_+)CQ'A[BE]"*['[2F
M*^C41!-=K\TF.L3BI7<3.IK'*D^9KJ!37B:Z7IM-=/#BZ&Y++4UD\)3I"CSE
MA4=_;L>].IOP2*29JMP&3ZJ[KG"1,EV!I[Q,>+U"F_`<G2*:3!]ILO2M@?/9
MM0&=*2[):B+TADMRY&@6CZ*S&X:(+OJGCHZK=.]EH6,-XXH.VVTB4B8\M$+J
M&X#X^KGIO3B`V-$3IKC3N;N;BD#F45`F:@(:ME[]);;>R\+&&L)E<F*["[0F
M@YQ)K^\*@)HXMVHG=DC^8[^-1"3&CE1WDYU)K^X*7.=EL<,$_PH[MLS'RF2R
MTPNX`M!Y60!(8IDLA9/Q(^<^5FJM=7!E8O3T`J[0R8F.<Q^3PFKHKM!#WBP_
MRF32TTNT`M!Y6?0X5#MZ[+<'KH0M=-+$Z.D56J'KO#IT\FY87H$66;7/-MGQ
M6'MI^4KWOCB,ZV5GEI?2S_$8M]+B.M@:F;3WU7PDFB](=;`L'XF'F"-TVAJA
MVV]Q.V*-1!B)G-%BC,3.D1%&1JZ1$/O!K;<#6XC]R&[)$813C(@K`VMDAA%Q
MJ\I'(LQ!8W*L$V$.FH)C!+0Y60O!&NY)'#-"L(8[#=<(6,/%@VL$K(5.UD*P
M%KI8PZN))W<L3'"M@<5=_D_QXDF^XN!T429=@8#(!>@9670F$3D4.L+C(QO.
M9"`7(A5!-P&O/,[)/ON<5/O\5'O';(>C,13"5LF7)O)#4YZA&7CQ439XV2'^
M/>#E5H:KO2&UT%U9-NT'9"'H7I>M_P<``/__`P!02P,$%``&``@````A`)IP
MNV=*"0``/C```!@```!X;"]W;W)K<VAE971S+W-H965T-RYX;6R<6EUOX[H1
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M_/%V:$_URT[Q_LG2>CW8-K^<F=]OUZ>V:U_[>V5N`8Z><RX6Q4)9>G[<;!4#
M'?;9J7E]FO_.'F16S!?/CR9`_]TVGYWW_UGWWG[^[;3=_&-[:%2T59YT!E[:
M]KN&_K'1?U*;%V>[OYD,_/,TVS2O]<>N_U?[^?=F^_;>JW1GBI$F]K#Y)9MN
MK2*JS-SS3%M:MSOE@/IWMM_JTE`1J7^:GY_;3?_^-!?Y?;9,!%/PV4O3]=^V
MVN1\MO[H^G;_/P`Q:PJ,<&M$*._M.K_92&J-J)^#D>54(PM@98(DZ[Y^?CRU
MGS-5><KO[ECK.F8/RO`0'>`RQNM:N%2<M)'?M15C2T6B4SG^\<Q6J\?%#Y67
MM<64@%%MY3`840T(G01M5IZ;S=FX9Z$8C#14@"D-H4KE<I('K_4F[#5/1_/&
M@_("!".J<T3.,42>0QP"L5#EX;,(>Z_!3W.5,Q?/58$_N02,JM,10PA6480,
M(9#WRI7IWFNP:B7/,\83XCU@"E-/=UQ0=A5:9\G2U0:4#UI?+@6_$G85']]Q
MW0/QXM&;2/@+2@`PH?!'$3*$0.'/,8MP\6@P"7]!PE<")N1]%"$!L;0I3!(7
M(>3[\A;?-1C[OG2)A;8%2,CU*$("8G`]XROW(<AW?5#P)F@X[AJ,?6>%LPO.
M`R8S,1.X)2I_C;E@0KW#(GC,5HD;!LC?XA9_-9CZ2WPJ`1,*=A0A!X26#LY<
M)2+/F9KHTT-MT,1WOL3Q+"T(@LTRHED56DY)HJ1=A8"+A%\).-,RYE7(M/EB
M=A'W"S*]2PL*Q3X.D2-$1U\L78QP]+6,>33"A<Y`]-"`+S(:?0`%W8]"I/VH
M(8<N2]A]K6.>^Q.S`.J':>24!H""-*(0R0:(.3YQ%RM,0XO:[31`"GT:.:GU
MD@$FR"(*D=8*]$1^=>#K$[A/(U),&DU[P94IC$UC\FD>]!_L!"#26AG&/E]=
MFT5:V6[/`^BAGP=6G"4B*JL5BT+D"-'E=,=S-[5Q/6F9NYT'B"/FX<:?34A4
M8RL6A<@1HGFLKK'0TN>QB)03"*7OO7HHITT]2.WULS.+0N0(T=[SW-4L3H*6
M/\_]B;,)1%/UY'BZYXDK5YN$05D=B(A(Q:(0&80@*OPFC39HW-B<MH/%P'B_
MXQEA6.%UEKD8PZG(KD-'\[QP98H=)RH=+B$.CZ9^"0GB6&DQUO&<]GF%UNG#
MC[2K=I#FWN$#NWV3*O-S51:D'$J+L6ZG3H=,."NTK%Z"X+:1=MG.3Y8+ET[L
MMPJ=7_*1<&LTKA-!59@#9O`[/W/<7Z=O)Z3=/?A=)(G;CQW7&NCU:L1Q4$SU
MT5Z/DIB5/"JKU0@QT]S%U);X8$"ONC+$?FOMF^XW*"7VVPU?F"WZ!9C*BHV9
MR%>D]2H+L"E9YJ34)#;`DEP4+JO8>R*WD:B#/*JH>%$G'U[RJ(96<8@,0C`%
MHK01"N<*R[V2M`F(RF?%HQ!I(9!&D0CO@103N$ED^261==FU!*(*6ED[H3.;
MA0R]RU;N8S`!(K.1#(`LXA8@%5[RJ'96(\2TKE,?V[I@8/"]N/;LJU](^>T[
M[8A@=N&YR1,R/4H+"D2XBD.DA0`1EHG<,45)$$1G)Q(YUUONO>"`:C*FPT\`
M<8@<(3I?PGLE@&D0W9U(XUQ_.7V-4PH`!?,1A4AK!?*ACK?N?(MY:%7T9&$B
M#[V+U)57N38=``KR&"`7>T/`*E!(L^3:^UNAY<_C$.YK@\9O;CD]QI06%/1]
M$%TG,D1B9-`*3H/Z))^"3D.J_A:AHG?1-%"5%@!2_XYB2/RLXA!I(;:]DU5Z
MY9@AB%!/K"?08I7OT4?.B)>E,1UI[ZBF2VO%%M7UOB!J/9''!=5F[B!I^R(J
MR96(0N0(,6/*S71<5D2R)[*X(-W,::IE$9=N$85("X%L9%QX'X.)$.F>2.2"
MA#,JX<)7X")A+I2&:(76V=(K?+,NT3I/5]Z+-40A_9*"FUVTQ8F+I06%6CP.
MD18"N;A+K[9&^B4%-[LH$7=&@**RH"`1.`D$('*T8E2%><=FG)`O27AZ0<+I
MPWMI0?;!Y^R5!5Y.R<26>#F[ZK^61T_VIO5$"J**1BUWP]SF`4!0"BLFB(>5
M-0+K3-`O/B5:7_%LZ:8'3@%1[HD40'DQ!?I0G0((7$S3U'D`;6W7(44YG0H2
M;5?G@\39QPQ4(7XA"7H7:09.@EQJ_1\?KUF^S,XH^`!>T"J4UH!"C:KJ-!6S
M^))JIQ=4^^P&A05!'G`@;2+`"@!$)LA\E@$#F`-1[/#1*06%544RQH9[W[G8
M-HC*<&7M7(ZQL2*#$$R!R'6$P@69YJ1&RG308#T+29M7H46)%YD;U=CE+PES
M"IJ+HT\27UI0(+15'"*#$$0E^Y)`FUVTE:E`6U"(2APB1XC)Y;5O=+(OR;/9
M16FXG$,_6%"01ER>1RN&AO?8B+-!U#G<"]D%51;ND=>Z#Z"@^U&(M!\%PI%>
MNQ62:07UQ#GB/N@M4K2S[Q.,2?W\8^)&OR>I\#+=+?&RMQM'7:OF=+=!8[';
M3BAMU`$4C'H4(K,0!%-0GW0#!8V.O0W(`!2D$(7(H!5,@<AQI'@NR#`]L949
M@((4HA!IK8!6JRMYUZZ\9#=IL4'CV4/O^I46$_0_JM8R:`6GX"8ISD!E58VZ
MT\39.R4+"E(8U-K9<2<V.$T$K6`*1)HC5022C'N9'DG516W=+?9*YHI^=UCA
M=4%?->N+WMY^GJ5.*,%UN,8--Y3WS>FMJ9K=KINMVP]]19NIT3?^%:Z/E^RA
M,G>M%^."NKU]K-^:/^O3V_;0S7;-J]J:W"]5X$]P_QM^Z=NCN?W[TO;JWK;Y
M[[NZI]^HF\?)O0*_MFT__*)OF(\W_Y__#P``__\#`%!+`P04``8`"````"$`
M\V/!@>P#``!P$```&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM;)286W.J
M/!2&[_?,_@\,]QN(>!ZUTWH^VSW?X1HA*E,@#,':_ON]0BHV,=MH+ZRP'EY6
M5MX$EIVGCS@RWG%&0Y)T360YIH$3GP1ALN^:__XS^M4T#9I[2>!%),%=\Q-3
M\ZGW\T?G1+(W>L`X-T`AH5WSD.=IV[:I?\"Q1RV2X@0B.Y+%7@Z'V=ZF:8:]
MH+@HCNR*X]3MV`L3DRNTLWLTR&X7^GA`_&.,DYR+9#CR<LB?'L*4GM5B_QZY
MV,O>CNDOG\0I2&S#*,P_"U'3B/WV=)^0S-M&,.X/5/7\LW9Q<"4?AWY&*-GE
M%LC9/-'K,;?LE@U*O4X0P@A8V8T,[[KF,VJ_UDR[URGJ\U^(3_3;=X,>R&F<
MA<$B3#`4&Z:)3<"6D#>&3@-V"BZVKZX>%1.PR8P`[[QCE/\FIPD.]X<<9KL&
M`V+C:@>?`TQ]*"C(6)4B#9]$D`!\&G'(G`$%\3Z*_Z<PR`]=TZU;M8;C(L"-
M+:;Y*&22IN$?:4[B_SF$6%*E2.5+I`K9\WBE9J&J4W]``^[&$VF4(O=G8O-1
M%44:>+G7ZV3D9(#Q(&^:>LS&J(U`^5P>/IBR8'^K%XR1J3PSF:X)2P9*06&.
MWWNH@3KV.TR,_\6\<`8^OS$5D>FK&%=D!BJF*C)#%2/=:Z1B:J+.6,7416:B
M8AHB,U4Q39&9J9B6R,P53-,1F86*D>9BJ6`:4LZK.YBU@FE*==YPIE*XPFU5
M7&D^7U4:EWFPP:BE6V$="6Y5+^*S*1G-3,E6(G/I"S\!]RL=V)0*W-<C`STR
MU",C/3+6(Q,],M4C,STRUR,+/;*\1I`C+8/5'<SZ#F:C8)!LO=N,8#U7LA[;
M*%UX&MVV(+M*L"`_\=V"R)$67O\.9G`',[QF6M+:'"D0J49C!7)9G<6ZFB@0
M:9.<*A!IV#,%(GEC?HT@1]K:%BI&&O92P2!I&UVI&.E>:P73E.JW43'2X^I5
MP:!+D04?PBO$`UL@H\&GWW8\U)2FYH4SR"DV:,=RI7A?$Q]HXD--?"3$JTVK
M*55G+`*6*\WF1!.?"O&:)<G/;H?G0A@YEKQA+61`,NV2Q^'UK7SJ2!FLM,1:
M2VRTQ.LM0K`8I/J`Q1@M6TQ:VB^<N5&"OI88:(FAEAAIB;&6F&B)J9:8:8FY
MEEAHB24GOA8VLNJ5>LVY_$E[V>HA>OT0O1'HBE5U6Y<\''D'AVZ0.>HK;Q?:
M,E=-<]/RSH\W-3'.]KB/HX@:/CFRK@[!KE:>+1O.9[?H&<L`-'RIM\=++]N'
M"34BO(-+':L!F62\9>0'.4F+EFE+<FCUBJ\'Z.PQO%PZ%L`[0O+S`6M*R]\*
M>G\```#__P,`4$L#!!0`!@`(````(0`DFG(965T``''8`P`8````>&PO=V]R
M:W-H965T<R]S:&5E=#4N>&ULI)U;<]M6NFW?3]7Y#RF_.Q8ET;)22>]:X/U^
MO[ZY'7?'M>,X9;L[W?_^3`@$:"R"&%,^^V''+0Q.0!0&-?D!7/KY?_[S\?<?
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MBLI";D\A^N\I1">8^=B[TV/UW_P`[NT'BWPZ>OWW].#&_8^W;YJ-YNMG'+Z^
MT:<4_?>4<NL?PNO\>S\_^GN>P2)&_\B_E<?G_R`>\J/1/Y[_O=SJQ_;T3*3_
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M:7!:!^[U[%?7`?6`]$$A?=338T5_48OY]]_>W/_\ZM^J'>].2%*!O"XCK0KD
M31EI5R"/9:1SB3S>E)%N!=(H([T*Y+:,]!D9,#*L0.[*.QHQ,F9D4H%$/Z,I
M(S-&YA5(L_P=+1A9,K*J0*)3:LW(AI%M!?)0_HYVC.P9.50@D0''"B0R(%3H
M^!@S%3XV;B)/0H61EU"%DXV;2*=08>4E5.'E)51A9N,F4C-4N'D)5=AY"57X
MV;B)!`T5AC9N(KE"A:.-FTB,4&'I)53AZ25486KC)M(C5+C:N(E.[5!AZR54
MX>LE5&'L)53A["5486WC)E(E5'A["568>PE5N'L)5=A["57X>P$E%0)?0I4&
M1T]!4F5P(SI]DRJ#+Z`J@R^@*H,OH"J#+Z`J@[^!7JFN%)U%A?>BLZ1O`>L[
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M(?,<R4,6\1>6^1>NAZQR)`]9QU_8Y%^X'K+-D3QD%W]AGW_A>L@A1_*08_R%
M$/*O7$\)%V=.*$Z=FD==G$WAXG0*Q?E4DW-QBH6+<RP8)UFX.,O"Q6D6BO,L
M?\)"<5K5'&%QIM4PQ<E7)%^<:Z$XV6IRC/,O%"=@34YQ3M8PQ6E:''-Q5M8\
MJCA1:QCCW`W%R5N34YS/UYG$.,.3X@ROR2G.^?S92(HSO.91Q3E?PQ@6)(4%
M-3F%%Y5,Z5>)KJ64?I6DPWE^HYL^2MR+<WZC$0V"DHS1G+]XN;^+VE.+D38C
M'4:ZC/0ND:@0])$8(#%$8H3$&(D)$E,D9DC,D5@@L41BA<0:B0T26R1V2.R1
M."!Q1"($1BK4B\[E4*%>C%2H%R,5ZL5(A7HQPNH%=B^P?('M"ZQ?8/\""QC8
MP,`*!G8PL(2!+0RL86`/0X6(\>^$P"H&=C&PC(%M#*QCPCHFK&-2H6/\Q"3L
M8\(^)NQCPCXFM3Z6^H5^_W]'OT@?%?>+Z+UBDC&U_8*1-B,=1KJ,]"Z1Z'6P
MC\0`B2$2(R3&2$R0F"(Q0V*.Q`*))1(K)-9(;)#8(K%#8H_$`8DC$B$P4J%>
M="Z'%J=4J!>G5*@7(Q7JQ0BK%]B]P/(%MB^P?H']"RQ@8`,#*QC8P<`2!K8P
ML(:!/0P5(L:_1@.K&-C%P#(&MC&PC@GKF+".286.\1.3L(\)^YBPCPG[F-3Z
M6.H7N@_S._I%^JBX7T3#B21CFD^W'D;7/5KYMO-L(WK1:2/1R8GTUL8HOYMO
MNYK?0Z*/Q`")(1(C),9(3)"8(C%#8H[$`HDE$BLDUDALD-@BL4-BC\0!B2,2
M(3!2F';U;`\L7&#C0J'<]1VQ>8'5"^Q>8/D"VQ=8O\#^!18PL(&!%0SL8&`)
M`UL86,/`'@86,;")@54,[&)@&0/;F+"-"=N8L(T)VYBPC0G;F+"-2:V-I3*A
MSW)\1YE('Q67B>B6BR1C]*:HN!@2%886$NV,>'@J)+?--U%?Z6!`%XD>$GTD
M!D@,D1@A,49B@L04B1D2<R062"R16"&Q1F*#Q!:)'1)[)`Y(')$(@1%6+K!S
MX21=C;B!Q0ML7F#U`KL76+[`]@76+[!_@04,;&!@!0,[&%C"P!8&UC"PAX%%
M#&QB8!4#NQA8QL`V)FQCPC8F;&/"-B9L8\(V)FQC4FMCJ57HHYVE5E%_MUY*
M1VWB-KHW,\F8;#3Q\N+.BU:^^6K9:"/10:*;$^G\XO(@>OGFJP?11V*`Q!")
M$1)C)"9(3)&8(3%'8H'$$HD5$FLD-DALD=@AL4?B@,01B1`8*7R[>BX'=BZP
M=(&M"X5VUX^%U0OL7F#Y`ML76+_`_@46,+"!@14,[&!@"0-;&%C#P!X&%C&P
MB8%5#.QB8!D#VYBPC0G;F+"-"=N8L(T)VYBPC4FMC:4JH=4=GE$E4CJN$M&5
MAB1CBBH1?;ZAE6^^^FK31J*3$U47.K[=5E$B\LU7=]]'8H#$$(D1$F,D)DA,
MD9@A,4=B@<02B142:R0V2&R1V"&Q1^*`Q!&)$!@I3+MZ+@>V+;!NH?#M^HZZ
M?+@]1MB]P/(%MB^P?H']"RQ@8`,#*QC8P<`2!K8PL(:!/0PL8F`3`ZL8V,7`
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M&`P7M1PD[\MP4DV$<PPK@Z&EF@CORQ!3ZT!RCJ%F,-Q4$^%]&79J"4C.,?Q4
M$^$<PU`U$<XQ'`V&I&HBO"]#4S41S%$38<;P5$V$<PQ/U40XQ_!4381SZCTM
M-Y%TL;CO:"+9&G/E)A+?_-G(H)KW42U&VB<D&XXT'A_BNT(ZG-%EI,=(GY$!
M(T-&1HR,&9DP,F5DQLB<D04C2T96C*P9V3"R963'R)Z1`R-'1M1)T#1U$F8,
M'=5).,=0,AA.JI/PO@PKU4DXQ_!2TQ'.,<S4=(1S##?523C'L%.=A',,/]5)
M.,<P5)V$<PQ'U4DXQ[!4TQ'.,3Q5)\$<34>8,3S52M2<8WBJZ0CG&)YJ.E*7
M4^XDZ9)\WW:2^CM'&RD>7ZB);QT]0:<;/IKQBIZM8OO5J46;D0XCW0)YNG_T
MXD!ZQ?:K!])G9,#(D)$1(V-&)HQ,&9DQ,F=DP<B2D14C:T8VC&P9V3&R9^3`
MR)$1]9!,Q9K&KQ["C&&C>@CG&#ZJAW".(:6NTG".H:5F(YQCB*G9".<8:FHV
MPCF&G+I*PSF&GKI*PSF&H+I*PSF&HKI*PSF&I)J-<(ZAJ68CF*,>PHSAJ68C
MG&-XJMD(YQB>:C;".?6>EGM(NN3@,WI(MD*A#J'XL&OC-OX#(8U\&<.G7_^O
M&]',I%5L/X=$GYAM,](ID'0OT06B;FGCR]>WT06<7K']ZB'T&1DP,F1DQ,B8
MD0DC4T9FC,P963"R9&3%R)J1#2-;1G:,[!DY,')D1`TD]^OJR:L&PHSAH1H(
MYYQ-O'X\9R&O,X:4:B!\/(:6:B"<8XBI!L(YAIIJ()QCR*D&PCF&GFH@G&,(
MJ@;".8:B:B"<8TBJ!L(YAJ9J()BC!L*,X:D:".<8GJJ!<([AJ1H(Y]1[6FX@
M>B?UG`:2XO$D)*H/22.#:MZCM1AIGY#3+:NW=_%?C.MP1I>1'B-]1@:,#!D9
M,3)F9,+(E)$9(W-&%HPL&5DQLF9DP\B6D1TC>T8.C!P941=!T]1%F#%T5!?A
M'$-)34,XQY!2781S#"W513C'$%-=A',,-=5%.,>04UV$<PP]U44XQQ!4781S
M#$7513C'D%1=A',,3=5%,$==A!G#4W41SC$\51?A',-3=1'.J?>TW$72%0V_
MG89X?S*ED2V$6)J*-**11'*"LJLST4=U6\7&JV^/VHQT"B0=B42[Z!8;K^ZB
M5R`5C^\7&Z\^?E`@%8\?EC;>1XUM5&R]FCXND#0]#IB<MIYNH;EK1CN8%H^^
MNH,91,PY8L'(DI$5(VM&-HQL&=DQLF?DP,B1$;4-8\51@S%T4]O@?9V%NWI2
MJ6UPSEF\ZSF&?[H'A/=U]O#ZO@P;U39X7[F4>HTNQL61EVH;G).;69=CV*E[
M0'A?AI^Z!X1S#$-U#PCG&([J'A#.,2S5/2"<8WBJMH$YN@>$&<-3W0/".8:G
MN@>$<PQ/=0](74ZY;:0K'7Y'V\@62"RWC>@:2]+`511;C+1/R&D"\G@;?32X
MPQ%=1GJ,]*,#>8C*U8`CAHR,"B1M&(\WT76M<;'YZJO9A)'I"<F>TSO]!=]H
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MR)J1#2-;1G:,[!DY,')D1$W$6.348`P=U41X7X:0:B*<8TBI)L(YAI9J(IQC
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MPCF&IVHAG%/O::F%W*:KG/DMY`F/[TF-?KTG)ZCF%:G%2/N$9"WC]<WM3;2;
M#F=T&>DQTF=DP,B0D1$C8T8FC$P9F3$R9V3!R)*1%2-K1C:,;!G9,;)GY,#(
MD9$0#,:P,1@ZAMS'&JN#H60PG`R&E,&P,AA:!L/+8(@9##.#H68PW`R&G,&P
M,QAZ!L//8`@:#$.#H6@P'`V&I,&P-!B:!L/3Q/`T,3Q-#$\3P]/$\#0Q/$T,
M3Y-Z3\M=)%T+[=LNXMV3>ILMH5::C%S<DWJ":EZ]6HRT&>DPTF6DQTB?D0$C
M0T9&C(P9F3`R963&R+Q`TAG80S0A6Q1;K[Y[7Q9(5<"JM/5UM##-NMAZ-7Y3
M(&E\'+`M;6U$1[\KMEZ-WQ=(&A\''(JM5P..C*AWX*J%(3$80SGU#MZ7(9UZ
M!^<8VJEW<(XAGGH'YQCJJ7=PCB&?>@?G&/JI=W".8:%Z!^><9;QZ.JMW<,[9
MR>LY9S.O,[F?V7O6Q[M&])95I8,/)G<T"VG>W$2O,6H<&*+&P8QAJ!H'YQB&
MJG%PCF&H&@?GU!M:;ASI*F;?T3BRQ<_*C2.ZZ2.YK5LA[>GNDA8C;48ZC'09
MZ3'29V3`R)"1$2-C1B:,3!F9,3)G9'%"3I?,'NX>HON+EYRQ8F1=WLW=XTVT
M&LR&,[:,[$J[N6W>1#5ESQ&'`DEKREUTD_.QV'K]M388C.&@9A_HJ3H(,X:&
MZB"<8XBH#L(YAHKJ()QCR*@.PCF&CNH@G&,(J0[".;F2->\(U4$XQ]!2'81S
M##4U^^"<LIS-A]N'BT\(JH9P3FYH]I)U=_.@Z_QQG3$\51/!?6GVP8SAJ68?
MG&-XJMD'YQB>:O91EU-N(BH3I292?U_J;8K'UV&B%_OD!&6?P[V+^DFKV'KU
M-;;-2*=`GE['HWUTBZU7]]%CI,_(@)$A(R-&QHQ,&)DR,F-DSLB"D24C*T;6
MC&P8V3*R8V3/R(&1(R.:@V0:UOT..5MXU0%U$,XQ9-3U%\XQG-3U%\XQK-3U
M%\XQO-3U%\XQS-3U%\XQW-3U%\XQ[-3U%\XQ_-3U%\XQ#-7U%\XQ'-7U%\XQ
M+-7U%\XQ/%4'P1QU$&8,3]5!.,?P5!V$<PQ/U4'J<LH=)%WM[-MI"'20;'$T
MQ1<?>6]<?#;F-H.R%OFR>7L?+=;1.@$U+Z%M1CJ,=.E(>IS19V3`R)"1$2-C
M1B:,3!F9,3)G9,'(DI$5(VM&-HQL&=DQLF?DP,B1$3417*E05V28,734-(1S
M#"$U#>$<0TI-0SC'T%+3$,XQQ-0TA',,-34-X1Q#3DU#.,?04],0SC$$U32$
M<PQ%-0WA'$-234,XQ]!4UV4P1TV$&<-379?A',-379?A',-379?AG'I/RTU$
M=>`Y323%XVE(-%-.]*G>%#K]S9A&-"QI%9O/;29:P*?-2*=`TG'(RW@GW6+S
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MRT(=CN@RTF.DS\B`D2$C(T;&C$P8F3(R8V3.R(*1)2,K1M:,;!C9,K)C9,_(
M@9$C(ZHD*)HJ"3.&C:HDG&,HJ=D(YQA2:C;".8:6FHUPCB&F9B.<8ZBIV0CG
M&')J-L(YAIZ:C7".(:AF(YQC**K9".<8DFHVPCF&IKJ!%7-429@Q/-4-K)QC
M>*H;6#G'\%0WL').O:>E2G+WO&55G_#H!M:[Z(^R)2<H_RC-0_R'85LG0'>J
M%!_(B2[<M1GIE';3:+Z)#J-;VO[RX>XVNBVJQ_OH,S)@9,C(B)$Q(Q-&IHS,
M&)DSLF!DR<B*D34C&T:VC.P8V3-R8.3(2`@&DXM8XUDP7`R&C"&WL6Y?N9%U
MC"%E,*P,AI;!\#(88@;#S&"H&0PW@R%G,.P,AI[!\#,8@@;#T)`KFOW2:-P_
MQF\]@V%H,!0-AJ/!D#08EB:&I8EA:6)8FAB6)H:EB6%I8EB:U%M:+B'I6FG?
MSD7J;V"]RY96*\]#H@*1G*":UYH6(^T3<CHKM;;[?50B.AS29:3'2)^1`2-#
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MAMD?S4X,QA!2`Y)\7T\?OXP&D2HD^>:K\\YPUK$RXJQBNCG^;618J(%(?A!5
M"8:!&H7D"=>_#<-!C4(XQ[!0HQ#.,3S4*(1S#!,U"N$<PT6-0CC'L%'#$,XQ
M?-0PA',,(]4_,$?#$&8,(S4,R7).'>YB;7J5#P#.0EX]V]4\^&CKW2PW#Y6'
M[VD>Z<.B:S+Q]"RYRZ#:YH%(FU,ZC'09Z3'29V3`R)"1$2-C1B:,3!F9,3)G
M9,'(DI$5(VM&-HQL&=DQLF?DP,B1$34/%$GS$&9:!F,8J?J1[>LTQ+R[B?N)
M(:2&(7S`9R73BO'Z/KI%316$,W(ALX.]?8BOZJJ%E+^;Q_A/!VD&PKLQ=-0,
MA',,(34#X1Q#2<U`.,>04C,0SC&TU`R$<PPQ-0/A'$--S4`P1QV$&<--S4`X
M)W<S.Y7O7K]Y\W@3*:$:DN7DI_OKUZ\?HG:O"S*\+T-/79"IRRDWD721M&]G
M('!!)EM33?'%_1R-^&Z+Y"Y?>"U]<6A&G^YM%5O/$=$5G38CG0*IVD>WV'IU
M'SU&^HP,&!DR,F)DS,B$D2DC,T;FC"P863*R8F3-R(:1+2,[1O:,'!@Y,J+>
MD1MV]?Q6[V#&<%$3#\XYVWC]>`PG53UX7X:5JA^<8WBI!L(YAIF:@W".X:;F
M()QCV*DY".<8?@9#4'40WI>AJ#H(YQB2JH-PCJ&I.@CFJ(,P8WBJ#L(YAJ?J
M()QC>*II".?4>UKN()I5/*>#I'@T!;E8Y/TN@[*V];)Q]_@8E8S6B:B9D[09
MZ3#2Q4/I<4B?D0$C0T9&C(P9F3`R963&R)R1!2-+1E:,K!G9,+)E9,?(GI$#
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M2;V*M53QR#=?54(W@S`3ZQE_/D-W@G"(X:>NPN0Y3]]/]#*@PI%OOO[]U*M9
M+ASIZF;?%@YO:?>[;%&T4O&XB]<L.T'9WY=I1'\JN55LO?I]M!GI%,C3DQ7M
MHUMLO;J/'B-]1@:,#!D9,3)F9,+(E)$9(W-&%HPL&5DQLF9DP\B6D1TC>T8.
MC!P94>6H6YLPO_64&<-%#3\XYVSC5=\T_.`<0TK5#\XQM%3]X!Q#3-4/SC'4
M5/W@'$-.U0_.,?14_>`<0U#5#\XQ%%7]X!Q#4M4/SC$T5?W`''409A*#,3Q5
M#>%]&9ZJAG".X:EN!JG+*7>1='VS[^@BV;)HY2X2W_]R5[=VVFD(@DC[E'*Z
MB>8VOO6DPWOI,M)CI,_(@)$A(R-&QHQ,&)DR,F-DSLB"D24C*T;6C&P8V3*R
M8V3/R(&1(R.J)&B1KL<PTS*87$=-8(O;P:++K)J(\+X,)W5O".<85NK>$,XQ
MO-2](9QCF*E[0SC'<%/WAG".8:?N#>$<PT_=&\(YAJ'ZC`SG&([J,S*<8UBJ
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M63"R9&3%R)J1#2-;1G:,[!DY,')D)`2#,70,AH\A%[)&ZV`H&0PG@R%E,*P,
MAI;!\#(88@;#S&"H&0PW@R%G,.P,AI[!\#,8@@;#T)`KFKWH7UFUS#CG#4F#
M86DP-`V&IXGA:6)XFN2>9L_/Z_MFL_D0O<%/#$\3P]/$\#0Q/$WJ/2V7D70-
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M/)0>A_09&3`R9&3$R)B1"2-31F:,S!E9,+)D9,7(FI$-(UM&=HSL&3DP<F1$
M7017,U078<;P41,1SC&,U$2$<PPI-1'A'$-+340XQQ!3$Q'.,=341(1S##DU
M$>$<0T]-1#C'$%03$<XQ%`V&H^HBO"_#4DU$.,?P5%T$<S018<;P5!,1SC$\
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M/4;ZC`P8&3(R8F3,R(21*2,S1N:,+!A9,K)B9,W(AI$M(SM&]HP<&#DRHM:!
MZQ=J_L&,X:+F'YQSMO&J;YI_<(XAI>8?G&-HJ?D'YQAB:O[!.8::FG]PCB&G
MYA^<8^BI^0?G&((&PU`U$-Z7X:@:".<8EJJ!<([AJ6H(YJB&,&-XJAK".8:G
MJB&<8WBJ^4==3KF+:$KQ/5TD?5@T!XD_HY+<9U#M'`21]BDENR/G[G4C+AP=
MWDV7D1XC?48&C`P9&3$R9F3"R)21&2-S1A:,+!E9,;)F9,/(EI$=(WM&#HP<
M&5$G08W429AI&4SN8XW5FHKPO@PG-17A',-*344XQ_!24Q'.,<S45(1S##<U
M%>$<PTY-13C'\%-3$<XQ#%4GX1S#4742SC$L52?A',-3=1+,42=AQO!4G81S
M#$_523C'\%2=I"ZGW$G21=*^8SZ2K:U6GH_$?R;G/E^`[6G0\QC=V]LJ-E]]
M,]5FI%,@E3OI%INO[J3'2)^1`2-#1D:,C!F9,#)E9,;(G)$%(TM&5HRL&=DP
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MAI0J(IQC:*DBPCF&F"HBG&.HJ2+".8:<*B*<8^BI(L(YAJ`J(IR3*YJ]Z%];
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M_>H+6YN13H%D:L=[Z1;;K^ZEQTB?D0$C0T9&C(P9F3`R963&R)R1!2-+1E:,
MK!G9,+)E9,?(GI$#(T=&0C"8LXE7'0B&C<'0,9Q]O+XOP\E@2!D,*X.A93"\
M#(:8P3`S&&H&P\U@R!D,.X.A9S#\#(:@P3`T&(H&P]%@2!H,2X.A:3`\30Q/
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M1U:29@:=1&D\-J*VTCH!-6VES4B'=M/EC!XC?48&C`P9&3$R9F3"R)21&2-S
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M3KF,Z+6E5$;2:S6O^5I-^K!X/!*5A:290=F=J]$M):UBX[G61..5-B.=`DDO
MOT:[Z!8;K^ZBQTB?D0$C0T9&C(P9F3`R963&R)R1!2-+1E:,K!G9,+)E9,?(
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M,YI(MGQ:N8G$GU-J9M#IDTRZ=S5:P+=U`C3D*6X\N;A"4[=.V]-<I<,I73J2
M'F?T&1DP,F1DQ,B8D0DC4T9FC,P963"R9&3%R)J1#2-;1G:,[!DY,')D1$T$
M'5$38<;044V$<PPAU40XQY!2381S#"W51#C'$%--A',,-=5$.,>04TV$<PP]
MU40XQQ!4381S#$751#C'D%1-A',,3=5$,$=-A!G#4S41SC$\51/A',-3-1'.
MJ?>TW$32==.>T42R9=;*320J&DD3UV)K,=)FI,-(EY$>(WU&!HP,&1DQ,F9D
MPLB4D1DC<T86C"P963&R9F3#R):1'2-[1@Z,'`LD'?F]O(]NAU(3R3VKWG[V
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MSCI>WY?A9#"D#(:5P=`R&%X&0\Q@F!D,-8/A9C#D#(:=P=`S&'X&0]!@&!H,
M18/A:#`D#8:EP=`T&)XFAJ>)X>G_X^S,=EPYLBOZ*PV]EU6LB45`+2"3\SR/
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M,%-EA',,-U5&.,>P4V6$<PP_548XQS!49:3(N1PM?-+_O"9?A-`*"3_,L%0K
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MVS6<8WBJ[1K.J?>TVD7B*K3KI1&SBQ0WJ.FCE%]^T2_[2;M(`14U[OWU,=EG
M:;_57</VL9W38:1[1NX]I<<1?48&C`P9&3$R9F3"R)21&2-S1A:,+!E9,;)F
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MYQB>:J>&<^H]K;:1N#+MNHW`(=;BAK5J"TD.E^9O!53LG31?&DE+:9]_KL94
M;O/<K(E<;G*+CI&LN'0K^:_-YW0+J%<!'EY:[ZUD$ZG/'V'`R)"1$2-C1B:,
M3!F9,3)G9,'(DI$5(VM&-HQL&=DQLF?DP,B1D1,C:B`7.>[ZHP;"C.&A&@CG
M7'RL\5D-A',,*=5`.,?04@V$<PPQU4`XQU!3#81S##G50#C'T%,-A',,0=5`
M.,=05`V$<PQ)U4`XQ]!4#01SU$"8,3Q5`^$<PU,U$,XQ/%4#X9QZ3ZL-)*Y*
M^X8&4MRL5FT@27W(W_#ZM38CG3-2])C&4_/QL9D\J,LI/4;ZC`P8&3(R8F3,
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MSC&T5"OA'$-,M1+.,=14*^$<0TZUDB+GO#[=>$_6IW5@A!]DR*D#(_`@PTV=
M%N$/8]BITR*<8_BITR*<8QBJ/H(Y.BW"C&&H3HMPCF&H3HMPCF&H3HO4Y53Z
M2/.K:UCY6[T??RPYN=I(O]5[AFK6;=N,=!CI,M)CI,_(@)$A(R-&QHQ,&)DR
M,F-DSLB"D24C*T;6C&P8V3*R8V3/R(&1(R,G1K+,8'*#,83,#",S0\G,<#(S
MI,P,*S-#R\SP,C/$S`PS,T/-S'`S,^3,##LS0\_LXN=YO;KUTGA,MKTSP\_,
M$#0S#,T,13/#T<R0-#,LS0Q-<T/3W-`T-S3-#4US0]/<T#0W-,WK-:V6DK@C
M[7J1I/[02+.X4JVR.'+S.WK/4/$UFI?79.VD7?[X[IYWAY%NB<2QDIN'],H?
MWWU(GY$!(T-&1HR,&9DP,F5DQLB<D04C2T96C*P9V3"R963'R)Z1`R-'1DZ,
MJ(34W6WX\=7X+#<80T:5$'[6IXYW?5,)X1Q#2I40SC&T5`GA'$-,E1#.,=14
M">$<0TZ5$,XQ]%0)X1Q#4+40SC$450OA'$-2M1#.,315"\$<M1!F#$_50CC'
M\%0MA',,3]5".*?>TVH+B:O1OJ&%%#>I55M(4I#S9@$5%?KA_>4I`=IGH&;-
MI,-(EY$>?9(^9PP8&3(R8F3,R(21*2,S1N:,+!A9,K)B9,W(AI$M(SM&]HP<
M&#DR<F)$3:3N6L-+$V'&T%%-A',,(=5$.,>04DV$<PPMU40XQQ!3381S##75
M1#C'D%--A',,/=5$.,<05$V$<PQ%U40XQY!4381S#$W51#!'3829R[\S:_Z5
MJ";".8:G:B*<8WBJ)L(Y]9Y6FXA*1:6)>+^=IAE_+-FDN?E=>6?H_+ORGI,]
MG';YX[M_A>HPTBV1CZ_;I`_IE3^^^Y`^(P-&AHR,&!DS,F%DRLB,D3DC"T:6
MC*P863.R863+R(Z1/2,'1HZ,G!A1&RE$K)E@6A=AQI!1;81S/G6\ZYO:".<8
M4JJ-<(ZAI=H(YQABJHUPCJ&FV@CG&'*JC7".H:?:".<8@JJ-<(ZAJ-H(YQB2
MJHUPCJ&IV@CFJ(TP8WBJ-L(YAJ=J(YQC>*HVPCGUGE;;2%R+=KTN8K:1XC8U
M?93R6[F-F]^5UZR[<JWX77F,=,Y(L<KR_I3^%IPN1_08Z3,R8&3(R(B1,2,3
M1J:,S!B9,[)@9,G(BI$U(QM&MHSL&-DS<F#DR,B)$542%$V5A)FVP5QTK*L_
MAI*J)/QY#"E523C'T%*5A',,,55).,=04Y6$<PPY54DXQ]!3E81S#$%523C'
M4%25A',,255).,?05)4$<U1)F#$\527A',-351+.,3Q5)>&<>D^KE42SI5))
MX,!(X,G"R&OR6V?R9@$5)>*MV4QN"6F??UXSU3HE\M4M(]7\U\?W9"NH5P$>
M7M^?&PG1+_,_*U7R!>(!(T-&1HR,&9DP,F5DQLB<D04C2T96C*P9V3"R963'
MR)Z1`R-'1DZ,J($4?M7XHP;"C.&A%D4XIVLP%R7K/K,AI1H(?QY#2S40SC'$
M5`/A'$---1#.,>14`^$<0T\U$,XQ!%4#X1Q#4340SC$D50/A'$-3-1#,40-A
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M]AU-I+ATK=I$DK.I>1-O9FLSTF&DRTB/D3XC`T:&C(P8&3,R863*R(R1.2,+
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M1K+,8"XNUJB6M8T<P\?,$#*[&%GW>0PI,\/*S-`R,[S,##$SP\S,4#,SW,P,
M.3/#SLS0,S/\S`Q!,\/0S%`T,QS-#$DSP]+,T#0S/,T-3W/#T]SP-#<\S0U/
M<\/3W/`TK_>TVD3BWK3K]1#O&[WOQ75KE761F_M%SM#UU'E.%T<,IF,P78/I
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M$LQ1)6'&\%25A',,3]5(.,?P5(V$<^H]K382E8I*(X&-F\"3C9O7Y+1V_EY`
MY[-/S?1BM/;YY]?+*$E_ZY1(U)"DZ70K^6^ME\?D3_<JP,/;\ULS(?IE_MW!
M.F!DR,B(D3$C$T:FC,P8F3.R8&3)R(J1-2,;1K:,[!C9,W)@Y,C(B1$UD,*O
M&G_40)@Q/%0#X9R+CW6?YZ)D'6-(J0;"G\?04@V$<PPQU4`XQU!3#81S##G5
M0#C'T%,-A',,0=5`.,=05`V$<PQ)U4`XQ]!4#01SU$"8,3Q5`^$<PU,U$,XQ
M/%4#X9QZ3ZL-)&Y/NUX3@0927+:FCU!^9;>1_@:\_!UO9&LSTCDC18]Y>GQ^
M?$U_26274WJ,]!D9,#)D9,3(F)$)(U-&9HS,&5DPLF1DQ<B:D0TC6T9VC.P9
M.3!R9.3$B-H(NJ8VPHPAI-H(YQA*ZO@(YQA2JHUPCJ&EV@CG&&*JC7".H:;:
M".<8<JJ-<(ZAI]H(YQB"JHUPCJ&HV@CG&)*JC7".H:G:".:HC3!C>*HVPCF&
MIVHCG&-XJC;".?6>5MN(_H92:2/>;2/O\<>2=9&;VT;.4-$G&HWWY#O`[?//
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MR6\`42GA1QF"JI1PCJ&H2@GG&)*JE'".H:E*">:HE#!C:*I2PCF&IBHEG&-H
MJE)2EU,M)7&AVG4I@<V:XOZU2AFYN6WD_7))6W$12'(Q7[O\\=U5BPXCW1+Y
M\B&]\L=W'])G9,#(D)$1(V-&)HQ,&9DQ,F=DP<B2D14C:T8VC&P9V3&R9^3`
MR)&1$R,J(1?'[O[SK1+"C"&C2@CG?.IX__,83NK0*C_+L%)+(YQC>*FE$<XQ
MS-32".<8;FIIA',,.[4TPCF&GVHAG&,8JA;".8:C:B&<8UBJ%L(YAJ=J(9BC
M%L*,X:E:".<8GJJ%<([AJ5I(74ZUA<0-:M_00HH+UZHM)/G]<_E[`145^N'E
M.;V.I'T&M'Y3'CQ)=D\ZC'09Z=$GZ7/&@)$A(R-&QHQ,&)DR,F-DSLB"D24C
M*T;6C&P8V3*R8V3/R(&1(R,G1M1$\/9#-1%F#!W51#C'$%++(9QC2*GE$,XQ
MM-1R".<88FHYA',,-;4<PCF&G%H.X1Q#3RV'<(XAJ(Z+<(ZAJ(Z+<(XA:698
MJB;"SS(\51/!'#419@Q/U40XQ_!4381S#$_51.IRJDTD;DB[;B+F;2/%Q6J5
M1G)[VTC=[6M_^=/O?_ZA_8Y(AY$N(SU&^HP,&!DR,F)DS,B$D2DC,T;FC"P8
M63*R8F3-R(:1+2,[1O:,'!@Y,G)B1*T$15(K8<804JV$<PPEU4HXQY!2K81S
M#"W52CC'$%.MA',,-=5*.,>04ZWD-B>]DT(+)`;TE:$W25\Y>@-]9>D-9'BJ
M:G+[N9._U6J1A!E#5543SC%D537!'%636R9]03K*>@LE_^7539@Q;%4WX1S#
M5G63VYRK_V*5<M+ZMDM9/_#D#.MK>G+D#)V_$]-Z3+[[VS[_O&Z5I$0^MF*2
M,ZR5_.;C>RL]Q%H!'MZ:K5;R_[)^F7]WH6;`R)"1$2-C1B:,3!F9,3)G9,'(
MDI$5(VM&-HQL&=DQLF?DP,B1D1,C668PN<$8'F8=(Z=K,#V#,:3,#"LS0\O,
M\#(SQ,P,,S-#S<QP,S/DS`P[,T//S/`S,P3-#$,S0]',<#0S),T,2S-#T\SP
M-#<\S0U/<\/3W/`T-SS-#4]SP].\WM-J`XG;TZZ71^J/B[2*R]8JRR)OZ4;-
M&:II&&U&.F?DW&/>WAZ?TR-374[I,=)G9,#(D)$1(V-&)HQ,&9DQ,F=DP<B2
MD14C:T8VC&P9V3&R9^3`R)&1$R-J(WC[898;C"&DV@@_RU`R,YS,#"G51OCS
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M3NDRTF.DS\B`D2$C(T;&C$P8F3(R8V3.R(*1)2,K1M:,;!C9,K)C9,_(@9$C
M(R=&U$10)#419MH&8QB9&4JJB?#G,:14$^$<0TLU$<XQQ%03N>1\M(STV+YV
M:*Y_WGBN[C>KA%S_^.$Y_;GAHPK()>/NCK,V9I@QE-3&#.<84FICAG,,+;4Q
MPSF&F-J8X1Q#3140S-'&##.&FMJ8X1Q#36W,<(ZAIC9FZG*J!20N3;M>"O$N
M%VD5=ZWI,>5W8'2/656I_`S5%A&\LZW#*5U&>HST&1DP,F1DQ,B8D0DC4T9F
MC,P963"R9&3%R)J1#2-;1G:,[!DY,')DY,2(B@B*I"+"3-M@#"-51/A9AI/:
MH.$<PTH=%^$<PTL=%^$<PTR5$<XQW-1Q$<ZYV%EL<3=>GAK5.:U*PB&&G*HD
M1<[=!QENJH_PAS'L5!_A',-/]1'.,0Q5'\$<]1%F#$/51SC',%1]A',,0]5'
MZG*J?41MX7OZ2/RQ9&'DYK*S5@'5]A%$.IS29:3'2)^1`2-#1D:,C!F9,#)E
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MWW:K[BZVC[M'.HQT&>F=D;N?I,\9`T:&C(P8&3,R863*R(R1.2,+1I:,K!A9
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M,3S5T@CG&)YJ:81S#$^U-,(Y]9Y6NDCC,;UKU2LCQ9]+3K"^)7TCOU`U?YEJ
M&TSGPA1+*2]/+\EOB>Q>@)H']0RF;S`#@QD:S,A@Q@8S,9BIP<P,9FXP"X-9
M&LS*8-8&LS&8K<'L#&9O,`>#.1K,R6"RS($<33/'TZP4M<;#S)$U<VS-'%TS
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M=\-=_4J>XA"+`^DU<Y)>,T-ZS0SI-=]"R7\YO65D-":1T91$1D,2&<U(9#0B
MD=&$1$8#$AG-1V0T'I'1=$1&PQ$9S49D-!J1T61$1H,1&<U%9#06D=%41"9Z
M#4-?ZIK\4Q^]AI.^U#5-^E+7%/I2UQ1R=(U5&O[@CK"Q2L-)CK*Q2L-)CK2Q
M2L-)CK:Q2L-)CKBQ2L-)CKJQ2L-)7\J;_MLFEFDXRO$WEFDXR3$XEFDP*8H-
M0X["L4QSFY2^J&@VMU1B7JS3,.0X'.LTG`0.)\U&W>2FV3QK,XK6:>+/I?M.
MR7:0WG-!%>LT3X]/R1?M]8X+H.8O;7K#R.@%US](+Q=#]&Z1T:M%1M,1&0U'
M9#0;D=%H1$:3$1D-1F0T%Y'16$1&4Q$9#45D-!.1T4A$1A,1&<U#9#0.D=$T
M1$;#$!G-0F2BSC!4.EJC8-093G)$C4TG3G)LC64:3G)\C64:3G*,C64:3G*<
MC64:3G*LC64:3G*\C64:3G+,C64:3G+<C64:3G+LC64:3G+\C64:3G(,CC:#
M2;%,PY!C<)093G(,CF4:3G(,CF6:NJ2DS,1]<=^S3%/<,Z<'E5_M::27`NDU
M%]3Y>T1?MIFZ^^J*;SU?4FK&K=XP/$FO%Y^DMXN,7BXRFH[(:#@BH]F(C$8C
M,IJ,R&@P(J.YB(S&(C*:BLAH*"*CF8B,1B(RFHC(:"`BHWF(C,8A,IJ&R&@8
M(A-UAJ'2TAJ_HLYPDH8A0Z6J=8]S;(TZPX]S?(TZPTF.L5%G.,EQ-NH,)SG6
M1IWA),?;J#.<Y)@;=8:3''>CSG"28V_4&4YR_(TZPTF.P5%G,"GJ#$..P5%G
M.,DQ..H,)SD&1YVI2TKJC*9*I<[0FDSPZ9I,<C)&K[>@SF=G7E_?D^\NZ=T6
MA/YW68>2)2V]V@OS\>6C9%U'+_7Z(:W'EU;RO6V]T6OBH?G22G]UAM[GY1EW
M/X=>)S*:A\AH'"*C:8B,AB$RFH7(:!0BHTF(C`8A,IJ#R&@,(J,IB(R&(#*:
M@<AH!"*C"8B,!B`RFG_(:/PA$P6&H=)/H??LBP+#25>.WD\J3:U[7"EK'>3H
M&MM+_,$=86-[B9,<96-[B9,<:6-[B9,<;6-[B9,<<6-[B9,<=6-[B9,<>6-W
MB9,<?6-WB9,<@6-W"9.BP##D&!R[2YSD&!R;2YSD&!R;2YP$!B<%)BZINUZ/
MH0)37&I778=)FH->;]W5=Y?3,LCHY1;,I0B]O;^^IM^<TLO%(+U;9/1JD=&;
M14:C$1E-1F0T&)'17$1&8Q$9345D-!21T4Q$1B,1&4U$9#00D=$\1$;C$!E-
M0V0T#)'1+$1&HQ`934)DHLLPY*@:78:32EDUH.ZV(D?6^$(3/\[1-;H,)SG"
M1I?A)$?9Z#*<Y$@;78:3'&VCRW"2(VYT&4YRU(TNPTF.O-%E.,G1-[H,)SD"
M1Y?!I.@R##D&1Y?A),?@Z#*<Y!@<78:3P."DR\15>-==QOV"=G&%7J73W/S*
MP\8C7K2GMXR,7C(R>L?(Z!4CHS>,C%XP,IJ0R&A`(J/YB(S&(S*:CLAH."*C
MV8B,1B,RFHS(:#`BH[F(C,8B,IJ*R&@H(J.9B(Q&(C*:B,AH("(3E88A#42&
M'%7C.]J<Y,@:E8:3'%VCTG"2(VQ4&DYRE(U*PTF.M%%I.,G1-BI-D53\W;'Y
MGAX6B,TE?M:5MK&*GIR>C&VEY"G)2GW4&'Z*(VS4&$YRE(T:PTF.M%%C,"EJ
M#$..M5%C.,FQ-FH,)SG61HWA)+`VJ3%Q/=[WU)CB6KUJC4EN_==KKKM\[[(T
M@XQ>,C)ZQ\CH%2.C-XR,7C`RFHK(:"@BHYF(C$8B,IJ(R&@@(J-YB(S&(3(:
MB,AH'B*CH8B,QB(RFHK(:"@BHYF(C$8B,IJ(R&@@(A,UAB''U%B9X23'U3CU
MRTF.K7%,AI,<7^.8#"<YQL8Q&4YRG(UC,ISD6!O'9#C)\3::#">5YA:%Z+71
M>'MZ2A;NH\]PDN-N')/A),?>.";#28Z_<4R&DQR#H])@4AR38<@Q.([)<))C
M<!R3X23'X#@F4Y>45)JXB>^ZTM`N4W%S7Z7*W/R>Q<;CY7Z_CP,NK\D_S'JS
MEY_?79#6BT5&[_7"?/D<O=++S^\^1V\4&;U09#01D=%`1$;S$!F-0V0T#9'1
M,$1&LQ`9C4)D-`F1T2!$1G,0&8U!9#0%D=$01$8S$!F-0&0T`9'1`$0F*@Q#
M&H`,.9K&2@PG78EZ5\18B>$D1]=8B>$D1]A8B>$D1]E8B>$D1]I8B>$D1]M8
MB>$D1]S87.(D1]U8E>$D1]Y8E>$D1]]8E>$D1^!8E<&DJ#`,.0;'J@PG.0;'
MJ@PG.0;'J@PG@<'5"M-(;_^%"O/!)R=]GY)?:I0WSE31R1^>GM^3]9KVA:C9
M5>\83-=@>A?F[J?I7XB:3S,PF*'!C`QF;#`3@YD:S,Q@Y@:S,)BEP:P,9FTP
M&X/9&LS.8/8&<S"8H\&<#$8UYBQ@S3_066EI'>2(JAIC/,Y1537&2')T58TQ
MDAQA56.,)$=9U1@CR9%6-<9(<K15C3&2''%58XPD1UW5&"/)D5<UQDAR]%6-
M,9(<@55C.$DUQH`<@U5CC"3'8-48(\DQ6#7&2`*#DQH3-^I=K\3$&1GCTM]&
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M%/?S5:O,S>]C:MS>XI=>+:C7?`O=?`W[S!2+*HU6JW7S:ZN-&+UB?)3>,#)Z
MP<AH0B*C`8F,YB,R&H_(:#HBH^&(C&8C,AJ-R"P-1H,1<S07D=%81$93$1D-
M160T$Y'12$1&$Q$9#41DHM(PI('(D&-JK,YPD@8B0XZM46DXR?$U*@TG.<9&
MI>$DQ]FH-)SD6!N5AI,<;S-'W%B=X<<YZL;J#"<Y\L;J#"<Y^L;J#"<Y`L?J
M#"9%I6'(,3A69SC),3A69SC),3A69S@)#$XJC4I)I=+0)E/PR2;36[*%I-=;
M4*T?8K7DJ?'ZG'04O=N"J%G@UJNMIOSTX__^_-./?_GYIX\SPWJIUS]NO;\_
M)V?E]4:OB8=F\_DI*5UZG_@Y]#J1T3Q$1N,0&4U#9#0,D=$L1$:C$!E-0F0T
M")'1'$1&8Q`934%D-`21T0Q$1B,0&4U`9#0`D='\0T;C#YDH,`R5?M;8%VLR
MG%0Z6I=4FEH'E;+608ZNL;W$']P1-K:7.,E1-K:7.,F1-K:7.,G1-K:7.,D1
M-PH,)SGJ1H'A)$?>*#"<Y.@;!8:3'(&CP&!2%!B&'(.CP'"28W`4&$YR#(X"
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M<7"F^`]__/;//_^@K;M__^V//W[[[X__\^^__O(?O_X>@."__O;;'Y?_\*,6
M3?[OM]__\^,9/_^_`````/__`P!02P,$%``&``@````A`.54US]$!0``8Q<`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C(N>&ULE)A?CZHX&,;O-]GO0+@?
MH8"B1#T9Y6]R-MEL]IR]9K`J&:$&F''FV^];"D@+0YVY$'WGUZ?MT[>E[?K'
M1W91WG%1IB3?J&BFJPK.$W)(\]-&_?6O_[14E;**\T-\(3G>J)^X5']L__QC
M?2/%:WG&N%)`(2\WZKFJKHZFE<D99W$Y(U><PW^.I,CB"GX6)ZV\%C@^U(6R
MBV;H^D++XC17F8)3/*)!CL<TP2Y)WC*<5TRDP)>X@O:7Y_1:MFI9\HA<%A>O
M;]>GA&17D'A)+VGU68NJ2I8XT2DG1?QR@7Y_("M.6NWZQT`^2Y."E.18S4!.
M8PT=]GFEK310VJX/*?2`VJX4^+A1GY$3(5/5MNO:H-\IOI6][TIY)K>@2`\_
MTQR#VS!.=`1>"'FE:'2@(2BL#4K[]0C\72@'?(S?+M4_Y!;B]'2N8+CGT"/:
M,>?PZ>(R`4=!9F;,J5)"+M``^%2RE*8&.!)_U,];>JC.&]5<S.:V;B+`E1=<
M5GY*)54E>2LKDOW'(-1(,1&C$8%G(X)6,V3IBV]HF(T&/%N-Q<Q8SM'\.RI6
MHP+/5L7X=G>@X[4G\&Q%%C/+F-O+[YBR:%3LNXHYLY&^,NW'G85I6C<%GDU3
M3.O[KJP:%7BV*@\/LL82ILX_-Z[B[;H@-P4F-:1$>8WI$H$<$&X3CZ5)EXI?
M92*D(!5YIBH;%;H'25;"]'G?6OI\K;U#RB<-LV,,?/:8!<_LASJ()]R6H'.`
M5NV-R=I\(;\M=*]Z(>@&+=+JAF.Z0G.C(7.7U<#@SF684GV7QZ=U:R:%J9EM
M4W9MX-Y\2U_R7=PS!AK4N6OPA#M460B(-T0,813]$82O)Y`2(2/Z;;60SJM$
M0^;>6,Y:6&GZUM($-F']G;:8%N(L%@-[%N#:J*_X-KIB(4\,^&(@$`,A"W#U
MH'L2U2D>C3%FUQ;.#5@Q^VY,NT!AS@4QL&<!]IJ@L\T5"4\,^&(@$`,A"_!=
MO@\NZ_((T[.?ZS(LP_TN/Y8`M-!&A5JZZ6(AJ[.T;L..,?!Y9WAB+R5<*>%)
M"5]*!%(BE!+1%,'Y#6_$OM_3*49AF)!]#Y&PI.P8`_5_Z;.4<*6$)R5\*1%(
MB5!*1(RPZY>D8??6<<YDV&[T37XLJ6DAT6SAE;5CS)39+4'?XG`,X%/>;?_[
MY6!Y4L*7$H&4"*5$U!+U;L2X]X/SF1Z@>MN?Z62FL.BOL-78,6;*WQ$""6]S
M=X3AQ\&3$KZ4"*1$*"6B*8)S&C:7CSM-8=YI^SZ`;'5FR)31C%C5,^W),%<Z
M_/$NNAR"='N(>-)Z?$%D.:<J0DV!"%FV.8!":5W1%,'9C6`/]+C?-<T;;B%A
MN[-KH"G+Y8@K1SPYXC<(6T:?D+ZPQDR7"X5R))I$>--A4],W_;%E&]%2@OF]
M]8JE>P--FL]T)A!7KN(U"',6K6B6BLGLRV4"7D9?P@Y?E`GE,M$DPGM/3PR]
MI?Q![]DYH[]!,9"XIB,&31B[;Q"VV*QTM!STUN409(\8XLDK\N5(P%5D6,O%
ML#$AQ]CUTBBL6-%D3;SU](#2LW[Z+0KW:,-T%XX\NP;B+#>$0\)^#!(6>#GB
MR1%?C@1R))0C](Z1>L-UN^L1\YS=(;([G`P7)[S'ETNI).2-W@\NX6W71;N[
MRV>+7B8(\3URX#9E&/>1`[<AP_C.<'9C.J[AP+%PR'N&`Z?#8=PW'#@D#N.!
MX<!9$>):UU"XXKS&)_Q77)S2O%0N^`A=U&?TYJU@EZ3L1T6N]4W6"ZG@<K/^
M>H;+;`PG5GT&\)&0JOU!*^BNQ[?_`P``__\#`%!+`P04``8`"````"$`?\4_
MHOX&``"('```&0```'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RLF5UOHS@4
MAN]7VO\0<3])("&DJ.VH">%S5UJM9G>O*2$-:A(BH-/IO]]C[&.P#\TDTMQ,
MI@_GO+9?CHTQ]U]_'`^C[WE5%^7IP3#'4V.4G[)R6YQ>'HQ_OOE?EL:H;M+3
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M=^"O:K3-=^G;H?F[?`_SXF7?P.VV841L8.[VP\OK#!P%F;%E,Z6L/$`'X-_1
ML6"E`8ZD/]K?]V+;[!\,:V:,GO.Z\0LF98RRM[HIC__QBZ:0X,F62(8,D3Q;
MC&UG.C.AK4N)<Y$(OR+1G%^5"+)M=^$7NSM>VO9\L70NM[@0B?`K$J_KJ2/R
MX%<V.+=L9_FS(<($:WL*O[<-\4XDPJ](G(VO:M&$XN'WDE41OU_0^H7[9\J[
M#_^Y:G@37CYM-7IIDS[>5^7["*8X"-3GE"T8ILMDL0YYZ[(R/RM,J$BF\L1D
M'@SH-=1>#;/I^^-L.KV??(<9D(F8%8TQU8@U1K!R9[*>#C8Z\'40Z"#40:2#
M6`=)#TS`)VD6S)M?81:386;A,%<(.O<LS1F,P!1/!QL=^#H(=!#J(-)!K(.D
M!Q1G8"7Y%<XP&:A$F.P7ZD@$P<R607/-+ADB_2)D0XA/2$!(2$A$2$Q(TB>*
M;["0*KX-+_\XRUAT:P\.:R6(.O'T:26#,,TC9$.(3TA`2$A(1$A,2-(GBAOP
M*+C!#1:MNL&)!<NHK(S95)]*,DBZ0<B&$)^0@)"0D(B0F)"D3Q0W8!8H;O"E
M><P>F)?+A"6JQG!B6W+)61/B$;(AQ"<D("0D)"(D)B3I$\4%F.:*"Y>'SJ+5
MH7-BWW5#YV2A5LE,74$\$<3W3>Q9M!E,TQ8>7P9A<06"=-:'1#J26?VZM=4>
MQ3((I9.^M.(9+`<W>,:B5<\XZ7O&R7PN7?0X6?0,DC'L\6]-3=T;>1T'$`B-
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ME2.MQK3MQYJ=KL%""376>283$6U$U*Q?4"(*)E:W4)K:]BS`1*@<&64Y6B="
MC.K7FI#O6HPQ2FU16P\2C/JL174FLPUVW^7>VT2S+[+750G=AI5]X&DS@V(1
MQSQ\FZZ8SY&Z3I)G#0]2ZE7F==YS-.\/FVZ"V.D`W,<YZQ7L,S57`G'9ZE<P
M:2I"D8M-Q1@EFM(>:XG2E.HVVYH3M^'D$HJ#F?VM/']F-IS`2K?Y!A^:08M6
M)D?]-SF*/(HV%/D4!12%%$44Q10E"E+=83MTW1W+9N[<>NS(]_J*0QRIAP"F
M]D1>P]$^*R*(0FL]BC84^10%%(44113%%+%/#EV_N&G\$P(_M#WFU4N^S@^'
M>I25;^SS`(S@\5YB_NUB9;MPJ@`#T_G"A??L`6XZ\+&C7<SU#'.)GT&T*Z'C
MANU*JO'(<>%-E;81+5UX5:,\@::'.'Q_>6K?"S7]%?LN,Z"SLEPXG*3Z3S/W
M"4RE%U8S%X[E!OC<A0.J`>ZXJR&=M>.NA[CGN/".3'4VC@NG!`-\Z?I#\8'C
MPGLRQ$^D$_`=Z)R^Y'^FU4MQJD>'?`>%,&T/ABK^)8G_T8A5YKELX$M0N^#L
MX8M?#J<94S;9=F79X!^L`?D-\?%_````__\#`%!+`P04``8`"````"$`%>,F
M,.,#``#8#@``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6R4E]]OHS@0
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MY`>U@'1>/=!^S6MO[4&F_39C4`&VW1'TL'/OR>8AB%UOO]4-^LGH179^._+$
M+U\%R_YB)85NPSSA##QS_H*NWS,T0;#7BW[2,_"/<#)Z2,ZY^I=?OE%V/"F8
M[A@JPL(VV?LCE2ET%-(LZF&D/(<!P*=3,%P:T)'D37]?6*9..S=8+TCD+\';
M>:92/3',Z#KI62I>_%_[$!Q3FR-H<L!WDR-<+N*5'Y+I)%X]'EW>8Z*2_5;P
MBP-K!I"R2G`%D@TD'JX'!H&^]^B\<V%-PU@E3,+K/@RCK?<*C4L;GX?:!SY;
M'])Z>`!MR4";3T9G)&,_<"@/M:&+"88QX2T8=(9.+#NC[U=8.\&\M17^[H%1
M870+&ITUNBVQL71K#,-XN$H8S?QFHK.):BS0U+:F,%P.HZ`Y713NA&`UM7(P
MR$0V%A.Y&D9"^AZ2K!8PZH_7*\:9U,8"4]@I]&Z8BMK=V1IZRT<P&Q\S,<ID
M-A:3N1YFKOO,U0HE98**<2:UL1C4R!^F$M!#N]3(OUNL)KDZT@1?329Y1`0(
M]+-+_KBWVMNB80(P&>LH&M$"].K2])2NP3B!Q3`+VYC,(L.1]H*7C0W]Y9SV
M8J1%;DPF>42!R$T2I+TM6B-"4.[O#1.-B!"^$.TZ@SG[5`=:8,P%)K/,$4E"
MP;;!9'JKZC`+V\B2B1V1)3*@2V2UGK%==:1%'I*F:$2:R)`V!7=SR'U]TLEZ
MK1X1*#*@4$&H3SU3NZBO43J938Y'1"JP1.KC/:N]S0Y?3<9:CD>$*;A)F+2W
M1;M%F`*4$_M=LX33W90TZ4`+/"1-\8@B!J@F%CA8PZ:?Z"Z&6=C&9.R<>$01
M@YMT27M;M"%=BD=4$%^?=I%D5G<;$5IVSIU#NA3;@EC?(^J#=D'%D7ZA>2Z=
ME)_QCA#`T;FUMO>7^P`IMCW<W,/PX0^O_0?N%55RI'\GXLA*Z>3T`#E]_381
M]<VD?E"\@J;!]8(KN%+HGR>X05(X/ONXL@Z<J^L#`MH[Z?X7````__\#`%!+
M`P04``8`"````"$``#`)E=0#``#4"P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6RL5EN/HS84?J_4_X!XWW#/!259)0/3KK25JFK;/A-P@C6`$78F
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MF:"_*+GQT7^+E^SV2T>+K[0AD&VH$U;@Q-@+FGXI$`)G9^;]+"OP>V<5Y)Q=
M*_$'N_U*Z*444.X((L+`XN(](3R'C`+-PH^0*6<5"(!?JZ;8&I"1[$T^;[00
MY<X.EHMHY08>F%LGPL4S14K;RJ]<L/IO9>1I*D7B:Q)XWB%YX!AH1WAJQW#A
MA>X2UW[@%FHW>&JW]4?<@%3&"D_MYKN+=12%R_7J[H*.2I;,?9*);+_MV,V"
MAH9T\#;#[>'%X-DG74D>RO!O58#T(\D!678V[$1(,(?6>=T'F_76>85RY]KF
M.+?Q3(NGW@)KB[3)%$A'@`,!#%%`N7Y`%,B"4?3K'WO@>UC^1')OT;LD4R`=
M`89D:)0?(!E9H'1+(_,;4^11&ZU&1J%I\C28#(',D'2,&*%`\TY#B:!2_[.'
MD$6&TDLX*L2'DV1HJ]!U)\H'H]XMF2'I&#&40\=/E7O1`K?0_5.G[W?T,[4J
M)/*'YGF:(<D,2<>((0P*.A;V6`T:FVH4$HPS%_C1)'/:",HZI-=?31H\T4:A
MW-31I+/2@0*2;^B'7ONX?C0V]2O$5ZOZKC>5KK]OAFPG"HE64N=ZTB3IV-[0
MB</#Z/A[G&<T-G4J!/*,1Q[H7$Y2K+^K.T8>:1KQI<=RDNU4?PTP+D/GQM2I
MCFG9J**D^<N1J9OMCOX`5E*'-'*8\A4":?[>`8$_C4$9A7"./6@3;82+R428
M>4CU0K)>1EPP4!@%D('!M0V+85S?6`N*_VLW2A(S,@V-]^,<2N803CB8)>6H
MI*J)1=V:->DNY(E4%;=R=L5I9`TA#^@P*1WD03#!CSA!86FGN!_#-3''#T%\
M`#WS#\<@AM/X#A[&<-;=P:,8CIH[N.?V,YTS:(*9JLTNY+>LN]"&6Q4Y0Y2N
M[+5.367J1>C:G)B`:4J6J83IF<#%[6(!SXR)_@66=H9Y?/\/````__\#`%!+
M`P04``8`"````"$`P%*3+I$&```&&@``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q.2YX;6RL65V/HS84?:_4_X!XWQ`@D`1-IIJ$\-E*5;5MGQE")FA"B(#9
MV?WWO<;?-I-.I'U9)H=[C^WCXXOM??CM>W,VOE5=7[>7C6G/YJ917<KV4%]>
M-N;?7Z,O*]/HA^)R*,[MI=J8/ZK>_.WQUU\>WMONM3]5U6``PZ7?F*=AN`:6
MU9>GJBGZ67NM+O#FV'9-,<#/[L7JKUU5',:DYFPY\[EO-45],3%#T'V&HST>
MZ[(*V_*MJ2X#)NFJ<S%`__M3?>TI6U-^AJXINM>WZY>R;:Y`\5R?Z^''2&H:
M31FD+Y>V*Y[/,.[O]J(H*??X0Z-OZK)K^_8XS(#.PAW5Q[RVUA8P/3X<:A@!
MDMWHJN/&?+*#W/9-Z_%A%.B?NGKOA;^-_M2^QUU]^+V^5*`VS!.:@>>V?46A
MZ0%!D&QIV=$X`W]VQJ$Z%F_GX:_V/:GJE],`T^W!B-#`@L./L.I+4!1H9HZ'
MF,KV#!V`?XVF1M8`18KOX_.]/@RGC>DN9@O'6ZYLB#>>JWZ(:L1I&N5;/[3-
MOSC*)ER8Q2$L\.0L*\];^*OEYUE<P@)/RC*_OR_0WC@B>!(69[:TYVL7]>3&
M&'R2!T^2!W_=B%^2>'B2>'OF+>?N/;JM"0<\Z8@YQXVV;?`)GC9D&#PCRQD7
M_%8JFW'XX]Z.6]@]HQG#8B@>'[KVW8`5#ES]M4#UP@YL^$%MB#O"C/F1+\&0
MB.4)T6Q,J$W@N!X6T[='=^T_6-]@`90D9JO'V'+$CD8@MR/:4`7V*A"I0*P"
MB0JD*I"I0"X`%NC$Q()5\C/$0C1(+#K,+06X>HZB#(V@*:$*[%4@4H%8!1(5
M2%4@4X%<`"1E8.7_#&40#3@1UJ_@HZ6LQ98$P?)E00LY9,="F%X:LM>02$-B
M#4DT)-603$-R$9%T6RBZ35=_NLI0]"@/'=86(PX4$Z:%.U?-PX)H6J@A>PV)
M-"36D$1#4@W)-"07$4D-J/,3+IJA^G];&)0H"X,1SV&+;*<AH8;L-232D%A#
M$@U)-233D%Q$)!7`_9(*MX>.HN6A8\1;\Z%CQ)==XLIK)B1!>'^`JN]^,DU9
M:A$+HN:*"<*E3S3JE&6)OO7D'F4LB%+G(K6D&12#.S1#T;)F&!$UP\ABP50,
M,>(+`K$8],%SYK:J#7M/!Q`3#D$;C35E6815F:B,O:>LN<@JR8(."^+7_;:5
M4+0L"T9<V3C*=WV'@SQ8U4(-4HIVR)AHI_<$@;ZS-&>IE*Z(<'OCEF*]E@T2
M$PJ7S5&B-9-^IIGL9C.YV(PD+^S^[I`71<OR8L21E5O)@]SA(`^LSW1RYXH2
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M*/0!<4[?C\2RQ]"F]PZ!\!Y9\AB&%(\I6XZ=C:/`8UPSEDBA/8ER14.1*/`$
M+Y2VLB6+:2+,#(MREDHG$AHE>HW0\Q8S&B6WJ-2#G$9]U**L,MI4BRKCZXSQ
M!#&<ZO)UVT*WH2A-;(1<,,MHQ2=T#:?620S)=5+[UI`MO>A7EL>UQ]!"'+:^
M\2%]6*!>P=Y2424FKX7"FE!(=/!GFLJ4II3/6DYY)SR-MN.:VOX,6AW%_MI>
M/Q(;KBB9VGA3+UD=0^+I#=T)P)P(4*A#>QV*="C6H42'4AW*=`A=$?-^82_B
M*U]\R]94W4NUJ\[GWBC;-W2=:Z/:P6!\U[SU`C@.@D-4W/;I);3R)O&#9*Q+
M"I[Z`1R;=*9T&<"Y0<=S:&`*A]OOI_&0HO!OT:WX!,_6">!N2.=_<H,GD$A_
ML74#N!69P!<!W`],X'ZPG>KHS@]V4WCH!W!@TWGV?@!'U@E\&413\;$?P*$-
MXBVF!-S"7XN7ZH^B>ZDOO7&NCC"M\['&=/@>'_\8B/V?VP&NW\>5<(+_;ZG@
M:#U':^38M@/]@1I@_X/S^!\```#__P,`4$L#!!0`!@`(````(0`-(K)5G04`
M`&(5```9````>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;*Q8VXZC1A!]CY1_
M0+RO,6!\D^W5V##)2HD419ODF<%M&XVA+6#&,W^?JK[1%];K6>W+,)RNKCZG
MNJAJ]^KS6W7V7DG3EK1>^^%H['ND+NB^K(]K_Y^OCY_FOM=V>;W/S[0F:_^=
MM/[GS:^_K*ZT>6Y/A'0>>*C;M7_JNLLR"-KB1*J\'=$+J6'D0)LJ[^"U.0;M
MI2'YGDVJSD$T'D^#*B]KGWM8-O?XH(=#69"4%B\5J3ONI"'GO`/^[:F\M-);
M5=SCKLJ;YY?+IX)6%W#Q5)[+[ITY];VJ6'XYUK3)G\Z@^RV<Y(7TS5X<]U59
M-+2EAVX$[@).U-6\"!8!>-JL]B4HP+![#3FL_8=PF461'VQ6+$#_EN3::O][
M[8E>?VO*_1]E32#:L$^X`T^4/J/IESU",#EP9C^R'?BK\?;DD+^<N[_I]7=2
M'D\=;'<"BE#8<O^>DK:`B(*;492@IX*>@0#\]:H24P,BDK^QY[7<=Z>U'P/T
M1-KNL417OE>\M!VM_N.#H7#!)T=B,CSEY.DHF8WC$-:Z-3$6$^$I)DY&T3P)
MD^EW)D[$1'B*B?/1/$DFT_GL]HHPRG3"4TR,XIM+!CQ0+.YIWN6;54.O'B0S
MA*2]Y/AIA$OP)@/.PZ2VX%L[`*%')P_H9>W#5PA!;B%M7C=Q.%\%K[#5A;#9
MNC:A:;&3%KBOZ#:U@4P#`A"@5,"6_005Z`55R/6W$NAE119E:2&GI#:0:8!!
M&9+E)U!&+[!UTYN1%T8SS6ABZ5`F2HB#9#IB2('TU:4,?ZPR5="8,98K;05B
M9L_"(JB,Y+3403(=,0A"8M]/$(U-@AR)H)KUZ1V-+8+*2!%TD$Q'#(*P?_<3
M1&.3H$`6!D'[ZU)&BJ"#9#IB$(3<T0EBF9A!<91E\>Y"@7Y,[ARQ@FM_9LI(
M<7>03$<,[G@XT$K<[?1$8Y.@0,S@QM;N*R-%T$$R'3$(@FN=(*O!8Z@;'RS"
MZ,:DSA$KMO:GKXP4=0?)=,2@'L)'X7!/1MB^;L>93339"BAAYPO6`'8NE+I0
M9D`F/6P8=^]]R-L+5%,9BJV`8O/;3ZS=EU90(56%B&96$J?2:L(:9&)5N$P.
MQ[BZJ0)[R/TJ>,<Q5'`HXBM'X]`1(`P62GD:<BB9,;9SJ]QE8CAB,TRVV"?N
M9RNZBAYS#D',\2`!;*=VN(4!/[[QDX*`(C9G:H4^"\7P0&RQ:6AL^0&()7!W
M*HOG+84=A;P8R.88UA+'']%Y=!$<@I#W*1%'CA)N-8%8WTH<884+LH"8\<A"
ML=;`7F#'L=6QNLW$?:67;XF#DZM2Q]N6D5`<,CY5!TKQY`X52;/*#,A,&^P]
M%M4H^8$6@X<AJPX*R"J$,S.,N]Y*?OZI"V4&9"K`#J0I&$@9/:J\7X$[N=HV
M%!!46Y4-<62=HW>]E9R8NE!F0"9-[$,:39;QX82E_`<[3BA:FJZ!0U:HK5JW
M$Q/!JM>@)DHH,ZQ,#=B0-`W?"35O7T:H!62$.K:*W"Y45I)3ZD*9`1DT,0HZ
M31;J:/8#2<T\F>U20/CHLR6V3WV]E9+@0ID!F1(^U$$CMX-*R(RT5:!WO55/
M4_CJ>U)F6)DTL5MI"<$BO0CQEN"CQRBXW[#KAX"L4-MGP-ZJU\!]P40)X?4)
MNN<0U\"O0_C/\HHT1[(CYW/K%?0%KSK`<K-2,+^'V8:+)>8=>+5'HC%<T;#U
MG!&\O&$]TQF)Y+6./0++#*X2PBIP[!I8/TQ@A-W-V+["*8RP4N&,S&!D-NAM
M#B/L%[DU!VZB'MA!T<*W(')8(T@<6.$A!C]#`]MX";]X!P1.EO!#<P`'W8.R
M0?6@:-`\*!D4,\&!4@8W7)?\2/[,FV-9M]Z9'"`MQJQ@-_R.C+]THIT_T0[N
MN%AG/\%=)H&KE#'6G`.EG7P!`8&Z'=W\#P``__\#`%!+`P04``8`"````"$`
M/?N2_$D&``"X%P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RL6-MN
MHT@0?5]I_P'Q/L;<C(WBC&)SE7:EU6IV]YE@;*,88P%)9OY^JV_07>UXK&A>
M0GRH.MUUNJJ:[H>OWYN3\59U?=V>UZ8]FYM&=2[;77T^K,U_OB5?EJ;1#\5Y
M5YS:<[4V?U2]^?7Q]]\>WMONI3]6U6``P[E?F\=AN(26U9?'JBGZ67NISO!F
MWW9-,<#/[F#UEZXJ=M2I.5G.?+ZPFJ(^FXPA[.[A:/?[NJRBMGQMJO/`2+KJ
M5`PP__Y87WK!UI3WT#5%]_)Z^5*VS04HGNM3/?R@I*;1E&%^.+==\7R"N+_;
M7E$*;OI#HV_JLFO[=C_,@,YB$]5C7EDK"Y@>'W8U1$!D-[IJOS:?[#"W%Z;U
M^$`%^K>NWGOI?Z,_MN]I5^_^J,\5J`WK1%;@N6U?B&F^(Q`X6YIW0E?@K\[8
M5?OB]33\W;YG57TX#K#</D1$`@MW/Z*J+T%1H)DY/F$JVQ-,`/X:34U2`Q0I
MOJ]-!P:N=\-Q;;J+F1_,71O,C>>J'Y*:4)I&^=H/;?,?,[(Y%2-Q.0D\.8DS
M\QP_6%*2&XX>=X0G=[3M66#/5VX`H]]PA+=TVO`4(]ZT7W![>(J!G)FS]&U_
M0>*\,5+`/>$I1KHO-J@P.D5XBB'G]WFNN"<\Q9#7IFBQI:29$15#\?C0M>\&
ME!LL5G\I2/':(7"(E&!!CDGR48Y`<A"2)\*R-F'VL/P])/;;H[OR'JPW2,:2
MVVQT&UNUV`H+DGF$-L)`C($$`RD&,@SD$F"!"*,2D-6_0`G"0I00,6P$,$GC
MH+"%A7"),!!C(,%`BH$,`[D$*&%#'?Z"L`D+I!"4C)0!OAKHAAM!=8Q&*$FV
MH\DHAH;$&I)H2*HAF8;D,J)(`AT&2^+XL['T[ZX*PD-%$<%L&.)`YQX5<!8K
M5:;M:"3<(@V)-231D%1#,@W)9431`*+%&MC^C'3:Z[N%Z`3$3XV9(;XSEL16
M0R(-B34DT9!40S(-R65$"1!250[P=E3$6(V*(8X4%4,\4'1:VV"NKFTT&HFU
MC34DT9!40S(-R1GBN$1F)5`HM_L#)<9JH`QQO&GY&.+YM,\[<QO5<#2^'V/D
M''1NM+,G'&%?&:37IZ,7V3V`U565R\;W@C67696(R?<JVM,<A]3O[44F;FKL
M#'%`6FE)\:[%C8)1H(@CTR80<V0UVB0<F61--9Y,X\EE'B5DV+KED&\'2HS5
M0!GBRGW)=E#N;KD1[)^2&F@SB[@1[#:2$5K+F!M!`Y:,4!HEXYS$@J=7W=`$
M,FZDEB':B?*K3-,$%&EM4.5^;:FU*BZ'H(3D<!=J?F^YE0MI*HF"HHN$E9J2
M6%\Q(H0I<4WQL1H45E(."OJ;D\B$E3H)K+&@_V@2JLCDJPS7[((<0WY2M#;[
MG&/')AK7AD-*-CM!@/5FCJY4M\)Q23N;O0R6OF<O5;]8&$G-3$#T]$7GD`IH
M8L\$Q-C=.1Q;/)0$N;#1N[A-OM\^)1#[\%,$8A!*2!3HEHX(1[RI:44<\N0^
MX7A(V9A;.9-C(B`YU=@D)/KL*GV`/H]RP75?7I&/O$_)QK\.Z7&<YQ6#U+Q:
MXBYI,RMO<HP$=#NOF)\_)5'"_7QV@*:[I*":V#,!C7GE!0O4$'+!Q.X'Y%./
M3;X`/R40<42-CD%((+Q?TA'7IC>51B2@*6-B#BER,'I%#@9)7)G.E2M<:MN!
M_H*CYY^YP[$N7S8M]$]H%%?V4Q>:!,V+)W*%@I5@D%IA2]3,M]S1@TJ0VC2R
MBH05Y,=DM40K'',K*#K)*M!:_CBO<5,5]#<GD0DK=1*(/O_9)%3MR1<KRCP;
M[I,@`"+]M_;RD?2P*XS:$Q*4A0R2#QSD7`I6$A3I4*Q#B0ZE.I3I$+G&FT9D
M8;-K.7;YTE3=H=I6IU-OE.TKN7*S2?F.,+L/A+*%"T':,]$;N"E\HD</A&_(
M#2+YR,2X$\(%@(X_N>$33%5_L8&1Z2:$B;P0SHQ7[/T0CEI7<'LA[C01TW81
MPBE&]]@&(9P@=#P-0C@#Z/@61-I>%0GZ;DA:B^X3PQO28?0WT'/#Y.J;%-ZD
M5]]`!PY)VP$V:PP2[DTOQ:'ZL^@.];DW3M4>%GE.#]`=NWEE/P:>YL_M`#>F
M-../<$->P9%H3FIAW[:#^$$&&._<'_\'``#__P,`4$L#!!0`!@`(````(0"O
M]&(<D`(``+L&```9````>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;)15VV[;
M,`Q]'[!_$/1>RY?<:B0ITA7="JS`,.SRK,BR+=2R#$EIVK\?:;E>TA1;^F)+
M]-$A#TG1RZLGW9!':9TR[8HF44R);(4I5%NMZ,\?MQ<+2ISG;<$;T\H5?9:.
M7JT_?ECNC7UPM92>`$/K5K3VOLL9<Z*6FKO(=+*%+Z6QFGO8VHJYSDI>](=T
MP](XGC'-54L#0V[/X3!EJ82\,6*G9>L#B94-]Q"_JU7G7MBT.(=.<_NPZRZ$
MT1U0;%6C_'-/2HD6^5W5&LNW#>A^2B9<O'#WFQ-ZK80USI0^`CH6`CW5?,DN
M&3"MEX4"!9AV8F6YHILDOUY0ME[V^?FEY-X=K(FKS?ZS5<57U4I(-I0)"[`U
MY@&A=P6:X#`[.7W;%^";)84L^:[QW\W^BU15[:':4Q"$NO+B^48Z`0D%FBB=
M(I,P#00`3Z(5=@8DA#_U[[TJ?`VK+$HF\0S09"N=OU7(2(G8.6_T[P$S,`6.
M=."`]\"1S:+I/,Z2_Y.P$$\O[X9[OEY:LR?0,N#2=1P;,,F!^&T](`2Q&P2O
M*+0TQ.J@!H_K;#%9LD=(G!@PUP$#SQ&3C`@&3D?/X.U\SPA&SYA9#.4Z&`[=
MI&^[R=[C!L&0B=E!]*<*`PCJ-BK\FX,CA9/WN$9P[WJ4&"Q]-QW1@N?S$X?@
M8]I@.:4%T>?3(OB8-EA.:>?OH47P,>U@.2QTMIB^76J<M0>]C'<T3>81"/YW
M6^.Y8Z^#!2H]UCA;S%YY#<,BW"8M;24_R:9Q1)@=#H(4[L=H'6?4)L46?FW/
M\DW?VFS\`+.CXY6\Y[92K2.-+($RCN:@Q8;I$S;>=!`YC!#C86STRQI^$A*N
M2(S"2V/\RP8<L_&WL_X#``#__P,`4$L#!!0`!@`(````(0#7FW.250T``*H]
M```9````>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*R;6V_C.@['WQ?8[Q#D
M_22QG3NF/9CX?@,6B[.[SYG4;8-IFB+)W+[]4I9H2J0G;8#S,IG^3%'R7Y1,
M*LZG/W\>7@;?F]-Y?WR]&WJCR7#0O.Z.#_O7I[OA?_Y*_E@.!^?+]O5A^W)\
M;>Z&OYKS\,_[?_[CTX_CZ>OYN6DN`_#P>KX;/E\N;^OQ^+Q[;@[;\^CXUKS"
ME<?CZ;"]P)^GI_'Y[=1L']I&AY>Q/YG,QX?M_G6H/:Q/'_%Q?'S<[YKHN/MV
M:%XOVLFI>=E>8/SGY_W;&;T==A]Q=]B>OGY[^V-W/+R!BR_[E_WE5^MT.#CL
MUOG3Z_&T_?("]_W3FVYWZ+O]0[@_['>GX_GX>!F!N[$>J+SGU7@U!D_WGQ[V
M<`=*]L&I>;P;?O;6]70R'-]_:@7Z[[[Y<;;^/S@_'W^DI_U#M7]M0&V8)S4#
M7X['K\HT?U`(&H]%ZZ2=@7^=!@_-X_;;R^7?QQ]9LW]ZOL!TS^".U(VM'WY%
MS7D'BH*;D3]3GG;'%Q@`_#LX[%5H@"+;G^WGC_W#Y?ENZ,]'_G+FS>9@/_C2
MG"_)7OD<#G;?SI?CX7_:RC.^M!??>(%/XR68CV:+2>#=X"0P3N`3G8P6WF05
M+&`@5SJ?FG;P:=IY]BU<:0E^VYN'SZY';SII[_Q*L[EI!I_8X7*TG,VF\^4[
M0UV8EO!I6LX_UA"6:SM2^#0-89H^U.7*M/14:)FY^^!HO2XXX#_8-OA8MQZ&
MA/J/:6O'Q!5Y/0P$]1_L]OJ0QSJJVT42;2_;^T^GXX\![#PP\//;5NUCWEJY
MP^6AN^\6S._6"RP4Y>6S<G,W!/%A)9QAD7^_#V;S3^/OL#!WQF8C;3S7(D0+
MM0J5VXB#F(.$@Y2#C(.<@X*#DH.*@]H"8U"RDQ/F\N^04[E1<J(0&P2DK\^T
M0PML$G$0<Y!PD'*0<9!S4'!0<E!Q4%O`T0ZB[^_03KF!:(:]QXK%A:O6QAC!
M-M,935V3L#/I%!4D%B01)!4D$R07I!"D%*02I+:)HRUL_8ZV_4\_7,W*NI40
M;WUCB+O`ETRQS@B;18+$@B2"I()D@N2"%(*4@E2"U#9Q%(-'W@V**6M7,4U\
M>*AT$1;,5DRQSJA33)!8D$205)!,D%R00I!2D$J0VB:.8K#B',7THV2DGOC7
MPTTU=,739.9W&V`H2"1(+$@B2"I()D@N2"%(*4@E2&T31RG8=AREKLNCK%UY
M-/$M>3290C1WT>8O)FZT19T11ELL2")(*D@F2*Z)'W3S56@R(U)J,G<6Q)P-
ML>J,<(BU[=H1$?:B&T14UJZ(FE@C##69SMK\Q9]X[(D0===Q<+$FUGTGANA*
M0N4P:==*947@-7!G)>NNH]=<>"TTL<9:FE;3WXRUZJZCU]KVZ@@)"?`-0BIK
M5TA-`G=B>6IGC&`VK0!E.4RDC69Z`J8L-F+C@D(JZ7K&FTP_TDWF=./-W/G(
M13>%Z*;\2#>5T\UBPE*0VN['F0]5B-PP(:VY.R,&^?9V$,R9VB%:K;I5&QDT
M6[1AY7GL"1_+)@FB:><E142.,]>QS[3(98L"$?DM$9'?RJ!YH`>\"MALUDX;
M5V:5P]NES_5=6-5Z+/`-8I'/UG>(5OI`0)<UVE<`F3"MABD3)<:&5L`C:H\\
MVA(I143N,T17W>=H1>X+1.2^1$3N*T1^JWFP9..N\7KKV)5<I?ZVY%:*<'G>
M[[YNCJ`'B-,S%6J&3:VI"PC(\''9;U0-#9/C!/R2U9^A,9HZLBS8JHC0RD34
M3"P!TQ4%84*]XX!2]'*UKPRM=%]3-I0<_5)7!2)[5>@!7;^MRC2<ZP=&,/%9
M*EJCY[8S=]9452%F#8ZO('K5I/UU?/O=I,'A5C=KIC:Q9TTC.\U31Q`PD1:*
M)(HE2B1*)<HDRB4J)"HEJB2J'>1JJ.H,6\.>"+?%,F6)+99&;D$Q9RE*Z'56
M&(J11+%$B42I1)E$N42%1*5$E42U@US]5-5AZV?M'.](J>L59[?0R`JR4)T(
M\[@3*)96B42I1)E$N42%1*5$E42U@US=5`UBZ_:.6+ID<<0R50QM0J$Z6P&Q
M6"K/GKP166$HQHBH<$D0T?,E1>0FE&PWS\@*W>>(R'V!B-R7B%SW;#NLR`K=
MUXA:]Z[*JDBY065=TX`_]+WQ-)K9*FL$*J-59*PL%".B>TX0T3VGB-Q[9@_N
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M0$2>2T3DN2+/>".U8^7LM_YMI5MKSM0U%9@;W+QT,PT7D)12`/(Z+2(K''IL
M4$`AER"BD$NIX17W&5FA^QQ]D?L"$;DO$9%5A8CFHD;4$\.JL/CX%@+'D2HK
ML+<0@U@,LU44&BO]$H#^WH\0*0/?<KLG-3&ZA_V&IF?!W"=H1?><(J+XRPR:
MZ[,G;S5A.WDNVQ2(R'.)B#Q7!EE+M':LW,A6]8^MN97G?KQ"A@-),14:N6<5
M?*L,3<,Y9281(G,D-('MG.^#L;%QPKWK#Z,V14_PQ+6FBQ6]&5JM].G"B)_H
MY+*S`I$=_+K_.7V'6KF>83MGR[U&-SU+@9=O?%H^5@.KA<"7B"G8*(9"8[6@
MNXD048(0&^13I"6(R%>*#<E7AHA\Y=B0?!6(R%>)#<E7A8A\U=BP]>7&MBJH
M[-B^7HNH%V.X6!JI+KH("A8LC0U-0VO!10;A,W$^G\_$9F)\DP:):07=40QW
M5C0"GS^5,QJ!.O-?CGC^DZ-GZJQ`1)V5Y`;[KP@ISXL1_S:A1C<]\M]6"OJR
M%#2([2%LHPS1BFXD,FCJM6O:@[>>@B5;]S$VHZ=5@H@"+D4$J[N+@![]]=@#
M<]@U"EB(Y.0&E2T046<E(KJ3BI">V16[C1H->O805<_=$/ZZ_',>IP91LA?Z
M`D42Q1(E$J4291+E$A42E1)5$M4.<O<*59;=():NXARQ#++%$BCR!8HE2B1*
M)<HDRB4J)"HEJB2J'>2*I0JN&\32]9DCED&V6`)%\*QI=V2RBB5*)$HERB3*
M)2HD*B6J)*H=Y(BE=J\;Q&K-W:P6$<D02A1)%$N42)1*E$F42U1(5$I4250[
MR!7KMD(KT%65'5F(;+&,%:%(6L42)1*E$F42Y1(5$I4251+5#G+%NJU>4M_^
ML?S&("@/\+$4&N2\V1'P@CXB*VP8HR_K>6J0]1I!2@WI>1HLV3?O&5FA^]QQ
M[\J@,F][-U*YLGIG&E*GZQD?U`]"$8U4A';/^V#)3AU"TS"P(\HTU(=04RCH
M)NRN8FQE*]1UAS>:HA4\:+L1R(S#6)E#*&\4L".7'-W(O`"R%%>O=T22-43K
M@7W[*8^*C)6=%AO4?7ON+:1(ICZA3#6A[D@D8951=RI3\D8KEG#GZ$9FJH%*
MLNT(>D<1G9,[NXY&+&Q8KA:V_=P-WSG>(2N\W=@@F%-$"2)*'U-J:$4./SW*
MR`I]Y>BK)U9NR^$#F<,;Q$HH=F82&BOUZAX%/1]Z1%8X]!C=V^&B!V%74=3P
MBON,K-!][KAW=QV5"-LQT^XZ:M%^^+T"V#[$]J,1BR-V;A":AO:I"2)]:C+W
M)CTKR_BV@ZCK#N\X14<@(LV$*#B-U4(7/![\LL0]*LN-@8Y85SB5`7/AO%G[
MVN8-7^\')I&FDZ,-(MJ50XDBB6*)$HE2B3*)<HD*B4J)*HEJ![DBJLS8%O&=
M'<LDTK98(K<.`X$BB6*)$HE2B3*)<HD*B4J)*HEJ!SEBP4'O+6*UYFX&CLB*
M+(DBB6*)$HE2B3*)<HD*B4J)*HG4#^"HLM)BZ1^TZ=_J')K34Q,V+R_GP>[X
M3?U8K7U)M</ZEW2PX-8J1F'O$%=6<*7=D_F5Z01_?L>O>,%:O=#2X\V;PI7V
M4$2TF<&5]MU7?L5?K%6YW^/-AU%#;=MW!48-A9R\`L^GM7KZR"LI7%$/#GD%
M?F?XN<VK^<C@]X?M\27G/G3>YR=8?X;IDAUL0*]>N4"M7K%`JUZIYFMX<USZ
MA_</8*1]0H6^MU;?0LDV\!736GV!)*]`80$2]MT@U`0@8=\52)B@3=^8(=>!
M-GU7-@$$&#P_Y0@V`2@/U92\`J\KK-7+"'U7EG"E3P-X^6.MOEJ7;>`=D+7Z
MAEU>@5=!UNI%C[XK"[C2-P+X8AZN]'D+8="]+<!5'P^7:WBC7/:=PBWV\1(Z
M[N,;N(M-_XC@BGK!0?8!;^*LU7L.\@J\D+-6KSO(*_!>#FC?JC7NU@K\4O9M
M^]34V]/3_O4\>&D>87.:M,G#2?_65O]Q,>\(?CE>X">RL)O#+PWA-]$-O"`_
M42\2/AZ/%_P#NAYWO[*^_S\```#__P,`4$L#!!0`!@`(````(0!^E?+9W`8`
M`!@?```9````>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;*Q9VX[;-A!]+]!_
M,/0>RQ)]QWH#6T':`"U0%+T\:V79%M:R#$F;3?Z^AQ>1XI#U#7E9KX>'P\.9
MX1E9?/KXK3P.ON9U4U2G51`-1\$@/V75MCCM5\'??WW^,`\&39N>MNFQ.N6K
MX'O>!!^??_[IZ;VJ7YM#GK<#>#@UJ^#0MN=E&#;9(2_39EB=\Q-&=E5=IBV^
MUONP.==YNA63RF,8CT;3L$R+4R`]+.M;?%2[79'EGZKLK<Q/K712Y\>T!?_F
M4)R;SEN9W>*N3.O7M_.'K"K/</%2'(OVNW`:#,IL^65_JNKTY8A]?XO&:=;Y
M%E\<]V61U553[=HAW(62J+OG1;@(X>GY:5M@!SSL@SK?K8)UM$S&HR!\?A(!
M^J?(WYO>_X/F4+W_4A?;WXI3CF@C3SP#+U7URJ%?MMR$R:$S^[/(P!_U8)OO
MTK=C^V?U_FM>[`\MTCW!COC&EMOOG_(F0T3A9AA/N*>L.H(`_@[*@I<&(I)^
M$Y_OQ;8]K`(V'4YF(Q8!/GC)F_9SP5T&@^RM::OR7PF*E"OI)%9.\*F<Q,/Y
M9#*>SF=P<F$B4Q/Q>??JH=R)",RGM$V?G^KJ?8!J`]?FG/+:C99PW$5$TM`Q
M^K\0(3;<R9I[604X)MA]@[Q^?6;SV5/X%;G(%&;C8B(;D70(GD+0TQP1J1_`
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M_8U')`YJ(E!.(#PR.U_P1G@W.:F;4#:L(;4VDB9"SFD`&N60XR+7J]1'^Y32
M2I2=KA4V)[6RB;2B&A0578-QJ')))%1CG,![,ZR4M1]$+;:&5SRF32O2*(<9
M5T7*+)H*D;F7'7=%ZD^:2(H9K3^-<MAQ:23L'JP_*;)6_4D3(><D5:,<<EQ"
M"3DV`OS>N$DIMJ@I=;8:VGA"XZ91#C6NN83:!%IP+S,EW?UZDR82-/H$$&F4
MP\PC^O&$]]HK(NMJ?*1,J&U]<.,Q[?H="BOT4*8%6U+,MT7CQN9"[R[3$Q/M
MVN],E^EU*)N>41^;GJ=3W$9/]H%^B>%90)S6*_04RJ(W,0W$IN?I%K?1<YM#
MK$Q7Z"F43<^T$)N>IU_<4GJQ;A`H9O4S09FNL%,HFYW19IL=?-'2NXD=GT<J
M3YFNL%,HFYW19IL=4)3=;:GE$PD]9;I"3Z'P8<[MQ*BS38^+--&[V^A)=;<.
MAC)=H:=0-CVCT#8]3Z>(I[-'FBQ_:J#QU&V@'RDJR6HB](9*<NQI%H^R<QN&
M\+X*N,[U\DA5VJ`<=IZ&P=_/W-G*8MT_#`VV,$*FSK5"(:*:K"DY@4DZ3^+9
MWDHS(]WC<LL0:/MD=":PT,O'$].K)`&#HK%BGOXPP]NHNZ,E'!%NLA.0/)I&
MI;AIE,/-TQP>R"/3K<*$B"V,XLL\=JA+>308ARII%%?RZ+8'IDQ6'J>DV!*#
M<@AP:29R]M@O8Z9$OO<$ITQV(J<D@HE!.>103I3<(XGD;D2)]1-IFJ-*I$)=
M3*3&.%1)6[B22+<7,&6R$TE()@;E$.#23!(93>4KG#L%C'%7Y$A*$\FDZ>#J
M2&J4P\XC_(]D4HM^/Y.$QH8I%-AH;:/2:C`.52[,O4!>R21'DU@IDYU)AX!&
M40*X@K`(\)<-\6._DX4KFYTRD4R:IPF928/2[.2UAGQ[7^;U/D_RX[$99-4;
MO[)@"[QWUV9UG\+FRS4\P04908J6"5+@&UE@9.$;&8^ZZQGB;<WBY1HJXO,6
MPUOL'6$88=Z1,49\WM9L@G5$,R8,-AA)F+BS<4:F&!&:Z(S,,.+U%B$Z^%WK
MV4^,.7B\\HU@#AYMW)%UO`!K\3J6,L`(?\9PYVP88HWF[QO!)9G?&YQY?47P
MA5>2'E\1?.&-H&\$><-+.W=D';'EVKM/O#?#'&]&(V04[Z5<;YL(>8,.^4:0
M-_FL3J,6(0>1+P>X/US[.&_X-GUK8),^_!I;]&Y^PVO6YPC[\VX/N_-N#GOS
MEB1VYMO8!K4E2BO4L<"]Y#G=Y[^G];XX-8-COH,(C,3/C%K>;,HO;76&_N!V
MLFIQ(RG^/>`&.L>]P(@_+>ZJJNV^(`NAOM-^_@\``/__`P!02P,$%``&``@`
M```A`(NRY&XS`0``0`(``!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````)R174_#(!2&[TW\#PWW
M+:6;7Z1EB9I=N<3$+1KO$,XZ8J$$T&[_7M9U=4:OO"3OR\-S#N5LJYOD$YQ7
MK:D0R7*4@!&M5*:NT&HY3Z]1X@,WDC>M@0KMP*,9.S\KA:6B=?#H6@LN*/!)
M)!E/A:W0)@1+,?9B`YK[+#9,#->MTSS$HZNQY>*=UX"+/+_$&@*7/'"\!Z9V
M)*(!*<6(M!^NZ0%28&A`@PD>DXS@[VX`I_V?%_KDI*E5V-DXTZ![RI;B$([M
MK5=CL>NZK)OT&M&?X)?%PU,_:JK,?E<"$-OOI^$^+.(JUPKD[8YMWUR3>+\I
M\>^LE**WH\(!#R"3^!X]V!V3Y\G=_7*.6)&3:9I?I&2R+`@M;NCTZK7$Q]9P
MGXU`/0C\FW@$L-[[YY^S+P```/__`P!02P,$%``&``@````A`"1QAT#,`@``
M<PD``!``"`%D;V-0<F]P<R]A<'`N>&UL(*($`2B@``$`````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````G%9=;YLP%'V?M/^`>&])VVB:*H=J2UIU4S\B
MA::/E@N7Q*JQF6VR9+]^U]"DL#ALRYNQ[\>YYUQ?0Z[6A0A6H`U7<A2>G0["
M`&2J,BX7H_`IN3GY'`;&,IDQH22,P@V8\"K^^(%,M2I!6PXFP!#2C,*EM>5E
M%)ET"04SIW@L\217NF`6/_4B4GG.4YBHM"I`VNA\,/@4P=J"S"`[*7<!PR;B
MY<H>&S13J<-GYLFF1,`Q^5*6@J?,8I7Q/4^U,BJWP?4Z!4&B]B%!=#-(*\WM
M)AZ0J/U)9BD3,,;`<<Z$`1*];Y!;8(ZT*>/:Q&1E+U>06J4#PW\A;>=A\,(,
M.#BC<,4T9](B+&?6?-1K41JKXV>E7\T2P!H2H4&S62_;MNTU'\87P]H"5UU+
M%Z%!@@==C`FW`LQC/F7:>B!?#-N8:Q0-X@;05D6*O4&OI46^Z#?9J,U5&_FN
MAK&21@F>,0L9_<H$DRG0V5ZE_V)/I^SO*686,[E.,U3E]+%$P7:Q'?5-(1U4
M79>I/L;E['_3C%E'Z1VR9`ETK(J2R4W-\JPJ"J8WKI@97WBS/("E=\H8.@6-
MU+(#!=R#7J#!3VZ7]*%:@5"H74J5I-^9K+R1;["QZ9R)"NB$FU0H4VGPXWX;
M#0WHZQ\5+YT(WJA87L%MHY%K)!3#XBW"$82#Q>OAXF&KW7")[8.FIJ;FF6F-
M5\KO4O-`W?US"0J<2Z:>!-[XR(,J@"9L?0!`ORI^\?=EP00O>/N\$/S\]7GT
MTDB]26I2]CGIR])?^;DWC:?R"5C&A;_TP^8T@;4W0W\O^_7P-S/M0W9`E.-=
M_,CZE3S&QZ]+_S7RYSG4,@T'7G'Z78Y)TRFG\[K]\9[=<?EJGLI$3?`5V#[8
MW4U2P\OP*=N>OV^06WRKM7!!QDN&(RG;VNP?N-^+>?,/%9\-3P<7`_QS:.V1
MZ*U[<*C%OP$``/__`P!02P$"+0`4``8`"````"$`&C,95=H!```Q%@``$P``
M````````````````````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(
M````(0"U53`C]0```$P"```+`````````````````!,$``!?<F5L<R\N<F5L
M<U!+`0(M`!0`!@`(````(0#^>]^4T@$``!P5```:`````````````````#D'
M``!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+`0(M`!0`!@`(````(0"'
M01`"3@,``"X+```/`````````````````$L*``!X;"]W;W)K8F]O:RYX;6Q0
M2P$"+0`4``8`"````"$`65+Y4S`%``"$%0``&`````````````````#&#0``
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!`BT`%``&``@````A`+J8@VV1
M`@``H08``!D`````````````````+!,``'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"+0`4``8`"````"$`**\Z?HP%``!\&P``&0``````````````
M``#T%0``>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+`0(M`!0`!@`(````
M(0#<MJ3TIP(``/$&```9`````````````````+<;``!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L!`BT`%``&``@````A`(TZ^&QL!```@1,``!D`````
M````````````E1X``'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"+0`4
M``8`"````"$`@;V6G\P"``!%"```&0`````````````````X(P``>&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+`0(M`!0`!@`(````(0`9@H%7XP(```L(
M```9`````````````````#LF``!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L!`BT`%``&``@````A`,"KRE-\`@``Z@4``!D`````````````````52D`
M`'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"+0`4``8`"````"$`\+.]
M$4`(``!6*@``&0`````````````````(+```>&PO=V]R:W-H965T<R]S:&5E
M=#,Q+GAM;%!+`0(M`!0`!@`(````(0"6#5O)I`,``&D-```9````````````
M`````'\T``!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L!`BT`%``&``@`
M```A`/+@&%E)!```/!```!D`````````````````6C@``'AL+W=O<FMS:&5E
M=',O<VAE970S,RYX;6Q02P$"+0`4``8`"````"$`@0RYN\8$``#+$@``&```
M``````````````#:/```>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!`BT`
M%``&``@````A`*71J2'7`@``WP@``!@`````````````````UD$``'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+`0(M`!0`!@`(````(0`HH%KD9T<```ON
M```4`````````````````.-$``!X;"]S:&%R9613=')I;F=S+GAM;%!+`0(M
M`!0`!@`(````(0#UHBX*4PP```5Q```-`````````````````'R,``!X;"]S
M='EL97,N>&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,`````````
M````````^I@``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`
MZO"D"S\#``!("@``&0````````````````"_GP``>&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+`0(M`!0`!@`(````(0!NAM_)>`,``*X+```8````````
M`````````#6C``!X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"+0`4``8`
M"````"$`2J#PV_`$``#$%P``&0````````````````#CI@``>&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;%!+`0(M`!0`!@`(````(0![HBL8T`T``(]````9
M``````````````````JL``!X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L!
M`BT`%``&``@````A`/$\9K=I`P``[0H``!D`````````````````$;H``'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"+0`4``8`"````"$`!468E),"
M``"!!@``&0````````````````"QO0``>&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+`0(M`!0`!@`(````(0"D6GR_VP8``#H;```8````````````````
M`'O```!X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"+0`4``8`"````"$`
M!DWYV3(&``!S&P``&`````````````````",QP``>&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L!`BT`%``&``@````A`)IPNV=*"0``/C```!@`````````
M````````],T``'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+`0(M`!0`!@`(
M````(0#S8\&![`,``'`0```8`````````````````'37``!X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"+0`4``8`"````"$`))IR&5E=``!QV`,`&```
M``````````````"6VP``>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!`BT`
M%``&``@````A`.54US]$!0``8Q<``!D`````````````````)3D!`'AL+W=O
M<FMS:&5E=',O<VAE970R,BYX;6Q02P$"+0`4``8`"````"$`?\4_HOX&``"(
M'```&0````````````````"@/@$`>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM
M;%!+`0(M`!0`!@`(````(0`5XR8PXP,``-@.```9`````````````````-5%
M`0!X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L!`BT`%``&``@````A```P
M"974`P``U`L``!D`````````````````[TD!`'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6Q02P$"+0`4``8`"````"$`P%*3+I$&```&&@``&0``````````
M``````#Z30$`>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+`0(M`!0`!@`(
M````(0`-(K)5G04``&(5```9`````````````````,)4`0!X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L!`BT`%``&``@````A`#W[DOQ)!@``N!<``!D`
M````````````````EEH!`'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M+0`4``8`"````"$`K_1B')`"``"[!@``&0`````````````````680$`>&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+`0(M`!0`!@`(````(0#7FW.250T`
M`*H]```9`````````````````-UC`0!X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L!`BT`%``&``@````A`'Z5\MG<!@``&!\``!D`````````````````
M:7$!`'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"+0`4``8`"````"$`
MB[+D;C,!``!``@``$0````````````````!\>`$`9&]C4')O<',O8V]R92YX
M;6Q02P$"+0`4``8`"````"$`)'&'0,P"``!S"0``$`````````````````#F
I>@$`9&]C4')O<',O87!P+GAM;%!+!08`````*P`K`)\+``#H?@$`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EJQAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-based Compensation (Details 1) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding beginning of period</a></td>
        <td class="nump">843,442<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
        <td class="nump">200,079<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Options Forfeited, cancelled or expired</a></td>
        <td class="num">(27)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding end of the period</a></td>
        <td class="nump">1,043,494<span></span></td>
        <td class="nump">843,442<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable, end of period, Number of Options</a></td>
        <td class="nump">266,655<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest, Number of Options</a></td>
        <td class="nump">1,031,382<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average exercise Price, Options Outstanding, Beginning of period</a></td>
        <td class="nump">$ 3.76<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted</a></td>
        <td class="nump">$ 1.91<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Forfeited, cancelled or expired</a></td>
        <td class="nump">$ 1,908.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average exercise Price, Options Outstanding, end of period</a></td>
        <td class="nump">$ 3.35<span></span></td>
        <td class="nump">$ 3.76<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Options exercisable, end of period</a></td>
        <td class="nump">$ 8.42<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average exercise Price, Options vested and expected to vest, end of period</a></td>
        <td class="nump">$ 3.37<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years) Options Outstanding</a></td>
        <td class="text">8 years 11 months 5 days<span></span></td>
        <td class="text">8 years 11 months 9 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at March 31, 2014, Weighted Average Remaining Contractual Term (in years)</a></td>
        <td class="text">7 years 1 month 17 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest, Weighted Average Remaining Contractual Term (in years)</a></td>
        <td class="text">8 years 11 months 1 day<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price of options that were either forfeited or expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001564590-14-002121-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-14-002121-xbrl.zip
M4$L#!!0````(`(R+K40XQ_O3:K4``,(P#``1`!P`86)I;RTR,#$T,#,S,2YX
M;6Q55`D``WB.<E-XCG)3=7@+``$$)0X```0Y`0``[?UK=Z-(LC`*?Y^UYC]P
M/-U[5:U75@ETK^KJLVQ7N:>>7;?'KI[>^WSIA2%E,85`S<4NS:]_(S(3!))`
M@`"!E+UFNF6)2V3<(S(B\I?_]\?"E)Z(XQJV]?9"[O8N)&)IMFY8CV\O?/=2
M=37#N)!<3[5TU;0M\O9B1=R+__?7O__ME__G\E*ZNWLG76F>\43>&:YFVJ[O
MD!?WGUY*_W-]]U'Z8.&-&I'>V9J_()8G74ISSUN^?O7J^?FY.S,L^-50S:[C
MZ%W-7KR2+B^#)]\X1/4`*NF=ZA&)_O-:4GKRX+(WO)3[WY3>:UEYW1]TQ\IP
M,A[(_[]>[W6O%WG`O]BJI,@_KR6Y.^GVN]'+OJK:=_612!_>12Y3WE]-Y=O1
M<-@;O+_J7\G*[6C<DT?#?G\\&=Q,^I<]^&?:&X^&``[`U!M$(;>7*\=XG'O2
M"^TE!5FZZ^+_WMF614R3K*3_DNYMRX4K%TO56G6E*].4[O`65[HC+G&>B-[E
M3_SQX)@24,ER7_N>\_8B@C_\J6L[CZ\4`.85_'K!+S1<>Z#(X\2+^Z_X%?R&
MM`LY"8-'JP^&';O<\I^(:5/JX5)[_;X<7(M/,E.>;1K6]P?5#9_]`[^(7?_<
MIU?+T^GT%?TUN-0"5/J+W<_6/>>5MUJ25W#1)5Q%'$,+[]M_4_P&O$#WPGNB
M"QB^8C\&EX*X/*KJ,KQVIKH/]%K^`^('.$>^7&,(?L&7NCOOH;_LN$FS?<MS
M5G&87*)U'^VG5_S'7;?YC@.RG70?_Q5O5.(WZL38?0_\L.,]Y(<VWWT]_K+C
M!L-Z(JZW^Q;VVXZ;7&_I[+X%?\$;Y(T;#"WA>D/;<;FE&IJ[^P;Z4_06$%-)
MHH)JOG:U.5FH=V0F47Y]C41\>^$:BZ6)?$Z_4QW-L4V233+H'7.'S-Y>H.Q=
M!D+6_>'J!00GNTR^8LOR+<.3#/WMQ>]_NG/5`>5/OX=?%D1%=?\K^_J75\'?
M]+97>-_6$[C:^?W^W=93^$^OX;><C_H3\;(!FVX\&3KA?_$;/Z-DJY[MA%]G
M>3V]ZM7N^^ECWQ'+7H`E2WCP+NRLG[E]\R^O(K`GK!T7_!6L(UC4;7+@CZ^#
M7S.A$BR'^]?,VWH2?/\:?\CTD"7\OO4$_#+Y;LVV//*#/>#FS[5)_9/RN-R3
M_PPM2O!@6)/AK=9(!$3!-S.#.!*5O+A0!1)[\^&_+WY=/_^75^O;0JS'GOS+
M$FR`K:_?`T;0\=`3^96Y("CZO[Q:?QM>2"P]<ED?U`,^6H]<],NKR,-_><61
MD`4CP][TZ(A@_H#W:^")]::_O`J^.W1]32!T?'V,?N6LKR\KS5I?_Q(L?8GK
M"R2VWPA"QB2VGTUB^Z5*+#@(BCQI#FM',0+H`.++DSIU&'>#KWP-X[I/JO.=
M>%_!L2'@>>KW!#Q0`XR6>^_9VO=[>#QQKWX8;G`;_^8363P0)\#NN'*D(M[(
M(\:N4>-.?BQ-0S,\!HVD&W`!"Z$YM*]SKG(S$(LZ92,69Q@7OP8/C^$":!.#
M)N)AQ"'/KAHX=XQ+40UED/U:D#TD^W6KR'[O@=9`:-[_Y0,0F/&P+?1,HT2^
ML2',<SSCP21KG"&FVD+VU%7F(_(>7)P6V1<+VSI?0F^L_I1(>Z7K!BI"U?RJ
M&OH'ZT9=&IYJGB&94S%Q$B3'A,,[,L-57&F:O_!-N%I_!Q;/>GQ',#N\Q'OA
M(8_DC!B`YF'RX:7I[%`;V9K,[GDT'$9_O7H"_[-1=07"V%Z8ZB@WL*^)M$W'
M2"D^WWF)2G7.7RN8H;C+<!YL<DS?H14,E-4(GSRG'"W,*'/WH$*=<?(,T)`P
MH]S-I(8X5L=D]S1_Z>29NM8<V;%(N]=X!340O<&YT/L($62V8@ZXK-0(LF;2
M-ATC!VO$\Q.5FB+(IC)#,6_P?-BD,1%D4QDHLQ$^=4XY6@0Y:$<$>?(,T)`(
MLDQV:(QC=4QV3_673IVI:XT@CT7:O<9K&/@[PW.A]Q$BR&$V#V=8;@19,VF;
MCI&#->+YB4I-$60#F.'&5%WWRXPN-?0$;PW']3ZXKH_MK;>V\]GVB/M57:D/
M)KFR]#M"O2!PB!R?@"+QB$-<CICS5M*;V,SA91Z`\T3F%!:FE2(D&/]0QA<L
M=8!6/@D?H&$,*1R8XXD*_Q$HB<0R3:)Y/E@HQX:W>ZN/A@9T(&S$B/!ARI.<
MW&AOC/`(-Z8L01+L7P+["\8Z3$,+?^8DM/*9NS3W!.[715*F5M$Y!.F-$1SA
MSI0C1(+U15[FJ)KYW!V9D]#&Y^/&E%AHU#8F;V?%42L8*+.7>NJ<<K3BQ&$[
MBA-/G@$:4IQ8)CLTIF;GF.R>ZNV=.E/76IQ8)6DSA`I'WI@:!4[5J!U,55KD
MT-X<Z!%2.:-L?N#HN%%WH:TI(0#'W9LZ5=8ZV,H+QFR=9JXIK7,\D2EE-G61
MK>'(U-<[HA.R4%-FX9Z1Y!1%TV$BT\+AW6<G0-_FAG/`)M<9R=`!F!)B=&37
M[:QB7Q$Z9DX@UDS:IF/D[((1X<L?&/[&C*+(41[%%VEO('P>=J8.01+L+Q*4
M1]?0)^$2-(\MA4M3;[>)[3O>7/@TM><H#\-[8\1'.#6EB9(0`.'6-$!+G[M?
M<RJ:^=P=&V,F)*:N_=9#4"T$IBZ!J6>?E5^PWFK/<%#O>0A+\)C,J!$[J:<L
M**R@#F_Y,H,W&-;CC>V>:320B`<A`BT6@?;PL&"4)C6HM81I6MZIUA`&*DW3
M-)I76JA@(NU@HR-U^NW?,6@TT5N79S\FR0N:BE-G@(;T,I?)#HVI0&R`AMN=
M.SQUIJZUE[D"TA[DLUP7[EB`']D3<G7^C`-O>MP.MBJQ)B4GMAJ?;+BN,@08
M9PL!Q@T+`7*)TU93I9"G7#VH0J#.1Z#:P^J"49J_TX&M@@3?%6B1UG%9&0HU
M`0N-UY.5)J^/Q_[%6+;4#)9@_L84@!RAEK5MK"\8]@19H;[P:PNA[?,U*^&K
M?=YE4]R`$_6""S*M\`.:Q/["$:B5^07+GA\SW!L_&M,K>$;,=QC:A58].4$2
M['_L1L$39:R#*Q<$6[9-*]?4]=18@2%/\)-P:NH7GP,1WQ@!$FY-><(D1$"X
M-HW0U&?OW)R*=CYS]R8Z!3U$!)`1_R*.9JBFD)3#)*40AH5X-$T\[N>J0]QO
M]OL?1/,]XXG<^P__!C7WS;XC2]_1YJI+A'0<(!W9$2R$HQG"<:.Z\\_$^S+;
M-9[@8"%03I[WT_!W!CP>Z<!1ZCY-L%K6'?2F_9Y@W;-@W<%E;WK9[YT*Z^)Q
MX7W!NF?!NNR<\GY]K!L[=ROGZ4J"L_,=:U;GD4R"\?.=RU=[8G((\>3@?'A?
M9"/WG=W=NY0'IWEV=\*L544Y[5A2'`:;:^`#1)Q*C>'F\4\=413EI/E?'#:2
ME_V5&MV?XT^G'RDG[ON+H?2Y!&!TJ=3J_Q]YUKPL]\:GS?]BQ'P.]I<A_!W7
MZ/\?O^A8GIPT^XM:X^SL3[=3Y4F=X>_Q"]-&)[XA)>K1<HK`J.1-J_H&!6VD
M^G*-9CO]0+@H=AH_6J#2Z=6E!\3UB4,L\Y%S4^TL).(`!`FA:*E0[)Y+F<]4
MR$KOQ(.&PY!TWL(A*Y>]4F.(8X^,SC+7=GCB%9E%,--X,2A[$DD\CABV=G)Z
M*:.>944Y1R,A)CQG$P^P$DHUF::S:B,73=B9#TZIF;1-Q\C9]6(U.0/9"F8H
M=LS4^;!)8TXD;.D\W*N8]]A@7FEWA#YNZ*%.@NS5N]Q-/(BRV41OG:=]3)(7
M]!!.G0$:<A!EF>S0F#"J`1IN=W1TZDQ=<UE&LWR6LLYOF@3!T:0=[-*T(VQ:
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M)6S2.G_^V$Q2/VF;CI$F%:"V3>J:5H/7PE1>0]B_`06H@OD;XTV?ART4VKJ9
M!:@M=0)**T`]9[X2!:AMTH65%*`*]A>.0)N87[#L*3)#??F`A,V)\V*K*K87
M1#:@^7ZP8/[V,O^):O[*MY*%!]R:;67A_PI-?0"[MI01RJK[;@EC"#^Q_H*Z
MEK"&J%`JRWS0TVSVG?-S=FQU@"G*@M#&^%'GP_PE5M*WC9G;65+?"@9*U7FG
MSAVUUJ9/F]I8=39DKKVQJG:2%S0'I\X`#6FL*I,=&E-E6Q.[[\X<J>[\,_&^
MS+[,(+0&6M[8;J$SH_?I2+G'/2;X]XG+RF'*LKY\60KI*_'@Y%XF#PXNJSM]
MFB8$+61=P11-THR[`H/6L52=$8)@]BJ971CQ!D8\QV:2^DG;=(P(#=^@'%`K
MF*%0YN",V*0IB>3&,E"J-CEU[J@SD;PF;<,2R>=#YKH3R?63O*`Y.'4&:$8B
MN51V:(S/7!.['R%=(@=>DGSJ\B'2)1%/3<[FJ<FMS0WN=0C.C_'%KLDI"$$+
M65<P12:F**D`O2WLT?("]+8RRK5@E'J;^II@9M+#`NSK\8P'DZR1*X*$5*2<
M*:.(^+&^S9B&,X.(KYJPH=U4)BF6HCT?EFG,CMT1&*A^0C<=(X<;X5.7EUKW
M,.6F[F&>#9EKW\.LG>0%#>2I,T!#]C#+9(?&6+D&:+B=QDL)G`'EU+F[Y@A2
MR>;)*$V-(,^/,8X001Z!2>HG;=,QTH`ZD/,3-E$'<E1FKW'4[)[M]+:Q?MT,
ME@FZMN_FME00\HV=%8)P$H)0Z6[U&;@_>_>[VR8(Q]OO;K;`"D$0`;@HD15"
M4%X&_GQ$HLQ4O!"09@E("QE9,$4)F7>A\YJ[_=@*!DK-()\Z=]1:A*(TM0CE
M;,A<>Q%*[20O:`Y.G0$:4H12)CLT9J>U)G8_<N*D'WA,_5.7%9$X2?#@^MD\
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M1QS[BT5N;=]A;PYOB.US*`&9%&726+G;O^H<(I@%-\7VZNCCD\F<`\9T9JA,
M42C9Q$*Y5";E64:E-^0FLC=HE*)`(PD8&69R''N#LE3GE*M._*",&X61WC23
MZF27*>,2,=(`1*R]I_7ZRO.>[E3KD43#@D_J#V/A+]J2)PKAS^?UQU;9DJP/
M.&W.OU33)]>K*]<E;/,]1CJ(@5:LBPE=1+<M-$Q<6$Z:[EQ^2XC[U;'A9F_U
MU83G75DZFG.:G;Q>A>[:.G!?^F"DPTM:%\]D6&SN('X72DXFLLG/)((Y0N80
M3!%:$-^Q#`\"?[CLUOB!G]I7?%8Z?R1CY8Q9Y=Z>><\JQ4GP,;)EULZRQ=(Y
M)S.2SIB1/A+5)7/;U#\LEH[]1+/V@G5>IZ#EC)DEU;4]*_ZHVJ-M0S33[,:W
M-I.\@E:W0V.3LY+NDY=J(<TG+\7[@LFS$N@:8LC&R'8ZX<],S.LE_'$E/F=.
MX*P40/VI@,;H@UQL<6;JX:AL<5QML3?Q<U;ZH8Y\3V,TPA[2GYD.J)GT1Y)Z
MK!_[@[C>`E]+G&A_P:1W!M2F]7-;"*B&P+T)S>363^!KQ[87@'53/]\,/B7T
M)B+.,6>?*/%GR1'5B?ZQ60+6.NF-&U!-'ZF$!`4X+N](25P?JWUMQD)CM:]T
MJ?MK7T.,E-HVL*ON/=X_\-4QGN!U'ZPG%`!8UP?KJ_\`?+]5D+ZKY;"1GF"D
MGCYU_7GZ;W)BZ62FW%;.2H*#*N:@BD*+/(RQIT?I+#7*,5IU&JX_,K")X(Y3
MTPU,"29T+:8.8^0GNIS@R5@'C&7,AI2#^Q1+LXH[J'^6NJ\6,1#<?T;<WW#=
M_LWP3/)E]L'2C2=#]U5S/0J+6CS;N;+TF[E!9N]_$,WWC">X>F9HL=1THQEZ
MYPKSC+[*A`?!S(WQ3AN>-VVOFWKL#&K9;"*XHSW;YML-]H9U#@WVT56VE51_
M$.-Q[A']"KS!%LW.+$BRG:MM">D^6)J](&$(\-'6U'`P44!=XA+5T>;@#D5*
ML-[_6`+ZVC<2+&7!^:B>`2TG8X=+9Y:6S,YL/[,<;Y9F:<S2EMF:K6>6(T[A
MS<`L]\0TP8?]C5A@94W`S96^`%_)]1P58W..GO9U2)?&-KD0=(:F*3<#G9N1
M:@`#-=I<Y66@LS-<QV>@9ILP,.R>XVL>/4CA9JXZC^?,+<G8:!MKZ,1X_9X"
MPC)O#L3FG]4%H;QR2WFEU[N0^#UW9+8]5G736;FZN[F2K@U["7A9J!T)L-[]
MY572BS;!N`&T@`1^L'3RX[_)*@J'G`^.*`LE/G_]^G>VYB-],&D9?:N2[ZUR
M[_+_LO=%'[A^S15\I>/7MZ;Z&'U//]][9JKI$O:BV".W%_25$O\]8XGH&P?Y
MWAAEL,3G;[_^UG`UU607W<)W;A2$83X0_N_&J[>>G?3Z_X6H9.OEH_SKW_7Z
M\-GKE]_XCA/[?0?VQ_G>?AEL8:4]?U.8;@V3.#?PPZ/MQ$1IDN_E]PO5A"=)
M=V1I.Q[H/`D'EZC6*BI9L9=MB?7ZR(5[T`O$_>)[F`C4\6$1P*;[`!OB)3K1
M#``)U/6'S[<7DF\9[/+?_W3IPX%8L(#>1![&1#\%!@9O.)9%=3&$Q?_@]L:3
M:A(\:,*[41UG!5?3R:41L.6]*A+1&`'[LA^#VG#M@2*/?[]_AY`K/5#YO5]>
MY8+FP`7LT:ULUSS;`N31>#@Z=`%?O#EQZ&18ES-[%-J].CD[NH?3:0S6[1?G
M`6R/$L^'QGR`)<*T5\WGX<T)\'H4JB(`[5'Z.9&D#+,"E-C\\YG$X-MK%W(@
M+"X(:1`4@W6/%<F#2V5:$-8(9WZV+6V;X'NM37:$3I1)DE2LWYT3O#TV)Q<_
M]GMYP6._1N!1RC0FRFBX2S[V@5"F.1CW)H/](&B:[8-1^*JNU`>3;&L-I4R=
M/XP;V-TOSPM@B;I_.!WG!O#]8FG:*T+N"#WR\*.A/A@F/<AD!ZPEV@19CEN$
MO7`<`':)EF,PG!X"-A7L=&!+-".#89P?$MZ>&\02K<=@,,H/XCM>:'L'O]S`
M?PUO!Y!@/7ZXQFO+,-]>>(Y/,J%U-Y0LR?,:'A?+/#WW@U2/_.I_/GV\Q]R4
M>LDJ%31XWZL"4$]S0<TQ7274J9S0+]'FR+(2-X+[N"`=LC)-T7`CLLK/GSL]
MB'Z)MBFN3-,`*`9JF1%*05`C6(]"5JI-4N0D0F>"I<P09=CK9X,%\Q,&[?-T
M,5J&]T-L3"QM`[91T_1A1KC'3=.(\3Z/S91(OW%V9P^\C;,XD7S;)K"#4A-F
M,?':?&MVF$K-@>6`*>&T^BAH)1J8Z632WP@)=[\_-Y`EFI9I;S"=Y`?RCGBJ
M81']O>I8>,)B]`AX=BA\%-X2#<[E>-Q7XK[%?E@.@;U$`W4Y'DS[_8-@IYR-
MX\Z(X[)^@"BL9>;3Y&$_GDS8?G4>T$H,@.3A<"+G`BWB"."LR%1`2TRA;>>$
M]@%2'.PR4VM;>:1\8,>MYU?5^>+02@"=:N2OQ*%[0A'@AWEMU.9>U!IZVN43
M;$WUNCTL$\H'UZ%KR6O;CK46MC%WY7MSVS'^0_3H&O(:P:2]07G#_J5#4!3:
MO-:P+F@_N*X?AS2O'4R"=`^0[,5%`,QK["H&</?6]3"OF2L(9>*F=0Y0\YJ]
MLD&-^,-9E%=>XU=,>64`ZJ!5Y+6%]:\B19V-<@=LH]W:K,?_V0EQNC;+"&GN
M,*X&2+=TVJ@L8X;1+Y8*I$"Y2Z]E@+`T`S8<38;#D7(HA+MUV:@LZY4!D5GT
M62JL91FR#"A-A#6U12<*;+[RN,S[X_&P/A6:@H#OLV[QWHB,@&_$=E7`G6[F
M-HNL,V[+C:;R9FR?&?)L1?'1)>PMWRO",[U)/+.2#:P#ES+>8_`*<=%D,CW"
M2M(-8D&^&H_&XX/7<NV[AD5<%[37@V&Q8GP-8G>7IOKX5CP],2.ZGG3366P]
MP\$X;NNS@[8E[5NM`5'@TZUJ,>"5P;:,;P$1!_/#8JD:#DH^3AL"0_&(DZ]8
M9<[['YKIH^'XS;;U9\.,)GG'Z>:V&/RC34<K%W0;50]+@@QG/08M.U'@\Y6;
M9T1^?QH'?@N"'`#NL;G%3%=O7!Z`Z;:U&/E!P0_&_4(@LHZ>C[8;`S)?=7O&
M+'DRG==`Y()R7SQ8A-:7R<0N!N4DW0P6(_AE&L4WX:1C@7Y3#0N_^F*!$C`>
M+:8:OH(.MKP['&$2@[D*@Z<$.BHC/'L-W35H97C*5Q]\,=4E^,0[HMF/%H:3
M5PNL]XNNJ0JCIPR5#=>J&)P;IL7"^4TNU@S3(C!&T.A:\K4Z9:=/Q(#LA"$O
MG%78.J6WD<_-`RK7AN_(0XPWJC!K\DX@(P#D@K`:NU8FA%48ML%@G!?&0/?=
M.O:"5=+XH!.Y<K0M]YK,;(>PZ[ZI/XC[R;!LQ_!6$3:*/X7MA7TBWMS6UY/D
M8_JR(GNY$>S4N+A&8+4J^[[)]V>%U6DE_LAX.MHHTCLR6N&!7$E<0SP]B]5^
M3*MP;RX59;*+L;8`B4/[F7@[W<9IOJ[IHBHE]OJ,D.U+:Y<CED4@J\+=V%&8
ME`):?!/O2M,<@KS^979'=+)8XN=WAJMM^*;3=/^C:$XC;=L[%;2T-;W#N<K$
MTMW`W;K2_^WO4#/I#DO!)4UZXY0UI8&6PD%73ZIA8E?0-SNR"<`+8:Y5U]"B
MZ\K7=5Z*7.X'L+35[7%DJI#M&E>7[E`4U`^37G\\*&]Y0<5@L-=,+\&M!L/T
MO>C^HIQSK$AD.4J6;?'+7E?N1]J[TN$JO(A]F\V)')=U$?UAP45LC';][.,X
MFB\S>F-D<S!E;85M>&_WIN5D/!D.<(K-82"6O<S"#L'N9<)E@_&H7^XJTZHL
M91SDDK7RGS_PRF?'AJG.=^*MS1#1?(?64[*-9'8R1FR,&/TF/OAI7&T70?K2
MA_4N_;I!2\_1!Q2L(9A\Q1Z&,UQLB[;M1!9ZL_=0F.,O/4<K4;ZEAQ:N08O-
MT8>49[$)#14-6GB.AJ9,"Z<'Q;#VA6A#`]TDC91"P$,>27/0@+.%LO=UU0)N
M<HF3C(.$&F.+N$FN8=5*@\Q0?:ON-\@"U;?J_-Y6F<:GOG7F=ZVJLCOUK;EL
MGZHLDU,?!G)U:5<.*4H#*PYF.&.C'FDU^V?R3']QH]"G)8!*9U),MO2*#TS(
MM+@#\9$Q9=2(53"VW+6,U(E8I>C8W4A(+!4?3B9[,;"QG$Q[`'+JX*V*-4YN
M1KB4-]K<\V]ZR'O&>E4/6*KOG3K3JU1]<J``%FR`EE,'@57(;P=1\[`5[]FL
MR@G9,!]D*98W=5[8P4JNJ&Y+[R7):X]2!XZ5*D]!<KHWR$'/<466+1D?>UH^
M&K6*%/N<YF8<S+K)2$ALCYJ.E?TH*&2@4P>E5:@P"W'"Y5`^M"I!WC-_K7K`
M4K5YZN2U<A5*CN5-RC-7J?/:JN2W/-0<*3MT3N$5[RF#R0>9/,T'68J!3AT*
M=[B6RVR@E7ZO.@O=+\L+V2M0PT!Q#!L0>R;C8T]=<*-6D6RA^V4E1G;R;C(2
M$IEXJBB'&>C<A,SCH]R8JNM^F;%2LT")WAJ.Z^%S,55U:SN?;8\$$YFO+)VW
M!&)E&L`4%(%R))VAY*2.^*L<X4U#4[)HIHX=;!1CEB;[XP.S9[E9,8^7N!_%
M_$?`-"+3-(GF^2"L_+R$CX:&Y=*L"ZPQXC_8,36O8OG/X[E6@?3&H2I%!^1)
MPQV;04M2`]->OV8MD,=_WXGD>P+WZ^UU`?K#^K5`GGBB?*0W$%4I6B!/=O2X
M#%J2#NC+O>FPFD1=ZL34"A,GA=CM4MX\CJ1`IF[/L-4:($O-ZZ2.4RU7.>81
M]$&OQ&Q=ZIC5*IDN#T65WJ3$_;0]4UGS@38:YR1&2KHN=0#KX;HNJXH;]93>
MJ+)T7>KLU@(FX\BAS2A04:,\^UT[]F"K=6I2!]+6@O7&X2K9JTF=B]LX%MTI
M[,FH3MR!'/?'-2<X4X?Z!@)81JEUD7@T4M*+_;IDH:84]Q;B[&E_5Y5(U;R=
MP<EL.\Z36'PX5L9]/%N]")/3(4H)-_P.8LE@=VF#=S2&V3BS14X=JEP[`;[-
M#>>`2+40WX_XH0@'8?0PHC`*1ZB2.BSZ=*B2)!D#\+#E<7&2,'QFMP;TMR]T
M!(+[_@=Q-,.-=;BF3L0^OO_6SZRV=RZT1#SM"64:NSK&,'N75VE`E%],)CUY
MFM%Z'$CX7:8[=6YX?KW2QL")CEVM-7!*'8!>!](;AZIDWS)U_GK3&+2LL*D/
MZZLW;$J=%I_-[;9]QYNW61'LJF*O6!'DR<Y7@O7&X2I%$QQ>NE0CBY:D"I1A
M[\"=H=QX3AWYGS$"G[4,S?V:2W%2#R.H-33D%ZQ3(QG:S@MI#%08M>N,U$,2
M6HSG1#[NC0>]R>B`;%1DI."7&4"%)R?8KO<>/FO>%VMKXROU)(?:DQSLEBC@
MAQJZ2WX`;W;DQ%DV,KWPFYW@MU!J/*@NGJ2QP"FC*CM<@YVS06!13Z`F&>7X
MT'&\8#,+F'HHQ?'=JWY\`[UJQ!R/#'M:*]N#O&(*(4/`5M:LFV*NZ[B00!=#
M1FV=GL646ZVXV-/E6>L*]E41I1Y+4F$)2S$D#)7!P1V.^XXXJ1ZRU`*;U--,
MRE8KN2JGIGF;ZU*765LG9[YH?[(C@5]XC4=JYLS%N.-^F=V<^\Y0R2=3XUVU
M^07KPU)/3:E:KA*+XA7X9SC.7B^6ML!*!TIDS^GVE-X@QXIR)A12#VXI@XS7
MA?>:X4?VA%R5&./`W(SS5+\<(\>0>F[,::$^,>TPPB,]:Z[T2CU9IG:\;U7G
MG33/IYX_<V*X3TS-CT>CT;C@/EVA""KUR)LRL5Z4%R_E08T!9>KI.K6G'B/0
ML[L/Q"6/*NK!Y,%-JDFK+S5D*<B3=2+RX'*:LMFHWN57'4SD,@M;J#Q4O<G%
MM@**H?+@NI?$Y3=!)NO$Y,&E+:4S4M'U%W654T^$RN9B&3\:4]Q33':S5Z"6
M%)^D'E15!](;AZK$>$))/06K:0RZ,Q&4/W[`DY1JC9B5U&.Z,D9:3_!3JQ5!
MW=--E=0#Q.K!>M-PE:((#HY$:F71DE3!:%!-[BP%SP<'*M$.NQ`)@&;\"UL3
M5+,AR%7&DVKT;`IV#R[PC[`O?<LW^_T/")$\XXG<^P__!B[^9M^1I>]H<]4E
MQS1B4[E@@2IU?J-@\(B0%:706Z(H/3@>NE'=^6?BQ;WLTOA2V8>QA+,M>]W^
MB`<"Z;@HA+2#0Y]JD3;H37&2=,.0=G"P5"W2ANRPSH8AK35S1=N#4[G<T:''
M&(<'YF10`*V#27<RJ`ZO)81!1Q_%H2A%K,V@VU>JP^O!@<[Q6_44/(FG86@]
M?(+H\?N>1DH1]3KL#GK5X;6$::-'[G.2Z1G`#4/KX5.ACI_*PQ/T<J-5[G7Q
M2(*J\%K"`*GC9T9&A?Q]P.PD#\<&X6B\V..KZGQQ*/`L9[4+R2<T/:J8*9.[
M(V44B>BSH?!0M#=J@-3!DW+:A/E&38[:7<B5C^]E&L"W`_M93O0\=NEHEM*Y
M8:'4E](=]*=U8[RN$KKZ"A=E12G"\/VN,NP?AOVT#2'Z6_(8)B7UQ-/C[Q+F
MF**X<Z4E(BHM_&OT\C+-XU(./WNUY.TB1<E:TYL!-?7U'2NI1[H>7Z*&\2KU
M4VW_5E(/L&TE\A(Z1I7#C[$MUL=7L.2N/YW&V^;R-\DJ^TZJK0$TJG02^@R5
M+$?0EM7-E\O>#*;]\@X84+(</UM:(T2NT0*3<7G'DBNIA\Z6J]%S^0Y]I<0U
M'NP'%E0BN<Z*D/M*F73=Y]+EJ^\?34H[W55)/7:V:@520SNPDN7XVLI41W+]
MUW`X'$_+66"E_<[9"X/`%LG[25:DHE])/8VV]J152L?.)'`')CDD6F&^7AV]
M$4JN`W&/U_A5"(^7M2+RX/J7LMFHUN5G.>6V&8U?A7#9']6(RH.K4^II_"K&
ME+5B\N!ZE-(9J>CZ\P3^?ZB.HUH>2UI%T5'6X/MJ6`-BX-PYCMA22\34GFD]
M35C?(2GE7$?`UL\).<X<K3CWGGIL:Z.7ERWWGNNHU=RQ0C)VDN?(R)F/4FI6
M\OWP<U8K%JEA;N73RNS[OM-?6XB]I%STX2?)%LN<%7-\Y.F@?^B,2B7U8-EZ
M0$M-[*6>`EMR]BS/$N7!=%AB^CW+F;)EY=!R+7,,,)2XS-KF:>=*#PW'.:<_
MIJ[Q8%>PH!+)(Z"#WGA8XI9#ZE&LN0.ZB5S>:<U*;:>7YO'*RDR_5WY4:)KJ
MJ"/]GN4HS@-<ZLSI]R&\4LZ8?@_=F5O;N754C>FJS?,LE2SG6>YIC*1K6A_X
M6%9=^32P^]--_/1V8N<R.)8R=>EQHK\SG@R=6+H;KY2C_XHBJ<89?<G+3IOI
M,(G[.FGK*H:!VBK["JW_LGH$[-G>K0OL0DG3+`="-F)OK1`6!TI]Z>?#3WFL
M96^M&#?6BLCR1^&U:OF-&NV=MB52")?3?HVH+'^[NY*]M6),62LFR]_O/I21
MBJX_2R(^>D9YI#MC+6`1U&0Y/[$^"YK@<A=&LISK'+^]>*N(!(WJ\BF=!)--
M7["))#AX\[W^8#$MM=AX?!\\):($?%=CV/I]FF%K./X/GB91LII`K)7.M;P#
M?WUM//C\9D<D;BM_E'HP8LG)S624)67,+L,T9_Y%EH&<JH]-S.1>)2(G3)$>
M!SF5UBGD1\>0UD$?B(QU[C%Q$_F.N)YC:!Y_WATQB>J26\=>!+_`/5$\U5:%
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M[\NSYS*0<W80)?=X]',=GG>X&"6/6`+S.AYD;UM)<7)WG&+7/_P4N](.PMHG
MFB!I3+'"OW,PA3S)'@:4<QIHO^)S[!J(BL1C$OL-/YXN!9.)(CD=R!FP6/A4
MWSW)EWZNL^OJ%SBYOV-2X5'R</W4`^N:O;Y,>;A^KM/C:A"-B3*8M'&T1S_7
M<7'UR]1@H[/_5$=[]%./EVLG]A+"R'ZN(]_*\_:+H?!R,E#B7G_^P+F?>AA;
M+9"EAB*Y#C7+KTR/$SCG.E'L,,668X&C86]7M7?A11YG2'T^/AU.Z`":TM:<
M/J4^'SG&>2>:IP3.64Z;*E&,DFNOQLI`42H+G+,<ZW3,N$8.E*E<20=,29%R
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ME4`5*DU.Z^8ZE>D@Y5(,'^"-UHZ2/0Y,T85D+T8I*Z6:>G)2`U*JR9A,G`VN
M3"=RUC[]"E*J@YKSA?F&"^[9"]A$=U,C_4'^C&.-XP-/!<D'Y"RK5A5[$\.M
M0?(!.=`&Z./&HO6`S.F1MZ;;@N)ACFQK32@N%N"U!N%RG0BO&3$UIA^S'/IU
MQ("FWXL7F9QL&CCU5+)V8B\I*7KXR63EJ+:,;8']P^N#4\\IJP6RU,1:ZI%B
MAWM)N1BVM&QAEL/(2E)L>3K5>I-I>6<9]K,<2%:)*.5*`X^GTQ+3P*EGE.6$
M3<E]Y&)*&CC7"6.'BU%B&G@TPI+_RM+`6<X(:TKXT`\4:S_7>:-*[7GE7,>.
M%?)?FX:*Y#1LZ@ED#0C[DS&96-D*6!QE'>:W@<8\D_SZ6<X_.\JY%060=CD:
M9!\#2*]#M&$\%0'@=X`O"!]CDT*1139]\%QGGAU!+T6.[2JTU#)1E3YQJ7T+
MW!:E*@>"%A"'@3(8%L3-EJ#$\\2Y='-YHT+W9JWSXTA6(L/I<RZR'/34-4FT
M"'+&4WE\1-RDGBS6X!4E^FSC_"G(LOI%-G%513+R0.0H1^L4:0%R^D?K$6D!
M<O*W895GAQN(COPE%-58F`:BINQ6JV+)L!8@*D?Q0IT+>D>`%GIP%O@UL2CN
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M/`U*.YPJ&[<F=O?@82*CV)CL]'CZ'5DZ\%2JM*XL_6IA.Y[Q'_IG='5[:@6*
M>4@QY*<`4@3BU!.B8LG"//:A5RG(Z9OS/5E6Y$ENDS;I38L!S=3*?QL6_-LC
MP$->%-;T\XJ*P:K(<46[#<$.>;S>-+U1*.MP$G9#D1?2/4<$%6+7@5(!H.F]
MRL4(W^\IT]R@!FT.02+`TB-]#=SM<K\X-Z9J+*+N5.K)0(57,(XWBN8";L.)
MUC2'X'+?_\"51YW>U/-^"FN(89Q--M^_@?7%4C4<-&)?9A]MZ_&C\43T*]<E
MGOM/8NJPNM_C(*?OR!4$68D[*YF`BNR5_^&`9_YE-OLR>\=WE+^I/SX:\)L9
M=V12S_0IK.:4"=-S&6")(Y_5OJNQ\HC?5,/:"!A2C^@I#/4H;J_38(E#'7S[
MQ;I738+;^/:2.-[JJZDR5XBZ<E'XJS"$EQN[N-F@BJ^$5J]]MBU-=><LIMF6
MT=1#:`H#KXSB^B41D@UIM4"608V^(^R_'RQZXXT/?&9Y3$*BL%=A+Y5AW*IG
M@>FP551A2^7AN.955&%H@8^FTVK6\06D!ZRT];B]DCW-H(6X:K2Q_YL-JD-7
MDFY_BW'69K%</2NIPBQ?CD8;+F<Y:P&/Q/;!=?JJKM#>1)=115QZ.1CN6<0&
M0,7A[U<1I?;E?40H#_Y*++4\ZN\3[IPKB'-=X%W%JF@'J2=>%.>ET3YF2H2M
ME$7ML>B%&&R23_66O:1T\UZ4Y\`L5D:IP+._@;#V,;Z8/:._BM%GSSHVP#D`
M^BI"Z<M][F(J^)^)AY4`X,UCTXE^O8+(3P?2A19'\XPG2K0;`-RP?/B._VA;
ML;7ML?7%U$%_-(G[D8?!6]7:,Y?1YDJX;Q]+TL"E5Q'Q`TN/^M-19:O'!UUI
M$+."5-PZ]H)^=HV-U%WJ.13%4W?]:=S=2`%F1S0-!CS87V7W7/NN81'P"Z-4
M23U;HG`629[$2;(/H,W\^,:%L0S"E:7O2FVD'A!15++B$5UVN,I83[I_49`P
MTZV-@()+<FR-$-U%-L0L#USY2?4P6;7Z,MN5P(JNK`HW0Q[V1QO4R@MB^@HW
M\EA)5*LDB;^Q+Y(#M'UK^F!YJO6(75=;@>R@"A>$1N3I:]D$*9,Y^F`]$3>7
M.1I4DG'8*M`X`-BJ%EY%@@("^XTM_S+7'F62</_'8>RR52(QJ,+/D'N3@9S(
MN+MA2E[#9]LC.V+^815NQ"!-XJ*`Q.9=[%C;[`X(YQB:MS7P8#"LPHG@F8KL
M`&7@F8U&1]"4[`L"/VXMJHKMAJ'2ES<[^HO`N=O!X'NBZS%U;DRCIXXZSU-)
MD]"A6]`D])7=;M:NU62A<:3.)[KX/7L7A:+.:4].-LT[(3I@`54D-.1Q%K56
MT@(J<2@&D]%A),@H.Y5.I2S$?)/^H*C<9%QSI95WQ3+P&^?KEK_FLGH[=JVY
M((L/!T47?4>6X;4)3D?J\/32G(XD0)+!C0R$>$<>HC%6ZASTX@[>,!'@#5`B
MCE)X%5ILP]*,I6I^L?Y%+-UV;@T+J7+UZ!"R$26F#ATOW+H8*7W)`U<)RZEB
M*V30/]IRJLA/#'O#0]:S)ZIB-^6)`E-';A>V2/)&'_5AX%:U],PCM//H#SKK
MH/%+KZ+,<:(,QYDR\(763I/>EH[_07/[!`$V[D[3KI_-':SH2O=LM!3B[\%@
M$%]H'N#*65;FT8)Y*G[D\7%7M6="==&:=Z6W8_^DQ'5=`9<[S@J8=[.';KQG
M&F"^HW(VRI@R`7,@_'LW4_)DK_M9V"L5_J!+`?L6HF!6TH40`S;ZYFPP55(C
M>2!,5>Q*R/)FO>,F5.P,$4US?!+VF7RQHNX_]ZR)_LW>RN..JT@7R*.(6YD/
MM&B5.^LX8'W5'W"ZGT7H"/4_#&]^XQ#=\&Y5;;/D?5Q)CX$<K7C/#M<VA<(B
M>7B$RXYZV0R.4V?_%HX5)\H629)@B4"]UXW?-X6WF')0(EGIO0'(7AA39^H6
M=T7E4F&L)-S.BL>P@L!Y5"W>30=\[=JFH0>==E]!>N$&^N>7&?<R53-,T[CO
M#%<S;==W<!/XWGBTC)FAX4XIJW7$L0CP/`W\T6^PRFLSGK=,G7F[S4B__I?I
MO=&-I_]Z]-[\_6_XQU)RO95)WEXL5.?1L"X?;,^S%Z][2^\-_\:SE_1/?,>E
M8>D`].O>SV]F\-9+U_@/>2WCK_3/F;HPS-7K;\:"N-)G\BS=V0O5>G.!K\.7
MX47!^^@-S\1XG'NO'VQ3S_-`=BD^Y[5E.T!0!IR'$CF#+^!;B["KGE3'`&R^
MEOB%%)87\DOIVYQ(F!U3K96D6KIT[R]@P2O)GDD1*DAK,D@!'21<RBM\>K"N
M5\O@4S9TCFI#)\41=H@;VIL\[\B'SW?$U1R##NM`_`6U,\U%5`XVXSCERSV4
M\Z[N;JXDT"O+N0I?=B1P[;L=R78D+\*.\"=>UY%4Z1TQU6?5(2#DSM)F06A'
M,EQI3E3]+U]UT#T`=\J2_@`O88$3]8G3@2>9<+%N4\Z&J]7U.S7B>\#:)CR1
MO6T99'G,E32S-1^'R``===9OCXS_2"Q"[S%7EQY67X+G@0`[ZA+%`=8M::JC
M&_:3ZFJ^J3J2;K@8J+A=*2IG_Z4NEF_^,0$]^\:53%@`O-O6?<V#VRT==2;I
M2+\1"QYF\VM!P;V17CSX$)GKL"93FJ]TQ];FL#R(WE]VV.+XRN""1P8FJO:_
M(&IX()YZ^8`ZDS@4%T!G70(P;=TP58_B7?4HMJ6E"324/%LBX/7[``MB594T
MT[`HOCP@ITD7B[3R(!*C,T*0X57^F_'@&*;)B814O.W@0Y;P#:IZZ1E<':2<
MXTDSU3!!YR-0K^!*D\P\Z0DN<@R.P94[\RTM?-0_;^_>W\;1*<U5=(#@)E!6
M0!&-9O4#:DF4_WB2Q9(<HI$E+)C^@0O8H)B[`LY9,'08'B#.-(`!\&I@*/!R
M&.QQXC!"1I#/-.E"1:8"AP[NXDN'U[M+&UOF`+_X=MWQ'[N'ZP=9.34%$:5O
MR)$>MN%[<Q3[U=(&_+F&R[CSZQRS%<KUJ_XFHP);<FIUI.^6_0Q7N])O[S^_
M__;AYO(*6`G?='4+CP%"L7YOY&U^C_0,5VMS&WP7B8ZY094`F@)%/7@/R*LJ
MS1Q[02D*%'\R;-\%X0.'!*4:;F+@]3=X_L4_;U]N08GK43KCW@18/9284#5>
MO[__QF[I2,]S0YM+KO_X"&BAF@AX-G@*,M\#@5\U#2S0S#<9\^NH01[Q:0@G
M808=L1!!"=,E"]_TC$N-6%21`MET>P',H'<DW?8A]@)U`BC;Q+8.)'FT$!B;
M*598)L+MJC/B,;$@,W0IM%5TS1YJ:`F#B"?"[Z-:"6"F`K]6'2B_E@?(U0WU
MT;*1(E0BES@F&]"`KLHM?<]<?<+%4=4G2_W)5*+R`A99FML+^S^K1Z`2:@G;
M6RU!X2*8P5\Q,Q3J`":\NBLM(,X!*CZ!;7D`4`!ZOA"NF(!!J`\%/O/2-IAN
MC./7`PG"^QRL;,1>0U`\"]!+"Q55UM7MJT"5FKX'!)!>7-U^?(ED`ZU^J:E@
MG"0<7:%BF)A-?U#Q@^L?K=>H9-\4\G.CCE54P2B9%`QJ2^O!71X%1+P^NZ+;
M\B`K\L"IQ47[A1E-%&(4`UU=4D%@PL34T8;"BID^G*E%;P;ODQ"+"OAL+3*!
MJ0YT)*S;UZGXJ4MP/'X`KWH$V!CBQ`UI8^^*<.X[5'7W3)8_V?!>&T<22=<V
M&%'IQ;O[3]<O01Q-$Y:AFJO_@"P38%*0XKB.#"%9XO@5YBPS9P)Y'H47Y`*L
M.,A/9ZUV5:X9($:U`OL)6NR2W>5B;.DRETYU77_!9N:AFB3HHT5>X,YMWZ1.
M%Q:AX*,"_4SUD^78=`5`B&#(E#10>A&L4+3@:MEB%^IWJC$,9PTWLR1KV!$?
M:*U@I0%.N,9$S*@S%'(D0$@U4%_HMX'=80!1WM#9UX@'DWJ?RD!Z)N0[?>X,
MKK*?+_TETV5+FC.GU%^`$TJ'1ZV1$'==UOKJDBJL+OM9'O6H(:;.C[%8KX(N
MFSK)='%/8-!HR0)=C$,>T:?*\C:)OJV#*IM:([`S8./IWP^^`W+=H8MFU@/P
M+MTSTGD!_K<@`YNKF;[.-#@%AWT9&`=J+#)Q#HL9F%<`,@_^!II+[OJJVAQL
M`JXQ>K<;!LP:V1"[?F@,*'6L]1+04H=LPXPEE<]M]HPR'MZEFJX=N56;JQ9V
MJ''18$_A.N2!`#ADO0@S?#ZE4_@*ZFB`W[L)E.I%G@DV,ADZKIFHPX]X!S>"
MR4*(^6V.")T(H!&=7DM]>`,L'PT,0EQUXO(&@89%?0[@`0CYV&ML*^$E^GIP
M&KYGN1&4K<U\FH9B"'AF3(A@Q%6H]\Q"35#ZEW/5G$DK</C<P!E"D5TK0>8"
MT%4X[CI"`'8-!1X3+B;C5G"!T:W:S?0`7%S!,I-@QC2*"#/VA!EH2ZG"?<0$
M/2`;,$=5,8\4?^_>=SO2>Q_[.)A>LJEA^3>H5A>C/*HUF+[UYK9.Z4+C8^9D
MTULB3GTLE%R;BB!N]5@-?N#G[_1(68A)=_#A,[;+2.0'Z#\7M^Y7@0H"3O:Q
MHRP69*#+[6'V`7@/CS"+KI*K/K@$?AGB+VS5(#$?UF:QLQLF%CI'7N4R(7G"
MV$$-OV;(90(-@0K<3?M)*,S\-Q1K6`]\=F/&U/8A^N)N\T;\P4)%BK$.`L%)
MV<F"J1AN8.%3U(5*K]_;0DV`#2%0VP(5476PYCFF13CO>7%?<H-RU,[[#Z#U
M*3%NWUUQML%0-\IHE&,L;GL<U0#NCCAJ&AL$VI4^S&)W`1?Z%O51X"[[@3I@
MD=MF/AMIB=8O>F6X%A70B\[)(TKF>L>K$QA+ZI?!#;KA:JQ>AL0LCAJ6TR`'
M!ZQF.[$;#%`*=EAC4P9_34XNP[Y&*1U_*MT9[G?P&#\:?_F&;O`<PV\V$O,&
M?$'B6"+]GFKVC-#`Q3TD1"[B$K[%+7<43ARBRKU'^!?*-'(LF<$K/?1RGL'O
M=[ET(0$@$O!I>GD5RC*+[D!JJ9?'A!6D&9-4&!.`!*$H;DG"5M"+/BA:2H<&
MOC27Y3,!Q(PU3_<#R/\FFD?32Y+E8X4W`NT@RX"S#MA6'>8NVZ!%X!=FT+?Q
MP/8(#`Q-#!I?(/0Z61+D!_#U0:2_DQ6-%L#"^."8=[8PBO$VC6RW<8)!(;K:
MCL:0^V10_<-W!?BS-E4>^8LFYZ-*+*C=VX'036@0E/4[@W&LG*+K%_/+EN"1
ML-0H>I@F[GTX:Z1LIR3F$!'9#M^#P/>339("0([M/\Z!3*PRW@VP0*-EC,YY
M?0&0P-:^=S!M^TPP,%_?BXMZ"#;9X-Z'(`B@GM5G'Y<;V5MB7PBSO4,AW!O(
MQC0;A1GOF<UH!JA\!ZR$@K/.",CC#@86,L4I()<LM[U!EI>B3IH>U1R2:=/A
M!DAABSRJ+.&KNG-I9MK/+N.OJ.`SP!+>$KY!I<_=O!LYZB>Y-^D.<;_+-#AG
MS=5,[^9WC[J#X&[!.;LL,DLL8?U+G#A43^D;`?)/\K3;#_#9`3)0O6CS0VM`
MAEVF[IA\NZK)]`+J#FW=X1%1#H$>`]I2/4&_>.;39EF\<DL>'!]U(99_Q&%<
M)])4:>D_@.\B$5;C%H(4V*J-=8R[TY"IP'SB0GA*A(;[0:BQX6)N)V-?]:,^
M\=H5CD`9RV+8UB/U;:(R<FA">`<,G4T@))1?W![WPA`/:1)$82A%E!3X@:PK
M1J4PP'-]W/>A*8[=1KXC\8<"[M!JTYU<%[G<`5OD.V3-%V'@B@!B@@I6!\0=
M`KW_:3^#E7-H^LE$/@\S-Y%B%M_B.5CJCZ_SE>LMO8BEQ#R-B2:&\YK+,1@I
M#,!=7/0V($S'S<5@NS&*/O)C"6NBO+$O=J'X8856;(>:,2FWSQ%*Y>23M0;?
MCHUT8JHK5D`1O"XU&MJ.G/@&?F*<%'TA!DR;<4]2L.24'!&=G`).+"P)(B(F
MRXCC8,1S&O/93H3,0*L$<C+GEZ7_(Z[U#'ZWG:B;W`$/S:/NN@D.-]VGYJ+!
M]BO@DM=I9`6/6J)[@F\O<%,P)``=#",]V(Y.G+<76*,)SJ&[5-'_#?]>X@+Y
MWYQ8[(Y+#5ZN+EWR.OCP!C25[LU?3X?=P>CG@&7PE:\'W>'@YS7I/2?\A#4T
M##;@K?`5[$'LKN<YK/D2X4+R/COJ\B)_[%D*@_(;_DM=VNZ;/P`KB!E74M@7
MF^]8[]C^0Q[*;U((],K3,^&#(_98RS^:?((Y>W0P0(DK;Y;D#V,Q%#6:PZ>V
ME55OX&#K]>;:FS0IB1#AU9H_7U$A"?_B!:]"JH14M5ZJF&.$OACU@L"T@`\2
M.+;)66;P;RBGH@E\Q!PP4,FE(44TX1S=#A!B)\1.B%U4[/CVV=(Q-!)$5[L<
MT'4\CE=P.\8<T""2HDG1M0_*8V_NB@K)$Y(G)"\J>;ND+!K3$597!E>:ANOQ
MM`_+G44R9+Q"YK/JZNI?$C\Y46+3-H7,"9D3,A?('-M@!+NDV9:],+2@)-!W
M/8>5]QN\5'`VPR9>7O*8:.J$81-")H0LOV'#1+%CFT'`Y[JVQO8WZ#YO?!M!
M")<0+B%<VVD23,Z#0&%"?NG8+M%\5EVJDQD)=W`D8L%3-?;7*JC#U-@AHNN*
M5RQ`-DVP>#Z67/*YYI*#@(/\X75"!H4,"AE<RR"6,@<;R*'7F)([(3]X`$>Y
M\X%VO#^QNC;3T+`@&D4T&,.1OC&:5^#.>2,5*TYV)Z7HONBZ`D7'>:?N^N@,
MUA)B&M^Q.L0AV/:"R>9HZ5/DF;IA^G1#G_?J)*;/YK8)RHH6LLRVJVO<[?J2
M:&D<+X^R6)H.R?0`3A,6R[$-6/L!1)47.SG$5-GF+*MCB%[-%X=%',3"UF?,
M-5!EC\_E(*9Q<["WO,X(:O2)Z->IM.3@B5A8L,-VO]CK'#XY/KG$(:D^E/9%
M::K%^I18`_XS/ICV@>G\+FE!RT,>(EMLM&6`-B_%Z<*:HN(D"1J<^/0FYHHF
M;IAWP]:U]<^J"5K!HH)-ZQQV;,;C"J(`;L#5D?"^K8MP3U[#@CEV"ZJ>[?H+
MN&-=V.$0K`$EJ+Q]WJ)D,$^;\!T6+->@)X[1'\SHV70LG<0D"0GKL%K:L#"3
M]:_`.SN2NK`Q*46=B.CR.Q+K:8X"2:N$'%Z0:^+=\0IDVLQ.-DOH0Z9`@5N7
MD;`@PB7.$UL`K5,"#@-H-2+J2A+586+1E`N:Q>:E/]3)S%HZ%>P';%1!Q5X%
M;.);T8Q)H.ZBZA3'$,"E#[:?K"(V8DC*(2I.-V#%41IO$*`=G2@$KLU$@O?.
MHDJ#)3#UXA+*0FRH%<`^"V98T1909H<C7;N@>'#Z@;[N>USWEJX;*F--+6D@
MTK)&7DJW*;7EB2J]W:8:Q>!]M%2AZO_V78^MD+YW9A*NF,/]TYF/-7K8#$#K
MW'B2&7M(P6;&DF$FP$HI'92T<=CYYBTCOIMP;70Y8:D$M[>1]L?@A7&CM(</
M-LP(/CG0K0'&*;-&2AG#JJE=*A>YRL-.B4[LQ1M-`9%>(&Q-0H7W;#!FVU!I
M;CA69@,L\@/#N91Z+=%*M*W?[K!.%/#,CL"X7P*_B$ZA+2Q]L7!G2)NOBT<'
MG1W%WM%":OD2'GPYHDTYB&"7HG;'3E17NJ):CWT#*HL;BB5K+@F_#54"UU\[
M-2_>.+-MSZ+-2FL]S'07[1'R')N-F#%7FVHL5%LS-E](B$T20URKO.,\.M%1
M",Y.]PE,`I,/-#+@;?NZP<K:][D1&V;KF3AD[5`8U-;8CDXKQ*E[P3>JL"^/
M6B&4P_7`1C[9SN0SZH+Q`>LW&YCU6S!*LBTN5G3/&K5LZ19^E>3>Y?^EO][Y
M8'7@KYZ,<-ZQ?C:\]?[R?[J1(3_AIRL*+4!BKCJ\'WWGJC<]#]9BR`QZ',"U
MH#N$G;4J/:P2EKP#-T$_MT7)06>04IQ?+0@VK;%)?N'`AAV@1FKIL<.$!M-+
M<("9CP(<I3[2"U.7&UTG=\GXZ!OPK6E^)^)V!:$KT2/-?<QOG:D&'>>UED:&
M-7<]N&4OQW'7ASE2%!<1KR.<]3=W",Z=LKPY#JG`!K$-V]"7J7$82*BUD98!
MK"!TX82U)^IS!J]BC1%$#]\R\P$?.#=#XGGI[0ZTX#51,FPVP:R;0RU[=W^H
MYT8C1#Y8APV*H:Z_2\CWA"[6#H)/<.U!BVS@T75P028;BY00ZN-"UY%MV$2R
MV9&)WX6M)#NZ9KO2IEQ%K#%S':GP/I`H\R2W^GI)Q.SRZ">/`N,CEAZ0I53>
M5F+]FP]RC(1$F1\8EWK$'<$$`>>9@%UP0DH2M_0#@0N1L"MBO+(LW-2X(SCX
M!=WZ0/?]-VZ?1,.YR+FY=";$#S9_!Y^Z,%R7=DE@C+&@<`&UN!/#)155-`B)
MPSLM>6+'(N@%H4]B^ZZ*XZ^><:GA'"(=^0NU&'62F'?$)DBAWP1(H!D<,3I@
MAT&FTP`L+]+=R::MTPD"PH'9PM=MQ#U`=X"'_QAS1\=(A3WV\3`[FL[1MC"O
M,<QC(WZ@<_E8,#04-.^3T%"XW>T(ZMV>S2X?5!/]H4MW3LB>5W;"5CT<BH7C
ML4@@O+320*6M[S9+U42_<<(;>&(=("#Z(]7>V''Z&#.FZSR"0=/<;N*J)`[\
M.L)!I8.)&=7Z#KIZP8S,TG8-A`,L,%D%9;BTDY)[/CR!L[DU@1IK%J.FX?E!
M%SY-H03^RGJ*#YVU3%'V#(IPONI*]XBS$%`Z?XQE^%RJDM@H9'RZ3_MRJ;83
M>FC'R$=V?`(8C"6QW":/43_>='`7;5G8NDL;JUD#%0N"4.#0?=OE*6Q,"(A$
M")@H`]9?4`>0$X%P(E"1-=SP58;U9)MT[C.;*TTC.-P^,+0@\>C-#8?:W+7[
M"#89E\<&)R1Y&`^$3H:CU18,G""';J)3QCQ/^J+(\\(J^G7M$RTJ#"<@K$=]
MA5"J81S)I59BNA&]K"ZPG[I8\O;Z`"WZ%E["("50@R%L,X+;-J$B)3@BD1]<
M&51LX>7`(3XVA8)28#.W-[?,.(%U%FZR\`F#%M6,;4HF81-;KX/[.WQPB#TC
MU/]"OM@)K0I2Y(`.Q7TG/J+0"J>=!!L9H8=O1XZUV-3MW(]V0Q2ZFTEJWPVX
M]=^^_LB4+!UDYB\YDR!Z>+K;<#1_@3L<2#\^K=H+IP6F[_+S'?SU83]U'\<1
M/PSDO>K@X`$\NNL>W=2=IW;D.QM*G-K!3NU07L+3/.DCCCP!]$H4O\*,I$ZY
M`HG&`?\HH"!^..>#\V<DD'K`J01/!DTZT'DRH"<<X\'W(O,/PN1U4/8`-Z%\
M,LA1@^)V%QL9%4EKV[Z'8LWF1JU'\;)]Q@X;1:@'@T_#3HW(_*HG-@V2#19Q
MN29ZAV4DJ*VWUT*GWBZ6].=2U[7N]<^Q0C0C],@^JLNY3:'5%JP2YHG/7U\_
M/%H,$7M/I$)DG>2/OMS@3D,XKS=^/T[_H?<8]`2N;N+!'-$@)X`R>$A@%7E#
M361@<#!Z)L@A1C8[1(W!MJ-'-X@M/.XLFKE$/B#L!``6T&#WA47_IL>RA$=W
M,)GF-S*Y9CO@3"XHLZ]E@@V<<%/'391A4;)-PT\FQ+[[*R#$.EN6@IN8Z<U=
M?LOK0MF)$IFK<<=!Q2A_JQ/YO"XV952ZD!X>\?P5@.<?M_2?\#4<$%;.B]0+
MOKBC6.QUQ\/(E]^0Q.PK!L50_OD-7VO`$=2=DMA5;*L==V<L+V]]:^3/$+@X
M;^$7^_V)'86[.\Y:X+6@(0(!70`W8'!T40,R@Z^NUYA@^.V/TO'[#W96_0[<
M1LZ,8)RU_]2("K"]SSNDB'P=K"+'XP]W@7#+YA/;LGF_WK*1^G)G?\EP[7*6
M0\RVZ^H;(GF-Y84-G9"!\J]BZE:HWD(,<!B]*S#SN5@@:B.4H]J("!\@\7;:
M!V%#*M`;F'\1MN*\:%Y(41R!\H4T0>--1LOY0!B,\V8:++9IMMH0!N/XBN*X
MP46BUL!XHSI:4X1/2MEQVD'J3$\_>/N)%KRR\C0W+$?;*-]?5Z:];)0F.,A8
MM$4KM#[B/"8?],IBA(B30)NEF^`C",XX2$,(!7`69!8T/3V:"N,N^$`8=\$9
MPK@?E\S%HOZ;V]O>[8W84FP@"V`E*M99E2+G9=$YBR>0EO(5NB`_(_S4$@X8
MEL@"P@W85ZK>Z4^FC6*,D]T+:!+=RTGZ'HWD@K[UNO="MEM$^V;9^>W`OA2:
M"\.^Q[#+G=Y8;B(G".%OA&$7I<,G1OD@SH\/(X[VUO'.P=8D_$HI#A-*Y%@>
M1/4L,JR31X3'45LJ0905MHCNS:H?$ZF$AJ<2A.-PPKS2%L<A2YF!<!S:EZH0
MCD.+Z%YQJJ+RC<IJ&Q%.A,A_;(XG"J81S>*3E"(#@AJ5M!0EB^UV-VLM5Q`E
MBU5RACSIC"?#SD">M(0S1,GB62@`X06<(DV%<1=\(/H1:N.,?J?7'W>&@U%+
M&$/8]B:W(X@RA<:RP$?BNJ^E("UPN9T6\"T<I4ST6'Z@4=E!T;S0!LW1G"T&
ML8-0!W/@6'"E6=PAMA'.5S.(0H0S(;3P!@0K"&^@0<SQ0NF,)V*^X=G1O27U
M!"*G4#KEO]F>:H8G(6WF%((3:=AQ2T`-R=H_$D&@>J_E#3]%!DH&!U>Q<Z1V
M'%O5FO2NJ"$]/H>U@U=$%TJ#N*>A12+"`3Q?S2$R06=":.%."%X1O2DGQ3U8
MEC+HC$?EI).$-]$BTI],K8IN^S@,0ND*/R,G"USO.;"X43GF,KV/&,L([^/T
M&V(+Y#"*\XAP.O9L8/6Z+3F?*]&T"%UQJH,TA#?1D$A4^`TGS"MM\1L*)"N$
MWU"AW]`?-HIQA-_0)+\AEI]XY>&(R/`ZW7C*C^<86G^.+E4)EIJ`E5T&L4#M
M13(`O4P`;%`UQ_T5T/&K[<$Z#-4T5RS?8#P1R26:[QB>`2]WR-(A+EYB/;**
M=WG4>R/WNHH$()J&;=%4A=SMKW\-?@AJ8_:-X7@F#L$30TU?AXL!:LF;$_B_
M0X@$5WES5R(6_O1)=;3Y^CU]N2/A,?04`CQ>N`/@NDNBX2+,54=Z()KJNT0R
M+'PV%N'`@Q?2L^V;NC0'J.!.^)]G7(9+)[,9W"\!;$&]SCKSTI72F)XS\R^O
M?/?R4567K]^KC@7O=+\2YQYO_P:$N39AP;_^_6^2]$MPV;7O&A9QW1M[\6!8
MJ@>8>V>X&KS:C]PC&?K;B]L_0?`'D\$%X,]".M^1V=N+&_RV-^V-1\/!GXB/
MGMR3V8=^7[[X%:'CP#$I/"ZK1T^KS<O[A]BI_DOI$W$>@9C/AC>7/OO`(W9'
M^F!I723W_U$M7W56:^Y2QLA=O6D:T;-A<G1J2N-+"KHZTM7=S95T@[9*U0,$
MOXA]^9*6Q9F$5FR!J&_3!4OG5$T#^ZU:&F&_4*5`G`55()';KAY!42P`L1V\
M"XRY-I=4^*\-.NW2?K;@):[_X!JZ`0#CO?P5"[Q=9\]&#6)8GKT)//TQ]AT5
M/</R49NH,X`G"HKJTK]`<I^,)[P"5K"$V[Q`3V:`JRM)'Q8+`M]ZH,1`'9JF
M_<QU%W]/AWX&A;%4K96DS54+%V)XKF2I"R+-''L1Y^]@80^&O015M%#9]QVV
M;K@OIH\?R"/H1>`&JC)MB[[ML^KJZE_2;Z;]H)JHB;^#?O2!H1D"W-4")%H*
MFJ*4WINKZP]?PC_E-[ME;,*8!M8,/+6AWBE#R3);K&FXM(J2DYZO/>S!&K_9
M6,,SDH+R,W$<M"J(D\1U`'XBO]VH2\,+?TS5^MD4`/5,3DH#?(M(+<4T4:FA
M=X'#'0+F'JSN@LL$LCV(LF]YW+K3JQZXV4.R!79/PN\8HZO:7[[A&O3;!?'F
MMHZDY\_!BW8HB*O[&VG2&P(SW>);UM<N?9!"E[@;NHF"#N(,(D@<5CS*G`)\
M-WZQUD51V0N$/%)@BK#%'[UT#/1C[*AVF*NH`%!_."#4;!&@0(CK!:]@N&!M
MR%2V$7E)_`ZD!:<*%9]D,)"0<O">R`^;<`%ND'3P3M_T*-@VN#<4^>R8=DUU
MY](,-([+O2;"R0'>$?,(UPH4B*6QGW6@?EPK=Z6OON/ZP#@!$AS?Y$?!.^31
M-_D[^4V_6P9RQ[T'#W*E^[7_B=>__\%4'&)A8;@NW-B1N)=X__Z&*8@Y*`C;
M,320VQFPDZ6!3PLT@N<A(G90"#Q;$R(^/>O=@4(-2**'3IK+R&=0;]EV//@/
M+@\YF2T=7.A+S@,AV\<560=4J8E?6S:7HP<2B$+T%H[Y'=S503_54Q$2>^NV
MO;PIE%R"D@/A-!8J*RU'FQ#52X'J8+H+T/R3+'>G85P$".::)"`;ZIL'%3L#
MN%%=,/.C,8-C_"=\$K]!I=1+=DT#7EQ#.5,-!W,L/I-4M.U\L@$?>;A<R_JS
MZ@`JD+O7<Q`99*I'19KK.F!LA%Q'+XN];V&[E,L->N+#@J@H!@%+Q]'"`BH:
MD,4,\C9VHF_F>BIP<2)4@&\Q,E-=EP#DH:J.Z6A\^`.1?NJ/UV%J)Q(%_C08
M=H<AG3`<!:W78;J/P`,!?U3J$4F,1'2=Z["X"^Y3DOE!#;'"<);+WIHB^%<"
M[`GVT'[B[E4RVP6JG#[D$>4?OGP`L<2/8/A`=;J$:2UNG?'ZN`?I$%P)ZIW$
M)U#V5H;=?H"VG,%PMB@W'AG?`N;^A8A;7^GN#(B'(B`N$!`/7DJ(88FB6(K@
M6$2\6\BZHJ*<D'^*"Q-Z>3\I<E?>5#`QU4*%.`QI(&XAJ\`:S""J<IE*`9T7
M.$)PU;0'NG'EHNN#OD(WIB+GW"U5'PS3\%:H`DT#7DA=,_B!IL'0%#"'!A\/
M:A_5@0=^CT<E.O9`G6"PC4(;56$\.^>273"CDL%%PNLC*42ZDH\0%)B2##`L
MP=A@<L_V'^?27S[U=_A3P#'14+DB'&`7:%[0LD.S09'`E><#\9X)L:*@S0W0
MB4"@%6`'7@8&"R#@/E0DF8A^D@'A1&I*4?A#.X3@=HUK`]V!&0U5.-]1VC$#
MSO*K#QAF:`0L/S7V+C%-FFY%^B$++U6#_A!0%XP/^A.,>]&:@>#@]DW@-ZB4
M24/"!RRC.IZA&4OJQ\"[J7?"_!$:`%'V?T%^&)R[7J+IIBQ(.S0]._1>(IR$
M386:"9`:,X/PQ!"+KX)<3,AKK],8!8R,Q+>[<%LH)"ES)]CNU-N+'E@O0`[N
M/\&CP[_YSA;]FY.?[V=I`(:Z=,GKX,,;B>UY38?=P>CGV$[4H#L<1&:%LLV8
MC:TXX-;P%>Q![*[M?;&<VV*C@$</97E^PW^I$,:_^0.P@IAQ)85]L7OSC,GT
M4,Y0^+`7'QRQQUK^T22>:^W(J*/?+57_MT\#"JZ[F=)F^1BZA<(DTZ6FPD#-
M1\-JKK?1=G$I-](]C0AM7JW9-GD'40B;$+83$#:EN+"Y!H"J.KM%[8WD)STM
M+JC['H0O#]Y*S;U*O32/0_0&+^=>G@U&$]U%,.7Q-X;WV0\N<9ZHA`;[OJ&#
ML/8&A)806D)HB:B6Z,>T1$2*N.35(TP9`Z%);8D3BE::2M6V6##M'07BH'\%
M&;TO5,G=AKL&'RR(J'T698M$RJZ<NJ8ZSHKNGR]PAX[N0E$DKK=>C#42HXE;
MEJ?E.WLN!'\K9$V6W73GM@.`$&=!-U'"7R5UN73L'UOY<4GW"=\$,1QV=R3?
MDC.]F9JJC&<UOSJXY>:MOIJ`G"M+?_^7;RQQI7NJ?D8BR5D@R3E\*04(9WN)
M`;:%;&[7`D8114)$\51EL+VS3H*\H)LNMN_"]>[+U$Q(?>6=R1C==W\%&%TG
M%M.S1)$*Z;Q^*'>0-(*E!)G=TDG@@1ZU;WBP9T)E\SI]$HJ'F]0=,<DV]3.U
MTX%Q4Q-:';:,QV%%\`?(\OMP#_JC,6M6%_9I#/MI#JD+-<T!M(!>H+-R<53Y
M'PGYKX0IZ$ZAU)<[6=P<@<M47&*8TFX-VI:>L>;0O*&=R,)V-H#,PG:>-E.\
M(QI9/!!'F,^RS&<[1K4(\WE$O7K<$P<2E2PF?1I)ZR:UU]_08P-`889IV%+D
MO?I!HI,,LSE:8CZ;Q`]]:474%AUD(`3\U"8$B\/)&SQSJ7KR#\29Y/4PQ'3:
M$HX0AY&?B=X7-#T]F@I;?L:V/,O\1&'+A2T7\MZ,E%SE^QXB)9>E\%Y]*#D;
M5TLMF$BVY:;TL,1D6QT#LX7HMK/T0-CC,R=S+R.=A9^]Y_S5@=(2B@O!/@O!
M%C;Y%&DJ1/<,R"QLLK#)0K";D_P2]6A-H/:M[UB&AV/2L#=X9OS`SVTI1Q)9
ML&-GP<0V=0,(VL)M:F&8SX#,.\=:"8\[-^$G8K?YE,G;.KD6)OD4:2I$]PS(
M+))@PB0+N6Y,#DP4@#6!VF%/IFO/O&?5:=8,*)'^:F['I=AP;@!!6[<3*6SR
M69!9^-HE;3B/1RVAN!#LLQ!L89-/D:9"=,^`S,(F"YLL!+LY";"R$J!M'3O?
M8!;X2%27S&U3EXS%TK&?Z+&;S:H:RC88/YWJ(E^VEP]<ESAX2(CODIEO2J8Q
M(^SDJ5EX-+R)S-)$WA`*H:G.7IW34';17@Q$.2-6V.,8B.$H9>Z--XHG3G:"
M<9-(WE!]('R`,R&T\`$$*P@?H$',(7R`LR.YJ)D3U&[P/H`HECL+,@O1/46:
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MY:E`B_`ZW7C*C_`8?G^.KED)UIR`GETK6)8)0"\3`!ODS7%_!02]M1TZ`LZ;
M.X1("[AN[DH$%J=+GU1'FU-T_4,>]=[TY8ZD].0!S4'"AWZ''3K+'[`DCF'#
MGXZ]D#Y8&EG2RD5XK.T_SI.>U4FO<Y3(CR6Q7"(]JZ[T4[\#_-^1?I)[[`->
M_9/<G4B`*Q.O=HB[))IG/!%SU972&)0SWB^O?/?R4567KX,$ZU<3,'1EZ>^#
M'.L[P]5,V_4=\@WP>FW:VO=?__XW2?HEN//&7BP,CTY7A/MNX'V@EXBE&<3=
M<:]DZ&\O;O\$^`>3\86DP>7PTQV9O;VXP6][T]YX-!S\B<CIR3V9?>CWY8M?
M$7`.-Q.FXW(L9\,'V]3S//#@G:_12RF"<LH$,:2GT3T;QD:G)N/?0#SQE!S5
M6DESD"206,.57/_AWR`MDF=3^9W9IFD_`QJ!*>/HU:+H?7TX?N5);2Q)<69X
MX'MH;_*\(Q]^WR^6IKU"A$E7CZ!&&>H$'Z;QX4(U+`_^#\9FC3UUC;UGPYM+
M+GDBCFJ"&2":CWJ=7TR(VY6D3[;K\0FF8"(B]^*\6T,GU#0MU17[$MC\`0R<
M"M_[@$]'TD#?`P#(WKJ!UL8%`\**[^%:5=+F*C"]Q*[P'-L,IJ4&2Z![<2`:
MGDGH]P%L>/NS^DBX]/#7/!"+S`R$+H#(LCU8F48(>K(2H$[25!-,K^K0,XZ8
M*<4'ZP`4?3EQ%H;%+"/BQ_8]N,5WZ3S7AU4<"%S\HPT6V2&J:UN`+T1_!$L+
M=848"1X*RU:!`K`N#S@A>%RP5DH.>&+\M?X2(7$,SR,6+L?02*!.`CA2[?"9
MZHLOX&JHJ%(E.J59:(IM#%G2E?_HN][:960>8S_&E71[&!@75`E*+!UCO&9Q
M*@+J$K3!#V,!#&ZNI&&GW^M)[E\^1(#2C!"J/^S9#!EWIFJ&"8H`U@;B^@=Q
M/9`+%U[0@?=!!*;J(-9S0YM3&^H2YPE%QHT"Q*"=*/+X#6HA>*L#,N:[AD5<
M-W@/_`7__J)Y]@-QMM;'Y90M!5^D<M><J@045J9W?BP-<'=!:TCWX&J31>Q9
M_1Y]V(@_;#=TY,FP_1`J^L).'*/P\%ORX/BXB@D^L3>A.-V)L&O'MA<S@YCZ
M&E^=`]`41`[A\B2^JGXW$L*%GZX)>"_HUJC@V"SH$[FZGOD>>.`0)%C&PE]P
MS(9*F#D[J/V"0&87D'RIJV3.0+=JEA@RO3`P%`)T`^W<ER7X4&4$PLD2O^_^
MJA(+%&DIN(F%/S25P',];R]Z$$P1T\1L#BC6\&^>)Z)_\PP4*RH)\TT\6:2!
M^ZLN7?(Z^/!&8@FE43!ZZDA]EHG)T,E(S%78RU9W!!U-G4W`1U&LHFJR4-_S
M!CTB!#LE_)>SL;`;WUD1GC^/?TH4&%9RUK5@^:I2Y,V9I#D4!B;#)EA/+J<2
M?X.<0L!*%+`"B*_NJ+E3(L6D)WB_X;S?A"DQ:$E$CVAY%J><LLTDEZ[LCDXA
MF:41Y[@]EJ=$KI%R-!DJ6H,DY*B)X5.BA1.5RX7WB6U/-=/S]I6ZG;67(9^'
M9%=29+S.!3:Y,/B4R`C^9RW25V;Y[GD(F"C./;$RB#NL8@AJ8%G5$BMVHL;0
M#;>L"Q3OLI):>8JEM+R25F%EM=$J6E9D2R\=3L?TVGP%OJ+\9YNJ[_SO1/K=
M`@0[+M84B/*?30Q]L*3/>&0]5GVP2O.4JA_-!`]1`X<1&)<@%T8J@&C9VB:^
M7^`7+[%0C5:G!,4IV\^QG4?5"DK1T\I#?GO_^?VW#S>75[?KI[B>KZ^Z$KR8
MBVT$K.AJ#)=*G&VY!MHY@`I\7`8SOA(K!I]MY[L$J%8?:7DN+RA4J9BZ09E+
M_,4=P(YF^K2R</T+&$QXF>;XK+R7U2?&?J5OH4`BZ%C>IP&<)J$H2'A3?&W/
MAFFNBPHWRPXE3;4VJ@X!UZ9!G,V*0UJ\!?]EY8N,DM.>I*LK=T?)(>*K"VJ)
MU1X^X9L`6G@7/GT5K9SL;-5P4EP_V[Z)I<[@>U"X)#(#"#R7PR%1G\3$0DA+
MO]3MYQ`;'`GXH%C!)'W>`TDE+JVTI.5<]&5(,]]!U@ZT:E+U)WO;^IHU5*P-
M0ZC=;:42T0"`S1O`M6$A.H7^W:5_KY:.8:+RE5.5+Y",.B<;*A?O2,0WW!C<
M1GZ`DG*QL!MTG*D_8]4V#:E<5H.]!*F802QGXR-^[]YW*><;"`.3!-!"2Y`/
MRW,[O#B3Z3W`4*`G$V[3#?71LEU0(,$30/H!8-28C\0B^`/0^#LL@<KJU=W-
M54SI@P^F2[KC/Z).TPT4TX[T&[$TU;&9VJ/Y"B]6DHZ(>5!=@SUSU_)UT%ZF
MS><[89$U:\%8+(BC&2`BW!QQ[1-`ZA'7XPC`NFY@1-#0H#=4A,"`9\5!-[YC
M-2Q7350O<<`E5G$*2M<+2V@U4#2@\*5_WG:DJUNFZFQXN1.\!FOG8Y8.555H
MF$+6Z%`<LK_U0!>F<HIJ63Z0*N"6&>$U]8`^^P'BRJ!8/TP5F8`&+*0/RSLI
MEE7`"KP#+[[WX!Z7DP6>X_KPI>L_N.0OGUIF.ZYSH_!OV3+5=&U`XE\^+<5U
M[)5JPA+"=P.5@#B2JYKHJJ/;'*46\ADH:Q1'0NMYX1FNN5KWT_G.TG8I%/B3
MYA@/>,N##\C1(>@TA8[?5EPW*IAO^TEU-=]4'>GK7(7?,$1_9*;^O05+)TS(
M;X!K?=-3J>[X^/&F@_T--U_?WPB#L'TR!0HN5J-S4=1WZFNN0Z*^IPK.(#9X
M!BYCS.,$*5.98)1"-[0`=AQ*#AM8@4"_T===?P*30$E-"\;9Y?ALU`0&6`96
M/?X!J/?DNP$XQ/<0;!>CWZ[T0L77F2"QX'9Q);*^]3W(Z.9]+SL2W,":?>`6
MQYT;RPCVPGZD`#T>$((C"9ZXMBP[]"Q&"0FFF&$FWLL#1*&N9D1C(I8##<9U
M*VV)HBT^>+>M4=\4>Q?@A0&PU-5&Y2]]8-KR]MV5].BHK,$(K"?5<[0)XPES
M^D"JD$OP\FV@7::AO;GJ;4-M/Q-&-W5;V2-8/TVZO742(N@+1CP`K*[Q(\B1
MJ#-`'84U`*W+VBY2P4EXJ;]$\OTT[/;"3F3#XJ8#GH-62G+G*`D/>)^A,Z3"
M+WC6B^VL=F$*GO#>QZ9D2IG_HP(.@M:0+1BI'4K`6\SN;Q-8<K#)C9LG6>D.
M?\:U*/`?6)B#U/7)NA$MZ(\#&'5?\]"3@;\P'M'F!EP<8`0C4V-F1*YD1M!$
MW\:-Z0<)7A6`16$/Q#)FX-%38/DOY'0;A,:P(HY!O.4GE)3-OE>Z!)0WV@SH
MKR0:,=%O*038R4+=3HH47$B($7G\,P:H"_4[@SH@/_Q$`=YF,8J_D,)K-DM+
MS6ZUI>=K+F>-Z>J#8;_&_G5O=0M80F?J$>_^0W6H7.[I2I^(KO0"7>GCE]N$
M;8Q7Q)A!6G,#U2D!/Q2!NQ:D-M</.Q8A:>)^FYH"3UOCDHTGM+H?K"=LUJ.A
MGB5]]<&D:`'^7GS]\/7]2^D;/E/5J"UL+!Z/V8?[?U0+&T#77I6B=/8GY>_!
M&X:0E>T1A4,1I!=X2^"2*+TW_.%L1^JK[VAS+/((KP^OE-^\9-XL0HE=JZJF
MP=MH2&]0(ML.3PV`?W`#S@BXX.'0@"^TH]3AK?P6T<(.>K3DG%>6)GCJ@0-C
M\,Y0N`P>#0:2;8,QA0E^&(#J^NHZ7[!G'7%4N2`.F%)>>X?PQOYPU!GT>^@H
MTK[>/3!0IRAX#W-`E<&T,^S)$I8H\1Q7RL-H6CL$X-&Q79JDPFD$](9XW_1/
M<N#:=L")A7LQ3X6.'7I#F,Q84$_-GLU8C,;W+.FP`]:F&4ON,]<,DR/A*SDB
M0V\?F&D3ADEON![\0U,D6Z1#QX9YI-ML.PP:K`]/FRBG)N=(CF1>H\2@7`L2
MY%N,ER!@9DDL[*"W".,U&AIN/D<-GA1CVEYW'.7VZ%T\T`DO!3IK9)W*0PC8
MGK32G<B,E^*PDA^8+'4IY]%8"Q-]8"VQP9TVSM/)(A;MJ7>WYVRLKT;PYRKN
M$5K!0P-P,-I4NLH$DWAL'1V<S(]Q.X0+O=[/Z^TRF^86'@Q]?>M6-CF&-1YR
M?U9=7?U+NE&7:#%QB_T[3BQ(T<F"N?>,G9E!`(\<"7H/V-=A,3`-G</PD06Z
M&+"&6WR,2VD`:JZ0EO@M$X1`+';J(\K($-,FO`UY6">:J:+A)*`[:=5%H"OO
MP7PY;+P"38']X`-I:$SHNG038#V@(3)(8B!X(6UG:],%@,#=985ES`W<V"#F
MNQ5`QDYT9%:8`/O!*V$PK>'Q;5_+]NAV%!\,%"HGJB%]#SC`PNQ'AQ,=$YC4
M?^+>DQ4M%;"#BUBQ`--,6WH6GN"N^066^`3PT3UG?&0GIA'I"`^Z^409*OPN
M]D`L,(AZ:A2;>*6#'!Y%5\1)"W:@"/Q*MY'6OC4\C_T8KWUP?>(RX$W3I4N,
MPAY9$C'HCM.+JY=K3J<I.78]%0>J73M;BGJ]5`8\+I\^C/U.LT[``BR91<T%
MD.<57(5K)NYZ1Q/60Y-6]#ZT6C3U_)=O>SQ9"ECL1#7&EC6,#%AB*4B\V`!%
M@IG>*'%='U"U&Q7TI2^N(WC@GNP:$Q$<1%<?7V^$F1\(+@OK7CR$T;47X=@4
M:A/38:5&;C?5X.T)"62*I3!-2+F/)[<\GE26=##4FH<)=K;3R/^*#.FR?2<R
M-X9!R'*IC,E]9].O`/D/_.,#Y!S]Z8!Y(ZOE24#TAM@`KW"D7M0/X(L/?.4.
M<VJ"*(9K$.ITQ/*5H3=DL.UDY&5U[76IT:0K3M!<[Q%'(.2&BM,V=-<YA5QU
MP?<4.M&I:&A]&.OP76PV*R<T>O:2.MTQ]@U?*78I=Y5UHCM`P^5WE*LQ0F64
M$"F(+"D(7EV:GH)PHRF(C4VQ0*IQC)/A^3Q<7F<2-O,4'X)?8AF)'?D$%,YM
M\BY9YFDM\LM(_F#;+.Y,$,BC06?4'QV0(!@-.Y/A,&-^@,?CX<+S)@S&?3ZE
M=RM=L([65:KM9X1$2DJ*)!,*91-&\BB>30C?MTXB;#O7PK=N6!)A<'`28=`=
M!%/W\F819ABN'9I$&'3E_LXD0EW)@WY\]&!HBQ`[+/9@$_S`H5>_DVCMZZX]
MYKMHK'L?QKHH3<`KTOTES@V'ARUHGT)0M?=`-'0^UD&PS4L0-T5/CBM/S-_:
MM!#:1X]VN31Y($_C_-!S+QQ+QS`3LD=TP*RFNG,3_<^0M/@&\*0]#@IE=V=M
M$SB[&A2%P$0&3H*-K#PA61`\@=J/H$9LO79TG\&B41<6GHJVC4V859]4PPQC
M/.K#;_CN"<'*1KIC'<2R^@(:Q,`]P;*%H[=C'XK9?>'=I7IWOD6V#.R.'9.X
MLW)/:&Q^A>5@8>3YU2&`:8?6>2(+O]CXXF6RB[2=_-APVO8Z0#\IO74%4+SX
MA->9R@K=P(BL9!/@?1Y<1QGV-AZQE6#8-'D(&F!V;6)VO'B'#]7A47^JX^9&
M/+>L_EIGISLFC[O3-?*V+!QSI&DKAIZXO[=4@0\T8ZFR;<&-,)NC!2$<3^0B
M1.A/.[UALK\A7,+MRA-TM9*8CCH8FZE*W#J)8#C)RTA.JS'K9"^C&1`LNR1.
M5TH'9Z[JM!CT+Q^+^5E"$:\(4E8_=7L]>2U&7&:2^0B?!Y8]>`C-F^D&.@Z6
M3M-5<"E9,$!9&2CS%>&>)YM*'"\.9;DG])IXL;F.(F6JSP#".Y_*'#^/Q32W
MC3K^M85YE$".^B!B7M]!JWT%;V?A[4`W.)OZAC(WU_N[8Y=A;CX/@Y=$%@X>
MKF]ZK"GQA]R-&H<.*[3E`0Z/)<(X!SLR:*]&9+[V[H!G*X(R%@NB&TS;;T13
M85HQ+%YE`LM`>:!^[MQXH-4>-,[BS]UR38T9BRTPE>V;7IA(#U;=B3P</MN/
MA%JN,'.C@B$Q$4;L)N(-?'AJ`S;>L$)O:8')#(#3DJ;=Z33<Y/7HR!++IRVK
M^-K=]ADNM4*N0,NYW@P2,I:04H@FV,,<PD8,&/%,PJ+H(.I^(,22(O%7V$<?
MC0JO-,HM\K3?CSV[<)0K1Z-<Z<5GN]OO]R_ER7C8F[P,HMXR-H`_J=$Z@&DG
M<C37+LT?K?QD^*0:B_/C+MRN8TR=.E:Q%X8S^07W9MQLWB;)+*CDC`<]X/!B
MTS&:#WC/)>890O=A1\)5B;0?>#:]^]&"E?-M.P^,D@OAS)-J^F'DCQWV.KYB
MK>:B^ZDSHN(^$=J2U1);4G`@!%6H*K`MP;ZU$*!(OS.VJV$N7@]T,0T@V!ZP
M2OO)M_H2",]=@(FQP@)E%>_0'#KWR;"B>6O:1('9=Y[<,JQ@O5&O#^Y<\JVP
MH*XO4,:HG;F-80CAHKX,2>/&[*F#17__M)_Q/*(./\$C[(G"3+VF^0N?[4OJ
M%).\YF\33;3;GU.&>G'J+C!3EDKMW_8R6.-"\FVLBS!A;8$Z4JE3N'B@I.#^
MS"[EMTY*H:7#AW$@(E=A&M/PTH_A.].L$)W#LEG%W=S<D-@E;8&I^;(K>]T/
M#MG<5>A@TYJ;:(E#M)`ZOO<X[,CRJ*,HD]R1>5(J96MWLZ.,,;LR+A+[[\QX
M87EI+.5UPVZC-K>3<SN3M1:.4XJ@LR;'@NJ5($G&`[5,FX_C@)Z!<Y=WSS.6
M8Q,.VR$[F,Q.,O^_C'U,99B^CWF4K4FE*P-<.PN<>8MH17N4B;IL4UQ2]RC/
M9)-R$$.-V*04FY2YE%Z8#1!>U=;8B[1#_3H)GDW,Y$Z[@^UY!`F\S+(QZXP@
M,G%<*;NT,YUN1J).9ZE;G#T`[EEW,NT$/6T,"Z@1\?S<1[*IVV-^$6CYOAP.
M+`K6%*:H$"@ZT($I6-QCP[N"1KPP>4$U2EB,NSYG-K1(L)K@)H^2[H%XSYB;
M"T=-C?BL@Z"73NEU-W)584YD.Q]P&8EVF?0;T6JRF0I_\MI@%O)S%1$81;I&
MR7=9?_\UN'/?+^\U"&R14G23YA*1AS\O;)UD[>0OT(T?/U]^?<&7&9HR\!JI
MUKUCCN2-[7KN/=+R&O/^7_GPH9VM_5/1VE^@M7_R4J+XO60-`E$:")6YA:[;
M[9&T?"9AUL&T^"$<@L7NS#=S=CN-RM-M="LKK,D/DJH=I@HY>;4H>8/1NSP7
MAGX^#A:G"B66!+/9B<Y8+2^.>LTTIKJ)1[U.!L6.>BWY*(E^VPY+2AC:O3D*
M'M`%<`,&1Q?'/-:PG_$0G=2Y_XRS]@_^SXCMJ&W+C_]]UO*P&?4'Y5/0"'RR
MZ4"D]VOU+X&J3O.>BIXA<*#D571NSS&/=6D.+VQHB=927I"Y?#*'ED&IPS)P
MD@\.H7EUIN`DN.!KQ&]_1S0VR5^F^Q<]67H1)J(#EYY.XQ>FX4RY);_.:,21
M;ZWSTT^(`6HW&HGA1-2.9#UZ[.CQQDEP#>9ZA*DX+YJW)8HHI`F$Q1`60UB,
M:BU&O]EZ0UB,1FB*!E)>D/DL#(+0]R)"$/J^!<FDF]O;WNU-A5H!\TN-I'63
MCKR^"\]\Q8,\UT?GE2+UE9,X2\#8%@W0)*[XJ27D5\JB?\0/H#,CFN`&-(DA
M!KV6<,3/0MZ/'^/5069!T].CJ;#EPI8+6UXU0\C#EG"$L.5GHO<%34^/IL*6
M"ULN;'G5##'NC5O"$L*8-SD97_D6G4C&9Z#V/3%-.OGA-V(1!_NP+5VZTA>&
MQ6=%/)%&[<8):3^VM!^9S$I&.@LSOB<DER<MH;@0[+,0;&&L3Y&F0G3/@,S"
M)I=#>*6<R%K(=3/)VSJY%B;Y%&DJ1/<,R"Q,<DEA<F?:+V?S6HAV,RG<MN+S
M$YEDT"06N".NY_B:Q\YE>\\F"+9FDRM+&Y)0#$>W^;5N@1_,"\(OR#(0<Z+(
M2K.XXV2[U1I'_.9IAM/H3Q:$%MZ`8`7A#;2..80W<,;$;YYF$-[`F1!:>`."
M%80WT"#FZ$^:52$OO(!&:H2&#D36;1]/;E&ZPC_(>W2&[:EF:_8*\XZSC/&%
M\!V.W5%72PE!?3PB?(I]'?3-*M=/\BD2K8?0%$>/,HY&>T'H=A):N`\-Y!7A
M/@CW(?\P/:517".\A_,U*L)[.!-""^^A@;PBO`?A/>3?T.CTE&FC&$<X$(VT
M*[$MC5?T"/CP.GXZ?#Z$Q_#[<W3-2K#F!/3L6L$R'P#T'<D0]#)!L$'?'/=7
M0-%[S]:^2S8]OY5.^G'I%^JSZNA,7%0-?W,E>)KDS0G\'X\#7\`3Y]*2G1!+
MUH>"L[HG>=1[TY?QH%AY(/GP*[OUQEXL56L5UD:-W[C\?7B&K(6CA21I:<)+
MI6?B$$G%MYJF_>R^EE(8KC[F22;=OONK$D:*ZA3<<!GCBAC%C^O'MQ>]"TDC
M)IZ=HX$N#?_FNI7^S;4V.Y4FU-%<P8)B,M6E2UX'']Y(3`E/!KQ-^*@;F8->
MVPJ=$E134\\[$L<=57+TS6>?GK-MSZ0O5"N[K7"S6E\YTAP&:&CP?AK5HRTG
M<U-TOSCKKAJF^(,"`<[TU1-QU,>TEF.!TFPH??^#.)J1VKTM4)D-E5\=0VO6
M\%?ACC333C60\H+,PAT1"O\P=T2Z(PO5L'`FR@W<Y*B:YZNF](TX"V%>#\;V
M"\.25D1UW)?MUK3"QC:U540<=]R$732>UY-LWW,]U4),2JHGO2,:P=3?UA9*
MOQ1U(,Y;:BF[M+FS5!R\5"5G3`;]SJ"D0DYQ^%(S:=PZZ1<.P"G25%CV"OA`
MG*0H&")>5MD=CUK"$\*:GXGF%S0]/9H*:R[X0)CU^N+T[G30$IX09KW)^?O*
M=U*Q:%I0>P^U?X,+/:(W:I/N8(D6.KR593"IUET0O@3"*[U>IS=N5K.CL-]G
M+MS"2I\B387HG@&9A5TNA_!R=RJWA.1"LL]"LH51/D6:"M$]`S(+HWRFA!?R
MW>1\=^7['2+?G:.#-D_&.UMG6/7[68-=]!5:O)V'UPDU?FPU?G0R"YH>KX]7
M:.OF4EQHZ_.@L]#6@J9"=`69JR\-%?FP<R2\D.\FY\/.?4)N@UG@UG9FQ,!9
M.3A%6U,MG*7<HB)1<19T8W7%\??&!'/4Q!POE'(."A>SGUI$]):/^Q+T;:?&
M%[)]]K3?8]IS$U^8]STUJYUI;]+M]9K("T(/G*\>$,9>$%H(^8G37AA[P0U"
M$S25]L<MD$W<$!!G<)<\Y?D3GI(I!8=CMF974!S/W1I-<OS2`7%.=U.X1^[T
M<$9TP\9/B;.ZSU=QY*:]('0["9VCV$`X"R6Q0@L'2@L7H&*>Z'?[PT:QA;#^
MYVL4A/4_$T(+ZR]80;@!#6*.27?:K'/DA!O02)4@!E.?$[4;TW:`!!..P+GR
M@5(6(P@OX,0X0_0CG@F9!4U/CZ;"N`L^$,9=<(8P[F=.9D'3TZ.I,.Z"#X1Q
M%YPAC+M(V(N$_6$]`H1-V%91=U;3(]`8>1=Z_L3TO!@56`[AE=&H,QJ64ZK7
M&&D7-&ZW<`L;?HHT%:)[K-)Z88[;0N])=Z"TA.1"H,]$;PN:GAY-A;(^1[H+
M*UT.X<==N9RJ]L:(NB!PJP?IB'QX&?GP)^(&D_3)CR71\`_/IE^7(NV-.4=#
MZ/?3:VD3A"]G<$U?[O0GY<3@C9%W0>5VB[>PX:=(4R&Z)SUJ1ACD<L;(E',T
MC1#H9A*XA7I;T/3T:"J4]3G275CILG:MIR)B/F4"'Y@/?^5AC7%XG6X\Y4=X
M#+\_1]8\0F3O@G)9SDOV(GT_`'S!7`!HO37K7GE[T;N0\,A69$=@V/!OSL#T
M;RXM&@!%G%`V>/L+<(FI+EWR.OCP1F*</@DR_T<]['?4;]LA/PDDW-1A@"Z`
M&S"H7!QU?V^<[9C45)O&.*L)1BVJNAYL4W]SF!(\0.-]]A</Q)'LF70_!_9T
M&[7=>[*'J32'_@VM[6"4SW&FDB!S^606NO^TF>(/"@31I:LGXJB/1/H-[O2D
M=ZI'I%O5<*1_J:9/&J@7A$5HE*IH:$T0^N2-I'63(MX[XGJ.04N`7,_6ODN^
M97A;QVJ](QI!/Y'RQC_D4>\-;Y]MUM#;M'3(WE.3VJ(IFL0]K<N$#LMB!)$J
M3>>,@3SM]$HZBEMD2YM)X[9)OR+\@9.CJ;#LU?!!6PJ0A$&OJV2XVY^VA">$
M-6]RW%]YOE#$_1FH35-]1&]4<D\4+C5.Q(],]Z$@?#G&>RIWQB5%XXV1=D'C
M5@NWB,9/CZ9"=,^#S,(NEQ543\5(RE,FL-A,/R=J_VL]6,,A)E'=7`%VMG*K
MZM-GXUV4%IH\@Z#_8Z+(2GLV3H1"/[JK)O8\VTI3H:W;3G&AK<^#SBW:TVIK
M,UF#6>#6=F;$"-QR3;6P[;`"O[P=;1#"&M1@#42S0]N(W[S<ZVDTP+6>T$+W
MGP-7"-U_QL1O478^,3R('0PKK$+I_6^?RC\RLA&5\6EL)*KG&^-4-J.,OC1F
M$3Y).O>,Y%YIU7KEFIYM?R31\@BU<3)J(RD6%5['B1%:^!(-Y)53ZL03+D1M
MA87#9LT3%_Y#(\U*?>-+Z9KWS)[D;_SEE>]>/JKJ\O4[P]5,V_4=\F5V8R^6
MQ')5/,/JCI@JA.PWMNNY=&[A-=;:?557"WBO^PU@N#8AF/_U[W^3I%^"AWVP
M-'M!OJD_UD\-KY0,_>W%[9]`PL$41Y,"V/#3'9F]O;C!;WO3WG@T'/R)X7]/
M[LGL0[\O7_R*D,<&GY:`K,E>7)5%D32&S3:H*L<##^7O%].7$J.B!&2$1Z>P
M>38$C2I"4`Y\E*L"/EB2JFF@8G&C6WHVO+GTNT6WO^\]$!E7^HU8Q%%-<R5=
M:1I9TO%O<(-O>9CK^NH8EF8L3>)V)!7-@D_E38(;[&?Z2'=N^Z8N/1!IZ=A/
MA@[W&S/)\"3#E1:V0R33^$[@Z=Y<M0`R#S\`;I!FMH//P5FCWIQ(*,^JM0H3
M\.,WKJ23&7$</(Y._2&IKDL\%]8`]^"#X)4.`4/U'Z)W)>E;PB/4!\,TO!4>
M:,>OIF][@&7/`$H;84UYD4Y`R>@2+!GO>J3(HAB`&V>^!SH#;Z&CC0W*B5WI
MG4_P;7B]#QAR/-6P`(#U#8`H>#6]QU[RY[FT'"'^J$X4+])<=6$%2$JL78!G
M`72["*(^POM<CR[+(MZNI<71!;@P#?($O("WX%4S0!D0?VF[QAHV>*VOL3\=
MIF[I*N%R6(-AZZ[D^@__)IJ'7Y,?P.$6`XWB$8CE^BZB`N[SEPBQKP/^X<ET
MF0X!;H85XRHM))5+G"<BP9=K)+*7!4!UTZ1]VW2D:?NX7;CV78#2==\15W,,
M>D;BE:6OA>(K>+*:0=R=QD*NQ5A4I::V]3C5/,"LL.0W>=Z13TM%4(UR$E!`
MZ/,M3%W=W5Q)#X:]!"]GH7;0_'4[J$FCJ@+^Q.M09;\#47T&APBXTEG:3-=T
M4#?/B:K_Y:N.1U`W@'#]05QO@9J#.!UX$GBQJFY3R8>KU?4[->)[AJ::\$3V
MMB6S$=2&S&S-!\\+]:4.*L6TEZA(4&W2>\S5I0?$(51Y@-"K2Y`C*N2:ZNB&
M_:2ZFF^JCJ0;+K9+N"F*W80%H"I%K81U7+JA@U+JH$&#A]G\VL%$>2.]>/`U
M8`!8DRG-5[IC:W-8'MBJEQVV.+XRN."1@8G;/G_Y:"8\]?(!A9PX%!=`9PR/
M7%LW0`=2O(,YHU19FD!#JOR86D8U#L_60)=2?'E`3I,N%FGE@37RT#U%AE?Y
M;\:#`\J2$PFI>-O!ARSA&W1DF?T&RCF>-%,-$XT)`/4*KL2(1GJ"BQR#8W#E
MSD!SAH_ZY^W=^]L-Q8_*UD"Y,&8&P>*&Q0((QZDE4?YC"A]@`-,#WH'MT#]P
M`1L4<U?`.0N&#L.+V!2<LZL"B2CL<>(P0D:0OV(X5I&IB&[`77SI:!#`:+BA
M9=4=_S'5`F33#[)R:@HB2M^0(\'10\<+Q7ZUM`%_KN$R[OP*/`#A]O6K_B:C
M`EMR:G6D[Q!QP]7@+;[__/[;AYO+*V`E?-/5+3P&",4L/?(VOT=ZAJNUN>T2
M2WI0N4H`38&B'KP'Y!7\&,=>4(H"Q9\,VW=!^,""HE3#30R\_@;/O_CG[<LM
M*'$]2F?<FP"KAQ(3JL;K]_??V"T=Z7EN:'-P1QX?67\6Y=G@*<A\U%D!;]@%
M$3(9\^NH01[Q:0@G8=XQ8B&"$J9+%K[I&9=LOG1'`K+I]@)]U([$<AN@3@RL
M/(UC6P>2/%K,IZ**U6%^JJO.B,?$@LQF<(.VBJ[90PT-'KYG/!%^']5*`#,5
M^+7J0/FU/$"N;JB/EHT4H1()SALP@X<R!BO`]\S5)UP<57VRU)],)2HO8)&E
MN;VP_[-Z!"JAEK"]U9([J<%?,3,4Z@`FO#H&!"Y2\0ELRX-)?7*^$*Z8@$%`
M.%<2N-Q+VV"Z,8Y?#R2(^?*:[V!B"!3/`O320D65=77[*E"EIN\!`:075[<?
M7_)(XU)3P3AA5(+^C+?*IC\BJ454LOLSB[O42=2QBBH8)9."V1?S5PIB)$^3
M0=%M>9`5A?[4XJ+]TM".TFIN2=75)14$)DQ,'6THK)CI@T#8H#>#]TF(105\
MMA:9P%0'.A+6[>M4_-0E.!X_@%<]#&V57F]#VMB[(IS[#E7=/9/E3S:\%]P/
M>-NU#494>O'N_M/U2Q8GJ99JKB!&#4*>N(X,(0%7+G"6F3.!/,_Z3-&*$XRJ
M0K6K<LU@N!C&VH&VO61W05#F@0*@N@C"0W_!3H5'-4G01XN\@,?ZL':-,%45
MZ&>JGRS'IBN0,-V+#X%;!DHO@A6*%EPM6^Q"_4XUAN&LX6:69`T[X@.M%:PT
M#`.9QD3,J#,4<B1`2#507^BW@=UA`/%*?_HUXL&DWJ<RD)X)^4Z?.[,Q>+[T
METR7L7"64G\!3JA/*14B(>ZZK/75)558W?5$;%PJ=7Z,Q7H5=-G42::+>P*#
M1@-^NAB'/*)/E>5M$GU;!U4VM49@9SS,T<#?#[X#<MVABV;6`_`NW3/2>0'^
MMR`#FZN9OLXT.`6'?1D8!VHL,G$.BQF85P`R#_X&FDON^JK:'&P"KC%Z-XJK
M@=8-$QAQL>N'QH!2QUHO`2UUR#;,6%+YW&;/*./A7:KIVI%;M;EJ@2L0B`9[
M"M<A#S0OL5Z$&3Z?TBE\!74TP._=!$KU(L_$K%4B=%PS48<?\0YN1)`_X9C?
MYHC0B0`:$<JG^&8#+!]A^22^ZDY<WB#0L*C/`3P0IFEXBFO[)3R0H[$*O&>9
MF#Y*TU`,`<^,"1&,N`KUGEFH"4K_<JZ:,VD%#I\;.$,HLFLER%P`N@K'74<(
MP*ZAP&.BQF3<"BXPNE6[F1Z`BRM89A+,F$818<:>,`-M*56XCVR((&*.JF(>
M*?[>O>]VI/>^8Z.[2,E,#<N_0;6Z&.51K<'TK3?'3"(R#=IUYF336R).?2R4
M7)N*(&[%8`=N#/S\G1XI"S%IOAH^.]^))Y$?H/]<XPF3Q5P%`2>#P^C&@PQT
MN3W,/@#O*3UE%%TE5WUP"?PRQ%_8JD%B/JS-8F<W3"QTCKS*94+RA+&#&G[-
MD!MF5>'N1P--",+,?T.QAO7`9S=F3&T?HB_N-F_$'RQ4I!CK(!"<E)TLF(KA
M!A8^15VH]/J]+=0$V!`"M2U0$54':YYC6H3SGA?W)3<H1^V\_P!:GQ+C]MT5
M9QL,=:.,QC9.N.UQ5`.X.^*H:>H2T[Q=Z4-L.P:YT+>HCP)WV0_4`8O<-O-9
M431:O^B5X5I40"\Z)X\HF8@,E>>DN+&D?AG<H!LN)LX-RR<QBT-C6W@;H1Y3
MP&JV$[N!EFB'6RDY=P9RY_O9=H'Z8-BOWZTAO??41W)GN-_=C\9?O@$86L%C
M?@//Y?'&QBT,BSYHM7/;0*EEVT">G-R^P9I1*/XE2H".%)*`B@<E@L2I(#85
M4HVY$9KMN-^'R&7;@$\VNO6@<K`C@OO$?!\7Y9#,X)6XD6@_0S3C<IV!!(#X
MQJ=)\U6HH5C,"KJ(^JY,!8&.PM0;1CJ@%U#!;,GW5BB/GC7?G"48!$-,Q'9A
M<4\@V,2([$^JDA4>=.D@RT`(`MA6'18$V*`;X1?FIFSC@>U\&!AP&31J0NC9
M3C'!"`84U7>RHC$0V$T?PHW.%D8QBT#C]6V<8*B+`82C,>0^&52K\KT._JQ-
M14[^HEL.4=4,GKU%LY;;"-V$AO;"A^\T_A/N<2/FUR_FERW!SV()7_2;3=S1
M<=9(V4ZTS"'.LQV^LX+O)YLD!8`<VW^<`YE<'Z-`-\`"S0%@SB'8QJ9M.1U,
M1C\33#>L[Z7[^L'6(=S[L-Z!!GOZV<?E1G;,V!?"&=FA$.X-9&.:8\,\_LQF
M-`-4;I_\)8^Q"ZHG4YP"<LERV\=EV3;J>NI1S2&9MHM.#E+8(H\J2V.K[ER:
MF?:SR_@K*O@,L(2WA&]0Z7,W[T:.^DGN3;I#W,4S#<Y9<S73N_G=H^X@N%MP
MSBZ+S-)E>!1<G#A43^D;8?]/\K3;#_#9H>4JJ'9GLR"9X3)UQ^3;54VF%U!W
M@+OT1!S/8)HQ4`Z!'@/:LO8]_`+L$$8S+HO";LF#XZ,N1'<J#N,Z/:A*2_\!
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MRD*"UZ7&>-OQ("]+2(S^HB_$,'`SFDL*`9VL<=ZY*N#$<ID@(F*RC#B.ED8F
M,9_M1,@,M$H@)W-^V:9&Q+6>P>^V$W63.^"A>=1=-\'A9D6$C!O8+@Q<\CJ-
MK.!12[PY`;<Z0P*P<DK62_#V`DNVP3G$;@%X8/@W[T.@?W-B\>X##5ZN+EWR
M.OCP1F(="M-A=S#Z.=8W,.@.!Y$A>ZQB?J-Q`G@K?`5[$+MKNXLA9Q/#*."H
M0QF4W_!?ZM)VW_P!6$',N)+"OMC=ZL`TQE#.T$ZP%Q\<L<=:_M'D$\S9HX,!
M2EQYLZV+,!9#4:,[$]2VLIH46N<>;AF^24URK8GP:LV?R?T<0JJ$5+5:JIAC
MA+X8]8+`M(`/$CBVR;ES\&\HIZ()Q+)YK"YW:4@13:-'-SF$V`FQ$V(7%3N^
M*;AT#(VD]?*LXW&\@MLQYH`&D11-BJY]4!Y[<U=42)Z0/"%Y4<G;V^[&JN7F
MV(/G>CSMPW)GD0P9K_OYK+JZ^I=TP^.^3U2JA<P)F1,R%\@<VV`$NZ39EKTP
MM*#0T7<]AS4M!.V2LQG1O*"0,]'4"<,FA$P(67[#AHEBQS:#@,]U;8WM;]!]
MWO@V@A`N(5Q"N+;3))B<IUW^'=Q@<XGFLYI9G!80[N!(Q(*G:NRO55!=JIFJ
ML7`C=;Q85FV:8/%\+"3%"D\'!)7.80+YP^N$#`H9%#*XED$LT`XVD$.O,25W
M0G[P`(YRYP/MXW]B=6VFH6&9-XKHHT/(8F_'0EZ!.^>-5*PXV9V4HONBZPH4
MG3P`V-B3RO:I6:,+'WWC$&SFP61SM/0I\DS=,'VZH<\[D!+39W/;!&5%"UEF
MV]4U[G9]2;0TCI='62Q-AV1Z`*<)B^78!JS]`**J;DUXH74,T:OYXK"(@UC8
MT(VY!JKL\;D<Q#1N#O:6UQE!C3X1_3J5EAP\$0L+=MCN%WN=PP=S)Y<X)-6'
MTFXO3;58]Q4;*_",#Z;=;7HPT&=!RT,>(EMLM!&"MF3%Z<):O>(D"=JV+**M
M2PX3-\R[84/>^F?5!*U@4<&F=0X[-N/YU*-UVV`<KHZ$]VU=9-,14&3)+"15
M/=OU%P\D4M@1#$K".1:\\<I@GC;A.RQ8KC''ND_Z@VDP[]P@8?$PDR0DK,-J
M:</"3-:5`^_L2.K"QJ04=2*BR^](K%,["B2M$G)X0:Z)=\<KD&F+/MEL#`B9
M`@5N74;"@@@V8H@FQ+!."3@,H-6(J"M)5(>)15,N:!:;E_Y0)S-KZ52P'[!1
M!15[%;");T4S)H&ZBZI3'*X`ES[8?K**V(@A*8>H.+.!%4=IO$&`]JFB$+@V
M$PG>$8PJS<`)7ZA>7$)9"*>:4DW)JZUY6RRSPY%>9%`\.--!7W=SKCMFUVVB
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MKH?H+L,ANM2U#*90K-]L8)IUP0>YTCU%UN7`.N-LZ19^E>3>Y?^EO][Y8.;A
MKYZ,<-ZQ!D*\]?[R?[J165'AIRL*+4!BKCI\K,'.56^Z>NO9O)L`KO62@_D0
MQ,K#*F').W`3C`6(#2*&5UTM"'8)LH&0X=R/':!&FA>PI8=F+Y80<3"G$#@*
M'!6\,'6YT75R'YA/4()@AB;4(GYND"L@>J2;D@4*,]6@4^'6TLBPYJ[G_^SE
M..YK,L^5XB+BYH4C(^<.P?%EEC?'62?8D;=ARH(3R20T,DC+`%80NG!0WQ-U
M\H-7L4X4HH=OH8.%<?R*Q#<"MEO^@M=$R;#9=;3NQJ7C?'<TY'IN-"3G\YG8
MO"$::[F$?$]H&^[0`<'T$#;>DQSXJ!U<D,FF:R7D5G"AZU1"V+6SV0*+WX6]
M.SO:E+O2IEQ%G`?FJU/A?2!1YDGNK?:2B-GEX68>!;:>RNW@F%26F_HWGP<:
MB4$S/S`N]8@[@AD9SC,!N^"@G21NZ0<"%R)A5XA^95FXBW1'<'X0QE&![OMO
MW*^*QL_WZVPK'2WR@XUQPJ<N#->E;2D8U"TH7$`M[G-Q2445#4+B\-96GDFS
M"#IMZ$+9ODMG4S_C4L-Q5CKR%VHQZM,Q9XX-(D,W#Y!`4V:Y)U!D<I[B#A>-
MN"R/Z0@,RFXPM>GAIZB7-11>5A$O*X9=JH\9>NE\">%M;>'K-N++H._"DT.8
MD8F.3@LG,,23,-%DG[:%>8UA'L<T!`:"C\)#JT:S@@GMIMN]L&"+[-GL\D$U
MT7F[=.>$['EE)VSDQ$%P.!*.!)J&UJ&H=#""S1)YT6^<\`:^[0(0$/V1FAKL
M1WZ,6?YUELF@FR!NXJHD#OPZ>D0-B6D[U?H.AF7!+"*=DP]P@+M`5D&1-NVS
MY6Y:,-5_8^,*U>LL1DW#\X,9#33!%CA7Z\E5=+XX1=DS:.WYJBO=(\Y"0.G,
M/9;_=:G^9.._\>D^[=JFJCFGTDQ1@)&\$^A4QR?Z^Q]X5@QQ4^+1D="4130E
M1[`48%@HQVT4N>@:A*WG=#``:P!D,26J!/2&=SE>&Q,N(@$7)GI!.!?4G^9$
M()P(5*D8;O@JPWJR33J-G4U[IP$Q;G\96I`X]^:&0UV8M3<.+@XNCX3'G^QR
MV!X(G==(JX48.,$>D(D^+G/DZ8LBSPN[0-:U>[0H-IS@L1[`%T*IAF$YURL2
MT][HM':!_=3%DH^'"-"B;^$EC/D"11W"-B.X[1BJ>H*#2]75NM.=7PX<XF-3
M,Z@M-@E_<\N7$Y@?E<*B48P!53-^;$H"-G%T0'!_AP^^L6>$NK/(%SNA54&*
M'-#RN&_*!X=:X;2>8",N#)ALYU&U^(2?3>O#PQ(W1*&[N<GBNP&W_MO7'YD9
MH.,%Z9DNU!RA_6/O-AS-7^`.'=*/SY#WPAF>>9*1Z6H\[AG?:V!G?9-\F;U7
M'9QVX7XE3G`JF*%=6?H[K+<@^C<D[TY;,*['%IS<)O$5W>$#'68:T4P(3@0@
M;#`]\SFP?-ZB?]/30L(3)4PMR&51?\;E-?8ZHQ>;ZK,.O-C$`#=U7D`9YZ)E
M&]*>3(A]]U=`B'7TG8*;&,OFKI_DA7WLH(/,Y93CH.2/OS5RW&#JN9.W])^R
MSIT<;A\\&3N?M'F'%R<=D;AQ<">@"^`&#((W6STR$P]_[8_2\1L<CYEZD"OC
MK":<Y+KE8!]VR.=!NQJ8`O[$4L#OURE@J2]W]M=\UBYG.<2L+>>[-H<7-G1"
M!LK'3G<5JO<<#_B-V@CEJ#:BP!GRPH:4H3<P;A&VXKQH7DA1'('RA31!XTU&
MR_E`&(SS9AK<O&^VVA`&X_B*XKC!1:+6P'BC.EI3A$]*V;3;0>I,3S^4TB]H
M`1TK=W'#\I:-ZN5UI<O+1FF"@XQ%6[1"ZR/.8_)!KRQ&B#@)M-NU"3Z"X(R#
M-(10`&=!9D'3TZ.I,.Z"#X1Q%YPAC/MQR5PLZK^YO>W=WH@MQ0:RP&?BT3JK
M4N2\+#IG\0324KY"%^1GA)]:P@'#$EE`N`%[<H5*IS^9-HHQ3G8OH$ET+R?I
M>S22"_K6Z]X+V6X1[9MEY[<#^U)H+@S['L,N=WICN8F<((2_$89=E`Z?&.6#
M.#\^338ZI8Q/MFU-PJ^4XC"A1([E053/(L,Z>41X'+6E$D1988OHWJSZ,9%*
M:'@J03@.)\PK;7$<LI09",>A?:D*X3BTB.X5IRHJWZBLMA'A1(C\!WT:3F["
M8R(>2="'@#/Y8H<6^Q[.%4),-RII*4H6V^UNUEJN($H6J^0,>=(93X:=@3QI
M"6>(DL6S4`#""SA%F@KC+OA`]"/4QAG]3J\_[@P'HY8PAK#M36Y'$&4*C66!
MC\1U7TM!6N!R.RW@6T_$90.DU_F!1F4'1?-"&S1'<[88Q`Y"'<R!$]>59G&'
MV$8X7\T@"A'.A-#"&Q"L(+R!!C''"Z4SGHCYAF=']Y;4$XB<0NF4_V9[JBD]
M)^04@A-I\`!BGQYF9>T?B2!0O=?RAI\B`R55SW.,!Y\?BA7-X)39?-*(_1_A
MV[7"MVM&`8AP_LZ[2$0X@.>K.40FZ$P(+=P)P2NB-^6DN`?+4@:=\:B<=)+P
M)EI$^I.I5=%M'X=!*%WA9^1D@>L]!Q8W*L=<IO<18QGA?9Q^0VR!'$9Q'A%.
MQYX-K%ZW)>=S)9H6H2M.=9"&\"8:$HD*O^&$>:4M?D.!9(7P&RKT&_K#1C&.
M\!N:Y#?$\A.O/!P1&5ZG&T_Y\1Q#Z\_1I2K!4A.PLLL@+C>!^>65[UX^JNKR
M];TV)[IODB^S]ZIC`9.Y7XESCR$X#=&O+/T="]"_X:*^`5C7IJU]__7O?Y.D
M7X*'?'5LB-R]U5<34`BWO/_+-Y8+@#V\7C+TMQ>W?P))!]/)A:3!`N"G.S)[
M>W&#W_:FO?%H./@3#USOR3V9?>CWY8M?$6X.-L-O-BR.4K'8RX3%#=;,<7\%
MS!@@F69-2(!A1*5KN![V]WAS(LULT[2?L13GA1$YK/3E:ZF4DIQ#^3(9H_ON
MK\IM_(<\ZJ6YC3'6HY+-->[;BQXP,C'QP&\-$![^S;4U_9O;`794=JCUN<H&
M56>J2Y>\#CZ\D9A:GPQXY_M1$YZ#')/%FV%*DK1>@]RZ2;9RY50731R\OBW+
M[UW/6*B82/YHS)J5/CZ-*H7FD+I0M`_0`GJ!SLK%4>5_).2_$J;XI#K:7.K+
MG2QNCL!E*B[1]VZW!FU+L-L<FC<TA2IL9P/(+&SG:3/%.Z*1Q0-QA/DLRWRV
M8X]9F,\CZM6&CE[&I$\C:=VD?8$;VN\("C-,PY8B[]570$\R;"JVQ'PVB1_Z
MTHJH+>K`%`)^:JT-8JIJ@XM%JB?_0`Q3K8<AILTZT3U-(0AY/PN]+VAZ>C05
MMOR,;;D8C"YLN;#EY]=E*E)R!PT_5Q]*SL;54@LFDFVY*3TL,=E61Z>/$-UV
MEAX(>WSF9.YEI+/PL_<,CALH+:&X$.RS$&QADT^1ID)TSX#,PB8+FRP$NSG)
M+U&/U@1JW_J.97@^3HFW=&EF_,#/;2E'$EFP8V?!Q#9U`PC:PFUJ89C/@,P#
MX7&70OB)V&T^9?*V3JZ%23Y%F@K1/0,RBR28,,E"KAN3`Q,%8$V@=MB3Z=HS
M[[D]1PB(]->Q.R[%AG,#"-JZG4AAD\^"S,+7+FG#>3QJ"<6%8)^%8`N;?(HT
M%:)[!F06-EG89"'8S4F`E7OX:OO&SC>8!3X2U25SV]0E8[%T[">"[9'-JAK*
M-A@_G>HB7[:7#UR7.'A(B.^2F6]*IC$CDNWP_[*S0TQDEB;RAE`(377VZIR&
MLHOV8B#*&;'"'L=`#$<I<V^\43QQLA.,FT3RANH#X0.<":&%#R!80?@`#6(.
MX0.<'<E%S9R@=H/W`42QW%F068CN*=)43#46?"".*JAO0D###O$4N_MG+OG"
MJI\B3855%WP@#BT05EU8]58EX$3-7F-9X$K3_(5OJA[1)9TL':(9JF?8%AWN
MIBYLQS/^0[]H8GI>E/$U2SLT<VM&Z(!V$EILT0M6R)/A$UOT%3/'B\%$[-*?
M'=5?MIOD@KZGIO*%]1>L(`KTCF']AXUB"V']FV3]CUN:EY@9U&W_P222TA5^
M04[*?W7L)7&\%<T$AJ>==B2+-.O(T\1<8`[2BUQ@._<(DTR`D/H3(_1!10%I
MS"'"A>*\\E-+6"1+%6!I/"+"B'2F49HU!BBW!1&*XF2,BO`>SH30PGMH(*^T
MQ7O(4FTHO(>ZO(=R3M$0WD.+:'Y@E>(K3P5:A-?IQE-^A,?P^W-TS4JPY@3T
M[%K!<A.87U[Y[N6CJBY?!TFWKR:@X<K2WP=YMV\`P;5I:]]__?O?).F7X/I[
M;4YTWR1?9K<^GL/ZR;",A;^X@SM4\ZNZHA/X;FWG"SQ5]8![Z8P^]QNB)'RD
M9.AO+V[_!$H/IM,+28/EP$]W9/;VX@:_[4U[X]%P\*?2DP<]N2>S#_V^?/$K
MKH(O@F$[&TY'J3CM9<+I!L?FN+\"'OTV)Q(>"J):*TKL?TP4>?S&E98.>3)L
MWY7LV<S0^-2[CD1SC$27#,NS)=N2;LF#XZO.2IIT)*77FTCPSN"6F:H9IN$9
ML`3#DJX=VU[,#&+J'7@A"*FJVQW))<X3/$YUZ6B]W8`8"WS!@^\:%G%#@+RY
M8_N/<^F>+#VR>"".U.\A#'*_&^':\-,U,>UGR7`E57+]!7TBG^<WH_PG+1@#
MLH5*2\Z!P%.+A>%AD2FN+`E(OM05+O0/XGKP,!<0M5XIKA#>]TEUM#F[4Q[U
MWO1E"O%`>@'W>7-`MVKI[LO7:>HBH@8*\&\9.B&9?_?=7Y6.I<A,05H,452K
M<K/W]J(':H.8)AHV4#+AW]QDTK^Y,6;Y]=#T<KL)]L94ERYY'7QX(S';.@JZ
M\)MV5OAD)%K,]K+5'5FHN#8Z#!1%M(H-Y$(M(!OTB!#LE/!?3HRU&]]9$9X_
MI#DE"@PK.?9/L'Q5T4)SA@H-A8')D`_HR>44)6V04PC8D7*\E9^Z<4JDF/0$
M[S><]YO0,(N61)3+EV=QRMG!3G+IRBYN%Y)9&G&.6VY^2N0:*4>3H:+;,4*.
MFA@^)5HX4<11>"_#]E0S/9]?J=M9>T7&>4AV)?46ZUQ@DVLD3HF,X'_6(GUE
M5C*<AX"=4YU"*74'2:4,[Q=+TUX1<D^<)T,C]W/@N&NX7<<]8V*Y=![1E0F/
MH)^^S.Z(9C]:L$[]*W$,&ZYS/7='><.PUQ/E#458^Y9OVGMSAX!/`-?-I25%
MM41@B7KBCCSVCF$Q`?T0;/WS.V>.O9`^6!I9TH%3025"PJ,ZT:H!R0DISHH/
M;."&9V`S@-JZU%1WWI%<9)O+!^0;+#\(&4<B/_`SD6BQ`$%^H/:*CL!R/?@/
M,B]N6-J,>>'WS<H"*47"105!LRH()H-B%00E1RC]MN7@DFS!AH<!Z`*X`8.C
MBV/NEO4SYF;J[/WD`O9@F_KA$>+6$P]S?0ZJ=4,C\`F-@"N]7ZM_"51U%:ZI
M&!#07%YH:,/':4P):CF90\N@U&$9LLV#:^$8@.9PP=>(W_Z.:*Q<6![3DF59
M>H$>-+K-1N#2OY0\6YB&<^66ENXDM,Y//R$&J-UHE#HSX.CQQDEP36E5XL)4
MM(;F;8DB"FD"83&$Q1`6HUJ+T6^VWA`6HQ&:HH&4%V0^"X,@]+V($(2^;T$R
MJ?*V<<PO-9+63:JDNB,NH6ECK!IY1YZ(:=,A**5(?9T'%(AS2AM7P%H]^15Q
M/&D]##$HI_VQ#H4@Y/WH,5X=9!8T/3V:"ELN;+FPY54S1$EC/(0M;R9Y6ZCW
M!4U/CZ;"E@M;+FQYU0PQ[HU;PA+"F#<Y&5_]B#V1C-]/[7MBFH"]CO0;L8BC
MFC0I?Z7C8`C7P_[()]*HW3@A[<>6]B.36:EL=N!Y$5Z6)RVAN!#LLQ!L8:Q/
MD:9"=,^`S,(FET-XI9S(6LAU,\G;.KD6)OD4:2I$]PS(+$QR26%R9]JOY`P*
M(=H-H7#;BL]/9))!DUC@CKB>XVN>[P"NI?=L@F!K-KG*/E)`<$5+*R"4HQY@
M<(;,@2>;*LWBCI/M5FL<\9NG&4ZC/UD06G@#@A6$-]`ZYA#>P!D3OWF:07@#
M9T)HX0T(5A#>0(.8HS]I5H6\\`(:J1$:.A!9'*UXT-&*K=DKK/T@1L$F97;4
MU5)"T.1C'\^+:>1AL\KU*SU14A"]T55'N6DO"-U.0@OWH8&\(MP'X3[D'Z:G
M-(IKA/=POD9%>`]G0FCA/3205X3W(+R'_!L:G9XR;13C"`>BD78EMJ7QBAX!
M'U['3X?/A_`8?G^.KED)UIR`GETK6&X"\\LKW[U\5-7EZWMM3G3?)%]F[Q=+
MTUX1<D^<)T,C]W-@H&O5)?J-O<#&`!4//[TR35NCG[[,[HAF/UH`E,Z.4+VQ
M7<_]!H!?PS7??_W[WR3IE^W7)#Q7\XPGPUM]0]2%SY`,_>W%[9_`$<.>?"%I
ML&SXZ8[,WE[<X+>]:6\\&@[^Q+,S>G)/9A_Z??GB5UPM7RRC2C;<4_0F([^7
M"?D;K)WC_@J8^=Y#1-KTZ%HZY,BE7ZC/JJ,S3:%J^)LKP=,D;T[@_W@2^@*>
M.)>6['!<LCX/G95\R:/>F[Z,9^3*`\F'7]FM2%+56H5E8>,W+G\?'I]KX50E
M25J:\%+IF3A$4O&MP%+/[FLI1=;JDYMDTNV[ORH]1%&=@IL8DU/-PTW#VXL>
MB`PQ\=@@#<Q(^#<W*_1O;K#8@3RA>>*V!72RJ2Y=\CKX\$9B]F<RX!W21]W#
M'?3:5N.5I)4;>M23..FIDE-_/OOTB'%[)GVA6MEMA8?9^J*9YC!`0_,6IU$X
MVW(R-T7WBV/^JF&*/R@0X$Q?/1%'?4SKMA8HS8;2]S^(HQFIC>L"E=E0^=6!
MR+_=1DFX(\(=$606[HA0^$7<$>F.+%3#PG$P-W"3HVJ>KYK2-^(LA'D]&-LO
M#$M:$=5Q7[9;TPH;V]0N&7'2<Q,V$'E>3[)]S_54"S$IJ9[TCF@$4W];6RC]
M4M2!.&JJI>S2YJ9:<>94E9PQ&?0[@Y)J6,6Y4\VD<>ND7S@`ITA38=DKX`-Q
MB*1@B'A%:7<\:@E/"&M^)II?T/3T:"JLN>`#8=;KB].[TT%+>$*8]2;G[RO?
M2<6B:4'M/=3^#2[TB-ZH3;J#)5KH\%:6P:1:=T'X$@BO]'J=WKA9?9["?I^Y
M<`LK?8HT%:)[!F06=KD<PLO=J=P2D@O)/@O)%D;Y%&DJ1/<,R"R,\ID27LAW
MD_/=E>]WB'QWC@[:/!GO;)UAU>]G#7;15VCQ=I[;)]3XL=7XT<DL:'J\/EZA
MK9M+<:&MSX/.0EL+F@K1%62NOC14Y,/.D?!"OIN<#SOW";D-9H%;VYD1`V?E
MX!1M3;5PEG*+BD3%,=B-U17'WQL3S%$3<[Q0RCDC7<Q^:A'16S[N2]"WG1I?
MR/;9TWZ/:<]-?&'>]]2L=J:]2;?7:R(O"#UPOGI`&'M!:"'D)TY[8>P%-PA-
MT%3:'[=`-G%#0!P_7O*4YT]X2J84'([9FEU!<3)Y:S3)\4L'Q!'E3>$>N=/#
M&=$-&S\ECBD_7\61F_:"T.TD=(YB`^$LE,0*+1PH+5R`BGFBW^T/&\46POJ?
MKU$0UO],""VLOV`%X08TB#DFW6FSSI$3;D`C58(83'U.U&Y,VP$23#@"Y\H'
M2EF,(+R`$^,,T8]X)F06-#T]F@KC+OA`&'?!&<*XGSF9!4U/CZ;"N`L^$,9=
M<(8P[B)A+Q+VA_4($#9A6T7=64V/0&/D7>CY$]/S8E1@.8171J/.:%A.J5YC
MI%W0N-W"+6SX*=)4B.ZQ2NN%.6X+O2?=@=(2D@N!/A.]+6AZ>C05ROH<Z2ZL
M=#F$'W?E<JK:&R/J@L"M'J0C\N%EY,.?B!M,TB<_ED3#/SR;?EV*M#?F'`VA
MWT^OI4T0OIS!-7VYTY^4$X,W1MX%E=LMWL*&GR)-A>B>]*@989#+&2-3SM$T
M0J";2>`6ZFU!T].CJ5#6YTAW8:7+VK6>BHCYE`E\8#[\E8<UQN%UNO&4'^$Q
M_/X<6?,(D;T+RN7F"W]YY;N7CZJZ?'VOS8GNF^3+['ZN.N1:=8E^8R^6Q')5
MS`5?:9[Q9'BK;PCW-WCSM6EKWW_]^]\DZ9>$9SQL/N..N)YC8!+YWH.;KRQ]
MXYO?+<-S=[]),O2W%[=_`N&'/>5"TF"Q\-,=F;V]N,%O>]/>>#0<_(F%VCVY
M)[,/_;Y\\2LNF*^7(?\P%.]EN73T<YFG)>:L8>?M10\61$P3)1!D-/R;RRS]
MFRL(#2`A3J@.>,</"(:I+EWR.OCP1F+"/0DV.XYZOO&HW[9SC9+$9D-M`[H`
M;L`@<.0QMS3'V4Z&337CC+.:8,>CVOK!-O4WA^G]`Y3\9W_Q0!S)GDE4H;F-
MVN$^V?-CFD/_AI:S,,KG.$9*D+E\,@O=?]I,\0<%@NC2U1-QU$<B_09W>M([
MU2/2K6HXTK]4TR<-U`O"(C1*532T#`I]\D;2NDE!_CH\!>@P"/4Q0-T\2>P=
MT0CZB90W_B&/>F]XQW"SYORF98#V'A35%DW1).YI7?)W6!8CB.QP.F<,Y&FG
M5]+IXR)!W$P:MTWZ%>$/G!Q-A66OA@_:4G,E#'I=5=+=_K0E/"&L>9/C_LKS
MA2+NST!MFNHC>J.2>Z)6JW$B?F2Z#P7ARS'>4[DS+BD:;XRT"QJW6KA%-'YZ
M-!6B>QYD%G:YK*!Z*J9PGC*!Q6;Z.5'[7^M9(@XQ"1:'EUYN57WZ;+R+TD*3
M9Q#T?TP466G/QHE0Z$=WU<2>9UMI*K1UVRDNM/5YT+E%>UIM;29K,`O<VLZ,
M&(%;KJD6MAU6X)>WHPU"6(,:K(%H=F@;\9N7>SV-!KC6$UKH_G/@"J'[SYCX
M+<K.)X8'L;-PA54HO?_M4_FG9#:B,CZ-C43U?&.<RF:4T9?&+,(G2>>>D=PK
MK5JO7-.S[8\D6AZA-DY&;23%HL+K.#%""U^B@;QR2IUXPH6HK;!PV*P1ZL)_
M:*1929G86L*45KK.`\>TECIBE0US51\,^S4;?/AE]A4>"H"[T>FK_93IJQS,
M?Q+5].8W`.`WQW>]6]_2KWX8[I_X[*]S@/G;W"$$KG*\6]4P?8=\HA-T=DQO
ME72B&4!#]^W%A\^W%S0#0=_[.WL:!_#B5V7<F_SR:B?T*0M#W*G6ZJL)3/3-
M?F\YMFE&%SO(-6HV.["]7@*LNP`Z`/YA,XDU4`JN_QMQ%E]F>)%)D-^C:QWE
M&PO\5?G?T2<.Q>9CXW.-ORR)`^!9CQ\LS5Z0C[8;$XAQZGM[2B*.+H<Q%!FN
M/5#D\>_W[RY^O91[DR'5FFO9WP%&',[/Q+M1W?E7QWXR=*)?KWX'[?#!"N_C
M8F^0&/B3:L`?#3;`SPY=?%5P@T:([MXZ]N*#Z_I8I/#%N5=1";[_RP<U%EW-
M-)T)^L%J^K*2>37RM+^QEOTP95@#\MO"MJA:CBQ![J4L`;F5O>`;VCU5H^<T
M?ELM22BS=^31<#WB$/V=X1#-^S*;$0?PRZ66@W1/--^AV+XU+``'+H@\,7S8
MMV?[_R.._<4BM[;OL#>'-[A11:`$7*(HDXQX'4^SH#6*IHUYX_C5W#;!8W(9
M:'?D"3X3^L/]TC2\*%[E?:RA](;L0Q_T_J_R)7@5ER/)8<^47'Q>Q!+O?WD<
MVF"@))\G&2@^-EGXRSJE?JVZAA:%.]^X\PCJ>S',N_1%L*[)>#(<R)/U4G)!
M5M*BTKR(F)QF6Q1<-AX.1M6MZ1U8/O2A-N^_TO\-1G,!IBNZNCUN0][5*>-)
M?\_2]L.7@W`H>Z"A-VF6YDQ4SX@1H`Y?RAY?H0#[#<:C?33:NY(KRS-T)*3Q
M1-8*^OT/S?3!8J)61!?%]ZBK#Y9&=2Q4PU^)0Q]\M;#].!^FNR8I%-O0VB')
M0$?&578I(%>,A70/)X7825C8=`<J0,*U[QH6<=$??@![BS?>@*4'S\FA?U!C
M#88=S#RS/A]PA#/$>IR[(/*C%A3S!Q%4I+M'\(FA`C\HXZSND;QIQTL$?B]6
M[HAF/UH04.L?,,8V9@;>=N6Z!.-<>+I#G_<1OC9,2A?XS5\0'?S1"&:4-*\K
M)T+ZXTTI*1GNZI""'CK\@%1Y`F\V'OHKZ1Y4+AP-AIOA3;7+V(NR:]5Y5`WK
MJ^]H&/3^!I_7K]_2*4JZ4U9,D)3AIF(I!F<D7D9$1+!`I=#%:.O+[)-MD=4G
MU?E.:,SO?E(]5%PKT$J&K4?7FB'C<Z=:CRP$X5]\4G\8"W\1C1!8U#WMO>-!
M=V'8(NO#2>QT$#MCBFOB/1-B_=,`10/X67T$E]QT`W7C;I.Q<'ZGETC%(+-1
M!+0XEW(NWL!3^-QWAJN9MNL[40VO9,CXA$^X7E'8;DS5=6/$VT3_!A4SLK,L
M;[!SY@5M1<]+XG@T*>1QL5ZB2_N[2V:^^=&8Q3"0YMOQ1R8^\7H5QM+\4F:Y
MB1->DIC]^O5K_W]CL>P^H`]:99IKEW^5658WK'%U:2Y;_M7=^N!P@08A<-FM
M\0,_N0U9:)I#EG^A]_;,>U;I.H./[U#/V/3Z&QL\K-K9]SWH](4*L5!PYU,L
M_]A/<[SR8^`C#A;`M,R'Q=*QGPA>E;+FCV!<V0E//H5.,I$^ML/_.Y.\.9'H
ML((,J-FUTHQ(^LV))Y7[::Y6R4IL4Z/W$S7Z=+J9KDM93=&5IWE6I:Y\.P5\
MY)5G\+,.5>G9:2T/E!J6G.9_E;+D/$2N9\D9'+0235MV@D_J8/%R?;/TQ><A
M?2V++]=ERVGK<TC^>%0#,LKU\'(A(Y=.J`49Y7J!>WV@'$JA^L4/:G4`<RF%
M&A:_9U,R#ZV&\J`&@/?L1N;![R$`7VF:O_!-]+;?D:4#KZ/9,?C,*CC@]JN%
M[7C&?^CWB8^.+FW/GF0>6@PF<>8I"]SJD;!OZS('?0>TA*5J)$0?M?&$Z+K2
M-R_3REQ2C,.D%_<;4F#9H)Q#U"^S.Z*:$#0"0H*U1B$NR5?"9.0?Q/46AH5E
M(1%5V)OT4FNV?,]Q_YIY(*C]&!D38(^OD.KA]S^6!MORP7,SY>CJ2G*&<'77
MCFTO9@8Q]>1`']=[V9M>]B,+V05B)+=,?\;*L"C8);DMB439F92)@Y,/SR6Y
M%ID!AD^C[(C>JFVCE[JW/OKRGPP+]Q"^JBMJQ._(0L5"6N?+[-9P-=7\7Z(Z
MD:4.T[?P\MG2N%P7!B__*M_YY,9WG+A6'I;H)DQZN9>VAJG0>CY8WYYMQ$;4
MD1CN+6O*OJ214F1):[`*K2JZEA(]!S1$!1:3NH0[3$[^P")Q$M_U'E:P_R6G
MBDX<E()0[RE$REJ]$X,ZE85*@3J]YBC%`TF&>C@=YP6;VI*K1X?0R`CM"=]8
M_FQ[AD:V=G^'^6J(HAN\^]X2`0BAQ!Z%3X8)1L:V2,#:OR_!DUIB)*=&"]N'
M>ZJ6)[UQYGU*JA##@OQ,D$11:=G>G#BY%["G$B?/`H:Q!>0!*+*.0*40!T^#
M5Q\)N'CV2C6]U9<'TWC<]*='>^IE`'Y6`+&UD$TO<PGZ[.+77E=6AGP%64")
M0LY*#3)#OJ>*)3_D:\`S0!(!//DZHG^S@5Z_HSOQP7._.,8CR(_Y$40'9#F4
MJ^BJ]A2DY%]5+UC5P6#NX3(L'0F>;!#WVUSU;E3KFES[JW?V<XQTZ7:V=*;;
M`]D>'LRQKG0S7&1=XQ26S+&L#>4!CL:6@1CMB:PW@/_U:]AUD_CT'67^K##P
MG8^=#.RB:"WMK>U@44D4JC1KN^ZBV-7\$&^G^.H83\#I'ZPGPNJH/UA??6!_
M;:L-(QI9)W69;-(K+"`&'HA&3-G7O%$RA*4\7V9_J`X>8??%H9VG8?5Q6)IZ
MH^*8S^L5O\[E%T;]\U&:W:\<@5GQI@RFPYX<J3`Z;/V9&(_6*B7R79IC<CR^
MNQPE>[Z!]Y![V1%%D7`/>)U!3T\41VF^S_%PE.QF3WK#M7^U?ZE1OY:5-_->
MIAO3=@EF/R+(&&=K]ZH%&3Q+)E^&5C$!_KB<Q"_"WZ/4'J?Y6T=;H++F]QW@
MIZTOL<]@G.:"'8^ME02VIJ\*]6AW(B=A)*U-(:>^?:]J\_BU4?RE>7>-L3B]
M[KA7V-YLKS\#.M__`.?-<`DL"]LA4VSV.,V//#H&$UE/F>Q!Z!X,1.O=,]Q.
MF3GJ$*-:PU9`0^=7\(Y3"F`4O6F>[M'1RUQ_N1L:JO)QD1'1V*2QSO9O!0SC
M!KGFOWX=_V\&=.U:40P9,:1M6OBC>M(I!C`)]A+"KW%9;O">;O9"P98\&HSZ
MHR8%6^.R/.(,Z,J*I=%P,APV*+*:E.4H'\)2R3'"N%]S%#4IRZ^N!A\C>519
MS#0IR]/.O72N/Y7+WJ"\"&E2EN-;=#GR93_1^]\1#Y7I]$_*<EE+U'R][J!\
M%_]0KVE2EO.9GTEH0]0!/E+..'I2EG]XB&++%#4/NH-^:5%S]C!O4I9#68+,
M)&)&[I<8U*6YUY.CN9HQ[7F0,YWN^)26+J7!0L(\**SDH[7RC%9L?&!PYSW<
M0=RK&QM"#\<S0-*_.H0-<*`79DI!IW0*]P[,01\4JTQ+R\`>%;^)T8XRS(+:
M&J.=:6D9X3H0GCE>HG@N[CBD1TP9;>>TM!ST47DY*:R(V1@(,/(8W_P1UK2T
MA'13%:\<CN#+'Z;%`0GFD0`CPSK!]D4K<Z>EY:53$/G-\'#\X@=+-YX,W5?-
M\"YFSFT'1T_,#3(#ST.CLYHXI`6$?3P)3/X^-%2F1$M+1C<%I_UI;UB5^DP4
MH*C9P\HX=J$;+QF;EI:Q;I+!DF/&*C^"-CO(HG=]-``C.F_CP1\(:.4H1DO+
MB1\#HTG5VS'SU.OVHI4I&?!3799E6EI52I,8^`!M4?%&[+15(5O!&%_NCO81
M('N,']V#_&9[JKDQL34Z!?C;G%CAH,#(K-./QL+POEC7Q")@@PS5_/)L@:J:
M&\LU:4:]5D5[V39]0=5,I],=Y;KE8[*49.:HUZH(L.1T*+WU@^4!Q*ZAT93&
ME]E[>)N.8]%#E*\-[2W!\7<DBK_3"//VIX0XH@M@Z_#$T"CUJ(MR,XO9#U((
MC9\LCY1HY<S1\SJCU-,RRL971C3)"H2XP_%1LS*CU&,XZF*D3#L:<JRZ+?N.
M1H&\]BCUP(ZZL)+6%S8^+"F=.^$T2CU*I`$8.2!;E+J',TH]A*32A>,>SH!N
MZ/?W[>%D*TX8I1Y!4M-:QGF*$TH,-$<9#R^IU02P!KUF;>>/4D\CJ99+RMK.
M/RQ&'J6>:U(SJR26)LM[6:<9M<FCU`-5:L9F4(D<=I%458F<2IA(.!O%T]Z)
M!]G.@)AN'F^U#X9R92?#$,F[K9'LK,/U<+$H*_%3%C(R#$K:1L;N^?0%D"&/
MNI-ID]"18;+2%CHVSJLI0W7V][5E'J@YW?A`H?>J8X+=CCDC>PY^V3VZ:)"F
MM!)>FA/6CUA3&8-TS[%UVY`JO<N>G`-2]LJ-(62F:6MJ<&K4]>99HGQR2`3,
MU$-2^%/9X81A[N@COB$X42[@/N(2/`/ARM(C0SKYZS*%*"DSY^):.=L2#T5+
MAF'=Y:$EY;BBE$EUPR.@)<,D[]+0TI-E19[DY99Q;WP$O&28\YT!+_?$-,&O
M^(U8H+)-G#:H+\#"NQX*_1/A[TV>?9^1<>3)$3"482QX%1@J)%K*,5@H@_]7
M`8**"9D\[1]#^V3P"K-I'\_Q-8\FN&[@W8\'XZ,_.0;'%#\*,,VJ'$,Y%#_.
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M+J8R6=M(`\8R=%$,[G$FBW53]KOC426RF+:JG*AT<UG)K.C,EZ?,7],QE7/@
MM;PEEHS;X-FYT3LMR[?8C>"6N!H9L95Z'$\)S#CM3;JQHIICKOO8BC3W\3\9
M%6F_1`->C2+-[C5D167>\P0RH7+2+3/$S+BJNCVDK!C.>\I!5F8M,4PY;+$[
M$/^P'Y:'W(+#C@K!A"*@TU$USU=-G)&O1+&][R"FS:KTR?_*\J?INPU<U@M_
MHQ"X-R+:*(NB"!R>$@*3]4T2`'(4@7OCI`T$CO]7_B2/2T1@`?C+16!N=9()
MKWE/U*",*9>(U_*659*IXG6J%NZUT%#@"QYA\6VN6ASBSS8=>DCTK6@^]42N
M//GDP<;!-;4MIBX<Q@.W*`KS59]DR8Q,Y7$]N(POJBY4,@':@4H\@^R4\MA[
M,<'#K]W(D,\,&<E:*O=I9XE39N1>39)U)"T5OG;#!%%!QTJV6]5P:,M-%+U[
M0I-B"4FYVR]C`ZW$)1_'5.2B1.$3Y;+F,LM(;92-@./8G5QT&9YT$C2KG<(T
M82ZTC<X;;<6T\=X`IYCH#\M(%)6KC7]Y]>/!P6/T_O]02P,$%`````@`C(NM
M1+:$$KIB#```?:0``!4`'`!A8FEO+3(P,30P,S,Q7V-A;"YX;6Q55`D``WB.
M<E-XCG)3=7@+``$$)0X```0Y`0``[5UM4^,X$OY^5?<??-FJJ]VZRCL,`S7<
M5B`P1QU,J,#,['W:$K82=&-+6<D.9'_]M>P$Y\5.),=RXG`454"P6MV/6JU6
M=TO^].NKYUICS`5A]+S2K#4J%J8V<P@=GE<"447")J3RZS__^I=/?ZM6K7Z_
M:W5LGXQQEPC;92+@^.>'NU^LWR[ZM]8MH3^>D,!6E]F!AZEO5:UGWQ^=U>LO
M+R^U`:&(V@2Y-<Z=FLV\NE6MSBA?<HQ\8,+J(A];X=>9U6HTCZJ-XVJS_=AJ
MG#5;9^VCVDGK^./)4?,?C<99HS%'X%LDA#7W=68U:Q]K[=K\8_?(_H&&V+KI
MSCW6NNJ<-J\_'!\WCJXZ[4ZS=?WAI-'\<-QNGWP\NOS8KC;@Z[1Q\N$8V`&>
M&D?SG+/1A)/ALV_];/\2LFSU:_*[RRC%KHLGUM^M!T8%/.F-$)W4K([K6GW9
M1%A]+#`?8Z<VI>C.,(2!H>*\,H??ZQ-W:XP/ZZU&HUV?/5B)GCQ[%63AZ9?V
M[-EF_;>[VP?[&7NH2JCP81#B5I),4KOFZ>EI/?PO/"K(F0C;WS(['"4%OJS4
M)^1?U=EC5?E1M=FJMINU5^%4``/+^L29B_MX8(4,G/F3$3ZO".*-7,EX^-DS
MQX/S"GHBK"HA;[2C]C\]8G@*5.@VY%S2^=J_66"7!F/LLE#_9BWK\KGZ8M/Z
M(B>JE'STRBCS)A')!Q_HR9EP">//7.+`G\X%<N40/#QC[(M-\O2!S._J9!:A
MFLI@(]<.W'#@I&P+C^)7'U,'.S,"DNW\A0SY`$Y<9B_(.^TGU(\!$D^ADH#9
M&2(TDMVUZ]CUQ>P3B0S,Q>945WZ:?OQ[SW_&O",$]'09<`Z<+,+A2JUE?/:A
MBYZP&UJWU-9ULPQ?(O'<H8[\<?5'0,;(A5Y%Q[]$G$_`]'Y#;H!U9%`D:%BL
M.22_,&IO-13S!`RS?<_9"'-_<@\:ZP.*$L&1U.<O6(O[]70,"Y%9_8O5_*@W
M??Z*T=U;`@;8)3[!F0U)$@G#K%^!L6<3#,N47+V<[810(&9:16R;!6"][M$$
M/;DXBTJG4##,>!</,/3D].52"#^)G\T*KJ=C6(CMM&<'ZM+'/B(4.U>(4UCI
M!`Q^X`6A\@*0Q"9:`JA0,ZW_#HPXN&K(O4?$N:&7:$1\Y&I-@#02IOT:YGF,
M/OC,_J'OPJRT-<QLV-4S<QW8.,JEVI_HL)O4N@!TB>^%GAWX>HSZH*&P6X?)
MI@MT*IGBK$M&LU(DBP#/=DJRF=:;,'-[M`ZW%_I`W)[1AU]7-FB+F^OI$W41
M>%Y(K4I@<S9K/^#,TV%OR@9+&0K&X>'S2K/1:#9JC4;%&G'".+0\K[0J5B"`
M43:*#%'%>L$RXA$&F1HE%'SMM(F!:!T\$$E/Q?*W2R6_^M`O+DVQO$<'*&^J
M^Q"+?7R`8JOX?C$"'TJ%0-+"FVS5W_SV6-230Q)U_>XJ%OIC685>WK:QS1OC
M6.K3`Y1:(:3Q!@!`<'@`I`:F8K'+Y;\M11'9\G\2!"R77Y8NX/H@<RQON?RP
M='E34@*QH.5RP)+#]/.^IEHF)Y:_7)[81OF3LG&QL!F=KD_UI12HL=SNVX>B
M-^C!1`U[C#:,WHCC9TP%&>-;)K9(_.KWL3=980W6S49Y;KP1(EQRTAO<4!_1
M(0&'*-*[JU?;#60%S&?&G!?B:H5>-0D;#XX+GP>V'W#H]?(9\:%>X"VYO6&F
M+P(!VS`A0">>"(WLDPVV4(2;TJD7=\F$7AY1AZKIR#-V7:D%F,(,<$'[.XY'
M*`&HD2RMNGH=P3S0"IZK4C2O;AA6`[F`=;$T$*%GDD&>#81,YX(CRT2'TPZU
M]"RAL6%VP<Q@#A-UVF$7/VFEO!*;%\0RC&^XX-]06$FT-"2-0O&VZ0*L(B+T
M/@!]10)_AM_[V&9#2O[$3L>3&^XM[912#ZF"K[H6\I/?)16YT/8H+$YD2*,E
MZQZL(/6CVD05KI5)%35E(SU8=7X4)^U\<^-S0';UB%ZG$^\"C/=`+UN=2J(0
MUB5*U^#=1[F0`-"+7;H+/&`<O_&'Q1VAH<L^-V\7J41QV3OL/S/XSQ@>"?U$
M?3@*8LMX4=HT3AG&KKMD3!SPR,7,W'6<_P89$-*A6JB`'=OF6`Y1;]#'#O;"
M[9RL,=<UGUID#8OX!?O9S-%2PR+9[(P1<65P^)'-I;VFN9,+)(B=61`5TCL-
M3F0%@J6.7%D3Y#D@H341,^7/JX<(U'J;G"G/OG<X):%0Z-I=UO2](HH)#F&F
MS/T^*,XN7$VV86-0UB*`'6&IO$<L:\7!CG4T:\2@K+4..X8[+?)4UB**/8%S
M(?R8J1YC'Y:K=7&HI&4E#A)GJL78*Y%7HN4+M75K`_IEK=-0DETU.5/6X@TE
M$'32;V4M[E"="0DIU;+6<RB)K)D3+VFYARS9N7;92TZ5'2OD]K*((^;2>,:!
M8R3=@^CG#9W5\6:H:E`@9CZ!LL1!Z$J^S::,YZ2TR!8NXE+U\7:"K1#;\8CI
M'VQ7I;@;P:;%=[F)M42OB-/\LEX4S%/DB6<H0EE#Q##[<;#D`;FX-U@H^GVK
M^-61196B8<'N$/^!?3EA'[`-'I"T1#/6=,193T>W%.([$`!,!KW!;!V`7>[,
M5BH=^%0B8WHBOX^2QGEN;IE<T\;8B9CY%W:=:\:_ZDUS18+F;[V($F09#-5J
M6]-C($0@;W?J#:+D'G6^(\[!D@A`ZP'S,;&QZ/%+%Q%/;_'0(VRZ3A.\07P!
M:UA8G@S(AGZV5EUF"@73M17AL<U_$QF6BZ)K6B44":V-7YTRXM@FT=Z5R@@U
M]\F?VG"O)?/_RL!W61E8DB(<<,ALC)TP>AZY:,M+K5X5U&9JA0N4>G1M.\G6
MD"U81.C\#LG`GC_I#9)<U&T$52!N?%69A%&?1Q9&;CG.9T`UJ!:Q:USA9V9V
M-8\!;*15Q!V34:^.U*&Y:+N.'&O)Z*XL?3R*$)&SEE";C)#;H]\P=1B_#F\'
MQITAQUA5AS(0-7X"9LJ,C(TR.@9%EC97]TS&6C(%BO"%^3A+O"Z=1H$F.=Y,
MS%7C937!*<0*,KG3_=",">W#;^OI[&1,ENI#J1-]@.6EP?D,U.8>=.U7<C]A
M1H_8_K0C9<.E2*W`T<DZW=-I[$*U>.07ZE_7ID+-_&Y%KKC`B2P#=BXF7P6&
M;7BTCLFD@+Q\/[K$(Z%01W-[LU5/NP$B*B8J`@CEGG8#1)PF,@V$<D\[N33]
M'G,B:\P6DT[:'JXRW9U66V2"@.4WPF4]SF((-V434=;K(0WAIKS&E/5:R9Q6
M<:;GFI3X5(M!M!;]T;+>8)D?1CI;C[(>="EH_BGL,,MZI,4`@FM#$)G.HNQ#
M]7M1JK80=2KK49/\P4H/-);V/(59D%:BR9F.7AP63AG2")G.:NPQ:KIQE>4;
M*],R1&4]RI$_3)L3@IG.@!RF3NDDA3,=%SE0V/1K!F+T#L)!S1&\M94E,6SE
M.CM=!&RKI48Q6@?AK^K&WA7N!VJ5Z][Y_(#1OQRB=1C^_!9*M/6%#ZW#</6W
M@'!MI7",TT&$G;>`*:D4/$;G(%SZ+=!)J^Z/$3J((/,6"&F>YXB!.XAX\Q;`
MK1[IB;$Y"$=]&Z52.[`5`W80+GI.@.G<O]!ZK]ZZTG'.-YC:);NC*'\%6W\<
M-P;JW7ONJL>P8\C>O:>^YA1^C-)A!.&W,?%*MR[$@&FX[N\*L)7;-V+(#B,H
MGRMD*Y>PQ&B]=P=>ZRJ>&+9W[]MOOIHI!BMKJ8B1^\'D9>8N$P''@(I<X^\Q
M#P,$7?E:85?M5C!5(KNX"VPC;V;+O[^'(PD;O3'HSQ!_";PGS+O$#62YFF1#
M]`)?P.9&;F;B2]-U*L$S=V&X\CV1K]Y@A27MUS-H$MZEF#*2!!8F5PD7:.[4
MD&J+SC(/8EEK^'.'2&5B;_]>"L-KS6P#.9^=SK;@*%#:[:JSCD'C=S,%7A#>
M4#N?-X+?79R00,KE6H3\^C1_!#.YY\]<\\*5391V)4CX9NT<Q`CI[-2&*HFH
M\K+QZ8B\F<>C<B6Z=''(;S+&B&4M5C.\H,@Z<Q+=UA^^EEENVX:8VK"'R[:N
MJ!/<[?*BP&=!K["\E1M?<1WXP-4=H<0+O%D]9#>`'?'C"_L/1CS;"R[5B1?U
MQL[U'"V_*CX_6=\H[X&@?>PA`JH,#NTU:"1RY1CD+7-*)WL@/HR&@0'>EZOQ
M%05/>CV(_FB6=7MG&*WY^5[6T]CF(9HW_UN?O4YR5#[5)6M/P`/\\3]02P,$
M%`````@`C(NM1,-+@6T[-```*]0#`!4`'`!A8FEO+3(P,30P,S,Q7V1E9BYX
M;6Q55`D``WB.<E-XCG)3=7@+``$$)0X```0Y`0``[7UI;]S(DN#W!>8_:/V`
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M?GCXY?`P`^"WB(B]S/^^[$T^?OYX_#'[:_>:_J>V('NW5YE?.[J>GD]N/IV>
M'IY<3X^GDZ.;3V>'DT^GQ\=GGT\N/Q_O'\+_S@_//IT".H#3X4D6<^=E[9J+
MI;_WK_J_A2CO/7RD_W?EV#:Q+++>^S][CX[MP6^N7C1[_7%O:EE[#_03;^^!
M>,1])<;'&**5\!`VQO9^_9#AW]NS:WUTW,7!T>'A\4'RBQ^BW_SRYID;O_WS
M./G=R<%_?[M[U)=DI>V;MN?#)K"O*)B\[R;GY^<'X;^FOPK+&W[ZNUEL3@^B
M?X1?]<PO7KC4G:.'&\I!PE[A;]#_VD]^;9_^:']RM'\\^?CF&1^`77M[OVBN
M[CH6>2#SO1#=+_[ZA?SZP3-7+Q8E,_S9TB7S0D02["G\4PKY;YIE?=B+`?]X
MN-VEV;3]`\-<'<2_<Q!^<"`/(5B+V/1X[QMDK@66CT,OY_-VD'56FFD+XQI_
M+1/5<(G]%5D]$Q>)Y^:G$I%<`@A7#Y[)?LH;'*JY`&*$>;'5GDUGGPJWP^/H
M^OWMB<!O@;"^"V7$-C*4+#MX)9832OKDRX,0H<U/MS#AA>1K;X[MK-81R.3)
M2?Z<VL:U[9O^^M:>.^XJ%$55%#T`H#\P@#;9%=,!5\RT3?IKE+R-WR1O/K$-
M8B3?4\QET!DB`JA8CIYWY,*#XA']X\)Y/3"(2=<ZIG^A[(#';A)+V+_!C_Z(
MH,/3M7+L1]_1_WQ<:B[Q9H%/7Q*J*&QRPZ)RWW&3'UK:,[%^_<`+Z:!YU&],
MB[B7<-H6CKO&X;KU::/(70:N"_MW`WJ49OT/T=QKVZ"Z#R^&Q=\WBF9RSM@Z
M-_`3CQ?+PL\E(GE/7-,Q:J"Y`4`*HM$*R!TO^+A1!*>P@!%RPM*X+_;61U(X
M]@0X8!D5?2-!I%P"<%>S;D&6O_T700J5G8\E(/A`%J8'J]C^=VW%S;?\;R6@
M=Q5K=ABTHF_^.%(,H8;1N2,+S8K@3]],;OFU\YF4.YA1,9ZT9PM]'W>_EXTF
M:&#DUB<K]$.0#R-%E^EX4U??``TZ=P(V5K\YK<?HF[GKK'@PB9=TJACLN`9Q
M?_TP`5OB\./AX8>]%W@[7#@FOWZ`FQ1X@)WS0G]?HRB$AL<7W;%]T%2O+4)A
M@GY+%O0O[-\MQR/&KQ]\-R#2>))KLW#P:/-@.@77@['E4S5;)%&88Y1OTU<D
M#9Q\P<BH.E.!J@V9*D24(B1M6OIU+FK^"\N(/!\.D3MJ3DKEA$,4J4_EII*9
M$G<T&0)Q6QH]HVX0M[#`D$JI/#X>$I4Y-BVC=!`"I]#)D-)Y,@B14^SR20D]
M'83XR?6^,1H'(81XO*$IR9^X)=(O!YO^YR9\ZX\^;`*EZ]*Q/<<R#?A/XT*S
M:"#Q<4F(GQ)7ZEGG!].!7YT#.1Y;=:YYS^')";S]A::]1`8KL7PO^<FVY1K_
M^(\[$]AF`7W$F]I&>"*6C@7[[UW_,X`MY[%@^6%Q&=[BQ-1#OP.$'X@/%YL8
MUYIKP]7SICK<Y(#&J(PK.'>ZZ6,(X($FF:"I89B19+C73./6OM1>3%^S,%04
M@I",>D8F_J99`9>;J?A;R<C>`RP"S[(AAF_NYZU?SNDS-4=UU!DO@]+"`3%]
M*JRI>`.![<,E([8.X@Y[5@K!2"8A(Z$%!;MT%*_BD_E`'T7XT_2_.[8>J:`8
MG,OAM,?G2SSJ>5^WSG4!O$N`2$9_YB^)6X_IA2`DHWX-VJ:S)J`GAP]U/2(X
M@,E6`'3="4"TW6MKZA(7H*$(0NM75N1Y*H/2'@&YVG=-<BI@RCY6GK=CJ%4<
MH_B+-B1/M);8.U4`0+K^Z+P0UU_?@Z49)G/!=KY0G>0[06%?#J>50R$B8C8_
M;.^(B+Y+[2)\J7E+JIK"'W0_7S4K5%;]2\UUUZ"LXLTC/H!M'A<1:5@`H!6T
MQ?%%(CIFL,@U@F-_'W<F2]&7;2&ZZTG&('O7?A8+!P5.,5M1$=5>9:Y4','*
MG)6CH\%E=QPI&7'%'>!M(<^(4S+X6/&J[1"V\]HJ'B[G4S8<M&[$8LI*AEK1
M9.>IM8Q&)?,#T#06D:=F))G_9I8;?2QZW',!5&"9I_2=]4``51_/#$&?E18M
M?,\AO\>*D:VTM$&[]?*94?R.GBLMC3C<LMDC7>`[3HB=\.2C]X58#F=_2O=$
M:5F%H[LP4I-2JV8VK!BU)4$U1F]?)!@'O:4;>]P76846U>7AZI0!:F:4-OQ6
M9>@][8O<0M-;F@:2TO^I+Y(,33^/:C;YI+1@PQ&<FW.54GJFM&3#'^W-;+B4
MS,]*RR\<F86)BBFUYTI++QRU/,FE">%'ATJ+K;J"*DNHT@*JH?>X()D[9<*$
M6W9U4R9PKU$M:DE\4V>IR#5K!G)A*EE`L(EI:SG40OUZ^."TEP@>+7[K>0';
M)"'\$Q!MHSX-_"7<R;]JHI\%TQX)<')G;GC`C5"/N"=NB(X@*<7@6DW6KW4Q
M*D%U0`K^>I1!Z8``L4M2!:E50IJX*KP0QS2B'8S&-*(QC2@_C6AP#7#JIA&I
MT?KF'32)P1U@7N&O>-.8.D3O/N&L=\S@=GA3Z>I)TI@XH?G]#=1.(>.CELO`
MZ4GV&)KBDBNK=@Z9(*4[]U7M5#)!*@N:D7"+IM:\C.D/O=E\!GI3V'HE"N>M
M7ERRI-K&*[ESO!J=2O!KJ.*%1&`NUPCYG="A%\28O@(2"_(]H"=V-@\/6^:L
M76B>J0-Z5Z85^#A?@.@*DJVO,K2RMTRDN`@/6W8A=1R82EZ]&MM9":IE4D3V
MIQB&9.2_$__6!ED1WNSIJV9:U$!\<C)B/@XDA6S%T(0&W:H/[LI\-0V0I%3$
M1;G#QC\"+TKQ$/?#E4-ME<"IKKN$"O'9_($89!4^NW0B$\VY%*>P`FR;QU7X
M,$I',UKJ27N[?GN!AY-<$!M>=!37"T&T@CKET@UHAU&F4P"BB>D$%V3NN"3%
MCWC?3#O4\6YMG\!S0HL,-J%$,>AO!!1_^)=7(G#-6D5+.HLCA.*=O2+/R).1
M\WE+*"=B+6*D"-;;$"0C?A%X8,UX'CPZSZ8=GI0+S5V`+70?N/I2\\A7^/L#
MT9V%36W2Z0HK'D57*"1\U]Z@/_F#0J$G=V9//<]<V/2LSN;WH+7;?C0GC@=K
M;E"RVRQ$]]9>B(GSW,_;0CF^>&((LX]E7]G5BV:ZT=;"Y=/LA0GJ5U1&=/VF
M6P'5][\ZCO'3M"S43<8!EMZ4$33E0/<#%U:]!-UY@=N8_._;ETI3'5XC+[3Y
MXQ*12\?#O9$8J+(CB<2RZ"D`I<75+)#Y4V-EVF%#>SH8-+X$J.@B)T3YQXUH
M(-:I?4FHHR4LI12@IP)06[(L/`ZT*C062R+&*P>P,0MAS$(8LQ#&9B9C,Y,!
M-3/AD/L]"57S/X<.]PO.XM9*1_V$2.=5QGH2WQ7B`4;;9F%1I2/ZHM<@QX!B
M%`]OYY$&,&M!,CQ!D./68)TZAB?R<]U./>G-@2*8VTW(>G4,[YZ+>G99'X_A
M'(@J-S[K;C&\6Y\;<&%=+H9(<(O!-M8M8XBWI2"(RUIF#$]L;H7:67N(X>TO
M*C6"=8\8WIYCLF!8>XGA'0ATSA/K/J'T,\+G$"K.8F,M&)3>\\I4OA)B=](.
M6<<%I>\[W];B$TA3\M7N=R:<=<O)G+*$XI1%_(4>G63+;SUS>0U&M@8@ULN<
MQZ^G8A8]@HIWF_A:D.MT18")1@(STIIU4[.`U7#%:#AF<W7NS"<\8"SJF]]'
M)4!7H6\TFJX=UGI])S_#?^%/V<*";1KM2!XVC_<.7"SB]#O:/B>C8?UX<>SK
M-^+JID=F\]\UU]7@%-XX+FW;'BW(C;\H>-ED<$_UJ0,=2P3]%#3@V7PVATU/
M5.=O&Z]O):[E0+`H,3'TY!2T@+OV?'-%A?>-9KHAY8P?_-U2FEQ-]HPB)IH+
MT8Q1PG>+$0`N84^9/-\XVX*O1G,+8DDMD_;9):._^S0.]=WQPR9P<022.B7@
MZ\0OQTVSA)4E[',8?#1U/V8PK$PTCU!_8_(OF624)O:9<T&TY,QP=//,;/@.
MD(\7$BH6Z?+]1HI]/F!XOE(J&1^P;U'!YZ*O>V)7/CGP].H!S95X#)[_070X
M<`_D)8XJ(9$4`RY.0N;D4'4!_HMJ$9IU9^K4/Q9%!H5I0$%'BU/R2KLK9C@6
MKT//F64!JP*X[_'`E#KTU%\(39KYU@IA-9=!OP',I_X(#Q#Q+I`(%P.HC4I=
M3,1/L>[81F83(KHR+S$-/Y`5=3UOBGWT*:Z[$):TIZ7IMD%9[76DEQDDRV=P
M$J58`"AVWV[,>1O2I^XR:+*<P&V%KKKKU+UGDNBJNXST2H,2GU3XC[/0_>XE
MCA*4)2P"O1N"0Z-.%KUEP!LRAZDO*VOKA+9$/%4*:3+56*$%8G!>/_$%:JA&
M6:_=-?Q=]V=VTH,>KRB501M;3?#ZV\(3^@S&7]C,"<2L%J6H1]GJ!+2?5Y"^
MT>F(TQGI+Z`GQ\O'I<L'`17\P$+L4/`W21=W&*J%_4HF[D5OST\;Y-W2?*%C
M4!O;P+(E.MQ1J917KM#EGF<J<)J[IIM`.]S7AJG+@=GEWA5$%1Z)#K\:39IK
M:$,Y5E*%$3_@^9-#>`RYP^/<QH;S+J2"EL8H8/%Z9`N0>NM(9D*:([35\YDW
M%LL'1SS*>..X-S3%+V09TFZL@"+[EM694M/^7)J\^63(F[[U]=A?9`>CSOJ+
MW#7>MH,[:S#,ILS..@Q?@DQU/BRSP,97L6"E/R6Y4AT?#J@`U-[D,#SJ.1]+
M1[>Q,(QX\*6A?L6AS*3>%\>&L\LOYTH!_''44\3;$XQ;RWN\TIP34*T8$&@M
M63]P4UD]M=;`!R%=S\]FDC0=-19?H':(7UJ>2LUU\(312'N=_.`2"/6X+.D*
MU%NDYAV0%XBOMTPMLB1M5*TU9*L?EN9Y,9_Q[][NURV\UDVCW-X[G5U;^(W>
M!2*]Y2HR/:[@PU;0G(JB.6W+R@I"#\XWS?V3^.Q-3SV&D<<I1.G)]"V"/^%B
M*[1P<54E727"L6(!#;I_S6"5ZRDJS'LV-?-$A;ZC9*X%EI]/O>B1%6//EAQ2
M?TILYVQ2A$G5;1!J"GVG\)UF]']^3_1?[-`_Z:Z)<8/"M$2_991VV,J&3VQ6
MJ_I.E?6DQ+1A+N%7DUA%2*V^PB4&I].$B<_8H'1#&RP;!+PW/>EBSL&)>LXY
MQH>^7XP2IRKK8ZYT[VKT9M<Y]VJ/(L=+`$0DHR=M[3EX4"LVI<*,=AEJ77YH
MD5&KO$7,%VW-]O$KBF8SHE4W;YNA61&*.;HTEN8!;,RJK\BT8`0K;9PB"-[)
MBTE)/.UPB$Z#)%9D+3%R^WV$A3+/&/'='6=90[$^'8Y#L3:>XBY'R4@:BO5)
M:1'%>X!WLY,9@1VJ3XT1N)LNSH:`]'@#>=+XV:P"#FFD*J%\912L;?\`SFR]
MLAC6L%YI+1$AG\3KI%A3\QY?]0I>%-;*I<0?*ZU<-DQ\U4G@T<QZRHR<"MF4
M[,\#D(N(LN>$[F.UX[CUM[NLM#UE@MK690.;S\6%SP._^9E&%@G-)UWF!+6R
M\WE$'P_@L9??G"9E5X?NE\;853#%Z^1SCX\"IKM43/#1IZ,>;V;--F`)#\[/
M>BSTZK9UBYEP?'@X\->NH$=?2O_1T'6>*@:<*GT+L!%O\?R'X\-SI8\"3_Y#
MW8:K"2LF:DL%KE20>CUU&2=Z?#V2WT*T2&9T*ZT@"(@%=#/LE!63'A^!ACJ>
M,U[T_5@4]JM/23Q2VA80(7$[;1]H[/V1KCFQ@7&B[X]^_:$<*2^.^_[J"PY<
M80SH^[40FYK#Z.^[="\:;113>'+2^W1OOHE2*;T=)O(VX^-`3OM*"#_KOT>O
ML;%M"4\^JUVL*>[PJC.^+V6.VH]?,P>&<YYCRI,SI=^#YB(D6Z,[$_K/SWM,
M?Y.C6V.&G$[4#AOP*`BE<W@3.L\_*5T,R;'Q@K.18P:<'9_W76\0'7&=<.!$
M[7I8#@Z@AY2GI)]T6.K>"ND%>1!G)V=]I_R*P"\821+L!;'#8HOLRU_PV)^=
M3I0N_^1[[#>)2W.!0?^;^4OB9G2!#.'\-M(O!XQNP.//Z(>4A`<RWZ-__GBX
M3<G]^?/G1SN@12T?=6=UD/3_._"U-\=V5NN#D';6R,"Q/<<R#2W4Y^,?>MM6
M#Y"RFXP?E]3<PX6V@4[?U+6T7J6H`^$#+/Z'[,6C(^&9JQ?65>F731YN_"9Y
M\V&_V(2VC>/3,3_E]J[:Q`I6GKDATI&L`K$5BNM-OI;WM.*%B.U:F2W'BQO+
M1.E#W!AR@1F;W^]@]/Z:W[^[H<!2)P%+[^<<+M/6YK2U-V,3<0YJVFPB/DZ[
M[]>T^W&,=CVZQC':#37I'^CT@;$[OF+=\8L,IU+?,Z_95`ID['X_J.[W/1LG
M-8XR$AME-(Y*&$<EC/,"QGD!X[R`L0]^+_K`CWWP=[IG=W=).FB8VI_N\$WU
M#E4[&Z215II'P^KY6S+*X:3#W."6AQMTV=JXO80]U7O[MC;$0>UVN&T.<>A]
M67MS??W5;NO47H5_IQV$U:KPY^L\K#8KFJGP5[T_;WNUL*HW\FVS%A9XT7>A
MV<`PE$]]%Y?-#$,YZ[NHK)T_Q5C1=UDIEAC'Z.^_A&RH%0CPHCL)*6L<`T^]
MX[L:QW#6H=M+TCB&/K=WY4J<9Y0J+:Q%"GJ*BQC2;O;\3<P[*>:A[JP;R_F9
M$ENO/&<'G(H%-PQ)9,+4;X":X]Z8-GVKI@N7D%C$5L9I2S_'YFW%^N%5?!*?
M7,WVHAD:\2@%3GPJX6`1VRA;OZ5M3VP2POO=])>7L(3IWVBZ:86M7SF11,$4
MY&2B:<_LK$(>ZR#`&"=I5XMC+#=8V5E;\7G_[M@Z_/46UO=\TUZ`Q1$=1OIW
MX.EK&'N\,CVJ*P0NF3Y[/AW.@DKRJKV69&8DFT)[#F`(V_Q.=B)(\/(2*7*:
ME7#TUIX[[BILE2VR,=P@6SB,<!CH'_3XOVI6&`;U+^&>K^%PQ(7_N!/'`;`3
MLJ+J[EM;=VDCG"L2_5F?NB*XDHG\3GR*R+WKT#IFXV+]PZ-2+N=B@Y"#6Q_`
MSV9@$80G#)6957<E[$/P0%ZT-;T<M!S7A"5>-&MFUWSO<4`E[UV*C+?A>[LB
MSR@Q4@JF11*R+ZHH_ILP)",/1UDGQ/!H-ZS<MH`8*CB`R28GY6+:TB(SRPM!
M22F<3O9DIQX_^@&!?VQHHZI7P,JO_'6V^K%Q"RY.:"WNCNAU+X;1Q=%R'^'Y
MGLWYK0D,-&7>?A'M5`1Z-P0SBT:VLL.]4HM'.3IR8`MI]H*^^U//(TB!SP&M
M=8*2$"R=O.6#/*9WZH57UQ,"VS*)L/@WS:?9Q>O9//+2:EN3!L4)Y0#>DC;R
MY(3C]%S2S(8BH$HF,.P6M8//1>"9-H%+@]J^:EAMV,K1J@8]0YD1B&C3N`B,
M,H]#@Z]A*?1N"(Z?H19>0^Z5I/L/-YTNMW;B/[]<:NX"=Q4Y@+5.3B@>4F[?
MF6`16.@G`@6V=1*GNNX$U(V&-R@X@'6\8WB5C!=B-X1=!B[M>M<865OPVB<J
M86O<[UCD@<!`;4,S2:,]=)3E]1N=Z8FZ525`)*/_53-M.GMS9N>H[$):(R]$
MR83EZ>$):AARRN&@(\0``'@RG\W3J+/VECP&B*!P!1C9EWKUHIENY-G?MEZO
MWW0K,.`B?G4<XZ=I6:A[C0/<(IEW#GVT7XD1(?-W8ADWCOL#=\TY`<IN*)",
MHQ(05+O?RMZ#S=1Q,#HS?<+C2<G>S+VT-!/7#1,)6';`FV9-76R/A$;%MPL@
M2/<\T-$%_V7:F1$>&`_#[M>2$;XB+R[1S2CH;QO3E>/ZYE]H=I>"D4Q"XJJ`
MC7XV[7#-"["6X%&ZCP=)T0<JGAS^%Z'(!;@W7'0%['/(=`60@N;"CH/%F@]_
M1G4@W$\B#RC9@C4[V80RQ]9-BVR,.']R.&U[$:U8SOKR'2O9"?`H/TGV0V7\
M/PTZO.KOR]B/>R#]N-]E_SK1#LCEWX]-]X;<=.\=M1#C[0[4G_8J374'4KO+
M"G=WH(J"/[5[K#32`^FDNXIG636-IQSU;N^JIO&TP]%VDFH:U6[[PW>`16R2
MGG3[J6',.84&:$\Z531#NQQ70T_:&DCU\S@(?Q:K+%;ZNLGF5UVO9<K&<Z5+
MT=MB8ZEKF_%*:2G7%J_R`AAIZ;OB/7A;8E%18"IETV0\2?AX9,H]M2>`M\6]
MW;BT0`.*(3.(,_4@Y9K:'I0NN,:1CY)R3VW[KQ7]M2I%B?%J%&"5:68IL]2V
M+=MB%F^*8<HVM=O$M<6VDBS3E%-J]ZAJQGF!R1Y.&:.V;2B09EW.D)Q,\805
M1X=*GQ$IK-BI!4B9T>&@D0Z8L5/LD?+A2.F72>ZAV*CF23ERK+1BTS1'=@JW
M4C[P!+SZ_J34+=I+F:5V&_A:D:/2\LV4`6J[_FO4O68CWF65NRDGU';J-\.)
MZEKLE!WG[^!@8"KN$\8<'RHM,AIB#+[E0LJ?R3OD3VGO#<89I34469S9[;>2
M,D1M);89AM3MMI,RZUCI]ZF6JE+:=REE@-H^\AH-JPJN3U'GK90A:@^V:IXA
MFQW54C:H/;:G'ALP_?%2AO12IV_BHG!T.DR9I/8<A(:85-KMDK&BCWI)(^=E
MHX5IR@^U<VV:X4=Q8]J$#2='[^"&E/879IP8\`41:!V=\D7M7(]F3DC=UN`I
MLSJLK6A,?\>UAT])'X*7E;/O?TJSVDH89U$-[Q"'E&JU50GLG(N-"$QV'D="
M[ZG:SD#^DUUOADK*CHG2A[ZQP33)LXD=O)/RZ4AID[5Q/J&&*J5,.GZ7AZEX
M/%;*F!.EA4[CC*E20T_Y-2L9,^\8!4]+0G/N-7L-M#X&JY7FKL'T-A>V.3=U
M&A>(TCF``?>.9>J9)J>E8_`:6:&#R7CU\);<1])=:'9<9L,&]T4E./<@S*F.
M0/]S-H\/K6:QF7Z90PODE%'Q!&R\L)!3/-K';6QNLX-19\UMFNNDT;LN//WH
M*'!X.G84V.@H<-BA&TA21X'#,Y55++X#W/XSPMC'/3=;KD;VG?@TG9_-249I
M6P5?=ZI);>,DN;F6YMJPU>ER0NI,"9!1[QCUCE'O&/6.4>\8D-Y1(N^54Q"^
M$7=!7.J&_!Y^=6OK,_L_-3O0W#7-C3\\1^H,_``[52,XT&R]J7;&722B9O!"
M''6.4><8=8Y1YQAUC@'I'+S"7SD%Y$8SW3!UA/T(&Q0J`]&IDI&+F%R!G;>D
MD#91`6A4(D8E8E0B1B5B5"(&I$14R'SE=(>DYC1OX#BG[E`&HE/=(1<QV>-/
M"DIX:SHF<'!'S6+4+$;-8M0L1LUB0)H%[@E03M&@99)FU#&1EL"$=4X+8@LD
ML')`ZE3M*,-/_JRX@I5KZA]8R*,&,FH@HP8R:B"C!C(@#03[""BG@T0U=&D%
MD9>9V(#403@@=:J#E.%7),T+!GZ7@!)4*H3`CAK%J%&,&L6H48P:Q0`T"J$7
M0#EUHFA,%DJ3*`?2J1)1@)I<V<V6#UMKI<L^$`M.E!'6L3/$TNZ[(DZ-VDN-
M.LFHDXPZR:B3C#K)`'22QEX%Y?24:'#4D_:&#K7D?-FI1I+%1ZZX3E>J&3@I
MAS,J$*,",2H0HP(Q*A`#4B#*1;YRVH%`7ZWV.H_UO0-992>R@J!+W,@O'O89
M@5GC@RQ58"0_69>.K<-MB?H8/YC>GU&?1OHW7/))"1C))("2;WJS^=;.K@4V
M!`NQD+""(_-`7HGK13,*'E\LTQ<]--6`L*A=$7K)PF0U$*$+0G?.NS/_&9B&
M&:9G?W7H#$.ZS:XMBG:]160?H[BV\(IXNFN^Q!V4&NKU)P!\-#Q&PV,T/$;#
M8S0\!F1X"+P#`M:(>O0W\/RG?)CT^!QP:F\IK4<<<DU56K':=$KT\7'_B2XU
MB%)*3R;]I93+>F64*N)*V6JL&;ZJ6"=)*0R5VH;&F$G6/?4E,8)P<N561SAZ
M\740ZU>F%=`!&10;(>M)>(G1AAIMJ-&&&FVHT88:D`TE_!HH%]?)ZWXAI)%4
M`U*NRT<KNDEA07:S'3Y&C6/4.$:-8]0X1HUCF!H'C^!73KDH*046TC&XX:G:
MV:-E;\A-X-,.[$#U*E@]$#J,-LE$OG'<>':TO;BC0Y2])GPCM18<]991;QGU
MEE%O&?66`>DM#;T-RJDV^56O0EH-#R@%*WQ;UF5"))ZWD7@@GN^:ND^,,)0-
M^M;63WX`@[QX"/2Z"15'!AZR'\M-Y'=VLG'V<*_0&N'7<'&<-2&/Q'TU]8(3
M/;5"*DTZJ/*!Z,["-O\BQCT!41,5]-6-'#:-Q*@QCQKSJ#&/&O.H,0]28V[\
MO1A$'F==G6,029SMZ*4".:#*52%>$5\SK1:*$+<6ZEL-8H*^;"T$#M;2L>!<
M>5%GKYU,9)Q:P@%.LF)U[SHZ(89W`]?WUO,"S=:CGB`KQP[10,;WJX!U08[[
MJ(4/4LCBVO1L0<.7,"Y,SR<N,:Y,E^C^;#Z'U\Y>?-N0IAP%C.5@L&A%Y#RY
M&HA>G5YQ[PE0X+>G*H'\<:0@4DVAQ&OC58+`HO/TT_E_Q'5F-KEQ`G>[VR#R
M3/$!DVWI$3V`1QID>KITAE6X_<?"+#VC_2>O8^)X+PD&FF2"OA/_4O.6\`Z\
MFJ#=7*Q_@(9Z:Z?N_ECUW&G>4$X8!JID`M,UHX8>M/8!0TGNYV@91MQ5U(;,
M(KM]0<ODU<Z'V*6_!U2FS>;W0`0-Y<1J)TU3\9Z<:QL44XL;'3Y@=5$41@>_
M=$S`=M4A*.5Q1=J]2SP:"@O%#)@`@69-G\%`@QO*C6:]148?<@T?<OFV<]M>
MH=V-\LLVL@R6K/NEYH%IZ1+R=Z*Y_@W8BS2BBU.1RH%(%M:PI.4O+VE=FAMX
M_DU@&]^UE8#"4`JH!26H'4*Z(`.KXQ2":.72RKVKW<46&N"(P[%'S"%]HD(L
M@LRUP/(W.<%[5,O)W10.ZH=@FJ9:$9JKW>Y\@M7A>LP8R9\[(WDGFMJD@N+4
M$Q0L$G,XL-!L,^*S/'P[Z;!Q@Z3P[>1(1=$@\<8(VFR,81T^FWP,JV?Z.H66
M.&-!=[*U4Q;D^T98`QLE@]O-LV77@\7ZO2C9N*A1%I1Z$5-&G"J9[2&%$1C'
M<,J?3]TU>VK9$.,)"#"V="A9^6PR1+2$FPF;L:R4&6<<*FJGEII<7BC""8ZT
M*6QT,'U(N$*WC`O=J:HMR8S*2#OC18?-\LH%!6_"03FY>>*@0]VB5!PT2;$B
M]%:H$%PI+JSO97G2#R-X^/HS)D<KY<NYDNTBV^/+9BX>8\O[.2Y<.9<)8R83
M[K>AU::;8EG!Y4!4:KO93C9O1?,S3!BO$I3D2.3OQ%PL8:$I'&6X'8FW)<3%
MH[>?A-=%Q]#$#[,+XF+.1MC,`M_S-=N@)K+QC\#S8Z=Z/5IYENAR7S,H-;NY
MNX#EI]DQU\_T%>Y^6,KA9%ZK6&2C"46#;I-484)$TLYU!XQ!RXR+K6#'J5/)
M<:F4(B"3P5B$_XH<3I>:I0=6_)M;LBPKI]')7I*Q&+/!=C!JO:*XO+?HQ3JZ
M>)>6YO'GH-0`+IG<7#QV`V>B*L1==_7*G)3QMY7-VQU4Z6NO8NCU[T-U!;02
M'NYF*Z"5C/7@KT0;CYT2J105UGL[6H=3J"4Q'BEYL!3@$8]*S`JIE9PKTPT7
MD184XZ&ZOC8U>,AC=K-$$24]^TUY+GB/VX8WIB>SD1KD3:7W3?4A2K&_,W9?
M-^+6W8*EH'<WP5"N@38%1=.@Y\!\)2RZ?OVF6P&01X,C-,(0^+$@VSY*TQ4-
M-&/LN(861->EQW`VIE<)EN1QP1I]+:.O9?2U]-+7,MA6<A)]+:J6.@VUVQS2
MU\+U9"GN9D*_XT[C6H=`=SFYBO(WXBZ(^[OI+[^'7]W:^LS^3\T.-'=]='8$
M.RF6"X&&VZD"S8^MW!<X&;X-9^F9^@*`\`O-7<"!O@]<G583?H6_LSZ.>.U9
M=`7)JD<.6@R'6P.>1'-NTA=EZGF$=B3\9V"Z@)UMW,&/32N\C?!OP8H8-,,_
M'H'SJEF\+3W:PJ1'C`2SLBO.A4NWSZI+!Q0!@T0SL<.<T3EQ`<<HD>W6IJFA
MGA^[@P#Q,.\/J?<WNNQH)"ID)"8[&YYL+WRVO(MUYK]JV(B\L%NZ,YF%A0S$
M<CAMFX=<5.4:A[S;\IYL0^0U&$U#5>PCT>O0Z(NFN`W9((_J*4?,DE0Z0M<E
MG_+4;Q8F5CIXUP#;N,PZ@:BY7'_$C6:ZOVE60-B/!'NT<T#JU.=0AI]<)2Z^
M%_2/S-W(P0>CT2&`8D-O*9#HSE\0_R<A]M]->%[@;*_O:.F2ESPR'K]/I`9P
M=/>X3;:$SZ-'ZVMG\V^.3=;?-/=/$K:3\KYI/O4NKJ,9'=QTU%A!>#\R)U<T
M%,H%:[1R.[=RTWVZT"Q:Z?BX),3_ZCK!"QRQN!!>L]*I))=:^&IX0L9A_;4D
M,V/G0G'W.*V"T-8N1L+N&]'HA3-F5#,(7#?.IO-^V,ZS1]Q7JF?=VB^!OYFX
M!L8<_3P,\^%;BLK"H86VJD-F7XL2)+,VMIUK"1#9=UY[HY-I!:[ZYH>2T7S0
M[`6BYW+.9RW<H_I(MH,B]G1F/FKO,N4]DFA',Q^\KGV,**J=W'WI44OAW2.X
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MN[A>8U60NB+D&AZ]%=V('QZ9!]:=^8H;O(H$W!69"1)SE(^4"YS(6#G0,.`E
MH9U6=V67T+A//H!C5+WSJ'KAD1**F_-`DTS0'=$\0IO;W*Y>7.<UM#T$PN.E
M8&3G\SMS_R<MV;.-Y*^9YLB7CB="$`*H[,A1X((>%H2HW)AO]&\"])1!D5VE
MGIQJ/-8[GTI&-2H))6X-E`M!="69<KKGUQ%-FP,4!D=4=R1=K'>&.M0A*0NN
MM8*J8@:+%U)5P>S:+XNFWD'N7H\BX)C#S<.&@FDMRL?,Y?%!$2Y4^[LQHMOA
M>#Y5B,/+([N87)Y9NKTCMTP;57QZ;$W*$7:%XE-A:S*BU&)4(4Q9&.1&^`!R
M2Y"KU`34*-Q>AK)%5*:*<+82R4F-AK./^BGXBP/6_(Y.Q@,EGP`Q/S"/GI=U
M3#,F**GGR6-"?NB!=:Q]9V<BCC#U871C'?J;"RJFL^K43/"HIT:4!YM3TGN0
MQR#6VYD?H*I9#>UT><[>H:VK@W'#E8+!AD[SF"):ALP%:PR8=AXP5<0W/+AH
M\-!LW7?09JLI6U=9[_=0VVL)V+I<SY,2I545*CWFS78X]0:!EDYRM53:!=T,
MAZEX-&$8Y(MI+XBMFVF#'S%E%0VW4YV5'UNDWO?-M(CG@V%XKZU#13@@R%XY
M)1"P2FA<W@F?ZP!(6X!@#@M"X0]GK5FT&]G34O,O-?N"7`0@JGYR:7OBL-$$
MP&&01H`(;+09D(4>@EW/GBUS04W_)P=V^`<<:??6]V:NN3!!"-R9\/L>F2Y<
M0GASE9M:J8GCM;$RIP&&`-;$`1)'D0L8%L6I[?A+XEZ_O1`=]FK[^GL_7N!9
M>:%QHVW968(J#BAZW%"CN$I",CW83\1=Q6T'OSL^G'JD0*X&)-GTFKV$O4KM
M11A']!ZHWQAX!I<76;U1`0C+X1`*90HW*S-?M)'K"\2949?7*Q"#$W22[\[W
ML@M<7**!3"%@57BT.#)12#&(%\,0R/XOTI%$/5D8D*-#JX9#"[^E*#<.`A@6
MQ0O7<59SDU@&?SYRP8?8I7^'YP<$O.<3%[EVSI=CMG"OLX4%9"*O:Y<34%?.
M/!R=/4_P'?-:&TQW*Q*%PTQG+7AT5$CIW`EQX!]_AUL0##>%#RT)Q[P])2ZT
MG-->&-%0.W$/:\(Y/*9D3_+U:M">;_^SWBF]//A5;74R[AE&J9()^0WL<(4S
M+&7`IT%N=;53,V7`YU[*MV(AS^EO3ND_[Z6,*Z8?%QM(TRP/>WD/BMG`%\UA
MY/=2#I:0SQ5O8^0K:;J)D]]`N#3EC9K%>\W>C,K(../&P,2E4*(#R\L?G-0L
MS$YA-'.+RJY3G1K/<>I)<I/DA/PMU?HFH$7/B52)M8RK`)4'S0VRW5A\$1ZW
M]M-/YW^(YJ)"%@+`U2#W,G!=SF0E4<@*$/I`J$`%(3>;W\!ETRRZ!TW37+#(
M&`UO-1HN+9C7@T#]$&(1/.;*>XY%J#'@I-F6^,/1M!MX+U0(0W;)EJSJH$*'
ME8YYD549AQB]0YL)C`F*&*LTV\!?Q\,Q[`4E^W?-=36*<)VZ'#3<3DU7?FRQ
M"A6=0#2;Q\!F[H.Y6/K>9H#O#O[?0R2S(D"B]3\.V->::YE-(\R`RFX_FX?,
M+/`]7[,-V'J,754-2S(QOQ.Z(C&FKR!^1*:'%@"0C'9/QL;&\EL`S<T/):/Y
MG@?'%HBQ6]MW35#V]7`*S6Q^#50:\%9<$!L>%#H$"IYV./+4'+@A='@1O]$M
M!+M._=Z3XVO6]X!NU&S^N-1<`C*'*BJ._>@[^I]/2V+?>EX`M]@V,M+GS@15
M9F8SO&8_;4!K:;YPTRH;#>F9W61.0!DW0@3O3'CDC;BS$?T'T.N0LRXXP$GO
MGD[/EF^"U;V)3K0CT0;02#H[A*@7300\OD=-%O)]X.I+4)J-B_5L#B<$4?Y0
M#0B+VB-Q00N9%K(!69_!"ZX=G2=<$E^CD?>U[(XVZ8B^S-K8]Z,$"/987)DN
MT6$E:A,N33*_?B-ZX)NO)#YHR&/!"TXREY],G_9,N04Q_6H:8-S\;OK+!V*%
M,HT*Z"<'Z[$7!-W"F`-UB&V?5.S-*0"`EO/!LV7J<*8)'=N+O"/Y'V-1>"`+
MDY:$$".Z<X+(5('!F]F.1R<9F\:]"Q>>&L`(:SKGVT;L?!!#KFYZU*//C'-D
MT3H><).HDY`EL7J:55ZWF)8JKJ%6TPAQHDMWX>[80CGQ="6>F=HND$KX71"=
MFBYTCKA)TZ<N-<NBVN*UIB\W?[<V!W"+M3`<RE]3W9T.18:S&9Z]9#HM/Z7E
M<%HE@DH]U#G-_1S=?V0#"+W8.-%=^#W:3*&J;&2,707T(8J$Z7?BW[N.3HC!
M+]-X0$G7]G-1"/TKT8]O')>.&,9I_]Q`U9)&C4MCS%+=['36N=#<5N="%;OR
MN8$AT68D&)!C^M4.1JUWUPV>/?+/@)9IO1+!MK/%,/"^,_,5GHQ;^Y76NP.L
M6SNRE*)3%<Z>AY,#^C76WD(#KGF5,A`]7/,0?FBE?@5UT&P<2=[[Q`^KW4N&
M;U>=^WWG?8G+J'(P[%>L?4G>?$+TN>1D0)]F$\KE@2(<J$BAPLE/1_CY4:&[
M2V%/]TJEP:F2$JC\TEZE%/-*QXJN)MQ]K?N32:QDRBSF2*/M&\7G+XJ:@(Z8
M<8IJ:=1+;M1V4/2A^XV4`Y/GN.I#.QPQ9G"[)OO0&:<&"PH]QGWHDU/O'N1Z
M[!G90Y60Y4&6E/Y3):>YM/]"Y(736`NE#G7$]IE4&75E?%%WO&4-62DC.L]8
MIN[X($DLR\_68"-2E1S\69\A.<DUC.;>"%U.KTM57A/KQ=8;!9/7WY2;7I:V
MDCGO3IMLS']2D<V7T'ITV.%-+G<I\R4TEI%:G7;*V-#AH\C5&%P6%Q3A0;4'
M2C2%-[GSO&G7C!W=R?O&I4!)-GQ*;Y>M#+BN0'5=P*Z2O%&WP$A5TGW$4;"1
M.D<X2TL8Q4-S%'"6`*4,^-0;'09K#8H4;25L.>Y/*!')%JYRO90-:@J$VM=#
M<@%GRCZ%NU778)]0K6_*D_/NCE3CZD.F&#NA[W2BA.%0HB[LEIUO4[3]2IY.
ME-:`\TK],R1M]1U@1"GIM^`E:K/G`R-*28\<)U$%?3=2XOBG=O=$G/*W3$EY
M<*SD593B<BULAI,RXU3)T]X&,Y)61BDK^*,7<CMGA2K4!;4V0(FB`SPBE(4Z
M/'/!ZK1#5CF&<K.#IU:8_4N,?"3B\2F;;*J85LL)4791&VRELR8$C/E7L%;S
MD9DN%BZA`P+89GB8HI,&%QO+478P:KL<A6\7H^,-?Z-SM'1G89M_$2.*X5TZ
MGH]KYBMM:=E=I^#=<`/=#W.'+@';!?$$^F250)%=%4$L@+GX"M:F"Z^H;4R-
M%0A[>ANIVSJ64@(T(0'+WR<"RL82\+@B]$4*IU_&2`AM6#4XR23=VO"HDM1=
M?1=?"7QOD5)`+;1-:8>0KLC`-D8I!2-;&.A+8@16Z(5J0@[C:ZSD(-"Y!TPJ
M7QW.P].#`B_,7:HFNT]E73(H5X3N:D\6WPO@(-]?%:JW9!"/U*P4GR)0YPP4
M*LTJU#L5%N[),J\<Z0\.JI2JGP6#LE_JBHI#51/$:E0<*OWRM'`7&_")*5ZT
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M/0]S-W6'*T/;RF9>B8>V.^S=P=-,5\XU:_Y-9_Q4L@!-;7[F*I4L7^`]<E3`
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MO*2J;BHZ`V+H%0%#V%1<RA$K.^`>G9N3JO?+`260IA;"?_Q_4$L#!!0````(
M`(R+K43IADK_A5X``+!V!0`5`!P`86)I;RTR,#$T,#,S,5]L86(N>&UL550)
M``-XCG)3>(YR4W5X"P`!!"4.```$.0$``.V]>W/DMI(G^O]&W.^`]6QLV''5
M;S^./7/.1NGEHQEUEZZDMG?6L7&"(E$2QRRB3++4K?/I+UXD018?``@0H-HG
M)L9JJ2HSD;_,!)!()/[M?WW>)N`19GF,TK]^]>;EZZ\`3$,4Q>G]7[_:YR^"
M/(SCKT!>!&D4)"B%?_WJ">9?_:^__3__[=_^^XL7X/KZ%*S"(GZ$IW$>)BC?
M9_#KF_??@/]]?'T)+N/T][L@A^`4A?LM3`OP`CP4Q>ZG5Z\^??KT<A.G01K&
M0?(RRZ*7(=J^`B]>E)1/,A@46"IP&A00T/_]!-Z^?O/MB]??O7CS[O;MZY_>
MO/WIW;<O?WC[W5]^^/;-__OZ]4^O7PL$?F&C`L+_?@)O7O[EY;N7XL>N@O#W
MX!Z"BU/A8V_/5C^^.?_^N^]>?WNV>K=Z\_;\^Q]>O_G^NW?O?OC+MR=_>??B
M-?[?CZ]_^/X[+`Z6Z?6WHN1H]Y3%]P\%^#K\AHH,KE^2_SM%:0J3!#Z!_PEN
M4)KC3VYW0?KT$JR2!%R3K^3@&N8P>X312TXQ*76(D4KSOWXEZ._S79:\1-G]
MJ[>O7[][57[P*_;)G\B_%3[^^>#SG][13[_Y\<<?7]&_5A_-XZX/8K)O7OWO
M]Y<WX0/<!B_BE%A-2!CD\4\Y_>4E"BFH$G*!WD^0?[TH/_:"_.K%F[<OWKUY
M^3F/OL(J`^#?,I3`:[@!Y+\?KR]ZV?WXBGSB50KOL9%%E\$=3+"XA/9/#QG<
M='\OR;+&UX@(/Q(1WGQ/1/B7+FK%TPZ[3AYO=PE6R*LI4GZ`A5E!VP0-RGH%
MLQA%9ZEAU7:3-2[W31%DAG7=1]B@[+<X[D&S4A^2-"DO*H+$L+P'),W(JV$,
MQ:&($L@GY!-D]N0?(L0&8B;EQ2.T0!1^+F`:01X4"5D4=LE.B>4P?'F/'E]%
M,,9$W[PC/[P@/[QX_88'UW_!O_K'65K$Q=,)GLRS(+G`Y#__!WQJ\DU(E$=9
M^4LZF+]^-?#E5Y6`Y*-DEL%?(BL0F+[X>"-+YQ_)74NK&<S1/J-3D+0:B]K6
M_\;8`,X'4$8`<_JW5U26AM2K+&SP#K*P9(M_'.',/_$J1'C"W!4O$M%"-AG:
M#JJ/LT6CNGG59PC!78P(V-^^?L>A)K_Y1[EL6Z41HWJ1;E"VI5/XZB['#,)"
M!GH%8DJF($W7C&E$G!,E_=7?JD4M7AOC53,UE;CF_=*%E:C#AI35Z#-$3"4U
M-)@CX%XL\`2_E5S_;Q=(?@U)#$CZXS(0^4OF`L/;X"Z!LL&___O*\;^/E$6-
M-]1,F77:SAS3P"@02$9+GBF][;D2^C9@TY=XP9@P1UI]CG-94S[XFK(R6Q3,
M&RYE4,:(WP@/9_;:IV0TH`H_%)I(Z]+8ROH4;8,X55M0E]_17$>SKUM;/O_&
MZ#LSOTZ]HCX%>*##1$I]=F9TO.F$%P7<2H?"81HF)IF*W%RS.V$(*$>?IOA#
M9/JG^9;*/$1A<+H?`,!8G+V&]S%9*Z?%AV`KO8;M_JYFS&B2L19_:S:`\'$;
MAGO4CL;TXI&*$U7MNDUH-<4=S649G%9NL<RJTPC[CG;`(E^W.$T0\JZGA(96
M4=_P/=!@.\1W*<^`M:TP\8@P.$^">UES:WU)65N-[YLWN(H\(/1=65RW9E&O
M!GS08B*C0(,QKCJ*)&4*JL&N]65MGVW0L1C^&!^\$8YH58;K2-BM>S2J&Y_T
MW`Z2(RHV:+GG<1X&">-WCG^GO./K(*"MV0-:%JV8\2HU3;FYMN1^+)"4GGS3
M>]NJ)51NW++_$P;9!+L6OCY1NQ4E^S9-6/EDT8<8=-IS2T-^Z;O'EOM5;<"2
M3_99UAB/X@*C__O*NNTC9=Z8.:>&@ETO-4:!0#):\DSIB;J^C:7=SN,$9B>8
MPSW*%,N&6E_5S`@UJ%C+N5$NH&3C-N76K7(THA1_U)LH:-9<@1O:;E%Z4Z#P
M]YN'`(N]WA>T"CY.I9,,,I1T2]\&B-JK@Z-,`>5Z!!A?(#!V7!8G@QA24Z*W
MZ"2]P$C@,N`DFR"_HZSV^8O[(-@Q3X%)D9>_:;L,__4_;@KLDF2!M-Z<E_<Z
MKE`>J]8*JM%3`DB%M%&8*H9@O0$52U#R'"E'L^U"6@@B'75ZCI88\O0AL^M=
MTA5W?=^<AH&E*KM:VPY+ZT9TW67QNN5T-O5Z$'/4J^<,V.FE2AW)T+>GZ?72
M7NV(H.!+MP4C$LKO,M[+"44BMA5]:,0#.K9BR:L\AT6NLW)I?U-+L4TB%DX8
M;V[.;F]<6FN/@M&P#KQ19GG02$G/O1Q@7'D"1]]&#PA,T&Z+EKWT8$#9_>3>
M=/O4?V#!G:KQ3=5->RZ5/;-=GP3YPRJ-R'_._MC'CT&"A<A7Q4F094]X)_M+
MD.R55K^2!+7`D*)MP0\P/WKE+"0_P)JS2X]0`PYI*=%WD!(!'W(_B_X@,`6K
M`I1L`>4[BT^MBP>8-0*'B@-U?5L+B$-"YEV#\@!A8Z)PZ14#JD?CFO%*S8FH
MX>8D,?^*1WNE8V+:-62V=8N"O]%V!1Z9[:C%FC)6>W;JP$*O,K2#6?%TA<=-
MKP7CR+\C>]</4,E@A^EHZ7F(I/DH7')C]^)+5D<@A0=`S&G54O@@%:5YBD72
M@H%R8C?&2U[@PR$6MA<?'S!$D]8?(H&I<V--R]8JQ'T8']9]]P*DK1??]-RU
M#*EYS+@245^"3)HC;2TZW%MI2YT'JXS)RPL+ZXI9[.PR#N[B)"YBF./83<_V
M'U`2X4!#PGCQI)/VDZ>II7!9\A:Z'5RLCB\N+VXOSF[`ZL,IN+E=G_S'W]>7
MIV?7-__S7_[R]LT/_PK._K^/%[?_Z=+6E2%%NKI=`'S<HP2F=(TBL@6,[]Q9
M2$&D"2GV(2I3X9DMV9[4/)UFW"4@Z?85<[EWV^KO\`='6?A5&*)]6N17P1.I
M'-!)NO10T)O&.XE9.!+E?,".,7*Z*AJ&`,EIQSMU)RU-<QZSYFG.MKL$/4%X
M#1/:IO?`K54,78*8%@BC=*V8?[:'$0C1=@?3G+7BH"D<+@NX@RG<Q&ZW"_+H
M(65M^HP4]YR2&^#L0,=T,5]B9YKO])+03SK,Z2?P,W$3K';B(X@F)(35DO/$
MCYQG#&K-/QP:Z1]7IG\*-Q!SBZXQPQ/\W[C0,/X!(EIJ[Z5GX=(I9P4RFM8O
MSZUV*"-3ADO#'T<&26O,1Q22%@"$#6!\9O6`:7'?6,BW%NU[SV8]"?!RL=UH
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M\8"R^)\PPFM]5/XVSG.2V:0)S;I]!`@*\!Y;_P-X]^:(O6=)/G$*0[B]@UGY
MVW=NBSO[C0!)0.07X-RY*OJ\L\=\=T:$!B;J5ZX.OJL]CXMD[*RC4#K@,MA=
MMG&2D'.P`[>1=8I_!6_?8,=[<_3]CZ_I)]Y\=_3]7[X[^N[[MV:\[@COV/,=
MI&_P)DXZ38T:#1I#U2,#21JV,;??K:*(MA<)DJL@CB[2DV`7X\VJ4NE%'PF]
M8H!N:A9.U2I&V`7CZ$6<@I#Q<EJ&,8('DM24?[I/#M1.F("+%)QTJ]V*O5_#
M(HA3&)T%68IC7KX*P_UV3T^V3^$F#F.EK8P,-2TDQ@E;2<@2PB"H>8%HGY&9
MH7B`(((XW"-VF0-/&?=.JY448$3J6O4:,NY')3M0\@,"0\`Y.LH*3,L&&-M_
MVDKDYKTY`+]2`');?Z-;?MM;?2_N06B>3/30LE(X/\,9!MT<^.D*T@`JW':P
M>,MA[ML-#I)D5T&VSFAOK8CN;:Y@1KN&ZN?-^BD:R*ST$;>1$AA(JE6I`7\2
M7:-`]N:^AG7J/6@]&3+,%*PSP-BR?3MY=(+UQ'7@:*P7[ZK*&ND[V"$E`QBU
MB<[L4`=)-7\<JQ>X7H?JUJ6W(/4X$&\>O>J%9#:GN:!9T:D.4U(QA@,C.+.C
ML`RQ;][10FC$,T3%>8G&L$=<=$(PFS<HOCX@3<H8$E;?'QAT#N3V`0)5U$;<
M9-H3!+,B-.PP<[\_(!P'F=C>2)&;>FXUY\9&/.OT8B>C`ECW":*%/<QLX'2=
M,[K?O1P\7**W=1DD,Q67.38MHK-XM4N1`:C;60SN3ZR#T>4<;G8F!T-5WY;T
MDC"C>WL;D@XG<+\1&0-DR/@G;T&L*G_`Z&?<?$Q]]TR.CAGM6]YS=-B_)WL-
MV:?.Y#7G*2`#/B&_OPCN8D3,_=O7[[BQD]_\X^<@3B]1GJ_359[']RE[8NH*
MK[W2XCJ^?Y#K\2=-2DG#DE3-*#GB+]O2CA]?_>WV`8)[S!J@#"28/<":+[(@
MS?$NC]P)#)*$_`GO(>@505*,DE%IZ!%DG&(G@CG^%ZG@PIMV0FE'968?8#^#
M8+=+XI"RS%^Z\"55&T"*J+RR&Z<OTA!M8?4^CL[-CUX26L&@AYK1.,!X`.%5
M("\>SAO#`DEJR3^]BQ.B@O+M=)S9P2P@5ZQ.4$[O=IWQ!BPZMB]!3*_[R1A=
M&PN5G(?6LB.-T[M/\C`A9;7Y#`D/414WP'"A;;?+3D$S>\PUS"&Y08!E.*W+
M1;DT*MXR0DBS0'.`IGDO*=E11Q&*9]V6S<K@@Y1TYBL620N&%;W+4M<P<V;S
ME,C"!-.\_QFFV%<3+,DJVL9I3%R3W*+1<!!9BGIUG5+$;5PUI'R/P#WC3%TG
M:/!V6F&KAB+24ZCWB"4-L`#G2?VKR756%SO>YW$*\QSOW._BE&[S5N$?^YB]
MGLR;%](94L7-5*AJ`2?/P+R[O8?9/=YATZTV7B*06X<AX>32QS1@1/K:7`1D
MW-]*MD#@"P3&58/.DRX,;2WWBFP?%O22T,E#@,U)R;NZOZ^[H#@@965-5W,I
M=S_.WQD:A`')Z,@SE2==VN8<9C'LB^TNB#.6:+M("ZP*4@G$GN(X^QPF>Y($
M_AFAZ%.<*-V5522LEY]1X6'A80R>P8TK,4C2-DY?[#(4DOB5>;@QT@,<35+Z
M4L`M4Z$UGNL-J'F7CR)5W$')?MXD79GST$K*U5^>EO$IZ5AK"WJ0>O,B\W:@
M^ZY,6U,W/NGY()-VUJ-<NQ;,\MTD?FK9L/CU:=JM*9FW8SH]$#,"B+%#J1\V
MW*']+BMNZ\8O31]8,C]#(1RZM.S3J;"XB/B9'@>GY+4XSI$L(OA)+CO\]7TX
MB3`2:O3K%-0<R1S*>(+KSN',E20YQJMJ+.(5'MY#D$,B[C4,T7U**MY66_)J
MRL2$B10'4SMQ"6;VK/6.,0<[SMVS1(H*U,-)%6DM+P[6H60+%P*44@"*>RT'
M8(+,LT/E52^K-*)O4[`XKU:,T4U!LR:@BYB-D@#&1W@")::LW%9C#&*!Y-3D
MG=Z3ELI)@I^]@W+1J7*K=LY7Y*?P3K'BJ./KDS0M4)JHYA^9FE-X3Y]QZC5P
MV'V*XL+"NU#H,.\#'7FB\1[#Y@P`X3"349>K_G.L9M;'>8]7Z^MJ1W0,-RB#
M['.WP6>8OX]3E,7%D^#P32JLM<=[6#P@_)='_!':*5K-6684:T+IV2P26MKY
MWE'Y^*0%"B*A^T+">2WQH#AQ1CR_#*NK`ERU]P>$)ZA%![7L@`E?9@JH^*"4
M'S1F_P."O/\V&P80QC%C&,4"\P!^S%Z+5`]Y'20F&,H!-1OK!$Z:9=+\BB;]
M@!QX?H^J/%)^IT=A)M6B@;.9Q>`_P$(O1]SZHI9^&S3,SXZ8/+O\P1X8V>XR
M^(`53,J(DI[DY5QFW:UV-*@:7U2<U-H=2`7/T%6$/&(*R82SWES#"&YWY.?3
M.`]5,XQ*9`WTLACD8".T7\(\_PE4;$GB&\L"X98^7#WP"H,_S4CDP.YM3"*A
M<L^!'6Y84F.[WH":-RB9.W#/T_@QCF`:Y64F:17]UUYC#ZE"U0"&0PSL^>8I
M=D8,9LO]0,2%\<</I5#M=<-QY?J-X+`35HR%Q*;`>_X%W>HQB!,2XV^1<,^9
MMVX]#O(X5'%$9=+35RSC7&PN&TOFH$!D_5A=I>?\O5E`*L#<M\245?1R(.U>
MIH**/;A%0+R37S8TIB+,XJIEF_VR*9/.'=!^&EI(]9$S?^PF[65@AZ,H;5WA
M]$KH*%A(5HL>`L-]I7KWH6K8-?=MS_8PJ3.2&WUQLB_46A:-DC*"0XNJ>3^A
M#%A=,V/ADQ/TP3/@"YT*\Q>*?L]@P-`KH-W`6'&07R$I[8+1"N_8@WOX84_>
M45MO#EK7Z,PEZK2U<%-E8]ZG2@GPW$-%Z.B,Y'2NT0893=7R@@!-6EAR[H"Q
M)VF0PR9+<T]G0YH1Q)HPR^ER,`YT/[-G/B=.Q%C29<?4NS@\)=VWX;VJ4VY/
MT[0Z)7..LO.,W5,.$A8N9)Q/AHIZJ[1!@E:ZI-4<P09E8%/QY!.BNYYF<A`A
M><WU=C+KLY$ZD[_>;&#&6^^<X9_#8IW*O]JE0DW#9F0(V[$=\3`)<=[T,AF`
ME#NI7F?O=CDT(R44D;I25<V*9II8)]13>@<9[R=B%'W<H92]#Y!3MA]0`?.K
MX(FD1:3?KI[(0-WX='E9L4>6@>?/4/,W1G=4'K#?T384I43$8%,B$]@QH5@;
M>7=6.MDHD!%`9K!EQ2EV`H=9K-GBU#S%G%U/WM,-8X)!2TWZAEIPE5TD\9+Y
MX`5&G02,)$'-AU4E:!M^:[5LLDD6\X=O1GK2^%0-1:2E4=\1:W1,TX?-BI>M
M]G0Y_S[(?H=%?=`/0QP0R).DK'4WC@LP7WV.E2I+E$EKX:C(Q3RB7`#`)`!"
MU4(EPU'9EYR*X=(==>%&$Q6^'&@3:50;H&*_Q2)XY[.W<9'`4[0-XM22ZS8X
MV(998.:!(Q\!*L]"_+G+%/3<^@"%Q<&NZ^14$/`;$V4>9^?Q[3TDB5NEY6[S
MBYI=2@4:-MK'4JVNW/:([=(O&M2!+[I,FFH$OS'B<QKFL:YA'ALPS&/+AGGL
MWC#;^CTPS&-#AFE4ETW#/)[9,,LMUDD2Y#G?WJEN7@:(3-MNMNE9>.V!<"!Y
MJQO7=TS&D>C:\'=KR$>M'Z1BF.K+G?V<>P)Q@.KK_:YOZ[WW=4#H.=OW@-+1
MN$Z\4G`BZK8V8+F5;L\1QGF<Y07)+P=8D^<H$Q/)JS3B[:_)>>`>1N6]=?GU
MQ'0>ZL<8$]A9.<B@\M"##"(0K3-HGE:0,IZ,]QD/F%C5`VSNSC!,6`8R!<D"
MK:#184L$GTH"K@3PRR;S7)JZ/P3>]_Y[D.Z#[`F\.P*8]G>Z#1J=JX,'+^8,
ME3[.#_2Q&M*'Y!I5)M;Q^(P%(-23!(;%/DBN,M)`M7BZC$/2B(!UD9P2[C38
M3+1U98YS!#V\$F#7.8D#Q()<8,<%`PF3C#<B]23NZ5M)9^C3Q&:9%M$;`$4I
M0"D&X'+PSJTD]*W#`I%*R#??&HQ]CI31'?ZJ1=RYK%JF1<`;B*T_LKS<F\9$
MHVQE`C\[E2M4H.6M^(Q8!S*&RA(MP="BSU3D<Z^0*LM(7<+-NH^E.,5"5M4E
MW0`%'2OM(68I&-'\;J,^V65EW"@62$Y-WNF]Z]"LI79]-[8J>?,DH&3#7[XU
MN>"PM^>:S&?J9./'KJN]\EC0MLN4I72O/V;;>'EA%9-W7N?P+J-9I[=OZ`+D
M>S,+$+=[K_8:9.[-5VL;>E+WG+NN.M$UVSA-2SPI,)B<8)#F93'9)`(KR`-J
M@4"[7163R9M<D[I)]&29%.%8&OR=\8T<-E;++C&$O9T6PMP.M3=O)&GATT+6
M[4.<V4X73>*A;KD3V%F)752>Y>6*3%@&,@7)`JU`#&',!#1S([IAS;D&$@.#
M=U2TQJX!G:#M#J6DK:5VX5HWH6EE5%TTS=LLOPE5L_&BAFT0F*XZMGYE^0K"
M03W;`1)SEK2UQJE>U=9#0*\=6A<M^Z;OM!W=H/Z1E&Y\TW72K>9YKW0(RVO=
M/;DT*;TBPV&J%G/:XLZCM=UP6N@IB1A2U*&_Z'!'&<!CWO61T,Q8QTL.OJRI
M^18="\7-0L]DMQ;?IV\TJ@^?=)L<JG5>PUU%4<P:9ET%,=[LG`2[N`@2=2,>
M(:1W!W.(IH4;MA4[0/B]B%/`.3J]0RN%$%+2FJ]H))U`X#UO"<3$I-XIW,1A
M7."]]'Z[I_MJUEGF%#["!.W(I@+O+NZA8AY/E:QZTD:-@Y5L'1>!).)*&<K>
M1%$M!<B)&.Z2<YH(HPEZ7@::8J`KH10$`$P"((@`J`RZ23878TS4A]<;4)12
M'^T&/6:&PUI^83&S@@-W#._C-&7=4!.2-#QB[>OFR0&V6SHKY?T.OZR79FK3
MF5'5K+6:TVQ?+P1H5$4^J;O,Y!WTZ-:--C.TSVVN%(=[YWH\C.1@!.3<H>;%
M&Z?/$E&J)[.:B0+Z_U2"RS`=+<,?(FEC0AY\`(X:65`OBLN'<IC[T`-4D@'9
MIW@&`D%:Q"]H:W32.V:7H<>8-$IT&;:D<$8JRO<4TW(!4CT%UTY*=29.+&WL
MJZ?G;E'/UDWHL%F>0M+*5[5]_Q0^FAM1?9;F?7<]6N<\7Z;``.3(I)X7"N_!
M')F3]^(&LA+,N9D\]8'^29=!6#J>[VR52_L[B[URA7QYW4-,[?A^$B/-D^4)
M/&VDP,7FR^+SR7G%U6U%@`E;0$;UOU3<JXH#P;UY)H$)`Z@T0+")5GWB3:]-
MS!D(V)I>5-K'-%:;YU4IFX2\AXEMWVXMQ[U(`.CA.^[-@RI>#);C_LI3#DV'
MI1+XY9^V9FII3G8Q=SY7TT+C17GTU/E:"83%HJ\9`?R;LNG"8A7^L8]SNNLP
MMDQOTC2^,A/)FW?H]S"[AQGX%!</X,.>G.4<D0>^7_:<@WC@R/TX2BZQ#Q6Z
M`,QD%\XB9_<3L&%WZR)J/K"Z<CC/ITY-E^O3Z1)PDY[[?/$Z&@/.MKL$/4%(
M/[/^E&+C>XAW5UB[IF:\(0[&8VD_,[L70,LS(0H^.PF"7!3^RQUF]1#D$.RP
M,/1N'7U,[!'F!3$13(/<*\KBL*@.H/9D8^3YW"IA/Y(S[1ATB[,5V5FXE(/G
ML2M)`!'%_;1L-4*,LS`?^I]CC/!\.6`D2LBAMSQ[D5XX>!LH:!S[`#_1OQC;
M*@L$C<?^BK9=EV>/,-,"DC#('T!O,R36!,GSN?X08<FIO:5MW]&4G;@Q6_9G
M#S;/)KWO@*+YF.JK_WD^C^IX8*?"O4=4>E*<V0FERF.(9'=X'1>1.\0PS>D=
MCFO(MOWP!F:/<0C9,*YAB.Y32D7ZM?GY9+%7031!+`LWC(DT+Z@X9)5>R>-]
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M27X"-N2,ZY[HB$ET5.4E/,_[#=N"9`YP`(LEX2Z;&^0I>B8#J(1PGRBTY=B#
MU,VGFY;CVIZG%*<Z]R@<B\)>.NVHY]\RW:[MO54RE<W$;L=^O%32:GN]H(=*
M#%E)9_/KV9XI\<$B#+Y2,K'%OP_:X"&OU0Y[]C=*L-S%@_T8.)F/QI,5TUC:
M>;B$RK3(,&C*4I!)>!9J%9,CX;_O4PC>OIOXT(D/JN!AD#N&NS@8;V8)@Q/9
MZ#S<,X6CI=>;-DN-@6:L!!G$9ID6,3D`?D"/5!SPP]3'GMPKHPR!U"WL1T`S
MR:[Z"2J#G?,5B&JE-Z3IF[=RX<DN3_OIJR.*M#6[!/02%>!,OKN&PQ!]>N'8
M_(N1D_E,SSPHLIPK&<4>N[AKM$O(:NA;AZS^9*-T+:4O':4%ST*M8N!-MG7U
MN.2QY,N+IG)13C31GXQ24X+IU\-MQ<'IC`R\%.U#).QZ0'PIH="8M?0^(3Y3
M,/3#,GKW9%4,P/NN4QBR?=?;O]"-UP_&'@IW&?>Z7@J?-?`)992,L6(\Z_V^
MNC'VD+(2?>I:SBKNN`LG8Q@@&05YIN]&^W91V>7C;@;J?LU+G;0%KOW1L)L=
M3_6S8X..=CROIX$[CWRM#42OLQT;]C:C2A]SMV-C[F94[`%_.YZZHH\_SW&N
M,I6-QIIM$D<[:WDBTB+/50Q9"3*(S3(M8OK!<I#2"ILW4Y?W'BBC7-Q3MW!V
MLGP#'[&+SA$#)S/2V;E.XVDIIT&%6F8D-&4MR"A"2[4,,X4V[UY/S77XH(LJ
MU\&\PUE`K-4@/"^,>9-_D7+N()D2!36IJQNX%B,K\:[WL@2]#%&)XTV,FV8`
M:+K^%P5VW[68QNO9!.E:EI:_'K%`EN!5W8_3`IE#-20M#:Q;&C@?TH"QB,5N
MH=RBL\\PW!?Q([S9W_T7CI:WZ!J6702U`Y8*\2DF+,_'>KCBC_D5B-SI8L*`
MG$E#?IE5\O@0K33`/PQ6JLI?$M!]H>JF0KF2!-S4*-?"3(]+<P^Y(RSQT=YV
MC?96'.W$J"2$X/=!]CLLKC+69H<*(!U_QLBH&^`P12LQY41<]FPI4[RW(_U[
M\`*611EW$402**2@OE>JMA+D#Q]@T6S2HKJT'B:B82<#].Q8">E%F&+3P#$)
M-1ZP=&@<,L@@:8WYB$+C;2)Z-_L#P\!,"R+[`TAJV:GH[<9#TU.$7;40<U4]
M.2AZ\K7F:9D53Z8+GAS5.SDL=^JO_S%?[^G%X$?KGF:I>NHN?;5:ZCY7?;M/
M1>W'`[$,;*E`OM6S&REBG[-RW:-R];E*U/VH2]<(3C[M8YOO=HYN8GT>2M(8
M!8.`,0.4&^GDPY(C$SJ\-DWM*LC6V0T.@)`U(#,[(#P!WJ$*G:MFX#P"NR#K
M[A\GF[ZI^R(V1W6+!+A8-DDAFZ-$52>YH\#`4JY';&W9=OH"-<\%F"`NDS\Z
M,"-];:NFANJFV;T-OJ^KUX\HMVN8P""'YWB0Y5\(,+(F:HZA1OFG(=Z6%G`0
M!)6`Q)*#NH/YCG0PCU,0\@[F]'0D1'A:+![(9I5**3Y51?PCN,_PY$C[H9<3
MB\.:7].&AJR`JNH_E&!/0\R>YY]IY]E5&F$QR-2U8LUX+W@O7OETCGG.&GMY
MTT+82?G0N6"@;VAS4A%WOZQ-,&F:S.4%7&!02NPP'V3-]I!=>"U,4J(TOP99
M%N"H=XZRYJQI<I*29&AEDI+B;6^2VJ(]GJ#8_(,=H3E37?&9JGQK(PA#^O$`
M>Q&9G?8)3?Z3::O9I?P3'PBM9FGG*3`/5+_KT*AS\GI*4S-+A2E-P00L>-M9
M7L1;XM[G09S1:%!+P<*%25>3X6;%S\89V[FM);L*A*5\8(,%9-O1ABO%5$BO
M/43!E!3<0Q8YY9-T&GAJYU,]0^_YNFZ519N2S>J*.EJ[KJ7H53^24(Y?JNY(
M`-:,IJ7[[`B<],@Z\2QH>-6HZ&5RQ-0-08:N%0^L-R$9WX2T7W!QYY)*R"%E
M3?J,4N/9M=%]HJXWSS>>1!S*:F`H!LY69D\C-R.MN/'8M5/[TQY#<C"VY&!8
MZ\/4^&UG:ES[2KI7J=1FJ\62+=\[EME1$K3$_.CS&#K'7M@S#+]]*:B'V0$7
M#A#IP/5T]7B:$NSW?['L*QV=:9^96LI2((4,Z;HK0SHT75ATM!DS8?T&-)2Y
M>AYC5PTR36LIA:.WM$:*4IP]'\Z%E,]>32!N[2WF!A_S9G\FEV^B*2J4II`=
M0WZ*BX>.(,L?I/3]M>]NNU!\OKL#ER79P('[CSVPS67@$XK%&#A7AM:0%["5
M%B:VC=/>M^X7IAK5N:%6'Q&,+R_$6:+;:-3NZ@H;+?+V:_E27&.B)!<Z*'?I
MQ)(F=?U+G$J,[%[7;>P=Z7NZI30'4SR]*7-$97)_<5?/$MHW=S6`4#U:4&6E
M6!JH2]Z^\5HL%M2UWB/GA8,3K4'7?J>4$C8W'H=;74;[`_Q$_R1ON<ITU4U6
MD8456VU5&)>KB(AMQG=L,\X6&RG\Q/[LT$!UT4935&[:)&FX-F^1;;+F#;+)
MP;$]'BW"('NPEK7'+HVKFN,I*<>-3N/'.()I=`Q3N(E)OYHZ7:)9KZ9.6-TD
M57E8,4HF!"BE`+488LZIE6-R9Y/:@*-)2E_4AD/OX?=&SI4]^=YY&V<!"DA:
M8U?=:?TRY[AM'<E.0G[2Y3B7&I@*_;0S7">KWMXN4?Q)@D:F^.!HOK-]R]$2
M]<"A;Y_2=Q[!\9Y26`+V=VLCM;&LM`+XI)CG0@LJ<+.4Z'2TW:S81+SY<JU=
MS1^5RS<2PN_J)9QP(6`#@V*O']3=##UIC%IMD6KL5G3)EE0.K(L'F`G'-A8\
M>KL+0NJBT52L`2TRKJ?^!Y1$^!-Z!P&_9G&!Y^[->G/*Y;D-/E_&^&])7#Q)
M;ZS&R*BOM(<I6KNT\XFP)6&40<4A*H+/("EY@R#/$<:&',W0TRIR1R?&^,89
M/=;AMW;B],4N0R',<U),!?%6Z($6S$3P$29H1S^**4&'-:F2X",%2-0S3UA%
M,,I)557=.Z-5%Z:0<)*BII-GDB!L*;W$.+.R/+%O30:;!7PN4THJ(")UG:I:
MU37<!4]$B:2T-$[#>!<DZ_07'%Y1=AZGA-.JO/0M;5QJ1-5M3(6^%5.K!&#5
MOEP$,MT\4B'`ADE17YAW9W):""-M32O?#6S6(*Y36OUWQ4IY>%4@#I_H[(^]
MRC2K2E;OY2]Y#K;OSE93*:^G+XM,L4DVBJ/PIX("?`KR^K;MW1/]Z@G"$W/Z
M!.[V1;F!JO_(5DZTKS8=3IFT)W_CB7M*F%W'9:4J`>:<DG0**+(@S0-:M>+V
MB3@-0T,3X%;UA4:AU06Y;\5K?7[%BZ<3O(J(B_,@5%QOJM#46'S*D[?F`MC,
M7E`[4RF<"L!=D/X.0BHBV'`9':XP-;!'NB!H!NEJ,5O[,VU7JQJ5^^EHA^$^
MDI;.C,K=3LV-Y9&JN(MC(8F-9)O*0S/FNR.H/%81D^QQ@MTNB5G+@UVY?L76
M2KZ0[^]R'&W)*H-]P7GL',4?J8"B:H03%Z7FEI\S+C1_\6XY*;EPU%HBFJG-
MI_W[V)J5'&F<)^A3OKK#>R5L@3+6(D='J]IZB*3AVS><$;U;0^9&R@O\5G+K
MO&@Y5Y6\%$)(16V>HM'H":T,B17OT.V!//Q]+?W/T]E6(BL^E]V/]1X>5XQG
M>NXY@Y+LW&#&H#_`@GC358;(L4!T_/0Q)XO@-5XSX4DTO5^1-5=<Q%!K$M"A
MK@62.B,[CVF`#8U*-(>*2N8@J+C_Y-*!)F"-IJMZ4;ARUR3/BU!82P'`\1,@
M(I`+-)40H)9B[OFH<0'MFKP?@#>J$(M]D89H"R]1CG]OT<'M\)]^%\^0*.:#
MA'AGCS>-I7+2PHH$RTA^2WZF*9E]SM(OWH42JW;7=YG3**C/S,:20_.BK]N5
MYD4B&1,2$"EI]Q%#@4UVX_]S$*>$]SI=Y7E\G_*#$;RN3POV,.A$5?S(5)'"
M>W)FSAV.<"5Y_!WEPU_;)0?B7(()=1['^SQ.89Z?H.T=OS]Z'&3WF.$5?U.0
M,"<8W*?Q/V&THH<--@=YQ]B#OA<<K<Q!IW"'PUA,Q[]*R2BS(OYG(-N%7(J,
MEK<.4+116E4S8[E)@9W+4"T##U)0FI]0)!THD!XHJP$4[&0(Z)WO_XA3I0[B
M0]_6V[4>$++18XV?'%7GIO#SCKSS[#1+T*]_-*X>KW1=Y@?XA7W"H+>'CYU<
M,*ES/L;S2$2.MS&RRD&]CX)>QK&3F(5<(^'SXHXP(@60%2>G2=]A*)"<EKQ3
M>R)H'%`>X&1`XU:L7'A*B^3?\*PAW#"Y@=EC',)\G9TD0;R5.JS5)*P%CA(/
MNQ<(&A>!I#JKS.4\>@BC25I>"II)"TCRFAM-0Y/54^.&4\D?K#/`))@GQ16&
M&206=,86%TKIJ8/OZFW[6V0LI(5*#L21R@KPN/NJR6PYGC[%HS'->*3DI*W?
ML^XEJIV9I2K67V\N47I_&3_":$5J\?._PR3"3O51S9XE">K%'AG:=BZLU!<:
M=AE)=9*[#SCZD&+)75^.9K:Y0PE#I*5/W_%*#J#"LP3A"2A3P+@"PI;.%!^[
MMX#.K^-TYLXHQQ>#-W&\'$P3&\H*P[(AT%05=I@=N.P;A960QYX8)56]-S#<
M9W02*Q._*I%NF(Z6PPR1M)F4W59\05XQ!L%C$"?TEV2YG`=N.V]*P894=.D;
M1$UWJ1F!FA.@B!%>L[A*?1YR@]$G5T38W'>%]52<E7.?BM/(4M3"1HZX#4?Z
MFK#^AIV.TLJ**,YW*"=7AGQ<,2CBBO14["^&34^K?`JL4T"XLK<0.&B4,3CK
M@\V*W]%+V!_8Y1IV)*JQLQP@HH5,+ST;#D69T5X.+OUD'`<DK1^O=-YT`,H%
M<#;E&?RLN]`4[WV#')Y"]E^A&H'W`-:I_%&AJK>_D69@H93O`8L'6Y4W;)-#
MIADA00.^YAU1V$U"<H4%!S.\]O[&:7V.!N9(7_6+P+?<Q'*VH.3;K'@INV+/
M7,?7H0P2-D[V>!N7%FQ_/=$[.^B9PNV`M+5)"X2,#?=&SURL'[)AY^K1GZ_P
MR#@4!8LSY?DAEXY4U]^9<J4#BB;1:A&WYT[>NE$?8...U*D[?\&1=B:A*M.E
M.ZW8^^'EW?UIGG1`S!!.+;I6SNO8<L^#5W/D,1ITGDZ=^8S'D,M4^%QUX^-D
M[KFLMPTF)Z`&62N!3N!@Y^B;W/GGM8-LAX5HR//D(%P'5X5YZD"[R\!09<:Z
M[`=R)D\LC\3PSCZ[G^I_!\0,(=:B:V/95QT-9J[/U:4A&G2E3I5Y"8>$VU3@
M<(Z>W0`^02G^Q1[_CO\1I4J.-)63Y1ND74P-37>H"!+N@!]D[O8MXY;PH#UH
MW1CNAV"QV"<U[&H7[FJ10"V3RXAPD3["W%I/@$'J)M$?8&2_)T!<,O?E(N\$
MK,<]?%35B\)5QI,K(1SV!"#"K?@I%.EY2W_.8]6K.X-DM(`;H&C)\S(80EJA
M2)UO"_&B*G/I;3+0(`6%^0E#(B!0,@*$$Q!8S5?J<<5Z\)(7FIDPY;UMM6W@
M."W](H0!LC8V@5=U^^6HMQFC\](0&=S:%2*CBO01HZYZD9(;?;R9\0,UPYEN
M,K<&W*@66Z615HVB"E7-V[BR#*RX%N^\X&=IH@:D2%^S?L/7OF1]Z&^M*D5R
M(6[>2D7QY0)2.HDE>$^>9HF+I_6FJU9:R1'5B6OVSU/D8Z.)H?BV!:FU)^[9
M69?OML&A+MQHLKJ7!&W20I4N+6EI,7'14@)29]Q9YN_$=5NUUMJSIPI9(Y@.
M<)C+43V<1S70'?#141TO`\E^OSPL^7<_F:XW%VF!E4C>.52O"I.A9@BU-F';
M;J?2*<V=P_6"-^AGW;KT&JA!KZI9SED5)I^!M71D*,W)<H)YYB/#K_F9X3=D
M2F2YY[NGSC.%91PI3#Q`5`)DL9:@?>S@W0$B>\_"U@'B('63Z`\PLG^`N"F9
M>WZ`*(/UN(>/JGI1N,IX<B6$PP/$S@<S,[;&D7](4(7:Y`58-V';*V7QE53Q
MU?3FFX%DUYK!A+WC*_9($Q]7]F5Q/8)WS^)Z2/U>8]NYN*Y[H6750ILQG=W]
MQ&<2=9VN26,R'"*Y.1V,/CA(/,N'.Q>C&/4XRJ'R/,2CTRDHF[[K%!*BS_V\
M]4!:D;8WS/=W_P7#@CW"T-<OW<-QC42L#:BY=C_9--^28=-\.FF51NP7$/]1
M^KWUJ1S,33^CS&P;+GVB6(B(N^KA*#^7$/+XCRTK)%6_.*Q'G;G]-AA)F]>2
MS.G@_'R<=Z8M991^P%:.SJ2*@2Z2EJNGT`8C039KSBNFI/#IJ.7H5YIO6/34
M:U3]BBNW.>G"8L99[X1NZPQ-<`UB!N.;0'?N:<OK;6\G>J/3TX$V?49J=-)A
M'&><7*[AKHH;NCO>?AI:6/21LS&A5+S8HBY.PWA'FANF?NUY1U%"LNKS"9&F
M4]1,B",,[GFM>\))G5$\A7=*1R2#9"9KOT5Q7I?HS;,Z77[)X-;C'IW:]`RC
M(2<1.`'"2C>'4E$EFR\.^#K]!:81RMBI"%S=9Q#:JMSN-[E'*@,_>H,@**58
MP$A[@&-;RW*(ZQ0PYOST"8)5WQ`='Q=;*B>1YF3YN''F<A*QB*3K7'D9Q\H3
MBTB48%@L_MI'S^Z*2.@UQ30B_R&';X]!0F:<*YC%*&KWZE")`6IT]6]82K*P
MX]]QV5XD3IFODT-H^@.L!7)^$U85W?;56"45+P3)1*C[(=E>^H/`&S#FX*"!
MS(2'C+M'N<)A*\N>L.O_$B1[0\/;4>EOBB`KQ`JG+O,\`G?P/DY3$GO(DHQ^
M<TFC/$NC\3%"TNVL;W1V7O7<[W8)7=T%"1'L/$&?+M(-RK;L>5Z-DCQIDGH/
M4,I1M_`0J,"804<J\7!,K7@[+;U3!1)IJM1_T)(.O*C/$:Y`8#M_7V_V7"]Y
MPU?%H9K?T^QG5I.P\&Q;^>3S#I-WVT>N0\-H2`V>:#-I*?*J0Y'6%M;$+ZJ7
M+\IB]C3JV).<QGF8H'R?09V)83HO[67;%+:6IY*H8DBF_I0_#2+<X\!K@GI#
M+G3F<%OJ;<QPD&FD%FPDXGJ?SE;U2S'5G0YL#IV;\UJF@7E--BO)^_"6\6B=
MBH<L/,D+HUMDJ[2Z[`,<EP$1S];-0NJP%((4[<'.@ER?!YLTQUD%_G7:/&@"
M%7_2C**[\%AVG/P!9W*Z2T:+*:>01I)?X^+A)(-17)P'H<'G*$5$.7-Z^,]Z
M7885?_`)"P!"*@'8<!$6,\JD.4#&F.30:M:`\`:,.3B?.$!N,]4KHO6,8+"R
MILL9U=I#>3.4EJO5[Z$*H^@L$Y(=A<W#&A&'7PP?/<UPR.3T*.D6?BZ.$U*Q
MJ;%8[?BRUL+B@(Y1_1+J@)(?F?3G6A;VZQR-ZN2577-89_=!&O\S8.$ES5$2
M1RS]0`MZ<[(<)_]<;_CZ*DAN\&^HO8HKOC2ZB>_3>!.'I'$&>UL"K\6N,+T0
M+\2JP:E8V_RRZ?6^FUE,\S'T]H$LJ;:[(&4=9&[VVVV0/9&MER`2J&4"I5!.
M6R"Z,EWD&OLOR$QY2!>%!PWIRX+_2GY2N5&-`-1#$/>"Y#LCE@U^JZ>1>3*A
M9T%&3G+(V=G-0Y!!K9@Y0$3+:GKIF8]"Y%26/H.,>0'*S&5T&4<#26O)1\US
MQRJYU$J?W_#+KJUX"KK#CDN<N/95+2^0I:@%C!QQ\_[QGC;G9FF!#_M'F*`C
M<L;]DJ2!_CU(]V3&?OO#$2#E>RX]1Q%.I*=9[Z'C#E:R!`+/1EIR;F\[#^*,
M'N370N@MST<(:0$T2-.\2Q%V@/(3('&ZJ)5#!REIS%<DDB$0YG>,WMZ/$R<C
M-;JZ]Z*D65BYS%9W'^UM63FG%VE!B:;H<R&P)2W$.EJ-.IV<R,6ZN*#[-5*(
M1DMK[V$:-HX7M;Q0E;+>@:D2$PN]T&K^U!D;$C@]&-?#%4U3[6(P3`[A6[7A
MT_1+<JA!O.W;U^^XK]%C#G9H6IV9DZ'RLSI=1],BJX20!@<S\$0HW&_+_!+>
M,U,1ZOH3YFMEX[*7+OQL"J9H@F:7@9\8(CEXYTWP2A%T3PU=C"KI&]!*&)#3
MV;SF32_ID]>KJ0M=LUY_]'R9YIR.@QQ&U;LF.M/[9%9:<\5$KA:*Z`BS%W>$
M&Q`%<CGWF[("9%CORT6<>[[@VJPG124-X.*P$@Z>UZ42U<]FS1X-+M(0;>%M
M\'GB2GZ8CN[+UKTD;52&$VX`LW.[*)<"!*EHR5/E)VV].YT5RXSP*<S#+-[Q
M(UA#-1,:Q"=ETJ7YF'<C@36I5"@E\N'H0QW:CE,01=4N"<;VV8@()5F]3CR/
M[]GSGD)R:$:37#=%<`^OX_SW_#+&Z^<(KZ`QWY\1YGA"8,Y2RO=)?0<\C8GZ
M?FH*/RN[8T$@D!.)0$9$`DDI$]UPW2/6%)"*Y6[+;,0DD#$HE@A_,R37V%-Q
M`)7G"%PVP*<R`2Z4[I;;_<B3P4$+8UZUQ\RBVI.!F':-F6/]TTYT-[LD+G3C
MUC@A=>,<HVDE_G"F91-KPM9=?)&&!RFIS%<HQ%A0XL!ZCU*>^NV@YA`^Z95;
MPUT-;16"/,[7F]9Z[$G#QU4IZJTFI8B;-S7*E^P!Q#I0I_L`-=R0G@J]QR@1
MX5EO#I;U3\X<B\[#:<&Z-9'IFEU#(S^I'2H/D-$\?>RE:..X6&!&'8C?QB/L
MW!X7C\.#%)3F)Q1)!PI4]4,PR"T+^;V^L\\D)0QSW47A&!GU=<@P13L;TD8O
M@:".03L6?,A#4^0>.>E_4C:J)^W!]NQ:YT-0@(?@D?92!4^P`'<0IN`N3A(8
MN5M82@*,%-3N)YA==VY+AA-OV%J5.^D6V=F,=Q,^P&A/7P=K72P@TW.(MZBG
M<;(G5_K)#7NMM:4V"[WV27K<;#0NJ6[+4<XTQ<%Y>W2A9:H!($.J7Q[8W)5+
M&>AC=X?79ACV*P%[*HM'=<QFJY>MU2S/XZH+*EK6*U6V6J#LH"S9X8QYOB_P
MZO%]G,;;_?::=J@JRRC.4<:[_J;WEZ3):&YB_IS$<&*`G<#;P@4=*@S@T@#*
MM"IA\6,V-6$<G7/K9""6;@@=\V[+'IA4=4T3E@M4@C%KR5U-P\*29;M+T!.$
M-S![C$-8EX>))5NKA`8'>@'_&H;H/HW_"2/6RIA6<4U=DIL68NHZSJP\%JZC
MH_0%Z3EWQ-9W+XX/BBK+39T?<<B6E76O^VV@]QPMJFOOP.4$7-!&>6;#OFIA
MV;.UI;AEAW-6W>DPLO7HF/5??#*Q$E+C,-&"5)A9W9RPL\<U+XCRXKF1B:!W
M1A%U?2\.X`[_[W=W+H?[%0L5\:ZMI]9KW7A[UOK-QS0N<N/>;U@.$R9D5"2K
MD>3ZYF/Y7E%G;TU'X<..;?4'&0N`/5,[Z@M8AW>*0"V:\/;VP2^IQ!-B6\\)
M)^]7UZX"Q"+P"@>Q%H1PVP>)2LM+`TS4#]2F\+-R=EIV!8S:1;U'-&]Z5Q;>
M[`2YW!V*&K$)9`R+WM:=/2;]8;^]@QDFC$F2=(:TF1Y^4=WTVC2LF!-C0@V&
MLW%F*[W*1H,*L=R.]?#FA4Z;WB$J6M-6/T'3A^6'USZ\Z.`K@0N25Y=J8."A
MB+3>9"L[O'P8[,%)YMC+.(47!=S*AY&I;+3G.TV.5F<\M3ZXY;*&R`:H<$[,
MU:2U((,8>1ET6I5%"I''HM?:==;9?-2Z:^:U:^:":[:K^[`\SI>CF@8PR?]T
M*_H<@MWJ8T617@E!>#T>A'^CXFB_[^-P\(F-<5M9H?X=!DGQ<$(:$F?[O#C?
MI]'J<ZSTQG@O":UIHH>:>:-DC`#A!"@K0'BY7)6.88$DM>2?WI,AE>.9&3-R
M9NX?@BT\1=L@3B<:O4C(%`0US;D<X`@0GIZY00=&P\[0UINO>`P[!N$&?F/\
M-%>M5P]!#F_Q1R#FD17G09R0*B!(DB'2B]-A(NK+DB%Z5I::E"$H"$?P0%B"
M#>/I;C4I!0R25IB/(#2:"E,$WC6U#[[^^_DWH,C(RQYXY?\S3,,@0[KK/?L#
M2L2Q4$Z`L@*<%_B-<9MWR6HX@6)@X2Z7/5F*0J8MYHWKPN%I4I=I'+;+(/OY
MSBO<X&LNU3<&7F]UKXUD3!&K2A'KEB*X/`;48.><IU$X*77(XT[6I"$FT72/
MF'JG=AQ><H4AOT5G*>:92"^<Y(A-/]WKHCO3B1\(N?WO"'/Z4#%E[VYEI81@
MW_%@OT953WMN8;9ES4432)4H:SR'7U0WE#8-*T9!F!"3""LV[L#OU38:U(C/
M+C@<C/O\SU20MC>NWL!=/5Y)F=(WP2<-R8X3=,/RA/<#%`7N#&3729I7[2/M
MM[#MB,^U3WV7MQMFY#7$+!,FU5T=UIJ57)8VKVMZ!9MX/$",'4K'IGHSN<,/
ML"`72*XR]!A',#I^^IB3Q]>K0=>%W2J)1!6J6EDL>086-@F8,=@DZ-,H8G,F
M&#6`1/KZ7`1H92R&!:"8E8S!\1,@K,%%*MS$Z[_"8*>0'8;[C+*K7D40WK57
M/:Z2H:97##Q*V$)I>,6S?C$""%R=UHC+PX;4M>@U1(D<.G.>?`T/_18/5?T0
M3)ZF!;1J\G^ZU2"0TL[5UN@"0)-U-,)WXDG:[2?T?V"&UBD\QV*V7PA2/%&3
M(Z:QWY>@:R<'\`F!?V+.`*40;#`U`-O/:CE,"JA`AY15Z3-,8E0C&!&V`/,%
MA#$X>&Q*>X\ZVX`2Z;'TGL:I/*DG!)&<!!'9U>8H"=VGUKJHV7P6KQ#X`4+<
M]8-X@X@@25WYI_V.1^U$9G0&F_:<G3W9DV&QY9:Y2FXHOU:5(&+*&$PN;!;J
MC(=+3TE]^8C!_"YI86G<[Y235L/7\#[.L8)@=!IG,"S6FPW,\*RKN`X>(Z/S
M,L(014M/5)0L041Y`L29NGRI0@H?I*`U/[%HOE%1`<$8@I*C_E,5]D>0C`D_
MI:Q,:/T80ACEY]A$+O)\C]?(<)W=!+33$@T19@;S"+,[)/3[2R.0!7%..V]G
M:'__`'+,DYT6I_C#14S*HW8XU$#:GYL4#X5HN\5[=OKBRSRY,<+I`241MB6F
MC(,G2I328C+D])(KXY3MO?PBO,#C-/^E`!;24)W?P)0)+X%?N?.5>*%'=FXG
M,,1)S!NK?<"374;LG?1EABG:XBTV_A<[DCH)DG"?\$^VNC>3H]JRL;-RLP[+
M4NC,9A8%LK0P$24F03<M9::!-JJE!GL2H^.4EBN$M?#D2W=5&_2(M\).R!G\
M#F8@)V-PN<J9PU+1?`9@N1_%2-_UXZ<3.O6>)$$N?W]Y`G$;S>,/^5@X'Y+I
M'7_\!)@D@(HR=)W5DT<#!O"7?RZ@3_]+PCHQ#[,5?^Y4RJ5*IQ!92EKH#1.U
MD*3IP\AU(P]%O)":"KW%)ID(RS-9E?7T<AQ;5CUCC50IC\;Z%$?92E;V\HJP
M/BVKT`2!R1<.GVEI/M$S[8J-4(Y7E[2N'H,XH:T:$0O\XF:,RF,CE4)*\ZA]
M!"5[7F5,4R5DJ%R"62:>7V%\_X"UO<)"!O>P+!JG*L_7^R(OL%UCGZ?J4)F'
M%`EKA3XE'N9#0,D>(TGY,_1R?H.BRGP!5$OB<L[2@QI-4O=28$U:B'+6H+[3
MP+@#@3T+6>Z\E,?)`[6LHO_:YP7)'DSV5QD6YB`>YS81[!\9V"F\#\BLR#"_
MA'G^$R@%>G'HR_OT$>;$*(;2V<X=6<$:QEQ:%H<%(2_GYN7*H\/7:TG<3\OD
MV`=&9F?D!DWS45L@;V@>1D60<`^^)3^#3ST>7.9#R3VN/;WUD)8KL&J%#H*B
MR.(["KZP&!.6@][Y^Y`QR,[9!Z@L`'CIF9IQ[IZDIVZOZZV5C1W"L>)^4K+^
MB@]$W`SJ]E^7HJ51"31.UDY15IG7\.4X1`4KI*H\CW'IS`%^3=A^(V0"3'8?
MF6UH[11:*[LQWDC$3E_SM(AID(D?87WWXNQSF.PC&)$:DQ,Z;?*\4CL8KK:D
M38[*(L000[W&Q29X6^BHA0H<BN(@29Y`*1Y?O#AMK6[4-)`5&)9N!CPHB!(!
MX0I4*1,@0@%!JIYS+";:+('C>)_'*=XY8Z'N2&*7E*/J/(DP3$<+WR&21F$K
M&0&1DR</(TCA@U24YBD68B15!<1R:48ISBK\8Q_G,97F^$GXUX3*#%G:$P_K
MY=C8K<NH4!6%(*?UPK_]JLE0!+ZS)$-%\PL"N:,@8PJ^5N<V@;]6*<8PG4GQ
MM(NDQ7C:0,*3$@PIE#IFN'[5>8I(>[4A"\9<Z[X3[*YQQ/L!T>M)[`H`JV:^
M2,E5B+S@F<!5&M%;"XH3GU&VIE8RNA)8R)7D1;P-6/::Y,(#P41"44H?'-:D
MZ0RO8*<!]#S,9&"O`AJ2`4&T\B9")5R932?U.:5\KN)-_=[Z1402)YN82+/*
M<UBP*)Q1-5[B7\<)W4CCO^VW,/H`IVY-I[$V95!3I+#0,A$6(*"\6=C)ZNL'
M[V%V#S//8HX1\QF..],!>CZF,A1_:NF`*!Y@\H%20!IU!!$!EQ%@(1<7A$A7
M/OP'$F`?@T3V.=FY)'%N=X="S1*QCG#((KE64AX08A&.Z/^GK8^X&/0\=AMD
MO\."VFA>I6F?2WP;L$Q+X:X/[&=KA3:#(6WW2?XH2*WY0":F)!"AJ\2<5,ZL
M-^]1"I_>4R\@5\+S]T%!O.#I"F8QBJ3K!R9PT'@[49>9G<<RVW$EK.0AQ89;
M(A&/,V!#9,+_8$*1P@0LE<-W,R?;!3(#B6KG_O,@SGX)DCUW_6-8?((P_7N,
M=SY9^/!T21[\R,OM3RY_J#V!N+H9Z_"Q8L%$$/!()"EGT3LF"W@HA0$)E8:U
M.2+B@(#*X\YV)YD`F@R!Y>O`E6"G<1XF*-]G>@_4#]/1FI:'2!J=5*E94DY`
M8.7)<:P40$A%:YZ"(:ZSE1&QZQO'3\=!0MKEW#Q`6/R<H?V.]+15347+T9L&
MSP!IJS`=/P'.&%#.H&3MP_FJ$I!=OC2J5<]!.PQTRGA9\;!KK"/I?JH=7])2
M>_5]"WV2"&F7EGZH4-0[<!^4EPAZF[,5/F4HWZBP\VOZ^K/6_,X+\SOL+]@[
M>#]4V#1"N8[19LSP??`YWNZWZH;8^J*6'ALTS!LC)^_2'+O5BP95X(LJDX86
MYS5+86%"]ZNTJXWJ-#U`9.IJJ4G/O.E2^JR7CR?+UAX8NM>J7>KQ4>6=JU)!
M]W,N"%H)FO<P(%O.:$U.`O99QGL&Y!]3=)?#[)$LD2_2W;YH]B\1]:3^EHX]
M&::A;UB<Y^^OMFRHR]VM@/,,[>4PV/#CL5).L*8G:4Q2_FBW*"N@PH)6PZ)V
MQ)+KJ&YH]=@^\%!?1O90T%L$=1*SL+"D!UV,$:"<G*XQAT%`<OKQ3N%)GZY=
MK40[$F3\G9\@N2F"`I)SII-@1^\`7.H4W4_G-7&1I<?6;EJW.T=8B04JN4`I
MF#=E_L9LIW.5/06L!=M)QYK=L(DH'LP+YT.Z/2FD:$TX=N\G.]O)F6SC@WE/
MU"6P.SA`'U.FQS@-'S>/]W%82-G2P>O?*C5+1^VBI84J(1'&+X@!:CG(!<:.
MY54I#+B:-'QW-3^-YR:K*AX,=JOD9U,7`[6K?Y8WZ-[=)9<!5$(`)@6H53-C
M[P5>G=KRC8X`J+)N5B"JM?"1IN]!^'*YWE4'%VDK>0E`BB&85#<?Q.+.B5BS
M\!EM=]@8,-7UYBI#>.HJGG@9^(XL?977I/($-<J:)6G;J6*NF!,/*MG3.Q*P
M%,!AH;(JCDA+IY:+.DL!KK`A%+IFJ$!,*QJ,TC4:!2I#H^RJVPZ4H2>5GO*H
M(64M^HQ0HZ.9'DR6V_'T*F)"&YXQFA,[LPR3M]MV9QA$]^6@RL!VMMF1T?`"
M0$S,X#?O/';\=/NT4RX<E2)G-E+6E.W%RB..4R#B=-3[-+7SZ:P#/)D)K:U*
MOX&2678</_%GN.<K<^F/*$\'+[=/\2B1G%F@:LI_>M0`>#(>U5:EWT#)>!1S
MISEK,%AK59A5,J@78?22T$NR=%.SD!OCC&KU.TU^C>"`)#7DG\Z3/G7/6XDQ
MP<#-&+9U@\;_\<.6)6S8G.W:M%E'IGJ^S]*XV&<03P[G\6?RDT9MW!`5O0*.
M7H(6R@!*7G0-4W)S6HTS#@J2UY67`"1MW:\$W<_K`C=H4WP*Z$C+'T_)N2.B
M[GB"\D+#(Q2(ZB4^9.E;7,R4C)WFIY3!0]I*7`)098J*LZ)N5?U#8`PHYWD=
M[1(&.7UV]6*[R]`CK7/3<*U!,EH8#5"TL'0JF0&1FTL?DL$%*6C+3PR2(?7/
MZPB]>8!+G5IL&6IFTQ67]NJIA_/IEWY42RO@)Y-;NC10\3P75E)'Q",P^5=W
MT5[>C!5=+&-4R<&`Q`,KI^?%O>;Z,8>;?7(9;Y2.BJ7(F?6KFK+-1O.$OI>1
MK@,GF5#7UIK?F,@$.\:S$ZAY/:<RFE(+C]#,,J*;L%GDNGA\D7XUB**,A_5K
M<BF(R7A=C63E?X^'.;MY'?#G#.5F/(Y3,@L8)6IQP=XZ`*;LO'2Q)DXR/B6H
MSEM,9+RF$Q,[+]Z&X7Z[3XB'GL)=!D/6`@#_G$#R`Y9KM459$?^3_KY702KN
M9(ZGWH.GAMA/-(<?F3FD\)Y(PIU4D`U$@G#4:0-!*J=/X9JV&60+G"7;1^M-
M7,$P1*E`)18-(:)@@R6/&AOCT2!I[CT=\FI7U[0%ZVDK'7WLI.=62]=V7O>2
MM10M];LL$F2M7&/Q[>**"E1(57<>PS*^;).^^^[5N-I+GU:=V^A=<>EK:]NX
MH*<%Y&(>2LG-1IB&L7XS!1626E?7)*G;NKQ6LJ=&%HH".+VUI@HCTE2HZ@,:
M]&CJ%F9;:0,2OJ%N']67K<!/J0,<<K;NL#Y4*.H>N^4[A@.&4U^FU;EOJ$A8
MMV!3GH?I@XLJ@M!+R2)OX1JR)W<2]5!&DS2M&F(&6"B=/2L0,SIQ&3[-7/R4
MU7G@K*C$I42%UB'MU-`P?=4G>Z%5DI#9%9ZY6X^+=Y*#"ZH*RO,5%'EG&+A$
M[,]PI&9\N>NT/8[\*\R+;9SF6''R)8=]WU2WB@,B5GQ3X.+.$_LUC8:5X8U6
M1><26!QA>TQ0%D1(UYDLR9L<B"I;S]CC+,<90MM-#)-(T5<.OZ@.:IN&%4^I
MF;ASE%XMHT%-^*)1T4MJ#M.=Q(ZT25O07A?Q;YNB,-E?&BF]G&E<<K.^W2%9
MS[2WU\O-T9E,N,\]2BGXE-/OA@H0,ABL-]<P2,YRTE.Y/!Q0*BCHI:%W`-Q#
MSL(;'Y@3*5Y&FTT<0K`)PO(9\R+X':8`I2`A"5"GI_UC`"%9S7D(1B+@L-X`
MP@8P/M7I^7PWKLX^[^*,U1I@`=ZH>$#W]_7O][1(6;I<!2!A,]04>=:;57WZ
M;U^IZE2.9[I.1#77'`!EH3MO&3Z(.K0'<@KEB7`-!=YVR&4E#JRQ*P1D4J9\
M\_,]N6;]/D[)<WE7P1.=NZ\AZ003P6R].8_S,$C^$P9*]S(G,-&R<FU^%AX3
M+=F069=LIUT&G>E@(V-*7B*PW$4K*0`3`S`Y`!<$E)*`&GP\U3-A`)'&&\\^
MW<.3?98IEM.J4K8&=<W$O.-BK7[GNZ]VP*?HH&T-+@8J55?$_`$7P"?ONTAO
M/R$2$I2NAV@0MPELS<>*&WZ_`#?LP%'=$]MZ7!)F.OYXD0(L!)T1Y[E[(JD;
M"ZYH%TSS1?"WY&>P8>!M.7@T,P1VG.\"O'*"+]KW0&=^Y\+5KLF]T,\[F.;P
M`YRRV&P3,H%0DZ:-/6!:D,P38>"1U_1@TN\K77KR5?]]?D&QX,S`!]TK/:O[
M#$)V:R'#T9%FNCZ@(@[A%<TL2I^*CQ-2/],=HVGEU+QB2E-JG"M(*5N>;G5W
MG"X-%U)2H:_0-,X8\;=BDG?`A/`Z*WP`0874I[AXP!/"[Q!\3.-'_*68-.WN
MQ4\W3SK/H,N#E6IT`C?`V/4\!BCG\B1FA`6,WL<)S`N4PG)*_;A#Z6I'&H8%
MB;3?2U)3MS`IPE8B0,D9+Q<YZVJI"/8[<J.8<W<7!]0P1.HJ52VZ7V$'>X"9
M6=M2(ZH1Q!3HVYEKF`!T2>6YQ6D!C+05K6I_Y:X$8D"P>N_A>G.-GH*D>%K?
M)?$]T[>LW<D14[<W&;I6[*S</.TJSN00)V.\`:J8NS,O)?R0LCZ5S2GX;-"<
MI(AIF),$73OFQ!C[;$XJ^"%E?:J:4S])&-TB'`4_DK.UBR)?9_$]7NHEEWB1
MA_=UU1I0VM8,<-*XW3^5J9V6#$/6B>?:`I%)%NSIL69,6F%RZ4#"Q*LW&`[[
M.!BS'&06+!,3-+:J2@A2P/D0%"=!>@R/]T^GZ-.T^7J4MIGI>X3-G+,Y$:6V
M=%H)B:4!89"".PCN]D\@PA+Y-<7+6L#0C"\%@8D%@#%SU:%M9GG@Q%R[5PO>
MF^L$"QA:4=@QU]:.ZG2OFK\=H*`3*7N(68J'K4TSB/;N4[7CD"`Y;7F=.FNT
MGI7-8NCF7V<<5](:4FUCU0$D80I6$X<T?PJJ<8E"-?^TG&$FS1%:!W*^W(X(
MH&QBQ_]1)<T!"9LW<KF$#V@]?4"SY4P:,$DF3/P?5=(<D"V8/,DHM+H)1ONP
M`'F``PA(R#-3>0GAPH?)01T$$X?.6T1B)J`R@0ORU$:9,.%B@4HND_%FECV+
M1%"5V[`L;N3#@9<.NK(&>MF5#!J+`8XAP(*`TRF#=K5%E0C.EN%V-?+A`&X9
M;KO;PJ8/]^\)/14_:4O.V=`*XTD%'W_LX^+I'$?J-(S3>W)Q_M<@PP9>:'=U
M52&IL7^5IFZG_H.R!S5_>N6_E$"ZG<$\A2#JV")-+:OFI&X*%/Y^D>=[&)WN
M,\R!V?`'6."E5`AA)-^%48:4NIF-4[5B7I0MB"E?')4(8QZ82&=VL..\W66N
M%(!#BJI4M2%FHX0P-E)XDJ`<DFO8BG&JX_NZ0>F`E,T(%'-F@'1ZA"#"[!R6
MG(U`@63T9+D),>.MTV6X_4VM:O`F$;.)2&81?G0![E$S&M:$-RIMY*S']&KG
M.?;]70[_V)/;`H^DG%BVR^KP]_7>[NX@95[--1=`V0QU[)S+B@=!0#(:\DSA
MB9JNM38/MWA]F&,_P=-4?HLE77V.Y9=Q4K0F;Q>ZR-J<I3<E8U`(G`%AXWJV
MEH.M9T/0KT>/(>J([157(+(%A*_V0>1<PTED1X)G,,S4CH^?(M+\PY27E]2,
M&Q$C_*>G#X(GZ>NB+KT&R@M_-SD@!8]G;#5]_BJ+'_&V[")])!V5L:E?I%?[
MNR0.&6>!G6)[9'7".L^)J?&P].0;%0+$E13X1["C<M`GX#!^0IQP^1:<)M1H
MDKJ7`FOCD/?BZDQT-?UWX5R,I#S'Y899<R<-2AA_P`.+((%L'W4K6]]+E1=Y
MQFF8V)%=VFML?;@UNQQN_.QH+WR(2O]^^-+`2SMV$>C=%X\HW\>CJH[USJ8^
MIR*]MS^IGE/Y.,R>55#K),Y1W^V>PXZ;AP`/E?W^'&4G0?Z@%-04J.HYF30#
M"X6F]_<9?:T;A&B[Q7-.3@_!<I0X[5VL@2325^@B4"N#)<6'T0>,,:]!`(QU
M^3?,'!#NLWC>21+D^7K#`\`ZNX[O'XH/>[)Z66]N8(CE)$4K)T&2P.CXJ0P4
M_(-*:XS)K/2>G)O&U<+30&6L#1Z#."%Y9'IO$I-\("W4@BB*R1H2!V'FV#G(
MJ7DX?:32D)4@P[@LUR)X4*"RD/(PS@6L,T#9`"80^5,M$F`R@>.G>L8NOS!/
ME\2>V/E+D.RAZ7FZBZC)@'](W^8L?9\AC'19BN+A%#V`X?@,W:?+)>`U/C]3
MSF/3LV\U4JU*>TH9$$L`Q0.L"V'0IK&`]'U4XV!AEN!JP,V<5R8U@&FDD-:;
M#:1#H1SI\QA>CJ"YERR9#$AML32IY$[8*BU'.[\^H:*F0<E.HBO,XAW-+]9]
M^J(>&YFW<*D;A(/JI0X5^:7P'L.F'#1?@NY:;)Y]AED8Y_`JBT.(UYQD?2_>
M6R".A,/`<1SQ3YS0",VVB=+'1C98:SQL;%P*.^]3TX4XG@QYL@_@63ZC"W'(
M9<5KMYC-EW0_UKK<$C*)P5T<U1\L)U8JML-'KNW9(+*,LFIU\Y`<9*M=/SZE
MV,Q!G;!95^GBX<81:,8"UH]XN>X*H0VYC.WVJUW=,AO&KE1SW_E='?LZ(&/%
MA`CASICHTDCZM8_&U#-+B7VYV,`V1@/@:HOV:D\O#=,QL-!JDK2Q&>(Y4#:!
M;G#D:9QM[-.X\QJTF[5N#U"]B]XN[7D*2L\R&+-B1Q6`,?/Q@.(L"!^:G[5X
M1-'%;(Z4]"%?:\<4V`,?8486N70*7-`AQ(`EZ!]#]&E^R:A//8H@<AU\R5UL
M:.TZC)]8CM(W9PLCK.PY/9N`\<J>[5V]\WI9C,<<74K!"\-SU)U+*0`50_C(
MP&'BTK,]S6=/.E(UY$S$Q#F(KPK0L`JVU&NV,REUAT6M/\BDY54L-A1G+_G1
M69CQ"6:PD>V@#?O*$[.C\J'XIX[7>OT>K:P1T$$+[[1WMTIQGG88=NJ^DQ&G
M(B=-:6LWDC@UZ[UV`C<PRV!$ST3+/31>+ZXW&TQ9Y9K)&"&=^P?#-"U=(^%,
M`3LFKMB".WK&2AB[O#LBB1=2TJ'R`PKTY+D\<5:]D=3Y90WSZ*!CQR38.7MU
MP,Y8N;.!(>6C4>7XI.B.:H:2C?95'VO")IURSGM=YS8N$KS$NTBC^#&.2)V_
MY(7_$0):VY1.6N8-@[(AR^R:D<L]Y3`$2$H]OJD[$36]%C4M=Y'=DG'_&A</
MUS"A83A_B'>WZ"PMXN))_@:\-FDS"`USL?$@<,V+%(8S;EYYBR2F0WXDH]7E
MX#?@>X0]:&!Z6V(Z\;KY:9S!$+O+*HU.'F*XP7NW<%_$CY`O"Q67=++DU-<>
M<I3MG$1SUO0:'V4.*N[N=P**""(-??J-EACW9*#275#..::D-9Q5_W!DUYU]
MW4#QXA7FJQ.4/L*LB.\2V-PI*@8`67(:74&E*-OI#$I9@Q40F(-V?L#Q9E`1
M1Z2A5;\Q:Y0Y2P"F?4=AQC$E\L/I#0-^)=F:]TG&,VQ^CR89&\AQ[T#L'&7W
M&:5X+9D\J\,^F$N^ECN)O-[!ISHG"Z<!C2OQ['8U;P]-SW+"BC=)2D!2P,"*
MNFG1=NVIN\H\>@\%9SL'GV`@R``\RS*&\IQE(.HV+]W3%ZMJ*6;Q^:9*+N,_
M]G'$SOSH'V!:CUG&QZ7(:<$H0=GF',/<.*G9<K\D?/TH4E%!$FGHU6_4>N92
M@2.H66H><@K5$K>H")*J3(YZ<54Q01C?/L"4>37>>ZWW15[@+66<WE_&V[A8
MI\<PA7A>CX-D_2G%]O80[^3/O2R+,>VA</,2S?"*>$&$!BDK,2PO5^7M:\FD
M/B<MIW"2(4"U^#@R8/D!(J\(E2,`J!R"'P^-6[39KE?(;5G"\[3/QJPSJW&:
M>.7.5ZTF!PI=;P`55BPH9@H5BLBH0HG,Y<J,)-`$L0&5&ZQ34$L.UGT*E9M=
M+M(BB],\#FFCA_7F#(L717C/67&H5X;G,"CVF?S=+2W:ZGZFP<9*<*_D`(^T
M:0;97G%11`\0-F`;)HV[.#T%?315_0M"6@R3VC#K1CQGHT[:`V;-8'#$*D40
M`U$M!#CO'O"$>\QY79))R@7/@BR)82[_Q)P:44/WEWOHSWMW.1<O+)/"4`"Y
M')[=6QZ#>/#.\J"JC=RD;W&X)'TQS-I?2=*.]3'JKFTOH5+X;7DM:%7L3E2R
MY:O3_(E=^9/.GB]JY5<:-*R]F>PRK=6M7C2H`E]4F32T.&^)YZ^0N`7><+&K
ML^KFV4-`2[>=M"S<GN%L`.?CTFZ']8^D=..;KI-N-<]KV)WA7]B<*QU)CM(R
M=_%2(&O>\C]4Z:&J4;R0`/+N[FP77&/W9`_TYS$TY=%?[R6W]3`X?NYTFG?=
MS&QS_!SI&'ZY>#.1MAHJ^=L<H\F=@R:6;-NPE$&JPWC9.3XK\]AIG)/F5/N,
MW;7>P32G@M!";1B=H+S(:6KZCM0"705/9*.7Z[R"/)635J"=QM1P'6PI"D_R
M5\(`+@V@XH!:'E`*Y,G;S(:,!9G%9[&&T2SZMF(==EK?AP\PVB<T][Q+T!.$
M-S![C$-(93LFLHD#6"4T,."?UIMK&*+[-/XG5BF]24_'I/Y$M1T!]%JTVY#%
M0C4Q%Y.EZYF@@$O*^UM069NF5TM+OE?+6W889R;IPWO;5DT2S0+W<S._Q)GE
M68EZ%VF(MO"FP+&81-U++I[JG>5!,EHF,$#1QG$G808J;J!DY]+[9:!!"@KS
M$X9D!($Y;S?W#%;]+O,((9-(V+JGO"27Z+^8+*$T7\$8=PRYZ\5F7.,:YA`#
M];!*HU/X"!.T(\+@+3Z>VS0.0*3(:2$C0=G&I7[&E%8'"FQ=^HH*8DA#?WZC
MD[2`636!`9SES"\YPP33O/\9IC`+$BS2*MK&:4QVN>3>,)<I5W<G1<)Z:W(5
M'C8NCE+V1X`+0%VM*8+3K9H6M&B2>I<"8])`L`)P=0!@Z97YO&Z)@T21[<."
M/C-V@O=N]SH^.$1%-U;V$+0R@=6\2A@<SUYCF"!Y57FI_Z1+]9S/O`Y@)LER
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M"KM8-$N@Z6<^KQGUR6'&JMA3Y3=%D!4\&'%^C8X]=_`^3E/R$]KPU\T7&65&
M#<I$T!D&[#D9C[&05-J<V-2(";J(`/4SO>)XP1^F^SE#^3QKH2'V3NRL0Q*;
METLYUR-`^<)%QZ0A&S(8E7H1>E[V8CPR,4G!1?GR(Z#"+B(ZG:-L`^."9K+3
MJ+YB6.E]SE@E(8P32QR5:Z)=_LCL,J6)_*@OD@$N!HR.0$A>5J4/BJ.,77Q=
M=H"3-T.#X4X2UF=I<K9"H2`W+4@3)*_CH\:=;,\7NVS;<Y9&`_LD2#J=LI>S
MNW=)7DX0PA/'\^^O.Y@[\<8#.<PO7$N+$=[1/BI-AIG+$3B8$I8<\OL-RV"(
M[P'N.1F1\1`N/FJ^H'WV+S`O:,]F<E8;XA]O$?F5T_R@O$Q.+%)6/'O1[I%*
M0.\>0"X#><23_/J9A3ME\S08!=5P_@),T7C,9.*7*UYFQ[>(_GJI>4M![%:;
M/CY!P*LL5GMQ9S:17.?1AZ2S=31ST.F0KR3)2TZ8[5%7'OT('#_;PQLIH[5S
MI#,.__,W4*O'/P>V?M:P=3_B:V]E46=^>[88:U(L.V9L3D*+;7N#=I3=L2B[
MA-,F"Y:I$DA-X_ME6*%"0!TI'.P]MGH68;64V;_(JBB9&[-6$M)!?"WY+SO"
MZAFIR2"K@?,78Y#F0VTUB*5%VZG'E+ZD#B8*ZN<9L&>A^4NN3Y@[VV#`-KY4
MFW93\Z`:[I]K7JA=*:&7MFP<C"]BIA1.57V9$Z5%<GU<[MD\-UZJL>2I3M50
M[51K>#I]S6J45BL[GL/N8_S0V)=0.U523\_D'07FL:7"8%7)LPG4AJQ_UCH3
M3\.Z#Y;NK";%FYG@;AS`.^4MS#4D3;U)QTF4TI9(^R"YA=GVK7+XGUL\?4^8
M5](9`GW%&PC,`>$.OHY3\`2#+/^F:Z?H/+X[LNEV4'=A$5^6_8KA^TXN>M_I
M5KOTN\/;143K_EU4'TAOYHS66N(YL78-26>YN0*"`KRG[P2\>W,$L!5]>Z1B
MQ4)07W(`GV+F!@.XMI%\629M.(`/YEKZ3?_-(@*X\G[)B[AN4FHGOF%N`(YN
M]'QY<X`%3S$X-9@VJ#^]POQ$HIW&\6*2T4G*G?VQCXNGBY2\XT%KK-;%`\QN
M'X*4Z^0#2EF8N49)<HXR\J59LOF:DLV;T]02TM(3.#$UUYL"A;\SLU[F'<YI
M%FDBPSX!U"_&^HQET-D8@#`(0$<!R#"JP%P-!)"1`#Z4YQ):9[PLKRZ4KR9M
MM_FF$%%S&E'W:5PT>\P$!3B%(7WJJDR]O'OF$=?"M7D]P+\$HW068I=P<7X4
MDN:5,3]B:ULFSZRX*9[Y5>H2KFN:MK=90F07<%^`;<T<(-M7.!<>(%FNPZ\`
MV9;),R-NBF>C$>DO=48W@PDD$C[/<-EC?;.$RRX8G[.EN0F7W)2?2[BL+MSY
M%3$[Q/+,E`\DM!$W*R8T=%8W(I]G[.PWQ5G"9P^@S]SLW`31VJZ=-G1VF96K
MKR_*Y>2:M5`+GW4JO;:.5>E>Y!0'P/,@SGX)DCWT]WA.373/PHC6*/X\X'-H
M]/,FI=7-XD\#=Y[@/BC?H(,%9+2`#!?0\3[+H\91E)<V>2S8H?X\N_0*#E]G
MD(5/&U_$7+'PZ6&POZ:O<X2RT)ZYD*+\?Y['SF+2#@YLESD#.#%?QT>^7\9L
MT#Q\6LALH"RT9^ZD*+_YV>`+/7KV;&;0,H,_3=GYZ?:7,3,(W3<7,BVH2>R9
M(ZD(;WY"^!+/U-4L>\[C=@4C^.*MV,TA/>U)K#<->(&3F\2UN>-]_O,EYH__
MC?^%?[C#6L#_^/\!4$L#!!0````(`(R+K40Y<T>YTC8``/YX!``5`!P`86)I
M;RTR,#$T,#,S,5]P<F4N>&UL550)``-XCG)3>(YR4W5X"P`!!"4.```$.0$`
M`.U]6W/<N)+F^T;L?]!Z(C9F8L.V[K(ZNG="5Q_-R"Z%))^>V9<.BH6JPFD6
M48<76>I?OP#)(EA5O"!!@,4"<6(F[);%1.)#`LA,Y.77?W^;>WNO*`@Q\7_[
M</!I_\,>\ETRQO[TMP]Q^-$)78P_[(61XX\=C_CHMP_O*/SP[__W?_Z/7__7
MQX][CX_7>Q=NA%_1-0Y=CX1Q@/[UZ=N_[?W7Y>/]WCWV_WQQ0K1W3=QXCOQH
M[^/>+(H6OWS^_//GST\3[#N^BQWO4Q",/[ED_GGOX\<EY:L`.1'E:N_:B=!>
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MS\F_YK\:XK)?I&0//O_7M_LG=X;FSD?L,ZEQV0`A_B5,?GA/W&11!?C:J_P-
M]E\?E[_VD?WHX\'AQZ.#3V_A^`.%;&_OUX!XZ!%-]MB?/Q[O5H;SXU?DD43<
MV-KL'QT=?&:_]_D9S1<>%;;[=*ILA%]F`9K\]L%YP>3C\I?9,/]2]KO1^X)N
MCQ#3?Z&3_BS'2>2\$9_,WU.6EOMF^>>%/[[Q(QR]W_D3$LP3+)M8?:2$_H`0
M*IW'(J!RZ4?)+[))K_PN>HN0/T;C)07&NXZ9)JQ09CSBKDPZ&RD1DQ"YGZ;D
M]?,883;6$?L+`X3NV8-,2/Z%_NB/E#K=@7/B/T7$_?-IYM`YCN(H.>SH`;B*
MA\=$EP3+'WK."_)^^R!*Z;-ZUF^QAX(K*H-3$KS#>%W[5"ES5W$0T/6[I=>!
MX_TW<H(;?\R.<%$.J[]7RN92SO@XM_0GH2B7E9]K9/(!!9B,6["Y0D`+H^D(
MP!6O^%@I@Q=T@'&"A.<(;^RUC[0@]DQY@`*5?J/A2+FBQ`/'NZ-G^=M_(N"A
MLO&Q!@8?T12'=!0_^N[,A7$K_U;+<A9N*WI+HKL(S<&;M9R&!C2OR=S!/@S%
MY3=*V;E'4\=+Z5^\86'`-C[3O:3/SHL'WJV;WU>RN:F\L9_\4:<37;PPF78C
M$:X`Q'(6BWK?1>"NC.($[G($^M<-I6]5:\]^X_/"8=?[1W>&O5Q?G`1D#F(O
MXX(T(4V",0JH74LMD_U/^]2X7=`K)J!4?_MP^&$O#BG#9,%^W_'8OZ$)HLK'
M^#Z%JW(JR3PB:EZBY#>W@Y:0B)**C<)Q.301EZKSA)2=9!R+(Q.Q$)61^MN'
M@W0\$)`VKV]2ITUP@+Y8@$K5P1RA@\&+T*HBGP-#1QLX,&L6%T?F=.C(5!C)
M.4)'1E[D,@B5^#HX2H,_G"L=5SE&QX,_GJM=D#E()X,_JDL]R1R?P1_8(J\"
M.5RG'9S>OWY>?\-1\4+U1,DAALD5\4/BX3']S_&EX[&7OZ<90E$.3.W[E#B9
MK;Q.";`GXGJ:..%+LDYQ^''J.(O4_X2\*%S^9-T1E?WXCWM,@?-PA%%XX8\3
M>9H1CTI/>///F`J,B/M'G):0'TU^,NW8WP+#CRARZ#X?WSB!3S=N>.'2<R!F
M[[_C:S3!+A9ROT&H:9[0Q7B,TW/EP<'C.__*6>"('3+BLZ@DH9GUPHGZ=\>+
MA=RQU=]J9O9A>6;+\5OZ>>>;$^)B%J'2@8#@B!W6['BC!W9$-QGR77K<066E
MDHSF*11.:,F#73N+UYED/K)+D?Z)H^_$=U/%&<)S/9WN<+Z"LU[V=>>H2_!=
M0T0S^Z-HAH)VH%>2T,SZ#=4WR3NBFG)R4;>;A``QW0J`ZY*8'FT/SCM[#)"8
M0Q6%SK>LS/541Z6["91JWRVGTT!3MUB%X8:IUB!&V1==G#SI6'+W5`4![?HC
M6:`@>G^@EF;R)$Z7<\%TDN\(Q'T]G4Z$0N:(6?VP.Q&1O9>Z9?C*"6=,-:5_
ML/5\=;Q$68VNG"!XI\HJW#P2(]BEN,B<AA4$.F%;GM_.&,U]69NN2R'#;O-K
M&YJVP9%<:)J"114.4:OZLBM&1Y/;9?K/`PDQ-)8-1F\;#P92,R;5"\/C)\Y,
M>UMID.+&*+8#(Y]UY:+8#LY-PZ)9.NHN)X.C:P1N=%*M9G!@C'OP;]#)-D#9
MT!4-#JL14[,)V"K@\2/&[C-AR,J,08Z/<9<5&)\J:#1$C9#(\7H#31TF]2X:
M'BDRX,.ZP@>78W-F^&'=O*4*8'Q1?PSW9"^)J3OB/G$.F;$G,_C1H1S(:CWI
MW+AX/\"#4W$;5KR*+8$Z,"]_1@XH@2?0'+,#8\]U&&:5;]\Y4N;:N#"D:D(<
M.%9#..T%L*H5J"-C-?(V5V)]T%(.GGF9%(KUB0)6)^K/>`,$K38(,<?N=`BG
M/A@[$97_X-382P`&5FFD<8[2F;':/7P[KL:/YQ!],?:LAT%4F1:0(W5NK#8/
M0THD#60)&F7$@E;^VT60U!_F!N@0S>E>.8`''6C[VTI#?$A`GJ$(NSS1J65.
M8BG-GB8HKO+:68Z65%5-,3K=)9JE@]^%8<P728K_)8FN6;^(HQG=T7^U9+](
MIKLI4,D=!8F`CQ.MZP$%"3N24ZDFUVDR8*N-T4AJ"U.!;X\Z*EN8@-PF::+4
MZ414;!51BC9,V88IVS!E*/O#"5,VK^1FVS!E6VS3Y&*;BL*4S0T0$(O;$54_
M#"ZXV0:P30649P88[,67!6II;@P@&%X>I/*:9>:&QHLA)>12&$!4/!BMFB/*
MW-AX290VSB?S"BNV1*BBH&('QWB'+QGY#\/19+1`03)B&A(RITS,D!_B5W1/
MPA;5%N%C].>E`\"[7K_![XAU\4/CBU?*Q!1]C^<O*!A-$E$M2.JE$V*7LG>-
MO3B"^1ME1]#L,*ECJ[A'99PG<-JZBT%E3_;+>[[%<C:2ZG@J,NM334,S\]]1
M=.?3LR+9V1>O#O:8R?U,"I=$]M2=P`J9$YATIW[^:_R*Q_0D94=<FA4U_D<<
MIH&"\K[^>JJ=3O#"=0/$#O'1Y!&-T3RYM%F+699=(3_#!K)=BJNT,&IG,QWJ
MV7F[>5O0BQ-=(A]-8"5N*TETPCI#Z9;JEFF\;$R/)JX37*()"5#.'PJ_83_1
M$.]\JN&AD*5>KE))HV2^(6JNT']Y11+;K%.VM$.<,I2M[#5Z`4I&R><=L;P\
MUE(@9;A>IZ"9\<LXI+90&-)+YP7[B:1<.L'4P?Y#'+@S)T1?Z=\?D4NF/K.D
M+^;0XU%V!&@+.T:%2>[(OPA#//73AZ8'JK7[4=KX6H1K85*Z2\6E^]:?RAWG
MI9]WQ7*V\>08YA_KWK+SA8.#=&GIYG/\*:;J5YKD?//F>C'3][\2,OZ)/5#9
M<B!A[87EJ:8<NU$<T%&OJ.X\A2U,^??=GTH7+KV-TK?B+*'SBH2P.Q)"5??C
M/_(\)@54:0D<CY[Y%^,Y]I-V;Q%^1=DF`#W_"U+4+V[(H<<ZLR\1<[0D!28D
MYM-`J*NS+!$'5BLC.Y9DC%<!8C;2R48Z&1OIE.H@^:`R6ZB2Q#:?$YKF92LM
MVDJ+MM*BEA`F<ZM0B+U1"J@4`X@W$=?2B+!BR8-/C'T&EX)-U+X80*"%%'X0
MXY/'&!A[S,ENW1)?!$?+2EP1+:`?BM<XM`=?Z57+/9.\G)_ZJ[4GZ>#MH"IZ
MG746\-M%L(1?&'A!/WNN-=RD0@]*O-B?/>!6[HF*ET=>QLX:$&5XK;PO\W)V
MZL`Z3\'RT32I7[FS<'48F<`+X]G+9G,12J)E>'4\=9>,&7*[%A'%Z[E9R:K.
MYFF(?N/EWJRTU<%8'R;)*\*I$T4S4`2'U/*2<<9:<F(.Y>H`:U[[S%BUN3%"
MO0:HC6AZ7NK,6+--3*3@.14Y=.86SI9.8A$$MBX_)X>WBTS1+:6NK:DC9=4(
M\]*7Q4@'V30V^'C]3&D#S&.P62@5@<?7B((X7M),+2M6VH9"33=H2%=T=73A
M,&0X82CKJ]^GF<#7R>L*O=XP25/-OZ.?R;^(QT]#R:IF.SU-U?.]01?*./N.
MU<LLZ*,_%L2_>4.!BT,TFOSN!(%#I?"6!*P;7CJ@,/^RY'5/0[A->!OJT$FP
M3ZF],)J,)G31EX;&-\0N4V%>ZXE`6>+'T#.IJ')]$T9XS@[O6P<'R<PY'N+E
M$56.IKOI.3^:*]G,6(*7AY0@KF%-^7F^(MN2MX:Z`:%3K3OMBT.F?X_8:_1W
M$B4UH[/X!^8^HE\O_;["<]8PLH9U3L(7L!ME`-.1D1,BYL]>_@O]1N4Z"PX(
M/CD+B*[*S(JG!7AY`:E"F:Y?;^"Q+T8,CBN;)<<!>A=5?"Y[NR^MTF="KUXW
M9E%>3_'+/Y!+!>X1+;*W5B"3<L3EIU"0'*8NT/]B6H3CW6.7>1/3MW;I.8"H
M@X]3]$HW]ZR`6#8.DS//HU#%=+]G/5W;S*?]0."IX;=.)M9R&/`=P%\_GN@%
MA,)+(,/5!%JSTI83>2EVB3\N+$(ZK\)-S!Z*T)PYZE>/?;`4MQT(.K7G&0ZZ
MF%GK<;3G_"V'+_`D.V,)HM!UN\63+DZ?ML.`IT7BH)-YM1VG[3[3-*^VPVA/
M]ZOQ227_.$J<]^'240*RA&6H;V?"B5&G:[YUQ!69P\R75;1U$ELB:^8,-)E:
MC-#!9&!>/_D!6JA&1:_=#?V[&XW\9<LJN*)41TWW7FG3ZF7CXS\\O.\==K/!
MUQJ%`7?PRM<=L;TC-;9$?)O)RK]00SNI8DFO-"=-1DKSDA#5-%_I39?NQ"R@
MFOV"\,[NCI=M7KZ@AR8HQ2U>LBKG)?SDU\%ZW<P7'GE'V3W_TZ<'R`PO'CQ'
MR/G:>H@MKJC6F3>.L,TU+^1:JMNFJT2WN*Z*9U="<YMK5_&"\X1<^JMIDW=%
M"RHP4E^`^$&O/ST3SRAO49R[6'#1@?J@I?$9\-@(8.VS=N-H!B&/QUIK#2+Z
M[BU&1_Y%]Y8$MRP8,X$,:*,W4-DINW#G+$*3"JM51A\F49G%UN[)*5>H;4*'
MF4+?::%DM1^3I2<6_%FA@9#F:13>B^&LEWRLG5UESSGRCSB*FA`DYP'S+!"?
MRJYXK<$&`EV=+VO#AZ*%"04)M7J2H1=;T2VK*LBFU1CP-\$@C(J!':H?<>4'
M:/WBKBULI.4X\(FQA^\VX;HU%-JAK&D+M!NDY1[0]R[>;IA6T]*T4*W&T'V+
M>TX89CC#[[VRK[NZ](IC2U]XFT2TU_8&AGY5?-@)FQ>R;%YTI?G'B<7\S0G^
M1!&_(',/36KA)RP]X\A#<`F7':$_$X?N#3!I6^U[@R-;[;N)T>S,77'(R-3^
M%B38BX1XH3F+U`7?/S`U`UZV+OB^<<V@Y>N"[Q^9AD6S=$A?7JL2=&@B:K*Z
M@ARL*UH01_?$5)ELJ8*22M698V=L%PC5V%UN8'<PP)M2P,A=/?6.C<:GTD]`
MZOT87(:,+6U5X_PA*GQ7!K=MD850PJ7)>W48I^0"4&SG[>88#GDSU[QP\,XF
MQG:5``M9F[UZ-.2]*O^<.8`&.P+XM7K<YCUVC-W)`-VW/*)A5?\]-1JCVN"0
M8NW2\A@6+D[&FO#UX3]%,Z$I3HF#9:S-#@!K(R(MA^?$6+-<&)Z&6$,.U7"W
MG52L*0?.V"W8LCWFB?E]0^_K2D^718+S-G'*'T\6:29-Y`31[D"T&=S/&TXI
M/[MW"2&1M`W>[F?@.ZT^Y88W33'_P;(6IG;I5[SAA_D77O.Y+I_+QULS&*N<
MML*Q,A<T!^[(6%55,7!-$F@U--',\QRR+P._0P"E"):8'9D;6-!>S.I*5>0`
MFFN;*Q`Z(03/[$DG4A!GB=?Q`&+[Y"6N#+"C@2MS^HMKY5`/P.%6"W5%3]#C
M+P,7P>I:?$N(3O:57P.I3^G&[T.W2DF?VP9*ZMU)NX,2I)QF!MCAZ>%`3Z26
M-5.7^)V?#53;:%L_-P?PW*JWT$+*&79'^X?6N`(7W<[!.S%VYT+#I^2#^([V
MSXT509$@OK:5_#F,QIZ"0K&0[1H]+%$\,-?TKT=Q^5N`GA\<,V,50(EC$-P9
M)H?Q8*"BIZAU$,=QR.)8V30JA^?06$>)##SKR8P4GT%OPY;MVCB*0U;JVG?S
MXS@.6:N3[/*8@W<TY*TLU^:38S?D6[2JCVN&SO'QH//WQ%KOYE@-($.JVK\)
M;*F\!.ULJ,]9BOMJ+_'\8FYI%'DG>YO>[#FPYBHH:@2UB._O3A`X?A12%6;U
M+"C@>6;LO:LNE"+#,95HCMWY^4"Q$Y7%FS#"<[:=;QT<)+N?R^0:F"<'YC[K
MBBB`3CC[CJ+5%_!U`^/D_-38BBL"`L<S)'(UACW;+A_*5HX[AN?JN_?9T?F0
M]4(H>&L*XMFQN<5^!-!;O3W%(Q7/F#5B8:N"K2(@]NSX;,BH72/Z"^-EEMTE
M\I-<Z:)F5Z',G=%+=)BX+7]K%9@\49':%:-HAH*"KE<`K0M_P:^?BYC1.?R9
M_IC]^B.:[+$_?SS>K1#V8Y8+_\DE\\_+#@>?(^>-^&3^GH[#J^$1/R0>'CN)
M?9K],%SW`%`8-J,VLTS\AV0%9BC"+IMO"FU5CX5'.O@?N@=/Q2G$\P6O8/WK
M.HHKOXO>(KK:O"G\AO!M$5&]!;A7N:(CCX*$Z?2$I8=M<D&M(EM?@5N4(K0S
M1[%^2%8@-(U"%^90B(SQ/>#:OU\+(MU^H%:-IO(!%4U'CKB:U>EJ<;I:&]L$
M3&`V738!:_L*+"QU;0<"3ZUEF(#HQ%H.`Q>^=E&$PB+8;ACPM-K&F(K.J^TX
M;6\F3?-J.XSM'FB[V_6SNUV545#K_18U"6J)V(9[1C7<V[&NRK85L5PK8D73
ML-T9%;)INS/:[HRV.Z/MSMA(L!?/1;8[H^W.*(R([<X(D0[IR\MV9[3=&;M"
MUW9G[+X[XX#/0E"'&K,[-*KJ4&-NX*&2IBN'YD>UMN^%:G8OJ-:]4(^-/;%5
MA=Z;W"BKLWZQYO:'ZK)?[*"+@*EKY6ENE>_N:JF9W(ZKPUIJ)C?OZJZ6VL'^
MZ9#O%T65='3T2MLE%%55TJ$X#OF"4=`K^G3(5XN:7M&G0[Y66L?&YS">#?E>
MD4N8X-@-^S915&22XFCL;=*R[^U0ZY<(I<'E*`VUO!,TG9$W>56^W^B6?R']
M2`MF+L];C_S,H6J7Z+M!KI^INYQ-8'CZWREK)+C%/CO%+Z8!2B@*!Z97?0Z-
MDL^TO>M,Z)X#QP_3)L59SUA!?AKI0!E;*8]TQ\H8^BBA]SN.9E=T"!S=.B[V
MDC8N@DR":$HBN=2;1WY1O<YN9PH,6;:>@0$K3%9WC'PF[]^)[]*_WM'QPPC[
M4VH_I,+(_DXQ?4W>_:]QZ'HDC`,D$Q+8?BS-8"P7A=6G@DQL]3O=D9KQ@IZ8
M['1PO"6B=_Z$!//T1I6)U10EV8$P4F%@?S#Q?W6\)"8@NJ+[_)T*1U:L"29Q
MC027S;:,G-R6II66[KGSW8!5P+Q&Z9_M9U=%5_,DOZ.(,?(0$%8L9GSY_B-D
M1WC)J45/<'JDQ?1GHP4*DNT#"O)O.Q+TEGM$"^<]C8&F9@$=8N%X([^E,@,C
MJGGM<F;"%1?C-7H!G9&U9#J<0E%=D.5_E89FYJDHNPB-0U8&M[1V.F06`L1T
M3R=',:]7EI;,$]2NQ>AL94TVRA:E/T#T'Q4M5/,(T/.K?)RU0LS"!Y<@M0Y7
M1W:[5]/8AF@%3_3Z'DW$324(M=[<_3*JMPSU[4R8FVNZE1WAD3H4Y53DJ*'G
M^%-V[U^$(0(>^`+4.I_0\I7ZP7/\B)[';$\M1'4]*;(=3Y$._LV)6-K"^VB2
MNK^3=JUY*D.;B0H0[T@;>287+L4X0&H6%$!5\P23DIP;_%S&(?81W32@Y6NF
MU86MG(XZ9C*4_#W$:5<(H&E<1:8WEX/"V["6^G8FG%U#'=R&PB-I=XZN.EWN
M_.7CP-7,"::PK2A`K//I),=#CO8]IA:!![XB0&0[G^*%ZY*8N='@!H4`L2VO
M&%PE$Z6XG8E=Q0%[UU8VK35ZW4]J"6O6^$/F@H!0[4(SR9^R7#)'-V\+%NH)
M5DG*B6AF_ZN#_7L2AB._1&67TAI%*6J>6)D>OF0-,IUZ.N#G;TJ`8C(93?(G
M=>=M>1D`7KP;R.C>U/.%@X/4L[]NO=Z\N5X\IAOQ*R'CG]CS0/L:1KC#:=X3
M=FF_HG'*S-^0-[XEP0_8-A<DJ+LVU;+/L,1!M?FM[C58C:ZG1F>A^<P3"EZQ
MB\)1<.4Y&%98'4A8]VL^"RF[I#?9F*5X4V0=J#5814&[YX'U\/I/[!?Z[T$\
M#)M?:V;X&BT"Y.(THL$?7\Q)$.&_P'#7DM$\A:6K@B[T"_:3,2^IM40OI8>L
M8RZ[H!Z12Z8^_@LQYF+8'2X[`O0ZY+H"/07QU,\>BYV(_IFFR@A?B2*D=!^L
MQ?:`#!S?Q1ZB]GRJTC'NGHF@;2^C%>L97[]CA;,']),4/^R-_T>APVN;Z])A
MVY)!EOF5;111_[VM3=S[VL2VTJJMM.JL5!W-DPU:%E@MH=.+;)NZ&8J44STR
M-C55MIQJ%VT(=Z6<ZK'YZ6JM2P@F\F)D\53E)03-K6\F7$*P(;W8W.IF2HHL
M'IN?9"R7?7UL_C6^:2N3=D;^`"JYM?"LD$IOT``JZZC!38_/<`#E4+0Z>PG`
MJ<WK-J@[(LY3K'VJD$?9[YJ-=MN'#[X(ZBZYP2Y"[=M:CO2YL2=[5SB7O;[F
M14T,[FK0$;Q5+_(YQ`=6@EM"#`SBR)$_M,+=5F_<"`326`YI:.`*QHGEB)OK
ML]H&X@*!ASGRYI:I[\2^:8ICY3BK.[`'JU;71S+G4"OTF`P6:M$8^!QTA:5/
M!PMZ31)%CK/"VI:]PUF-0Q"26L-A-=:U+Y&_5`]F20K6$L9#A7UC>R>=6H#<
M2-'+H5386-!X*#<R.',4#XTUY?2*XTIZ;X[FD;%>!]5H;F2!YQ@J?$3NW;Y6
M]A+:JGY`#K6&1D.$2D(/@&[U7E];A2('S]R'SQ:E/XH1-'7%2W(4%3YI&HEB
M<RF;',IS@W5+-6!"RAUQ6(=W'T%AA5?+6J)[M&^L7:D'V]J2:SFJ!\;JH;I0
MW2S1EX-IKHFD!LRVQ1USH(_4ZP(FJ*.U)4)S\,Q](6Q1E[5BRU<5F,W!-+<=
ML'HP5XL.YQ":VSBT'820\M,YF(.S-55L;H$BY!S@H:FA4(!KB]CG,'XQ^!%?
MIZ2N]#7(T30W_E4-EM6=+I80'A\,SWAO`>)&NY,<1X7AE(;A*-$')T=581RE
M8:C"J=3;EL<:<C9WRK:$==G*81OZ"Y%@Z[4<+_6*^B)9(LIM$)F%VK(;'\=.
MN:REV-WX?3@/Q9`3;M"8HZ90Y>Z9D@CM?[D2;U#LTYECI?`IIV]8">_+=GU9
MEU">'!CKD5#6*'>I'$(;`><8'QKK0E..,:A!=`[PD15BH!!7MPGGH!I[R"H'
MM<E`/.FBTLROGXM0TOOCS_3'[-<?T62/_?GC\6Z%L!^_(H]\<LG\\[+D[^?(
M>2,^F;^GX_#9/\\0RXYU_'>*TU,\GSO!^VCRA*<^GF"7O6&GP:D4O`?B8;?0
MAZ6JLO`C'>$/)2.D\A+B^8(7!/QU'8^5WT5O$5TUE(O(AG3IQD9SLXM@ZOA9
M*CX]14,ZZGB9IO]0P&4TR43>\7+=HRCR=#IULWBF,%YZP%:CW?.VB^4^=ZX@
ML*U/NIWZI+F<RQ0E+?EXFU=S]5Q$RH\JS,KIF<HB6WYT_W!XB`B5N-LWSB:3
MK\NZ?VP:%C!W2O?Z"(?^R^X;!M]1Q#*#'U"0U-$!*OT57V]9H5_G2G.Q?B?P
MJ:#DPTEIU35$K/IKU5^K_EKU=_?O<:O^6O77JK]JU=\:Q<$H/?4;"J8H8`])
MWY.O[GQWY/^'X\=.\'YXQF*O@*JK.,$M:[,"C';>!['@/)?1=D4I6M77JKY6
M];6J[^[?X5;UM:JO57W5JKZB6H11>O"M@X,D<I?_"!JI44=BR[IN*6MZK^&R
M(:64V@9"5I>UNJS59:TNN_N7LM5EK2YK=5FUNFR#\F"4"KNLG;5:-@NDPM:1
MV+(*6\J:WMNWLAA92S<MC*Y5<*V":Q5<J^#N_DUM%5RKX%H%5ZV""],EC-)W
M65TIG#;F8?48DA(I4^1+Y-@)4-JR]EO'H=X;NF;DEFHPE+)5A*TB;!5AJPCO
M_HUN%6&K"%M%6''Y'Z`V890JG%;7R>MTA(5.XD!56(#2EE7A.@ZK[NC-:2<E
M2FI(2>JV4F2M8FL56ZO86L5V]V]HJ]A:Q=8JMFH46RE5PBBM-DF\NW1"-&9U
MQ)`?)N,`%=IZ(EO692N8TWLC\^&3W@SYL(_(8^75DY*'G+&\K:",B[?U4%8U
MMJJQ58VM:KS[=[Q5C:UJ;%5CM3[?UNJ%4>KRG4]_#3T[;^#XAY(OMZP8%SG2
M>PGG([6,9JBG8_58J\=:/=;JL;M_(5L]UNJQ5H]5J\?6ZPY&*:D232&Z:YRQ
M^PTT&AMI5$1"9!UP;MZ8#961>8='/C21T:R(7!'?I4N3-LA\Q.&?:7,D]C=8
M8'(-&<U3H)8J#D>3M95]EU@0*,7*B56(S"-Z9:='TM?Y:>'A2%9HF@E!6;M&
M;),E:1#T`)XBMG+A/?YGC,<XR2#]2B@.R3('OBS;[0;1+499#9]K%+H!7F1U
MVQ6UJI$@;NU?:_]:^]?:O[NOR%O[U]J_UO[54W$0H%!T:A3W$3L%.FB.X<'I
M@#%L-C]RG`Z'OD\%3<D<L"/S;[]:P&H]"3E*Q_O#1$G(9<11,L#[N=9!*]&<
MH'[-6AK]ZA"6\:;93'1G:!Q[:#19[]G!CBN77H+7V(M9$WK&C93#0WH(Z_:P
M;@_K]K!NC]V_P*W;P[H]K-M#K74@K588%1%05MA52C%N)M3#$K:=J,B51>+4
MEJ^UBJ]5?*WB:Q5?HVYPJ_A:Q=<JOAT5K355QZTI3B:EZ@K3ZV_9VHY]P[=Q
MQ'K^8A_/X_DCF[VWS`>\)<&(BJ/#>+M'3ICQUM)3W&I`JSY;]=FJSU9]WGT]
MP*K/5GVVZK,NOW$K)<,H#;N\DI:4<BU"JI=UPSI6J1,F7M:9>$3T(L1NA,9)
M1!U5^]=^\L/'U!IP(_Q*14V%IJV##]VZVBKS&RNI'![A$3J;^`W=.N0=H2<4
MO&*W0J(OO&26]&^CR2-RR=3'?Z'Q`Z('55K=I6TXCVHFK.%F#3=KN%G#;?<U
M4&NX6</-&F[:`GY4*QZ#SX=JJ_@./AFJ&\.JTURJ'A:SN4:1@[T.:MFL#;1[
MI6R6$]"M?%.QG!&/2F68%MO?R`>$:>0"Y#2KZ0\!<1$:A[=T\]^%8>SX;EH?
M=4[\A`U@L%\3L6U,)WARDFLT@;CU?-:HP2OA3'%(3Q\TOL8!<J/1A)Y:5)*_
MH?D+"D2X$R(#92N=SG/@T(/;95L\?*8LB+L3!(BH84G4.&\D`67G^2?Y?R@@
M(Q_=DCA8[[4!7#XQ8KI]"<B-Z6U*C\]\Z`)4L/6'T]SJY$2E"$)-\X2^H^C*
M"6?T3'K%]*:]?/]!=:T[/W^WR92HC8IT]1.#4-4\P7S,M,(ARPV%S*3T<_`F
M1\$\+0_N(;:RXAMZXT/HT-]CMNE'DP<Z"?8FEZE`+.PM?"8W/E62/&%VQ(BU
M95&:'?C0V036:UA0!3&K,_!04$^9"1$['L3SJ&`0R2D)Z[B)=01RGBL9!CJM
MAQDU`I_IKZ"_(2>(;JE>SIZ=8?=C/1'-!Q$=THMF5RPG/8C#Z#;VQ]^=N<1E
MV$"H^VE`K[U*$KOX=-6;ER"5YX'>8T"[C&Z.*_-<5$=EFSXT@=F1=LMC\".3
M@CTQP(>H%N\MQKT]J9&@QKMP59H.34)05)6HAZFH\W"P3DP3-YCZ2(0T70[7
MF6EPJ=F=2DP<CO*Y1;G:TB1*S&3^=FKTA=/.4T$J'2<</J-/!#WPE;O!>`5*
MXU[SU4.ZZ>CD11>-B]A1"E^MHSH'\<2XD!PM($+>+7)L3XTS]]2:."*O7*O6
MSK%)8$H\'0J#5WSYY/)HG+HI_;2<7R]"#^,Y@F?6[55M%M5%/ZQNXU/C$!0(
M'JF':6.SGIFIW0@%_O#R]_511QPLJTF+:#$B`68YIN?**[^_HN"%#`35U3!$
M#JH55!%(A4)5EZ`>''2@9W=<?5\N%+N>2+_J[W<30MU0O!;RZMM(2O/;]>\(
M3V=TH`NZ$>C>6OJ:$EY"=NZ@9+.YD#F)T]S&Y#)D4VY&<11&CC]FQO;X'W&8
M5.YJ/5>1(;:YK@66U"[N)F']\:3<`77Q2O=^DGU#"O=D=N"#)PHFW>54I2<B
M$^OO$FJX>CC+RZ,KSMQ3)&"G%*)G,C5LZ7^EKJLKQW-C+_O-M;.L>$Z#HQHU
M<Z%Y[4I/^<VW*=G[XEY3.8&AQ;0IK_A1MEB7[^D)<N4YH7CX6POB'<NV3.Q;
M-8UM^O\:9R;>V:!L70P.6FJ_%9JCWHSS9+6(>C,V#*F5`(G>F1Q'X_PH0`6$
M=*-M\?`/X_I`=J@RDTH5G^-KYCO\=O$5L05YT0?E7L2>^+L[7P.@XX&O@'&'
M>H_P%_%T\<@T=2K;>;H2/E67HNQWMWO!MG4UB@KZBOM49S]E$CF>6;@VNMHU
M-EXN.[2W\_B3O9,I>0-:H]7+IZ`ECYI3`*EA-F9RA%\1#QNZ>7.]F$Z/O>&R
MQ\PXRH[@#<_"G,7"0#PFB@8$ES/)Z*STO)9,5!>B91VSUC%K';/6,;L=QZQQ
M@9E=.&:-BT^WZ<A;=\P:Y^R7=,P*Z4P&5\8%*Z%$N<K<:=E<W3;B-Q1,4?`[
MCF;?DZ_N?'?D_X?CQT[P?GC&'"UR,8-@NENV'<7YU:NS7<8AW?LAR_%\80X\
M.O%+)YC26^4A#ER69?^5_IV7QH8;CK(C:%962]CB/-R-J13@"6;WR$48(E9L
M^9\QIMOJPA_?TQ]C+]G+]-_B.1JSG+JLQ^JKXR'!&F]=<;)#0'Y';46KW=#=
M0W5%_!"/D_1+XB?Y).GQG8:+W_DL;22,,B\L93R)S`=:BDJ'[0BB9*U"G!W$
M<.](/1WK&^F1;Z1DJ<++]\)_M7"-B-+N?N-+E6RKI[--LT)HAJ5>$M$E&I23
M!+@GK(_$^DA:RH_8Q3D`!XF0!E("F!+MRF!/BD)\VRGYW)]B9;@C$Y3'1AD7
M?ZD0<B&W2*=A9KJ]@;<.#O[N>#'B/Y)LWR1`:<L>OSH.]5H?V8YD?Q1V90D_
M$%,$0!0:\Y$324^;2Q3]1,C_&Z87*MT9[_<L/3]<7JNAN$>R!7%P5?)56!*%
M(&2U9T:3;\1'[]^<X$^4%#D-OSD1>QEX3YL."L^CQ0C2ZU&07-D8'"%:FJWQ
MG(=+QV-5+IYF"$5?`Q(O*'Q9V23'RUOY73G)>1I*^:':CZ49C`UA$6XYT42A
MJU5,-_(WY#!A&H_8G1D'01:8'?[PR4N(@E>FO=SYBSA:C6.F1A'[/'DVAK>J
MT,=#9UN@,#:TST4-$=U"Z[SA>3R7D-75#S6S^>CX4T`/E]+/NF`1NO"%CZPG
M?>N>],(V++MDP-YS,7I=3:J@)\AXS.OI;--@%)HA@2[+`+SD('FWGG'K&9>0
MF9*;;@`-2S:5@74H-CML&%L)H$QY(Y6:I,$M1]KNH1HS80!EL9LMK3*HE-N3
M!E=`Z,PA0)I]'AQFX]0*=<>`K"=L``]WRER3!.)O-;U\!\2!3=K[US76XMA9
M..6>74ROJ0%$4N+MC=?"Z.#>U_U<_!"0!0JB]RR\(*G0+?=<+$!IR\_%=1SJ
M=;TM1V;]OJ+B\,#H_'HZ^ELDQW-6@0:-KQ%=-3?5[NC?TP9<E!]ZR`01_BOY
M>26OD`FK&U,S.)4C4TT#5NJWB=*V)G)#K^HY6X@?(9K$WCU^16KF54YX6]-<
M,C$!.?B%R,GT8:=Z$;V'6)N$S;,+'"D@3G!;Z$L%!(A0TSRA>VH9(U8^[FZ^
M",AK8DE(O/O7DM&=/4(FT4^6(^N/EW\M=.VX(J',A`!$=;]^Q8&/J5'!6+G%
M;^QO$O.IHZ*[%,A2JN%<;WRJF=4T!QL%+5BN)+&MDZFD&56;HZE(;EM3NGS?
M:$769DI%<C:&8>LQ##QSI5H(Y;,`FVAN2Z9E`AH$B&W3@2D^U])DP*:5&D!X
M`W@KV!`'&^(@*3>@:W(``1`0[4,$OM*6J.:&3$#T42*@/@\@J$(2LAJHC.V.
M+0E5G17,'SZ-52<D40/X0CB(QMZMDB#6>L@X;,;>!UI4DM*`D.'=#]4A'^*.
M<_Z\;MSQ)_<F(2)_Q4<2#J!Q>U@?@.5/:+P7@I5%82BS5]8<NS/C`N-:8Z?N
M43YOU*XPK*MW;65@]XU8J$<.G(88I(VN,5N,09+K=").L+\12=WT/"GNW[5M
M"_&@UY*!ACV4@2);&T&(UC"#'>SKFWU]LZ]O]O6MERX+^_IF7]\Z<W696WA3
MPM4EI#$97%,3K((2036XTX*-NDTVUAD()UTZ0Y8U0WR6QH5\%^<%^.0L-S#=
M+1MPXOP"C:!OV$-A1'STX+PG5F&,@-7L:BA`+;(L,9]^[C)8I_1(3E+YZ1_D
MW?%8I=+GF1-=.?XENHSI'?53R%*0IPV>`/;U34"&-M@F+E)/R+Z/7CR<N+B>
M"5WA'U2D@[LH'`5XBND1<H_I[X?H8AH@))ITHVHD%>*U,K*@-P)`3(4`R;,H
M1`S*XH5/HAD*;MX6R*5KM;[]PQ\+>BDMV*/I^NE9PRJ,*+@3K5)>-3&9"_8S
M"N996>'O)*)2#SR0FPEI-MM'BZ1^NC]-'M'#1_9P1#&CFQ>8AMA`"(IP0H6!
M(@QEX8LN$GOHY'!:>?Z:'H,'$*C*O]>=J1D@AYXIB)J3(:MKL%1G(8Q7TY!(
M8ZO2D63=NA"2"MD%.6P!Q*`L7@:$S"<8>6/QQ)J*#Z%#_TZ/5GIXA=3D`(Y=
M\J7-Y;&Y/(:_)DB<B:+/`H*$].?Z55K`N9DL\RX`)+Q--YL<!D1X"0U^)(#M
M!OLR,.B7`;"PV&0<FXRSO9CU*K77YN"4(K5IG!B<2P(^R@#FI,$Q_'`+743+
MJGS>-#>('^J1(2*>H0'$[K?`K=P5R#$S+LNP!6;K7EY><W%X2FVS9#7XXW/P
M3JR(K8E8\YM,#MZ7P=T%U9>IX%-;CMWYX.Z#:NQ@3ZH<PL'MW6H(Q1[0\QR9
MX3E":J`3"H_@T%D+@D=&MH^,R7$=GD$+V\V-`50<27NUU&YN`)+VABG(9&7P
M),]9[>!:V7X<K_(`WIV)W-6<>KEFM-W&K(S.\BS,=$$J=BWBLJI)=AMH5L7'
MG?_\D_PW<@)0S(($\7Y,]RH.`L%(7%G*/9CH(V+.?7I$CB:W=+,Y'EL#U7.N
M&&270[UL,(T-IK'!-)T&TQB7]J<ZF,8XTZI%,(V9W;)TOT!;_U'=0PU$MQEP
M+$1K2(LJLL$U(KO`L6A6<2BMYT@"RN+;OWI74N=5O%B(5_2>-53UIPRRWYT@
M<-ADVZ2$@^ENV;$DSB_4S&']DT>3C-@H>,33612N!I3<T_\/`7E4`))@JTR`
M]HT3>%@UPYRH;FNMC)E1'(61XX_ITH,,M$9:FB?S.V(CHO'%*SV\I@C>L:F"
M@&:VLR</.+MK'^IF,SW])=A<_5`SF\EK$9S)E<^Z8!&:YU;X"'J,W?E1@/T0
MNTD?X-'DALYR3.^*2^2C"6:MPZEB0$4^I*?/+6)MJ\7]35*TVY2.>&9:P?>8
M+=1H\C2CZ@\]<YB:0_RGB+A_/L^0?Q>&,=W%_KAP^MQCJ@B-?,[7Z*=/V9KA
MA?!<=;.A/?$RT[X2!N\QO>3'675;]@]4*P3V"Q4@I]W9R&0KPM3,7V4G79%T
M`5@T$A="F,M1@CR\5FB1\D,<N#.J<H\OWT<3*B&`[.1F0E#6GE!`M9"+2AB`
MZ=.BY+K1>9(AX2G495_K+L3)0M29R54<&WI_U!"!BL4U#I!+1V(6Y0RCR<T;
M<N,(OZ),T(!B(4I.,\K/.&*%^N[H,?V*Q]2X^1U'LT?D)6<:.Z"?"?2Q2IIT
MUU.%"E,%`?#1%[]XV*7+3`\&?PH4F_*/H2P\HBEFB6UHG(JA)#--9."6)PGI
MYY=X_!#0/<!L0H"!6?*M$M.7[LS`Q2'SJG-[%5A""$Y8)>LH@233V(KZW!IH
MN2Z77/1*)B<[]#8\`&LL+YT_2V=%:Z]`(_UM3#K7YNGU$V`6:7CE>!Y3H&X<
M=[;ZNZT1@`VF&8[4W\?46<=/TD82V;N8DQ@6ZU-/I]-)L%,/)*>EGX.KP:T0
M81L;=G17?@_6W)EVE]HGUS&[B-+#]#N*'@+B(C06/]-$2&E7@$M92%P.Z8]O
M27#EA#.80BQ,M%^GD?+3&#+4=E:Z:&^K6^I2JG);OO2M1+8T'(2D[O6(7T+T
MSYAE8[XBR78?U33@KA+\2H_#._^55:2@M.[\U`I($7NF$(44%:H[0FT),.&6
M8E*@&,)*N4&H*692U$H4IV5#23<XZKS+R^KNA'=T*?V^$UU/)HIT_<MMAHE6
MS((T@6MP+34AJ;0EU`9=0DU41L2O(8/+IH'O=4'@!E`R34)O(]+ZI,'AQJ+[
MM=E>X"`9%ZTI;'!5[,]:(Y%'N1IW&<C:X$3..V!Z7;IV2+;V+IE>M4Z+H)9Y
M+$TO8R<'I+`_V_2*=BW@JWRB,+V^7;N]6_J\Q"&SMTD39.NOB;PBH)EIC9W>
MQ&5OSCG`IQTT>S0#X,:P!HZIF8G;+>X5':$S'&XS>[QJ@KL\#"L'\\PX[VI[
M,$LB[CA>@[B@!#UC38&2O%;M(`P747]B::QK7L;MBW%6"M1G6!&0O.K8/S81
MH?I8[CJ(FH+0E^`=FE=EIFW,_W)?BJ8N<"B-NPO`WOWJ/)35W7IJ)$J-J3R;
M-L9*JE$N2>;54!'(S\I]>(*99!PMZY/:>*)LRA;,P3L=A"H&=0#(Y(8N(3T:
MQFLY$%*AC.(<0O,.P-9;6G-^>@Z]H4U86D`O508AQ_/<.%&&:H6%ZA:K6N`7
M$U'9+`"R#L6Z`G-R8*P-5E:PI0#'6O48#HBQEE03(*M5?S@@QOFX!0&IJ-J4
M`W-HWZ\$WZ]6BG7E^!T9=_1H>3RI+.&6`WEBW`[M`LAE\;X<QB[>3G57FDPT
M\DMF<%.=G+4Y3*<KU:]$B-:6*TK6\Z@W6>C"2U*"T+B<B:S-)"2)2)2B[BPH
MNICD':$G%+QBMP+CB^DT0*S!%U^,4"IQJOU@O8`C73KZ-];_UR53'_^%QND;
M]Q4)(UC7#&U#ZZY`2$_4(':C)/[QBG([1:%$S<0:*KJS%I%':4Z_4O,ZH/>+
M/[X8SZFAP"2-/;]D.U!B3D#"^M<)T5MX1OFX1NRT31K09TQ(+5@S.<U3NO/I
MA8'R=Y#[;$O`BVHU$-K.-*"%M&K)V.SH#8XZSXYV9V@<>XE'3\41#T^OUL.`
M9MCX]9\XG7/VDJ=UE'*23."%36!94%Y&+6D[TC;]&HI0(MJE90@)YUHWNLU8
MMQGK70B9D%IA<+8[1#MKAFL`.>XPK9P`38D!)+6#@0,:F`-(>9>1O4J_@\$]
MQCJ_191[M0RN0Z#;"0E>EEI/K,%E#-0[QPG<\=]I_OA6WZH.5#Y6Y<3Z_%IU
MH/FYBEO\*Y+*7DBGR05Y^;[A%+CXZ03C42)1X=_I[9A$]3%I=.E?GPG[4>%M
M?RU@(NW6R:Y2XB>2'SO>,PKF:ZO1X*?J$=>Z?8(MIUK(LNSC2DBQUW/(X6)T
MV"7D4NQU`?GFA;DQITM5&WHEUQN,_A8Y[?E"5._GK2$NS%+/H>VA,`NR](>'
M][W^'R*W))@@'"5J>;(_L[BP\"XK2]`7V%LRNNUE",4V+.H>=\6<]1WHKTG8
M9.]0AK"U;8B-/;-[#VVS(I4FI/5+N5ORU'-P"SI3]RB6#-YSN+8J=!N#FZ)N
M]4JEVFXSHN0?UY00&#X2U'LN/ZMJPM>`A+!&03J&[SED_3JG^@O7YHN83GSN
M@9'X-@BWFR!<>4.F1>!MZT%ML*WAP;:M)610`;:J-K$-JK5!M;H$2Z4&P=?`
MN$1Z#6J="O"KU5N^%LIS\1>I^18Y0617!&*A\6`TX^HC:%X-"0\"CTRS8'<J
M^@+N+-X.1-W:G*=KXR=1CF.[.E"/;;XFQYHNC!O?K@K@V8&W?;'G5Z=K(?Z0
M9G#7C7XOD?`[,F^RH-PBL5JPXG"*?*W.K?78[2H!0XOR;AS6S.^99BVX;N:6
M6.WGN@%#5?-U.M1T:5E-7$'$=KY*YE4-[?<*M<UBR!?NV"X<?.%>FJF^@(_!
MFN2??+7,:\[9[]62RH[CC=KL:G6Z6BJS2O-%/.]@$;>:TYWG/JK(Z5Y+I.QG
M3O=A%SG=,KLCZX'MLX(GB<TZBF8H>)XY?B;AWUE;$2;D:X*<N!A8^>Q;!P=)
M4Y).`N<4\MOWF.G&J1;LTAU9'!C'.[LPZ:U0X1WHZ]J`F=[9Y:GUCO9U><!,
M[^SRF'OC#&)1J.[FT7.>4=VU]5EA??>7JL-\#RA3INA>_,+L!\PE;.TLQ*L*
M23_P7>=I9\%=52?Z`>XZ3SL+[BZ<P";`VU]5HTM-8G!MB6PRI.U(8CN2V"1)
MG=(RJ(1)VY'$)D_NJI!I4T4&D%7902WYKG5MC?F7=M5T6*$\7U!YU$._4@5V
M>MG673,#R/+<Z?5:]U/RS,]3<S,_=WK%2CSW/#54G09B%ZV#5RV>0ZK<QNE3
M)H$92P=[%>:YI^H.TIY=?+W#O)]B49"%,UOKQ5R)``=>\>1G>T28*!#@0$F;
M86VV0,"BFGD:MW$.<"L-4@D(/$%<DPMLW5PH3?[Y]3,#B;V[T?_X_U!+`P04
M````"`",BZU$#X1C73(1``#SM0``$0`<`&%B:6\M,C`Q-#`S,S$N>'-D550)
M``-XCG)3>(YR4W5X"P`!!"4.```$.0$``.U=ZU/K.++_OE7W?_#EP]:9NA.2
MP.$\V,-N`8%9MH"D0F9F=[],"5M)M,>6LI(,Y+^_+<E._(H?<1C$5$[-%(G=
M:G7WK]5J/?/M;R^![SQA+@BC9P?]P]Z!@ZG+/$)G9P>AZ"#A$G+PM[_^SY^^
M_6^GXXS'`^?<E>0)#XAP?29"CC\\W/W@_/-B?.L\N',<(&?`W##`5#H=9R[E
MXK3;?7Y^/IP2BJA+D'_(N7?HLJ#K=#HQWTN.D001G`&2V-'_3IVC7O]CIW?2
MZ1]/CGJG_:/3XX^'GX].OGS^V/^_7N^TUTLP^,6HX"3^G3K]PR^'QX=)LA%R
MOZ,9=FX&";*CJ_.O_>M/)R>]CU?GQ^?]H^M/GWO]3R?'QY^_?+S\<MSIP;^O
MO<^?3D`<D*GW,2DY6RPYF<VE\\']08OLC`_5?P-&*?9]O'3^[#PP*H`R6""Z
M/'3.?=\9JR+"&6.!^1/V#B..PE@00*'BE`*',#@[2!CQY9'[AXS/NI[D7;E<
MX"X0=8`*<^(>1.4`-O5*K$I.D7C4I>(W79`3U.IWCOMQ(2$7?%5`5R.P>SAC
M3UWU1A7H9PH0=P,]<0O("7W"0A:7,.\*A%)47J:0TN.HUSOIFI<Q*7HD+&4J
M&CYAGVE'4ZCTCM=LP0PSA!:%]E$O"B3Q,"F6'5YL$)P4(P>R'X/&0D)KP#&]
MRT(J^;*XBNAE034^H=]+:E&O'Y%8U?*2HW\^UM3]KU^_=O7;E4`AYQ`(-DD4
MO54B':5%HHBXHKB4?E7@&OC%G1>74&\*U*[1*N(6@:3DY#&4^)KQ8("G*/3!
MGT+ZWQ#Y9$JP!_'.QRI:I0@2KR7B,RSO48#%`KFXIH\561DPZ7?_>7=KPN0!
MM'?'^4:"!>/2,0W_EKDZ#)9@JKYU8O?IJ$<=@."X?_@B0%A:*.8FW^NV$"'V
MK:U$6#OF5B+$;5_5?;*IUN)@T;R^K$^I2K\JA?N?:BF<]\DV,C!ZWU:,9(=1
M2Q3-HS!&=K$OQ:I7Z:Q;ZB:1RGNB74FCGC04)A?VZ\N2[0G4AQJUE_8BS6M/
M]*'1YZ8R%/3"S<5(]E7QEZ:"%/5W6TB2[*-6WSKK'JN>+$4]77-A5AV9_M34
M(+ENL+D`Z[[7?.RLN^%:(N3[[N8RQ(FA^M"T_FQ2N47M<1JK/S6N/YL$1P(@
M2IG4M>KOZLEB0>B415_A@>KL3CGS\00"GD.\LX,)#A8^#'1N=<*E7OT\OJE*
M++J*KILNVBP+7(D4"^5A&)01+;P:XL!`*3EVBZMR5%W?NMD266:AP-Z0_E5_
M7G`8UU!CET3IB*2LI(M\-_2W*+B6;'.YZ&F,10:BV$YC/'5T+GR*N*MHRS/F
M[H*S!>:20&>62+@U@SG'T[,#-33IQ##^!AH>`FXQ2:Z"-'@:](Q1(B%C#I)(
MQ>)R3:01$S\ZR%]5HSK;LP,![<7'KSEZZ+Z-40']ID9-.TRQ30<KFDJ3OI'B
M/GILJC@4P?YFG6_5:UO5A<#25-UL+"K6>I2@:JS\*KC7#>42O3#*@J61,(ZY
M\=]SZEU1D&MY`_T(#[1,![KC&`/Y;[7(RV)]OR#8KSXBZCF&G9/@URS\;QW$
MM^\WVH?_EB`^@-1Z'N&24<%\XL%7[P+Y:J3],,=8B@2$-8BK`.PK`%=\'#41
MN6;E1+P<PVR/7GOT1@C&`7*.)0'[-((R7;(*UZ,&N#H?4KQ_V..\%<ZKAV(X
M'4)OI!43$%;5C#W'<TP%><*W3%0VX0:<JOS@N-0/UA4Y;.JLJ]+A.U69HVK;
M.T9KQX`$88HY5P^9^QT@U7_GS/<P%U?_#:'#5-FB2V03)VG`M<IA/C9PF%6U
MCJY/>TVRYC^C!1-_<8P`SH=(A'U\^3W=J%&'LXLJJASLY/4=;-^A[=SA+I&8
M7_OLN5'?M2Y4Y12?&CB%XNIHMGM<*\>$J^T5DSF.=@ZHIAP&`>++X?2!S"B!
M1H-@_.?J"7-"9R,PO`M#Z>1@L16?*O0_ZU'DJ@HU:3C'\48'T^A-10K^1%7.
MNBXGKFSO$_5]XAY+E=:-,'^80\`LQ#M+4X7EEQR6P$%GCP[P<#23/4;U,;K#
M?(;YKT3.[W6I&^H.Z3\0#:$Y''U6J[>%L-4H5H7DUQR2AJGS#%P=P_9'!Q@?
M.HPZ$6_GZ/./CF*_Q[@^QM>(\%^0'R9VPQ4'WT+""AS[O1R.BHVC^22>[R-G
M`\1&9KY9]8$J^5RHY*00L4+"*L3Z.<1B-F9>-6:T1ZP^8I!-!$3J)%)/I.BL
M`=.->4X9?15^1SG\$MRBN94$OSV,]6$T0[UKLPF8SA0VOR+.(1DLAK&,O@K&
MXQR,T4!SS4Z#&3/<XU@?1YT'7B"H6Z7YF(K<\E05:15Z'W/H:48=1ZW<F=G-
MF-<>N/K`0;['`CQ!+QOB9O)]%40G.8A,:4<7WZ/RJJ/[78_RZX[V^Y]V.-IW
M/L2?]I-\VP_\)^C1W^`(Q915$.<G=/*3`,X'PVP/7,MQ1PEZ)>15$.;G<8K'
M('L8=SL8*4&SNE05J/DIG=*!R1[;G66V);"6%JA`]"@_N6.RW'R2NP?S]\FK
M!E@BXN\LK8K953E"?LZH3585U;KWE>V3JC(_V$!:A7%^7JDHK=ICMROL)OA%
MAJE=$W5+5"&9GUHJ0=*)N.X1W>FZ65D#K5^Z"NG\-%235;1]:][5>EH9VF7T
M5?CFY["*5]?V2.YJO%N&9!E]%9+Y>:E-(]X]DCM%LJR;K5&L"M?\9%0%KOO^
M=K=3&C5@KE^Z"NW\O%7%%,<>]-<$?4NT*V%N/).UC]D[76ROT:;KEZX`^S@_
MR56^$+]OU+N?P"QKS^4EJM#-SUQMGL+<M^(=X]EO#FB_$M'\/%4EHDY_C^FN
M,#UJCNE1):;Y&:MJ3(_^R)A^ZR:O:(%OZ2M<OD7WP6DHU.T#OY4=M#]_%)(C
M5YH+9,X.ZM&:ZP3T)8&G\`SZP1N)`R7C@2-"(",R5"5^XBQ<Q(0$2`X<\QE&
M081Y$\W&"WFT!XL2WU=+16<'DH?`"D45QM^[&Q3\"1&JIC"']%P(,J/J[7`Z
M0A+^FHLJ8_7J4":5"Q@%E^++5U9OBGQ];X0N_&C.2)\=N!Q[1&Y6^]S[3RAD
M=/??M>($U2!?-X^5QA5$*23UL]]'U8TZN:"UXC&<#J=3K%SKD@EY!9]=.:0F
M_5KI5H_XW0"J3QC>"!%B;Q`J;4:ZVI\7C,*@(KKE=CB]9Q*+$5JJJO5T7VR/
M[<O_D4V4;@\M&-C65JX)%U*IHDP'K3LI,\3O,5:W7WFJD8"R-U1BD%C>X>`1
M\]@:K5@8>YA;?D\]%D!L?=-N(*7,<*J1!IV4V+X/$0'&8_$$W"UQ(6O`)N27
MF&0++K99Y0&[C'KMW*0=#_LLP@D6R1Y#9-7=2&"?+DEDMG;ZUFQLLTNF%9O0
M+@EP&F,/XT#Q3%\T4!H%&I2WS1*3.>$MFW\K%K;9([JK`:0-@U`+;O*``5:C
M8+T@\R#1#*=-T+24;5JG(-PZ3+3E8IM5KEG(Y;Q]RM"6C75V(=-=F*4E%]NL
MDO5^G25<-.Y:6K.QS2ZYY&%+P[3G8YME$A,41IFTPAM?6Z_'184B%[9J\D!>
M=A#9VG*QSBJ0Q=!=V*4U']LLDQP"!`&CL4+J&^;JYZ!*S+%E87MM8&;")NSJ
M!;NA^A6MA_#Q/X#JA(WQ(N3N'`F\R01-RMIF@01\=XA_QW+$`;CU]45&URJJ
M2"M0:1$]:Z&4^14<V6+Z4%UG=H]E>NX\X\'E-+;!5)Q`["@/><=I2''&V29;
M?6\62$[MIR6>L$2S32\5-"QDV_+`>N5OPLX]CYB%OQ$BW@V]1`LBD3_&:O76
ME9%:8^`!4?B:LR!^8T3(K"2VY??>5YOTHEG2.Q*Q0<^-;9P4JUB%:L/XW1BU
MAA\E31#OK8.\*=T(&_AE37Y_)!->@:R!<I35&9.UZL;Q&MBO#K-W8SP3NM<N
MD<EX-KRUK4<K#P=IG>K1VJ9AG'0DNEJU2@_C!Q@Z"9QJR2I/36V%V++PNW'B
MIOJE,YMM2]N6XJ0#>+X_-7+?XV?]:J5^XV+O36_MS8W5SI9Z-XUA`&,14(4\
M$0]3[P)3O5B7[/:+,X?FY:PQB8<?RRSR*X<J8<P^G`XB!2;HY9;`.S^Q?ZZ*
MRAIMJQQ@Q)F+L2?42&,]5LV,1M;-H!:Q-<I70#W&"[2,]K%"6W;)`OE#^@LX
M-./FF`H^GW&,S4VQQ@3-REACB<JT.)W8#&ERHT(TE`(?9_E=I$U*66..JAA@
M^G`3YV]42DNQ'H"KVP4NM2FOD9L."$V*O!<[1/BN0AQH*,PV:#V9F7&#S63O
M1=_RIF]](Z_0KNQPW_JZ(_PB+_Q$S&]:*C46DO'SMTWZLEN-QD1\%[<$-(-F
MJ<ZI_\3T!#U8D5-]H](R9X=V/&RTRABK5`V;F=@%1*8-FE?3V:A=%)2N7M0A
MI^BJT[QN550V:A9=$)9U2'#!"R2(^1FHU=&JZ#1M]K!2.QZI0=W;'V*Z#]4T
MC#Z,1#!=]TOYYTG!"60M,\RMP++VU7+Z/L!;0O7ZI\B@N347R_#<2IU6MMC*
M!)X\G<-[[H:/VI"O8XR16MV?S"';^#M&'))(XNO+KI*SE.4TMLU.9IMEA-@(
MLABUR8%RIGY]N;@)%]-:UZPGF`=ZZ\K"Q\F%P/SSI.AQQ6\L^S/[-^9L2+':
MG)M-_S)+W+5H;7-`(V=BF"(4Y_,7(M));S'%=I'"(X'Z558#[N^IUD#;NURQ
MF,8VH,9X1H2:6_`&A*N#J=%6FK035E'9IY4+HP3B$V3V?4*,4S_BRSCT60-,
M60`-"+[]+/1$POI\_7"J<C-744%\E]A+7F:93?!>N1++,H8KQ*F*.*E[[XLS
MWUJDEJE7=-GA!O5JD5JFGEHG4X'I"?FFCX=`*52.-IS>,8J79DO@=4@]<8=D
MR"&"F667Y%Z[+1GLN/]MO[=P!>"Y$%B*"RR?,:9_)]!ZN3M?WJH1F]`!'**<
M.`]4.IL#OU%9:^:O:FP_6(!\T4\=YR\9+!KDUJ.WK$$4_@9$<7NO16J9>F4_
MBK!QNJ)V"<N4O57[^%3>'^N2>&!?\E]BZ*)9AQJTEL%1]8,<=3S.\AF#7[&0
M@>J(,$\GR@4O;,N-+SACP91@WTN+GG]NF^2K!2'5M%5R#=SNF33'&!*Y2C6=
M?5%!38^K]?T[XH,+09<Z,FO@0FU].E\L.'M"JRF;FL0[SCKJ)UY-5\8IDW/,
M&YF@69GW8HD[0DD0!N"FKEH9F*FM'VR)?+D</OID%CN9MD`]VJ@-FV,]BO!M
MW?P.O=17L!:M90INEE;MT@#O_)EZ:NI4##F906R*#]GEEL)WP,@RTQ0Y+*)K
M_52_/T?R$M$+?!$N!^RYU-<KB]JF?H$[UU5_FZ*VJ9^)T(,PTVN7$%C876_>
MLK%I4JQ!"<L2^@T[<N_5&5*S6['BY%"*TIJYD%I[>5:;T7TF\`"";QK/@M<I
M9X4G5CEJ]8I,!:GE2S,;I2]:HZDDMFT`-.+D27D4?<+F3-0-'860%+BY-:?,
MXG7C<K9I?NDC(58G/X9<WTD0GPC1)]FC,_S)/E(U2D#W@G@1172B)'V.]A4X
M[[+KW<%1^A(-%4,80Q&#3V;*OW$Y^_KI#%#)`%[XRJ[@G3[@,8KNH?`NEL/I
M%$1.M.\JNE38;GM&J+U+FNA3O-9<_,ZV@&36P?5:[^6<X.GJXI#(Y)D+^FI2
MVZ:EN5#A/''0N_QJBGK4MFF9C.P3)I$?;XDR\3QU0<YDCJE)<`'+82A52_#`
M3V])0.20KH]I#9\IYF).%D4#^M>HQ:Y.YX:JY%`0-SJ0?06Z>AXN/,=VC=6*
M\2HP;U7TO8PJ"CM5L>Y*53=TA8!CXCZ&9F62EIC]"R-^Q]2M5V_<#5=K<`O_
M-],Y+O'6&G_K"G>.`P0?_Q]02P$"'@,4````"`",BZU$.,?[TVJU``#",`P`
M$0`8```````!````I($`````86)I;RTR,#$T,#,S,2YX;6Q55`4``WB.<E-U
M>`L``00E#@``!#D!``!02P$"'@,4````"`",BZU$MH02NF(,``!]I```%0`8
M```````!````I(&UM0``86)I;RTR,#$T,#,S,5]C86PN>&UL550%``-XCG)3
M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`C(NM1,-+@6T[-```*]0#`!4`
M&````````0```*2!9L(``&%B:6\M,C`Q-#`S,S%?9&5F+GAM;%54!0`#>(YR
M4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(R+K43IADK_A5X``+!V!0`5
M`!@```````$```"D@?#V``!A8FEO+3(P,30P,S,Q7VQA8BYX;6Q55`4``WB.
M<E-U>`L``00E#@``!#D!``!02P$"'@,4````"`",BZU$.7-'N=(V``#^>`0`
M%0`8```````!````I('$50$`86)I;RTR,#$T,#,S,5]P<F4N>&UL550%``-X
MCG)3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`C(NM1`^$8UTR$0``\[4`
M`!$`&````````0```*2!Y8P!`&%B:6\M,C`Q-#`S,S$N>'-D550%``-XCG)3
E=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``&*>`0``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Merger with Nuvelo, Inc. on January 27, 2009 (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jan. 27, 2009</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Estimated total acquisition consideration</a></td>
        <td class="nump">$ 11,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired in the Merger</a></td>
        <td class="nump">37,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Net assets acquired, including cash, cash equivalents and marketable securities</a></td>
        <td class="nump">45,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Gain on bargain purchase</a></td>
        <td class="nump">$ 25,300,000<span></span></td>
        <td class="nump">$ 25,282,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (f)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 30<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 30<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 25<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 25<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 30<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 30<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4845-128472<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4845-128472<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 37<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25498275&amp;loc=d3e2207-128464<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(2) Net Loss Per Share </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company calculates basic earnings per share by dividing loss attributable to common stockholders by the weighted average common shares outstanding during the period, excluding common stock subject to vesting provisions.  Diluted earnings per share is computed by dividing loss attributable to common stockholders by the weighted average number of common shares outstanding during the period increased to include, if dilutive, the number of additional common shares that would have been outstanding if the potential common shares had been issued. The Company&#8217;s potentially dilutive shares include stock options and warrants for common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the numerator and denominator used in the calculation of basic and diluted loss per share follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except shares and per share data)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss available to common shareholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares of common stock outstanding</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,037,546</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Weighted-average shares of unvested common stock</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,783</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total weighted-average shares used in computing net loss</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; per share attributed to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,034,763</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted loss per share</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.13</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potentially dilutive securities representing&#160;10.2 million and 1.3&#160;million weighted average shares of common stock were excluded for the three months ended March&#160;31, 2014 and 2013, respectively, because including them would have an anti-dilutive effect on net loss per share. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B
M83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?;V9?4')E/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A
M=&5D7U-T871E;65N='-?;V9?4')E,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-BYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-A
M<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E1H95]#
M;VUP86YY7V%N9%]3=6UM87)Y7V]F7U-I9SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/DYE=%],;W-S7U!E<E]3:&%R93PO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DUE<F=E<E]W:71H7TYU
M=F5L;U]);F-?;VY?2F%N=3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,"YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/D9A:7)?5F%L=65?1&ES8VQO<W5R97,\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,3$N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y0<F]P97)T>5]A;F1?17%U:7!M
M96YT/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M
M;6ET;65N='-?86YD7T-O;G1I;F=E;F-I97,\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y%<75I='E?1FEN86YC:6YG<U]A;F1?5V%R
M<F%N=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3
M:&%R95]B87-E9%]#;VUP96YS871I;VX\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y);F-O;65?5&%X97,\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,38N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y4:&5?0V]M<&%N>5]A;F1?4W5M;6%R
M>5]O9E]3:6<Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^3F5T7TQO<W-?4&5R7U-H87)E7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q."YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/E!R;W!E<G1Y7V%N9%]%<75I<&UE;G1?
M5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M0V]M;6ET;65N='-?86YD7T-O;G1I;F=E;F-I97-?/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(P
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4VAA<F5B87-E9%]#;VUP96YS871I
M;VY?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^5&AE7T-O;7!A;GE?86YD7U-U;6UA<GE?;V9?4VEG,CPO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970R,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYE=%],;W-S7U!E<E]3:&%R
M95]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(S+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^3F5T7TQO<W-?4&5R7U-H87)E7T1E=&%I;'-?5&5X/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#(T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^365R9V5R7W=I=&A?3G5V96QO
M7TEN8U]O;E]*86YU,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D9A:7)?5F%L=65?1&ES8VQO<W5R97-?1&5T86EL<SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970R-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E!R;W!E<G1Y7V%N9%]%
M<75I<&UE;G1?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-RYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/E!R;W!E<G1Y7V%N9%]%<75I<&UE;G1?1&5T86EL<S$\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,C@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VUM:71M96YT
M<U]A;F1?0V]N=&EN9V5N8VEE<U\Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(Y+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^0V]M;6ET;65N='-?86YD7T-O;G1I;F=E;F-I97-?
M,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970S,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D5Q=6ET
M>5]&:6YA;F-I;F=S7V%N9%]787)R86YT<S$\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S$N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y3:&%R96)A<V5D7T-O;7!E;G-A=&EO;E]$
M971A:6P\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,S(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3
M:&%R96)A<V5D7T-O;7!E;G-A=&EO;E]$971A:6PQ/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,S
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4VAA<F5B87-E9%]#;VUP96YS871I
M;VY?1&5T86EL,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-"YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@(#PO>#I%>&-E;%=O<FMS:&5E=',^#0H@(#QX.E-T
M>6QE<VAE970@2%)E9CTS1")7;W)K<VAE971S+W)E<&]R="YC<W,B+SX-"B`@
M/'@Z06-T:79E4VAE970^,#PO>#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C
M=%-T<G5C='5R93Y&86QS93PO>#I0<F]T96-T4W1R=6-T=7)E/@T*("`\>#I0
M<F]T96-T5VEN9&]W<SY&86QS93PO>#I0<F]T96-T5VEN9&]W<SX-"B`\+W@Z
M17AC96Q7;W)K8F]O:SX-"CPO>&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*
M("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I
M=&@@36EC<F]S;V9T($5X8V5L(%A0(&]R(&YE=V5R+CPO<#X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T83A?
M-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34O
M5V]R:W-H965T<R]3:&5E=#`Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,D%!13X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y($EN9F]R;6%T
M:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#`Y+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D1O8W5M96YT($EN9F]R;6%T:6]N(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!2
M96=I<W1R86YT($YA;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B=!4D-!($)I;W!H87)M82P@26YC+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X
M($ME>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S`P,#`Y,#<V
M-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$;V-U;65N="!4>7!E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG,3`M43QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%M96YD;65N="!&;&%G/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!097)I;V0@16YD($1A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DUA<B`S,2P-"@D)
M,C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@1F]C=7,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B=1,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!9
M96%R($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-U<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<M+3$R+3,Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($9I;&5R($-A
M=&5G;W)Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG4VUA;&QE
M<B!297!O<G1I;F<@0V]M<&%N>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM;VX@4W1O8VLL(%-H
M87)E<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(Q+#`Q,"PX,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y
M-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X
M7S1F.3)?838T,%]B83DR83`W-#AD.34O5V]R:W-H965T<R]3:&5E=#`R+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%4#%!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYS
M;VQI9&%T960@0F%L86YC92!3:&5E=',@*%531"`D*3QB<CY);B!4:&]U<V%N
M9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E
M;G0@87-S971S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C$L,C`R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-BPW-38\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R
M(&-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y4;W1A;"!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C$L.#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38L.3(U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@
M97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]T:&5R(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.#(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@87-S971S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,BPV-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPP.#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R<F5N="!L
M:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@8V]M<&5N<V%T:6]N(&%N
M9"!E;7!L;WEE92!B96YE9FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-R=65D(&5X<&5N<V5S(&%N9"!O=&AE<B!L:6%B
M:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$969E<G)E9"!R96YT+"!C=7)R96YT('!O<G1I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PQ,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@<F5N="P@;F5T
M(&]F(&-U<G)E;G0@<&]R=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y4;W1A;"!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PQ,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N=',@86YD(&-O
M;G1I;F=E;F-I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R
M<^*`F2!E<75I='DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4V5R:65S($$@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T
M;V-K+"`D,"XP,#$@<&%R('9A;'5E.R`Q,S4L,#`P('-H87)E<R!A=71H;W)I
M>F5D+"!N;R!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!A="!-87)C
M:"`S,2P@,C`Q-"!A;F0@1&5C96UB97(@,S$L(#(P,3,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VUM;VX@<W1O8VLL("0P+C`P,2!P87(@=F%L=64[(#$P,"!M:6QL:6]N
M('-H87)E<R!A=71H;W)I>F5D(&%T($UA<F-H(#,Q+"`R,#$T(&%N9"!$96-E
M;6)E<B`S,2P@,C`Q,SL@,C$L,#`Q+#8Y,"!A;F0@,34L-C@U+#4V,B!S:&%R
M97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!A="!-87)C:"`S,2P@,C`Q-"!A
M;F0@1&5C96UB97(@,S$L(#(P,3,L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN
M(&-A<&ET86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDX+#@S
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDP+#0Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&5F:6-I="!A8V-U;75L871E9"!D=7)I;F<@=&AE(&1E=F5L
M;W!M96YT('-T86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W
M-RPS,C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-S0L.3,S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L('-T;V-K:&]L9&5R<^*`F2!E<75I='D\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q+#4S-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#4X,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(&QI86)I;&ET:65S(&%N9"!S=&]C:VAO;&1E<G/B@)D@97%U:71Y
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(R+#8U-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3<L
M,#@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B
M-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?
M8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE970P,RYH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14--04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0V]N<V]L:61A=&5D($)A
M;&%N8V4@4VAE971S("A087)E;G1H971I8V%L*2`H55-$("0I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N
M=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!P87(@=F%L=64\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T
M:6)L92!P<F5F97)R960@<W1O8VLL('-H87)E<R!A=71H;W)I>F5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S4L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,U+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N
M=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!I<W-U960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!P<F5F97)R960@
M<W1O8VLL(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P87(@=F%L=64\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O
M8VLL('-H87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL
M('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(Q+#`P,2PV.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-2PV.#4L-38R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!O
M=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L
M,#`Q+#8Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$U+#8X-2PU-C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T
M.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C
M-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34O5V]R:W-H965T<R]3:&5E=#`T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%0DQ!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!/<&5R871I;VYS(&%N9"!#;VUP
M<F5H96YS:79E($QO<W,@*%531"`D*3QB<CY);B!4:&]U<V%N9',L(&5X8V5P
M="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,30W($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@
M,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#;W-T<R!A;F0@97AP96YS97,Z/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D
M979E;&]P;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M+#,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,3@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`T-BPY,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-E;&QI;F<L(&=E;F5R86P@86YD(&%D;6EN
M:7-T<F%T:79E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`X
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C@X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0W+#8W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^365R9V5R('1R86YS86-T:6]N(&-O<W1S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-#<P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<G5C='5R:6YG
M(&5X<&5N<V4L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+#0Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&]S<R!O;B!I;7!A:7)M96YT(&]F(&EN+7!R;V-E<W,@<F5S
M96%R8V@@86YD(&1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&]T86P@8V]S=',@86YD(&5X<&5N<V5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,Y,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#<P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`X+#0W
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQO<W,@9G)O;2!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R+#,Y,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q+#`W,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,#@L-#<S*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V%I;B!O;B!A<W-I
M9VYM96YT(&]F('!A=&5N="!R:6=H=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D=A:6X@;VX@8F%R9V%I;B!P=7)C:&%S93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PR.#(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R
M97-T(&%N9"!O=&AE<B!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPP,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&%N9"!O=&AE<B!E>'!E;G-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#0W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@
M8F5F;W)E(&EN8V]M92!T87AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,BPS.#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,2PP-S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-SDL-C`S*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5N969I="!F<F]M(&EN8V]M
M92!T87AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#(X
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!L;W-S(&%N9"!C;VUP<F5H96YS:79E(&QO<W,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,S@Y*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,#<Q*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<W+#,R,BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE
M<W,Z($%C8W)E=&EO;B!O9B!R961E96UA8FQE(&-O;G9E<G1I8FQE('!R969E
M<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M-#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y,97-S.B!$965M960@<')E9F5R<F5D('-T;V-K(&1I=FED96YD/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L.#`W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L
M;W-S(&%V86EL86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(L,S@Y*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,2PP-S$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@X,"PS
M-S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/DYE="!L;W-S(&%V86EL86)L92!T;R!C;VUM;VX@<W1O
M8VMH;VQD97)S('!E<B!S:&%R93H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD(&1I;'5T960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XQ,RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,S4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY796EG:'1E9"!A=F5R86=E('-H87)E<R!O=71S=&%N9&EN9SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S
M:6,@86YD(&1I;'5T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$X+#<X-2PT,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#`S-"PW-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE
M970P-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P15).05,^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O
M;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@4')E9F5R<F5D(%-T;V-K
M(&%N9"!3=&]C:VAO;&1E<G,G($5Q=6ET>2`H1&5F:6-I="D@*%531"`D*3QB
M<CY);B!4:&]U<V%N9',L(&5X8V5P="!3:&%R92!D871A/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^5&]T86P\8G(^55-$("@D*3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397)I97,@02!#;VYV
M97)T:6)L92!0<F5F97)R960@4W1O8VL\8G(^55-$("@D*3QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y#;VUM;VX@4W1O8VL\8G(^55-$("@D
M*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!9&1I=&EO;F%L
M(%!A:60M:6X@0V%P:71A;#QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E9FEC:70@06-C=6UU;&%T960@1'5R:6YG($1E
M=F5L;W!M96YT(%-T86=E/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^27-S=6%N8V4@9F]R($YO=&5S(%!A>6%B;&4@86YD
M(%)E;&%T960@06-C<G5E9"!);G1E<F5S="!O;B!*86YU87)Y(#,L(#(P,#4\
M8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y)
M<W-U86YC92!F;W(@3F]T97,@4&%Y86)L92!A;F0@4F5L871E9"!!8V-R=65D
M($EN=&5R97-T(&]N($IA;G5A<GD@,RP@,C`P-3QB<CY#;VUM;VX@4W1O8VL\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^27-S=6%N8V4@9F]R
M($YO=&5S(%!A>6%B;&4@86YD(%)E;&%T960@06-C<G5E9"!);G1E<F5S="!O
M;B!*86YU87)Y(#,L(#(P,#4\8G(^061D:71I;VYA;"!086ED+6EN($-A<&ET
M86P\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y)<W-U86YC92!F;W(@26YT96QL96-T=6%L(%!R;W!E<G1Y($QI8V5N<V4@
M4FEG:'1S(&]N($]C=&]B97(@,30L(#(P,#4\8G(^55-$("@D*3QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y)<W-U86YC92!F;W(@26YT96QL
M96-T=6%L(%!R;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($]C=&]B97(@,30L
M(#(P,#4\8G(^0V]M;6]N(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U86P@4')O<&5R='D@
M3&EC96YS92!2:6=H=',@;VX@3V-T;V)E<B`Q-"P@,C`P-3QB<CY!9&1I=&EO
M;F%L(%!A:60M:6X@0V%P:71A;#QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O<B!.;W1E<R!087EA8FQE
M(&%N9"!296QA=&5D($%C8W)U960@26YT97)E<W0@;VX@3V-T;V)E<B`Q-"P@
M,C`P-3QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DES<W5A;F-E(&9O<B!.;W1E<R!087EA8FQE(&%N9"!296QA=&5D($%C
M8W)U960@26YT97)E<W0@;VX@3V-T;V)E<B`Q-"P@,C`P-3QB<CY#;VUM;VX@
M4W1O8VL\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^27-S=6%N
M8V4@9F]R($YO=&5S(%!A>6%B;&4@86YD(%)E;&%T960@06-C<G5E9"!);G1E
M<F5S="!O;B!/8W1O8F5R(#$T+"`R,#`U/&)R/D%D9&ET:6]N86P@4&%I9"UI
M;B!#87!I=&%L/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A;"!0<F]P97)T>2!,
M:6-E;G-E(%)I9VAT<R!O;B!&96)R=6%R>2`R,2P@,C`P-CQB<CY54T0@*"0I
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O
M<B!);G1E;&QE8W1U86P@4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@1F5B
M<G5A<GD@,C$L(#(P,#8\8G(^0V]M;6]N(%-T;V-K/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U86P@
M4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@1F5B<G5A<GD@,C$L(#(P,#8\
M8G(^061D:71I;VYA;"!086ED+6EN($-A<&ET86P\8G(^55-$("@D*3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y)<W-U86YC92!F;W(@26YT
M96QL96-T=6%L(%!R;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($9E8G)U87)Y
M(#(R+"`R,#`V/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A;"!0<F]P97)T>2!,
M:6-E;G-E(%)I9VAT<R!O;B!&96)R=6%R>2`R,BP@,C`P-CQB<CY#;VUM;VX@
M4W1O8VL\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^27-S=6%N
M8V4@9F]R($EN=&5L;&5C='5A;"!0<F]P97)T>2!,:6-E;G-E(%)I9VAT<R!O
M;B!&96)R=6%R>2`R,BP@,C`P-CQB<CY!9&1I=&EO;F%L(%!A:60M:6X@0V%P
M:71A;#QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U86P@4')O<&5R='D@3&EC96YS
M92!2:6=H=',@;VX@2G5N92`R,RP@,C`P-CQB<CY54T0@*"0I/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE
M8W1U86P@4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@2G5N92`R,RP@,C`P
M-CQB<CY#;VUM;VX@4W1O8VL\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A;"!0<F]P97)T>2!,:6-E
M;G-E(%)I9VAT<R!O;B!*=6YE(#(S+"`R,#`V/&)R/D%D9&ET:6]N86P@4&%I
M9"UI;B!#87!I=&%L/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A;"!0<F]P97)T
M>2!,:6-E;G-E(%)I9VAT<R!O;B!.;W9E;6)E<B`W+"`R,#`V/&)R/D-O;6UO
M;B!3=&]C:SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!8V-R
M971I;VX@;V8@4V5R:65S($$\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y!8V-R971I;VX@;V8@4V5R:65S($$\8G(^061D
M:71I;VYA;"!086ED+6EN($-A<&ET86P\8G(^55-$("@D*3QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!8V-R971I;VX@;V8@4V5R:65S($(\
M8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!
M8V-R971I;VX@;V8@4V5R:65S($(\8G(^061D:71I;VYA;"!086ED+6EN($-A
M<&ET86P\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y)<W-U86YC92!F;W(@26YT96QL96-T=6%L(%!R;W!E<G1Y($QI8V5N
M<V4@4FEG:'1S(&]N($IA;G5A<GD@,3@L(#(P,#<\8G(^55-$("@D*3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y)<W-U86YC92!F;W(@26YT
M96QL96-T=6%L(%!R;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($IA;G5A<GD@
M,3@L(#(P,#<\8G(^0V]M;6]N(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U86P@4')O<&5R
M='D@3&EC96YS92!2:6=H=',@;VX@2F%N=6%R>2`Q."P@,C`P-SQB<CY!9&1I
M=&EO;F%L(%!A:60M:6X@0V%P:71A;#QB<CY54T0@*"0I/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U
M86P@4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@2G5N92`S,"P@,C`P-SQB
M<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DES
M<W5A;F-E(&9O<B!);G1E;&QE8W1U86P@4')O<&5R='D@3&EC96YS92!2:6=H
M=',@;VX@2G5N92`S,"P@,C`P-SQB<CY#;VUM;VX@4W1O8VL\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^27-S=6%N8V4@9F]R($EN=&5L;&5C
M='5A;"!0<F]P97)T>2!,:6-E;G-E(%)I9VAT<R!O;B!*=6YE(#,P+"`R,#`W
M/&)R/D%D9&ET:6]N86P@4&%I9"UI;B!#87!I=&%L/&)R/E531"`H)"D\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^27-S=6%N8V4@;V8@0V]M
M;6]N(%-T;V-K(&9O<B!#;VUM97)C:6%L($QI8V5N<V4@4FEG:'1S+"!O;B!*
M=6QY(#$Y+"`R,#`W/&)R/D-O;6UO;B!3=&]C:SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y)<W-U86YC92!O9B!3:&%R97,@=&\@17AE8W5T
M:79E(%-U8FIE8W0@=&\@4F5P=7)C:&%S93QB<CY#;VUM;VX@4W1O8VL\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^0V]M;6]N($-O;G9E<G-I
M;VX\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y#;VUM;VX@0V]N=F5R<VEO;CQB<CY#;VUM;VX@4W1O8VL\8G(^55-$("@D
M*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y#;VUM;VX@0V]N
M=F5R<VEO;CQB<CY!9&1I=&EO;F%L(%!A:60M:6X@0V%P:71A;#QB<CY54T0@
M*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DYO=&5S(&%N
M9"!296QA=&5D($%C8W)U960@26YT97)E<W0\8G(^0V]M;6]N(%-T;V-K/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D-A<V@L($YE="!O9B!/
M9F9E<FEN9R!#;W-T<SQB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D-A<V@L($YE="!O9B!/9F9E<FEN9R!#;W-T<SQB<CY3
M97)I97,@02!#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL\8G(^55-$("@D
M*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y#87-H+"!.970@
M;V8@3V9F97)I;F<@0V]S=',\8G(^0V]M;6]N(%-T;V-K/&)R/E531"`H)"D\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^0V%S:"P@3F5T(&]F
M($]F9F5R:6YG($-O<W1S/&)R/D%D9&ET:6]N86P@4&%I9"UI;B!#87!I=&%L
M/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M0V%S:"P@3F5T(&]F($]F9F5R:6YG($-O<W1S/&)R/D1E9FEC:70@06-C=6UU
M;&%T960@1'5R:6YG($1E=F5L;W!M96YT(%-T86=E/&)R/E531"`H)"D\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($$\8G(^55-$
M("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397)I97,@
M03QB<CY397)I97,@02!O9F9E<FEN9R!C;W-T<SQB<CY54T0@*"0I/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<FEE<R!!/&)R/DES<W5A
M;F-E(&]F(%-E<FEE<R!!(&]N($9E8G)U87)Y(#(R+"`R,#`V/&)R/E531"`H
M)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($$\
M8G(^5&AI<F0@27-S=6%N8V4@1F]R($YO=&5S(%!A>6%B;&4@06YD(%)E;&%T
M960@06-C<G5E9"!);G1E<F5S=#QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<FEE<R!!/&)R/E)E9&5E;6%B;&4@0V]N
M=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K/&)R/E531"`H)"D\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($$\8G(^06-C<F5T:6]N
M(&]F(%-E<FEE<R!!/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5R:65S($$\8G(^0V]M;6]N($-O;G9E<G-I;VX\8G(^
M55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397)I
M97,@03QB<CY#87-H+"!.970@;V8@3V9F97)I;F<@0V]S=',\8G(^55-$("@D
M*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397)I97,@0CQB
M<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E
M<FEE<R!"/&)R/E1H:7)D($ES<W5A;F-E($]F(%-E<FEE<R!"($-O;G9E<G1I
M8FQE(%)E9&5E;6%B;&4@4')E9F5R<F5D(%-T;V-K/&)R/E531"`H)"D\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($(\8G(^27-S
M=6%N8V4@9F]R(%-E<FEE<R!"(&]N($1E8V5M8F5R(#(X+"`R,#`W/&)R/E53
M1"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S
M($(\8G(^06-C<F5T:6]N(&]F(%-E<FEE<R!"/&)R/E531"`H)"D\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($(\8G(^0V]M;6]N
M($-O;G9E<G-I;VX\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397)I97,@0CQB<CY#87-H+"!.970@;V8@3V9F97)I;F<@
M0V]S=',\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F5G:6YN:6YG($)A;&%N8V4L('9A;'5E(&%T($1E8RX@,3<L
M(#(P,#$\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y"96=I;FYI;F<@0F%L86YC92P@<VAA<F5S(&%T($1E8RX@,3<L(#(P,#$\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U
M86YC92!O9B!E<75I='D@9F]R(&-A<V@@;W(@:6YT96QL96-T=6%L('!R;W!E
M<G1Y(')I9VAT<RP@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!E<75I='D@9F]R(&-A
M<V@@;W(@:6YT96QL96-T=6%L('!R;W!E<G1Y(')I9VAT<RP@<VAA<F5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3@X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M,38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3$V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L('9A;'5E(&%T
M($1E8RX@,S$L(#(P,#,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$Q-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q,38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@<VAA<F5S
M(&%T($1E8RX@,S$L(#(P,#,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPU.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@97%U:71Y(&9O
M<B!C87-H(&]R(&EN=&5L;&5C='5A;"!P<F]P97)T>2!R:6=H=',L('9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^27-S=6%N8V4@;V8@97%U:71Y(&9O<B!C87-H(&]R(&EN=&5L;&5C='5A
M;"!P<F]P97)T>2!R:6=H=',L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ.2PW,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4Q,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,3$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;F1I;F<@0F%L86YC92P@=F%L=64@870@1&5C+B`S,2P@,C`P-#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C$Y*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8R-RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!S:&%R97,@870@1&5C+B`S,2P@,C`P
M-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPS,#@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^27-S=6%N8V4@;V8@97%U:71Y(&9O<B!C87-H(&]R(&EN=&5L
M;&5C='5A;"!P<F]P97)T>2!R:6=H=',L('9A;'5E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-30\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(&5Q=6ET>2!F;W(@8V%S:"!O<B!I;G1E;&QE8W1U86P@<')O
M<&5R='D@<FEG:'1S+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPY,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#DW.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3`S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2PP.34\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PT-3DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PT
M-3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@=F%L=64@870@1&5C+B`S
M,2P@,C`P-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C<X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PT,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@R+#`X-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!S:&%R97,@
M870@1&5C+B`S,2P@,C`P-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV,"PR,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@97%U:71Y(&9O
M<B!C87-H(&]R(&EN=&5L;&5C='5A;"!P<F]P97)T>2!R:6=H=',L('9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL,S$V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!E<75I='D@9F]R(&-A<V@@
M;W(@:6YT96QL96-T=6%L('!R;W!E<G1Y(')I9VAT<RP@<VAA<F5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPS
M-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$S+#DP-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPU,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M-S(W+#,U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS+#`W-"PP.#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D(&-O;7!E
M;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#4L,C0Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#4L,C0Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3V9F97)I;F<@0V]S
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3<I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DX*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^27-S=6%N8V4@;V8@<')E9F5R<F5D('-T;V-K('5P;VX@
M8V]N=F5R<VEO;B!O9B!N;W1E('!A>6%B;&4@86YD(&%C8W)U960@:6YT97)E
M<W0L('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!P<F5F97)R960@<W1O8VL@=7!O
M;B!C;VYV97)S:6]N(&]F(&YO=&4@<&%Y86)L92!A;F0@86-C<G5E9"!I;G1E
M<F5S="P@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT,C`L.#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P;VX@97AE<F-I<V4@
M;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('-H87)E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#`Q.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I
M;F<@0F%L86YC92P@=F%L=64@870@1&5C+B`S,2P@,C`P-CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-2PW-#0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4X,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<L,S(W*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY,3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@<VAA<F5S(&%T($1E8RX@,S$L
M(#(P,#8\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`R+#`T
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL
M,C(R+#(U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&5Q=6ET>2!F;W(@
M8V%S:"!O<B!I;G1E;&QE8W1U86P@<')O<&5R='D@<FEG:'1S+"!V86QU93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!E<75I='D@9F]R(&-A<V@@;W(@:6YT
M96QL96-T=6%L('!R;W!E<G1Y(')I9VAT<RP@<VAA<F5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,S`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPW.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPY,34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#8X."PY,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#<V-BPV-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D(&-O;7!E;G-A=&EO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$S+#DY-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,RPY.30I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9E<FEN9R!#;W-T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q-#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@=7!O;B!E
M>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS+"!F;W(@8V%S:"P@=F%L=64\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E(&]F('-T
M;V-K(&]P=&EO;G,L(&9O<B!C87-H+"!S:&%R97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BPR,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A
M;&%N8V4L('9A;'5E(&%T($1E8RX@,S$L(#(P,#<\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$Y+#8X.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-C,R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C$L,S(Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY,S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3<L.#<Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!S:&%R97,@870@1&5C+B`S
M,2P@,C`P-SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C(L
M.3$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.2PR,C(L,C4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8L-#4U+#4W.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!C
M;VUP96YS871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4T
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-30U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$Y+#0S,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.2PT,S$I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9E
M<FEN9R!#;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S8I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S8I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O
M8VL@=7!O;B!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS+"!F;W(@8V%S:"P@
M=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C
M:7-E(&]F('-T;V-K(&]P=&EO;G,L(&9O<B!C87-H+"!S:&%R97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8L,34T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5S=&EM871E9"!F86ER('9A;'5E(&]F('=A<G)A;G1S(&ES<W5E9"!I;B!C
M;VYN96-T:6]N('=I=&@@8V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDY/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.3D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%;F1I;F<@0F%L86YC92P@=F%L=64@870@1&5C+B`S,2P@,C`P.#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S@L,3<X*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU-S0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T,"PW
M-3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T
M+#DU.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-RPY,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L('-H87)E
M<R!A="!$96,N(#,Q+"`R,#`X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$U.2PP-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY+#(R,BPR-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPT-34L-3<Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D
M:G5S=&UE;G0@9F]R(&9R86-T:6]N86P@<VAA<F5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$P,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E96UE9"!P
M<F5F97)R960@<W1O8VL@9&EV:61E;F0@9F]R(&%D9&ET:6]N86P@8V]M;6]N
M('-H87)E<R!I<W-U86)L92!U;F1E<B!A;G1I+61I;'5T:6]N('!R;W9I<VEO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S@Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S@Q*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!C;VYV97)T:6)L92!S96-U<FET
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,RPW.#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,L-S@P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,34L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3@L-S@Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E<G-I;VX@;V8@8V]N
M=F5R=&EB;&4@;F]T97,L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,30U+#0V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUE<F=E<B!W:71H($YU
M=F5L;RP@26YC+BP@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$Q+#DQ,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3$L.3$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^365R9V5R('=I=&@@3G5V
M96QO+"!);F,N+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#0W+#@R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@
M<W1O8VL@=6YD97(@96UP;&]Y964@<W1O8VL@<'5R8VAA<V4@<&QA;B!A;F0@
M=7!O;B!V97-T:6YG(&]F(')E<W1R:6-T960@<W1O8VL@=6YI=',L('9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5N9&5R(&5M<&QO>65E('-T
M;V-K('!U<F-H87-E('!L86X@86YD('5P;VX@=F5S=&EN9R!O9B!R97-T<FEC
M=&5D('-T;V-K('5N:71S+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D(&-O;7!E
M;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#0U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#DL,3,X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#DL,3,X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3V9F97)I;F<@0V]S
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#0R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#DS*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#DS*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P;VX@
M97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('9A;'5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,30\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E(&]F
M('-T;V-K(&]P=&EO;G,L(&9O<B!C87-H+"!S:&%R97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-3(Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E
M<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K+"!S:&%R97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-3`W+#$R,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DL,C(R+#(U-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BPT
M-34L-3<Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K(')E;&5A<V4@9G)O;2!R
M97-T<FEC=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!C;VYV97)T:6)L92!N;W1E
M<R!A;F0@<F5L871E9"!A8V-R=65D(&EN=&5R97-T/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX+#4P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PU,#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV
M97)S:6]N(&]F('=A<G)A;G1S(&9O<B!P<F5F97)R960@<W1O8VL\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S
M=&EM871E9"!F86ER('9A;'5E(&]F('=A<G)A;G1S(&ES<W5E9"!I;B!C;VYN
M96-T:6]N('=I=&@@;&5A<V4@=&5R;6EN871I;VX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S<W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A
M;&%N8V4L('9A;'5E(&%T($1E8RX@,S$L(#(P,#D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<L-#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-RPS,#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T.2PX.3`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%;F1I;F<@0F%L86YC92P@<VAA<F5S(&%T($1E8RX@,S$L(#(P,#D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR-S`L,#<T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES<W5A;F-E(&]F(&5Q=6ET>2!F;W(@8V%S:"!O<B!I;G1E;&QE
M8W1U86P@<')O<&5R='D@<FEG:'1S+"!V86QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<L,3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW+#$X,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N
M8V4@;V8@97%U:71Y(&9O<B!C87-H(&]R(&EN=&5L;&5C='5A;"!P<F]P97)T
M>2!R:6=H=',L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3DT+#$P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D(&-O;7!E;G-A
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-3@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH."PT,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH."PT,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C
M;VUM;VX@<W1O8VL@=7!O;B!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS+"!F
M;W(@8V%S:"P@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('-H
M87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#(T.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@=F%L=64@870@1&5C+B`S,2P@
M,C`Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPW-S$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U
M+#`X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#4X+#,Q,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!S:&%R97,@
M870@1&5C+B`S,2P@,C`Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#0W,BPT,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@97%U:71Y
M(&9O<B!C87-H(&]R(&EN=&5L;&5C='5A;"!P<F]P97)T>2!R:6=H=',L('9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP,3<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,#$V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!E<75I='D@9F]R(&-A<V@@;W(@
M:6YT96QL96-T=6%L('!R;W!E<G1Y(')I9VAT<RP@<VAA<F5S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU-3<L.#DP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#,V-"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#,V-"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E
M(&]F('-T;V-K(&]P=&EO;G,L(&9O<B!C87-H+"!V86QU93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O
M;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E(&]F('-T;V-K(&]P=&EO;G,L(&9O
M<B!C87-H+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!V86QU92!A="!$
M96,N(#,Q+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M+#<S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-CDL-#`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-C,L-C<T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L
M('-H87)E<R!A="!$96,N(#,Q+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,#,P+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O
M9B!E<75I='D@9F]R(&-A<V@@;W(@:6YT96QL96-T=6%L('!R;W!E<G1Y(')I
M9VAT<RP@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,3@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#$X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&5Q=6ET>2!F;W(@
M8V%S:"!O<B!I;G1E;&QE8W1U86P@<')O<&5R='D@<FEG:'1S+"!S:&%R97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R.2PX,34\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3:&%R92UB87-E9"!C;VUP96YS871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO
M<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,S(P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L
M,S(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P;VX@
M97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('9A;'5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG
M($)A;&%N8V4L('9A;'5E(&%T($1E8RX@,S$L(#(P,3(\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L.3`W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,"PX.3@\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-RPY.30I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;F1I;F<@0F%L86YC92P@<VAA<F5S(&%T($1E8RX@,S$L(#(P,3(\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV-C`L,S$U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%D:G5S=&UE;G0@9F]R(&9R86-T:6]N86P@<VAA<F5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-C0I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VYV97)S:6]N(&]F(&-O;G9E<G1I8FQE('-E8W5R:71I97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DES<W5A;F-E(&]F(&5Q=6ET>2!F;W(@8V%S:"!O<B!I;G1E;&QE8W1U86P@
M<')O<&5R='D@<FEG:'1S+"!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L-#(Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#0R,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@
M97%U:71Y(&9O<B!C87-H(&]R(&EN=&5L;&5C='5A;"!P<F]P97)T>2!R:6=H
M=',L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3(Q+#`V
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C@S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.#,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M-BPY,SDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-BPY,SDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N(&]F('!R969E
M<G)E9"!S=&]C:RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3(U+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E
M(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E(&]F('=A<G)A;G1S(&9O
M<B!C87-H+"!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P
M;VX@97AE<F-I<V4@;V8@=V%R<F%N=',@9F]R(&-A<V@L('-H87)E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,C0U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DES<W5A;F-E(&]F(%-E<FEE<R!!(&-O;G9E<G1I8FQE('!R969E<G)E9"!S
M=&]C:RP@;F5T(&]F(&]F9F5R:6YG(&-O<W1S+"!3:&%R97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#DQ-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R-2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L.3$W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^27-S=6%N8V4@;V8@4V5R:65S($$@8V]N=F5R=&EB;&4@<')E
M9F5R<F5D('-T;V-K+"!N970@;V8@;V9F97)I;F<@8V]S=',L(%9A;'5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5E;65D
M('!R969E<G)E9"!S=&]C:R!D:79I9&5N9"!F;W(@8F5N969I8VEA;"!C;VYV
M97)S:6]N(&9E871U<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,#(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#`R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEM<&%C="!O9B!D965M960@<')E
M9F5R<F5D('-T;V-K(&1I=FED96YD(&9O<B!B96YE9FEC:6%L(&-O;G9E<G-I
M;VX@9F5A='5R92!O;B!C;VUM;VX@<W1O8VMH;VQD97)S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@R+#`R-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,#(V*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5N9&EN9R!"86QA;F-E+"!V86QU92!A="!$96,N(#,Q+"`R,#$S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PU.#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,"PT.3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-"PY
M,S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@<VAA<F5S(&%T($1E8RX@
M,S$L(#(P,3,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L
M-C@U+#4V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!E<75I='D@9F]R(&-A
M<V@@;W(@:6YT96QL96-T=6%L('!R;W!E<G1Y(')I9VAT<RP@=F%L=64\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#@V-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPX-C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES<W5A;F-E(&]F(&5Q=6ET>2!F;W(@8V%S:"!O<B!I;G1E;&QE
M8W1U86P@<')O<&5R='D@<FEG:'1S+"!S:&%R97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4L,3$V+#(R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E
M+6)A<V5D(&-O;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,34X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,BPS.#DI/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPS.#DI/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@=7!O;B!E>&5R8VES92!O9B!S
M=&]C:R!O<'1I;VYS+"!F;W(@8V%S:"P@=F%L=64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S$X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@
M;V8@8V]M;6]N('-T;V-K('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N
M<RP@9F]R(&-A<V@L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ.3DL.3`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN
M9R!"86QA;F-E+"!V86QU92!A="!-87(N(#,Q+"`R,#$T/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(Q+#4S-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y."PX,S4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#<W
M+#,R,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!S:&%R97,@870@36%R
M+B`S,2P@,C`Q-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,2PP,#$L-CDP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A
M,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA
M,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34O5V]R:W-H965T<R]3:&5E
M=#`V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%,TY!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N
M9SY#;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!0<F5F97)R960@4W1O8VL@
M86YD(%-T;V-K:&]L9&5R<R<@17%U:71Y("A$969I8VET*2`H4&%R96YT:&5T
M:6-A;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y*86XN(#`S+"`R,#`U/&)R/D-O;6UO;B!3=&]C:SQB<CY#
M87-H+"!.970@;V8@3V9F97)I;F<@0V]S=',\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`P-#QB<CY#;VUM;VX@4W1O8VL\
M8G(^0V%S:"P@3F5T(&]F($]F9F5R:6YG($-O<W1S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#(\8G(^0V]M;6]N(%-T
M;V-K/&)R/D-A<V@L($YE="!O9B!/9F9E<FEN9R!#;W-T<SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#`S+"`R,#`U/&)R/D-O;6UO
M;B!3=&]C:SQB<CY)<W-U86YC92!F;W(@3F]T97,@4&%Y86)L92!A;F0@4F5L
M871E9"!!8V-R=65D($EN=&5R97-T(&]N($IA;G5A<GD@,RP@,C`P-3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#$T+"`R,#`U/&)R
M/D-O;6UO;B!3=&]C:SQB<CY)<W-U86YC92!F;W(@26YT96QL96-T=6%L(%!R
M;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($]C=&]B97(@,30L(#(P,#4\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R,2P@,C`P-CQB
M<CY#;VUM;VX@4W1O8VL\8G(^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A;"!0
M<F]P97)T>2!,:6-E;G-E(%)I9VAT<R!O;B!&96)R=6%R>2`R,2P@,C`P-CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(R+"`R,#`V
M/&)R/D-O;6UO;B!3=&]C:SQB<CY)<W-U86YC92!F;W(@26YT96QL96-T=6%L
M(%!R;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($9E8G)U87)Y(#(R+"`R,#`V
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,C,L(#(P
M,#8\8G(^0V]M;6]N(%-T;V-K/&)R/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U
M86P@4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@2G5N92`R,RP@,C`P-CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y.;W8N(#`W+"`R,#`V
M/&)R/D-O;6UO;B!3=&]C:SQB<CY)<W-U86YC92!F;W(@26YT96QL96-T=6%L
M(%!R;W!E<G1Y($QI8V5N<V4@4FEG:'1S(&]N($YO=F5M8F5R(#<L(#(P,#8\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`Q."P@,C`P
M-SQB<CY#;VUM;VX@4W1O8VL\8G(^27-S=6%N8V4@9F]R($EN=&5L;&5C='5A
M;"!0<F]P97)T>2!,:6-E;G-E(%)I9VAT<R!O;B!*86YU87)Y(#$X+"`R,#`W
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,#<\8G(^0V]M;6]N(%-T;V-K/&)R/DES<W5A;F-E(&9O<B!);G1E;&QE8W1U
M86P@4')O<&5R='D@3&EC96YS92!2:6=H=',@;VX@2G5N92`S,"P@,C`P-SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(R+"`R,#`V
M/&)R/E-E<FEE<R!!/&)R/DES<W5A;F-E(&]F(%-E<FEE<R!!(&]N($9E8G)U
M87)Y(#(R+"`R,#`V/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D9E8BX@,C(L(#(P,#8\8G(^4V5R:65S($$\8G(^5&AI<F0@27-S=6%N8V4@
M1F]R($YO=&5S(%!A>6%B;&4@06YD(%)E;&%T960@06-C<G5E9"!);G1E<F5S
M=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#`X+"`R
M,#`V/&)R/E-E<FEE<R!!/&)R/E-E8V]N9"!)<W-U86YC92!/9B!397)I97,@
M4F5D965M86)L92!0<F5F97)R960@4W1O8VL\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%Y(#,Q+"`R,#`W/&)R/E-E<FEE<R!"/&)R/E1H
M:7)D($ES<W5A;F-E($]F(%-E<FEE<R!"(%)E9&5E;6%B;&4@4')E9F5R<F5D
M(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,C@L(#(P,#<\8G(^4V5R:65S($(\8G(^27-S=6%N8V4@9F]R(%-E<FEE<R!"
M(&]N($1E8V5M8F5R(#(X+"`R,#`W/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@;6%R:V5T('!R:6-E('!E<B!S
M:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C,V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T."XX-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"XS,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"XS,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2XT/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+C0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$P+C`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q,"XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<&%R('9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,2XV,C8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q+C8R-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#$N-C(V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXT,SD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N,C4S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X
M7S1F.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU
M+U=O<FMS:&5E=',O4VAE970P-RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14)%0DD^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@
M0V%S:"!&;&]W<R`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T
M:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$T-R!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F;&]W<R!F
M<F]M(&]P97)A=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#,X.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#<Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-S<L,S(R
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!R96-O;F-I;&4@;F5T(&QO<W,@
M=&\@;F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I=&EE<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V%I
M;B!O;B!P871E;G0@<FEG:'1S(&%S<VEG;FUE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN(&]N(&)A<F=A:6X@<'5R
M8VAA<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C4L,C@R
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#`Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM8V%S:"!I;G1E<F5S
M="!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L,#(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!W87)R86YT
M<R!F;W(@;&5A<V4@=&5R;6EN871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!8V-R971I;VX@;V8@;&EA8FEL:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);7!A:7)M96YT
M(&]F('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y,;W-S(&]N(&EM<&%I<FUE;G0@;V8@:6XM
M<')O8V5S<R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=R:71E+6]F9B!O9B!D969E
M<G)E9"!T87@@;&EA8FEL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(L,C@Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1V%I;B!O;B!M87)K971A8FQE('-E8W5R:71I97,@
M879A:6QA8FQE(&9O<B!S86QE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/BA'86EN*2!L;W-S(&9R;VT@9&ES<&]S86P@;V8@<')O
M<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W1H97(L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0VAA;F=E(&EN(&]P97)A=&EN9R!A
M<W-E=',@86YD(&QI86)I;&ET:65S("AN970@;V8@86UO=6YT<R!A8W%U:7)E
M9"DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]T:&5R(&-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R-3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,34W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-CDY/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!A<W-E=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8Y."D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L-C0R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT
M<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q+#8S."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8W)U960@97AP96YS97,@86YD(&]T:&5R(&QI86)I;&ET
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-C4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.2PP
M,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$969E<G)E9"!R96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPV.#<I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S8T
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$P-BPS.38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O;2!I;G9E<W1I;F<@
M86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%S:"!R96-E:79E9"!F<F]M(&UE<F=E<CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"PS.3(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A>6UE;G0@;V8@
M9&5F97)R960@=')A;G-A8W1I;VX@8V]S=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PQ.#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A
M;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q+#DQ,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@<V%L92!O9B!M87)K971A8FQE('-E
M8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L
M,S8Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F]C965D<R!F<F]M('-A;&4@;V8@<')O<&5R='D@86YD(&5Q=6EP
M;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M;V-E961S(&9R;VT@<&%T96YT(')I9VAT<R!A<W-I9VYM96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@*'5S
M960@:6XI('!R;W9I9&5D(&)Y(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-2PP,C(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0V%S:"!F;&]W<R!F<F]M(&9I;F%N8VEN9R!A8W1I=FET:65S.CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D
M<R!F<F]M(&ES<W5A;F-E(&]F(&-O;G9E<G1I8FQE(&YO=&5S('!A>6%B;&4@
M86YD(')E;&%T960@=V%R<F%N=',@9F]R(&-O;6UO;B!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PX-#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R
M;VT@:7-S=6%N8V4@;V8@8F%N:R!N;W1E('!A>6%B;&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@<W1O
M8VL@<W5B:F5C="!T;R!R97!U<F-H87-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!I<W-U86YC92!O
M9B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3(L,S$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!I<W-U86YC92!O9B!C
M;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL
M,#$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PW-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR-"PX-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)E<&%Y;65N="!O9B!P<FEN8VEP86P@;VX@8F%N
M:R!N;W1E('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y297!A>6UE;G0@;V8@<')I;F-I<&%L(&]N(&-O;G9E<G1I
M8FQE(&YO=&5S('!A>6%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$P-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E<&%Y;65N="!O9B!P<FEN8VEP86P@;VX@=F5N9&]R
M(&9I;F%N8V4@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@U,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@T,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@U,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@<')O=FED960@8GD@9FEN86YC
M:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C@L,3,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PS.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX,BPU-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@:6YC<F5A<V4@:6X@8V%S:"!A;F0@
M8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PT-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR,2PR,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',L
M(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$V+#<U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L.3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<RP@96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C$L,C`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,RPU,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,2PR,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5P<&QE;65N=&%L(&-A
M<V@@9FQO=R!I;F9O<FUA=&EO;CH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@<&%I9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5P<&QE;65N
M=&%L(&1I<V-L;W-U<F4@;V8@;F]N8V%S:"!I;G9E<W1I;F<@86YD(&9I;F%N
M8VEN9R!T<F%N<V%C=&EO;G,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@:6YT97)E<W0@;VX@;F]T97,@
M<&%Y86)L92!C;VYV97)T960@=&\@97%U:71Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!I<W-U960@:6X@8V]N;F5C
M=&EO;B!W:71H(&-R961I="!F86-I;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@9&5F97)R960@=')A;G-A8W1I
M;VX@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#@R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y696YD;W(@9FEN86YC92!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$S,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D(%-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F
M;&]W<R!F<F]M(&9I;F%N8VEN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y087EM96YT(&]F(&]F
M9F5R:6YG(&-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(L,S(Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M;6]N(%-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F;&]W<R!F<F]M(&9I;F%N8VEN
M9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y087EM96YT(&]F(&]F9F5R:6YG(&-O<W1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#@S-"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#,P."D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(L-30X
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X
M-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A
M.3)A,#<T.&0Y-2]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!
M1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY4:&4@0V]M<&%N>2!A;F0@4W5M
M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1H92!#;VUP86YY
M(&%N9"!3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@
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M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#PO9F]N=#X\+W`^/'`@
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M86YT.B!N;W)M86P[)SY$97-C<FEP=&EO;B!O9B!"=7-I;F5S<R`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY
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M:&5R87!I97,@9F]R(&-A<F1I;W9A<V-U;&%R(&1I<V5A<V5S+B`@5&AE($-O
M;7!A;GDF(S@R,3<[<R!L96%D('!R;V1U8W0@8V%N9&ED871E+"!'96YC87)O
M)B,X-#@R.R`H8G5C:6YD;VQO;"!H>61R;V-H;&]R:61E*2P@:7,@82!P:&%R
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M4D5&+B`@5&AE($-O;7!A;GD@:&%S(&ED96YT:69I960@8V]M;6]N(&=E;F5T
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M<&]T:&5S:7,@:6X@82!0:&%S92`R0B\S(&-L:6YI8V%L('1R:6%L(&]F($=E
M;F-A<F\L(&MN;W=N(&%S($=%3D5424,M048N(%1H92!!1B!I;F1I8V%T:6]N
M(&9O<B!'96YC87)O('=A<R!C:&]S96X@8F%S960@;VX@<')I;W(@8VQI;FEC
M86P@9&%T82!F<F]M('1H92!P<F5V:6]U<VQY(&-O;F1U8W1E9"!0:&%S92`S
M(&AE87)T(&9A:6QU<F4@*$A&*2!T<FEA;"!O9B!'96YC87)O(&EN(#(L-S`X
M($A&('!A=&EE;G1S+"!O<B!T:&4@0D535"!T<FEA;"P@=VAI8V@@<W5G9V5S
M=&5D('1H870@1V5N8V%R;R!M87D@8F4@<W5C8V5S<V9U;"!I;B!R961U8VEN
M9R!O<B!P<F5V96YT:6YG($%&+B`@1T5.151)0RU!1B!I<R!A(&UU;'1I+6-E
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M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CQP('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M=V5I9VAT.F)O;&0[.V9O
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M=61Y(&]F(&%P<')O>&EM871E;'D@,C`P($A&4D5&('!A=&EE;G1S+B!4:&4@
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M;R!0:&%S92`S(&%N9"!E;G)O;&P@86X@861D:71I;VYA;"`T,C`@<&%T:65N
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M<V%F971Y+B`@(%-H;W5L9"!T:&4@1%--0B!I;G1E<FEM(&%N86QY<VES(&-O
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M,C8@:6X@=&AE(%4N4RX@86YD(&EN=&\@,C`R-2!I;B!%=7)O<&4N("!);B!A
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M=&\@,C`R.2!O<B`R,#,P(&EN('1H92!5+E,N(&%N9"!%=7)O<&4N(#PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HQ.'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1&5V96QO<&UE;G0@4W1A9V4@
M4FES:W,L($QI<75I9&ET>2!A;F0@1V]I;F<@0V]N8V5R;B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
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M;RP@26YC+BP@;W(@3G5V96QO+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP
M)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY3:6YC92!!4D-!('=A<R!F;W5N9&5D(&]N($1E8V5M8F5R)B,Q-C`[
M,3<L(#(P,#$L(&]R($EN8V5P=&EO;BP@=&AE($-O;7!A;GD@:&%S(&EN8W5R
M<F5D('-U8G-T86YT:6%L(&QO<W-E<R!A;F0@;F5G871I=F4@8V%S:"!F;&]W
M<R!F<F]M(&]P97)A=&EO;G,N(%-I;F-E($EN8V5P=&EO;BP@=&AE($-O;7!A
M;GD@:6YC=7)R960@82!L;W-S(&9R;VT@;W!E<F%T:6]N<R!O9B`D,3`X+C4@
M;6EL;&EO;B!A;F0@:&%D(&YE9V%T:79E(&-A<V@@9FQO=W,@9G)O;2!O<&5R
M871I;VYS(&]F("0Q,#8N-"!M:6QL:6]N+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN
M9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY$=7)I;F<@,C`Q,RP@=&AE($-O;7!A;GD@<F%I<V5D(&%P
M<')O>&EM871E;'D@)#$Y+C,@;6EL;&EO;BP@;F5T(&]F(&]F9F5R:6YG(&-O
M<W1S+"!T:')O=6=H('-A;&5S(&]F(&ET<R!C;VYV97)T:6)L92!P<F5F97)R
M960@86YD(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',N("!);B!&96)R=6%R
M>2`R,#$T+"!T:&4@0V]M<&%N>2!C;VUP;&5T960@82!P=6)L:6,@97%U:71Y
M(&]F9F5R:6YG(')A:7-I;F<@87!P<F]X:6UA=&5L>2`D-RXY(&UI;&QI;VX@
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M871I;VYS+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z
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M:6YG.B`\+V9O;G0^/"]P/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D
M97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4]
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M)B,Q-3$[/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4]
M,T1W:61T:#HY-2XT-B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
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M:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL
M87!S93L@=VED=&@Z.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT
M9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C
M93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HV<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG
M<R`R)SMF;VYT+7-I>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\
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M9F]R($=E;F-A<F\[(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D
M:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDU+C0V)3MM87)G:6XM;&5F=#HT+C4T
M)3LG/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z-"XU-"4[
M=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B=7:6YG9&EN9W,@,B<[9F]N="US:7IE.C$P<'0[)SXF(S$U,3L\+V9O;G0^
M/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV
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M:6]N86P@97%U:71Y(&-A<&ET86P[(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO
M=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B
M;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDU+C0V)3MM87)G:6XM
M;&5F=#HT+C4T)3LG/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED
M=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B=7:6YG9&EN9W,@,B<[9F]N="US:7IE.C$P<'0[)SXF(S$U
M,3L\+V9O;G0^/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I
M9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
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M92!.87-D87$@0V%P:71A;"!-87)K970[(#PO9F]N=#X\+W`^/"]T9#X\+W1R
M/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS
M1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDU+C0V)3MM87)G
M:6XM;&5F=#HT+C4T)3LG/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$
M=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B=7:6YG9&EN9W,@,B<[9F]N="US:7IE.C$P<'0[)SXF
M(S$U,3L\+V9O;G0^/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS
M1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
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M8V]S="!O9B!C87!I=&%L.R`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE
M/CPO9&EV/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(],T0P(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R
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M;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY
M-2XT-B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@
M=VED=&@Z.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT9"!V86QI
M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R
M87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV
M<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG<R`R)SMF
M;VYT+7-I>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L
M:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z.34N-#8E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C9P=#MF;VYT+7-I>F4Z,3!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SYT:&4@8V]S=',@
M;V8@9FEL:6YG+"!P<F]S96-U=&EN9RP@9&5F96YD:6YG(&%N9"!E;F9O<F-I
M;F<@86YY('!A=&5N="!C;&%I;7,@86YD(&]T:&5R(&EN=&5L;&5C='5A;"!P
M<F]P97)T>2!R:6=H=',[(&%N9"`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A
M8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(],T0P
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R
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M/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T
M:#HY-2XT-B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
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M8V5N<VEN9R!A9W)E96UE;G1S+B`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A
M8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT
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M+B`@268@=&AE($-O;7!A;GD@<F%I<V5S(&%D9&ET:6]N86P@9G5N9',@=&AR
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M<&5R871I;VYS+B`@5&AE($-O;7!A;GD@86QS;R!C86YN;W0@<')E9&EC="!W
M:&%T(&-O;G-I9&5R871I;VX@;6EG:'0@8F4@879A:6QA8FQE+"!I9B!A;GDL
M('1O('1H92!#;VUP86YY(&]R(&ET<R!S=&]C:VAO;&1E<G,L(&EN(&-O;FYE
M8W1I;VX@=VET:"!A;GD@<W1R871E9VEC('1R86YS86-T:6]N+B`@4VAO=6QD
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M+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF
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M96%S;VYA8FQE('!E<FEO9"!O9B!T:6UE+B`@5&AE<V4@8V]N<V]L:61A=&5D
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M<G-E(%-T;V-K(%-P;&ET(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
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M3VX@36%R8V@F(S$V,#LT+"`R,#$S+"!T:&4@0V]M<&%N>2!C;VUP;&5T960@
M82`Q+69O<BTV(')E=F5R<V4@<W!L:70@;V8@:71S(&-O;6UO;B!S=&]C:RX@
M06QL(&-O;6UO;B!S:&%R97,@86YD('!E<B!C;VUM;VX@<VAA<F4@86UO=6YT
M<R!I;B!T:&4@9FEN86YC:6%L('-T871E;65N=',@86YD(&9O;W1N;W1E<R!H
M879E(&)E96X@861J=7-T960@<F5T<F]A8W1I=F5L>2!T;R!R969L96-T('1H
M92!E9F9E8W1S(&]F('1H:7,@86-T:6]N+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN
M9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M
M<W1Y;&4Z:71A;&EC.SMF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D)A<VES(&]F(%!R97-E;G1A=&EO;B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
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M,3`M42!A;F0@4G5L92`Q,"TP,2!O9B!296=U;&%T:6]N(%,M6"XF;F)S<#LF
M;F)S<#M!8V-O<F1I;F=L>2P@=&AE<V4@9FEN86YC:6%L('-T871E;65N=',@
M9&\@;F]T(&EN8VQU9&4@86QL(&]F('1H92!I;F9O<FUA=&EO;B!A;F0@9F]O
M=&YO=&5S(')E<75I<F5D(&)Y(&%C8V]U;G1I;F<@<')I;F-I<&QE<R!G96YE
M<F%L;'D@86-C97!T960@:6X@=&AE(%5N:71E9"!3=&%T97,@;V8@06UE<FEC
M82!F;W(@8V]M<&QE=&4@9FEN86YC:6%L('-T871E;65N=',N)B,Q-C`[($EN
M('1H92!O<&EN:6]N(&]F(&UA;F%G96UE;G0L('1H97-E(&9I;F%N8VEA;"!S
M=&%T96UE;G1S(&EN8VQU9&4@86QL(&YO<FUA;"!A;F0@<F5C=7)R:6YG(&%D
M:G5S=&UE;G1S(&-O;G-I9&5R960@;F5C97-S87)Y(&9O<B!A(&9A:7(@<')E
M<V5N=&%T:6]N(&]F('1H97-E(&EN=&5R:6T@8V]N<V]L:61A=&5D(&9I;F%N
M8VEA;"!S=&%T96UE;G1S+B`@5&AE(')E<W5L=',@;V8@;W!E<F%T:6]N<R!F
M;W(@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C:"8C,38P.S,Q+"`R,#$T
M(&%R92!N;W0@;F5C97-S87)I;'D@:6YD:6-A=&EV92!O9B!R97-U;'1S(&5X
M<&5C=&5D(&9O<B!T:&4@9G5L;"!Y96%R(&5N9&EN9R!$96-E;6)E<B8C,38P
M.S,Q+"`R,#$T+B8C,38P.R!4:&4@0V]M<&%N>2!H87,@9V5N97)A=&5D(&YO
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M=&AE(&1E=F5L;W!M96YT('-T86=E(&%T($UA<F-H)B,Q-C`[,S$L(#(P,30N
M(%1H97-E('5N875D:71E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E
M;65N=',@<VAO=6QD(&)E(')E860@:6X@8V]N:G5N8W1I;VX@=VET:"!T:&4@
M875D:71E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@86YD
M(&9O;W1N;W1E<R!T:&5R971O(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E
M<B8C,38P.S,Q+"`R,#$S(&EN8VQU9&5D(&EN('1H92!#;VUP86YY)B,X,C$W
M.W,@06YN=6%L(%)E<&]R="!O;B!&;W)M(#$P+4L@9FEL960@=VET:"!T:&4@
M4V5C=7)I=&EE<R!A;F0@17AC:&%N9V4@0V]M;6ES<VEO;BP@87,@86UE;F1E
M9"X@06UO=6YT<R!P<F5S96YT960@87)E(')O=6YD960@=&\@=&AE(&YE87)E
M<W0@=&AO=7-A;F0L('=H97)E(&EN9&EC871E9"P@97AC97!T('!E<B!S:&%R
M92!D871A(&%N9"!P87(@=F%L=65S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN9&5N
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M+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV
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M)SY!8V-R=65D($5X<&5N<V5S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
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M;R!E<W1I;6%T92!A8V-R=65D(&5X<&5N<V5S+B`@5&AI<R!P<F]C97-S(&EN
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M8V5S(&MN;W=N(&%T('1H92!T:6UE+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?
M8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T
M.&0Y-2]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY.970@3&]S<R!097(@4VAA<F4\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($QO<W,@4&5R
M(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-
M"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXH,BD@3F5T($QO<W,@4&5R(%-H87)E(#PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M=&\@=F5S=&EN9R!P<F]V:7-I;VYS+B`@1&EL=71E9"!E87)N:6YG<R!P97(@
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M:&%R92!F;VQL;W=S.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M
M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C
M,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HW-B4[)SX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-3$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$-B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C,V)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
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M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C4Q)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$T/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN
M9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-3$E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="US:7IE.CAP=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="US:7IE.CAP=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BA);B!T:&]U
M<V%N9',L(&5X8V5P="!S:&%R97,@86YD('!E<B!S:&%R92!D871A*3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$P
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-3$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DYE="!L;W-S
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$U)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@R+#,X
M.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$P)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,2PP-S$\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[=VED=&@Z-3$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@R+#,X
M.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,2PP
M-S$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M-3$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY796EG:'1E9"!A=F5R86=E('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VL@;W5T<W1A;F1I;F<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ-24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXQ."PW.#4L-#$X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,L
M,#,W+#4T-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.C`N-S5P=#MW:61T:#HU,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,X,C$R.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W=I9'1H.C4Q)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY4;W1A;"!W96EG:'1E9"UA=F5R86=E('-H87)E<R!U
M<V5D(&EN(&-O;7!U=&EN9R!N970@;&]S<SPO9F]N=#X\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[)FYB<W`[('!E<B!S:&%R92!A='1R:6)U=&5D('1O(&-O;6UO;B!S=&]C
M:VAO;&1E<G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ-24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS
M+#`S-"PW-C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,24[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,34E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#`N,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#`N,S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*
M/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE
M.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/E!O=&5N=&EA;&QY(&1I;'5T:79E('-E8W5R
M:71I97,@<F5P<F5S96YT:6YG)B,Q-C`[,3`N,B!M:6QL:6]N(&%N9"`Q+C,F
M(S$V,#MM:6QL:6]N('=E:6=H=&5D(&%V97)A9V4@<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:R!W97)E(&5X8VQU9&5D(&9O<B!T:&4@=&AR964@;6]N=&AS(&5N
M9&5D($UA<F-H)B,Q-C`[,S$L(#(P,30@86YD(#(P,3,L(')E<W!E8W1I=F5L
M>2P@8F5C875S92!I;F-L=61I;F<@=&AE;2!W;W5L9"!H879E(&%N(&%N=&DM
M9&EL=71I=F4@969F96-T(&]N(&YE="!L;W-S('!E<B!S:&%R92X@/"]F;VYT
M/CPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F
M.3)?838T,%]B83DR83`W-#AD.34O5V]R:W-H965T<R]3:&5E=#$P+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^365R9V5R('=I
M=&@@3G5V96QO+"!);F,N(&]N($IA;G5A<GD@,C<L(#(P,#D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^365R9V5R('=I=&@@3G5V
M96QO+"!);F,N(&]N($IA;G5A<GD@,C<L(#(P,#D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O
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M97)G97(@=VET:"!.=79E;&\L($EN8RX@;VX@2F%N=6%R>28C,38P.S(W+"`R
M,#`Y(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
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M,38P.S(W+"`R,#`Y+"!!4D-!($-O;&]R861O+"!);F,N("A!4D-!($-O;&]R
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M8G-I9&EA<GD@;V8@3G5V96QO+B`@26UM961I871E;'D@9F]L;&]W:6YG('1H
M92!-97)G97(L('1H92!#;VUP86YY(&-H86YG960@:71S(&YA;64@9G)O;2!.
M=79E;&\L($EN8RX@=&\@05)#02!B:6]P:&%R;6$L($EN8RXL(&%N9"!I=',@
M8V]M;6]N('-T;V-K(&)E9V%N('1R861I;F<@;VX@=&AE($YA<V1A<2!';&]B
M86P@36%R:V5T('5N9&5R('1H92!S>6UB;VP@)B,X,C(P.T%"24\F(S@R,C$[
M(&]N($IA;G5A<GDF(S$V,#LR."P@,C`P.2X@($]N($UA<F-H)B,Q-C`[-RP@
M,C`Q,2P@=&AE(&QI<W1I;F<@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!C;VUM
M;VX@<W1O8VL@=V%S('1R86YS9F5R<F5D(&9R;VT@=&AE($YA<V1A<2!';&]B
M86P@36%R:V5T('1O('1H92!.87-D87$@0V%P:71A;"!-87)K970N(#PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M<GDF(S$V,#LR-RP@,C`P.2!A;F0@=&AE(&5S=&EM871E9"!F86ER('9A;'5E
M<R!O9B!I=',@=F5S=&5D('-T;V-K(&]P=&EO;G,@86YD('=A<G)A;G1S(&]U
M='-T86YD:6YG(&]N('1H870@9&%T92P@87,@=&AI<R!W87,@9&5E;65D('1H
M92!M;W-T(')E;&EA8FQE(&UE87-U<F4@;V8@=&AE(&-O;G-I9&5R871I;VX@
M969F96-T:79E;'D@=')A;G-F97)R960@=&\@86-Q=6ER92!.=79E;&\@;VX@
M=&AA="!D871E+B`@5&AE($-O;7!A;GD@97-T:6UA=&5D('1H92!N970@87-S
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M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S
M7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W
M-#AD.34O5V]R:W-H965T<R]3:&5E=#$Q+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^1F%I<B!686QU92!$:7-C;&]S=7)E<SQB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A
M;'5E($1I<V-L;W-U<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-"D@1F%I<B!686QU92!$:7-C
M;&]S=7)E<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D%S(&]F($UA
M<F-H)B,Q-C`[,S$L(#(P,30L('1H92!#;VUP86YY(&AA9"`D,C$N,2!M:6QL
M:6]N(&]F(&-A<V@@97%U:79A;&5N=',@8V]N<VES=&EN9R!O9B!M;VYE>2!M
M87)K970@9G5N9',@=VET:"!M871U<FET:65S(&]F(#DP(&1A>7,@;W(@;&5S
M<RX@5&AE($-O;7!A;GD@:&%S('1H92!A8FEL:71Y('1O(&QI<75I9&%T92!T
M:&5S92!I;G9E<W1M96YT<R!W:71H;W5T(')E<W1R:6-T:6]N+B`@5&AE($-O
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M<FEO9"!E;F1E9"!-87)C:"8C,38P.S,Q+"`R,#$T+B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MT
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M=&AE(&9O;&QO=VEN9R!H:65R87)C:'DZ(#PO9F]N=#X\+W`^/&1I=B!A;&EG
M;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P
M<V4[('=I9'1H.CDU+C0V)3MM87)G:6XM;&5F=#HT+C4T)3LG/CQT<CX\=&0@
M=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z
M;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B=7:6YG9&EN9W,@
M,B<[9F]N="US:7IE.C$P<'0[)SXF(S$U,3L\+V9O;G0^/"]P/CPO=&0^/'1D
M('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4]
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M;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@
M=VED=&@Z.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT9"!V86QI
M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R
M87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV
M<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG<R`R)SMF
M;VYT+7-I>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L
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M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"`R)B,X
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M9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS
M1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[
M('=I9'1H.CDU+C0V)3MM87)G:6XM;&5F=#HT+C4T)3LG/CQT<CX\=&0@=F%L
M:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W
M<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B=7:6YG9&EN9W,@,B<[
M9F]N="US:7IE.C$P<'0[)SXF(S$U,3L\+V9O;G0^/"]P/CPO=&0^/'1D('9A
M;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G
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M8FEL:71Y(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
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M9'5E('1O('1H96ER('-H;W)T(&UA='5R:71I97,N(#PO9F]N=#X\+W`^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B
M-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?
M8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE970Q,BYH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y(&%N9"!%<75I
M<&UE;G0\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S
M,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')O<&5R='D@86YD($5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
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M9R`H:6X@=&AO=7-A;F1S*3H@/"]F;VYT/CPO<#X\<"!S='EL93TS1"=M87)G
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M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z.#0E
M.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C0P)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ."4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^17-T:6UA=&5D($QI9F4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ-B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-B4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HT,"4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/D-O;7!U=&5R(&5Q=6EP;65N=#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C,@>65A<G,\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,30E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.3D\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/CDY/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C0P
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^3&%B(&5Q=6EP;65N=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3@E.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,3`E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,3`E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z-#`E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ."4[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4@>65A<G,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-"4[=VAI=&4M<W!A
M8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@Y/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$P)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.#D\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z-#`E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY#;VUP=71E<B!S;V9T=V%R93PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,3@E.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS('EE87)S
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ-S8\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ-S8\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z-#`E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$X)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HT
M,"4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3@E.SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ-"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU,30\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^-3$T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C0P)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY!8V-U;75L871E
M9"!D97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,3@E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,30E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*#0X.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@T
M.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-#`E.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E!R;W!E<G1Y(&%N
M9"!E<75I<&UE;G0L(&YE=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[=VED=&@Z,3@E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$T)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M4F]M86X[)SXF;F)S<#L\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
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M:')E92!M;VYT:',@96YD960@36%R8V@F(S$V,#LS,2P@,C`Q-"!A;F0@,C`Q
M,RP@86YD(&9O<B!T:&4@<&5R:6]D(&9R;VT@26YC97!T:6]N('1H<F]U9V@@
M36%R8V@F(S$V,#LS,2P@,C`Q-"P@9&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ
M871I;VX@97AP96YS92!W87,@)#,L,#`P+"`D,3`L,#`P+"!A;F0@)#$N."!M
M:6QL:6]N(')E<W!E8W1I=F5L>2X@/"]F;VYT/CPO<#X\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T
M83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD
M.34O5V]R:W-H965T<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I
M97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
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M:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD
M96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HQ.'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^16UP;&]Y;65N="!!9W)E96UE
M;G1S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
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M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ.'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3W!E<F%T:6YG($QE87-E(#PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HV<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3VX@075G=7-T)B,Q-C`[,2P@,C`Q
M,R!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!L96%S92!A9W)E96UE;G0@
M9F]R(&%P<')O>&EM871E;'D@-2PS,#`@<W%U87)E(&9E970@;V8@;V9F:6-E
M(&9A8VEL:71I97,@:6X@5V5S=&UI;G-T97(L($-O;&]R861O('=H:6-H(&AA
M<R!S97)V960@87,@=&AE($-O;7!A;GDF(S@R,3<[<R!P<FEM87)Y(&)U<VEN
M97-S(&]F9FEC92!S:6YC92!/8W1O8F5R)B,Q-C`[,2P@,C`Q,RX@(%1H92!L
M96%S92!H87,@82!T:')E92!Y96%R('1E<FT@86YD(&5X<&ER97,@;VX@4V5P
M=&5M8F5R)B,Q-C`[,S`L(#(P,38N("!4:&4@0V]M<&%N>28C.#(Q-SMS('!R
M979I;W5S(&]F9FEC92!L96%S92P@96YT97)E9"!I;G1O(&]N($9E8G)U87)Y
M(#@L(#(P,#@@9F]R(&]F9FEC92!F86-I;&ET:65S(&EN($)R;V]M9FEE;&0L
M($-O;&]R861O+"!S97)V960@87,@=&AE($-O;7!A;GDF(S@R,3<[<R!P<FEM
M87)Y(&)U<VEN97-S(&]F9FEC92!T:')O=6=H(%-E<'1E;6)E<B`S,"P@,C`Q
M,RXF;F)S<#LF;F)S<#M"96QO=R!I<R!A('-U;6UA<GD@;V8@=&AE(&9U='5R
M92!M:6YI;75M(&QE87-E('!A>6UE;G1S(&-O;6UI='1E9"!F;W(@=&AE($-O
M;7!A;GDF(S@R,3<[<R!F86-I;&ET>2!I;B!797-T;6EN<W1E<BP@0V]L;W)A
M9&\@87,@;V8@36%R8V@F(S$V,#LS,2P@,C`Q-"`H:6X@=&AO=7-A;F1S*3H@
M/"]F;VYT/CPO<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF(S$V,#L\+V9O;G0^/"]P
M/CQD:78^#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC
M;VQL87!S93IC;VQL87!S93L@=VED=&@Z-C@E.R<^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C@V)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
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M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$=VED=&@Z,3$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4Y/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HU-B4[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ,"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.#`\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C4V)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXR,#$V/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,3`E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXV,CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[=VED=&@Z-38E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$Q)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M;6EL>3I4:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\+W`^/'`@<W1Y;&4],T0G
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M('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C:"8C,38P.S,Q+"`R,#$T(&%N9"`R
M,#$S('=A<R`D,3DL,#`P(&%N9"`D,3(L,#`P+"!R97-P96-T:79E;'DL(&%N
M9"!W87,@)#4Y-RPP,#`@9G)O;2!);F-E<'1I;VX@=&AR;W5G:"!-87)C:"8C
M,38P.S,Q+"`R,#$T+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF;VYT
M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<W1Y;&4Z:71A;&EC
M.SMF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D1U
M:V4@56YI=F5R<VET>2`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M
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M>2`H1'5K92D@=&\@<V5R=F4@87,@=&AE(&-L:6YI8V%L(')E<V5A<F-H(&]R
M9V%N:7IA=&EO;B!F;W(@=&AE($-O;7!A;GDF(S@R,3<[<R!'14Y%5$E#+4%&
M(&-L:6YI8V%L('-T=61Y+B`@56YD97(@=&AE(&%G<F5E;65N="!T:&4@0V]M
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M8GD@=&AE($-O;7!A;GD@9F]R(&%N>2!R96%S;VX@=VET:"`Y,"!D87ES('=R
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M('=I;F0M9&]W;B!P97)I;V0N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II
M=&%L:6,[.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^56YI=F5R<VET>2!O9B!#:6YC:6YN871I(#PO9F]N=#X\+W`^/'`@<W1Y
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M=#H@;F]R;6%L.R<^26X@07!R:6P@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E
M9"!I;G1O(&$@;&EC96YS92!A9W)E96UE;G0@=VET:"!T:&4@56YI=F5R<VET
M>2!O9B!#:6YC:6YN871I('1O(&QI8V5N<V4@97AC;'5S:79E('=O<FQD=VED
M92!R:6=H=',@=&\@82!P;W)T9F]L:6\@;V8@52Y3+B!A;F0@:6YT97)N871I
M;VYA;"!P871E;G1S+"!W:&EC:"!I;F-L=61E<R!C97)T86EN(%4N4RX@86YD
M(&EN=&5R;F%T:6]N86P@9&EA9VYO<W1I8R!P871E;G1S(&-O=F5R:6YG(&=E
M;F5T:6,@;6%R:V5R<R!F;W(@05)#028C.#(Q-SMS(&QE860@9')U9R!C86YD
M:61A=&4L($=E;F-A<F\N("!4:&5S92!P871E;G1S('!R;W9I9&4@=&AE(&)A
M<VES(&9O<B!E>&-L=7-I=F4@=V]R;&1W:61E(&1E=F5L;W!M96YT+"!U<V4@
M86YD(&-O;6UE<F-I86QI>F%T:6]N(&]F('1H92!G96YE=&EC('1E<W0@=VAI
M8V@@;6%Y(&EN9&EC871E(&$@<&%T:65N="8C.#(Q-SMS(&QI:V5L>2!R97-P
M;VYS92!T;R!'96YC87)O(&%S(&$@=')E871M96YT(&9O<B!C:')O;FEC($A&
M+"!!1BP@86YD(&]T:&5R(&EN9&EC871I;VYS+B`@56YD97(@=&AE('1E<FUS
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M:&]L9&EN9R!O=VYE<G-H:7`@<FEG:'1S('1O(&-E<G1A:6X@8VQI;FEC86P@
M=')I86P@9&%T82!O9B!'96YC87)O+B`@56YD97(@=&AE('1E<FUS(&]F(&ET
M<R!L:6-E;G-E(&%G<F5E;65N="!W:71H($-014,L('1H92!#;VUP86YY('=I
M;&P@:6YC=7(@;6EL97-T;VYE(&%N9"!R;WEA;'1Y(&]B;&EG871I;VYS('5P
M;VX@=&AE(&]C8W5R<F5N8V4@;V8@8V5R=&%I;B!E=F5N=',N("`@268@=&AE
M($9$02!G<F%N=',@;6%R:V5T:6YG(&%P<')O=F%L(&9O<B!'96YC87)O+"!T
M:&4@;&EC96YS92!A9W)E96UE;G0@<W1A=&5S('1H870@=&AE($-O;7!A;GD@
M=VEL;"!O=V4@0U!%0R!A(&UI;&5S=&]N92!P87EM96YT(&]F("0X+C`F(S$V
M,#MM:6QL:6]N('=I=&AI;B!S:7@@;6]N=&AS(&%F=&5R($9$02!A<'!R;W9A
M;"X@5&AE(&QI8V5N<V4@86=R965M96YT('-T871E<R!T:&%T(&$@;6EL97-T
M;VYE('!A>6UE;G0@;V8@=7`@=&\@)#4N,"!M:6QL:6]N(&EN('1H92!A9V=R
M96=A=&4@<VAA;&P@8F4@<&%I9"!U<&]N(')E9W5L871O<GD@;6%R:V5T:6YG
M(&%P<')O=F%L(&EN($5U<F]P92!A;F0@2F%P86XN("!4:&4@;&EC96YS92!A
M9W)E96UE;G0@86QS;R!S=&%T97,@=&AA="!T:&4@0V]M<&%N>28C.#(Q-SMS
M(')O>6%L='D@;V)L:6=A=&EO;B!R86YG97,@9G)O;2`Q,BXU)2!T;R`R-24@
M;V8@<F5V96YU92!F<F]M('1H92!R96QA=&5D('!R;V1U8W0@8F%S960@;VX@
M86-H:65V96UE;G0@;V8@<W!E8VEF:65D('!R;V1U8W0@<V%L97,@;&5V96QS
M+"!I;F-L=61I;F<@82`U)2!R;WEA;'1Y('1H870@0U!%0R!I<R!O8FQI9V%T
M960@=&\@<&%Y('5N9&5R(&ET<R!O<FEG:6YA;"!L:6-E;G-E(&%G<F5E;65N
M="!F;W(@1V5N8V%R;RX@5&AE($-O;7!A;GD@:&%S('1H92!R:6=H="!T;R!B
M=7D@9&]W;B!T:&4@<F]Y86QT:65S('1O(&$@<F%N9V4@;V8@,3(N-24@=&\@
M,3<E(&)Y(&UA:VEN9R!A('!A>6UE;G0@=&\@0U!%0R!W:71H:6X@<VEX(&UO
M;G1H<R!O9B!R96=U;&%T;W)Y(&%P<')O=F%L+B`\+V9O;G0^/"]P/CPO9&EV
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X
M-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A
M.3)A,#<T.&0Y-2]7;W)K<VAE971S+U-H965T,30N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!
M1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%<75I='D@1FEN86YC:6YG<R!A
M;F0@5V%R<F%N=',\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17%U:71Y($9I;F%N8VEN9W,@86YD(%=A<G)A;G1S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E
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M<V%C=&EO;B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D]N($IA;G5A
M<GDF(S$V,#LR,BP@,C`Q,RP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@
M4W5B<V-R:7!T:6]N($%G<F5E;65N="`H=&AE("8C.#(R,#M*86YU87)Y(#(P
M,3,@4'5R8VAA<V4@06=R965M96YT)B,X,C(Q.RD@=VET:"!V87)I;W5S(&%C
M8W)E9&ET960@:6YV97-T;W)S(&%N9"!I=',@0VAI968@17AE8W5T:79E($]F
M9FEC97(@:6X@8V]N;F5C=&EO;B!W:71H(&$@<')I=F%T92!P;&%C96UE;G0@
M;V8@:71S(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',N("!0=7)S=6%N="!T
M;R!T:&4@2F%N=6%R>2`R,#$S(%!U<F-H87-E($%G<F5E;65N="P@=&AE($-O
M;7!A;GD@<V]L9"!A;B!A9V=R96=A=&4@;V8@,S4V+#0S,"!S:&%R97,@;V8@
M:71S(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',@=&\@<'5R8VAA<V4@=7`@
M=&\@,C0Y+#4P,2!A9&1I=&EO;F%L('-H87)E<R!O9B!I=',@8V]M;6]N('-T
M;V-K(&9O<B!A9V=R96=A=&4@9W)O<W,@<')O8V5E9',@;V8@87!P<F]X:6UA
M=&5L>2`D,2!M:6QL:6]N+"!B969O<F4@9&5D=6-T:6YG(&5S=&EM871E9"!O
M9F9E<FEN9R!E>'!E;G-E<R!P87EA8FQE(&)Y('1H92!#;VUP86YY+B!4:&4@
M;F5T('!R;V-E961S('1O('1H92!#;VUP86YY('=E<F4@87!P<F]X:6UA=&5L
M>2`D.#`U+#`P,"P@86YD('1H92!P<FEV871E('!L86-E;65N="!C;&]S960@
M;VX@2F%N=6%R>28C,38P.S(U+"`R,#$S+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN
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M97,@;V8@8V]M;6]N('-T;V-K+B`@5&AE('!U<F-H87-E('!R:6-E(&9O<B!E
M86-H('5N:70@=V%S("0R+C@Q+B!4:&4@=V%R<F%N=',@=V5R92!E>&5R8VES
M86)L92!U<&]N(&ES<W5A;F-E+"!E>'!I<F4@<V5V96X@>65A<G,@9G)O;2!T
M:&4@9&%T92!O9B!I<W-U86YC92P@86YD(&AA=F4@86X@97AE<F-I<V4@<')I
M8V4@;V8@)#(N,C@@<&5R('-H87)E+"!E<75A;"!T;R`Q,#`E(&]F('1H92!C
M;&]S:6YG(&)I9"!P<FEC92!O9B!!4D-!)B,X,C$W.W,@8V]M;6]N('-T;V-K
M(&]N('1H92!.87-D87$@0V%P:71A;"!-87)K970@;VX@2F%N=6%R>28C,38P
M.S(R+"`R,#$S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
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M)B,Q-C`[,30L(#(P,3,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O
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M<R!A;GD@8V]N=F5R=&EB;&4@<V5C=7)I=&EE<R!E:71H97(@*$$I)B,Q-C`[
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M;VYV97)T:6)L92!S96-U<FET:65S+"!O<B`H0BDF(S$V,#MW:71H(&$@8V]N
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M86YT.B!N;W)M86P[)SY296=I<W1E<F5D($1I<F5C="!/9F9E<FEN9R`\+V9O
M;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D]N($IA;G5A<GDF(S$V,#LS,2P@
M,C`Q,RP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@<W5B<V-R:7!T:6]N
M(&%G<F5E;65N="!W:71H(&-E<G1A:6X@:6YS=&ET=71I;VYA;"!I;G9E<W1O
M<G,@*'1H92`F(S@R,C`[26YV97-T;W)S)B,X,C(Q.RD@:6X@8V]N;F5C=&EO
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M("0W,S`L,#`P+"!B969O<F4@9&5D=6-T:6YG('!L86-E;65N="!A9V5N="!F
M964@86YD(&]T:&5R(&5S=&EM871E9"!O9F9E<FEN9R!E>'!E;G-E<R!P87EA
M8FQE(&)Y('1H92!#;VUP86YY+B`@5&AE(&YE="!P<F]C965D<R!T;R!T:&4@
M0V]M<&%N>2!W97)E(&%P<')O>&EM871E;'D@)#8Q-BPP,#`L(&%N9"!T:&4@
M;V9F97)I;F<@8VQO<V5D(&]N($9E8G)U87)Y)B,Q-C`[-"P@,C`Q,RX@/"]F
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M<F-H87-E(#`N-#`@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RX@(%1H92!P=7)C
M:&%S92!P<FEC92!F;W(@96%C:"!U;FET('=A<R`D-"XT,RX@(%1H92!W87)R
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M87)Y)B,Q-C`[,S$L(#(P,3,N("!4:&4@3V9F97)I;F<@=V%S(&5F9F5C=&5D
M(&%S(&$@=&%K961O=VX@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!296=I<W1R
M871I;VX@4W1A=&5M96YT(&]N($9O<FT@4RTS+"!A<R!A;65N9&5D+"!W:&EC
M:"!B96-A;64@969F96-T:79E(&]N($%P<FEL)B,Q-C`[-"P@,C`Q,2P@<'5R
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M;F<@=&AE('=A<G)A;G1S(&%T('1H92!T:6UE(&]F(&5X97)C:7-E+B`\+V9O
M;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V9O;G0M<W1Y;&4Z:71A;&EC.SMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E!U8FQI8R!/9F9E<FEN9R`\+V9O
M;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D]N($IU;F4F(S$V,#LT+"`R,#$S
M+"!T:&4@0V]M<&%N>2!S;VQD('-H87)E<R!O9B!I=',@4V5R:65S($$@0V]N
M=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K("A0<F5F97)R960@4W1O8VLI(&%N
M9"!W87)R86YT<R!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL@:6X@82!P=6)L
M:6,@;V9F97)I;F<@9F]R(&%G9W)E9V%T92!G<F]S<R!P<F]C965D<R!O9B`D
M,C`N,"!M:6QL:6]N+B!4:&4@0V]M<&%N>2!I<W-U960@,3(U+#`P,"!S:&%R
M97,@;V8@4')E9F5R<F5D(%-T;V-K(&%N9"!W87)R86YT<R!T;R!P=7)C:&%S
M92!U<"!T;R`V+#(U,"PP,#`@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!A="!A
M('!U<F-H87-E('!R:6-E(&]F("0Q-C`@<&5R('-H87)E(&]F(%!R969E<G)E
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M<FEN9RP@<'5R8VAA<VEN9R`W.#$@<VAA<F5S(&]F(%!R969E<G)E9"!3=&]C
M:R!A;F0@=V%R<F%N=',@=&\@<'5R8VAA<V4@,SDL,#4P('-H87)E<R!O9B!C
M;VUM;VX@<W1O8VLN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M
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M=&EO;B!P<F5F97)E;F-E(&]F("0N,#`Q('!E<B!S:&%R92X@(%1H92!S:&%R
M97,@;V8@4')E9F5R<F5D(%-T;V-K(&AA9"!N;R!P<F5F97)E;G1I86P@9&EV
M:61E;F1S(&]R(')E9&5M<'1I;VX@<FEG:'1S+"!A;F0@;F\@=F]T:6YG(')I
M9VAT<R!E>&-E<'0@87,@<F5Q=6ER960@8GD@;&%W+B`@1'5R:6YG(#(P,3,L
M(&%L;"!O9B!T:&4@<VAA<F5S(&]F('1H92!0<F5F97)R960@4W1O8VL@=V5R
M92!C;VYV97)T960@:6YT;R!S:&%R97,@;V8@05)#02!C;VUM;VX@<W1O8VLN
M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O
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M:&%S92`U,"!S:&%R97,@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!C;VUM;VX@
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M9F9I;&EA=&5S+"!W;W5L9"!B96YE9FEC:6%L;'D@;W=N(&UO<F4@=&AA;B`Y
M+CDY)2!O9B!T:&4@=&]T86P@;G5M8F5R(&]F('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VL@=&AE;B!I<W-U960@86YD(&]U='-T86YD:6YG+B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P
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M.S(Y+"`R,#$S+"!A;F0@=&AE(%!R969E<G)E9"!3=&]C:R!A;F0@5V%R<F%N
M=',@=V5R92!O9F9E<F5D(&%N9"!S;VQD('!U<G-U86YT('1O(&$@<')O<W!E
M8W1U<R!D871E9"!-87DF(S$V,#LS,"P@,C`Q,RX@/"]F;VYT/CPO<#X\<"!S
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M<G)E9"!S=&]C:R!P=7)C:&%S97)S+B`@2&]W979E<BP@<VEN8V4@05)#02!H
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M-SL@97%U:71Y+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
M>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<W1Y;&4Z:71A;&EC.SMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,30@
M17%U:71Y($9I;F%N8VEN9R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O
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M9W)E9V%T92!O9B`U+#$Q-BPR,C@@<VAA<F5S(&]F('1H92!#;VUP86YY)B,X
M,C$W.W,@8V]M;6]N('-T;V-K(&%N9"!W87)R86YT<R!T;R!P=7)C:&%S92!A
M;B!A9V=R96=A=&4@;V8@,2PR-SDL,#4W('-H87)E<R!O9B!T:&4@0V]M<&%N
M>28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!A="!A('!U<F-H87-E('!R:6-E(&]F
M("0Q+C<P('!E<B!S:&%R92!O9B!#;VUM;VX@4W1O8VLL(&9O<B!A9V=R96=A
M=&4@9W)O<W,@<')O8V5E9',@;V8@87!P<F]X:6UA=&5L>2!O9B`D."XW(&UI
M;&QI;VXL(&)E9F]R92!D961U8W1I;F<@<&QA8V5M96YT(&%G96YT(&9E97,@
M86YD(&]T:&5R(&]F9F5R:6YG(')E;&%T960@97AP96YS97,N("!4:&4@;V9F
M97)I;F<@8VQO<V5D(&]N($9E8G)U87)Y)B,Q-C`[-RP@,C`Q-"P@86YD('1H
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M;B!S=&]C:R!A;F0@82!W87)R86YT('1O('!U<F-H87-E(#`N,C4@<VAA<F5S
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M,#LT+"`R,#$T+B`@5&AE('=A<G)A;G1S('!R;W9I9&4@9F]R(&-A<VAL97-S
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M87)I86YT.B!N;W)M86P[)SY787)R86YT<R`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD
M96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D%S(&]F($UA<F-H)B,Q-C`[,S$L(#(P,30L('=A<G)A;G1S
M('1O('!U<F-H87-E(&%P<')O>&EM871E;'D@.2XT)B,Q-C`[;6EL;&EO;B!S
M:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@;W5T<W1A;F1I;F<@870@97AE
M<F-I<V4@<')I8V5S(')A;F=I;F<@9G)O;2`D,2XV,"!T;R`D,3$V+C@Y+"!W
M:71H(&$@=V5I9VAT960@879E<F%G92!E>&5R8VES92!P<FEC92!P97(@<VAA
M<F4@;V8@)#(N,S$N("!4:&5S92!W87)R86YT<RP@=VAI8V@@=V5R92!G<F%N
M=&5D(&%S('!A<G0@;V8@=F%R:6]U<R!F:6YA;F-I;F<@86YD(&)U<VEN97-S
M(&%G<F5E;65N=',L(&5X<&ER92!A="!V87)I;W5S('1I;65S(&)E='=E96X@
M07!R:6P@,C`Q-B!A;F0@2F%N=6%R>2`R,#(P+B!787)R86YT<R!W97)E(')E
M8V]R9&5D(&EN(&%D9&ET:6]N86P@<&%I9"UI;B!C87!I=&%L(&%T('1H96ER
M(&5S=&EM871E9"!F86ER(&UA<FME="!V86QU92!A="!T:&4@9&%T92!O9B!G
M<F%N="!U<VEN9R!A($)L86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D
M96PN(#PO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE
M970Q-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/E-H87)E+2!B87-E9"!#;VUP96YS871I;VX\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M
M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXH."D@4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N(#PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HV<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1F]R('1H92!T:')E92!M;VYT:"!P
M97)I;V0@96YD960@36%R8V@F(S$V,#LS,2P@,C`Q-"!A;F0@,C`Q,R!A;F0@
M9F]R('1H92!P97)I;V0@9G)O;2!);F-E<'1I;VX@=&AR;W5G:"!-87)C:"8C
M,38P.S,Q+"`R,#$T+"!T:&4@0V]M<&%N>2!R96-O9VYI>F5D('1H92!F;VQL
M;W=I;F<@;F]N+6-A<V@L('-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E
M;G-E(&EN('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT(&]F(&]P97)A=&EO
M;G,@*&EN('1H;W5S86YD<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
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M.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C@T
M)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,R4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,S`E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M=V5I9VAT.F)O;&0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1H<F5E($UO
M;G1H<R!%;F1E9"!-87)C:"`S,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW
M:61T:#HQ-"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E!E<FEO9"!F<F]M($1E8V5M
M8F5R(#$W+"`R,#`Q("AD871E(&]F(&EN8V5P=&EO;BD@=&\@36%R8V@@,S$L
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C4S)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,30E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,30\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,30E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,30E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C(P,30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z-3,E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-#`\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXW,#<\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z-3,E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY396QL:6YG+"!'96YE<F%L(&%N
M9"!!9&UI;FES=')A=&EV93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C<\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#DS-3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,R4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,X,C$R.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)B,X,C$R.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,S@W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-3,E.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/E1O=&%L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$U.#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M>3I4:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.W1E>'0M:6YD96YT.C`E
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M(&9O<B!T:&4@=&AR964@;6]N=&@@<&5R:6]D(&5N9&5D($UA<F-H)B,Q-C`[
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M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S
M93L@=VED=&@Z.#0E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C0P
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY.=6UB97(@;V8@3W!T:6]N
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ-"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960@079E<F%G93PO9F]N
M=#X\+W`^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4')I8V4\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,30E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L
M(%1E<FT\+V9O;G0^/"]P/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH:6X@>65A
M<G,I/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C4S)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^3W!T:6]N<R!O=71S=&%N9&EN9R!A="!$96-E;6)E
M<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^.#0S+#0T,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,RXW-CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXX+CDT/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C0P
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^1W)A;G1E9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,3(E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXR,#`L,#<Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,2XY,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HT,"4[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/D5X97)C:7-E9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,30E.SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-"4[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)B,X,C$R.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HT,"4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1F]R9F5I
M=&5D(&%N9"!C86YC96QL960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@R-SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,3(E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L.3`X+C`P/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$R)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HT,"4[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3W!T:6]N<R!O
M=71S=&%N9&EN9R!A="!-87)C:"`S,2P@,C`Q-#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C$L,#0S+#0Y-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R
M)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,N,S4\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HT,"4[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$R)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[(&)O<F1E
M<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C0P)3L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^3W!T:6]N<R!E>&5R8VES86)L92!A="!-87)C:"`S,2P@,C`Q-#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@N-#(\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C<N,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-#`E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/<'1I
M;VYS('9E<W1E9"!A;F0@97AP96-T960@=&\@=F5S=#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ+#`S,2PS.#(\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,RXS-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^."XY,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\+W1R/@T*/"]T86)L93X\+V1I=CX\<"!S='EL93TS
M1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT
M.C`E.V9O;G0M<VEZ93HV<'0[.SXF;F)S<#L\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[=&5X="UI;F1E;G0Z,"4[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HV<'0[.R<^
M)FYB<W`[/"]P/CQD:78^#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$
M)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z.#`E.R<^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C8S)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-R4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^3G5M8F5R(&]F(%-H87)E<SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C(E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-R4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-C,E
M.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY297-T<FEC=&5D('-T;V-K('5N:71S(&]U='-T86YD:6YG(&%T
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXT,3DL,#`P/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,B4[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN
M9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ-24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+C,Y
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C8S)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1W)A;G1E9#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,34E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ.3$L-S`P/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$U)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XY-3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HV,R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$W)3L^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3<E.SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z-C,E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D9O<F9E:71E9"!A;F0@8V%N8V5L
M;&5D/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3<E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C.#(Q,CL\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HV,R4[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4F5S=')I8W1E
M9"!S=&]C:R!U;FET<R!O=71S=&%N9&EN9R!A="!-87)C:"`S,2P@,C`Q-#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$U)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C8Q,"PW,#`\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C(E
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M-24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D
M:78^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#L[/B9N8G-P.SPO<#X\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T
M,%]B83DR83`W-#AD.34O5V]R:W-H965T<R]3:&5E=#$V+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^26YC;VUE(%1A>&5S/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M92!4
M87AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
M<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HX<'0[.SXF;F)S<#L\+W`^/'`@<W1Y
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M(&)E(')E86QI>F5D+B`@5&AE($-O;7!A;GDF(S@R,3<[<R!A8FEL:71Y('1O
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M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y
M,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34O5V]R
M:W-H965T<R]3:&5E=#$W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%34-!0SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY4:&4@0V]M<&%N>2!A;F0@4W5M;6%R>2!O9B!3:6=N
M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A0;VQI8VEE<RD\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5S8W)I<'1I;VX@
M;V8@0G5S:6YE<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O
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M+B`@5&AE($-O;7!A;GDF(S@R,3<[<R!L96%D('!R;V1U8W0@8V%N9&ED871E
M+"!'96YC87)O)B,X-#@R.R`H8G5C:6YD;VQO;"!H>61R;V-H;&]R:61E*2P@
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M;VXL(&]R($A&4D5&+B`@5&AE($-O;7!A;GD@:&%S(&ED96YT:69I960@8V]M
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M="!T:&ES(&AY<&]T:&5S:7,@:6X@82!0:&%S92`R0B\S(&-L:6YI8V%L('1R
M:6%L(&]F($=E;F-A<F\L(&MN;W=N(&%S($=%3D5424,M048N(%1H92!!1B!I
M;F1I8V%T:6]N(&9O<B!'96YC87)O('=A<R!C:&]S96X@8F%S960@;VX@<')I
M;W(@8VQI;FEC86P@9&%T82!F<F]M('1H92!P<F5V:6]U<VQY(&-O;F1U8W1E
M9"!0:&%S92`S(&AE87)T(&9A:6QU<F4@*$A&*2!T<FEA;"!O9B!'96YC87)O
M(&EN(#(L-S`X($A&('!A=&EE;G1S+"!O<B!T:&4@0D535"!T<FEA;"P@=VAI
M8V@@<W5G9V5S=&5D('1H870@1V5N8V%R;R!M87D@8F4@<W5C8V5S<V9U;"!I
M;B!R961U8VEN9R!O<B!P<F5V96YT:6YG($%&+B`@1T5.151)0RU!1B!I<R!A
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M:7IE.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[
M/"]P/CQP('-T>6QE/3-$=&5X="UA;&EG;CIL969T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M=V5I9VAT
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M87-E(#)"('-T=61Y(&]F(&%P<')O>&EM871E;'D@,C`P($A&4D5&('!A=&EE
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M<')O8V5E9"!T;R!0:&%S92`S(&%N9"!E;G)O;&P@86X@861D:71I;VYA;"`T
M,C`@<&%T:65N=',N("!4:&4@1%--0B!W:6QL(&UA:V4@=&AE:7(@<F5C;VUM
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M9&5N+"!A;F0@<V%F971Y+B`@(%-H;W5L9"!T:&4@1%--0B!I;G1E<FEM(&%N
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M(&QE87-T(#(P,C8@:6X@=&AE(%4N4RX@86YD(&EN=&\@,C`R-2!I;B!%=7)O
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M96YC87)O(&EN=&\@,C`R.2!O<B`R,#,P(&EN('1H92!5+E,N(&%N9"!%=7)O
M<&4N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HQ,G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O(&-O;7!L971E
M(&)O=&@@<&AA<V5S(&]F('1H92!'14Y%5$E#+4%&(&-L:6YI8V%L('1R:6%L
M(&%N9"!S=6)M:70@9F]R($9$02!A<'!R;W9A;"P@=&AE($-O;7!A;GD@=VEL
M;"!N965D('1O(')A:7-E(&%D9&ET:6]N86P@8V%P:71A;"X@268@=&AE($-O
M;7!A;GD@:7,@=6YA8FQE('1O(&]B=&%I;B!A9&1I=&EO;F%L(&9U;F1I;F<@
M;W(@:7,@=6YA8FQE('1O(&-O;7!L971E(&$@<W1R871E9VEC('1R86YS86-T
M:6]N+"!I="!M87D@:&%V92!T;R!D:7-C;VYT:6YU92!D979E;&]P;65N="!A
M8W1I=FET:65S(&]N($=E;F-A<F\@;W(@9&ES8V]N=&EN=64@:71S(&]P97)A
M=&EO;G,N(#PO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$979E;&]P;65N="!3=&%G92!2
M:7-K<RP@3&EQ=6ED:71Y(&%N9"!';VEN9R!#;VYC97)N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF
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M(&YE8V5S<V%R>2!T;R!F=6YD(&ET<R!O<&5R871I;VYS+B`@5&AE($-O;7!A
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M9"!O;B!$96-E;6)E<B8C,38P.S$W+"`R,#`Q+"!O<B!);F-E<'1I;VXL('1H
M92!#;VUP86YY(&AA<R!I;F-U<G)E9"!S=6)S=&%N=&EA;"!L;W-S97,@86YD
M(&YE9V%T:79E(&-A<V@@9FQO=W,@9G)O;2!O<&5R871I;VYS+B!3:6YC92!)
M;F-E<'1I;VXL('1H92!#;VUP86YY(&EN8W5R<F5D(&$@;&]S<R!F<F]M(&]P
M97)A=&EO;G,@;V8@)#$P."XU(&UI;&QI;VX@86YD(&AA9"!N96=A=&EV92!C
M87-H(&9L;W=S(&9R;VT@;W!E<F%T:6]N<R!O9B`D,3`V+C0@;6EL;&EO;BX@
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M<G)A;G1S+B`@26X@1F5B<G5A<GD@,C`Q-"P@=&AE($-O;7!A;GD@8V]M<&QE
M=&5D(&$@<'5B;&EC(&5Q=6ET>2!O9F9E<FEN9R!R86ES:6YG(&%P<')O>&EM
M871E;'D@)#<N.2!M:6QL:6]N(&EN(&YE="!P<F]C965D<R!T;R!P<F]V:61E
M(&%D9&ET:6]N86P@9G5N9',@9F]R('1H92!0:&%S92`R0B\S($=%3D5424,M
M048@=')I86P@86YD('1H92!#;VUP86YY)B,X,C$W.W,@;VYG;VEN9R!O<&5R
M871I;VYS+B!4:&4@0V]M<&%N>2!H87,@:6YI=&EA=&5D('-C<F5E;FEN9R!O
M9B!P871I96YT<R!F;W(@=&AE(%!H87-E(#)"+S,@1T5.151)0RU!1B!T<FEA
M;"P@86YD('1H92!#;VUP86YY(&%N=&EC:7!A=&5S('1H870@:71S(&-U<G)E
M;G0@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R`@=VEL;"!B92!S=69F:6-I
M96YT('1O(&9U;F0@:71S(&]P97)A=&EO;G,L(&%T(&ET<R!P<F]J96-T960@
M8V]S="!S=')U8W1U<F4L('1H<F]U9V@@870@;&5A<W0@=&AE(&5N9"!O9B`R
M,#$U+B`@2&]W979E<BP@:6X@;&EG:'0@;V8@=&AE('-I9VYI9FEC86YT('5N
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M:6YG(&]P97)A=&EO;G,N)B,Q-C`[268@=&AE($-O;7!A;GD@:7,@9&5L87EE
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M/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S
M93L@=VED=&@Z.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT9"!V
M86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN
M;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HV<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG<R`R
M)SMF;VYT+7-I>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\=&0@
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M;6%Y(&)E8V]M92!A=F%I;&%B;&4[(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO
M=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B
M;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDU+C0V)3MM87)G:6XM
M;&5F=#HT+C4T)3LG/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED
M=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B=7:6YG9&EN9W,@,B<[9F]N="US:7IE.C$P<'0[)SXF(S$U
M,3L\+V9O;G0^/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I
M9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
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M<VEB;&4@1D1!(&%P<')O=F%L(&9O<B!'96YC87)O.R`\+V9O;G0^/"]P/CPO
M=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T/CQT86)L
M92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
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M,'!T.R<^)B,Q-3$[/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@
M<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M>2!A;F0@8V]S="!O9B!A9&1I=&EO;F%L(&5Q=6ET>2!C87!I=&%L.R`\+V9O
M;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L
M969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W
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M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T
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M(&-O;6UO;B!S=&]C:R!O;B!T:&4@3F%S9&%Q($-A<&ET86P@36%R:V5T.R`\
M+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX]
M,T1L969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E
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M86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ
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M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z
M.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT9"!V86QI9VX],T1T
M;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG<R`R)SMF;VYT+7-I
M>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$
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M:71S(&]P97)A=&EO;G,[(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^
M/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M
M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDU+C0V)3MM87)G:6XM;&5F=#HT
M+C4T)3LG/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z-"XU
M-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B=7:6YG9&EN9W,@,B<[9F]N="US:7IE.C$P<'0[)SXF(S$U,3L\+V9O
M;G0^/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU
M+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED
M=&@Z.34N-#8E.VUA<F=I;BUL969T.C0N-30E.R<^/'1R/CQT9"!V86QI9VX]
M,T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[
M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ)U=I;F=D:6YG<R`R)SMF;VYT
M+7-I>F4Z,3!P=#LG/B8C,34Q.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N
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M;VUP86YY+"`@;W(@;F]T(&)E(&%V86EL86)L92!O;B!A8V-E<'1A8FQE('1E
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M;7!A;GD@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N+B`@5&AE($-O
M;7!A;GD@;6%Y(&YO="!B92!A8FQE('1O(')A:7-E('-U9F9I8VEE;G0@8V%P
M:71A;"!O;B!A8V-E<'1A8FQE('1E<FUS+"!O<B!A="!A;&PL('1O(&-O;G1I
M;G5E(&1E=F5L;W!M96YT(&]F($=E;F-A<F\@;W(@=&\@;W1H97)W:7-E(&-O
M;G1I;G5E(&]P97)A=&EO;G,@86YD(&UA>2!N;W0@8F4@86)L92!T;R!E>&5C
M=71E(&%N>2!S=')A=&5G:6,@=')A;G-A8W1I;VXN(#PO9F]N=#X\+W`^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y2979E<G-E(%-T;V-K(%-P;&ET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z
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M9F5C=',@;V8@=&AI<R!A8W1I;VXN(#PO9F]N=#X\+W`^/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I
M<R!O9B!0<F5S96YT871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HQ.'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0F%S:7,@;V8@4')E<V5N
M=&%T:6]N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
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M;G-T<G5C=&EO;G,@=&\@1F]R;2`Q,"U1(&%N9"!2=6QE(#$P+3`Q(&]F(%)E
M9W5L871I;VX@4RU8+B9N8G-P.R9N8G-P.T%C8V]R9&EN9VQY+"!T:&5S92!F
M:6YA;F-I86P@<W1A=&5M96YT<R!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE
M(&EN9F]R;6%T:6]N(&%N9"!F;V]T;F]T97,@<F5Q=6ER960@8GD@86-C;W5N
M=&EN9R!P<FEN8VEP;&5S(&=E;F5R86QL>2!A8V-E<'1E9"!I;B!T:&4@56YI
M=&5D(%-T871E<R!O9B!!;65R:6-A(&9O<B!C;VUP;&5T92!F:6YA;F-I86P@
M<W1A=&5M96YT<RXF(S$V,#L@26X@=&AE(&]P:6YI;VX@;V8@;6%N86=E;65N
M="P@=&AE<V4@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!A;&P@;F]R
M;6%L(&%N9"!R96-U<G)I;F<@861J=7-T;65N=',@8V]N<VED97)E9"!N96-E
M<W-A<GD@9F]R(&$@9F%I<B!P<F5S96YT871I;VX@;V8@=&AE<V4@:6YT97)I
M;2!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N("!4:&4@<F5S
M=6QT<R!O9B!O<&5R871I;VYS(&9O<B!T:&4@=&AR964@;6]N=&AS(&5N9&5D
M($UA<F-H)B,Q-C`[,S$L(#(P,30@87)E(&YO="!N96-E<W-A<FEL>2!I;F1I
M8V%T:79E(&]F(')E<W5L=',@97AP96-T960@9F]R('1H92!F=6QL('EE87(@
M96YD:6YG($1E8V5M8F5R)B,Q-C`[,S$L(#(P,30N)B,Q-C`[(%1H92!#;VUP
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M36%R8V@F(S$V,#LS,2P@,C`Q-"X@5&AE<V4@=6YA=61I=&5D(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!S:&]U;&0@8F4@<F5A9"!I;B!C
M;VYJ=6YC=&EO;B!W:71H('1H92!A=61I=&5D(&-O;G-O;&ED871E9"!F:6YA
M;F-I86P@<W1A=&5M96YT<R!A;F0@9F]O=&YO=&5S('1H97)E=&\@9F]R('1H
M92!Y96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@:6YC;'5D960@
M:6X@=&AE($-O;7!A;GDF(S@R,3<[<R!!;FYU86P@4F5P;W)T(&]N($9O<FT@
M,3`M2R!F:6QE9"!W:71H('1H92!396-U<FET:65S(&%N9"!%>&-H86YG92!#
M;VUM:7-S:6]N+"!A<R!A;65N9&5D+B!!;6]U;G1S('!R97-E;G1E9"!A<F4@
M<F]U;F1E9"!T;R!T:&4@;F5A<F5S="!T:&]U<V%N9"P@=VAE<F4@:6YD:6-A
M=&5D+"!E>&-E<'0@<&5R('-H87)E(&1A=&$@86YD('!A<B!V86QU97,N(#PO
M9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VYC96YT<F%T:6]N<R!O9B!#<F5D:70@4FES
M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\<"!S
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M86YT.B!N;W)M86P[)SY#;VYC96YT<F%T:6]N<R!O9B!#<F5D:70@4FES:R`\
M+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z-G!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
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M<G)E;F-Y(&AE9&=I;F<@87)R86YG96UE;G1S+B`@5&AE($-O;7!A;GD@;6%I
M;G1A:6YS(&-A<V@@86YD(&-A<V@@97%U:79A;&5N="!B86QA;F-E<R!I;B!T
M:&4@9F]R;2!O9B!B86YK(&1E;6%N9"!D97!O<VET<RP@;6]N97D@;6%R:V5T
M(&9U;F0@86-C;W5N=',@86YD(&1E8G0@<V5C=7)I=&EE<R!W:71H(&9I;F%N
M8VEA;"!I;G-T:71U=&EO;G,@=&AA="!M86YA9V5M96YT(&)E;&EE=F5S(&%R
M92!C<F5D:71W;W)T:'DN(%-U8V@@8F%L86YC97,@;6%Y(&%T('1I;65S(&5X
M8V5E9"!T:&4@:6YS=7)E9"!A;6]U;G0N(#PO9F]N=#X\+W`^/"]D:78^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8V-R=65D($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,3AP=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT
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M;64N(#PO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE
M970Q."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/DYE="!,;W-S(%!E<B!3:&%R92`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F($)A<VEC(&%N9"!$
M:6QU=&5D($QO<W,@4&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,3)P=#MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P
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M<&5R('-H87)E(&9O;&QO=W,Z(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
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M.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C<V
M)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,S8E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/E1H<F5E($UO;G1H<R!%;F1E9"!-87)C:"`S
M,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-3$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,30\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HU,24[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+7-I>F4Z.'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+7-I>F4Z.'!T.V9O
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M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,3`E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$P)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3F5T
M(&QO<W,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M
M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,34E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#(L,S@Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,3`E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q+#`W
M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HU,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,34E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#(L,S@Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN
M9RU";W1T;VTZ,'!T.W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B@Q+#`W,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HU,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/E=E:6=H=&5D(&%V97)A9V4@<VAA<F5S(&]F(&-O
M;6UO;B!S=&]C:R!O=71S=&%N9&EN9SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$X+#<X-2PT,3@\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,RPP,S<L-30V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W=I9'1H.C4Q)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF(S@R,3([/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[=VED=&@Z-3$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#LF;F)S<#L@<&5R('-H87)E(&%T=')I8G5T960@=&\@8V]M;6]N
M('-T;V-K:&]L9&5R<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C,L,#,T+#<V,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C4Q
M)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY"87-I8R!A;F0@9&EL=71E9"!L;W-S('!E<B!S:&%R93PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH,"XQ,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH,"XS-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T
M9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE970Q.2YH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y
M(&%N9"!%<75I<&UE;G0@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4W5M;6%R>2!O9B!0<F]P97)T>2!A;F0@17%U
M:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-
M"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0@8V]N
M<VES="!O9B!T:&4@9F]L;&]W:6YG("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ
M,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-
M"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E
M.F-O;&QA<'-E.R!W:61T:#HX-"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z-#`E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S
M<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$X)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY%<W1I;6%T960@3&EF93PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$V)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY-87)C
M:"`S,2P\+V9O;G0^/"]P/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$T/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$V)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B`S,2P\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C0P)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0V]M<'5T97(@
M97%U:7!M96YT/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3@E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,R!Y96%R
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-"4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXY.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,3`E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.3D\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z-#`E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ."4[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4@>65A<G,\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$T,CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,"4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$T,CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HT,"4[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$X)3L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^-2!Y96%R<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$T)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^.#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,3`E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXX.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HT,"4[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/D-O;7!U=&5R('-O9G1W87)E/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ."4[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C,@>65A<G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ,"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ,"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HT,"4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3&5A<V5H;VQD(&EM
M<')O=F5M96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED
M=&@Z,3@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DQE<W-E<B!O9B!U<V5F=6P@
M;&EF92!O<B!L:69E(&]F('1H92!L96%S93PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN
M9RU";W1T;VTZ,'!T.W=I9'1H.C0P)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ."4[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$T)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C4Q-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU,30\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED
M=&@Z-#`E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A
M9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-"4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3`E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^*#0X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O
M;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T
M:#HT,"4[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ."4[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,30E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C8\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ,"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR.3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/B9N8G-P.SPO<#X\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W
M.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34O5V]R:W-H965T<R]3:&5E=#(P+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I
M;F=E;F-I97,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1G5T=7)E($UI;FEM=6T@3&5A<V4@4&%Y;65N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4]
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M;&5A<V4L(&5N=&5R960@:6YT;R!O;B!&96)R=6%R>2`X+"`R,#`X(&9O<B!O
M9F9I8V4@9F%C:6QI=&EE<R!I;B!"<F]O;69I96QD+"!#;VQO<F%D;RP@<V5R
M=F5D(&%S('1H92!#;VUP86YY)B,X,C$W.W,@<')I;6%R>2!B=7-I;F5S<R!O
M9F9I8V4@=&AR;W5G:"!397!T96UB97(@,S`L(#(P,3,N)FYB<W`[)FYB<W`[
M0F5L;W<@:7,@82!S=6UM87)Y(&]F('1H92!F=71U<F4@;6EN:6UU;2!L96%S
M92!P87EM96YT<R!C;VUM:71T960@9F]R('1H92!#;VUP86YY)B,X,C$W.W,@
M9F%C:6QI='D@:6X@5V5S=&UI;G-T97(L($-O;&]R861O(&%S(&]F($UA<F-H
M)B,Q-C`[,S$L(#(P,30@*&EN('1H;W5S86YD<RDZ/"]F;VYT/CPO<#X\+V1I
M=CX\9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C$R<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\
M9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C8X)3LG/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HX-B4[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E)E;6%I
M;F1E<B!O9B`R,#$T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$Q)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU.3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D
M:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P
M.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-38E.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M,#$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$=VED=&@Z,3`E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@P/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HU-B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-C(\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W=I9'1H.C4V)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY4;W1A;"!F=71U<F4@;6EN:6UU;2!L96%S
M92!P87EM96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^
M/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C$R<'0[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?8S1A
M.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y
M-2]7;W)K<VAE971S+U-H965T,C$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4U1CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@*%1A
M8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S
M,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F]N+4-A<V@L(%-H87)E+4)A<V5D($-O;7!E;G-A=&EO;B!%>'!E;G-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.W1E>'0M:6YD
M96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D9O<B!T:&4@=&AR964@;6]N=&@@<&5R:6]D(&5N9&5D($UA
M<F-H)B,Q-C`[,S$L(#(P,30@86YD(#(P,3,@86YD(&9O<B!T:&4@<&5R:6]D
M(&9R;VT@26YC97!T:6]N('1H<F]U9V@@36%R8V@F(S$V,#LS,2P@,C`Q-"P@
M=&AE($-O;7!A;GD@<F5C;V=N:7IE9"!T:&4@9F]L;&]W:6YG(&YO;BUC87-H
M+"!S:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS92!I;B!T:&4@8V]N
M<V]L:61A=&5D('-T871E;65N="!O9B!O<&5R871I;VYS("AI;B!T:&]U<V%N
M9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N
M=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R
M9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HX-"4[)SX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z-3,E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-B!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C,P)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+7=E:6=H
M=#IB;VQD.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY4:')E92!-;VYT:',@16YD960@36%R
M8V@@,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,30E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY097)I;V0@9G)O;2!$96-E;6)E<B`Q-RP@,C`P,2`H
M9&%T92!O9B!I;F-E<'1I;VXI('1O($UA<F-H(#,Q+#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M.C`N-S5P=#MW:61T:#HU,R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXR,#$T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXR,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$T)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$T
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C4S)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^-S`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C4S)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$Q.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,2PY,S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z-3,E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E)E<W1R=6-T=7)I
M;F<@17AP96YS93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$R)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,X-SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C4S)3L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ-3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXT,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C,L,#(Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[=&5X="UI;F1E
M;G0Z,"4[9F]N="US:7IE.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5M;6%R>2!O9B!3=&]C:R!/<'1I
M;VX@06-T:79I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
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M97)I;V0@96YD960@36%R8V@F(S$V,#LS,2P@,C`Q-"!U;F1E<B!T:&4@0V]M
M<&%N>28C.#(Q-SMS('-T;V-K(&EN8V5N=&EV92`@<&QA;G,@=V5R92!A<R!F
M;VQL;W=S.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ
M,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO
M9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HX-"4[)SX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[=VED=&@Z-#`E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$T)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^17AE<F-I<V4\+V9O;G0^/"]P/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY0<FEC93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D
M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ-"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960@079E<F%G
M92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;3PO9F]N=#X\+W`^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
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M9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-3,E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/<'1I;VYS
M(&]U='-T86YD:6YG(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[
M=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXS+C<V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@N.30\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z-#`E.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A
M9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,"PP-SD\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+CDQ/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[
M<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C0P)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ-"4[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,X
M,C$R.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$T)3L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF(S@R,3([
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T
M=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W=I9'1H.C0P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY&;W)F96ET960@86YD(&-A;F-E;&QE9#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*#(W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,2PY,#@N,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W=I9'1H.C0P)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY/<'1I;VYS(&]U='-T86YD:6YG(&%T($UA<F-H(#,Q
M+"`R,#$T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T
M.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z
M,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,RXS-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP
M+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^."XY,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP
M861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C0P)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.R!B;W)D97(M=&]P
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T
M;VTZ,'!T.W=I9'1H.C$R)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[
M(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z-#`E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/<'1I;VYS(&5X97)C:7-A
M8FQE(&%T($UA<F-H(#,Q+"`R,#$T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I
M;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z
M,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW
M:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C(V-BPV-34\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^."XT,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$<&%D9&EN9RUL969T.C!P
M=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D
M9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-RXQ,SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HT,"4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/D]P=&EO;G,@=F5S=&5D(&%N9"!E>'!E8W1E
M9"!T;R!V97-T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN
M9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ,B4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L,#,Q
M+#,X,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O
M='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3(E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C,W
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M
M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I
M;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O
M;3HP<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXX+CDR/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C9P=#L[/B9N
M8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@4E-5(&%C=&EV:71Y/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M:6YD96YT
M.C`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z-G!T
M.SLG/B9N8G-P.SPO<#X-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HX,"4[)SX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D
M:6YG+51O<#HP+C<U<'0[=VED=&@Z-C,E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$W)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY.=6UB97(@;V8@4VAA<F5S/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG
M+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,B4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U
M<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$W)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY796EG:'1E9"!!=F5R86=E($=R86YT($1A=&4@1F%I<B!686QU93PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT
M.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
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M9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HV,R4[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E)E<W1R:6-T960@<W1O8VL@=6YI=',@;W5T<W1A;F1I;F<@870@
M1&5C96UB97(F(S$V,#LS,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C0Q.2PP,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D
M9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O
M<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A
M9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4
M;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HR)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG
M+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N
M-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I
M9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$N,SD\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ
M,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z-C,E.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$Y,2PW,#`\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P
M=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HR)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'!A9&1I;F<M
M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW
M-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1P861D:6YG
M+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N
M-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,34E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C8S)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5F5S=&5D(&%N9"!R96QE87-E
M9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z
M,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP
M861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,3<E.SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$<&%D9&EN9RUL969T
M.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[
M<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F
M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HR)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W!A9&1I
M;F<M0F]T=&]M.C!P=#MW:61T:#HQ-R4[/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)B,X,C$R.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M5&]P.C`N-S5P=#MW:61T:#HV,R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T
M.W!A9&1I;F<M0F]T=&]M.C!P=#MW:61T:#HQ-R4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU"
M;W1T;VTZ,'!T.W=I9'1H.C$W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,X,C$R.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I
M9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M<'0[<&%D9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C8S)3L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY297-T<FEC=&5D
M('-T;V-K('5N:71S(&]U='-T86YD:6YG(&%T($UA<F-H(#,Q+"`R,#$T/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,'!T.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M
M5&]P.C`N-S5P=#MP861D:6YG+4)O='1O;3HP<'0[=VED=&@Z,34E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^-C$P+#<P,#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG
M+51O<#HP+C<U<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D
M:6YG+5)I9VAT.C`N-S5P=#MP861D:6YG+51O<#HP+C<U<'0[=VED=&@Z,B4[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,'!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-7!T.W!A9&1I;F<M5&]P.C`N-S5P=#MP861D
M:6YG+4)O='1O;3HP<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C!P=#MP861D:6YG+5)I9VAT.C`N-S5P=#MP
M861D:6YG+51O<#HP+C<U<'0[<&%D9&EN9RU";W1T;VTZ,'!T.W=I9'1H.C$U
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M9&EN9RU4;W`Z,"XW-7!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/"]T86)L93X\<"!S
M='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.W1E>'0M
M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.SL^)FYB<W`[/"]P/CPO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A
M,#<T.&0Y-2]7;W)K<VAE971S+U-H965T,C(N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5014%'
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E1H92!#;VUP86YY(&%N9"!3=6UM
M87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@*$1E=&%I
M;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/C$T-R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,#0L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CY0871I96YT<SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L
M(#(P,30\8G(^5'=O(%IE<F\@3VYE($9O=7(@17%U:71Y($9I;F%N8VEN9W,\
M8G(^4F5G:7-T97)E9"!$:7)E8W0@3V9F97)I;F<\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CY0:&%S92`S(&AE
M87)T(&9A:6QU<F4@*$A&*2!T<FEA;"!O9B!'96YC87)O/&)R/E!A=&EE;G1S
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D-O;7!A;GD@1&5V96QO<&UE;G0@4W1A9V4@86YD($)A<VES(&]F(%!R97-E
M;G1A=&EO;B`H5&5X='5A;"D@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!P
M871I96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L-S`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.=6UB97(@;V8@<&%T:65N=',@8V]M<&%N>2!P;&%N<R!T;R!E
M;G)O;&P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3G5M8F5R(&]F('EE87)S('1O(&-O;7!L971E('1H92!S='5D>3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R('EE87)S(#8@;6]N
M=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y,;W-S(&9R;VT@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,BPS.3`L,#`P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,2PP-S`L,#`P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#$P."PU,#`L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,3`X+#0W,RPP,#`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@9FQO=W,@9G)O
M;2!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3`V+#0P,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y&=6YD(')A:7-E9"!T:')O=6=H('-A;&4@
M;V8@8V]N=F5R=&EB;&4@<')E9F5R<F5D(&%N9"!C;VUM;VX@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#,P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L
M.#0Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!I<W-U86YC92!O9B!C;VUM
M;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DL
M,#$X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PW-#$L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(T+#@V."PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<L.3`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E=F5R<V4@<W1O8VL@<W!L:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<Q+69O<BTV(')E=F5R<V4@<W!L:70\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X
M7S1F.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU
M+U=O<FMS:&5E=',O4VAE970R,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13%904<^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3F5T($QO<W,@4&5R(%-H87)E("A$971A:6QS
M*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@97AC97!T(%-H87)E(&1A=&$L
M('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3`^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,C0@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,30W($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`Y/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#@\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`V/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#4\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-#QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4W5M;6%R>2!O9B!B87-I8R!A;F0@9&EL=71E9"!L;W-S('!E<B!S:&%R93PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#(L,S@Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,2PP-S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@V+#DS.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#0L,S(P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-2PS-C0I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@X+#0R,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#DL,3,X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,3DL-#,Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3,L.3DT*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-2PR-#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q
M+#0U.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#4Q,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#$Q-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#<W+#,R,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S(&%V86EL86)L
M92!T;R!C;VUM;VX@<VAA<F5H;VQD97)S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#(L,S@Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,2PP-S$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#@P+#,W
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=E:6=H=&5D(&%V97)A9V4@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!O
M=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@L
M-S@U+#0Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,L,#,W+#4T-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&5S<SH@5V5I9VAT960M
M879E<F%G92!S:&%R97,@;V8@=6YV97-T960@8V]M;6]N('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPW.#,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@=V5I9VAT960M879E<F%G92!S:&%R97,@=7-E9"!I;B!C;VUP
M=71I;F<@;F5T(&QO<W,@<&5R('-H87)E(&%T=')I8G5T960@=&\@8V]M;6]N
M('-T;V-K:&]L9&5R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3@L-S@U+#0Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,L,#,T+#<V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD(&1I
M;'5T960@;&]S<R!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,"XQ,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#`N,S4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F
M.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O
M<FMS:&5E=',O4VAE970R-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14A(/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/DYE="!,;W-S(%!E<B!3:&%R92`H1&5T86EL<R!497AT
M=6%L*3QB<CY);B!-:6QL:6]N<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I
M960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^16%R;FEN9W,@*$QO<W,I(%!E<B!3:&%R92`H5&5X='5A;"D@6T%B<W1R
M86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!O=&5N=&EA;&QY(&1I;'5T:79E('-H87)E<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$N,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?
M8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(T
M.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-2]7;W)K<VAE971S
M+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5)1D%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/DUE<F=E<B!W:71H($YU=F5L;RP@26YC+B!O;B!*86YU87)Y(#(W
M+"`R,#`Y("A$971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,30W($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#(W+"`R,#`Y/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0G5S
M:6YE<W,@06-Q=6ES:71I;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D('1O=&%L
M(&%C<75I<VET:6]N(&-O;G-I9&5R871I;VX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,3$L.3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!A<W-E=',@86-Q=6ER
M960@:6X@=&AE($UE<F=E<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S<L,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DYE="!A<W-E=',@86-Q=6ER960L(&EN8VQU9&EN
M9R!C87-H+"!C87-H(&5Q=6EV86QE;G1S(&%N9"!M87)K971A8FQE('-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0U+#4P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y'86EN(&]N(&)A<F=A:6X@<'5R8VAA<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,C4L,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C4L,C@R+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?
M8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T
M.&0Y-2]7;W)K<VAE971S+U-H965T,C8N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)2T%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9A:7(@5F%L=64@1&ES8VQO<W5R97,@
M*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E($1I<V-L;W-U<F5S("A4
M97AT=6%L*2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4<F%N<V9E<G,@;V8@87-S971S(&)E='=E96X@
M9F%I<B!V86QU92!H:65R87)C:'D@;&5V96QS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DUO;F5Y($UA<FME="!&=6YD<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E
M($1I<V-L;W-U<F5S("A497AT=6%L*2!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&5Q=6EV86QE
M;G1S(&-O;G-I<W1I;F<@;V8@;6]N97D@;6%R:V5T(&9U;F1S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(Q+#$P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I
M<B!686QU92!$:7-C;&]S=7)E<R`H5&5X='5A;"D@6T%B<W1R86-T73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!E
M<75I=F%L96YT<R!C;VYS:7-T:6YG(&]F(&UO;F5Y(&UA<FME="!F=6YD<RP@
M;6%T=7)I='D@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG.3`@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y
M,E]A-C0P7V)A.3)A,#<T.&0Y-2]7;W)K<VAE971S+U-H965T,C<N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5)2D%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y
M(&%N9"!%<75I<&UE;G0@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A
M;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VUP;VYE;G1S(&]F(%!R
M;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@17%U:7!M96YT+"!'
M<F]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4Q
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-C=6UU;&%T960@9&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0X."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T.#4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M<&5R='D@86YD(&5Q=6EP;65N="P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUP=71E<B!%<75I<&UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;7!O;F5N=',@
M;V8@4')O<&5R='D@86YD(&5Q=6EP;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!,:69E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y
M(&%N9"!%<75I<&UE;G0L($=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,86(@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VUP;VYE;G1S(&]F(%!R;W!E
M<G1Y(&%N9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@3&EF93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@17%U
M:7!M96YT+"!'<F]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y&=7)N:71U<F4@86YD($9I>'1U<F5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VUP;VYE;G1S(&]F(%!R
M;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@3&EF93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@
M17%U:7!M96YT+"!'<F]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M<'5T97(@4V]F='=A<F4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;7!O;F5N=',@;V8@4')O<&5R
M='D@86YD(&5Q=6EP;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!,:69E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!%<75I
M<&UE;G0L($=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQE87-E:&]L9"!);7!R;W9E;65N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;7!O;F5N=',@;V8@4')O
M<&5R='D@86YD(&5Q=6EP;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!,:69E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG3&5S<V5R(&]F('5S969U;"!L:69E(&]R
M(&QI9F4@;V8@=&AE(&QE87-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD($5Q=6EP;65N="P@
M1W)O<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A
M,#<T.&0Y-2]7;W)K<VAE971S+U-H965T,C@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)14%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y(&%N9"!%<75I<&UE
M;G0@*$1E=&%I;',@5&5X='5A;"D@*%531"`D*3QB<CY);B!4:&]U<V%N9',L
M('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ
M-#<@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4')O<&5R='D@86YD($5Q=6EP;65N="`H5&5X='5A;"D@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.#`Y/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#@P.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?8S1A
M.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y
M-2]7;W)K<VAE971S+U-H965T,CDN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V54%'/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/D-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG96YC
M:65S("A$971A:6QS(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$T-R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;"X@,S$L(#(P,#@\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CY797-T
M;6EN<W1E<BP@0V]L;W)A9&\\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^075G+B`P,2P@,C`Q,SQB<CY797-T;6EN<W1E<BP@0V]L;W)A9&\\
M8G(^<W%F=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$T/&)R/D)R;V]M9FEE;&0L($-O;&]R861O/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;6UI=&UE;G1S
M(&%N9"!#;VYT:6YG96YC:65S("A497AT=6%L*2!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M<F5A(&]F(&]F9FEC92!F86-I;&ET:65S('1A:V5N(&]N(&QE87-E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,S`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&5A<V4@
M97AP:7)Y('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/E-E<"`S,"P-"@D),C`Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#Y397`@,S`L#0H)"3(P,3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE87-E('1E
M<FT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,R!Y96%R
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y296YT(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$Y+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,3(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U.3<L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;&EN:6-A;"!R
M97-E87)C:"!A9W)E96UE;G0@=VET:"!$=6ME(%5N:79E<G-I='DL('1E<FUI
M;F%T:6]N(&YO=&EC92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG.3`@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E9"!M:6QE<W1O;F4@<&%Y
M;65N=',@=7!O;B!A<'!R;W9A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^."PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;F]T:&5R(&5X<&5C=&5D(&UI;&5S
M=&]N92!P87EM96YT<R!U<&]N(&%P<')O=F%L/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EN:6UU;2!P97)C
M96YT86=E(&]F(')O>6%L='D@;V)L:6=A=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3(N-3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87AI;75M('!E<F-E;G1A
M9V4@;V8@<F]Y86QT>2!O8FQI9V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V1U8W0@<V%L97,@;&5V96QS
M(')O>6%L='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4N,#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y-:6YI;75M('!E<F-E;G1A9V4@;V8@<F%N9V4@;V8@<F]Y86QT
M:65S('1H870@8V%N(&)E(&)U>2!D;W=N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,BXU,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T@<&5R8V5N=&%G92!O
M9B!R86YG92!O9B!R;WEA;'1I97,@=&AA="!C86X@8F4@8G5Y(&1O=VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+C`P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EL
M97-T;VYE('!A>6UE;G0@9'5E('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S8@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T
M,%]B83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E
M=',O4VAE970S,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q
M=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA
M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14)"04,^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q
M/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,@*$1E=&%I
M;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E
M('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^0V]M;6ET;65N=',@06YD($-O;G1I;F=E;F-I
M97,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y296UA:6YD97(@;V8@,C`Q-#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q-3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/C(P,38\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@9G5T=7)E(&UI;FEM=6T@;&5A<V4@<&%Y
M;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C`Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA
M,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P
M-S0X9#DU+U=O<FMS:&5E=',O4VAE970S,2YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15I%0DD^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^17%U:71Y($9I;F%N8VEN9W,@86YD
M(%=A<G)A;G1S("A$971A:6QS(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D5Q=6ET>2!F:6YA;F-I;F=S(&%N9"!W87)R86YT<R`H5&5X='5A
M;"D@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!W87)R86YT<R!O=71S=&%N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PT,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQA
M<W,@;V8@=V%R<F%N="!O<B!R:6=H=',@97AP:7)A=&EO;B!D871E(&5A<FQI
M97-T+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S(P,38M,#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;&%S<R!O9B!W87)R86YT(&]R(')I9VAT<R!E>'!I<F%T:6]N(&1A=&4@
M;&%T97-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`R,"TP
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUI;FEM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D5Q=6ET>2!F:6YA;F-I;F=S(&%N9"!W87)R86YT<R`H5&5X
M='5A;"D@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@<')I8V4@<&5R('-H87)E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5Q=6ET
M>2!F:6YA;F-I;F=S(&%N9"!W87)R86YT<R`H5&5X='5A;"D@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=A<G)A;G0@<')I8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$Q-BXX.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5Q=6ET>2!F
M:6YA;F-I;F=S(&%N9"!W87)R86YT<R`H5&5X='5A;"D@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A
M<G)A;G0@<')I8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(N,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y025!%(%1R86YS86-T:6]N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%<75I='D@9FEN86YC
M:6YG<R!A;F0@=V%R<F%N=',@*%1E>'1U86PI(%M!8G-T<F%C=%T\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A
M=&4@8V]M;6]N('-T;V-K('-O;&0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS-38L-#,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!A=F%I;&%B;&4@=&\@<'5R8VAA
M<V4@861D:71I;VYA;"!C;VUM;VYS('-H87)E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(T.2PU,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!G<F]S<R!P<F]C
M965D<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PP,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F]C965D<R!F<F]M('1H92!I<W-U86YC92!O9B!C;VUM;VX@<W1O
M8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#4L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M=6)L:6,@17%U:71Y($]F9F5R:6YG($-L;W-E($1A=&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#Y*86X@,C4L#0H)"3(P,3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U8G-C<FEP
M=&EO;B!A9W)E96UE;G0@9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/DIA;B`R,BP-"@D),C`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'5R8VAA<V4@<')I8V4@9F]R(&-O
M;6UO;B!S=&]C:R!U;FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`R+C@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y787)R86YT(&-O=F5R86=E(')A=&EO/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XW/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT('!R:6-E('!E<B!S
M:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXR.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0VQO<VEN9R!B:60@<')I8V4@;V8@=&AE(&-O;6UO;B!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S('=E
M<F4@97AE<F-I<V%B;&4@=7!O;B!I<W-U86YC92P@97AP:7)Y('EE87(\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-R!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQO<VEN
M9R!B:60@<')I8V4@9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/DIA;B`R,BP-"@D),C`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5G:7-T97)E9"!$:7)E8W0@3V9F97)I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D5Q=6ET>2!F:6YA;F-I;F=S(&%N9"!W87)R86YT<R`H5&5X='5A;"D@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%G9W)E9V%T92!C;VUM;VX@<W1O8VL@<V]L9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PQ,38L,C(X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38T+#8S-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N
M=',@879A:6QA8FQE('1O('!U<F-H87-E(&%D9&ET:6]N86P@8V]M;6]N<R!S
M:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C<Y+#`U
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8U+#@U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06=G<F5G871E(&=R;W-S('!R;V-E961S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XX+#<P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,S`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D
M<R!F<F]M('1H92!I<W-U86YC92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.3`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Q-BPP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U8FQI
M8R!%<75I='D@3V9F97)I;F<@0VQO<V4@1&%T93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^1F5B(#<L#0H)"3(P,30\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y&96(@-"P-"@D),C`Q,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W5B<V-R:7!T:6]N(&%G<F5E;65N="!D871E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^2F%N(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!P<FEC
M92!F;W(@8V]M;6]N('-T;V-K('5N:70\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2XW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T+C0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT(&-O=F5R86=E(')A=&EO
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C(U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XT/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R
M86YT('!R:6-E('!E<B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R+C$R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-"XQ,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0VQO<VEN9R!B:60@<')I8V4@;V8@=&AE
M(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3(U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=A<G)A;G1S('=E<F4@97AE<F-I<V%B;&4@=7!O;B!I<W-U
M86YC92P@97AP:7)Y('EE87(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-L;W-I;F<@8FED('!R:6-E(&1A=&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D9E8B`S+`T*"0DR,#$T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M2F%N(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0=6)L:6,@3V9F97)I;F<@?"!397)I97,@02!#
M;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5Q=6ET>2!F:6YA;F-I;F=S(&%N
M9"!W87)R86YT<R`H5&5X='5A;"D@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!C;VUM
M;VX@<W1O8VL@<V]L9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=A<G)A;G1S(&%V86EL86)L92!T;R!P=7)C:&%S92!A9&1I
M=&EO;F%L(&-O;6UO;G,@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-BPR-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@9W)O<W,@<')O8V5E9',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]C965D<R!F<F]M('1H92!I<W-U86YC92!O9B!C;VUM;VX@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPY,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C
M:&%S92!P<FEC92!F;W(@8V]M;6]N('-T;V-K('5N:70\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!C;W9E<F%G92!R
M871I;SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R
M86YT('!R:6-E('!E<B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2XV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y787)R86YT<R!W97)E(&5X97)C:7-A8FQE('5P;VX@
M:7-S=6%N8V4L(&5X<&ER>2!Y96%R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!S:&%R97,@:7-S=65D
M('5P;VX@8V]N=F5R<VEO;B!O9B!E86-H('-H87)E(&]F(&-O;G9E<G1I8FQE
M('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')E9F5R<F5D('-T;V-K(&QI<75I9&%T:6]N('!R969E<F5N
M8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4&5R8V5N=&%G92!O9B!T;W1A;"!N=6UB97(@;V8@<VAA<F5S
M(&]F(&-O;6UO;B!S=&]C:R!T:&5N(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@
M;&EM:70@;VX@8F5N969I8VEA;"!O=VYE<G-H:7`\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY+CDY)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT<FEN<VEC('9A;'5E(&]F(&5M
M8F5D9&5D(&)E;F5F:6-I86P@8V]N=F5R<VEO;B!F96%T=7)E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U8FQI8R!/
M9F9E<FEN9R!\($1I<F5C=&]R(&%N9"!#:&EE9B!%>&5C=71I=F4@3V9F:6-E
M<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M17%U:71Y(&9I;F%N8VEN9W,@86YD('=A<G)A;G1S("A497AT=6%L*2!;06)S
M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V%R<F%N=',@879A:6QA8FQE('1O('!U<F-H87-E(&%D9&ET:6]N
M86P@8V]M;6]N<R!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS.2PP-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R969E<G)E9"!3=&]C:R!0=7)C:&%S960@8GD@3V9F
M:6-E<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8C0X-C<Y83-?
M8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V(T.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T
M.&0Y-2]7;W)K<VAE971S+U-H965T,S(N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5.4T%%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO
M;B`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O
M=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ-#<@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BUC87-H+"!S
M:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!E>'!E;G-E
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-3@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S
M+#`R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+6-A<V@L('-H87)E
M+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&5X<&5N<V5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y396QL:6YG
M+"!'96YE<F%L(&%N9"!!9&UI;FES=')A=&EV93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BUC87-H+"!S:&%R92UB
M87-E9"!C;VUP96YS871I;VX@97AP96YS93PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!E>'!E;G-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DS-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')U
M8W1U<FEN9R!%>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^3F]N+6-A<V@L('-H87)E+6)A<V5D(&-O;7!E;G-A
M=&EO;B!E>'!E;G-E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E1O=&%L(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,S@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR
M83`W-#AD.34-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C0X-C<Y
M83-?8S1A.%\T9CDR7V$V-#!?8F$Y,F$P-S0X9#DU+U=O<FMS:&5E=',O4VAE
M970S,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14I1044^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N("A$971A:6QS(#$I("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E($)A<V5D($-O;7!E;G-A=&EO;B!!
M<G)A;F=E;65N="!">2!3:&%R92!"87-E9"!087EM96YT($%W87)D(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]P=&EO;G,@;W5T<W1A;F1I;F<@8F5G:6YN:6YG(&]F('!E<FEO
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#0S+#0T,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU
M;6)E<B!O9B!/<'1I;VYS+"!'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR,#`L,#<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@9F]R(&-A<V@L('-H
M87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYU;6)E<B!O9B!/<'1I;VYS($9O<F9E:71E9"P@8V%N8V5L;&5D
M(&]R(&5X<&ER960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]P=&EO;G,@;W5T<W1A;F1I;F<@96YD(&]F('1H92!P97)I;V0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#0S+#0Y-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@T,RPT-#(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D]P=&EO;G,@97AE<F-I<V%B;&4L(&5N9"!O9B!P97)I;V0L($YU;6)E<B!O
M9B!/<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-C8L
M-C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W!T:6]N<R!V97-T960@86YD(&5X<&5C=&5D('1O('9E<W0L($YU
M;6)E<B!O9B!/<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#`S,2PS.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E(&5X97)C:7-E(%!R:6-E
M+"!/<'1I;VYS($]U='-T86YD:6YG+"!"96=I;FYI;F<@;V8@<&5R:6]D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-S8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E
M9"!A=F5R86=E(&5X97)C:7-E('!R:6-E+"!'<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N.3$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E
M(&5X97)C:7-E('!R:6-E+"!%>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E
M(&5X97)C:7-E('!R:6-E+"!&;W)F96ET960L(&-A;F-E;&QE9"!O<B!E>'!I
M<F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.3`X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V5I9VAT960@079E<F%G92!E>&5R8VES92!0<FEC92P@3W!T:6]N<R!/=71S
M=&%N9&EN9RP@96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`S+C,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S+C<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E(&5X97)C
M:7-E('!R:6-E+"!/<'1I;VYS(&5X97)C:7-A8FQE+"!E;F0@;V8@<&5R:6]D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@N-#(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG
M:'1E9"!!=F5R86=E(&5X97)C:7-E(%!R:6-E+"!/<'1I;VYS('9E<W1E9"!A
M;F0@97AP96-T960@=&\@=F5S="P@96YD(&]F('!E<FEO9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S+C,W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G
M92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;2`H:6X@>65A<G,I($]P=&EO
M;G,@3W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<X('EE87)S(#$Q(&UO;G1H<R`U(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG."!Y96%R<R`Q,2!M;VYT:',@
M.2!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/<'1I;VYS(&5X97)C:7-A8FQE(&%T($UA<F-H(#,Q+"`R,#$T
M+"!796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M
M("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<W
M('EE87)S(#$@;6]N=&@@,3<@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@=F5S=&5D(&%N9"!E
M>'!E8W1E9"!T;R!V97-T+"!796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#
M;VYT<F%C='5A;"!497)M("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<X('EE87)S(#$Q(&UO;G1H<R`Q(&1A>3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T
M83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD
M.34O5V]R:W-H965T<R]3:&5E=#,T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,TQ!0SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@
M*$1E=&%I;',@,BD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5M<&QO>65E(%-E<G9I8V4@4VAA<F4@
M0F%S960@0V]M<&5N<V%T:6]N($%L;&]C871I;VX@3V8@4F5C;V=N:7IE9"!0
M97)I;V0@0V]S=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K('5N:71S
M(&]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT,3DL,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.3$L-S`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y697-T960@86YD(')E
M;&5A<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y&;W)F96ET960@86YD(&-A;F-E;&QE9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!S
M=&]C:R!U;FET<R!O=71S=&%N9&EN9R!A="!-87)C:"`S,2P@,C`Q-#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$P+#<P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2
M97-T<FEC=&5D(%-T;V-K($%W87)D<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!S=&]C:R!U;FET<R!O
M=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@,C`Q,SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N.34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E9E<W1E9"!A;F0@<F5L96%S
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D9O<F9E:71E9"!A;F0@8V%N8V5L;&5D/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K
M('5N:71S(&]U='-T86YD:6YG(&%T($UA<F-H(#,Q+"`R,#$T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-3<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(T.#8W.6$S7V,T83A?-&8Y,E]A
M-C0P7V)A.3)A,#<T.&0Y-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B]B-#@V-SEA,U]C-&$X7S1F.3)?838T,%]B83DR83`W-#AD.34O5V]R:W-H
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M/3-$(E-H965T,#$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`R
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#<N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`X+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,3`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Q+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,BYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,3,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,38N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3DN:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(P+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(S+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-"YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-RYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C@N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#(Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970S,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S$N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,R+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970S,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S0N:'1M;"(O/@T*/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7V(T
F.#8W.6$S7V,T83A?-&8Y,E]A-C0P7V)A.3)A,#<T.&0Y-2TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6UAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 31, 2008</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Westminster, Colorado</div>
        </th>
        <th class="th">
          <div>Aug. 01, 2013

</div>
          <div>Westminster, Colorado

</div>
          <div>sqft</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Broomfield, Colorado</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_CommitmentsAndContingenciesTextualAbstract', window );"><strong>Commitments and Contingencies (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office facilities taken on lease</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,300<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiry period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Sep. 30,
				 2016<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Sep. 30,
				 2013<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_LeaseTerm', window );">Lease term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 19,000<span></span></td>
        <td class="nump">$ 12,000<span></span></td>
        <td class="nump">$ 597,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AgreementTerminationNoticePeriod', window );">Clinical research agreement with Duke University, termination notice period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">90 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ExpectedMilestonePaymentsUponApproval', window );">Expected milestone payments upon approval</a></td>
        <td class="nump">8,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AnotherExpectedMilestonePaymentsUponApproval', window );">Another expected milestone payments upon approval</a></td>
        <td class="nump">$ 5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_MinimumPercentageOfRoyaltyObligation', window );">Minimum percentage of royalty obligation</a></td>
        <td class="nump">12.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_MaximumPercentageOfRoyaltyObligation', window );">Maximum percentage of royalty obligation</a></td>
        <td class="nump">25.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement', window );">Product sales levels royalty</a></td>
        <td class="nump">5.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown', window );">Minimum percentage of range of royalties that can be buy down</a></td>
        <td class="nump">12.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown', window );">Maximum percentage of range of royalties that can be buy down</a></td>
        <td class="nump">17.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_MilestonePaymentDuePeriod', window );">Milestone payment due period</a></td>
        <td class="text">6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AgreementTerminationNoticePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Agreement termination notice period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AgreementTerminationNoticePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AnotherExpectedMilestonePaymentsUponApproval">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Another expected milestone payments upon approval.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AnotherExpectedMilestonePaymentsUponApproval</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_CommitmentsAndContingenciesTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_CommitmentsAndContingenciesTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ExpectedMilestonePaymentsUponApproval">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected milestone payments upon approval.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ExpectedMilestonePaymentsUponApproval</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_LeaseTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Lease term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_LeaseTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum percentage of range of royalties that can be buy down.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_MaximumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_MaximumPercentageOfRoyaltyObligation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum percentage of royalty obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_MaximumPercentageOfRoyaltyObligation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_MilestonePaymentDuePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Milestone payment due period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_MilestonePaymentDuePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Minimum percentage of range of royalties that can be buy down.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_MinimumPercentageOfRangeOfRoyaltiesThatCanBeBuyDown</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_MinimumPercentageOfRoyaltyObligation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Minimum percentage of royalty obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_MinimumPercentageOfRoyaltyObligation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of royalty obligated to pay under its original license agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PercentageOfRoyaltyObligatedToPayUnderItsOriginalLicenseAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Area of a real estate property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AreaOfRealEstateProperty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:areaItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LeaseExpirationDate1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesRentExpenseNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Details Textual) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PropertyAndEquipmentTextualAbstract', window );"><strong>Property and Equipment (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">$ 3<span></span></td>
        <td class="nump">$ 10<span></span></td>
        <td class="nump">$ 1,809<span></span></td>
        <td class="nump">$ 1,809<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PropertyAndEquipmentTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PropertyAndEquipmentTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Remainder of 2014</a></td>
        <td class="nump">$ 59<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2015</a></td>
        <td class="nump">80<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2016</a></td>
        <td class="nump">62<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum lease payments</a></td>
        <td class="nump">$ 201<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_CommitmentsAndContingenciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_CommitmentsAndContingenciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the next fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the remainder of the fiscal year following the latest fiscal year ended for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EZEBI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity Financings and Warrants (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
        <td class="nump">9,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightsExpirationDateEarliest', window );">Class of warrant or rights expiration date earliest.</a></td>
        <td class="text">2016-04<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightsExpirationDateLatest', window );">Class of warrant or rights expiration date latest</a></td>
        <td class="text">2020-01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="nump">$ 1.60<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="nump">$ 116.89<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Weighted Average</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="nump">$ 2.31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">PIPE Transaction</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Aggregate common stock sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">356,430<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants available to purchase additional commons shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">249,501<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Aggregate gross proceeds</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodNetProceeds', window );">Proceeds from the issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">805,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityIssuanceCloseDate', window );">Public Equity Offering Close Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 25,
				 2013<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuanceDates', window );">Subscription agreement date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 22,
				 2013<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuancePerShareAmount', window );">Purchase price for common stock unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.81<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant coverage ratio</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.70<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.28<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares', window );">Closing bid price of the common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightExercisableExpirationPeriod', window );">Warrants were exercisable upon issuance, expiry year</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClosingBidPriceDate', window );">Closing bid price date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 22,
				 2013<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Registered Direct Offering</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Aggregate common stock sold</a></td>
        <td class="nump">5,116,228<span></span></td>
        <td class="nump">164,636<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants available to purchase additional commons shares</a></td>
        <td class="nump">1,279,057<span></span></td>
        <td class="nump">65,855<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Aggregate gross proceeds</a></td>
        <td class="nump">8,700,000<span></span></td>
        <td class="nump">730,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodNetProceeds', window );">Proceeds from the issuance of common stock</a></td>
        <td class="nump">7,900,000<span></span></td>
        <td class="nump">616,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityIssuanceCloseDate', window );">Public Equity Offering Close Date</a></td>
        <td class="text">Feb.
				07,
				 2014<span></span></td>
        <td class="text">Feb.
				04,
				 2013<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuanceDates', window );">Subscription agreement date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 31,
				 2013<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuancePerShareAmount', window );">Purchase price for common stock unit</a></td>
        <td class="nump">$ 1.70<span></span></td>
        <td class="nump">$ 4.43<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant coverage ratio</a></td>
        <td class="nump">0.25<span></span></td>
        <td class="nump">0.40<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="nump">$ 2.125<span></span></td>
        <td class="nump">$ 4.13<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares', window );">Closing bid price of the common stock</a></td>
        <td class="nump">125.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightExercisableExpirationPeriod', window );">Warrants were exercisable upon issuance, expiry year</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClosingBidPriceDate', window );">Closing bid price date</a></td>
        <td class="text">Feb.
				03,
				 2014<span></span></td>
        <td class="text">Jan. 31,
				 2013<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Public Offering | Series A Convertible Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Aggregate common stock sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">125,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants available to purchase additional commons shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,250,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Aggregate gross proceeds</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodNetProceeds', window );">Proceeds from the issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,900,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuancePerShareAmount', window );">Purchase price for common stock unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 160<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant coverage ratio</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant price per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.60<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ClassOfWarrantOrRightExercisableExpirationPeriod', window );">Warrants were exercisable upon issuance, expiry year</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common stock shares issued upon conversion of each share of convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock liquidation preference per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership', window );">Percentage of total number of shares of common stock then issued and outstanding limit on beneficial ownership</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9.99%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature', window );">Intrinsic value of embedded beneficial conversion feature</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,000,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Public Offering | Director and Chief Executive Officer</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsTextualAbstract', window );"><strong>Equity financings and warrants (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants available to purchase additional commons shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">39,050<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PreferredStockPurchasedByOfficer', window );">Preferred Stock Purchased by Officer</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">781<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ClassOfWarrantOrRightExercisableExpirationPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right exercisable expiration period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ClassOfWarrantOrRightExercisableExpirationPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right exercise price of share percentage of closing bid price of common shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ClassOfWarrantOrRightExercisePriceOfSharePercentageOfClosingBidPriceOfCommonShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ClassOfWarrantOrRightsExpirationDateEarliest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or rights expiration date earliest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ClassOfWarrantOrRightsExpirationDateEarliest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearMonthItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ClassOfWarrantOrRightsExpirationDateLatest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or rights expiration date latest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ClassOfWarrantOrRightsExpirationDateLatest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearMonthItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ClosingBidPriceDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date of closing bid price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ClosingBidPriceDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_EquityFinancingsAndWarrantsTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_EquityFinancingsAndWarrantsTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_EquityIssuanceCloseDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity issuance close date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_EquityIssuanceCloseDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Intrinsic value of embedded beneficial conversion feature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_IntrinsicValueOfEmbeddedBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of total number of shares of common stock then issued and outstanding limit on beneficial ownership.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PercentageOfTotalNumberOfSharesOfCommonStockThenIssuedAndOutstandingLimitOnBeneficialOwnership</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PreferredStockPurchasedByOfficer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Preferred Stock Purchased by Officer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PreferredStockPurchasedByOfficer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_StockIssuedDuringPeriodNetProceeds">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock issued during period net proceeds.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_StockIssuedDuringPeriodNetProceeds</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued for each share of convertible preferred stock that is converted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuanceDates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date of issuance for equity securities of development stage entities, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityIssuanceDates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuancePerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityIssuancePerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockLiquidationPreference</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued as consideration for cash for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares issued as consideration for cash for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>The Company and Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">The Company and Summary of Significant Accounting Policies</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(1) The Company and Summary of Significant Accounting Policies </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA biopharma, Inc., or the Company or ARCA, a Delaware corporation, is headquartered in Westminster, Colorado and is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases.  The Company&#8217;s lead product candidate, Gencaro&#8482; (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that ARCA plans to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  The Company has identified common genetic variations in receptors in the cardiovascular system that it believes interact with Gencaro&#8217;s pharmacology and may predict patient response to the drug. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company plans to test this hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. The AF indication for Gencaro was chosen based on prior clinical data from the previously conducted Phase 3 heart failure (HF) trial of Gencaro in 2,708 HF patients, or the BEST trial, which suggested that Gencaro may be successful in reducing or preventing AF.  GENETIC-AF is a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype the Company believes responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF is time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality. </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA has created an adaptive design for GENETIC-AF. The Company has initiated screening of patients for the Phase 2B study of approximately 200 HFREF patients. The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to the pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&#8217;s primary end-point.&#160;The interim analysis will focus on available data regarding the trial&#8217;s primary end point, AF event rates, AF burden, and safety.   Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.  The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3.  The Company, in consultation with the trial&#8217;s clinical steering committee and the DSMB, will make the final determination on the trial&#8217;s development steps.  The Company believes the Phase 2B portion of the study would take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which the Company believes may provide market exclusivity for these uses of Gencaro into at least 2026 in the U.S. and into 2025 in Europe.  In addition, the Company believes that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the U.S. and Europe. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To complete both phases of the GENETIC-AF clinical trial and submit for FDA approval, the Company will need to raise additional capital. If the Company is unable to obtain additional funding or is unable to complete a strategic transaction, it may have to discontinue development activities on Gencaro or discontinue its operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Development Stage Risks, Liquidity and Going Concern </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is in the development stage and devotes substantially all of its efforts towards obtaining regulatory approval and raising capital necessary to fund its operations.  The Company has not generated revenue to date and is subject to a number of risks similar to those of other development stage companies, including dependence on key individuals, the development of and regulatory approval of commercially viable products, the need to raise adequate additional financing necessary to fund the development and commercialization of its products, and competition from larger companies. The Company has historically funded its operations through issuances of common and preferred stock, as well as through the business combination with Nuvelo, Inc., or Nuvelo. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since ARCA was founded on December&#160;17, 2001, or Inception, the Company has incurred substantial losses and negative cash flows from operations. Since Inception, the Company incurred a loss from operations of $108.5 million and had negative cash flows from operations of $106.4 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2013, the Company raised approximately $19.3 million, net of offering costs, through sales of its convertible preferred and common stock and warrants.  In February 2014, the Company completed a public equity offering raising approximately $7.9 million in net proceeds to provide additional funds for the Phase 2B/3 GENETIC-AF trial and the Company&#8217;s ongoing operations. The Company has initiated screening of patients for the Phase 2B/3 GENETIC-AF trial, and the Company anticipates that its current cash and cash equivalents  will be sufficient to fund its operations, at its projected cost structure, through at least the end of 2015.  However, in light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, the Company expects to need to raise additional capital to finance the completion of GENETIC-AF and the Company&#8217;s ongoing operations.&#160;If the Company is delayed in completing or is unable to complete additional funding and/or a strategic transaction, the Company may discontinue its development activities or operations. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s liquidity, and its ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress of GENETIC-AF enrollment and any data that may become available; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs and timing for the GENETIC-AF clinical trial in order to gain possible FDA approval for Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market price of the Company&#8217;s stock and the availability and cost of additional equity capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to retain the listing of its common stock on the Nasdaq Capital Market; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general economic and industry conditions affecting the availability and cost of capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to control costs associated with its operations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions of the Company&#8217;s existing collaborative and licensing agreements. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities would likely result in substantial additional dilution to the Company&#8217;s stockholders.  If the Company raises additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of the Company&#8217;s capital stock and could contain covenants that would restrict the Company&#8217;s operations.  The Company also cannot predict what consideration might be available, if any, to the Company or its stockholders, in connection with any strategic transaction.  Should strategic alternatives or additional capital not be available to the Company,  or not be available on acceptable terms, the Company may be unable to realize value from its assets and discharge its liabilities in the normal course of business which may, among other alternatives, cause the Company to further delay, substantially reduce or discontinue operational activities to conserve its cash resources. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The significant uncertainties surrounding the clinical development timelines and costs and the need to raise a significant amount of capital raises substantial doubt about the Company&#8217;s ability to continue as a going concern for a reasonable period of time.  These consolidated financial statements have been prepared with the assumption that the Company will continue as a going concern and will be able to realize its assets and discharge its liabilities in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability of the Company to continue as a going concern.  The Company may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or to otherwise continue operations and may not be able to execute any strategic transaction. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reverse Stock Split </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;4, 2013, the Company completed a 1-for-6 reverse split of its common stock. All common shares and per common share amounts in the financial statements and footnotes have been adjusted retroactively to reflect the effects of this action. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&nbsp;&nbsp;Accordingly, these financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&#160; In the opinion of management, these financial statements include all normal and recurring adjustments considered necessary for a fair presentation of these interim consolidated financial statements.  The results of operations for the three months ended March&#160;31, 2014 are not necessarily indicative of results expected for the full year ending December&#160;31, 2014.&#160; The Company has generated no revenue to date and its activities have consisted of seeking regulatory approval, research and development, exploring strategic alternatives for further developing and commercializing Gencaro, and raising capital. Accordingly, the Company continues to be considered in the development stage at March&#160;31, 2014. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes thereto for the year ended December&#160;31, 2013 included in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission, as amended. Amounts presented are rounded to the nearest thousand, where indicated, except per share data and par values. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company has no off-balance-sheet concentrations of credit risk, such as foreign exchange contracts, option contracts, or foreign currency hedging arrangements.  The Company maintains cash and cash equivalent balances in the form of bank demand deposits, money market fund accounts and debt securities with financial institutions that management believes are creditworthy. Such balances may at times exceed the insured amount. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing its financial statements, the Company is required to estimate accrued expenses.  This process involves identifying services that third parties have performed on the Company&#8217;s behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date. Examples of estimated accrued expenses include contract service fees, such as fees payable to contract manufacturers in connection with the production of materials related to the Company&#8217;s drug product, and professional service fees, such as attorneys, consultants, and clinical research organizations.  The Company develops estimates of liabilities using its judgment based upon the facts and circumstances known at the time. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-based Compensation (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Non-cash, share-based compensation expense</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total expenses</a></td>
        <td class="nump">$ 158<span></span></td>
        <td class="nump">$ 42<span></span></td>
        <td class="nump">$ 3,029<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and Development</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Non-cash, share-based compensation expense</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total expenses</a></td>
        <td class="nump">40<span></span></td>
        <td class="nump">15<span></span></td>
        <td class="nump">707<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Selling, General and Administrative</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Non-cash, share-based compensation expense</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total expenses</a></td>
        <td class="nump">118<span></span></td>
        <td class="nump">27<span></span></td>
        <td class="nump">1,935<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restructuring Expense</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Non-cash, share-based compensation expense</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total expenses</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 387<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EP1AE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 21,202<span></span></td>
        <td class="nump">$ 16,756<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
        <td class="nump">599<span></span></td>
        <td class="nump">169<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">21,801<span></span></td>
        <td class="nump">16,925<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">26<span></span></td>
        <td class="nump">29<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
        <td class="nump">828<span></span></td>
        <td class="nump">130<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">22,655<span></span></td>
        <td class="nump">17,084<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">552<span></span></td>
        <td class="nump">597<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee benefits</a></td>
        <td class="nump">111<span></span></td>
        <td class="nump">459<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
        <td class="nump">457<span></span></td>
        <td class="nump">446<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent, current portion</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">1,120<span></span></td>
        <td class="nump">1,502<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, net of current portion</a></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">1,121<span></span></td>
        <td class="nump">1,503<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A convertible preferred stock, $0.001 par value; 135,000 shares authorized, no shares issued and outstanding at March 31, 2014 and December 31, 2013</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 100 million shares authorized at March 31, 2014 and December 31, 2013; 21,001,690 and 15,685,562 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively</a></td>
        <td class="nump">21<span></span></td>
        <td class="nump">16<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">98,835<span></span></td>
        <td class="nump">90,498<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Deficit accumulated during the development stage</a></td>
        <td class="num">(77,322)<span></span></td>
        <td class="num">(74,933)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">21,534<span></span></td>
        <td class="nump">15,581<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#x2019; equity</a></td>
        <td class="nump">$ 22,655<span></span></td>
        <td class="nump">$ 17,084<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCreditCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.26(c))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCreditNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3NAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jan. 03, 2005

</div>
          <div>Common Stock

</div>
          <div>Cash, Net of Offering Costs</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2004

</div>
          <div>Common Stock

</div>
          <div>Cash, Net of Offering Costs</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2002

</div>
          <div>Common Stock

</div>
          <div>Cash, Net of Offering Costs</div>
        </th>
        <th class="th">
          <div>Jan. 03, 2005

</div>
          <div>Common Stock

</div>
          <div>Issuance for Notes Payable and Related Accrued Interest on January 3, 2005</div>
        </th>
        <th class="th">
          <div>Oct. 14, 2005

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on October 14, 2005</div>
        </th>
        <th class="th">
          <div>Feb. 21, 2006

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on February 21, 2006</div>
        </th>
        <th class="th">
          <div>Feb. 22, 2006

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on February 22, 2006</div>
        </th>
        <th class="th">
          <div>Jun. 23, 2006

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on June 23, 2006</div>
        </th>
        <th class="th">
          <div>Nov. 07, 2006

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on November 7, 2006</div>
        </th>
        <th class="th">
          <div>Jan. 18, 2007

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on January 18, 2007</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2007

</div>
          <div>Common Stock

</div>
          <div>Issuance for Intellectual Property License Rights on June 30, 2007</div>
        </th>
        <th class="th">
          <div>Feb. 22, 2006

</div>
          <div>Series A

</div>
          <div>Issuance of Series A on February 22, 2006</div>
        </th>
        <th class="th">
          <div>Feb. 22, 2006

</div>
          <div>Series A

</div>
          <div>Third Issuance For Notes Payable And Related Accrued Interest</div>
        </th>
        <th class="th">
          <div>Dec. 08, 2006

</div>
          <div>Series A

</div>
          <div>Second Issuance Of Series Redeemable Preferred Stock</div>
        </th>
        <th class="th">
          <div>May 31, 2007

</div>
          <div>Series B

</div>
          <div>Third Issuance Of Series B Redeemable Preferred Stock</div>
        </th>
        <th class="th">
          <div>Dec. 28, 2007

</div>
          <div>Series B

</div>
          <div>Issuance for Series B on December 28, 2007</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_CommonStockMarketPricePerShare', window );">Common stock market price per share</a></td>
        <td class="nump">$ 0.36<span></span></td>
        <td class="nump">$ 0.36<span></span></td>
        <td class="nump">$ 0.36<span></span></td>
        <td class="nump">$ 0.36<span></span></td>
        <td class="nump">$ 48.84<span></span></td>
        <td class="nump">$ 4.32<span></span></td>
        <td class="nump">$ 4.32<span></span></td>
        <td class="nump">$ 5.40<span></span></td>
        <td class="nump">$ 5.40<span></span></td>
        <td class="nump">$ 10.08<span></span></td>
        <td class="nump">$ 10.80<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.6265<span></span></td>
        <td class="nump">$ 1.6265<span></span></td>
        <td class="nump">$ 1.6265<span></span></td>
        <td class="nump">$ 2.439<span></span></td>
        <td class="nump">$ 3.253<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_CommonStockMarketPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock market price per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_CommonStockMarketPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EPEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>The Company and Summary of Significant Accounting Policies (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">147 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 04, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Patients</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014

</div>
          <div>Two Zero One Four Equity Financings

</div>
          <div>Registered Direct Offering</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Phase 3 heart failure (HF) trial of Gencaro

</div>
          <div>Patients</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract', window );"><strong>Company Development Stage and Basis of Presentation (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_NumberOfPatients', window );">Number of patients</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,708<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_NumberOfPatientsCompanyPlansToEnroll', window );">Number of patients company plans to enroll</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">420<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_TermOfCompletion', window );">Number of years to complete the study</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2 years 6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (2,390,000)<span></span></td>
        <td class="num">$ (1,070,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (108,500,000)<span></span></td>
        <td class="num">$ (108,473,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(106,400,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Fund raised through sale of convertible preferred and common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,841,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 9,018,000<span></span></td>
        <td class="nump">$ 1,741,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 24,868,000<span></span></td>
        <td class="nump">$ 7,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
        <td class="text">1-for-6 reverse split<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_CompanyDevelopmentStageAndBasisOfPresentationTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_NumberOfPatients">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of patients</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_NumberOfPatients</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_NumberOfPatientsCompanyPlansToEnroll">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of patients company plans to enroll.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_NumberOfPatientsCompanyPlansToEnroll</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_TermOfCompletion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Term of completion.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_TermOfCompletion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityReverseStockSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share (Details Textual)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EarningsLossPerShareTextualAbstract', window );"><strong>Earnings (Loss) Per Share (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares</a></td>
        <td class="nump">10.2<span></span></td>
        <td class="nump">1.3<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_EarningsLossPerShareTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_EarningsLossPerShareTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBEBI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,389)<span></span></td>
        <td class="num">$ (1,071)<span></span></td>
        <td class="num">$ (77,322)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_GainLossOnAssignmentOfPatentRights', window );">Gain on patent rights assignment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Gain on bargain purchase</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(25,282)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">3<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="nump">1,809<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">211<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
        <td class="nump">158<span></span></td>
        <td class="nump">42<span></span></td>
        <td class="nump">3,029<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of warrants for lease termination</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">377<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of liabilities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">152<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">125<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Loss on impairment of in-process research and development</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_WriteOffOfDeferredTaxLiability', window );">Write-off of deferred tax liability</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,281)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Gain on marketable securities available for sale</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(263)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Gain) loss from disposal of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">83<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">267<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities (net of amounts acquired):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
        <td class="num">(251)<span></span></td>
        <td class="num">(157)<span></span></td>
        <td class="nump">2,699<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
        <td class="num">(698)<span></span></td>
        <td class="nump">20<span></span></td>
        <td class="nump">6,642<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
        <td class="num">(45)<span></span></td>
        <td class="nump">312<span></span></td>
        <td class="num">(1,638)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
        <td class="num">(465)<span></span></td>
        <td class="nump">88<span></span></td>
        <td class="num">(19,005)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCharges', window );">Deferred rent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(8)<span></span></td>
        <td class="nump">1<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
        <td class="num">(3,687)<span></span></td>
        <td class="num">(764)<span></span></td>
        <td class="num">(106,396)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash received from merger</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">30,392<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment of deferred transaction costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,186)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9)<span></span></td>
        <td class="num">(1,911)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,369<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">358<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from patent rights assignment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,000<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash (used in) provided by investing activities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9)<span></span></td>
        <td class="nump">45,022<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance of convertible notes payable and related warrants for common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,841<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of bank note payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ProceedsFromIssuanceOfRestrictedStock', window );">Proceeds from stock subject to repurchase</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">38<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from the issuance of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">52,316<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock</a></td>
        <td class="nump">9,018<span></span></td>
        <td class="nump">1,741<span></span></td>
        <td class="nump">24,868<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of principal on bank note payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of principal on convertible notes payables</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(105)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_RepaymentOfPrincipalOnVendorFinanceAgreement', window );">Repayment of principal on vendor finance agreement</a></td>
        <td class="num">(51)<span></span></td>
        <td class="num">(43)<span></span></td>
        <td class="num">(505)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by financing activities</a></td>
        <td class="nump">8,133<span></span></td>
        <td class="nump">1,390<span></span></td>
        <td class="nump">82,576<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
        <td class="nump">4,446<span></span></td>
        <td class="nump">617<span></span></td>
        <td class="nump">21,202<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
        <td class="nump">16,756<span></span></td>
        <td class="nump">2,920<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
        <td class="nump">21,202<span></span></td>
        <td class="nump">3,537<span></span></td>
        <td class="nump">21,202<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">119<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing transactions:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccruedInterestOnNotesPayableConvertedToEquity', window );">Accrued interest on notes payable converted to equity</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">163<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_WarrantIssuedInConnectionWithCreditFacility', window );">Warrant issued in connection with credit facility</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">111<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccruedDeferredTransactionCosts', window );">Accrued deferred transaction costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">482<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_VendorFinanceAgreement', window );">Vendor finance agreement</a></td>
        <td class="nump">128<span></span></td>
        <td class="nump">131<span></span></td>
        <td class="nump">128<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,329)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Common Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
        <td class="num">$ (834)<span></span></td>
        <td class="num">$ (308)<span></span></td>
        <td class="num">$ (2,548)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AccruedDeferredTransactionCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Deferred transaction costs accrued at the end of the respective period and applied to proceeds in the subsequent period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AccruedDeferredTransactionCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AccruedInterestOnNotesPayableConvertedToEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the interest accrued on notes payable that was recorded by the Company but converted by the holder to equity during the period that resulted in a noncash transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AccruedInterestOnNotesPayableConvertedToEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_GainLossOnAssignmentOfPatentRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gain or loss on transfer of all or part of the rights and interests in certain patents and patent applications.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_GainLossOnAssignmentOfPatentRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ProceedsFromIssuanceOfRestrictedStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ProceedsFromIssuanceOfRestrictedStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_RepaymentOfPrincipalOnVendorFinanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Repayment of principal on vendor finance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_RepaymentOfPrincipalOnVendorFinanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_VendorFinanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Vendor finance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_VendorFinanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_WarrantIssuedInConnectionWithCreditFacility">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The non-cash value of warrants issued in connection with a bank credit facility.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_WarrantIssuedInConnectionWithCreditFacility</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_WriteOffOfDeferredTaxLiability">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The write off of deferred tax liability associated with the impairment of the in-process research and development asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_WriteOffOfDeferredTaxLiability</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 410<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 420<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccretionExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (f)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAcquiredFromAcquisition</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=8077374&amp;loc=d3e2420-110228<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 958<br><br><br><br> -SubTopic 225<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28367520&amp;loc=d3e92212-112881<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Impairment<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherCurrentAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(c))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(c)-(e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNoncashIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherPaymentsToAcquireBusinesses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaidInKindInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfConvertibleDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECMAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
        <td class="nump">135,000<span></span></td>
        <td class="nump">135,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">21,001,690<span></span></td>
        <td class="nump">15,685,562<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">21,001,690<span></span></td>
        <td class="nump">15,685,562<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EMCAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>The Company and Summary of Significant Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Description of Business</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA biopharma, Inc., or the Company or ARCA, a Delaware corporation, is headquartered in Westminster, Colorado and is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases.  The Company&#8217;s lead product candidate, Gencaro&#8482; (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that ARCA plans to evaluate in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and/or left ventricular dysfunction, or HFREF.  The Company has identified common genetic variations in receptors in the cardiovascular system that it believes interact with Gencaro&#8217;s pharmacology and may predict patient response to the drug. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company plans to test this hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. The AF indication for Gencaro was chosen based on prior clinical data from the previously conducted Phase 3 heart failure (HF) trial of Gencaro in 2,708 HF patients, or the BEST trial, which suggested that Gencaro may be successful in reducing or preventing AF.  GENETIC-AF is a multi-center, randomized, double-blind clinical trial designed to compare the safety and efficacy of Gencaro to an active comparator in HFREF patients recently diagnosed with persistent AF and having beta-1 389 arginine homozygous genotype, the genotype the Company believes responds most favorably to Gencaro.  The primary endpoint of GENETIC-AF is time to recurrent symptomatic AF/atrial flutter (AFL) or all-cause mortality. </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARCA has created an adaptive design for GENETIC-AF. The Company has initiated screening of patients for the Phase 2B study of approximately 200 HFREF patients. The GENETIC-AF Data Safety Monitoring Board (DSMB) will analyze certain data from the Phase 2B portion of the trial and recommend, based on a comparison to the pre-trial statistical assumptions, whether the trial should proceed to Phase 3 and enroll an additional 420 patients.  The DSMB will make their recommendation based on analysis of certain trial data after 200 patients have been enrolled and have completed 24 weeks of follow-up, the period for measuring the trial&#8217;s primary end-point.&#160;The interim analysis will focus on available data regarding the trial&#8217;s primary end point, AF event rates, AF burden, and safety.   Should the DSMB interim analysis conclude the data is consistent with the pre-trial statistical assumptions and indicates potential for achieving statistical significance for the Phase 3 endpoint, then the DSMB may recommend the study proceed to Phase 3.  The DSMB may also recommend changes to the study design before potentially proceeding to Phase 3, or it may recommend that the study not proceed to Phase 3.  The Company, in consultation with the trial&#8217;s clinical steering committee and the DSMB, will make the final determination on the trial&#8217;s development steps.  The Company believes the Phase 2B portion of the study would take approximately two and one-half years to complete from the time the first patient is enrolled until the planned DSMB interim analysis of data from the initial 200 patients. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has been granted patents in the U.S., Europe, and other jurisdictions for methods of treating AF and HF patients with Gencaro based on genetic testing, which the Company believes may provide market exclusivity for these uses of Gencaro into at least 2026 in the U.S. and into 2025 in Europe.  In addition, the Company believes that if Gencaro is approved, a Gencaro patent will be eligible for patent term extension based on our current clinical trial plans which, if granted, may provide market exclusivity for Gencaro into 2029 or 2030 in the U.S. and Europe. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To complete both phases of the GENETIC-AF clinical trial and submit for FDA approval, the Company will need to raise additional capital. If the Company is unable to obtain additional funding or is unable to complete a strategic transaction, it may have to discontinue development activities on Gencaro or discontinue its operations. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock', window );">Development Stage Risks, Liquidity and Going Concern</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Development Stage Risks, Liquidity and Going Concern </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is in the development stage and devotes substantially all of its efforts towards obtaining regulatory approval and raising capital necessary to fund its operations.  The Company has not generated revenue to date and is subject to a number of risks similar to those of other development stage companies, including dependence on key individuals, the development of and regulatory approval of commercially viable products, the need to raise adequate additional financing necessary to fund the development and commercialization of its products, and competition from larger companies. The Company has historically funded its operations through issuances of common and preferred stock, as well as through the business combination with Nuvelo, Inc., or Nuvelo. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since ARCA was founded on December&#160;17, 2001, or Inception, the Company has incurred substantial losses and negative cash flows from operations. Since Inception, the Company incurred a loss from operations of $108.5 million and had negative cash flows from operations of $106.4 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2013, the Company raised approximately $19.3 million, net of offering costs, through sales of its convertible preferred and common stock and warrants.  In February 2014, the Company completed a public equity offering raising approximately $7.9 million in net proceeds to provide additional funds for the Phase 2B/3 GENETIC-AF trial and the Company&#8217;s ongoing operations. The Company has initiated screening of patients for the Phase 2B/3 GENETIC-AF trial, and the Company anticipates that its current cash and cash equivalents  will be sufficient to fund its operations, at its projected cost structure, through at least the end of 2015.  However, in light of the significant uncertainties regarding clinical development timelines and costs for developing drugs such as Gencaro, the Company expects to need to raise additional capital to finance the completion of GENETIC-AF and the Company&#8217;s ongoing operations.&#160;If the Company is delayed in completing or is unable to complete additional funding and/or a strategic transaction, the Company may discontinue its development activities or operations. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s liquidity, and its ability to raise additional capital or complete any strategic transaction, depends on a number of factors, including, but not limited to, the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress of GENETIC-AF enrollment and any data that may become available; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs and timing for the GENETIC-AF clinical trial in order to gain possible FDA approval for Gencaro; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market price of the Company&#8217;s stock and the availability and cost of additional equity capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to retain the listing of its common stock on the Nasdaq Capital Market; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general economic and industry conditions affecting the availability and cost of capital; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s ability to control costs associated with its operations; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions of the Company&#8217;s existing collaborative and licensing agreements. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities would likely result in substantial additional dilution to the Company&#8217;s stockholders.  If the Company raises additional funds through the incurrence of indebtedness, the obligations related to such indebtedness would be senior to rights of holders of the Company&#8217;s capital stock and could contain covenants that would restrict the Company&#8217;s operations.  The Company also cannot predict what consideration might be available, if any, to the Company or its stockholders, in connection with any strategic transaction.  Should strategic alternatives or additional capital not be available to the Company,  or not be available on acceptable terms, the Company may be unable to realize value from its assets and discharge its liabilities in the normal course of business which may, among other alternatives, cause the Company to further delay, substantially reduce or discontinue operational activities to conserve its cash resources. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The significant uncertainties surrounding the clinical development timelines and costs and the need to raise a significant amount of capital raises substantial doubt about the Company&#8217;s ability to continue as a going concern for a reasonable period of time.  These consolidated financial statements have been prepared with the assumption that the Company will continue as a going concern and will be able to realize its assets and discharge its liabilities in the normal course of business and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability of the Company to continue as a going concern.  The Company may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or to otherwise continue operations and may not be able to execute any strategic transaction. </font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reverse Stock Split </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;4, 2013, the Company completed a 1-for-6 reverse split of its common stock. All common shares and per common share amounts in the financial statements and footnotes have been adjusted retroactively to reflect the effects of this action. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&nbsp;&nbsp;Accordingly, these financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&#160; In the opinion of management, these financial statements include all normal and recurring adjustments considered necessary for a fair presentation of these interim consolidated financial statements.  The results of operations for the three months ended March&#160;31, 2014 are not necessarily indicative of results expected for the full year ending December&#160;31, 2014.&#160; The Company has generated no revenue to date and its activities have consisted of seeking regulatory approval, research and development, exploring strategic alternatives for further developing and commercializing Gencaro, and raising capital. Accordingly, the Company continues to be considered in the development stage at March&#160;31, 2014. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes thereto for the year ended December&#160;31, 2013 included in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission, as amended. Amounts presented are rounded to the nearest thousand, where indicated, except per share data and par values. </font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company has no off-balance-sheet concentrations of credit risk, such as foreign exchange contracts, option contracts, or foreign currency hedging arrangements.  The Company maintains cash and cash equivalent balances in the form of bank demand deposits, money market fund accounts and debt securities with financial institutions that management believes are creditworthy. Such balances may at times exceed the insured amount. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccruedExpensesPolicyTextBlock', window );">Accrued Expenses</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing its financial statements, the Company is required to estimate accrued expenses.  This process involves identifying services that third parties have performed on the Company&#8217;s behalf and estimating the level of service performed and the associated cost incurred for these services as of the balance sheet date. Examples of estimated accrued expenses include contract service fees, such as fees payable to contract manufacturers in connection with the production of materials related to the Company&#8217;s drug product, and professional service fees, such as attorneys, consultants, and clinical research organizations.  The Company develops estimates of liabilities using its judgment based upon the facts and circumstances known at the time. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AccruedExpensesPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for estimating costs incurred that have not yet been billed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AccruedExpensesPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Development stage risks liquidity and going concern.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_DevelopmentStageRisksLiquidityAndGoingConcernPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ReverseStockSplitPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reverse stock split.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ReverseStockSplitPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for credit risk.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61082-112788<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61044-112788<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskCreditRisk</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2AAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>May 09, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">ARCA Biopharma, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000907654<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Mar. 31,
				 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">21,010,815<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentInformationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Basic and Diluted Loss Per Share</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the numerator and denominator used in the calculation of basic and diluted loss per share follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except shares and per share data)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss available to common shareholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,389</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,071</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares of common stock outstanding</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,037,546</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Weighted-average shares of unvested common stock</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,783</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total weighted-average shares used in computing net loss</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; per share attributed to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,785,418</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,034,763</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted loss per share</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.13</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBLAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">$ 1,308<span></span></td>
        <td class="nump">$ 181<span></span></td>
        <td class="nump">$ 46,913<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
        <td class="nump">1,082<span></span></td>
        <td class="nump">889<span></span></td>
        <td class="nump">47,677<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Merger transaction costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,470<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expense, net</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,413<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Loss on impairment of in-process research and development</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,000<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total costs and expenses</a></td>
        <td class="nump">2,390<span></span></td>
        <td class="nump">1,070<span></span></td>
        <td class="nump">108,473<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(2,390)<span></span></td>
        <td class="num">(1,070)<span></span></td>
        <td class="num">(108,473)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_GainLossOnAssignmentOfPatentRights', window );">Gain on assignment of patent rights</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Gain on bargain purchase</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,282<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income</a></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,035<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest and other expense</a></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(447)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
        <td class="num">(2,389)<span></span></td>
        <td class="num">(1,071)<span></span></td>
        <td class="num">(79,603)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,281<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
        <td class="num">(2,389)<span></span></td>
        <td class="num">(1,071)<span></span></td>
        <td class="num">(77,322)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Less: Accretion of redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(245)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Less: Deemed preferred stock dividend</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,807)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
        <td class="num">$ (2,389)<span></span></td>
        <td class="num">$ (1,071)<span></span></td>
        <td class="num">$ (80,374)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss available to common stockholders per share:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
        <td class="num">$ (0.13)<span></span></td>
        <td class="num">$ (0.35)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted</a></td>
        <td class="nump">18,785,418<span></span></td>
        <td class="nump">3,034,763<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_GainLossOnAssignmentOfPatentRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gain or loss on transfer of all or part of the rights and interests in certain patents and patent applications.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_GainLossOnAssignmentOfPatentRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 23<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917927&amp;loc=d3e1043-128460<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationAcquisitionRelatedCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (f)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph h<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestAndOtherIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpenseDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingCostsAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of accretion of the preferred stock redemption discount during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockAccretionOfRedemptionDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockDividendsAndOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 420<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 420<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 5.P.4(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 420<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 5.P.3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section P<br><br><br><br> -Subsection 3, 4<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386349&amp;loc=d3e3636-108311<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SellingGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(5) Property and Equipment </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Life</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of useful life or life of the lease</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation and amortization</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(488</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(485</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended March&#160;31, 2014 and 2013, and for the period from Inception through March&#160;31, 2014, depreciation and amortization expense was $3,000, $10,000, and $1.8 million respectively. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Disclosures<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(4) Fair Value Disclosures </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March&#160;31, 2014, the Company had $21.1 million of cash equivalents consisting of money market funds with maturities of 90 days or less. The Company has the ability to liquidate these investments without restriction.  The Company determines fair value for these money market funds and equity securities with Level 1 inputs through quoted market prices.  There were no transfers of assets between fair value hierarchy levels during the three month period ended March&#160;31, 2014. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Inputs used to measure fair value are classified into the following hierarchy: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#8212;Unadjusted quoted prices in active markets for identical assets or liabilities </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#8212;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.46%;margin-left:4.54%;"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Wingdings 2';font-size:10pt;">&#151;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#8212;Unobservable inputs for the asset or liability </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Other Financial Instruments </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying amount of other financial instruments, including cash, accounts payable, and short-term notes payable approximated fair value due to their short maturities. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1YAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="10">12 Months Ended</th>
        <th class="th" colspan="1">24 Months Ended</th>
        <th class="th" colspan="1">147 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2003</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract', window );"><strong>Summary of basic and diluted loss per share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,389)<span></span></td>
        <td class="num">$ (1,071)<span></span></td>
        <td class="num">$ (6,939)<span></span></td>
        <td class="num">$ (4,320)<span></span></td>
        <td class="num">$ (5,364)<span></span></td>
        <td class="num">$ (8,420)<span></span></td>
        <td class="num">$ (9,138)<span></span></td>
        <td class="num">$ (19,431)<span></span></td>
        <td class="num">$ (13,994)<span></span></td>
        <td class="num">$ (5,241)<span></span></td>
        <td class="num">$ (1,459)<span></span></td>
        <td class="num">$ (511)<span></span></td>
        <td class="num">$ (116)<span></span></td>
        <td class="num">$ (77,322)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common shareholders</a></td>
        <td class="num">$ (2,389)<span></span></td>
        <td class="num">$ (1,071)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (80,374)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding</a></td>
        <td class="nump">18,785,418<span></span></td>
        <td class="nump">3,037,546<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Less: Weighted-average shares of unvested common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,783)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Total weighted-average shares used in computing net loss per share attributed to common stockholders</a></td>
        <td class="nump">18,785,418<span></span></td>
        <td class="nump">3,034,763<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share</a></td>
        <td class="num">$ (0.13)<span></span></td>
        <td class="num">$ (0.35)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfBasicAndDilutedLossPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e2646-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesIssuedBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Life</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">March 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31,</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of useful life or life of the lease</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation and amortization</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(488</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(485</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share- based Compensation<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(8) Share-based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three month period ended March&#160;31, 2014 and 2013 and for the period from Inception through March&#160;31, 2014, the Company recognized the following non-cash, share-based compensation expense in the consolidated statement of operations (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Period from December 17, 2001 (date of inception) to March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">707</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, General and Administrative</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,935</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring Expense</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,029</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option and stock award transactions for the three month period ended March&#160;31, 2014 under the Company&#8217;s stock incentive  plans were as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Options</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Price</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Remaining Contractual Term</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in years)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843,442</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.76</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.94</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200,079</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.91</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,908.00</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,043,494</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.35</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,655</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.42</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.13</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and expected to vest</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,031,382</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.37</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.92</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Grant Date Fair Value</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">419,000</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191,700</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.95</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and released</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610,700</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.57</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(6) Commitments and Contingencies </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has or is subject to the following commitments and contingencies: </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employment Agreements </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains employment agreements with several executive employees.  Most of these agreements provide for payments to be made under certain conditions related to a change in control of the Company and entitle the employee to wages and certain benefits payments not exceeding one calendar year from the date of termination without cause or by the employee for good reason.  The agreements may be terminated at any time by the Company with or without cause upon written notice to the employee. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Operating Lease </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;1, 2013 the Company entered into a lease agreement for approximately 5,300 square feet of office facilities in Westminster, Colorado which has served as the Company&#8217;s primary business office since October&#160;1, 2013.  The lease has a three year term and expires on September&#160;30, 2016.  The Company&#8217;s previous office lease, entered into on February 8, 2008 for office facilities in Broomfield, Colorado, served as the Company&#8217;s primary business office through September 30, 2013.&nbsp;&nbsp;Below is a summary of the future minimum lease payments committed for the Company&#8217;s facility in Westminster, Colorado as of March&#160;31, 2014 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;">
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Remainder of 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense under these leases for the three months ended March&#160;31, 2014 and 2013 was $19,000 and $12,000, respectively, and was $597,000 from Inception through March&#160;31, 2014. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Duke University </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2013, the Company entered into a clinical research agreement with Duke University (Duke) to serve as the clinical research organization for the Company&#8217;s GENETIC-AF clinical study.  Under the agreement the Company is responsible to pay Duke for its work managing certain aspects of the clinical study, including clinical site recruitment and clinical site management.  Upon completion of the clinical study, the agreement will terminate.  The agreement can be terminated earlier by the Company for any reason with 90 days written notice to Duke. In the event of an early termination, the Company and Duke would coordinate efforts for an orderly wind-down of the study, and the Company would be responsible to pay Duke for time and effort incurred through the date of termination and through the wind-down period. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">University of Cincinnati </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2011, the Company entered into a license agreement with the University of Cincinnati to license exclusive worldwide rights to a portfolio of U.S. and international patents, which includes certain U.S. and international diagnostic patents covering genetic markers for ARCA&#8217;s lead drug candidate, Gencaro.  These patents provide the basis for exclusive worldwide development, use and commercialization of the genetic test which may indicate a patient&#8217;s likely response to Gencaro as a treatment for chronic HF, AF, and other indications.  Under the terms of the agreement, ARCA agreed to pay the University of Cincinnati annual license fees and is obligated to future milestone payments for each United States patent issued subsequent to the date of the agreement.  The agreement also requires royalty payments on net sales from genetic testing performed expressly for the purpose of prescribing bucindolol. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARCA has licensed worldwide rights to Gencaro, including all preclinical and clinical data from Cardiovascular Pharmacology and Engineering Consultants, LLC, or CPEC, who has licensed rights in Gencaro from BMS. CPEC is a licensing subsidiary of Indevus Pharmaceuticals Inc. (a wholly owned subsidiary of Endo Pharmaceuticals), holding ownership rights to certain clinical trial data of Gencaro.  Under the terms of its license agreement with CPEC, the Company will incur milestone and royalty obligations upon the occurrence of certain events.   If the FDA grants marketing approval for Gencaro, the license agreement states that the Company will owe CPEC a milestone payment of $8.0&#160;million within six months after FDA approval. The license agreement states that a milestone payment of up to $5.0 million in the aggregate shall be paid upon regulatory marketing approval in Europe and Japan.  The license agreement also states that the Company&#8217;s royalty obligation ranges from 12.5% to 25% of revenue from the related product based on achievement of specified product sales levels, including a 5% royalty that CPEC is obligated to pay under its original license agreement for Gencaro. The Company has the right to buy down the royalties to a range of 12.5% to 17% by making a payment to CPEC within six months of regulatory approval. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity Financings and Warrants<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_EquityFinancingsAndWarrantsDisclosureTextBlock', window );">Equity Financings and Warrants</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(7) </font><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Equity Financings and Warrants</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">2013 Equity Financings </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Private Investment in Public Equity (PIPE) Transaction </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;22, 2013, the Company entered into a Subscription Agreement (the &#8220;January 2013 Purchase Agreement&#8221;) with various accredited investors and its Chief Executive Officer in connection with a private placement of its common stock and warrants.  Pursuant to the January 2013 Purchase Agreement, the Company sold an aggregate of 356,430 shares of its common stock and warrants to purchase up to 249,501 additional shares of its common stock for aggregate gross proceeds of approximately $1 million, before deducting estimated offering expenses payable by the Company. The net proceeds to the Company were approximately $805,000, and the private placement closed on January&#160;25, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.70 shares of common stock.  The purchase price for each unit was $2.81. The warrants were exercisable upon issuance, expire seven years from the date of issuance, and have an exercise price of $2.28 per share, equal to 100% of the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on January&#160;22, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company filed a registration statement for the resale of the shares underlying the units sold in the private placement.  That registration statement was declared effective by the Securities and Exchange Commission on February&#160;14, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with this transaction, the Company agreed that, subject to certain exceptions, it would not, while the warrants are outstanding, effect or enter into an agreement to effect any issuance of common stock or securities convertible into, exercisable for or exchangeable for common stock in a &#8220;variable rate transaction,&#8221; which means a transaction in which the Company issues or sells any convertible securities either (A)&#160;at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of, or quotations for, the shares of common stock at any time after the initial issuance of such convertible securities, or (B)&#160;with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of the convertible securities or upon the occurrence of the specified or contingent events directly or indirectly related to our business or the market for our common stock.  In addition, the Company agreed that, subject to certain exceptions, if it issues securities within one year following the closing of the offering, each investor would have the right to purchase its pro rata share of a specified portion of the securities in the future offering on the same terms, conditions and price provided for in the proposed issuance of securities. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Registered Direct Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;31, 2013, the Company entered into a subscription agreement with certain institutional investors (the &#8220;Investors&#8221;) in connection with its Registered Direct public offering, pursuant to which the Company sold an aggregate of 164,636 shares of its common stock and warrants to purchase up to 65,855 additional shares of its common stock to the Investors for aggregate gross proceeds of approximately $730,000, before deducting placement agent fee and other estimated offering expenses payable by the Company.  The net proceeds to the Company were approximately $616,000, and the offering closed on February&#160;4, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in units consisting of one share of common stock and a warrant to purchase 0.40 shares of common stock.  The purchase price for each unit was $4.43.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $4.13 per share, equal to the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on January&#160;31, 2013.  The Offering was effected as a takedown of the Company&#8217;s Registration Statement on Form S-3, as amended, which became effective on April&#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&#160;1, 2013.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Public Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;4, 2013, the Company sold shares of its Series A Convertible Preferred Stock (Preferred Stock) and warrants to purchase common stock in a public offering for aggregate gross proceeds of $20.0 million. The Company issued 125,000 shares of Preferred Stock and warrants to purchase up to 6,250,000 shares of common stock at a purchase price of $160 per share of Preferred Stock.  The net proceeds, after deducting placement agent fees and other offering expenses payable by the Company, were approximately $17.9 million. ARCA&#8217;s Director and Chief Executive Officer participated in the offering, purchasing 781 shares of Preferred Stock and warrants to purchase 39,050 shares of common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each share of Preferred Stock was convertible into 100 shares of the Company&#8217;s common stock at any time at the option of the holder. Each share of Preferred Stock had a liquidation preference of $.001 per share.  The shares of Preferred Stock had no preferential dividends or redemption rights, and no voting rights except as required by law.  During 2013, all of the shares of the Preferred Stock were converted into shares of ARCA common stock. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each purchaser in the offering was issued a warrant to purchase 50 shares of the Company&#8217;s common stock for each share of Preferred Stock purchased.  The warrants have an exercise price of $1.60 per share, will expire on the five year anniversary of the date of issuance, and were exercisable immediately upon issuance, provided that the holder will be prohibited from exercising the warrants if, as a result of such exercise, the holder, together with its affiliates, would beneficially own more than 9.99% of the total number of shares of common stock then issued and outstanding. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The securities were sold pursuant to a placement agreement and have been registered under the Securities Act of 1933 pursuant to the Company&#8217;s Registration Statement on Form S-1, as amended (No.333-187508), which was declared effective by the Securities and Exchange Commission on May&#160;29, 2013, and the Preferred Stock and Warrants were offered and sold pursuant to a prospectus dated May&#160;30, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Preferred Stock financing, the Company recorded a non-cash dividend of approximately $2.0 million to recognize the intrinsic value of the embedded beneficial conversion feature.  Typically, such a deemed dividend would be represented as a reduction in a company&#8217;s retained earnings and an increase in additional paid in capital in recognition of the reapportionment of common shareholder value to the preferred stock purchasers.  However, since ARCA has an accumulated deficit, the deemed dividend is recognized by a reapportionment of additional paid in capital from common shareholders to additional paid in capital of preferred stock purchasers, which are combined in the Company&#8217;s statement of stockholders&#8217; equity. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">2014 Equity Financing </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Registered Direct Offering </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;3, 2014, the Company agreed to sell to certain investors an aggregate of 5,116,228 shares of the Company&#8217;s common stock and warrants to purchase an aggregate of 1,279,057 shares of the Company&#8217;s common stock at a purchase price of $1.70 per share of Common Stock, for aggregate gross proceeds of approximately of $8.7 million, before deducting placement agent fees and other offering related expenses.  The offering closed on February&#160;7, 2014, and the net proceeds to the Company were approximately $7.9 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The common stock and warrants were sold in combination consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock.  The warrants were exercisable upon issuance, expire five years from the date of issuance, and have an exercise price of $2.125 per share, equal to 125% of the closing bid price of ARCA&#8217;s common stock on the Nasdaq Capital Market on February&#160;3, 2014.  The offering was effected as a takedown off the Company&#8217;s Registration Statement on Form S-3, as amended, which became effective on April&#160;4, 2011, pursuant to a prospectus supplement filed with the Securities and Exchange Commission on February&#160;4, 2014.  The warrants provide for cashless exercise and settlement in unregistered shares if there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the shares of common stock underlying the warrants at the time of exercise. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Warrants </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March&#160;31, 2014, warrants to purchase approximately 9.4&#160;million shares of common stock were outstanding at exercise prices ranging from $1.60 to $116.89, with a weighted average exercise price per share of $2.31.  These warrants, which were granted as part of various financing and business agreements, expire at various times between April 2016 and January 2020. Warrants were recorded in additional paid-in capital at their estimated fair market value at the date of grant using a Black-Scholes option-pricing model. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_EquityFinancingsAndWarrantsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity financings and warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_EquityFinancingsAndWarrantsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(9) Income Taxes </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with United States Generally Accepted Accounting Principles, a valuation allowance should be provided if it is more likely than not that some or all of the Company&#8217;s deferred tax assets will not be realized.  The Company&#8217;s ability to realize the benefit of its deferred tax assets will depend on the generation of future taxable income. Due to the uncertainty of future profitable operations and taxable income, the Company has recorded a full valuation allowance against its net deferred tax assets.  The Company believes its tax filing positions and deductions related to tax periods subject to examination will be sustained upon audit and, therefore, has no reserve for uncertain tax positions. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3LAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-based Compensation (Details 2) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units outstanding at December 31, 2013</a></td>
        <td class="nump">419,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="nump">191,700<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and released</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited and cancelled</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units outstanding at March 31, 2014</a></td>
        <td class="nump">610,700<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units outstanding at December 31, 2013</a></td>
        <td class="nump">$ 1.39<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
        <td class="nump">$ 1.95<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and released</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited and cancelled</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units outstanding at March 31, 2014</a></td>
        <td class="nump">$ 1.57<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E5F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Non-Cash, Share-Based Compensation Expense</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three month period ended March&#160;31, 2014 and 2013 and for the period from Inception through March&#160;31, 2014, the Company recognized the following non-cash, share-based compensation expense in the consolidated statement of operations (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Period from December 17, 2001 (date of inception) to March 31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">707</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, General and Administrative</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,935</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring Expense</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,029</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Stock Option Activities</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option and stock award transactions for the three month period ended March&#160;31, 2014 under the Company&#8217;s stock incentive  plans were as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Options</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Price</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Remaining Contractual Term</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in years)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843,442</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.76</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.94</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200,079</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.91</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,908.00</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,043,494</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.35</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,655</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.42</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.13</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and expected to vest</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,031,382</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.37</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.92</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of RSU activity</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;;">&nbsp;</p>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Grant Date Fair Value</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">419,000</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191,700</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.95</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and released</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units outstanding at March 31, 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610,700</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.57</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIKAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Disclosures (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_FairValueDisclosuresTextualAbstract', window );"><strong>Fair Value Disclosures (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount', window );">Transfers of assets between fair value hierarchy levels</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Money Market Funds</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_FairValueDisclosuresTextualAbstract', window );"><strong>Fair Value Disclosures (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents consisting of money market funds</a></td>
        <td class="nump">$ 21,100,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_FairValueDisclosuresTextualAbstract', window );"><strong>Fair Value Disclosures (Textual) [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod', window );">Cash equivalents consisting of money market funds, maturity period</a></td>
        <td class="text">90 days<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash equivalents consisting of money market funds maturity period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_CashEquivalentsConsistingOfMoneyMarketFundsMaturityPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value assets between hierarchy levels transfers amount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_FairValueAssetsBetweenHierarchyLevelsTransfersAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_FairValueDisclosuresTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_FairValueDisclosuresTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ERNAS">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit) (USD $)<br>In Thousands, except Share data</strong></div>
        </th>
        <th class="th">
          <div>Total

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A Convertible Preferred Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Common Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Deficit Accumulated During Development Stage

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on January 3, 2005

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on January 3, 2005

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on January 3, 2005

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on October 14, 2005

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on October 14, 2005

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on October 14, 2005

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on October 14, 2005

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on October 14, 2005

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Notes Payable and Related Accrued Interest on October 14, 2005

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 21, 2006

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 21, 2006

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 21, 2006

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 22, 2006

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 22, 2006

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on February 22, 2006

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 23, 2006

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 23, 2006

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 23, 2006

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on November 7, 2006

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Accretion of Series A

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Accretion of Series A

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Accretion of Series B

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Accretion of Series B

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on January 18, 2007

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on January 18, 2007

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on January 18, 2007

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 30, 2007

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 30, 2007

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance for Intellectual Property License Rights on June 30, 2007

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Issuance of Common Stock for Commercial License Rights, on July 19, 2007

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Issuance of Shares to Executive Subject to Repurchase

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Common Conversion

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Common Conversion

</div>
          <div>Common Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Common Conversion

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Notes and Related Accrued Interest

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Cash, Net of Offering Costs

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Cash, Net of Offering Costs

</div>
          <div>Series A Convertible Preferred Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Cash, Net of Offering Costs

</div>
          <div>Common Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Cash, Net of Offering Costs

</div>
          <div>Additional Paid-in Capital

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Cash, Net of Offering Costs

</div>
          <div>Deficit Accumulated During Development Stage

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Series A offering costs

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Issuance of Series A on February 22, 2006

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Third Issuance For Notes Payable And Related Accrued Interest

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Redeemable Convertible Preferred Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Accretion of Series A

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Common Conversion

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series A

</div>
          <div>Cash, Net of Offering Costs

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>Third Issuance Of Series B Convertible Redeemable Preferred Stock

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>Issuance for Series B on December 28, 2007

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>Accretion of Series B

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>Common Conversion

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Series B

</div>
          <div>Cash, Net of Offering Costs

</div>
          <div>USD ($)</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance, value at Dec. 17, 2001</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, shares at Dec. 17, 2001</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,588<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(116)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(116)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2003</a></td>
        <td class="num">(115)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="num">(116)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2003</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,588<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,720<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(511)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(511)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2004</a></td>
        <td class="num">(619)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="num">(627)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2004</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">22,308<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">44<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44<span></span></td>
        <td class="nump">1,354<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,354<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,922<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,978<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">903<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,095<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(1,459)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,459)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2005</a></td>
        <td class="num">(678)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,408<span></span></td>
        <td class="num">(2,086)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2005</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">60,206<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">75<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">75<span></span></td>
        <td class="nump">60<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">60<span></span></td>
        <td class="nump">15<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,316<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,372<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,907<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,505<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">38<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,727,354<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,074,086<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">39<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">39<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,241)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,241)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccretionOfOfferingCostEffectOnEquity', window );">Offering Costs</a></td>
        <td class="num">(17)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(17)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17<span></span></td>
        <td class="num">(98)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue', window );">Issuance of preferred stock upon conversion of note payable and accrued interest, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">684<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares', window );">Issuance of preferred stock upon conversion of note payable and accrued interest, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">420,817<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,019<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2006</a></td>
        <td class="num">(5,744)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,583<span></span></td>
        <td class="num">(7,327)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,919<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2006</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">102,047<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,222,257<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,000<span></span></td>
        <td class="nump">9,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,303<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">642<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,783<span></span></td>
        <td class="nump">13,915<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,688,902<span></span></td>
        <td class="nump">2,766,677<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(13,994)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(13,994)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccretionOfOfferingCostEffectOnEquity', window );">Offering Costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(19)<span></span></td>
        <td class="num">(19)<span></span></td>
        <td class="num">(18)<span></span></td>
        <td class="num">(18)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(147)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">18<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">16<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,227<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2007</a></td>
        <td class="num">(19,689)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,632<span></span></td>
        <td class="num">(21,321)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,938<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,871<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2007</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">122,917<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,222,257<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,455,579<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">545<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">545<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(19,431)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(19,431)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccretionOfOfferingCostEffectOnEquity', window );">Offering Costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(20)<span></span></td>
        <td class="num">(20)<span></span></td>
        <td class="num">(36)<span></span></td>
        <td class="num">(36)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">36<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">54<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">54<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">36,154<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Estimated fair value of warrants issued in connection with convertible notes payable</a></td>
        <td class="nump">399<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">399<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2008</a></td>
        <td class="num">(38,178)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,574<span></span></td>
        <td class="num">(40,752)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,958<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,907<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2008</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">159,071<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,222,257<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,455,579<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AdjustmentForFractionalShares', window );">Adjustment for fractional shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(102)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(7)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision</a></td>
        <td class="num">(781)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(781)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">781<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">33,781<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">33,780<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(15,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(18,781)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">145,465<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Merger with Nuvelo, Inc., value</a></td>
        <td class="nump">11,913<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,913<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Merger with Nuvelo, Inc., shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">447,826<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value</a></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">177<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">845<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(9,138)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9,138)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AccretionOfOfferingCostEffectOnEquity', window );">Offering Costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(42)<span></span></td>
        <td class="num">(42)<span></span></td>
        <td class="num">(93)<span></span></td>
        <td class="num">(93)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">42<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">93<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">114<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">114<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,521<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ConversionOfPreferredStockToCommonStockShares', window );">Conversion of preferred stock, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">507,123<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9,222,257)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6,455,579)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction', window );">Restricted stock release from restriction</a></td>
        <td class="nump">75<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">75<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest', window );">Conversion of convertible notes and related accrued interest</a></td>
        <td class="nump">8,501<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,501<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock', window );">Conversion of warrants for preferred stock</a></td>
        <td class="nump">36<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">36<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued', window );">Estimated fair value of warrants issued in connection with lease termination</a></td>
        <td class="nump">377<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">377<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2009</a></td>
        <td class="nump">7,412<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">57,301<span></span></td>
        <td class="num">(49,890)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2009</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,270,074<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,182<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,182<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">194,100<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">458<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">458<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(8,420)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(8,420)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">139<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">139<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,248<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2010</a></td>
        <td class="nump">6,771<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">65,080<span></span></td>
        <td class="num">(58,310)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,472,422<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,017<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">4,016<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">557,890<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">308<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">308<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,364)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,364)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">188<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2011</a></td>
        <td class="nump">5,732<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">69,404<span></span></td>
        <td class="num">(63,674)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,030,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="nump">1,189<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1,188<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">629,815<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">306<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">306<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(4,320)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,320)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2012</a></td>
        <td class="nump">2,907<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">70,898<span></span></td>
        <td class="num">(67,994)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,660,315<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_AdjustmentForFractionalShares', window );">Adjustment for fractional shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(64)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(20)<span></span></td>
        <td class="nump">13<span></span></td>
        <td class="num">(33)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,421<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,421<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">521,066<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">283<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">283<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(6,939)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6,939)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ConversionOfPreferredStockToCommonStockShares', window );">Conversion of preferred stock, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(125,000)<span></span></td>
        <td class="nump">12,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue', window );">Issuance of common stock upon exercise of warrants for cash, value</a></td>
        <td class="nump">12<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares', window );">Issuance of common stock upon exercise of warrants for cash, share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,245<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PreferredStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A convertible preferred stock, net of offering costs, Shares</a></td>
        <td class="nump">17,917<span></span></td>
        <td class="nump">125,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,917<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_PreferredStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A convertible preferred stock, net of offering costs, Value</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_DeemedDividendBeneficialConversionPreferredStock', window );">Deemed preferred stock dividend for beneficial conversion feature</a></td>
        <td class="nump">2,026<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,026<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Impact of deemed preferred stock dividend for beneficial conversion feature on common stockholders</a></td>
        <td class="num">(2,026)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,026)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Dec. 31, 2013</a></td>
        <td class="nump">15,581<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16<span></span></td>
        <td class="nump">90,498<span></span></td>
        <td class="num">(74,933)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2013</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,685,562<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of equity for cash or intellectual property rights, value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,866<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5<span></span></td>
        <td class="nump">7,861<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of equity for cash or intellectual property rights, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,116,228<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
        <td class="nump">158<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">158<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(2,389)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,389)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, value</a></td>
        <td class="nump">318<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">318<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, for cash, shares</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">199,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, value at Mar. 31, 2014</a></td>
        <td class="nump">$ 21,534<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 21<span></span></td>
        <td class="nump">$ 98,835<span></span></td>
        <td class="num">$ (77,322)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, shares at Mar. 31, 2014</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">21,001,690<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AccretionOfOfferingCostEffectOnEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accretion of offering cost effect on equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AccretionOfOfferingCostEffectOnEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AdjustmentForFractionalShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustment for fractional shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AdjustmentForFractionalShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount recorded to additional Paid in Capital account as a result of the conversion of warrants for preferred stock to outstanding common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustment to additional paid in capital estimated fair value of warrants issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The adjustment to additional paid in capital to record the release of restriction agreements on stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ConversionOfPreferredStockToCommonStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion of Preferred Stock to Common Stock Shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ConversionOfPreferredStockToCommonStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_DeemedDividendBeneficialConversionPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Deemed Dividend Beneficial Conversion Preferred Stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_DeemedDividendBeneficialConversionPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance Common Stock Upon Exercise Of Warrants For Cash, Shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_IssuanceCommonStockUponExerciseOfWarrantsForCashShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance Common Stock Upon Exercise Of Warrants For Cash ,Value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_IssuanceCommonStockUponExerciseOfWarrantsForCashValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PreferredStockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Preferred stock issued during period value new issues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PreferredStockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_PreferredStockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Preferred stock issued during period value, new issues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_PreferredStockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock issued during period upon conversion of notes payable shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_StockIssuedDuringPeriodUponConversionOfNotesPayableShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock issued during period upon conversion of notes payable value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_StockIssuedDuringPeriodUponConversionOfNotesPayableValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock Issued During Period Value Conversion of Convertible Notes and Related Accrued Interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndRelatedAccruedInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11149-113907<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11178-113907<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Warrant<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 405<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DividendsPreferredStockStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockDividendsAndOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period pursuant to acquisitions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 25<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418455&amp;loc=d3e16649-113920<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued pursuant to acquisitions during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 25<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418455&amp;loc=d3e16649-113920<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Merger with Nuvelo, Inc. on January 27, 2009<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Merger with Nuvelo, Inc. on January 27, 2009</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(3) Merger with Nuvelo, Inc. on January&#160;27, 2009 </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;27, 2009, ARCA Colorado, Inc. (ARCA Colorado) completed the Merger with Nuvelo in accordance with the terms of the Merger Agreement, in which a wholly-owned subsidiary of Nuvelo merged with and into ARCA Colorado, with ARCA Colorado continuing after the Merger as the surviving corporation and a wholly-owned subsidiary of Nuvelo.  Immediately following the Merger, the Company changed its name from Nuvelo, Inc. to ARCA biopharma, Inc., and its common stock began trading on the Nasdaq Global Market under the symbol &#8220;ABIO&#8221; on January&#160;28, 2009.  On March&#160;7, 2011, the listing of the Company&#8217;s common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger was treated as a reverse merger and accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.  For accounting purposes, ARCA Colorado was considered to have acquired Nuvelo in the Merger, as the stockholders of ARCA Colorado prior to the Merger had a controlling interest in the combined company and the Company&#8217;s management is the former management of ARCA Colorado.  The results of operations and cash flows include the activities of Nuvelo since the date of the Merger. Pursuant to the rules and regulations of the United States Securities and Exchange Commission, or the SEC, the historical financial statements of ARCA Colorado replaced the historical financial statements of Nuvelo, and the disclosures in this report relating to the pre-Merger business of the Company, unless noted as being the business of Nuvelo prior to the Merger, pertain to the business of ARCA Colorado prior to the Merger. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated total acquisition consideration of $11.9 million to acquire Nuvelo was based on the market capitalization of Nuvelo as of January&#160;27, 2009 and the estimated fair values of its vested stock options and warrants outstanding on that date, as this was deemed the most reliable measure of the consideration effectively transferred to acquire Nuvelo on that date.  The Company estimated the net assets acquired in the Merger to be $37.2 million, including $45.5 million of cash, cash equivalents and marketable securities. In accordance with ASC 805, any excess of fair value of net assets acquired in a business combination over the acquisition consideration results in a gain on bargain purchase, and as a result, the Company recorded a gain on bargain purchase of $25.3 million. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1383-128463<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6996-128479<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4922-128472<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4934-128472<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4926-128472<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e7000-128479<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1392-128463<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1486-128463<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1497-128463<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1490-128463<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e7008-128479<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4845-128472<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1500-128463<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1524-128463<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIJAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">$ 514<span></span></td>
        <td class="nump">$ 514<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
        <td class="num">(488)<span></span></td>
        <td class="num">(485)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">26<span></span></td>
        <td class="nump">29<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computer Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Life</a></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">99<span></span></td>
        <td class="nump">99<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Lab Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Life</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">142<span></span></td>
        <td class="nump">142<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Furniture and Fixtures</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Life</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">89<span></span></td>
        <td class="nump">89<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computer Software</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Life</a></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">176<span></span></td>
        <td class="nump">176<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abio_ComponentsOfPropertyAndEquipmentAbstract', window );"><strong>Components of Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated Life</a></td>
        <td class="text">Lesser of useful life or life of the lease<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
        <td class="nump">$ 8<span></span></td>
        <td class="nump">$ 8<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abio_ComponentsOfPropertyAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>abio_ComponentsOfPropertyAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>abio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>266</ContextCount>
  <ElementCount>225</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>53</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfPreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - The Company and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>The Company and Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Merger with Nuvelo, Inc. on January 27, 2009</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009</Role>
      <ShortName>Merger with Nuvelo, Inc. on January 27, 2009</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Fair Value Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosures</Role>
      <ShortName>Fair Value Disclosures</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Equity Financings and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrants</Role>
      <ShortName>Equity Financings and Warrants</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Share- based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensation</Role>
      <ShortName>Share- based Compensation</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>The Company and Summary of Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - The Company and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureTheCompanyAndSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>The Company and Summary of Significant Accounting Policies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Net Loss Per Share (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureNetLossPerShareDetailsTextual</Role>
      <ShortName>Net Loss Per Share (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Merger with Nuvelo, Inc. on January 27, 2009 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureMergerWithNuveloIncOnJanuary272009Details</Role>
      <ShortName>Merger with Nuvelo, Inc. on January 27, 2009 (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Fair Value Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureFairValueDisclosuresDetails</Role>
      <ShortName>Fair Value Disclosures (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosurePropertyAndEquipmentDetailsTextual</Role>
      <ShortName>Property and Equipment (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsTextual</Role>
      <ShortName>Commitments and Contingencies (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Equity Financings and Warrants (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureEquityFinancingsAndWarrantsDetailsTextual</Role>
      <ShortName>Equity Financings and Warrants (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Share-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails</Role>
      <ShortName>Share-based Compensation (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Share-based Compensation (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails1</Role>
      <ShortName>Share-based Compensation (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Share-based Compensation (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nuvelo.com/20140331/taxonomy/role/DisclosureShareBasedCompensationDetails2</Role>
      <ShortName>Share-based Compensation (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_StockIssuedDuringPeriodValueIssuedForCash had a mix of decimals attribute values: -6 0.</Log>
    <Log type="Info">'Monetary' elements on report '100210 - Disclosure - The Company and Summary of Significant Accounting Policies (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100240 - Disclosure - Merger with Nuvelo, Inc. on January 27, 2009 (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Shares' elements on report '100300 - Disclosure - Equity Financings and Warrants (Details Textual)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 100010 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 17, 2001'</Log>
    <Log type="Info">Process Flow-Through: 100020 - Statement - Consolidated Balance Sheets (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</Log>
    <Log type="Info">	Process Flow-Through: Removing column '1 Months Ended
Jan. 27, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '24 Months Ended
Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '147 Months Ended
Mar. 31, 2014'</Log>
    <Log type="Info">Process Flow-Through: 100050 - Statement - Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2013'</Log>
    <Log type="Info">Process Flow-Through: 100060 - Statement - Consolidated Statements of Cash Flows</Log>
    <Log type="Info">	Process Flow-Through: Removing column '147 Months Ended
Mar. 31, 2014'</Log>
  </Logs>
  <InputFiles>
    <File>abio-20140331.xml</File>
    <File>abio-20140331.xsd</File>
    <File>abio-20140331_cal.xml</File>
    <File>abio-20140331_def.xml</File>
    <File>abio-20140331_lab.xml</File>
    <File>abio-20140331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future Minimum Lease Payments</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s previous office lease, entered into on February 8, 2008 for office facilities in Broomfield, Colorado, served as the Company&#8217;s primary business office through September 30, 2013.&nbsp;&nbsp;Below is a summary of the future minimum lease payments committed for the Company&#8217;s facility in Westminster, Colorado as of March&#160;31, 2014 (in thousands):</font></p></div><div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;">
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Remainder of 2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
